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ABSTRACT 
Retinitis pigmentosa (RP, MIM#268000) is a heterogeneous disease characterised by loss of 
rod photoreceptors and pigment deposits in the retina. Historically, genes linked to RP were 
associated with rod-specific functions. Recently, a novel class of ubiquitously expressed 
causative genes has emerged including splicing factor genes and TOPORS (NM_005802). To 
date, studies show TOPORS is expressed in all tested human tissues, including the retina. 
However, mutations in this ubiquitously expressed gene only cause RP without any systemic 
symptoms.  
The purpose of this work was to understand why mutations in TOPORS, which encodes 
a multifunctional protein, cause a retina-only disease by identifying protein interacting 
partner(s) of TOPORS, using a yeast-two hybrid (Y2H) screen. In case the interacting partner(s) 
turn out to be retina specific, it may explain the retina-only phenotype. 
Human retinal cDNA library was constructed from total retinal cDNA directly in the Y187 
Saccharomyces cerevisiae yeast strain. Retina-specificity of the cDNA library was validated by 
sequencing, leading to identification of several retina-specific genes, including rhodopsin (RHO; 
NM_000539). The library was screened for protein interacting partners of TOPORS, using 
MatchmakerTM Gold Yeast Two-Hybrid System (Clontech, CA, USA).  
Over 107 cDNA clones were screened, leading to isolation of 53 potential interactions. 
The identified interacting partners were prioritised for further evaluation, based on literature 
and database searches, and re-tested in yeast leading to identification of three candidates for 
further functional studies: a soluble fragment of integral membrane protein 2B (ITM2B; 
NM_0219999), previously linked to neurodegenerative disorders, and more recently 
associated with an inherited retinal dystrophy; a brain prostaglandin D2 synthase (PTGDS; 
NM_000954), highly expressed in the retina, previously suggested to play a role in retinal 
homeostasis; a regulatory subunit 4 of the 26 S protease (PSMC1; NM_002802), conferring 
substrate specificity to the proteasome complex during degradation of ubiquitinated proteins. 
The outcomes suggest several scenarios for why mutations in TOPORS result only in RP; 
however, further studies are essential to elucidate the role of TOPORS and its interacting 
partners in the aetiology of this debilitating disease. 
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CONTEXT 
"In the study of this membrane [the retina] I for the first time felt my faith in Darwinism 
(hypothesis of natural selection) weakened, being amazed and confounded by the supreme 
constructive ingenuity revealed not only in the retina and in the dioptric apparatus of 
the vertebrates but even in the meanest insect eye." 
- Santiago Ramón y Cajal 
 
 
1 
 
  
                                                          
 
1 Image modified from Wade (2007). 
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ABBREVIATIONS 
Ψ Hydrophobic amino acid 
A AbA aka Aureobasidin A 
aa  Amino acid(s) 
AAA-ATPase ATPase Associated with diverse cellular Activities 
Ab(s) Antibody (-ies) 
Aβ Beta amyloid 
AbA Aureobasidin A 
ABCR  ATP-binding cassette transporter, retina specific 
ABri FBD ITM2B C-terminal amyloid peptide 
AD  Activation domain 
ad autosomal dominant 
ADAM10  A Disintegrin and metalloproteinase domain-containing protein 10 
ADan FDD ITM2B C-terminal amyloid peptide 
adPRD autosomal dominant pericentral retinal dystrophy 
adRD autosomal dominant retinal dystrophy 
adRP  Autosomal dominant retinitis pigmentosa 
aka  also known as 
APP Amyloid Precursor Protein 
arRP  Autosomal recessive retinitis pigmentosa 
Asn Asparagine 
ATP  Adenosine triphosphate 
att  attachment site (on Gateway cloning vectors) 
b/bp  Base/base pair 
BBS  Bardet-Biedl Syndrome 
BD  Binding domain 
BH3 Bcl 2 homology 3 (domain) 
BSA Bovine Serum Albumin 
C  C-terminal TOPORS fragment 
CC  Connecting cilium 
cDNA  Complementary deoxyribonucleic acid 
cGMP  cyclic guanosine monophosphate 
CIAP  Calf Intestinal Alkaline Phosphatase 
CNS Central Nervous System 
coIP co-immuno-precipitation 
CP Core catalytic particle of the proteasome (20 S) 
CRABP Cellular retinoic acid-binding protein 
CRALBP  Cellular retinal-binding protein 
CRBP Cellular retinol-binding protein 
CSF cerebrospinal fluid 
CTPP C-terminal pro-peptide (of ITM2B) 
CTS  Ciliary Targeting Sequence 
Cys Cysteine 
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Da  Daltons 
DAPI 4', 6-diamidino-2-phenylindole 
ddNTP  Dideoxynucleotide 
DDO  Double Dropout 
dH2O Distilled water 
DIC differential interference contrast 
DMEM  Dulbecco's modified Eagle's medium 
DNA Deoxyribonucleic acid 
dNTP  Deoxynucleotide 
EST Expressed Sequence Tag 
F forward primer 
FBD  Familial British Dementia 
FCS Foetal Calf Serum 
FDD  Familial Danish Dementia 
FL full-length 
Gal galactose 
GalNAc acetyl galactoseamine 
GCL  Ganglion cell layer 
gDNA  Genomic DNA 
GDP  Guanosine diphosphate 
Glc glucose 
GlcNAc acetyl glucosamine 
Gly Glycine 
GTP  Guanosine triphosphate 
h hours 
HEK293  Human embryonic kidney cell line 
HeLa Human adenocarcinoma cell line 
Hex hexose 
HexNAc acetyl hexosamine 
His Histidine 
hTop1 Human topoisomerase I 
ICD intracellular domain (of ITM2B) 
INL  Inner nuclear layer 
IP Immuno-precipitation 
IPL  Inner plexiform layer 
IPM  Inter-photoreceptor matrix 
IRBP  Interphotoreceptor retinoid-binding protein 
IS  Inner segment 
ITM2B  Integral Membrane Protein 2B 
ITM2BL Integral Membrane Protein 2B long 
ITM2BS Integral Membrane Protein 2B short 
JS  Joubert syndrome 
KD knock-down 
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LRAT  Lecithin:retinol acyl transferase 
Lys Lysine 
Lys/His  Lysine-Histidine-rich motif 
M  Mid-TOPORS fragment 
M Ab Antibody raised in mouse 
Man mannose   
Mata  Mating type a 
Matα  Mating type alpha 
MDCK  Madin Darby canine kidney cell line 
mRNA  Messenger ribonucleic acid 
N  N-terminal TOPORS fragment 
NAD+/H  Nicotinamide adenine dinucleotide 
NADP+/H  Nicotinamide adenine dinucleotide phosphate 
NDS Normal Donkey Serum 
NEDD8 Neural precursor cell Expressed Developmentally Down-regulated protein 8 
Neu5Ac neuraminic acid aka sialic acid 
NGS Normal Goat Serum 
NLS  Nuclear localisation signal 
nt nucleotide 
NTF N-terminal fragment (of ITM2B) 
OCT Optimal Cutting Temperature 
OD  Optical density 
O-dT Oligo-dT-primed (cDNA library) 
ONL  Outer nuclear layer 
OPL  Outer plexiform layer 
OS  Outer segment 
PAGE  Polyacrylamide gel electrophoresis 
PBS Phosphate-buffered saline 
PCM1 Pericentriolar material 1 
PCR  Polymerase chain reaction 
PD Parkinson’s disease 
PEST  Proline, Glutamate, Serine, and Threonine-rich domain 
PFA  Paraformaldehyde 
PG Prostaglandin 
PLK4 polo-like kinase 4, centriolar-centrosomal 
PNA Peanut agglutinin 
PPI  Protein-Protein Interaction 
PMSF  Phenylmethylsulfonyl fluoride 
PRPF  Pre-mRNA processing factor 
P/S Penicillin/Streptomycin 
PSMC1  Regulatory subunit 4 of the 26 S protease 
PTGDS  Prostaglandin D2 synthase aka Prostaglandin-H2 D-isomerase 
QDO  Quadruple Dropout 
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R Reverse primer 
RARRES3/RIG1 Retinoic acid receptor responder protein 3 aka Retinoic acid-inducable gene 1 
Rb Ab Antibody raised in rabbit 
RBP Retinol-binding protein 
R&O-dT Random- & Oligo-dT-primed (cDNA library) 
RegP  Regulatory particle of the proteasome (19 S) 
RDH  Retinol dehydrogenase 
RHO  Rhodopsin 
RK  Rhodopsin kinase 
RNA  Ribonucleic acid 
RP  Retinitis pigmentosa 
RPE  Retinal pigment epithelium 
RPE1 Human hTERT-immortalised retinal pigment epithelial (hTERT-RPE1) cell line 
RPGR  Retinitis Pigmentosa GTPase regulator 
rpm  Revolutions per minute 
RT-PCR  Reverse transcription polymerase chain reaction 
S Svedberg unit 
SAM  S-adenosine methionine 
SCD secreted C-term domain (of ITM2B) 
SD  Synthetic Dropout 
SDM  Site-Directed Mutagenesis 
SDO Single Dropout 
SDS  Sodium dodecyl sulphate 
Ser Serine 
SK-N-SH Human neuroblastoma cell line 
SLS  Senior–Løken syndrome 
SR  Serine-Arginine-rich domain 
SPPL signal peptide peptidase-like 
SUMO1 Small ubiquitin-related modifier 1 
SV40 T Ag  Large T antigen of the tumour-inducing Simian virus 40 
TBS Tris-buffered saline 
TF  Transcription factor 
Thr Threonine 
TM Transmembrane (domain) 
TOPORS  Topoisomerase I binding RS domain protein 
Tx100 Triton X-100 
Tyr Tyrosine 
U unit(s) 
UAS  Upstream activation sequence 
Ub ubiquitin 
UPS ubiquitin-proteasome system 
USH  Usher Syndrome 
UTR  Untranslated region 
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UV  Ultra violet 
WB Western Blot 
X X-α-Gal aka 5-bromo-4-chloro-3-indolyl α-D-galactopyranoside 
xlRP  X-linked retinitis pigmentosa 
X-α-Gal  5-bromo-4-chloro-3-indolyl α-D-galactopyranoside 
X-β-Gal  5-bromo-4-chloro-3-indolyl-β-D-galactoside 
Y2H  Yeast two-hybrid 
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1 INTRODUCTION 
For most diurnal vertebrates vision dominates over their other senses. It is required for finding 
and gathering food, or hunting, as well as for avoiding predators and other potential dangers. 
Humans are no exception: the responsibilities of daily life, both at home and at work, are often 
hard, if not impossible, to fulfil without being able to see.  
Despite the superiority of vision over other senses, and our strong dependence on it for 
completing everyday tasks, incurable eye disorders continue to exist. Retinitis pigmentosa (RP) 
is an example of such a disease (Hartong, Berson e Dryja, 2006); it results in degeneration of 
photoreceptor cells, which are highly specialised first order neurons, absolutely essential for 
eyesight to persist. A Scandinavian study demonstrated that RP is one of two leading causes of 
blindness in working age (20-64) adults (Buch et al., 2004). 
RP is a term referring to a broad group of retinal dystrophies, which can be caused by 
mutations in various genes, of which over fifty are known (Retnet, 1996-2010), yet many 
remain to be identified. TOPORS (MIM 609507; locus RP31) is one of the causative genes 
(Chakarova et al., 2007); its expression in human is not restricted to the retina, and it has no 
known retina-specific functions. Hence this thesis aims to evaluate the role of TOPORS protein 
in the retina by characterising its interactions with three proteins from the human retina, 
identified as its interacting partners via a yeast two-hybrid (Y2H) screen (Fields e Song, 1989). 
 
1.1 THE SENSE OF VISION 
Vision is the principal sense, which humans rely on to perceive external signals. It is conveyed 
by a highly specialised organ: the eye. Several types of eyes have evolved in the animal 
kingdom, which can be divided into two distinct categories: the camera eye and the compound 
eye.  
The camera eye (Figure 1-1), specifically a cup eye with a lens and pupil is found in vertebrates. 
Its less evolutionarily advanced variants exist in some invertebrates, such as worms or 
molluscs, which possess simple cup eyes without a lens, but sometimes with a pinhole, serving 
to restrict light entry as in case of the pupil.  
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Figure 1-1. Structure of the Eye.  
The eyeball is enclosed into three layers. The outermost fibrous layer consists of connective tissue, 
comprising the transparent cornea at the front of the eye, and tendon-like sclera, enclosing most of 
the eyeball in regions not exposed to the outside environment. This outermost layer of the eye has 
structural and protective functions. Below lays a layer of vasculature (the uvea), which comprises 
the choroid at the posterior eye regions underneath the sclera, as well as the iris and ciliary body at 
the anterior region of the eyeball. The vascular choroid nourishes the outer layers of the eye and its dark 
colouration prevents the scattering of light inside the eye. The ciliary body forms a ring of smooth 
muscle tissue around the lens and controls its shape. The iris is the coloured front part of the eye, which 
regulates the size of the pupil, and thus the amount of light that enters the eye. It consists of a smooth 
muscle tissue, shaped similarly to a flattened doughnut; it is continuous with the ciliary body. The retina 
forms the innermost, sensory layer of the eye. Several types of neurons are arranged into further sub-
layers within the retina; axons of the innermost ganglion cell layer (GCL) collectively form the optic 
nerve, accompanied by the neighbouring central artery and central vein of the retina (these vessels 
serve the inner retinal layers of ganglion and bipolar cells). The outer retina (the photoreceptor cells) is 
supported by the retinal pigmented epithelial (RPE) cells, and nourished by blood from the choroidal 
capillaries. The primate retina is additionally characterised by the presence of a fovea, a region greatly 
enriched in cone photoreceptors, responsible for acuity and colour vision. The lens, which refracts light 
waves, separates the anterior and posterior eye cavities. The anterior cavity is filled with a constantly 
circulating aqueous humour, whereas the second one is filled with a gelatinous vitreous humour, which 
remains unchanged since completion of eye development (reviewed in: Martini e Nath, 2006; Marieb e 
Hoehn, 2007; Barrett et al., 2010). Image from the Webvision electronic book (Kolb et al., 1995). 
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The compound eye is common in arthropods, for example, insects, such as the fruit fly 
Drosophila melanogaster. This category can be further subdivided into apposition and 
superposition eyes. In apposition eyes each ommatidium detects a different signal; these 
signals are then combined into an image in the brain. The photons detected by ommatidia of 
superposition eyes all reach a shared retina before conducting the signal to the brain. 
Despite these clear architectural differences, the key component of every type of eye is 
the photoreceptor cell, without which eyesight would have never developed. 
In the camera eye, which evolved in vertebrates, the photoreceptor cells are located at 
the back of the eye in the retina (Figure 1-1). In order to reach the retina, specifically 
a photoreceptor cell, a photon of light enters the eye though the pupil, it is then focused by 
the lens (both structures are found within the anterior part of the eyeball), and it subsequently 
reaches the retina in the posterior fragment of the eye. 
 
1.2 THE RETINA: ANATOMY AND PHYSIOLOGY 
The retina forms the innermost of the three layers of the eye. It is a sensory tissue, consisting 
primarily of nerve cells, supported by glial cells, which are collectively referred to as the neural 
retina (Figure 1-1). It is itself sub-divided into several distinct layers and it comprises 
the outermost projection of the central nervous system (CNS).  
Just below the choroid lays the non-neural portion of the retina, the retinal pigment 
epithelium (RPE), a monolayer of epithelial cells, indispensable for correct functioning of 
the photoreceptor rod and cone cells. The photoreceptors are highly specialised nerve cells, 
which form the outermost layer of the neural retina, nourished and supported by the RPE 
(Figure 1-2).  
The retina converts the light energy captured by the photoreceptors into graded electrical 
activity, and, subsequently, into action potentials along the optic nerve, formed from axons of 
ganglion cells. The structure of the retina is astonishingly well adapted to its function; 
however, this is also the reason why it is especially vulnerable to dysfunction (reviewed in: 
Martini e Nath, 2006; Marieb e Hoehn, 2007; Barrett et al., 2010). 
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Figure 1-2. Structure of the Retina.  
Left: Histological appearance of healthy human retina. Right: Diagram of the types of neurons found 
within specific layers of the retina.  In order to reach the photoreceptor cells, light that enters the eye 
must first travel through the inner and outer retinal layers. Namely, first the light waves pass in between 
axons of the ganglion cells and the ganglion cell layer (GCL), which consists of the cell bodies of these 
neurons. The light then passes the inner plexiform layer (IPL), where the dendrites of the ganglions 
receive signal from the axons of bipolar and amacrine cells. The IPL is followed by the inner nuclear layer 
(INL), which comprises the nuclei, and thus the cell bodies, of the bipolar, horizontal and amacrine cells. 
The outer plexiform layer (OPL), located behind the INL, constitutes dendrites of the bipolar and 
horizontal cells as well as axons of the photoreceptor cells. The nuclei of the rod and cone 
photoreceptors are found within the next layer, known as the outer nuclear layer (ONL). Finally, the light 
reaches and activates the visual opsins in the photoreceptor outer segments (OS), supported by cells of 
the RPE. Image modified from Hartong et al. (2006). 
 
1.2.1 PHOTORECEPTORS OF THE RETINA 
Photoreceptor cells are neurons modified to transduce light into graded electrical energy. Rods 
and cones (Figure 1-3), which comprise the two major classes of these nerve cells, have their 
nuclei, and thus the cell bodies, located within the outer nuclear layer (ONL), whereas 
their axons extend into the outer plexiform layer (OPL), where their synapses make 
connections with dendrites of the bipolar as well as the horizontal cells (Figure 1-2). 
Whereas the bipolar and ganglion cells are served by the central artery and the central vein of 
the retina, which runs through the centre of the optic nerve, the photoreceptor layer is 
supplied by blood from vessels found in the choroid. 
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Rods are the predominant photoreceptors found in the human retina, where they reach 
numbers of 120 million. The rod cells generate responses to dim light (scotopic vision) and are 
involved in peripheral vision. The cone photoreceptors function most efficiently in bright light 
(photopic vision), and are required for high acuity and colour vision. They are about 20-fold 
less numerous than rods, reaching numbers of six to seven million (reviewed in: Masland, 
2001; Sung e Chuang, 2010). 
Due to the fact that rods are involved in peripheral vision, their density is greatest in the lateral 
peripheral side of the retina and it decreases towards the macula lutea, i. e. the ‘yellow spot’. 
The latter is an oval spot at the posterior pole of the eye, which contains predominantly cones. 
It is a region located laterally to the blind spot and includes the fovea centralis, a pit 
approximately 600 µm in diameter, which, in humans, comprises cones only. 
Before light excites the photoreceptors, it must first pass through the cornea, aqueous 
humour, lens, vitreous humour and most of the neural layers of the retina. Consequently, in 
order to enhance the acuity of vision, retinal structures, such as axons and cell bodies are 
mainly displaced at the macula lutea to allow direct passage of light to the sensory area rich in 
cones. Furthermore, each cone (or a maximum of a few) is connected to one bipolar cell, 
which then transmits the signal onto one ganglion cell, enhancing the signal acuity further. On 
the contrary, as many as a hundred rods can ultimately feed into one ganglion cell, resulting in 
a less precise signal (refer to section 1.2.3 for an overview of phototransduction). 
The photoreceptor cells (Figure 1-3) are highly specialised neurons, which comprise a cell 
body, continuous with inner and outer segments adjacent to the RPE, and, at the opposite end, 
with a synapse involved in transmitting the signal to the bipolar cells. In both types of 
photoreceptors the inner segment is continuous with the cell body, whereas the outer 
segment is joined to the inner segment via a connecting cilium; the connecting cilium and 
the outer segment jointly form a modified primary cilium (section 1.9).  
The connecting cilium is a bridge-like structure connecting the inner and outer segment, which 
allows movement of cargo via the kinesin II-powered anterograde transport, and, 
subsequently, through the dynein 2 (DHC1b/2)-maintained retrograde transport (Sung e 
Chuang, 2010).  
The shape of the outer segment, embedded within the RPE, is conical in cones and cylindrical 
or rod-shaped in rods. The human cone outer segments are normally between 40 µm and 
50 µm long, and their diameter can be within the range of 0.5 – 4.0 µm, depending on how 
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tightly they are packed (reviewed in: Marieb e Hoehn, 2007), whereas the rod outer segment 
can have a diameter within the range of 1.4 –10 μm, and can reach the length of 30 – 60 µm 
(reviewed in: Sung e Chuang, 2010). 
The key elements of the outer segments are the discs of cellular membrane, containing 
the photo-pigments, which are embedded within them. In cones the ‘discs’ are continuous 
with the plasma membrane of the cell, and (in human) can contain one of three types of 
opsins:  
 Long wavelength-detecting opsin: red; 
 Middle wavelength-detecting opsin: green; 
 Short wavelength-detecting opsin: blue. 
In rods the discs are discontinuous separate fragments of membrane, stacked onto each other 
within the outer segment. They contain only one type of opsin, rhodopsin, therefore, cannot 
generate colour vision. 
These four opsins are G-protein coupled receptors, which covalently bind  retinaldehyde 
chromophores derived from vitamin A. Light-sensitive rhodopsin binds, specifically, 11-cis 
retinal, which becomes isomerised to all-trans retinal, when a photon hits rhodopsin, initiating 
phototransduction (section 1.2.3). This occurs due to a conformational change in the photo-
pigment (section 1.2.3). 
The photo-pigment-containing discs are regenerated daily. The discs’ precursors are 
synthesised in the inner segment and they are assembled at the proximal end of the outer 
segment; as a result the old discs become pushed towards the RPE, where they are 
phagocytised (shown in Figure 1-3). In rods the regeneration occurs at the end of each night, 
whereas in cones it happens at the end of each day (reviewed in: Martini e Nath, 2006; Marieb 
e Hoehn, 2007; Barrett et al., 2010). 
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Figure 1-3. Structure of the photoreceptor cells.  
Rods and cones are nerve cells modified to convert light impulses into electrical graded potentials. 
The two cell types have an analogous structure with the exception of the outer segments (OS), their 
strategic elements. The OS of a rod is cylindrical in shape and its membrane discs are individual 
structures, not continuous with the plasma membrane. On the contrary, the membranous structures 
of cone OS, within which opsin molecules reside, are continuous with the plasma membrane; they do 
not form individual ‘discs.’ As the OS of both photoreceptor (PR) types get turned over, they become 
phagocytised by the retinal pigment epithelium (RPE; depicted with fragments of discs and pigment 
vesicles inside the cell); at their proximal ends they are joined to the inner segments (IS) via connecting 
cilia (CC). The OS and CC together form a highly specialised primary cilium (section 1.9). The IS of rods 
and cones contain the ‘house-keeping’ organelles; at their distal regions they are especially rich in 
the energy-generating mitochondria. The IS are continuous with the cell bodies, where the nuclei are 
found. The synaptic endings of rods and cones contain vesicles enclosing the inhibitory neurotransmitter 
glutamate, which is constantly released when the PRs receive no light stimulation. When a photon of 
light reaches a PR cell and hits an opsin molecule (e.g. rhodopsin: magnified fragment of the rod disc 
membrane), its conformation changes, triggering a cascade of intracellular reactions, leading to 
inhibition of glutamate release, and, consequently, phototransduction initiation (section 1.2.3). 
Rhodopsin and cone opsins are membrane-spanning proteins, residing within the phospholipid bilayer 
(phospholipid molecules with the fatty acid chains: magnified fragment of the rod disc membrane) of 
discs. Figure from Neuringer (2000). 
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1.2.2 THE RETINAL PIGMENTED EPITHELIUM 
The retinal pigment epithelium (RPE; Figure 1-4) is a monolayer of cells forming the blood-
retina barrier. 
In addition to absorbing light scattered within the eye, like the choroid does, the RPE serves 
a number of other functions. The primary role of the RPE is to phagocytise dead and damaged 
photoreceptor cells; about 10 % of photoreceptor outer segments are shed every day and then 
phagocytised by the RPE (Young, 1967). Furthermore, this single-celled layer is also involved in 
recycling of retinal; this is essential for the photoreceptors to be able to retain their 
phototransduction activity, as all-trans retinal cannot be re-isomerised to the 11-cis form 
within photoreceptor cells. 
  
 
Figure 1-4. The Retinal Pigmented Epithelium, its components and functions.  
The basolateral surface of the RPE lays adjacent to fenestrated blood capillaries, whereas the apical 
membrane contacts the outer segments (OS) of photoreceptor (PR) cells; it forms microvilli (MV) 
extending towards the OS and surrounding them. Light Absorption: the pigments of the RPE absorb 
light, preventing its scattering. Epithelial Transport: the RPE is involved in transport of nutrients (e.g. 
glucose, vitamin A) from blood to PRs and in ion exchange important for maintaining correct pH in 
the sub-retinal space; the latter is also a major function of Müller (glia) cells. Furthermore, a constant 
circulation of retinal (visual cycle: section 1.2.4) keeps occurring between the RPE and rods, as all-trans 
retinal can only be isomerised back to 11-cis retinal in the RPE. Phagocytosis of shed fragments of OS 
and secretion of growth factors (PEDF, pigment epithelium-derived growth factor; VEGF, vascular 
epithelium growth factor) important for maintenance of neighbouring cells are also performed by 
the RPE. Figure from Strauss (2005). 
 
The RPE forms a part of the blood-retina barrier; it captures nutrients from the blood and 
displaces waste metabolites from the sub-retinal space into the blood. Nutrients taken up by 
the RPE include vitamin A, i.e. retinol, glucose and fatty acids. This layer also releases growth 
factors involved in sustaining the retina as well as the endothelium of the choroid capillaries. 
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The RPE is additionally involved in spatial buffering of ions in the interphotoreceptor (IPR) 
matrix; this function is performed with the assistance of the Müller glia cells (reviewed in: 
Strauss, 2005; Martini e Nath, 2006; Marieb e Hoehn, 2007; Barrett et al., 2010). 
 
1.2.3 PHOTOTRANSDUCTION 
Phototransduction is a term used to describe a process by which light energy is converted into 
a graded action potential. 
Retinal is the key molecule involved in phototransduction. It combines with different opsin 
proteins to form four different types of photo-pigments, each of which preferentially absorbs 
light of different wavelengths. Vitamin A is the dietary precursor for retinal in the human body. 
Overall, many isomers of this molecule exist; when bound to an opsin the retinal is present as 
the 11-cis isomer. 
In the dark, the cation channels in the photoreceptor (PR) outer segments (OS) are held open 
by cyclic GMP (cGMP), allowing a continuous inflow of sodium and calcium cations, which 
results in a ‘dark membrane potential’ of – 40 mV. Consequently, the PR cells remain 
depolarised, and thus the voltage-gated calcium channels at the synaptic terminals of the PR 
cells remain open, resulting in a continuous release of glutamate. This neurotransmitter 
triggers the inhibitory postsynaptic potentials (IPSPs) in the bipolar cells, leading to their 
hyperpolarisation. The IPSPs inhibit neurotransmitter release from the synapses of the cells, 
and signal transmission stops. When a photon of light is absorbed by the 11-cis retinal, its 
conformation changes to all-trans and it subsequently detaches from the opsin, triggering 
the cascade of phototransduction reactions. This bleaching of the pigment is very rapid, taking 
a few milliseconds and is the only light-dependent stage of the visual perception process. 
The activated, retinal-free form of rhodopsin is referred to as metarhodopsin II; it activates 
a G-protein, called transducin, which in turn activates a phosphodiesterase (PDE). This last 
enzyme breaks down cGMP into GMP, which results in closure of the cGMP-gated calcium and 
sodium channels in the PR OS, subsequently leading to hyperpolarisation of the PR cells. This 
hyperpolarising membrane potential, i.e. – 70 mV, causes closure of the voltage-gated cation 
channels at the synaptic terminals of the PRs. When the concentration of calcium and other 
cations falls within the synapses, no glutamate neurotransmitter is released. 
The absence of glutamate at the bipolar cell receptors results in no IPSPs forming; therefore, 
the cells depolarise, the voltage-gated cation channels open, allowing inflow of calcium ions. In 
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consequence, the bipolar cells release their neurotransmitter molecules, which bind to 
receptors on the ganglion cells’ synapses. Binding of the neurotransmitter triggers excitatory 
postsynaptic potentials (EPSPs) in the ganglion cells, resulting in generation of action 
potentials, which are then propagated along the optic nerve (reviewed in: Thompson e Gal, 
2003; Martini e Nath, 2006; Marieb e Hoehn, 2007; Barrett et al., 2010) 
 
1.2.4 THE VISUAL CYCLE 
Photo-pigments bleached in the first step of the phototransduction need to be regenerated in 
order for vision to continue. In contrast to the rapid breakdown of the photo-pigments, their 
replenishment is a slow, energy-requiring process. It involves re-isomerisation of the all-trans 
retinal to its 11-cis form. In the meanwhile, more 11-cis retinal is being synthesised by 
oxidation of vitamin A acquired from diet. 
The process of regeneration of the rhodopsin and cone opsins is referred to as the visual cycle 
(Figure 1-5). When a photon of light hits rhodopsin, it triggers a conformational change of 
retinal from 11-cis retinal to all-trans retinal. As a consequence, the latter isomer is released 
from the pigment opsin, which it was bound to via a protonated Schiff base linkage, into 
the space inside the disc. The retinal then reacts with phosphatidylethanolamine to form N-
retinylidene-phosphatidylethanolamine, which becomes bound by the retina-specific ATP-
binding cassette transporter (ABCR), and is transferred to the cytoplasmic surface of the disc. 
The all-trans retinal is released into the cytoplasm, where it is reduced to vitamin A, i.e. all-
trans retinol, by the all-trans retinol dehydrogenase (RDH). The vitamin A is transported across 
the sub-retinal space into the RPE; it is additionally supplied to this cell layer by vessels in 
the choroid (from dietary intake). In the RPE the all-trans retinol becomes bound by 
the cellular retinol-binding protein (RBP), and is esterified to all-trans retinyl esters by 
the lecithin retinol acyltransferase (LRAT). These esters are subsequently isomerised to 11-cis 
retinol; this step also involves the action of retinyl ester hydrolase (REH) and the RPE65 
protein. At last, the 11-cis retinol dehydrogenase isomerises 11-cis retinol to 11-cis retinal in 
a process accelerated by the presence of the cellular retinaldehyde-binding protein (CRALBP). 
The product is then transported into the rod outer segments; the interphotoreceptor retinoid-
binding protein (IRBP) is present throughout the transfer of the 11-cis retinal to the rod (OS), 
however, its role is not understood. Alternatively, 11-cis retinol can be esterified and stored in 
the RPE (reviewed in: Thompson e Gal, 2003). 
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In addition to the cycle summarised in Figure 1-5, another pathway for 11-cis retinal 
production has been shown to exist in the RPE and the Müller glia cells. The reaction involves 
the RPE-retinal G-protein coupled receptor (RGR), and it is light-dependent. Specifically, 
the all-trans retinal, bound to the RGR via a Schiff base linkage, is converted to 11-cis retinal, as 
a result of illumination of the RGR (reviewed in: Thompson e Gal, 2003). 
 
 
Figure 1-5. The Visual Cycle.  
Schematic representation of retinal regeneration with the major intermediate analogues is illustrated. 
When a photon of light (hv) hits rhodopsin in the rod OS, the conformation of its chromophore 11-cis 
retinal changes to all-trans retinal, and is released from the covalent bond holding it with the opsin. 
Whilst still in the OS, all-trans retinal is reduced to all-trans retinol, and in this form it is transported 
across the sub-retinal space to the retinal pigment epithelium (RPE); there it is, firstly, esterified and 
then further isomerised to 11-cis retinol. At last, 11-cis retinol is oxidised to 11-cis retinal and 
transported back across the sub-retinal space to the rod OS to form a light-sensitive rhodopsin. Image 
from Arshavsky (2010). 
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1.3 RETINITIS PIGMENTOSA 
Retinitis pigmentosa (RP) is an inherited, heterogeneous retinal dystrophy, characterised by 
the loss of photoreceptors and pigment deposits on the fundus of the eye (reviewed in the 
seminar by: Hartong, Berson e Dryja, 2006). RP is the most common type of inherited 
photoreceptor (PR) degeneration (Wright et al., 2010). The disorder may occur as 
a component of a broader syndrome characterised by other non-ocular features, or it can be 
non-syndromic. 
It has been estimated, based on population studies, that non-syndromic RP has a prevalence of 
approximately 1 in 4 000, whereas Usher syndrome and Bardet-Biedl syndrome (BBS), the two 
most commonly diagnosed forms of syndromic RP, have a prevalence of approximately 
1 in 20 000 and between 1 in 13 500 and 1 in 175 000, respectively (Hamel, 2006; Kremer et 
al., 2006; Rooryck e Lacombe, 2008; Zaghloul e Katsanis, 2009). Overall, approximately 
1.8 million people are affected by RP worldwide.  Furthermore, a Scandinavian study 
conducted by Buch et al. (2004) has demonstrated that RP is one of the two major causes of 
blindness in people aged 20-64. 
More than fifty different genetic subtypes of RP have been identified (Retnet, 1996-2010; 
Fahim, Daiger e Weleber, 2000 Aug 4 [Updated 2013 Mar 21].). The disease is usually inherited 
in a monogenic mode; however, a case of digenic inheritance has also been demonstrated 
(Kajiwara, Berson e Dryja, 1994). It has been estimated that autosomal dominant (adRP) traits 
comprise 15 – 25 % of all RP cases, the autosomal recessive (arRP) disease contributes 5 – 20 % 
of cases, and 5 -15 % are due to the X chromosome-linked (xlRP) inheritance. Mutations 
responsible for the cases as yet unaccounted for, comprising the remaining 40 – 50 %, remain 
to be identified. The functions of known genes involved in photoreceptor degeneration 
(inclusive of, but not limited to RP), and their approximate contribution to the known causes of 
retinal dystrophies are summarised in Figure 1-6. 
It must also be highlighted that most causative genes contribute only a very small proportion 
of cases (less than 1 % per causative gene). Exceptions include mutations in the retinitis 
pigmentosa GTPase regulator (RPGR), which, being the predominant cause of xlRP (up to 90 % 
incidence), is responsible for up to 13.5 % of all RP cases. Up to 8 % of total RP can be 
attributed to mutations in rhodopsin (RHO; both dominant and recessive); whereas, usherin 
(USH2A) and PRPF31 have been associated with up to 3 % and 2.5 % of all RP cases, 
respectively. 
Identification of Interacting Protein Partners of TOPORS in the Retina   ||   Barbara Czub 
PhD Thesis 2015   ||   Introduction    - 45 - 
 
 
Figure 1-6. Functional categorisation of genes that influence photoreceptor degeneration. 
Pie chart showing the functional categorization of 146 genes implicated in PR degeneration. ECM, 
extracellular matrix; pre-mRNA, precursor mRNA; unknown, function undetermined; VRD, vitreo-retinal 
degeneration. Some of the categories include genes specific to retinal structure and function, such as 
‘Outer segment structure,’ ‘Phototransduction’ and ‘Visual cycle.’ However, others, such as ‘Lipid 
metabolism,’ ‘Protein degradation,’ or ‘Ciliary trafficking’ comprise ubiquitously expressed genes. Figure 
from Wright et al. (2010). 
 
Furthermore, mutations in certain genes, although not known to be prevalent worldwide, have 
extremely high incidence within smaller social groups. For instance, mutations in the EYS gene 
are estimated to cause up to 30 % of all recessive RP cases reported in Spain (Fahim, Daiger e 
Weleber, 2000 Aug 4 [Updated 2013 Mar 21].). 
Bowne et al. (2008) and Sullivan et al. (2013) characterised the contributions of causative adRP 
genes (Figure 1-7), using a panel comprising samples of predominantly (but not exclusively) 
Western European origin, and the eyeGENE resource, respectively. 
Most of the causative genes have numerous disease alleles. There are cases where a specific 
allele predominates; for instance, the 2299delG allele of the USH2A gene causes a substantial 
proportion of the Usher syndrome cases (Dreyer et al., 2001; Aller et al., 2004; Aller et al., 
2010). 
The RP phenotype can also be influenced by modifying or low penetrance genes, which are 
difficult to identify, but which significantly contribute to the variability of RP. The already-
mentioned processing factor 31 of the precursor mRNA, PRPF31 (Vithana et al., 2003), as well 
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as the A229T allele of the RPGR-interacting protein 1-like (RPGRIP1L) (Khanna et al., 2009), are 
two examples of such modifiers. 
 
A 
 
Figure 1-7. Frequency of 
adRP mutations found 
in adRP cohorts by gene.  
A, The cohort was mostly, 
but not exclusively, of 
Western European origin 
(Bowne et al., 2008); testing 
identified mutations in 60% 
of 215 families. 
B, The cohort comprised 
adRP eyeGENE probands 
(Sullivan et al., 2013); 
testing identified mutations 
in 52% of 170 families. 
Figures and legends 
modified from Bowne et al. 
(2008) and Sullivan et al. 
(2013). 
B 
 
 
1.3.1 RETINA-LIMITED DISORDERS 
In its most typical course, the non-syndromic RP first manifests itself in early mid-life, as night 
blindness. This is followed by a progressive loss of vision in the peripheral field, and, in some 
patients, by the subsequent loss of central vision. Many patients are often left with a residual 
field of central vision due to the remaining functional macular cones (reviewed in: Hartong, 
Berson e Dryja, 2006). Physiologically this is reflected as degeneration and loss of, firstly rod, 
then cone, photoreceptors (PRs). Nonetheless, cone-rod degenerations, where the primary 
defects occur in cones, have also been observed, and they have a prevalence of approximately 
1 in 40 000. The progression of degeneration varies between patients, even within the same 
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family carrying the same mutation; in some cases PR death occurs very rapidly, whereas in 
others it can be slow and never lead to complete blindness (reviewed in: Hamel, 2006). 
Typically, autosomal-dominant (ad) RP cases manifest as the mildest RP forms, and they can 
sometimes be mistaken for sporadic RP, if earlier generations experienced milder symptoms.  
This may happen due to partial or variable penetrance of the causative mutations, not unusual 
in dominantly inherited RP, and quite frequently associated with some genes, such as, PRPF31  
(RP11; MIM 600138) (Vithana et al., 2003). Moreover, the onset of disease may occur quite 
late, sometimes even in the fifth decade of life (reviewed in: Hamel, 2006). 
On the contrary, autosomal recessive (ar) RP forms are usually diagnosed much earlier, often 
already within the first decade of life, and the disease progression tends to proceed faster, 
causing the recessive form to manifest as more aggressive. The same is often also true for 
the X-linked (xl) RP, where transmission is usually (but not always) recessive (reviewed in: 
Hamel, 2006). 
Although these are the overall trends of RP manifestations depending on a specific mode of 
transmission, it must be highlighted, that exceptions from these assumed patterns exist. 
Dominantly-inherited aggressive early-onset RP cases have been recorded for some rhodopsin 
mutations (Keen et al., 1991). The opposite is also true: apparently milder, adRP-resembling 
forms of arRP have also been recorded (Kaplan et al., 1990). 
 
1.3.2 SYSTEMIC DISEASES 
Numerous syndromic forms of RP have been identified, overall 20-30 % of RP patients suffer 
also from non-ocular disease. Of these Usher Syndrome (USH) and Bardet-Biedl Syndrome 
(BBS), inherited via the autosomal recessive mode, are the most common, contributing to 
approximately  19 % (Boughman, Vernon e Shaver, 1983) and 5 % (Haim, 1992) of all RP cases, 
respectively. They are both ciliopathies (section 1.9.3). 
Besides photoreceptor degeneration, Usher Syndrome is characterised by defects of the inner 
ear, which lead to a hearing impairment, and which sometimes also result in vestibular 
malfunction. Three subtypes of Usher Syndrome (USH 1-3) have been identified based on the 
clinical features, and genetic heterogeneity is characteristic of all three forms. Twelve USH loci 
have been identified to date (reviewed in: Petit, 2001). 
The BBS phenotype is variable, and can be divided into numerous subtypes, based on clinical 
features, which include cognitive impairment, obesity, renal disease, hypogenitalism and 
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polydactyly. Fourteen BBS loci with variable occurrence frequencies have been identified to 
date (reviewed in: Zaghloul e Katsanis, 2009). 
Numerous other forms of syndromic RP have been identified, many of which may result from 
mutations in one gene. For instance, the above-mentioned BBS can be caused by a mutation in 
a gene encoding a centrosomal protein NPHP6 (CEP290). A mutation in this gene can also lead 
to Senior-Løken Syndrome (SLS) encompassing the renal cystic disease, Joubert Syndrome (JS) 
where cerebral malformation is a common clinical feature, or Meckel Syndrome (MS), which 
encompasses developmental abnormalities of the renal, the biliary, and/or the central nervous 
system. Similarly, mutations in the RPGRIP1L gene, encoding the RPGR interacting protein-1-
like NPHP8, may be a cause of either JS, or MS; furthermore, these genes may also act as 
modifiers in ciliopathic RP (reviewed in: Retnet, 1996-2010; Wright et al., 2010). 
 
1.4 TOPORS MUTATIONS ASSOCIATED WITH RETINAL DYSTROPHIES 
TOPORS is located on the short arm of chromosome 9, within the 9p21 region; the gene spans 
approximately 13 kb of genomic DNA, and encodes a 3135-nucleotide long transcript, 
comprising three exons. The largest portion of the gene is encoded within the third exon. 
Exon 1 encodes just the start codon; exon 2 is 195 bases long. An isoform of TOPORS has also 
been detected, in which the whole exon 2 is spliced out (Chakarova et al., 2011). 
In year 2007 a role for TOPORS has been demonstrated in inherited eye diseases, specifically 
autosomal dominant retinitis pigmentosa (adRP; RP31 phenotype MIM: 609923). Chakarova et 
al. (2007) identified two mutations in TOPORS in families of French-Canadian and German 
origins  (Figure 1-8). The large French Canadian family had eighteen affected members and 
harboured a heterozygous 1-bp insertion (c.2474_2475insA) in exon 3, which resulted in 
a frameshift (p.Tyr825*) leading to a premature stop codon. The small German family (four 
affected members) carried a 2-bp deletion in a proximate region (c.2552_2553delGA) in 
the same exon, which also lead to shifting of the reading frame (p.Arg851fs). The observed 
phenotype was intriguing as it was limited to retinal degeneration despite the ubiquitous 
expression of TOPORS (refer to section 1.4.1 for an overview of the pedigrees and phenotype). 
No mutant protein was detected in the affected individuals, and consequently, the authors 
suggested haplo-insufficiency as a likely disease mechanism. 
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Figure 1-8. Pedigrees and sequence analyses of TOPORS mutations in French-Canadian and German 
pedigrees. 
A and C, Canadian and German adRP-affected pedigrees, respectively. Circles indicate females; squares 
indicate males. Black filled symbols are affected individuals, open symbols are unaffected individuals, 
and deceased individuals are indicated by a slash (/). Asymptomatic individuals are marked by an 
asterisk (*). Mutation segregation is shown on the pedigree as (homozygous/normal) or +/− 
(heterozygous/affected). Roman numbers indicate the generation and Arabic numbers indicate pedigree 
position. B and D, Electrophero-grams of the hetero-zygous mutations in exon 3 of the TOPORS gene. B, 
Mutation found in the French-Canadian family (c.2474_2475insA/p.Tyr825*). D, Mutation found in 
the German family (c.2552_2553delGA/p.Glu852Aspfs*20). Both mutations were identified after cloning 
of the amplified PCR product into pGEMT-Easy vector (Promega, WI, USA). Figure and legend modified 
from Chakarova et al. (2007). 
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A year later Bowne et al. (Bowne et al., 2008) attempted to determine the frequency of 
TOPORS mutations in a cohort of 215 adRP families. The group demonstrated that small 
insertion/deletion (indel) mutations in TOPORS contribute approximately 1 % to all adRP 
mutations. In the same study, the researchers identified two novel TOPORS mutations (Figure 
1-9), which also led to premature stop codons, and were found in a proximal location to 
the previous two mutations, suggesting this region is a mutational hotspot. The first identified 
proband harboured a 1-bp deletion:  c.2569delA (p.Arg857Glyfs*9), whereas the second 
proband, which came from a different family, carried a nonsense point mutation: c.2422G>T 
(p.Glu808*). 
 
 
Figure 1-9. Pedigrees of adRP families UTAD102 and RFS169 affected by TOPORS mutations.  
A, UTAD102 family carrying the c.2569delA/p.Arg857GlyfsX9 mutation. B, RFS169 family carrying 
the c.2422C>T/p.Glu808X mutation. Circles indicate females; squares indicate males. Black filled 
symbols are affected individuals, open symbols are unaffected individuals, and deceased individuals are 
indicated by a slash (/). The “Q” indicates an individual in New York who reports being asymptomatic. 
“E”s indicate individuals who had eye examination at either the Retina Foundation of the Southwest or 
the Jules Stein Eye Institute. “M”s indicate individuals for whom ophthalmic medical records were 
reviewed. Plus signs show individuals whose DNA tested positive for the family's mutation; minus signs 
are individuals whose DNA tested negative for the family's mutations. Figure and legend modified from 
Bowne et al. (2008). 
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Another two heterozygous novel missense mutations were found in a panel of adRP patients, 
mostly of German origin, but including a smaller proportion of probands from other regions 
within continental Europe. Nonetheless, it could not be confirmed then that these mutations 
were causative of the observed retinal phenotypes, as relatives of the probands were not 
available for examination. The changes included c.1205A>C (p.Gln402Pro) and c.1818T>G 
(p.Ser606Arg) (Schob et al., 2009), neither one of which is located in the previously established 
mutational hotspot region. The former change was later shown to segregate in a Norwegian 
pedigree, dating back to the eighteenth century (Selmer et al., 2010). 
The Scandinavian study identified the above-mentioned missense TOPORS mutation 
(c.1205A>C/p.Gln402Pro) in a large Norwegian family (Figure 1-10), in which 35 members were 
known to be affected by autosomal dominant pericentral retinal dystrophy (adPRD) (Selmer et 
al., 2010); this phenotype is milder and has a more favourable prognosis than canonical adRP 
(refer to section 1.4.3 for an overview of the pedigree and phenotype). 
Selmer et al. (2010) elegantly linked the p.Gln402Pro change to the Norwegian retinal 
dystrophy, which provided indirect support that the aetiology of disease in the proband from 
the German/European panel (Schob et al., 2009) was very probably the same, even though 
pedigree data were not available2. 
Finally, a recent cohort study by Sullivan et al. (2013) identified two novel TOPORS mutations 
in a panel of ‘presumed adRP’ patients (c.2264A>G/p.Asn755Ser; 
c.2554_2557delGAGA/p.Glu85Glnfs*13) from the National Ophthalmic Disease Genotyping 
and Phenotyping Network (eyeGENE) (Goetz et al., 2012; Blain et al., 2013).  
However, for the substitution mutation, it could not be confirmed whether it segregates with 
the disease, and thus is responsible for the observed phenotype, as only one family member 
was available for examinations. The novel deletion/frameshift mutation occurs in 
the previously delineated mutational hotspot region (Sullivan et al., 2013). 
This study additionally found another patient, affected by the mutation initially identified by 
Chakarova et al. (2007) in the small German family (c.2552_2553delGA/p.Arg851fs3). 
                                                          
 
2
 Phenotype details were not provided by Schob et al. (2009). 
3
 This notation was later corrected by Sullivan et al. (2008) to c.2556_2557delGA (p.Glu852Aspfs*20). 
Three GA di-nucleotides are found in tandem at this region (c.2552_2557), overlapping with codons for 
Arg and Glu. 
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Figure 1-10. Pedigree of the adPRD Norwegian family carrying a missense TOPORS mutation.  
Circles indicate females; squares indicate males. Black filled symbols are affected individuals, open 
symbols are unaffected individuals, half-filled symbols are individuals affected by history, and deceased 
individuals are indicated by a slash (/). Examined individuals are marked by an asterisk (*). Mutation 
segregation is shown on the pedigree as +/+ (homozygous/normal) or +/− (heterozygous/affected). 
Roman numbers indicate the generation and Arabic numbers indicate pedigree position. Figure and 
legent modified from Selmer et al. (2010). 
 
Table 1-1. Mutations identified in TOPORS to date. 
DNA 
mutation 
Protein mutation Phenotype Reference 
c.2474_2475
insA 
p.Tyr825* 
adRP with perivascular RPE 
atrophy (the latter observed in 
affected children, but not adults) 
(Chakarova et al., 
2007) 
c.2556_2557
delGA 
p.Glu852Aspfs*20 
adRP with perivascular RPE 
atrophy (the latter observed in 
affected children, but not adults) 
(Chakarova et al., 
2007; Sullivan et al., 
2013) 
c.2569delA p.Arg857Glyfs*9 adRP 
(Bowne et al., 2008) 
c.2422G>T p.Glu808* adRP 
c.1205A>C p.Gln402Pro adPRD 
(Schob et al., 2009; 
Selmer et al., 2010) 
c.1818T>G p.Ser606Arg 
N/A  Uncertain pathogenicity 
or variable expressivity/partial 
penetrance  
(Schob et al., 2009) 
c.2264A>G p.Asn755Ser N/A  Uncertain pathogenicity 
(Sullivan et al., 2013) c.2554_2557
del 
p.Glu852Glnfs*13 adRP 
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1.4.1 THE RP31 PHENOTYPE 
The RP31 phenotype was firstly described by Papaioannou et al. (2005) when the new adRP 
locus was shown to segregate with retinal disease in a French-Canadian family (before it was 
known that TOPORS was the causative gene).   
Fourteen members of the pedigree (Figure 1-8 A) were phenotyped (age range: 8 – 64 years); 
they had an early disease onset at 10-50 years of age, which differed between generations. 
Their visual acuity was good: better than 20/40 in 13/14 individuals among whom nine had 
20/20 vision, and all were able to count fingers (for explanation of visual acuity tests and 
definitions refer to: Schulze-Bonsel et al., 2006). The visual fields of the affected individuals 
ranged from 10° to 80°, and their ERG abnormalities were also very variable. Typically, rod 
defects were followed by cone defects. Interestingly, the earliest disease sign, found in three 
children from the youngest generation, was an ‘unusual perivascular cuff of RPE atrophy (…) 
surrounding the superior and inferior arcades.’ The disease in these children subsequently 
progressed to a diffuse pigmentary retinopathy with choroidal sclerosis. Furthermore, one of 
the affected patients was found to be asymptomatic and had a completely normal retinal 
appearance; the only phenotype results suggestive of disease were ERG abnormalities similar 
to those observed in symptomatic family members (Papaioannou et al., 2005). 
When TOPORS was identified as the adRP-causative gene within the RP31 locus (Chakarova et 
al., 2007), the French-Canadian family members were re-examined. This time 17 family 
members (rather than 14 as previously) were available for phenotyping. All had good visual 
acuity: 16/17 patients had better than 20/40 vision, among whom eleven had 20/20 vision; all 
were able to count fingers. The results of visual fields and ERG testing were still variable 
between individuals, and rod defects were still followed by cone dysfunction.  
The ‘perivascular cuff of RPE atrophy (…),’ followed by the diffused pigmentary retinopathy 
with choroidal sclerosis remained as the earliest disease signs in this RP31 pedigree. In fact, 
a fourth child was diagnosed with these characteristic clinical features (Figure 1-11). 
Interestingly, three of the affected patients were asymptomatic and had a normal retinal 
appearance, but ERG abnormalities were analogous to those observed in symptomatic 
patients. During the previous phenotyping by Papaioannou et al. (2005) only one of 
the asymptomatic affected patients was examined and identified. No phenotype details of 
the small German family (Figure 1-8 C) were provided. 
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Figure 1-11. Colour photograph of the right eye of a 10-year-old affected child (IV:3 in Figure 1-8 A). 
At this age, a very obvious and unusual perivascular “cuff” of atrophy (arrows) around the superior and 
inferior vascular arcades is visible. The optic disc appears normal in colour, although the retinal 
arterioles are narrow, and there was no pigmentary degeneration at this stage. The cuff of RPE atrophy 
was found in three other children in this family as well but was not found in the adults of this pedigree. 
At a later age, this feature apparently disappears. Figure and legend modified from Chakarova et al. 
(2007). 
 
TOPORS expression analysis, performed by Chakarova et al. (2007), demonstrated that 
TOPORS transcript was found in all tested tissues; however, the expression levels appeared 
much higher in the retina than in the other tested tissues (with the exception of liver and 
pancreas; Figure 1-12). Subsequently, the researchers also extracted lymphoblasoid cell lysates 
from affected and unaffected individuals in order to determine whether the truncated mutant 
TOPORS proteins are expressed. Only wild-type TOPORS protein was detected (Figure 1-13), 
leading the scientists to conclude that the mutants were rather unstable and quickly degraded; 
hence, haploinsufficiency was proposed as the disease mechanism. 
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Figure 1-12. RT-PCR analysis of TOPORS transcript in human tissues. 
PCR was performed with primers selected from exon 3 (with 28 cycles). A band of 2.69 kb was observed 
in all the tested QUICK-Clone cDNAs (Clontech) from retina, brain, kidney, liver, heart, skeletal muscle, 
pancreas, lung, and placenta. A ubiquitously expressed gene, PGM1, was used as a control. Figure and 
legend modified from Chakarova et al. (2007). 
 
Figure 1-13. TOPORS expression in patient lymphoblastoid cell lines.  
Protein extracts from cell lines from one unaffected and two affected individuals from the Canadian and 
German families with p.Tyr825* and p.Glu852Aspfs*20 mutations, respectively, were analysed by SDS-
PAGE and immunoblotting, with the use of anti-TOPORS antibody (Abnova, Taiwan). α-tubulin was used 
as a control. WT = wild type. Figure and legend modified from Chakarova et al. (2007). 
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1.4.2 DISSIMILAR PHENOTYPES OF UTAD102 AND RFS169 PROBANDS  
The cohort study performed by Bowne et al. (2008) on a panel of adRP patients, who were 
mostly (but not only) of Western European origin, led to identification of two novel TOPORS 
mutations. The mutations were found in a member of Hispanic family UTAD102 
(c.2569delA/p.Arg857Glyfs*9) as well as a member of a Caucasian family RFS169 
(c.2422G>T/p.Glu808*), both males (Figure 1-9). 
The 52 year old UTAD102 proband had severely impaired eyesight with only hand motion 
acuity of vision in both eyes (for explanation of visual acuity tests and definitions refer to: 
Schulze-Bonsel et al., 2006). The patient’s fundus examination revealed features of end-stage 
RP; specifically, he had extensive bone-spicule-like pigment deposits and severely attenuated 
blood vessels.  Optic disc pallor and macular RPE atrophy were also present. The proband’s 
two brothers and three children also had RP. 
On the contrary, the phenotype of the RFS169 family was considerably milder. The 31 year old 
proband was fully aware of his poor peripheral vision, and his main complaint was ‘difficulty 
going down steps and curbs in dim light or at night.’ He reported that his mother was affected 
by severe night blindness at the age of thirty, and at present at the age of 60 years she has 
very poor vision. In addition to his mother, his sister, maternal aunt, grandfather, great 
grandfather and great uncle all had RP (Figure 1-9 B). 
Except for the above-mentioned signs of early-stage RP, the proband had good eyesight with 
visual acuity of 20/20-2. Fundus examination showed abundant bone-spicule-like deposits in 
mid-periphery (but not far periphery) and his optic discs and maculae appeared normal. 
The proband’s visual sensitivity was slightly impaired in the fovea and central 15° (based on 
static perimetry using a Humphrey Field Analyser (Humphrey Instruments, CA, USA), and was 
equal to zero at most regions beyond 7° eccentricity. On the contrary, the patient’s 60-2 field, 
corresponding to peripheral retina, showed an area of preserved function in lower temporal 
field. ERG recordings showed no detectable standard rod response, whereas the cone b-wave 
was decrease to less than a quarter of normal lower limit response. 
A 41 year old sister of the proband displayed a similar phenotype (Figure 1-14 A and B). 
Remarkably, the fundus appearance resembles that described in the Norwegian family with 
autosomal dominant pericentral retinal dystrophy (adPRD) caused by a missense TOPORS 
mutation (section 1.4.3) as well as the fundus of a pericentral RP patient (Figure 1-14 C), from 
a retrospective study clearly demonstrating that the pathology began in mid-
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periphery/pericentric retina rather than the further periphery as would happen in classical RP. 
Cousins of the proband were also affected by early-stage RP. Interestingly, the cousins’ mother 
was an asymptomatic carrier of the c.2422G>T TOPORS mutation. According to a self-reported 
questionnaire (which she competed aged 66 years), she was not affected either by night 
blindness, or by peripheral vision problems. This is a fourth known case of an asymptomatic 
carrier of a TOPORS mutation, the previous three being members of the French-Canadian 
family, in which the RP31 locus was first identified. 
 
 
Figure 1-14. Fundus photographs from a member of family RFS169 (A and B) and a patient with 
a pericentral retinal dystrophy (C).  
A and B, Right mid-pheripheral fundus (A) and right peripheral fundus (B) photographs from the 41-year-
old sister of the proband from family RFS169. The mid-periphery of both eyes contained numerous 
bone-spicule-like pigment deposits and the retinal arterioles were slightly narrowed by comparison to 
the veins. There was no evidence of a perivascular cuff of retinal pigment epithelium atrophy around 
the superior and inferior arcades in this family. Note the sharp border between the abnormal area and 
the normal appearance of the periphery. Figure and legend modified from Bowne et al. (2008). 
C, Fundus photographs from Patient 5276 with pericentral retinitis pigmentosa/pericentral retinal 
dystrophy, taken in year 1982 and then in 2000, demonstrating an increase in pericentral bone-spicule 
pigmentation over an 18-year interval. Note the sharp border between the abnormal area and the 
normal appearance of the periphery. Figure and legend modified from Sandberg et al. (2005).  
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1.4.3 THE SCANDINAVIAN PERICENTRAL RETINAL DYSTROPHY  
The large Norwegian pedigree (Figure 1-10) was affected by autosomal dominant pericentral 
retinal dystrophy (adPRD) caused by a missence TOPORS mutation: c.1205A>C/p.Gln403Pro 
(Selmer et al., 2010). Comparing to classical RP, PRD is characterised by less severe night 
blindness, which typically appears later in life. As the authors described, the pathology begins 
‘within 15° of fixation point, encircles, but spares, the macula, and comes close to the optic 
disc’ (Figure 1-14 and Figure 1-15). Fundus periphery looks essentially normal and ERG 
recordings also tend to be closer to the norm. Nonetheless, expressivity may be variable and, 
therefore, end-stage PRD may be apparently indistinguishable from end-stage classical RP. 
Sixteen family members were examined (marked by an asterisk (*) on the pedigree diagram in 
Figure 1-10), ten affected, and six unaffected by the adPRD. Among the unaffected ones three 
were older than sixty years of age, and they were fully examined, confirming that they had no 
signs of disease. All of the affected individuals presented with adPRD except for a 23 year old 
male (VII:4 in  Figure 1-10), who was only affected by night blindness at the time of 
examination.  
In contrary to the truncating TOPORS mutations, for which haploinsufficiency was proposed as 
disease mechanism, and which did not cause any symptoms in four of the affected patients 
(Chakarova et al., 2007; Bowne et al., 2008), suggesting incomplete penetrance, the missence 
TOPORS mutation appears to show complete penetrance in the Norwegian family. As a result, 
Selmer et al. (2010) speculated that a dominant-negative effect of the mutation TOPORS 
protein probably underlays the disease mechanism in this adPRD phenotype. 
 
Figure 1-15. Fundus photographs from a member of 
the Norwegian family. 
The right eye of person VI:28, a 64-year-old male. 
The pericentral localisation of an area of abnormal 
pigment deposits is apparent on the fundus. Note 
the sharp border between the abnormal area and 
the normal appearance of the periphery. Figure and 
legend modified from Selmer et al. (2010). 
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1.5 TOPORS: NUCLEAR AND CELL CYCLE CONTEXTS 
A Drosophila study identified, using a Y2H screen, the Gypsy chromatin insulator complex as 
an interacting partner of dTopors. The Gypsy insulator has three known components: Su(Hw), 
Mod(mdg4)2.2, and CP190. Mod(mdg4)2.2 was used as bait in the protein-protein 
interaction (PPI) with dTopors, whereas subsequent studies in yeast showed that dTopors also 
directly associates with Su(Hw), but less strongly. All three Gypsy insulator components were 
found in immune complexes precipitated using antisera against dTopors. Further 
characterisation showed that dTopors is required for Gypsy insulator function, as its lack 
impairs the establishment of independent chromatin domains. On the other hand, dTopors 
over-expression rescues the Gypsy insulators activity, induced by Mod(mdg4)2.2 knock-down. 
Localisation of dTopors to the nuclear lamina was also demonstrated; this localisation was 
disrupted by mutations in lamin, which also negatively affect the Gypsy insulator activity and 
nuclear organisation. 
This is in agreement with the fact that interactions between chromosomes and the nuclear 
membrane affect homologue pairing and fusion (synapsis) in the beginning of meiosis in many 
organisms; however, synapsis does not occur in Drosophila males. A study of dTopors showed 
that it corresponds to nbl, a gene involved in nuclear blebbing (Matsui et al., 2011), and that it 
localised to nuclear lamina at prophase. Further characterisation demonstrated that dTopors 
was required for maintaining nuclear shape and lamin localisations in spermatocytes. During 
meiosis dTopors was needed chromosome transmission, prophase I chromatin condensation, 
and prevention of anaphase I bridges formation. The group also showed that dTopors is 
required for correct centriole separations, and, in contrast to previous findings, it is not 
essential for Gypsy insulator findings. 
Outcomes of the Drosophila studies support conclusions from the functional experiments 
aiming to evaluate the role of TOPORS in the retina. Chakarova et al. (2011) confirmed 
the nuclear localisation of TOPORS in hTERT-RPE1 cell line; however, the group additionally 
showed that the protein also localises to centrosomes  and mid-body (Flemming body) in a cell 
cycle-dependent manner. During stages G0, G1, S and G2 TOPORS was observed mostly in 
the nucleus in association with PML NBs as well as co-localising with γ tubulin in centrioles of 
centrosomes. During mitosis higher levels of TOPORS were observed in the centrioles of 
the spindle poles, and just prior to the completion of cytokinesis the protein was enriched in 
the mid-body. 
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The nuclear localisation of TOPORS was also demonstated in MDCK cells, but only when they 
were dividing. In ciliated non-dividing MDCK cells TOPORS localised only to the basal body of 
primary cilium. The same localisation was observed in ciliaed ARPE19 and IMCD3 cell lines. Due 
to its key localisation at the basal bodies, TOPORS may also mediate primary cilia signalling 
pathways,  in addition to its role the syndecan-based signalling (Braun et al., 2012). 
Cellular localisation of TOPORS at the base of primary cilium was in agreement with 
the protein’s localisation in adult retinal sections of mouse, pig and human, where the protein 
was observed mostly at the basal body of the connecting cilium in rod photoreceptors, its 
daugther centriole as well as the pericentriolar region. TOPORS signal was also observed in 
the nuclei of retinal ganglion cells. 
Furthermore, Chakarova et al. (2011) also showed that TOPORS co-immunoprecipitates with 
cilia-centrosomal proteins from bovine retinal extracts. Specifically, TOPORS was found in 
complexes with γ tubulin, and proteins involved in the retrograde transport, namely p150glued, 
p50-dynamitin and dynein intermediate chain (DIC). It should be emphasised that, in 
Drosophila spermatocytes, dTopors is required for centriole separations (Matsui et al., 2011), 
which could suggest homologus functions for mammalian TOPORS proteins. 
 
1.6 TOPORS: PROTEIN STRUCTURE AND FUNCTION 
TOPORS protein was first identified as a human topoisomerase I (hTop1)-binding partner in 
a Y2H screen (Haluska et al., 1999).  TOPORS bound to the first 250 amino acids (aa) of hTop1, 
a fragment, which also participates in interactions with helicases. The fragment of TOPORS 
pulled out from the cDNA library with the hTop1 bait, encompassed residues 456-882. 
The same group also showed that, in HeLa cells, TOPORS localised in a punctate pattern in 
the nucleus, and was precipitated in complexes with hTop1. Furthermore, it was emphasises 
that TOPORS possesses a RING finger domain homologous to a domain in a family of ICP0 viral 
proteins, which regulate viral transcription. Hence, it was suggested that TOPORS may be 
involved in recruiting hTop1 to RNA polymerase II transcriptional assemblies. Later Hammer et 
al. (2007) showed that TOPORS acts as a SUMO1 E3 ligase for hTop1. 
Approximately a month after identifying the hTop1-TOPORS PPI, an independent paper was 
published, in which Zhou et al. (1999) performed a Y2H screen and identified a novel p53-
binding protein, which was later confirmed as TOPORS. The researchers showed that TOPORS 
was ubiquitously expressed at mRNA level, and had a mouse orthologue. Subsequent 
functional work by Rajendra et al. (2004) demonstrated that the E3 ubiquitin ligase activity of 
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TOPORS is dependent on its C3HC4 RING finger, specifically on a conserved tryptophan residue 
within this domain. It was also demonstrated that TOPORS ubiquitinates p53, leading to 
proteasome-mediated decrease in its levels, providing evidence that TOPORS serves as 
ubiquitin E3 ligase for transcription factors. An analogous proteasome degradation of p53 
occurs during over-expression of MDM2. Association between TOPORS and E2 ubiquitin-
conjugating enzymes: UbcH5a, UbcH5c, and UbcH6, was also documented (Rajendra et al., 
2004). An evolutionary study of RING finger domains additionally suggests that TOPORS 
(alongside Mul1 and Deltex) has the ability to bind a greater variety of E2 conjugating enzymes 
than other RING E3 ligases (Ying et al., 2011) 
Thus, TOPORS was the first protein shown to possess dual ubiquitin and SUMO1 E3 ligase 
activity. Since then three other such dual ligases have been identified, namely: TRAF7 (Morita 
et al., 2005), TRIM27 (Chu e Yang, 2011), and UHRF2 (Oh e Chung, 2013). 
TOPORS protein comprises several characteristic domains (Figure 1-16).  
 
 
Figure 1-16. TOPORS protein structure.  
Protein domains and known TOPORS mutations are indicated. PEST: proline-glutamate-serine-threonine 
domain associated with short protein half-life; RING finger: domain responsible for DNA-binding and for 
ubiquitin E3 ligase activity; SR domain: serine-arginine domain typical of proteins cycling between 
nucleus and cytoplasm depending on phosphorylation status (often found in spicing factors); Lys/His 
domain: lysine-histidine-rich region associated with punctate nuclear localisation of TOPORS; CTS: ciliary 
targeting sequence; NLS: nuclear localisation sequence. 
 
The already-mentioned ring finger domain, located near the amino-terminus, is usually 
involved in modulation of chromatin structure, and regulates RNA polymerase II-mediated 
transcription. This structural motif strongly resembles a domain in the infected-cell protein 0 
(ICP0) family of viral proteins, which are implicated in regulation of viral transcription, as well 
as in reactivation of latent viruses, such as the Herpes simplex virus (Everett, 1984; Gelman e 
Silverstein, 1986; Boutell et al., 2005). Regions rich in arginine (R) and serine (S) dipeptides are 
found in the centre of the protein; there are 33 of these RS/SR domains, which are separated 
in the middle by a nuclear localisation signal (NLS). TOPORS is unique in the respect that it is 
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the only known protein, which possesses both the RING finger domain and the RS/SR 
dipeptides domain; the latter is characteristic of proteins, which travel between the nucleus 
and cytoplasm depending on their phosphorylation status (Gui, Lane e Fu, 1994; Colwill et al., 
1996), and of some splicing proteins (Gross et al., 1997; Siebel et al., 1999; Cowper et al., 
2001). Amino acid sequences enriched in proline (P), glutamic acid (E), serine (S) and threonine 
(T) are also abundant in TOPORS, which possesses five of these PEST regions. These sequences 
are associated with targeting proteins for rapid degradation (reviewed in: Rechsteiner e 
Rogers, 1996). The protein also has a lysine/histidine (Lys/His) cluster, located towards 
the carboxyl-terminus. This fragment is thought to give TOPORS its distinct localisation pattern 
within the nucleus; it is punctuate and mostly excludes nucleoli. The speckled localisation is 
similar to patterns exhibited by RS/SR-rich splicing proteins as well as ring finger proteins; 
TOPORS associates, and thus co-localises with promyelocytic nuclear bodies (PML) (Rasheed et 
al., 2002). 
 
1.7 UBIQUITIN-LIKE PROTEIN MODIFICATIONS 
TOPORS is known to have a dual E3 ligase activity for ubiquitin as well as SUMO1 (Weger, 
Hammer e Heilbronn, 2005; Pungaliya et al., 2007; Guan et al., 2008; Miteva et al., 2010), 
which, however, do not share a significant sequence homology. In both processes, 
ubiquitination and SUMOylation, a reaction cascade involving three types of enzymes: E1, E2 
and E3, and analogous steps occur. TOPORS plays a role of the E3 enzyme. 
Modifications by ubiquitin-like proteins result in covalent attachments of a single ubiquitin-like 
protein, or a chain of such proteins. Depending on whether a protein becomes modified by 
a mono- or a poly-ubiquitin-like protein, the cellular site at which this mutation occurs, as well 
as the specific site on the protein being modified, to which the ubiquitin-like protein (chain) 
attaches, the resulting modification will trigger variable consequences for cellular functions. 
The canonical role of ubiquitination is marking proteins for degradation (Figure 1-17). 
SUMOylation on the other hand is associated with less clearly defined functions, and could 
influence DNA transcription, replication and repair, chromatin modifications, or cell cycle and 
apoptosis regulation (Perry, Tainer e Boddy, 2008; Wilson e Heaton, 2008). 
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1.7.1 UBIQUITINATION 
Ubiquitination is initiated with the involvement of ATP by an E1 ubiquitin-activating enzyme, 
which binds a ubiquitin molecule. The ubiquitin monomer is subsequently transferred from E1 
to an E2 ubiquitin-conjugating enzyme. The E2 enzyme and the substrate for ubiquitination are 
then bound by an E3 ubiquitin ligase (E3 enzymes are often specific for specific E2-substrate 
pairs), which catalyses the transfer of ubiquitin from the E2 onto a lysine residue of 
the substrate protein; an isopeptide bond is formed between ubiquitin and its substrate. At 
this point, depending on the purpose of the ubiquitination, the substrate may remain mono-
ubiquitination, or poly-ubiquitin chain formation may occur (reviewed in: Welchman, Gordon e 
Mayer, 2005).  
 
 
Figure 1-17. The ubiquitination pathway leading to proteasomal degradation.  
Ubiquitin is activated by the ubiquitin-activating enzyme (E1) and then transferred to a ubiquitin-
conjugating enzyme (E2), which transfers it to the protein substrate that is bound specifically to 
a particular ubiquitin ligase (E3; e.g. TOPORS). The transfer of ubiquitin takes place either directly (in 
the case of RING finger ligases, such as TOPORS) or via an additional thiol-ester intermediate on 
the ligase (in the case of HECT domain ligases). Repeated conjugation of ubiquitin units to each other 
generates a polyubiquitin chain that serves as the binding and degradation signal for the 26 S 
proteasome. The protein substrate is degraded, generating short peptides and free ubiquitin that can be 
further re-used. Ub, ubiquitin. Figure and legend modified from Rahimi (2012). 
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1.7.1.1 THE 26 S PROTEASE 
As was mentioned in the introduction to this section, the classical purpose of ubiquitination is 
to mark proteins for degradation. Poly-ubiquitin-marked proteins can either be targeted for 
degradation either by the lysosomal degradation system, or by the 26 S proteasome. The latter 
is introduced here, as this project resulted in identification of a key regulatory protein of this 
multi-component protease (Chapter 4). 
The 26 S proteasome is a multi-subunit protease system, which comprises two main 
components: a 20 S catalytic core particle (CP), and a 19 S regulatory particle (RegP). The CP is 
approximately barrel-shaped, and it comprises four stacked heptameric rings. The middle two 
rings are made from seven β subunits (PSMB1-7), of which β1, β2 and β5 confer the peptidase 
activity of the CP, i. e. the central proteasomal compartment contains a total of six catalytic 
sites, which are not substrate-specific. The outer two rings of CP consist of seven α subunits 
each (PSMA1-7); these peripheral rings form narrow pores, which prevent entry of proteins, 
which have not yet been unfolded. Additionally, subunits α2-4 have flexible extensions at their 
amino terminals, which enhance the proteasome gating. The CP is independent of ubiquitin 
and/or ATP binding (Voges, Zwickl e Baumeister, 1999; Lee et al., 2011). 
The 19 S RegP, of which at least twenty protein subunits have been identified to date, docks 
onto the α-rings of the CP, and confers substrate specificity and ATP-dependence to the fully 
assembled 26 S proteasome.  The RP can further subdivided into a base and cap. The base 
comprises a hexameric ring of AAA-ATPases (ATPases Associated with diverse cellular 
Activities), encoded by human genes PSMC1-PSMC6 as well as three non-ATPase subunits, 
encoded by PSMD1, PSMD2 and PSMD4. ATPases PSMC1-4 have ΨYX motifs at their carboxy-
termini, which are used for docking of the RP onto the CP. The ΨYX fragments, comprising 
a hydrophobic residue (Ψ), a tyrosine (Y) and any amino acid (X), become embedded in 
between the α subunits of the CP, stabilising the assembled proteasome. The ATPase ring also 
regulates the gating of the 26 S proteasome, by moving the extended parts of α2-4. The AAA 
cassette domains of each of the six ATPases contain two Walker P-loop motifs. ATP binding to 
Walker A promotes CP-RP assembly, whereas ATP hydrolysis within Walker B is believed to 
promote unfolding and import of ubiquitinated proteins.  The lid of the RP comprises 
regulatory non-ATPase particle and other accessory proteins; its main known function is to 
identify ubiquitin-tagged substrates, and remove the ubiquitin chains prior to import into 
the CP (Voges, Zwickl e Baumeister, 1999; Lee et al., 2011).  
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1.7.1.2 ROLE OF TOPORS IN REGULATED PROTEOLYSIS 
Park et al. (2008) demonstrated that the ubiquitin E3 ligase activity of TOPORS is modulation 
by phosphorylation of its serine 98 (Ser98) located just four amino acids upstream of the RING 
finger domain. The Ser98 phosphorylation enhanced the ubiquitin E3 ligase activity as well as 
binding of TOPORS to UbcH5a. The phosphorylation had no effect on the punctate nuclear 
localisation of TOPORS or its SUMO1 E3 ligase activity. In agreement with these findings, 
phosphorylation of TOPORS Ser718 by Polo-like kinase 1 (Plk1) leads to inhibition of p53 
SUMOylation by TOPORS, and, simultaneously, to enhanced ubiquitination of p53 by TOPORS, 
and hence its degradation. Expression of phospho-deficient S718A TOPORS mutant leads to 
p53 accumulation due to inhibition of its degradation  (Yang et al., 2009). 
This demonstrates that the ubiquitin and SUMO1 E3 ligase activities of TOPORS are mutually 
exclusive, and result in antagonistic outcomes. Furthermore, TOPORS Ser718 phosphorylation 
is essential for its degradation, which in turns delays the onset and progress of mitosis. In 
physiological conditions TOPORS is degraded in response to spindle checkpoint activation 
(Yang et al., 2010). 
Findings regarding the Drosophila orthologue of TOPORS, denoted as dTopors, provide 
additional valuable insight into this protein’s functions. In this species, like in mammals, 
dTopors is also shown to localise to cell nucleus, where it binds to the basic region of Hairy, 
an orthologue of mammalian Hes1 (Secombe e Parkhurst, 2004). The relationship between 
dTopors and Hairy occurs at both: a genetic as well as proteomic level. Genetically, dTopors 
antagonises transcriptional repression by Hairy, however, it does not affect its ability to bind 
DNA. Furthermore, dTopors is involved in degrading the Hairy protein by ubiquitinating it, i.e. 
similarly to its mammalian orthologues, dTopors also possesses the ubiquitin E3 ligase activity; 
hence, the authors concluded that regulated proteolysis of Hairy is required for correct fruit fly 
segmentation. 
It is noteworthy that Hes1, the mammalian homologue of Drosophila Hairy, the expression of 
which is regulated by Notch, in turn itself regulates the expression of PTGDS (Fujimori, 
Kadoyama e Urade, 2005), which has been identified as an interacting partner of TOPORS in 
this project. Furthermore, the proteolytic processing of Notch is homologous to the processing 
of ITM2B (Martin et al., 2008), which has been identified here as yet another protein, 
associating with TOPORS. 
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Differential expression of TOPORS has also been documented in a muscle atrophy (Fujita et al., 
2010), characterised by a decrease in protein synthesis and/or an increase in protein 
degradation. This presents a possible involvement for TOPORS as a ubiquitin E3 ligase in 
muscle protein degradation. Hence, the summarised findings provide evidence that TOPORS-
regulated proteolysis is important in developmental as well as degradation processes. 
 
1.7.2 SUMOYLATION 
Steps involved in SUMOylation are analogous to those described for ubiquitination (section 
1.7.1); however, SUMOylation involves one additional step. Specifically, prior to SUMO 
activation, a specific proteolytic cleavage of its C-terminal tail must occur. A proteolytically 
processed SUMO molecule is then activated, with involvement of ATP, by an E1 enzyme, 
precisely the Uba2/Aos1 hetero-dimer. The activated SUMO molecule is subsequently 
transferred to the Ubc9 protein, which acts as an E2 SUMO-conjugating enzyme. At last, the E2 
enzyme and a substrate become bound by an E3 SUMO ligase, which catalyses the attachment 
of the SUMO molecule to a lysine residue on the substrate. In most cases mono-SUMOylation 
occurs; however, formation of poly-SUMO chains has also been observed (reviewed in: Geiss-
Friedlander e Melchior, 2007).  
 
Figure 1-18. The SUMOylation 
pathway. 
Pre-SUMO (small ubiquitin-
related modifier) peptide 
needs to be proteolytically 
cleaved by SUMO-specific 
isopeptidases (sentrin-specific 
proteases; SENPs). These 
enzymes remove carboxy-
terminal amino acids from pre-
SUMO proeins to reveal their 
carboxy-terminal G-G motif 
(where G is glycine). Cleaved 
mature SUMO is activated by 
the E1 heterodimer AOS1–
UBA2 in an ATP-dependent 
reaction, which results in 
a thioester bond between the 
carboxy-terminal glycine and 
cysteine 173 (C173) in UBA2 
ubiquitin protein. 
SUMO is then transferred to the catalytic cysteine residue of the E2 enzyme UBC9. Finally, an isopeptide 
bond is formed between the carboxy-terminal glycine residue of SUMO and a lysine residue in 
the substrate protein. This step is usually aided by an E3 ligase, for instance, TOPORS. SUMOylated 
targets serve as substrates for SENPs, which ensures the reversible and dynamic nature of this process. 
Figure and legend modified from Geiss-Friedlander and Melchior (2007). 
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1.7.2.1 TOPORS AS SUMO1 E3 LIGASE 
Shortly after TOPORS was first described, it was shown, also via a Y2H method, that TOPORS 
associates with AAV2 proteins, involved in the virus’s replication, specifically Rep68 and Rep78 
(Weger, Hammer e Heilbronn, 2002). This interaction involved residues 871-917 of TOPORS – a 
region additionally shown to be required for interaction with p53, and later demonstrated to 
also mediate an interaction with Ubc9, and included within a basic C-term region mediating 
interactions of TOPORS with SUMO1 (Weger, Hammer e Engstler, 2003), and DEDa fragment of 
caspase 8 (Yao et al., 2007). Overall, TOPORS enhanced AAV gene expression, and it was 
concluded that it has a role as a transcriptional regulator. 
Rasheed et al. (2002) later showed that speckled localisation of TOPORS in the nucleus of 
exponentially growing HeLa cells was due to its association with promyelocytic leukaemia 
nuclear bodies (PML-NBs). The above-mentioned basic C-term region of TOPORS is required 
for this localisation. Importantly, the experiments established that the association of TOPORS 
with PML bodies was dynamic; if the cells were treated with transcription-inhibiting nucleoside 
analogues, or with hTop1 inhibitor, then TOPORS would re-located to nucleoplasm. 
TOPORS was also shown to act as a SUMO1 E3 ligase towards mammalian Sin3A, which is 
a repressor of transcription (Pungaliya et al., 2007). 
Independent functional experiments demonstrated that TOPORS also SUMOylates p53 and DJ-
1 (Shinbo et al., 2005), involved in transcriptional regulation and anti-oxidative stress 
responses; its loss of functions is associated with early-onset Parkinson’s disease. DJ-1 and p53 
interact not only with TOPORS, but also with each other; moreover, in cells DJ-1 co-localised 
with both TOPORS and p53, however, its co-localisation with the latter needs to be stimulated 
by UV irradiation. Overall, in the described experimental settings, DJ-1 positively regulated 
p53, whose transcriptional activity was repressed by TOPORS SUMOylation. On the contrary, 
Weger et al. (2005) showed in an independent study that TOPORS acts as a SUMO1 E3 ligase 
for p53, which is associated with an increase in p53 protein levels as well as its transcriptional 
activity. 
Detailed Y2H-based analysis showed that regions involved in PPIs with SUMO1 included 
residues 415-737 as well as 854-1045, whereas the fragment sufficient for interaction with 
UBC9 entailed amino acids 871-917 (Weger, Hammer e Engstler, 2003). The authors also 
showed that SUMO1-interaction motif (SIM) in TOPORS is homologous to the SIM of human 
PIASx, and that TOPORS itself is modified by SUMO1 on lysine 560. Residues 437-574 were 
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sufficient for SUMOylation of TOPORS as well as for its localisation to nuclear speckles in HeLa 
cells; it was shown that some, but not all, of these speckles co-localised with PML bodies, and 
that SUMOylation of TOPORS was not necessary for this localisation. 
It should be noted that PIASxα and PIASy also SUMOylate DJ-1 (Shinbo et al., 2006); and 
the SIMs of TOPORS and PIASx are homologous. In addition, PIASy associates with CGI-55, 
which in turn is an interacting partner of TOPORS (Lemos e Kobarg, 2006). The interaction with 
CGI-55 was demonstrated by a Y2H as well as co-localisation in HeLa cells. It was also re-
established that TOPORS localised to the PML bodies, however, CGI-55 associated with them 
only weekly, despite what its punctate localisation in the nucleus (and the cytoplasm) might 
have initially suggested. It is also worth highlighting that in another Y2H screen TOPORS 
interacted with Mx1, which is involved in cellular responses to viral stress (Engelhardt et al., 
2001). Mx1 also associates with Daxx, which was also shown to interact with CGI-55 (Lemos e 
Kobarg, 2006). Furthermore, it was also demonstrated that Mx1 localises to PML NBs and 
interacts with SUMO1 as well as with a subunit of its activating enzyme SAE2 (Engelhardt et al., 
2001). 
 
1.8 THE CENTROSOME CYCLE 
As was described in section 1.5, TOPORS protein is involved in cell cycle regulation and its fate 
and functions differ depending on the cell cycle stage. This is further reflected the close 
association of TOPORS with the centrosome, a unique organelle, which is also essential for 
development of the primary cilium, forming its basal body (section 1.9.1), where TOPORS was 
shown to localise. 
The centrosome is a key organelle in animal cells, where it acts as the main microtubule-
organising centre (MTOC), and is involved in maintaining the polarity, adhesion and motility of 
interphase cells, whereas in mitotic processes it mediates processes such as spindle formation, 
positioning and cell division. Moreover, it is also distinct in the sense that, like the DNA, it is 
doubled at every cell cycle in a semi-conservative manner – a process referred to as 
the centrosome cycle. Aberrations of centrosome functions and duplications often lead to 
malignant changes due to resulting chromosomal segregation and cytokinesis complications as 
well as enhanced motility. 
The semi-conservative duplication of the centrosome is possible due to the fact that 
the organelle constitutes two centrioles: a mother centriole (which can form the basal body 
at G0) and a daughter centriole, both surrounded by peri-centriolar material (PCM). 
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During cell division (phase M in Figure 1-19) the two centrioles separate, moving off to 
opposite sides of the cell, where they facilitate the formation of spindle poles and, ultimately, 
cell division.  Just following cytokinesis, i.e. at G1 stage of the cycle, a cell will only possess one 
centrosome. As the cell-centrosomal cycle progresses the centrosome will either start 
duplicating at the S phase (step E in Figure 1-19), whilst DNA synthesis is also occurring, or it 
will leave the cell division cycle and enter the quiescent G0 stage (step B in Figure 1-19). 
The classic cell cycle comprises four major phases, specifically G1, S, G2, and mitosis (M), 
followed by cell division (Figure 1-19). G1 is characterised by overall growth and duplication of 
cellular contents other than DNA and centrosomes, which are duplicated at the S-phase. 
The G2 phase involves further cellular growth as well as activities, serving to verify that 
the processes, performed at G1 and S phases, were completed without errors, before the cell 
enters mitosis, and subsequently divides.  
It should be noted that as the centrosome prepares for duplication at the G1 phase, its two 
centrioles become disengaged from each other, i.e. they are held together by a loose tether 
rather than being tightly combined and positioned at 90° to each other (compare centrosome 
appearance at stage M and G1 in Figure 1-19). The original two mother and daughter 
centrioles remain bound by this tether until late G2 phase. As duplication commences in the S 
phase, new pre-centrioles grow from both: the mother centriole and the daughter centriole; 
once the cycle is complete the ‘old’ daughter centriole acquires appendage proteins (not 
shown in Figure 1-19) and becomes the ‘new’ mother centriole. During the G2 phase the pro-
centrioles are elongating and maturating. The elongated pro-centrioles become ‘new’ 
daughter centrioles closely engaged with their mother centrioles in each of the resulting 
centrosomes. Maturation is completed towards the end of the G2 phase, and the two 
centrosomes become separated during the G2/M transition. Centrosome disengagement 
additionally occurs approximately during the M/G1 transition, and is involved in preparation of 
the centrosome for the subsequent cell cycle (reviewed in: Meraldi e Nigg, 2002).  
As was mentioned above, some cells, such as neurons, including the photoreceptors, become 
differentiated and exit the cell cycle in a transition from a G1 to G0 phase. It is at this quiescent 
stage that cells will undergo ciliogenesis and acquire a primary cilium, whilst the mother 
centriole will be acting as the basal body.  
It is noteworthy that centriolar staining can be indicative of the cell cycle stage, at which 
an observed cell was fixed (Durcan et al., 2008; Li, J. et al., 2012; Li et al., 2013). 
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Figure 1-19. Model of the regulation of cilia formation by CP110 in cycling and quiescent cells. 
A, When a cell enters a new cycle it only has one centrosome comprising a mother and a daughter 
centriole. The mother centriole matures on mitotic entry, recruiting molecules that enable it to form 
appendages, such as ODF2 (brown triangle). It is possible that upon mitotic exit, CEP97 (yellow circle) is 
degraded or removed from centrioles leading to destabilization of CP110 at the mother centriole (blue 
square). B, In G1, the absence of CP110 and presence of ODF2 specifically in the mother centriole 
enables it to become a basal body, tethering at the membrane, where it begins to form a ciliary 
axoneme. C, If nutrients are removed, cells can exit the cell cycle and become quiescent (G0). At this 
stage, the cilium can grow further. D, On serum stimulation, cells re-enter the cell cycle and the cilia are 
re-absorbed. E, The centrioles (or basal bodies) duplicate in S phase. CP110 is necessary in the daughter 
centrioles for their biogenesis. F, On centrosome maturation at the G2/M transition, the cilium is re-
absorbed and centrioles move to the centre to participate in mitotic-spindle assembly. The mitotic 
kinase Aurora A (pink oval) activates tubulin deacetylase, hence promoting ciliary disassembly and 
internalization of the basal body. Figure and legend modified from Bettencourt-Dias and Carvalho-
Santos (2008). 
 
Specifically, two dots, shown by centrin-2 immuno-staining, represent G1-phase cells; three to 
four clustered dots of centrin-2 indicate the S-phase of the cell cycle; whereas G2-phase cells 
can be recognised by centrin-2 staining, which shows three to four dots, where pairs of dots 
are observed at least 3 µm apart from each other (Li et al., 2013).   
Throughout the centrosomal cycle, tightly coupled to the cell division cycle, diverse groups of 
proteins are associated with this organelle, among which cyclins and cyclin-dependent 
kinanses (CDKs) comprise the backbone for cell cycle progression (Meraldi e Nigg, 2002). 
However, the focus in Figure 1-19 is to depict proteins involved, specifically, in promotion or 
inhibition of entering the G0 stage and primary cilium formation (section 1.9.1).  
It will be demonstrated in the experimental Chapter 7 that some of the novel interacting 
partners of TOPORS will associate with the centrosome throughout the cell cycle (like TOPORS 
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does), whereas others will be observed co-localising with this organelle only in dividing cells, 
and then sometimes with only one of its centrioles.  
It is also noteworthy that the centrosome was revealed to function as a central hub for protein 
degradation machinery in dividing human embryonic kidney (HEK) 293 and HeLa cells (Wigley 
et al., 1999), of which the key constituents are the 26 S protease/proteasome complexes 
(section 1.7.1.1). Additionally, the components of the ubiquitin-proteasome system (UPS) were 
shown to interact with centrosomes in primary neurons to regulate dendrite development, 
demonstrating that the centrosome-proteasome relationship is not limited solely to cycling 
cells, but also occur in cells at the G0 stage (Puram et al., 2013). Furthermore, independent 
studies demonstrated that close cooperation between these two structures is critical for 
maintenance of cell signalling (Gerdes et al., 2007; Liu et al., 2014). Consequently, these 
findings allow for speculating that modulation of the UPS activity may serve as a potential 
therapeutic strategy for ciliopathies (section 1.9.3).  
 
1.9 VERTEBRATE CILIA 
Eukaryotic cilia, often referred to as flagella, when they are involved in generating movement, 
are cellular organelles, which appeared early in evolution; they are remarkably well conserved 
from protozoa to humans (reviewed in: Singla e Reiter, 2006; Gerdes, Davis e Katsanis, 2009). 
In vertebrates, these organelles are found ubiquitously in polarised cells, where they serve 
a number of sensory and signalling functions; they are a characteristic of quiescent cells, most 
of which develop just one cilium per cell, a non-motile primary cilium. The proteome of these 
highly complex structures has been shown to comprise approximately a thousand various 
polypeptides (Gherman, Davis e Katsanis, 2006). Cilia are profoundly involved in development, 
as well as maintaining homeostasis of specific cell types, tissues and organs. Hence, 
a significant association between ciliary defects and numerous clinical phenotypes, including 
inherited retinal disorders, has been demonstrated (section 1.9.3). 
 
1.9.1 THE PRIMARY CILIUM 
Cilia are polarised structures consisting of two major components: the basal body and 
the axoneme (Figure 1-20). The basal body is formed from a modified mother centriole, 
surrounded by a pericentriolar material, and it serves as an anchor for the whole organelle; 
this structure forms a hollow cylinder comprising nine evenly distributed microtubule triplets. 
The axoneme, which protrudes away from the cell, is connected to the basal body via 
a transition zone, and it can be of two main types.  
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Figure 1-20. Ciliary structure in vertebrates.  
A: Scanning electron micrograph of motile cilia; B: Scanning electron micrograph of a solitary primary 
cilium; C: Structural comparison of the motile and primary cilia. Figure from Davenport et al. (2005). 
 
The axonemes of primary cilia comprise nine microtubule doublets continued from 
the microtubules of the basal body; this is known as the 9+0 microtubule configuration, and it 
is found predominantly in non-motile cilia (primary cilia). An additional doublet of 
microtubules, centrally located inside the axoneme and embedded within a sheath (9+2 
configuration), is found in most motile cilia (flagella). The microtubules within both axoneme 
types are joined together by nexin links, and they are held in place by radial spokes, which 
extend from the outer microtubules towards the centre of the structure. Within each 
microtubule doublet, the ‘A’ tubule serves for binding dynein and retrograde intraflagellar 
transport (IFT) proteins, whereas the anterograde IFT proteins and kinesin-2 bind to the ‘B’ 
tubule (Fliegauf, Benzing e Omran, 2007; Gerdes, Davis e Katsanis, 2009). 
 
1.9.2 THE CONNECTING CILIUM OF THE PHOTORECEPTOR CELL 
The outer segment of the photoreceptor cell can be considered a specialised primary cilium. 
The sensory photoreceptor cells are unique in the fact that they comprise two segments 
physically joined together by a bridge-like structure, the photoreceptor connecting cilium (CC). 
Of all the cellular functions, performed by photoreceptors, impairment of the ciliary transport 
is the most frequent cause of photoreceptor degeneration (reviewed in: Wright et al., 2010). 
As is depicted in Figure 1-21, the cellular organelles required for protein synthesis in the rod 
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cell are all located within the inner segment. The outer segment, responsible for light-sensing, 
is entirely dependent on the anterograde ciliary transport for receiving rhodopsin and 
the building blocks required for its daily renewal. Metabolised, turned-over protein products 
are transported back to the inner segment by the retrograde IFT proteins. Consequently, any 
defects in the structure of the connecting cilium or the components of the IFT system within 
this organelle result in photoreceptor malfunction and, eventually, cell death. 
 
 
Figure 1-21. Figure 1 21. The connecting cilium of photoreceptor cells.  
Left: an electron micrograph of rod photoreceptors and a corresponding detailed diagram, depicting the 
inner and outer segments joined together by a connecting cilium (CC); structural components of the CC, 
and proteins known to be involved in its function are highlighted. Right: Schematic representation of rod 
and cone photoreceptor cells, demonstrating the distinct structure of their outer segments. Figure from 
Wright et al. (2010). 
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1.9.3 CILIA AND CILIOPATHIES 
In addition to photoreceptors, cilia are found on almost all types of differentiated, mammalian 
cells, which have exited the cell cycle (i.e. which are at the quiescent phase, or G0).  
It has been shown in recent years that defects in these organelles lead not only to retinal 
disorders due to impaired function of the photoreceptor connecting cilium, but they result in 
a much wider range of disease phenotypes (Table 1-2). The variable diseases resulting from 
malfunction of this cellular organelle are collectively referred to as ciliopathies. 
 
Table 1-2. Clinical phenotypes associated with ciliary dysfunction syndromes. 
BBS, Bardet-Biedl Syndrome; SLS, Senior-Løken Syndrome; MS, Meckel Syndrome; JS, Joubert Syndrome; 
USH, Usher Syndrome. Table modified from Badano et al. (2006). 
Disease BBS SLS MS JS USH 
Retinitis pigmentosa √ √ √ √ √ 
Renal cystic disease √ √ √ √  
Polydactyly √  √ √  
Situs inversus/Isomerism √ √ √ √  
Mental retardation/developmental delay √  √ √  
Hypoplasia of corpus callosum √  √ √  
Dandy-Walker malformation √ √ √ √  
Posterior encephalocele √*  √ √  
Hepatic disease √ √ √ √  
Impaired vestibular function     √ 
Sperm abnormalities     √ 
Ataxia     √ 
Anosmia √    √ 
Hearing impairment √    √ 
*In mice. 
Besides retinal dystrophies, clinical phenotypes associated with the ciliopathies include hearing 
impairment due to defects of the inner ear, cysts in the pancreas, liver and kidney, polydactyly, 
situs inversus, as well as developmental and nervous system abnormalities (reviewed in: 
Fliegauf, Benzing e Omran, 2007; Gerdes, Davis e Katsanis, 2009). The outlined phenotypic 
features have all been identified in different combinations in a number of ciliopathic 
syndromes, as summarised in Table 1-1. USH and BBS, which are the two most commonly 
diagnosed forms of syndromic RP (section 1.3.2), are also classified as ciliopathies, which 
further underlines the key role of the cilia and, in particular, the connecting cilium in 
maintaining the photoreceptor cell homeostasis. 
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1.10 HYPOTHESES AND AIMS 
To date, the studies of TOPORS have revealed that it is a protein of a multifunctional character 
with numerous important functions within a range of cellular processes, such as ubiquitination 
or SUMOylation (Weger, Hammer e Heilbronn, 2005; Guan et al., 2008). It is ubiquitously 
expressed in human tissues, including the retina, and it has been shown to localise to 
the nucleus as well as to the centrosome and basal body of dividing and non-dividing cells, 
respectively (Chakarova et al., 2011). 
Interestingly, mutations in TOPORS are only known to cause retinal dystrophies with no other 
systemic symptoms. Hence, the aim of this project is to ascertain why mutations in 
a ubiquitously expressed, multifunctional gene like TOPORS only result in a retina-specific 
disease by identifying interacting protein partner(s) of TOPORS from the retina. 
Since TOPORS does not appear to have a role in classical retinal pathways, such as 
phototransduction, or the visual cycle, it may be assumed that its retinal pathology is probably 
associated with the protein’s localisation to the basal body of the photoreceptor connecting 
cilium.  
The uniqueness of the photoreceptor cell structure and physiology, coupled to the localisation 
of TOPORS at the base of the cell’s strategic organelle, may help explain the restricted disease 
phenotype caused by TOPORS mutations. If the identified interacting partner(s) are also found 
to localise to the basal body, this would reveal an additional valuable piece of the puzzle. 
 
1.10.1 RETINAL LIBRARY CONSTRUCTION AND VALIDATION 
A human retinal cDNA library was generated (Chapter 3) and used for the yeast two-hybrid 
(Y2H) screening (Chapter 4), aiming to test the hypothesis that novel interacting partner(s) of 
TOPORS are proteins expressed specifically in the retina rather than ubiquitously, or that they 
perform a function specific to the retina.  
The library was made in-house in the Y187 Saccharomyces cerevisiae yeast strain, using 
the ‘Make Your Own “Mate & Plate” Library System’ (Clontech, CA, USA).  The library was 
cloned into the pGADT7-Rec vector in order to generate constructs coding for retina-expressed 
proteins fused to the GAL4 activation domain (GAL4 AD).   
The generated library was characterised in order to determine its suitability for the Y2H 
screen. Transformation efficiencies, cell densities, titres and numbers of independent clones 
were calculated, and examples of the obtained retinal cDNA sequences were identified. 
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The approximate insert sizes were also determined for a proportion of library clones.  It was 
critical that rhodopsin, or another retina-specific transcript, was isolated in order to validate 
the retinal cDNA library. 
A ready-made human brain cDNA library (Clontech, CA, USA) was purchased for contingencies.  
 
1.10.2 BAIT CONSTRUCTION AND Y2H CONTROL EXPERIMENTS 
Full-length TOPORS cDNA sequence, encoding the TOPORS bait, was cloned into a Y2H-
compatible vector, in frame with the cDNA, encoding GAL4 DNA binding domain (GAL4 DNA-
BD) (Chapter 3). The purpose for generating a TOPORS - GAL4 DNA-BD fusion-encoding 
construct, was to express a bait fusion protein in yeast, which would be compatible with 
the cDNA library clones fused to GAL4 AD. If TOPORS and its prey(s) from the retinal library 
interact, this will bring the two domains of GAL4 into sufficient proximity to activate 
the expression of reporter genes, demonstrating protein-protein interactions (PPIs). 
The Y2H Gold Saccharomyces cerevisiae yeast strain (Clontech, CA, USA) was transformed with 
the resulting bait vector. Following yeast transformation with the bait plasmid, control 
experiments to check for expression, auto-activation, and potential toxicity to the host yeast 
cells, were completed in order to determine whether the bait construct was suitable for use in 
the Y2H (or whether an alternative method for detecting PPIs should be used).  
Additional Y2H control PPI experiments were also performed prior to the screening to test 
the experimental set-up. Specifically, previously reported interactions between p53 and 
the SV40 T antigen (Ag) as well as p53 and TOPORS were tested. 
Yeast-two hybrid (Y2H) screen (Chapter 4) was performed by mating the library yeast culture 
with the bait culture, and spreading the mated cultures on media selective for interactions. 
Identification of interacting partner(s) of TOPORS, which would have an obvious relation to 
the retina, was anticipated. 
 
1.10.3 VALIDATION OF INTERACTIONS AND mRNA EXPRESSION 
The interacting partners of TOPORS identified through the Y2H screen (Chapter 4) were 
prioritised for downstream experiments based on their retinal status. Specifically, if a protein 
expressed only in the retina, or a more widely-expressed protein with a function exclusive to 
the retina, was found to interact with TOPORS, this protein would be prioritised for 
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downstream experiments (rather than a ubiquitously expressed protein with no known 
associations to the retina). 
The selected interaction(s) were verified by additional studies in yeast (Chapter 5). The goal 
was to confirm that the PPI(s) occur, when they are repeated, using a full-length cDNA 
corresponding to the interacting partner(s), rather than just its/their fragment from 
the retinal library. 
Furthermore, known protein-coding isoforms of the identified interacting partner(s) were 
searched for on the Ensembl genomic database to subsequently determine whether any of 
them was also expressed in the retina (Chapter 5).  
Isoform-specific primers were designed and a reverse-transcriptase (RT) PCR study was 
performed to establish whether any of the known protein-coding transcripts of the identified 
interacting partner(s) could also be amplified from the human retinal RNA. If this was the case, 
they would also be included in the further validation and characterisation experiments. 
 
1.10.4 CONFIRMATION OF PPI(s) IN HUMAN CELL LINES 
Following the completion of validation experiments in yeast as well as the isoform expression 
study, the subsequent objective was to show that the PPI(s) also occur in human cell lines 
between endogenously-expressed TOPORS and its newly identified endogenously-expressed 
partner(s) (Chapter 6).  
Firstly, Western blotting was performed to confirm that the interacting partner(s) were 
expressed in human cell lines at protein level. If their expression was not detected, then 
transfections of cells with constructs encoding the interacting protein(s) of interest would 
need to be performed prior to the co-immunoprecipitation (coIP) studies.  
Following positive validation of expression of protein(s) of interest, coIP was performed on 
cultured cells to test the hypothesis that the PPI(s) identified via the Y2H do indeed occur in 
human cell lines. 
 
1.10.5 CO-LOCALISATION STUDIES TO VALIDATE PPI(s) 
In order to test the hypothesis that, like TOPORS, its newly-identified and validated interacting 
partner(s), also localise to the centrosome, and/or the basal body of primary cilia, 
immunofluorescence (IF) localisation studies with centriolar and ciliary markers were 
performed in human cell lines (Chapter 7). The localisation was subsequently studied in mouse 
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retinal sections to test the hypothesis that the identified PPI(s) could have occurred within 
the native retinal tissue (Chapter 8).  
Ultimately, findings from the tissue localisation studies would allow for evaluating 
the argument that the retinal protein(s), shown to interact with TOPORS in two different 
systems (yeast and human cells), would also co-localise with TOPORS at the base of 
the connecting cilium in the mouse retinal sections.  
Demonstration of interaction(s) and localisation at the expected retinal region would fulfil 
the overall aim of the thesis, which was to identify protein partner(s) of TOPORS from 
the retina and to characterise the interaction(s). Ultimately, this could help answer a major 
question of the thesis in RP context, i.e. why mutations in ubiquitously-expressed TOPORS 
result only in retinal disease by investigating the functional relationship(s) between TOPORS 
and its interacting partner(s). 
 
1.10.6 FUTURE CONTEXT 
The results of this research would ultimately help to elucidate the role of TOPORS in causing 
the retina-specific phenotype regardless of the ubiquitous expression of this protein. The work 
may help define the cellular pathways and/or networks that TOPORS is implicated in within 
the retina as well as this may help to understand the general intra- and intercellular protein 
interactions implicated in retinal degeneration. Finally, the knowledge gained throughout 
conducting this project could aid the development of future therapies, targeting, for instance, 
the identified cellular pathways, which TOPORS and its protein partner(s) are involved in. 
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2 METHODS AND MATERIALS                      
This chapter provides a synthesis of techniques and materials required to fulfil the aims and 
objectives of this project. Firstly, an overview of the yeast two-hybrid (Y2H) system is provided. 
This is followed by basic molecular biology and genetics as well as immuno-chemical methods. 
The chapter ends with a summary of materials and recipes for buffers and other solutions used 
throughout the project. 
 
2.1 YEAST TWO-HYBRID SYSTEM 
The yeast two-hybrid (Y2H) method (Figure 2-1) for detecting protein-protein interactions 
(PPIs) was used to fulfil the preliminary objective of this PhD thesis, specifically, to identify 
the interacting partners of TOPORS from the human retina. 
 
 
Figure 2-1. Basis of the Y2H assay. 
If GAL4 DNA-BD is fused with TOPORS, here called the bait protein, whereas GAL4 AD is fused with one 
of its interacting protein partners, denoted as the prey protein, and bait and prey interact, BD and AD 
are brought into sufficient proximity to activate transcription of the reporter genes (BD of 
the reconstituted transcription factor binds to the promoter region of a reporter gene, whereas AD 
activates transcription of the reporter gene by recruiting RNA polymerase (pol) II. Figure from 
the Matchmaker
TM
 Gold Yeast Two-Hybrid System (Clontech, CA, USA) user manual. 
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2.1.1 Y2H: AN OVERVIEW 
The method was pioneered by Fields and Song (1989), who demonstrated the advantageous 
properties of GAL4, a protein, which, in its endogenous environments, acts as a transcriptional 
activator of galactose utilisation genes in the yeast Saccharomyces cerevisiae. 
Results presented in experimental Chapters 3, 4 and 5 are based on the Y2H system. 
 
2.1.1.1 Y2H: FUNCTIONAL BASIS 
GAL4 comprises two strategic functional domains: a DNA-binding domain (BD) and 
a transcriptional activation domain (AD). The binding domain, located at the amino terminus of 
GAL4, binds to specific DNA sequences upstream of the gene to be transcribed, i.e. the GAL 
upstream activation sequences (UAS) or promoters. The carboxyl-terminus activation domain 
is essential for activating transcription via recruiting RNA polymerase II. 
The GAL4 BD and AD domains can be physically separated and still retain their functions, as 
physical separation does not interfere with GAL4 protein folding. This quality of GAL4 is 
exploited in the Y2H system, where each one of the two GAL4 domains is fused to another 
protein (in context of this project: TOPORS and one of its interacting partners). If both hybrid 
proteins are brought into sufficient proximity due to an interaction between TOPORS and 
the interacting partner, they can act as a fully functional transcriptional activator (Navaratnam, 
2009). 
 
2.1.1.2 Y2H: PLASMID CONTRUCTS 
In order to screen for the interactions, suitable DNA vectors must first be designed and 
constructed (Methods and Materials section 2.2.5 and experimental Chapter 3). For 
the purposes of the Y2H method the GAL4 BD and GAL4 AD are normally cloned into two 
different vectors. Each one of the vectors also carries a gene for antibiotic resistance for 
propagation in bacteria, as well as nutritional selection genes for use in the Y2H. 
A complementary DNA (cDNA)  encoding the protein of interest, i.e. the bait is normally cloned 
into the GAL4 BD vector in frame with the GAL4 BD cDNA. The preys are cloned into 
the GAL4 AD vectors in frame with the cDNA encoding the activation domain. Plasmids 
manufactured by Clontech (CA, USA) as well as the Gateway cloning vectors 
(LifeTechnologies, CA, USA) were used (Table 2-1, Table 2-2). 
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Table 2-1. In-fusion cloning (Clontech, CA, USA) vectors. 
Vector Purpose Features 
pGBKT7 
(Clontech, CA, USA) 
In-fusion cloning 
(Clontech, CA, USA) vector 
containing the GAL 4 DNA BD. 
Genes encoding Y2H bait proteins 
can be cloned into this vector. 
Contains the TRP1 nutritional 
reporter gene for selection in 
yeast and a gene for kanamycin 
resistance for selection in 
bacteria. 
pGADT7 
(Clontech, CA, USA) 
In-fusion cloning 
(Clontech, CA, USA) vector 
containing the GAL 4 AD. Genes 
encoding Y2H prey proteins can be 
cloned into this vector. 
Contains the LEU2 nutritional 
reporter gene for selection in 
yeast and a gene for ampicillin 
resistance for selection in 
bacteria. 
pGADT7 –Rec 
(Clontech, CA, USA) 
In-fusion cloning 
(Clontech, CA, USA) vector 
containing the GAL 4 AD. 
Recommended vector for cloning 
of a cDNA library. 
Contains the LEU2 nutritional 
reporter gene for selection in 
yeast and a gene for ampicillin 
resistance for selection in 
bacteria. 
 
Table 2-2. Gateway cloning (LifeTechnologies, CA, USA) vectors. 
Vector4 Purpose Features 
pDONR/Zeo 
(LifeTechnologies, CA, 
USA) 
Donor vector used in the Gateway 
cloning BP reaction as shuttle 
vector (see section 2.2.5.3 
Gateway cloning). 
Contains attP1 and attP2 
sequences and a gene for zeocin 
resistance. 
pAD5 
Destination vector, containing 
the GAL 4 AD, used in 
the Gateway cloning LR reaction 
(see section 2.2.5.3 Gateway 
cloning). Genes encoding Y2H 
prey proteins can be cloned into 
this vector. 
Contains attR1 and attR2 
sequences, the LEU2 nutritional 
reporter gene for selection in 
yeast and a gene for ampicillin 
resistance for selection in 
bacteria. 
pBD5 
Destination vector, encoding 
the GAL 4 DNA BD, used in 
the Gateway cloning LR reaction 
(see section 2.2.5.3 Gateway 
cloning). Genes encoding Y2H bait 
proteins can be cloned into this 
vector. 
Contains attR1 and attR2 
sequences, the TRP1 nutritional 
reporter gene for selection in 
yeast and a gene for 
chloramphenicol resistance for 
selection in bacteria. 
 
                                                          
 
4
 The E. coli DB3.1 cells were used for propagation of Gateway vectors in bacteria (see bacterial 
transformation section 2.2.3). 
5 These vectors were a gift from Dr Ronald Roepman. They had been modified from original Stratagene 
(CA, USA) vectors to contain the att sequences, i.e. to allow compatibility with Gateway cloning 
(LifeTechnologies, CA, USA; see section 2.2.5.3). 
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2.1.1.3 Y2H: PPI SCREENING 
The process of screening for bait - prey interactions requires the expression of genes encoded 
on both plasmids within a single yeast cell. Yeast cells intended for use in Y2H screening can 
grow either as haploid, or as diploid mated cells; in natural conditions higher ploidy levels have 
also been recorded (Gunge e Nakatomi, 1972).  
Traditionally, the standard Y2H PPI screening procedure involved co-transformation of baits 
and preys into haploid yeast cells. As an alternative, the bait and prey plasmids can be 
transformed into haploid yeast cells of different mating types. When the yeast cells mate to 
form diploids, both plasmids are then found within one cell, where the genes can be expressed 
and their products can interact. 
The MatchmakerTM Gold Yeast Two-Hybrid System (Clontech, CA, USA), used for this project, is 
based on the yeast mating procedure. Two strains of the yeast S. cerevisiae are provided; 
the Y2H Gold, which serves as the bait reporter strain, is of the MATa mating type, whereas 
the Y187 prey reporter strain is of the MATα mating type. 
The Y2H Gold strain and the Y187 strain possess four and two reporter genes, respectively, 
which are under control of GAL4-responsive promoters (Table 2-3, Table 2-4). 
 
Table 2-3. Y2H Gold (the bait host strain) reporter gene constructs. 
GAL4-responsive promoter Reporter gene 
G1 Promoter HIS3 
G2 Promoter ADE2 
M1 Promoter AUR1-C 
M1 Promoter MEL1 
 
Table 2-4. Y187 (the prey host strain) reporter gene constructs. 
GAL4-responsive promoter Reporter gene 
G1 Promoter lacZ 
M1 Promoter MEL1 
 
The Y2H Gold strain is auxotrophic for histidine and adenine, encoded by the HIS3 and 
the ADE2 genes, respectively. However, both of these genes can be expressed under control of 
the GAL4-responsive promoters, therefore, when bait and prey proteins interact, this allows 
the yeast to synthesise both the essential amino acid as well as the purine base. Thus, strains, 
in which the protein interaction occurs, should be able to grow on media that lack both of 
these substrates. 
Identification of Interacting Protein Partners of TOPORS in the Retina   ||   Barbara Czub 
PhD Thesis 2015   ||   Methods and Materials   - 83 - 
 
The AUR1-C is a dominant mutant version of the AUR1 gene, which codes for the inositol 
phosphoryl ceramide synthase. This enzyme, when expressed in yeast, confers resistance to 
the highly toxic antifungal agent, Aureobasidin A (AbA). According to the MatchmakerTM Gold 
Yeast Two-Hybrid System User Manual (Clontech, CA, USA) the use of AbA, as a drug reporter, 
leads to less background than, for instance, the use of histidine reporter, hence, using AbA is 
advantageous over using the nutritional reporters only. 
MEL1 codes for the enzyme α-galactosidase, which allows the yeast to utilise the colourless 5-
bromo-4-chloro-3-indolyl α-D-galactopyranoside (X-α-Gal). The resulting product is blue, which 
is reflected in the appearance of yeast colonies, in which MEL1 is expressed. Both the Y2H Gold 
and the Y187 strains can express MEL1, if protein interactions occur. The latter strain also 
expresses a component of the lac operon, the lacZ gene, if protein interactions occur. This 
gene encodes β-galactosidase; the expression of this enzyme also results in the yeast colonies 
producing a blue product, given that they are grown on media supplemented with 
the colourless 5-bromo-4-chloro-3-indolyl-β-D-galactoside (X-β-Gal). 
The yeast methods described in subsequent sub-sections were used to generate results 
reported in experimental Chapters 3, 4 and 5. 
 
2.1.2 YEAST CELL STOCK MAINTENANCE 
In order to prepare for the Y2H experiments the yeast cells need to be maintained in 
appropriate conditions throughout the course of the project. 
Two strains of yeast cells were provided with the MatchmakerTM Gold Yeast Two-Hybrid 
System (Clontech, CA, USA) as frozen glycerol stocks: the Saccharomyces cerevisiae Y2H Gold 
strain (MATa mating type) and the S. cerevisiae Y187 strain (MATα mating type).  
In addition to maintaining a frozen glycerol stock, both strains were maintained on solid media 
by re-streaking on fresh YPDA agar (Table 2-5) plates every month. The untransformed yeast 
cells were spread on YPDA agar dishes, sealed with Parafilm (Pechiney Plastic Packaging, IL, 
USA), incubated at 30 °C for approximately 48-72 hours to allow for sufficient growth, and 
stored at 4 °C.  
The Y2H Gold strain was used for transformation of plasmids encoding the bait, whereas 
the Y187 strains serves as a host for the prey fusion proteins. 
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Table 2-5. Yeast Peptone Dextrose Adenine (YPDA) media for yeast culture. 
YPDA Agar Medium YPDA Liquid Medium 
25 g YPD 25 g YPD 
0.02 g adenine hemisulphate salt 0.02 g Adenine hemisulphate salt 
10 g agar - 
500 ml dH2O 500 ml dH2O 
 
2.1.3 TRANSFORMATION OF COMPETENT YEAST CELLS 
For the purpose of performing the Y2H PPI experiments, yeast cells needed to be transformed 
with constructs, encoding the human retinal proteins of interest. Specifically, these included 
TOPORS and clones of the human retinal cDNA library (section 2.1.8 and experimental 
Chapter 3). 
Prior to yeast transformation the yeast cells must firstly be made competent. This is performed 
using the TrisEDTA/lithium acetate (TE/LiAc) methods (section 2.1.3.1). Yeast cells prepared in 
this way are subsequently ready for transformation using the TE/polyethylene glycol (TE/PEG) 
method (2.1.3.2). 
Construction of the cDNA library in yeast and culture of TOPORS bait constructs as well as 
the control plasmids (Chapter 3) in yeast highly relied on the transformation procedure. 
 
2.1.3.1 PREPARATION OF COMPETENT YEAST CELLS 
Preparation of competent yeast cells was performed under sterile conditions based on Section 
VI. A. of the Yeastmaker™ Yeast Transformation System 2 User Manual (Clontech, CA, USA); 
several changes were introduced. 
A single yeast colony (either Y2H Gold, or Y187, depending on the plasmid to be transformed – 
see section 2.1.2) was inoculated into 3 ml YPDA medium in a sterile 50-ml tube; the culture 
was incubated with shaking (7-8 h, 30 ˚C, 250 rpm; Innova 4200 Incubator Shaker, New 
Brunswick Scientific, NJ, USA).  
Fifty microlitres of this culture were then inoculated into 200 ml of fresh YPDA medium in 
a sterile 250 ml conical flask; the culture was incubated with shaking (16-20 h, 30 °C, 215 rpm; 
Innova 4200 Incubator Shaker, New Brunswick Scientific, NJ, USA) until it reached an optical 
density of 0.8 - 1.0, when measured at a 600 nm wavelength (OD600 0.8-1.0).  
The culture was equally divided into two sterile conical-bottom 50 ml tubes and centrifuged 
at 1700 rpm for five minutes (RT) to pellet the cells (Megafuge 1.0 R, Heraeus, UK); 
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the supernatant was discarded and each pellet was re-suspended in 30 ml sterile, deionised 
water (dH2O).  
The centrifugation was repeated, the supernatant was discarded, and each pellet was re-
suspended in 6 ml of 1.1X TE/LiAc (Table 2-6).  
Each cell suspension was 
transferred to 1.5 ml micro-
centrifuge tubes (1 ml per tube) 
and centrifuged at 14000 rpm for 
20 seconds (Centrifuge 5417R,  
Table 2-6. 1.1X Tris-EDTA/Lithium Acetate (TE/LiAc) Solution. 
1.1X TE/LiAc Solution 
1.1 ml 10X TE (supplied with the kit) 
1.1 ml 1 M LiAc (10X) (supplied with the kit) 
7.8 ml sterile dH2O 
 
Eppendorf, Germany). The supernatant was discarded and each pellet was re-suspended in 
a final volume of 600 µl 1.1X TE/LiAc. The competent cells were used for transformation with 
plasmid DNA (section 2.1.3) 
  
2.1.3.2 YEAST TRANSFORMATION 
The freshly prepared competent yeast cells 
(section 2.1.3.1) were trans-formed with 
plasmid DNA, according to Section VI. B. of 
the Yeastmaker™ Yeast Trans-formation 
System 2 User Manual (Clontech, CA, USA) 
and were spread on appropriate agar 
media (Table 2-7, Table 2-8), using sterile 
glass beads (3 mm; Merck, Germany). 
Table 2-7. Synthetic Minimal Media for yeast culture. 
Synthetic Minimal Media 
3.35 g Yeast nitrogen base 
91.1 g D-sorbitol 
0.37 g of relevant dropout solution 
20 g agar 
20 ml 50 % glucose 
pH 5.8 
500 ml dH2O 
 
 
Table 2-8. Details of yeast media selecting for bait or prey constructs. 
Media type Selects for 
SD/-W (synthetic dropout lacking tryptophan) bait plasmids 
SD/-L (synthetic dropout lacking leucine) prey (library) plasmids 
 
The Y2H Gold competent cells were transformed (Table 2-9) with either the pGBKT7 vector 
(Table 2-1), or the pBD vector (Table 2-2); both vectors carry the GAL4 binding domain (BD), 
and a selective nutritional marker, TRP1, encoding the amino acid tryptophan. Inserts encoding 
the bait proteins were cloned into these vectors. 
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The Y187 competent cells were transformed (Table 2-9) with the pGADT7 as well as 
the pGADT7-Rec vectors (Table 2-1), carrying the GAL4 activation domain (AD), and a selective 
nutritional marker, LEU2, encoding the amino acid leucine.  
The human retinal cDNA library (Methods and Materials section 2.1.8 and experimental 
Chapter 3) was cloned directly into the pGADT7-Rec, and transformed into the Y187 
competent yeast cells. The potential prey proteins were subsequently cloned into the pGADT7 
vector for verification in yeast (direct interaction). Both plasmids are based on the same 
backbone sequence; however, the few differences between them are significant. The pGADT7-
Rec vector comprises two short sequences; the SMART III Sequence and the CDS III Sequence, 
which enable in vivo cloning by homologous recombination, whereas the pGADT7 vector 
contains specific restriction sites, which are not found in the former vector. 
 
Table 2-9. Summary of yeast strains and main associated plasmids. 
Yeast strain 
GAL4 
Domain 
Plasmid(s) used 
for strain 
transformation 
Insert(s) carried in the plasmid Function 
Y2H Gold BD 
pGBKT7 
(Clontech) 
TOPORS fragments 
Baits in Y2H 
direct PPIs 
Y2H Gold BD pBD6 Full-length TOPORS 
Bait in Y2H 
screen 
Y187 AD 
pGADT7-Rec 
(Clontech) 
Fragments of clones amplified 
from human retinal cDNA 
library 
Preys in 
the Y2H 
screen 
Y187 AD 
pGADT7 
(Clontech) 
Full-length and/or deletion 
constructs of interacting 
partners identified in the initial 
Y2H screen 
Preys in Y2H 
direct PPIs 
 
2.1.3.2.1 SMALL SCALE TRANSFORMATION 
The small scale transformation procedure was used for introducing bait plasmids into the Y2H 
Gold strain as well as relevant control plasmids into the corresponding strains (Chapter 3), or 
the newly-identified preys into the Y187 strain (Chapter 5). 
                                                          
 
6
 This vector was a gift from Dr Ronald Roepman. It had been modified from original pBD-GAL4 Cam 
(Stratagene, CA, USA) vector to contain the att sequences, i.e. to allow compatibility with Gateway 
cloning (LifeTechnologies, CA, USA; see section 2.2.5.3). 
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Before each transformation the Yeastmaker Carrier DNA (from herring testes cells; 10 µg/µl) 
was denatured by incubation at 95 °C for five minutes, and then immediately stored on ice; 
5 µl of the denatured carrier DNA was then combined with 100 ng of the plasmid DNA in 
a sterile 1.5 ml tube. 
The competent yeast cells (50 µl) and 
the PEG/LiAc solution (500 µl; Table 2-10) 
were subsequently added, and 
the suspensions were mixed gently; the cells 
were incubated at 30 °C for thirty minutes 
Table 2-10. Polyethylene glycol/Lithium Acetate 
(PEG/LiAc) Solution. 
PEG/LiAc Solution 
8 ml 50 % PEG 3350 (supplied with the kit) 
1 ml 10X TE Buffer (supplied with the kit) 
1 ml 1 M LiAc (10X) (supplied with the kit) 
 
with mixing by tapping or gentle vortexing (~800 rpm) every ten minutes. Twenty microlitres of 
DMSO were added to each tube, and the tubes were incubated in a 42 °C water bath for 15 
minutes with gentle vortexing (~800 rpm) every five minutes; Vortex Genie 2 (Scientific 
Industries, NY, USA) was used. The cells were pelleted by centrifugation at 14000 rpm for 
15 seconds (Centrifuge 5417R, Eppendorf, Germany).  
The supernatant was removed and the pellet was re-suspended in 1 ml of YPD Plus Medium 
(Clontech, CA, USA). The cells were then incubated in Innova 4200 Incubator Shaker (New 
Brunswick Scientific, NJ, USA; 1 h, 30 °C, 215 rpm).  
The cells were pelleted by centrifugation at 
14000 rpm for 15 seconds (Centrifuge 5417R, 
Eppendorf, Germany); and the superna-tant was 
discarded. The pellet was re-suspended in 500 µl 
of 0.9 % (w/v) NaCl Solution (Table 2-11). 
Table 2-11. 0.9 % Sodium Chloride (NaCl) 
Solution. 
0.9 % (w/v) NaCl Solution 
0.9 g NaCl 
100 ml dH2O 
Dissolved and filter-sterilised 
 
A hundred microlitres of each cell suspension (diluted 1:10 and/or 1:100) were spread on 
100 mm agar plates with the appropriate SD selection media; i.e. SD/-W for pGBKT7, and SD/-L 
for pGADT7 (Table 2-8). The plates were incubated upside down at 30 °C for 72-120 hours or 
until colonies appeared. 
 
2.1.3.2.2 LIBRARY-SCALE TRANSFORMATION 
This transformation procedure was used for construction of the human retinal cDNA library in 
the yeast Y187 stain (experimental Chapter 3).  
Before each transformation the Yeastmaker Carrier DNA (from herring testes cells; 10 µg/µl) 
was denatured by incubation at 95 °C for five minutes, and then immediately cooled on ice; 
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20 µl of the denatured carrier DNA was then combined with 5-15 µg of the plasmid DNA and 
purified cDNA in a sterile 15 ml tube.  
The competent yeast cells (600 µl) and the PEG/LiAc solution (2.5 ml) were subsequently 
added, and the suspensions were mixed gently; the cells were incubated at 30 °C for 
45 minutes with mixing by tapping or gentle vortexing (~800 rpm) every 15 minutes (Vortex 
Genie 2, Scientific Industries, NY, USA).  
One hundred and sixty microlitres of DMSO were added to each tube, and the tubes were 
incubated in a 42 °C water bath for twenty minutes with gentle vortexing (~800 rpm; Vortex 
Genie 2, Scientific Industries, NY, USA) every ten minutes. The cells were pelleted by 
centrifugation at 700 x g for five minutes.  
The supernatant was removed and the pellet was re-suspended in 3 ml of YPD Plus Medium 
(Clontech, CA, USA). The cells were then incubated with shaking (1 h 30’, 30 °C, 215 rpm; 
Innova 4200 Incubator Shaker, New Brunswick Scientific, NJ, USA). The cells were pelleted by 
centrifugation at 1700 rpm for five minutes; and the supernatant was discarded (Centrifuge 
5417R, Eppendorf, Germany).  
The pellet was then re-suspended in 15 ml of 0.9 % (w/v) NaCl Solution. A hundred microlitres 
of each cell suspension (diluted 1:10 and/or 1:100) were spread on 100 mm agar plates with 
the appropriate SD selection media; i.e. SD/-W for pGBKT7, and SD/-L for pGADT7. The 
remaining mixture was spread at a volume of 150 µl per 150 mm plates. The plates were 
incubated upside down at 30 °C for 72-120 hours or until colonies appeared. 
 
2.1.4 AUTO-ACTIVATION AND TOXICITY TESTING 
Baits constructed and transformed into yeast for the purposes of the Y2H PPI screening first 
had to be tested for potential auto-activation of PPI reporter genes and potential toxicity 
towards their yeast host cells. The former test was supposed to ensure that any reporter gene 
activation, observed as a result of the Y2H PPI screen, would be more likely to represent 
a genuine interaction, given that the reporter gene expression could not be triggered by 
the bait on its own.  
Competent Y2H Gold cells were transformed according to the Clontech protocol (section 
2.1.3). The cells were transformed with: 100 ng of the pGBKT7 vector without inserts, or 
the pBD-wt vector without inserts, and with 100 ng of the pGBKT7-bait(s) plasmids, or 
the pBD-bait plasmid (i.e. TOPORS fragments or its full-length cDNA). 
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Each transformation mixture was diluted 1:10 and 1:100, and spread onto selective agar plates 
(Table 2-12). 
 
Table 2-12. Details of yeast media used for auto-activation and toxicity testing. 
Media type Selects for 
SD/-W (=SDO) bait plasmids 
SD/-W/+X-α-Gal (=SDO/X) bait plasmids activating the Mel1 reporter 
SD/-W/+X-α-Gal/+AbA (=SDO/X/A) bait plasmids activating the Mel1 and Aur1-C reporters 
 
The expected results of the auto-activation test are summarised in Table 2-13. Diploid positive 
control mating plasmids (section 2.1.5.1) were re-streaked, as a control. 
In order to evaluate the potential toxicity of the baits the SD/-W plates were to be examined. 
Colonies transformed with a vector-bait plasmid were expected to be smaller than 
the corresponding empty vector, if the bait was toxic. 
 
Table 2-13. Expected bait auto-activation test results. 
Sample Selective agar medium Colonies Colour 
Auto-activation test SD/-W Yes White 
Auto-activation test SD/-W/+X-α-Gal Yes 
White or 
Very Pale Blue 
Auto-activation test SD/-W/+X-α-Gal/+Aba No n/a 
Positive control 
DD/-W/-L/+X-α-
Gal/+Aba 
Yes Blue 
 
The outcomes of the auto-activation and toxicity procedures are described in Chapter 3. 
 
2.1.5 YEAST MATING 
Yeast mating, rather than co-transformation, was the method of choice for the YH PPI 
screening (section 2.1.1.3). Additionally, prior to the Y2H PPI screen (experimental Chapter 4), 
control mating procedures were performed to validate the system (section 2.1.5.1 and 
experimental Chapter 3). 
Plasmids carrying DNA sequences for the bait and prey proteins, fused with the GAL4 BD and 
AD, respectively, were transformed into different haploid strains of yeast (section 2.1.3.2.1). 
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They were grown on media selecting either for baits or for preys (Tab;e 2-14). Vectors with 
inserts encoding the bait were transformed into the Y2H Gold MATa strain, whereas the prey-
encoding plasmids were transformed into the Y187 MATα strain. 
The two compatible yeast strains (mating types a and α) underwent a mating procedure, 
forming diploid yeast cells containing both of the previously transformed bait and prey 
plasmids, after being inoculated together into 500 µl of 2X YPDA in a 15-ml tube.  
The tubes were incubated with shaking (20-24 h, 30 °C, 200 rpm; Innova 4200 Incubator 
Shaker, New Brunswick Scientific, NJ, USA). Dilutions of the mated cultures were prepared 
(1/10, 1/100 and 1/1000), and 100 µl of each dilution were spread on agar plates selective do 
mated diploid yeasts and on additional control media (Table 2-14). The plates were incubated 
upside down at 30 °C for up to 72-120 hours. 
 
Table 2-14. Details of yeast media used for mating. 
Media type Selects for 
SD/-W bait plasmids 
SD/-L prey (library) plasmids 
SD/-L/-W (=DDO) both: bait and prey plasmids 
 
Equation 2.1 was used to calculate the efficiency of yeast mating. According to 
the MatchmakerTM Gold Yeast Two-Hybrid System User Manual (Clontech, CA, USA) ‘mating 
efficiencies of 2-5 % are readily achieved’. 
 
Equation 2.1. Mating Efficiency. 
MATING EFFICIENCY (% OF DIPLOIDS) = 
# OF CFU/ML OF DIPLOIDS 
X 100 % 
# OF CFU/ML OF LIMITING PARTNER 
    
2.1.5.1 CONTROL MATING PRIOR TO Y2H PPI SCREENING 
The Y2H PPI screen was carried out using the yeast mating strategy (section 2.1.1.3). Before 
this could be attempted, control mating experiments had to be completed in order to 
demonstrate the correct functionality of the system (Table 2-16) as well as compatibility of 
the Y2H vectors acquired from Clontech (CA, USA) and Life Technologies (CA, USA) (Table 2-1, 
Table 2-2, Table 2-18). Four control mating experiments were set up, using control vectors 
(Table 2-15): two for the positive controls and two for the corresponding negative controls 
(Tab;e 2-16). The tubes were incubated with shaking (20-24 h, 30 °C, 200 rpm; Innova 4200 
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Incubator Shaker (New Brunswick Scientific, NJ, USA). Dilutions of the mated cultures were 
prepared (1:10, 1:100 and 1:1000), and 100 µl of each dilution were spread on agar plates 
selective for PPIs, and on additional control plates (Table 2-17).  
Table 2-15. Y2H vectors for control mating procedures. 
Strain Transformation Plasmid Plating Medium 
Y2H Gold pGBKT7-p53 SD/-W with Agar 
Y2H Gold pBD-p53 SD/-W with Agar 
Y2H Gold pGBKT7-Lam SD/-W with Agar 
Y2H Gold pBD-pLC SD/-W with Agar 
Y187 pGADT7-T SD/-L with Agar 
 
Table 2-16. Control mating to check for Y2H system performance and vector compatibility. 
 Y187 [pGADT7-T] colony 
Y2H Gold [pGBKT7-p53] colony Positive control mating (1) 
Y2H Gold [pBD-p53] colony Positive control mating (2) 
Y2H Gold [pGBKT7-Lam] colony Negative control mating (1) 
Y2H Gold [pBD-pLC] colony Negative control mating (2) 
 
The positive control experiments involved mating the Y2H Gold strain, transformed with 
the GAL4 BD vectors, i.e. either the pGBKT7-53 or the pBD-p53, and the Y187 strain, 
transformed with pGADT7-T, the GAL4 AD vector (Table 2-18). The DNA binding domain 
vectors carried an insert, encoding the tumour suppressor p53 protein (bait), whereas 
the activation domain vector carried a gene for the large T antigen of the tumour-inducing 
Simian virus 40 (SV40; prey). These two proteins are known to interact (Carbone et al., 1997); 
hence, they can be used as a reliable positive control interacting protein-protein pair. 
The negative control experiment involved mating of the Y2H Gold strain, transformed with 
either pGBKT7-Lam or pBD-pLC (Table 2-18), both of which encode GAL4 BD fused with human 
lamin C (bait), and the Y187 strain, transformed with the pGADT7-T plasmid described in 
the previous paragraph. No interaction between these two proteins had ever been reported, 
therefore, the diploid yeast cells, resulting from the negative control mating, were not 
expected to grow on selective media enriched with AbA. 
Prior to the mating procedure, competent yeast cells had to be transformed with relevant 
plasmids (section 2.1.3.2.1). The plates were incubated at 30 °C for approximately 
72 hours; colonies used in each mating experiment were picked and inoculated into 500 µl of 
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2X YPDA in 50 ml conical-bottom tubes (Table 2-16). The plates were incubated upside down 
at 30 °C for up to 120 hours. 
 
Table 2-17. Details of yeast media used for Y2H PPI studies.  
Media type Selects for 
SD/-W bait plasmids 
SD/-L prey (library) plasmids 
SD/-L/-W (=DDO) both: bait and prey plasmids 
SD/-L/-W/+X-α-Gal/+AbA (=DDO/X/A) 
bait and prey plasmids and PPI interaction 
(Mel1 and Aur1-C PPI reporter genes) 
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Table 2-18. Y2H control plasmids.  
Vector Purpose Features Notes 
pGBKT7 -53 
(Clontech, 
CA, USA) 
In-fusion cloning 
vector encoding 
GAL 4 BD fused to 
p53 protein. 
Contains the TRP1 
nutritional reporter gene 
for selection in yeast and 
a gene for kanamycin 
resistance for selection in 
bacteria. 
Positive control for PPI 
mating, when used with 
pGADT7-T. 
pGBKT7 -
Lam 
(Clontech, 
CA, USA) 
In-fusion cloning 
vector encoding 
GAL 4 BD fused to 
human lamin C. 
Contains the TRP1 
nutritional reporter gene 
for selection in yeast and 
a gene for kanamycin 
resistance for selection in 
bacteria. 
Negative control for PPI 
mating, when used with 
pGADT7-T. 
pGADT7 –T 
(Clontech, 
CA, USA) 
In-fusion cloning 
vector 
encoding GAL 4 AD 
fused to SV40 large 
T antigen. 
Contains the LEU2 
nutritional reporter gene 
for selection in yeast and 
a gene for ampicillin 
resistance for selection in 
bacteria. 
Used in positive and 
negative PPI mating 
control experiments with 
pGBKT7-53 and pGBKT7-
Lam. 
Control for Clontech-Life 
Technologies vectors 
compatibility (with pBD-
p53 as positive PPI 
control and with pBD-pLC 
as negative PPI control). 
pAD-p537 
 
Vector 
encoding GAL 4 AD 
fused to p53 protein. 
Contains the LEU2 
nutritional reporter gene 
for selection in yeast and 
a gene for ampicillin 
resistance for selection in 
bacteria. 
Used with TOPORS fused 
to GAL4 DNA BD as 
a known PPI interaction 
control. 
pBD-p537 
 
Vector 
encoding GAL 4 BD 
fused to p53 protein. 
Contains the TRP1 
nutritional reporter gene 
for selection in yeast and 
a gene for chloramphenicol 
resistance for selection in 
bacteria. 
Used with pGADT7-T as 
control for Clontech-Life 
Technologies vectors 
compatibility (positive 
PPI control). 
pBD-pLC7 
 
Vector encoding 
GAL 4 BD fused to 
human lamin C. 
Contains the TRP1 
nutritional reporter gene 
for selection in yeast and 
a gene for ampicillin 
resistance for selection in 
bacteria.. 
Used with pGADT7-T as 
control for Clontech-Life 
Technologies vectors 
compatibility (negative 
PPI control). 
 
                                                          
 
7
 These vectors were a gift from Dr Ronald Roepman. They had been modified from original Stratagene 
(CA, USA) vectors to contain the att sequences, i.e. to allow compatibility with Gateway cloning 
(LifeTechnologies, CA, USA; see section 2.2.5.3). 
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2.1.6 PLASMID ISOLATION FROM YEAST 
In order to verify the identity of interacting partners of TOPORS isolated via the Y2H PPI screen 
plasmids, carrying library clone inserts, must be isolated. Two different plasmid isolation 
methods were used depending on the intended destiny of the isolated constructs.  
Plasmids needed to be isolated from yeast after to Y2H screen for protein interacting partenrs 
of TOPORS in order to determinat the identity of the latter. This was described in Chapter 4. 
 
2.1.6.1 EASY YEAST PLASMID ISOLATION 
In order to prepare a yeast plasmid for bacterial transformation and subsequent plasmid 
propagation the Easy Yeast Plasmid Isolation Kit (Clontech, CA, USA) was used. This procedure 
led to extraction of pure plasmid DNA without any contamination from the yeast genomic 
DNA. 
Plasmids were isolated from yeast, using the Easy Yeast Plasmid Isolation Kit (Clontech, CA, 
USA); several changes were introduced to the Clontech protocol. All values are given per 
plasmid isolation, i.e. per a 1.5-ml tube, and all spins were performed in a micro-centrifuge. All 
buffers and solutions were provided with the kit, unless specified otherwise. 
Up to 10 mg of yeast cells, taken either from an agar plate or a liquid culture, were used. 
The cells were re-suspended in 500 µl of 10 mM EDTA in a 1.5-ml tube. The cells were 
centrifuged at 13000 rpm for 2 minutes (Centrifuge 5417R, Eppendorf, Germany), and 
the supernatant was discarded.  
The pellet was re-suspended in 200 µl of ZYM buffer until the suspension was homogenous. 
Twenty microlitres of a uniform zymolyase suspension were added, the tubes were vortexed 
gently (~1000 rpm; Vortex Genie 2, Scientific Industries, NY, USA), and incubated with shaking 
(1 h, 30 ˚C, 100 rpm; Innova 4200 Incubator Shaker, New Brunswick Scientific, NJ, USA). 
The enzyme dissolved the yeasts’ cell walls, resulting in formation of spheroplasts, which were 
subsequently centrifuged at 5800 rpm for ten minutes (Centrifuge 5417R, Eppendorf, 
Germany) and the supernatant was discarded. The spheroplasts were re-suspended in 250 µl 
of Y1 Buffer/RNAse A solution (see Table). Two hundred fifty microlitres of Y2 Lysis buffer  
were added, the tube was inverted ten times, and incubated at room temperature for up to 
five minutes; 300 µl of Y3 Neutralisation buffer  were added and the tubes was inverted again 
ten times.  
The lysate was clarified by centrifugation at 13000 rpm for six minutes (Centrifuge 5417R, 
Eppendorf, Germany); this step was performed twice. The supernatant was loaded into a Yeast 
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Plasmid Spin Column, placed in a 2 ml collection tube, and centrifuged at 13000 rpm for 
2 minutes (Centrifuge 5417R, Eppendorf, Germany); the column flow-through was discarded. 
Y4 Wash buffer (supplied with the kit; previously diluted with ethanol: Table 2-19) was added 
to each column (450 µl), and the tubes were centrifuged at 14000 rpm for five minutes 
(Centrifuge 5417R, Eppendorf, Germany). The spin column was transferred to a 1.5 ml tube, 
30 µl of deionised H2O (dH2O) were added, and the tubes were incubated at room 
temperature for three minutes before centrifugation to elute the DNA. 
 
Table 2-19. Easy Yeast Plasmid Isolation Kit Buffers.  
Table A. Y1 Re-suspension Buffer/RNAse A Solution. 
Y1 Buffer/RNAse A solution 
RNAse A (supplied with the kit) 
Y1 Resuspension Buffer (supplied with the kit) 
Stored at 4 ˚C 
 
Table B. Y4 Wash Buffer.  
Y4 Wash Buffer 
Y4 Wash Buffer  
(supplied with the kit) 
24 ml 96-100 % ethanol 
 
 
2.1.6.2 YEAST ‘SMASH & GRAB DNA’ METHOD 
For the purposes of library characterisation (Methods and Materials section 2.1.8.8 and 
experimental Chapter 3) and identification of clones pulled out from the Y2H PPI screen 
(Methods and Materials section 2.1.1.3 and experimental Chapter 4) the Yeast ‘Smash & Grab 
DNA’ technique was used.  
As the name suggests, this is a rather crude, but less expensive procedure, thus allowing for 
higher throughput. It is based on phenol-chloroform separation and ethanol precipitation 
(Sambrook e Russell, 2001). 
The disadvantage of this method is that yeast genomic DNA is isolated together with 
the plasmid DNA. In this form it is suitable for amplification of library clones by PCR (section 
2.2.1), and the products can then be sequenced (section 2.2.7). However, such a preparation 
of plasmids together with genomic DNA is not suitable for subsequent bacterial transformation 
(section 2.2.3). 
Plasmids were isolated from yeast, using the Yeast ‘Smash & Grab DNA’ method, based on 
a protocol by Rose et al. (1990). All values are given per plasmid isolation, i.e. per a 1.5-ml 
tube.  
The procedure was performed in a fume extraction cupboard. Prior to plasmid extraction, glass 
beads (425-600 µm; Sigma-Aldrich, MO, USA) were prepared. The beads were fully submerged 
in a beaker with 1 M HCl, and allowed to stand for 15 minutes. The beads were then washed 
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with large volumes of sterile dH2O until all HCl was removed (determined  with a pH 
meter); they were dried in an oven cupboard for several days, and poured into a sterile bottle 
for storage. 
Yeast cells (10 mg per sample), taken either from an agar plate or a liquid culture, were used. 
The acid-washed glass beads (425-600 µm; Sigma-Aldrich, MO, USA) were added (300 µl per 
tube), and the cells were re-suspended in 200 µl of yeast lysis buffer (Table) and 200 µl of 
a 25:24:1 Phenol:Chloroform:Isoamyl Alcohol mix (Sigma-Aldrich, MO, USA) per tube. Tubes 
were vortexed at maximum speed for 2 minutes, and 200 µl of TE (Table) were added per tube.  
The tubes were centrifuged for a further five minutes at 14000 rpm (Centrifuge 5417R, 
Eppendorf, Germany), and the upper, aqueous layer was transferred into a fresh 1.5-ml tube 
(300 µl). Two volumes (600 µl) of 100 %, room temperature ethanol were added to each tube, 
the tubes were vortexed, then micro-centrifuged at 14000 rpm for three minutes (Centrifuge 
5417R, Eppendorf, Germany).  
The supernatant was discarded, and the precipitate was rinsed with cold (4 ˚C) 70 % ethanol 
(500 µl per tube). The samples were centrifuged at a maximum speed for 30 seconds 
(Centrifuge 5417R, Eppendorf, Germany), supernatant was discarded, and the tubes were left 
open to air-dry. The DNA pellet was dissolved in 30 µl of dH2O. 
 
Table 2-20. Yeast ‘Smash & Grab DNA’ Buffers. 
Table A. Yeast ‘Smash & Grab DNA’ Lysis Buffer  
Lysis Buffer 
10 mM Tris, pH 8 
1 mM EDTA 
100 mM NaCl 
1 % SDS 
2 % Tx100 
 
Table B. Tris-EDTA Solution. 
TE, pH 8 
10 mM Tris 
1 mM EDTA 
pH 8 
 
 
2.1.7 PROTEIN ISOLATION FROM YEAST 
In order to verify the expression of proteins encoded on the Y2H plasmids, they must firstly be 
isolated from the yeast cells, prior to their identification by biochemical methods. 
The outcomes of these procedures are summarised in Chapter 3 (section 3.2.2.2) and 
Appendix 11.4. 
For the purpose of protein extraction, the yeast clones to be tested were re-streaked on fresh 
nutritional selective agar media, and they were incubated for up to 96 hours at 30 ˚C. A single 
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colony of each clone was then picked and inoculated into 5 ml of relevant nutritional selective 
liquid media (in 50 ml sterile tubes).   
An untransformed yeast colony was inoculated, in parallel, into 10 ml YPDA as a negative 
control (in a 50 ml sterile tube).  The cultures were incubated overnight with shaking (16 h, 
30 ˚C, 250 rpm; Innova 4200 Incubator Shaker, New Brunswick Scientific, NJ, USA). 
The following morning all cultures were vortexed at maximum speed for one minute in order 
to disperse cell clumps. Each 5 ml culture of the transformed clones was then inoculated into 
50 ml of YPDA (in 250 ml sterile flasks). One hundred microlitres of the 10 ml untransformed 
culture were inoculated into 50 ml of YPDA (in a 250 ml sterile flask). The cultures were 
incubated with shaking (5 h, 30 ˚C, 250 rpm; Innova 4200 Incubator Shaker, New Brunswick 
Scientific, NJ, USA). 
One hour before the end of the 5 hour incubation period, pre-labelled 50 ml sterile tubes 
and dH2O were pre-chilled at -20 ˚C, and a centrifuge (for the 50 ml tubes) was pre-chilled to 
4 ˚C.  
After the 5 hour incubation period, the 600 nm wavelength optical density (OD600) of 
the incubated cultures was measured, using a spectrophotometer; the OD600 was expected to 
be within the range of 0.4-0.6. 
The 50 ml tubes were half-filled with ice; each yeast culture was poured into one of the tubes, 
and centrifuged at 2400 rpm for five minutes at 4 ˚C (Megafuge 1.0 R, Heraeus, UK). 
The supernatant and ice were removed, and the yeast cell pellets were re-suspended in 25 ml 
of ice-cold dH2O, previously pre-chilled at -20 ˚C.  
The suspensions were centrifuged at 2400 rpm for five minutes at 4 ˚C, and the supernatants 
were removed (Megafuge 1.0 R, Heraeus, UK). The obtained cell pellets were frozen on dry ice, 
or liquid nitrogen, for five minutes, and stored at -80 ˚C. The OD600 units (u) were calculated for 
each culture, as summarised in Equation 2.2. 
 
Equation 2.2. OD600 u calculation. 
Key: u, unit. 
OD600 u   =  obtained OD600   x  final culture volume 
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Prior to protein extraction the required amount of complete cracking buffer (Table 2-21) 
was calculated (100 µl per 7.5 OD600 u); the buffer was prepared and pre-heated to 60 ˚C. 
Protein extraction from the yeast cell pellets was performed in a fume cupboard, and tubes 
with all samples were kept on ice, unless stated otherwise. 
Table 2-21. Cracking Buffer. Recipe for one protein extract.  
Table A. Stock solution. 
Cracking Buffer Stock Solution 
8 M Urea 
5 % (w/v) SDS 
40 mM Tris-HCl, pH 6.8 
0.1 mM EDTA 
0.4 mg/ml bromophenol blue 
dH2O 
 
Table B. Complete Buffer. 
Complete Cracking Buffer 
1 ml of Cracking Buffer Stock Solution  
10 µl of β-mercaptoethanol 
70 µl of pre-chilled protease inhibitor solution ( 
Table 2-22) 
50 µl of 100X PMSF stock solution (Table 2-22) 
Up to 1.13 ml total volume with dH2O 
 
 
Table 2-22. Protease Inhibitors. 
Table A. Phenylmethylsulphonyl fluoride (PMSF) 
stock solution [100X]. 
100X PMSF Stock Solution 
0.1742 g PMSF 
10 ml isopropanol 
 
Table B. Protease Inhibitor Solution. 
Protease Inhibitor Solution 
0.1 mg/ml Pepstatin A 
0.03 mM Leupeptin 
145 mM Benzamidine 
0.37 mg/ml Aprotinin 
 
 
The pre-heated complete cracking buffer (Table 2-21) was added to the 50 ml tubes with cell 
pellets to thaw them quickly; the tubes were placed onto the 60 ˚C heat block to enhance 
thawing for a maximum of 2 minutes (to avoid proteolysis).  
The thawed pellets were re-suspended, and each suspension was transferred to 
a corresponding micro-centrifuge tube, containing glass beads (425-600 µm; Sigma-Aldrich, 
MO, USA). The tubes were heated to 70 °C for ten minutes, and 50 µl of serine protease 
inhibitor, Phenylmethylsulfonyl fluoride (PMSF; Table 2-22), were added to each tube.  
The tubes were vigorously for one minute, and centrifuged at 14000 rpm for five minutes at 
4 ˚C (Centrifuge 5417R, Eppendorf, Germany). The supernatants were transferred to fresh, 
pre-chilled micro-centrifuge tubes (‘first supernatants’) and kept on ice. Fifty microlitres of 
PMSF were added to each tube (with pellets and with first supernatants). 
The tubes with pellets were placed in a 100 ˚C water bath for 3-five minutes, vortexed (Vortex 
Genie 2, Scientific Industries, NY, USA) vigorously for one minute, and centrifuged at 
14000 rpm for five minutes at 4 ˚C (Centrifuge 5417R, Eppendorf, Germany). The obtained 
supernatants (‘second supernatants’) were combined with their corresponding first 
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supernatants, and boiled briefly (100 ˚C). The tubes were then kept on dry ice, or stored at -
80 ˚C until they were used for SDS-PAGE and Western blotting (sections 2.5.2 and 2.5.3). 
If no ‘second supernatant’ was obtained, 50-100 µl more complete cracking buffer were 
added, the tubes were vortexed vigorously for one minute, and centrifuged at 14000 rpm for 
five minutes at 4 ˚C (Centrifuge 5417R, Eppendorf, Germany) prior to combining with the ‘first 
supernatant’. 
 
2.1.8 GENERATION OF HUMAN RETINAL CDNA LIBRARY 
Prior to the Y2H screening for novel interacting partners of TOPORS, the human retinal cDNA 
library had first to be created. The experimental outcomes of the library construction and 
characterisation procedures are summarised in Chapter 3. 
The human retinal cDNA library was constructed directly in the Y187 yeast strain, using its 
endogenous homologous recombination machinery, using the ‘Make Your Own “Mate & 
PlateTM” Library System’ (Clontech, CA, USA), which utilises the SMARTTM technology (Zhu et 
al., 2001). Library generation was performed according to the manufacturer’s instructions. 
 
2.1.8.1 COMPLEMENTARY DNA SYNTHESIS 
The complementary DNA (cDNA) was synthesised from human retinal total RNA purchased 
from Clontech (CA, USA). The procedure comprised three major steps: 
 First-strand cDNA generation; 
 Amplification of cDNA by long distance PCR (LD PCR); 
 Column purification of double-stranded cDNA with a CHROMA SPIN TE-400 column. 
The first cDNA strand was transcribed from the total retinal RNA using the Moloney Murine 
Leukaemia Virus Reverse Transcriptase (MMLV RT). In addition to catalysing the transcription 
of RNA into cDNA, MMLV RT also possesses terminal transferase and template switching 
activities.  
Due to these characteristics, when MMLV RT encounters a 5’ terminus of the RNA template, it 
not only transcribes this template into cDNA, but it also adds several extra nucleotides, 
specifically deoxycytidine, to the 3’ end of the cDNA. This allows for hybridisation of 
the SMART III Oligonucleotide, which comprises an oligo-G tail. This annealing of the SMART III 
Oligo with the dCTPs leads to extension of the RNA template, and subsequently, it results in 
switching of the template by the MMLV RT, which then continues the transcription (Figure 
2-2).  
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The generated single-stranded (ss) cDNA 
comprises the complete 5’ end of the mRNA as 
well as a sequence complementary to 
the SMART III Oligo; the latter then serves as 
a universal priming site, the SMART anchor, and 
it is essential for amplification of the ss cDNA 
by LD PCR.  
Two different primers were used for the retinal 
cDNA library construction: a modified oligo-dT 
primer, the CDS III Primer, and a random 
primer, the CDS III/6 Primer. The former oligo-
nucleotide hybridises to the 3’-end of poly A+ 
RNA, which may result in sequences located 
towards the 5’-end being slightly under-
represented. 
The CDS III/6 Primer is able to hybridise to 
a variety of sequences on the RNA template, 
hence a library generated using this priming 
molecule should contain a wider array of 
sequences, all of which should be present in 
a similar proportion to each other. 
 
Figure 2-2. SMART cDNA synthesis.  
Figure from the ‘Make Your Own 
“Mate & PlateTM”  Library System 
User Manual (Clontech, CA, USA). 
 
Consequently, two retinal cDNA libraries were generated. One primed just by the oligo-dT 
CDS III Primer, and another one primed by both primers. 
 
2.1.8.1.1 FIRST STRAND cDNA GENERATION 
Total human retinal RNA (0.1-2.0 µg; Clontech, CA, USA) and a primer (1 µl; Clontech, CA, USA; 
Table 2-23) were combined in a sterile 1.5-ml tube in a total volume of 4.0 µl adjusted with 
sterile dH2O (Table 2-24).  
 
Table 2-23. Primers for cDNA library generation. 
Provided with the ‘Make Your Own “Mate & PlateTM” Library System (Clontech, CA, USA). NOTE: N = A, 
G, C, or T; V = A, G, or C. 
Primer Sequence 
 ATTCTAGAGGCCGAGGCGGCCGACATG-d(T)30VN 
CDS III/6 ATTCTAGAGGCCGAGGCGGCCGACATG-NNNNNN 
SMART III Oligo AAGCAGTGGTATCAACGCAGAGTGGCCATTATGGCCGGG 
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Table 2-24. RNA denaturation and priming reaction mixture. 
Components Volume 
0.1-2.0 µg 1 µl 
CDS III or CDS III/6 primer 1 µl 
dH2O 2 µl 
Total volume 4 µl 
 
A positive control reaction was set up in parallel, using 1 µl of Mouse Liver Poly A+ 
RNA. The reactions were denatured at 72 ˚C for 2 minutes, followed by cooling on ice for 
2 minutes, and centrifugation at 14000 rpm for 10 seconds (Centrifuge 5417R, Eppendorf, 
Germany).  
The following components were mixed in a total volume of 9.0 µl (Table 2-25): 2.0 µl of 5X First-
Strand Buffer, 1.0 µl of DDT (100 mM), 1.0 µl of dNTP Mix (10 mM) and 1.0 µl of SMART MMLV 
RT.  
 
Table 2-25. Single-stranded cDNA generation reaction mixture. 
Components Volume 
5X First-Strand Buffer 2 µl 
DTT (100 mM) 1 µl 
dNTP Mix (10 mM) 1 µl 
SMART MMLV RT 1 µl 
Components from RNA denaturation and priming (see Table 2-22) 4 µl 
Total volume 9 µl 
 
This reaction mix was then combined with the previously denatured, primed RNA, and mixed 
by tapping; if the random primer (CDS III/6) was used, the reaction was additionally incubated 
at 25 ˚C for ten minutes. 
The reactions were incubated at 42 ˚C for ten minutes in a heated lid thermal cycler in order to 
prevent evaporation. One microlitre of SMART III-modified Oligo (Table 2-23) was added; 
the reactions were mixed and incubated for one hour.  
The first-strand synthesis was terminated by incubation at 75 ˚C for ten minutes. The reactions 
were allowed to cool down to room temperature, 1 µl of RNAse H (2 units) was added to each 
reaction, and the reactions were incubated at 37 ˚C for twenty minutes.  
The reaction products were either immediately used in the LD PCR amplification, or they were 
store at -20 ˚C for up to 3 months. 
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2.1.8.1.2 cDNA AMPLIFICATION BY LONG DISTANCE PCR 
First-strand cDNA was prepared and the thermal cycler was pre-heated (Table 2-25). Two PCR 
reactions were prepared for each experimental sample. Each reaction was prepared in a total 
of 100 µl and contained the following components: 2 µl of the first-strand cDNA, 10 µl of 
10X Advantage 2 PCR buffer, 2 µl of 50X dNTP Mix, 2 µl of 5’ PCR primer, 2 µl of 3’ PCR primer 
(Table 2-26), 10 µl of 10X Melting Solution, 2 µl of 50X Advantage 2 Polymerase Mix and 70 µl 
of dH2O (Table 2-27).  
The thermal cycling conditions involved initial denaturation at 95 ˚C for 30 seconds, followed 
by 22 cycles of denaturation at 95 ˚C for 10 seconds and annealing/extension at 68 ˚C for 
initially 6 minutes, increasing by 5 seconds with each successive cycle; the reaction was 
completed by a final extension at 68 ˚C for five minutes. 
 
Table 2-26. Primers for LD-PCR. 
Provided with the ‘Make Your Own “Mate & Plate
TM
”  Library System (Clontech, CA, USA). 
Primer Sequence 
5’ PCR primer TTCCACCCAAGCAGTGGTATCAACGCAGAGTGG 
3’ PCR primer GTATCGATGCCCACCCTCTAGAGGCCGAGGCGGCCGACA 
 
Table 2-27. LD PCR components. 
Components Volume 
First-strand cDNA 2 µl 
10X Advantage 2 PCR buffer 10 µl 
50X dNTP Mix 2 µl 
5’ PCR primer 2 µl 
3’ PCR primer 2 µl 
10X Melting Solution 10 µl 
50X Advantage 2 Polymerase Mix 2 µl 
dH2O 70 µl 
Total volume 100 µl 
 
The concentrations of the PCR products’ were determined using the Nanodrop 
spectrophotometer, absorbing at 260 nm wave length; a minimum of 3 µg of DNA was 
expected per PCR amplification.  
The samples were also analysed by agarose gel electrophoresis; 7 µl aliquots of each sample 
were subject to electrophoresis on 1.2 % agarose gels with ethidium bromide. The obtained 
PCR products were either immediately purified (next section) or stored at -20 ˚C. 
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2.1.8.1.3 PURIFICATION OF DOUBLE-STRANDED cDNA 
The amplified human retinal cDNA was purified using the CHROMA SPIN TE-400 Columns 
(Clontech, CA, USA). The columns contain resin, which serves to fractionate DNA molecules 
according to size; it selects for DNA molecules larger than 200 bp. 
One CHROMA SPIN column was prepared per each double-stranded (ds) cDNA sample 
according to manufacturer’s instructions: the column was inverted to re-suspend the gel 
matrix until homogenous, the top cap was removed, the break-away end was snapped off 
from the bottom of the column, and the column was placed in a collection tube.  
The columns were centrifuged at 1700 rpm for five minutes (Centrifuge 5417R, Eppendorf, 
Germany) to purge the equilibration buffer, which was then discarded along with 
the collection tube. The spin column was placed in a second collection tube, and each ds cDNA 
sample (93 µl) was then loaded onto the centre of the semi-dry gel matrix (two samples were 
generated for each library, i.e. two columns were used for each library constructed); the tubes 
were centrifuged at 1700 rpm for five minutes (Centrifuge 5417R, Eppendorf, Germany). 
The two samples were then combined into a single 1.5-ml tube, and were subject to ethanol 
precipitation as described previously (Sambrook e Russell, 2001).  
The cDNA was re-suspended in 20 µl dH2O per tube, and the cDNA concentration was 
determined using the Nanodrop spectrophotometer; the expected amount of DNA was within 
the range of 2-5 µg. The double-stranded (ds) cDNA was stored at -20 ˚C until being used for 
library construction by in vivo recombination in yeast. 
 
2.1.8.2 CONTROLING FOR HOMOLOGOUS RECOMBINATION IN YEAST 
Prior to construction of a cDNA library in yeast, it is essential to establish that the yeast 
endogenous homologous recombination machinery functions properly. A control experiment 
was performed, which involved a homologous recombination-mediated cloning of 
SV40 Large T antigen PCR fragment into the pGADT7-Rec Cloning Vector. 
The Y187 yeast competent cells were prepared (section 2.1.3.1 in Methods and Materials). 
The SV40 Large T antigen PCR product fragment (25 ng/µl) and the pGADT7-Rec vector 
(500 ng/µl) were provided ready-linearised using the SmaI restriction enzyme. Two samples 
were prepared in sterile 1.5-ml tubes: 
 1 µl pGADT7-Rec only; 
 1 µl pGADT7-Rec + 3 µl SV40 Large T antigen PCR fragment. 
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Each sample was used to transform the Y187 yeast competent cells (section 2.1.3). One 
hundred microlitres of 1/10 and 1/100 dilutions were spread on SD/-L yeast media, which 
selects for the pGADT7-containing yeast colonies. The plates were incubated at 30 ˚C for 48-
72 hours. 
Given that the homologous recombination was successful, it was expected that approximately 
ten times more colonies would be observed on plates, where cells were co-transformed with 
both the linearised vector and the PCR product, than where cells were transformed with 
the vector only. Such a result would imply that over 90 % of colonies contain SV40 Large 
T antigen PCR fragment successfully cloned into the pGADT7-Rec plasmid, using the yeast 
homologous recombination system (see ‘Make Your Own “Mate & PlateTM” Library System 
User Manual, Clontech, CA, USA). 
 
2.1.8.3 DETERMINATION OF TRANSFORMATION EFFICIENCY 
Transformation efficiency was determined for the large-scale retinal cDNA library 
transformation. Colony-forming units (cfu) were counted, and the transformation efficiency 
was determined, using Equation 2.3. 
 
Equation 2.3. Transformation efficiency calculation. Key: CFU, colony-forming unit. 
TRANSFORMATION EFFICIENCY 
(CFU/µL) 
= 
CFU X SUSPENSION VOLUME (ML) 
X 
DILUTION 
FACTOR  
VOLUME PLATED (ML) X AMOUNT OF 
DNA (µG) 
 
2.1.8.4 DETERMINATION OF NUMBER OF INDEPENDENT CLONES 
Number of independent clones was determined following the large-scale retinal cDNA library 
transformation, as summarised in Equation 2.4. A viable cDNA library is expected to comprise 
at least a million independent clones. 
Equation 2.4. Number of independent clones calculation. 
Key: #, number; cfu, colony-forming unit; SD/-L, synthetic dropout media lacking leucine, thus selecting 
for prey plasmids. 
# of independent clones = # of cfu/ml on SD/-L x re-suspension volume (15 ml) 
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2.1.8.5 ETERMINATION OF cDNA LIBRARY TITRE 
The titre of the library is the number of colonies (colony-forming units, cfu) per 1 ml of diluted 
library spread on solid media. Colony-forming units were counted on plates having 30-300 
colonies, and the titre was determined (Equation 2.5). 
 
Equation 2.5. Titre determination. 
Key: #, number; cfu, colony-forming unit. 
TITRE (CFU/ML) = 
# OF COLONIES 
VOLUME PLATED (ML) X DILUTION FACTOR 
 
2.1.8.6 HARVESTING OF THE cDNA LIBRARY 
Following confirmation of the number of independent clones, the human retinal cDNA library 
was harvested according to the manufacturer’s instructions.  
The agar plates were chilled to 4 ˚C for 3-4 hours, and 5 ml of freezing medium (YPDA & 25 % 
glycerol) were added per plate. Sterile glass beads (3 mm; Merck, Germany) were used to 
detach the colonies from the plates, and all liquids were combined into a sterile flask, yielding 
a combined total of approximately 0.5 L of library.  
Cell density was determined using a haemocytometer, and it was adjusted to yield at least 
2 x 107 cells per 1 ml. The library was separated into 50-ml aliquots for long-term storage 
at _80 ˚C. 
 
2.1.8.7 DETERMINATION OF CELL DENSITY 
The mean number of yeast cells in each library was counted using a haemocytometer; growth 
of new buds observed on a yeast cell was counted as one cell. The volume over the 1 mm2 
counting area of the haemocytometer is 0.1 µl. Cell density was calculated using Equation 2.6. 
 
Equation 2.6. Cell density calculation. 
CELL DENSITY (CELLS/ML) = 
# OF CELLS PER 1 MM2 COUNTING AREA X DILUTION FACTOR 
VOLUME OVER THE 1 MM2 COUNTING AREA (ML) 
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2.1.8.8 CHARACTERISATION OF THE cDNA LIBRARY 
In order to characterise and validate the oligo-dT-primed and the oligo-dT- & random-primed 
human retinal cDNA libraries, an aliquot of each library was spread on SD/-L media and 
incubated at 30 ˚C until growth appeared.  
Single colonies were subsequently picked, re-patched on fresh SD/-L media as 1 cm2 squares, 
and incubated at 30 ˚C until growth appeared. Cells were then picked from each ‘square’, and 
plasmids were isolated from these cells (section 2.1.6). 
Inserts contained within the isolated plasmids were amplified by PCR (section 2.2.1), 
sequenced (section 2.2.7), and identified using the BLAST and BLAT programs available on the 
NCBI and UCSC Genome Browser websites, respectively. 
Thirty clones from each library were initially analysed. Firstly, numbers of library plasmids with 
inserts were determined. Next, the proportions of protein-coding and different types of non-
coding sequences were determined. Following the outcomes of such preliminary analysis, only 
one library, richer in protein-coding sequences, was analysed in depth. 
For comparison, the quality control data, provided with the ready-made brain cDNA library 
purchased from Clontech (CA, USA; Mate & PlateTM Library – Human Brain (Normalised)) for 
contingencies, were summarised (Table 2-28). 
 
Table 2-28. Mate & Plate
TM
 Library – Human Brain (Normalised). Quality control data. 
Quality Data 
Titre ≥5 x107 cfu/ml 
Number of independent clones 3.2 x 106 
Average cDNA size 1.56 kb 
cDNA size range 0.7 – 3.0 kb 
  
TOPORS expression levels in the library were expected to be within a comparable range to 
other tissues in the human body according to a graphical summary, provided by the Gene 
Cards (Figure 2-3). In contrast, Chakarova et al. (2007) showed by RT-PCR that although 
TOPORS is expressed ubiquitously, its levels in the retina appear strongly enhanced (Figure 
1-12). The Serial Analysis of Gene Expression (SAGE) data, accessible on Gene Cards (Figure 
2-3), also suggests that TOPORS levels are higher in the retina than in most other evaluated 
tissues. 
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According to the Swiss-Prot (UniProtKB) records at mRNA level TOPORS is most highly 
expressed in testis and at lower levels in adrenal gland, bone marrow, brain, colon, heart, 
kidney, liver, muscle, ovary, pancreas, placenta, prostate, skeletal muscle, skin, small intestine, 
spleen, stomach, testis, thymus, thyroid and uterus. It is also expressed in healthy lung, but at 
decreased levels in lung cancers (and colon adenocarcinomas).  
This strongly contrasts with the mRNA expression of rhodopsin (RHO), specific to rod 
photoreceptor cells (Figure 2-4), as was also demonstrated by the EyeSAGE Project (Figure 
2-5). 
 
2.1.9 MACROSCOPIC IMAGING 
The yeast work was documented using one of the following cameras: 
 Olympus µ780 All Weather Compact Digital Camera (Olympus Corporation, Japan); 
 Olympus SP-590UZ (Olympus Corporation, Japan); 
 Canon PowerShot A810 (Canon Corporation, Japan). 
For imaging purposes the yeast plates were placed on a light box, and the camera was 
mounted on a tripod above the light box. All images were collected sequentially using 
the same settings. 
 
2.1.10 Y2H PROCEDURES SUMMARY 
In summary, full-length TOPORS cDNA was used as bait in the Y2H PPI screen (Chapter 4). The 
cDNA was cloned into GAL4 BD Y2H vector, and it was transformed into the Y2H Gold yeast 
strain (Chapter 3). Auto-activation and toxicity testing was subsequently performed 
(Chapter 3). The preys comprised fragments of the human retinal cDNA library cloned into 
GAL4 AD Y2H vectors transformed into the Y187 yeast strain (Chapters 3 and 4). Relevant 
control plasmids were also transformed and used for control mating experiments (Chapters 3 
and 5). The initial Y2H screen involved mating of both yeast strains, expressing the bait and the 
preys, and spreading the resulting diploid cultures on selective media (Chapter 4). Positive 
clones were then amplified by PCR and sequenced, and their functions were characterised to 
determine whether they showed a retina-specific expression pattern or a function exclusive to 
the retina (Chapters 4 and 5). On this basis, candidate interacting proteins were selected for 
further analyses (Chapters 6, 7 and 8). 
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Figure 2-3. TOPORS expression at mRNA level. Image from GeneCards Database. 
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Figure 2-4. RHO expression at mRNA level. Image from GeneCards Database. 
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Table 2-29. Description of column headings and SAGE tags from Figure 2-5.  
Legend modified from the EyeSAGE_Legend.xls file available online (Eyesage, [Accessed 03/02/2015]). 
Column 
Heading 
Description 
Tag Sequence sequence of the 10 bp short SAGE tag 
Best Tag For 
Gene 
sequence of the 10 bp short SAGE tag considered the most representative match for 
the given UniGene cluster.  If this tag matches the tag in the adjacent 'Tag Sequence' 
column, then all the associated data to the right should be the most representative for 
that gene.   
Long Tag 
sequence of the 17 bp long SAGE tag that matches the short tag in 'Tag Sequence', if 
there was a match in '4cRET Long'.  There may be several long SAGE matches for a 
given short SAGE tag. 
4cRET Long 
tag counts from "LSAGE_Retina_central_normal_B_4cRet"; long SAGE library prepared 
from pooled 4 mm punches of human macula and central peripheral retina from 7 
morphologically normal donor eyes 
4MAC 
tag counts from "SAGE_Retina_Macula_normal_B_4Mac"; SAGE library prepared from 
5 pooled 4 mm punches of human macula from morphologically normal donor eyes 
4PERI 
tag counts from "SAGE_Retina_Peripheral_normal_4Peri"; SAGE library prepared from 
5 pooled 4 mm punches of human peripheral retina from the same donor eyes as 
'4Mac'  
4Mac RPE 
tag counts from "SAGE_Retina_Pigment_Epithelium_normal_B_4MacRPE"; SAGE 
library prepared from 10 pooled 4 mm punches of human RPE/choroid from 
morphologically normal donor eyes 
4Peri RPE 
tag counts from "SAGE_Retina_Pigment_Epithelium_normal_B_4PeriRPE"; SAGE library 
prepared from 10 pooled 4 mm punches of human RPE/choroid from the same donor 
eyes as '4MacRPE' 
Our RPE Ave average tag count per library for '4Mac RPE' and '4Peri RPE'  
Our Retina 
Ave 
average tag count per library for '4MAC' and '4PERI' 
RPE Ave average tag count per library for 3 RPE short SAGE libraries included in 'RPE Sum' 
RPE Sum summation of tag counts from RPE SAGE libraries ('4Mac RPE', '4Peri RPE', and 'RPEB1') 
Mac Ave average tag count per library for the two macular retina libraries 
Mac Sum summation of tag counts from macular retina libraries ('4MAC' and 'HMAC2') 
Peri Ave 
average tag count per library for the two peripheral retina libraries included in 'Peri 
Sum' 
Peri Sum summation of tag counts from peripheral retina libraries ('4PERI' and 'PeriB2') 
Retina Ave average tag count per library for 5 retina short SAGE libraries included in 'Retina Sum' 
Retina Sum 
summation of tag counts from retina short SAGE libraries ('4MAC','4PERI', 'HMAC2', 
'PeriB2', and 'PeriB1')  
Neural Ave average tag count per library for the 9 libraries included in 'Neural Sum' 
Neural Sum 
summation of tag counts from 9 publicly archived SAGE libraries prepared from the 
different regions of the brain designated in columns BC through BK (text in green) 
Eye Ave average tag count per library for all 8 eye short SAGE libraries 
Eye Sum summation of tag counts from all 8 eye short SAGE libraries 
Body Ave average tag count per library for the 30 libraries included in 'Body Sum' 
Body Sum 
summation of tag counts from 30 publicly archived SAGE libraries prepared from the 
various non-neural tissues designated in columns BL through CO 
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The scarce information demonstrating TOPORS protein expression (Figure 2-6), suggests that 
levels of this protein can be variable in healthy as well as malignant tissues. 
 
 
Figure 2-6. TOPORS expression at protein level. Image from GeneCards Database. 
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2.2 DNA TECHNIQUES 
Standard DNA techniques have been used throughout the project, starting with PCR 
amplification of TOPORS cDNA and its fragments for construction of Y2H cDNA library and 
baits (Chapter 3 and Appendix 11.2), followed by amplification and cloning of its novel 
interacting partners (Chapters 4 and 5). 
Plasmids propagation and isolation from bacterial cultures was frequently performed 
(Chapters 3, 4 and 5). 
Di-deoxy chain-terminating sequencing was also used throughout the project to validate 
results of cloning, colony screening, and mutagenesis procedures (Chapters 3, 4 and 5). 
 
2.2.1 DNA AMPLIFICATION BY POLYMERASE CHAIN REACTION 
Polymerase chain reactions (PCRs) were carried out using KOD DNA polymerase 
(Novagen, Merck KGaA, Germany), BioTAQ DNA polymerase (Bioline, UK) and MangoTAQ DNA 
polymerase (Bioline, UK). PFU DNA polymerase (Promega, WI, USA) was added to the BioTAQ 
DNA polymerase (Bioline, UK) before first use (7 units of PFU per full tube of BioTAQ), in order 
to enhance the proof-reading activity of the enzymatic mixture. 
The reactions were normally performed using approximately 1 µg of DNA in total volume of 
25 µl (see Table 2-30) according to the respective manufacturer’s specifications. 
 
Table 2-30. DNA polymerases used and general PCR conditions 
Components 
BioTAQ polymerase 
(Bioline) with PFU 
polymerase (Promega) 
MangoTAQ 
polymerase (Bioline) 
KOD Hot Start DNA 
Polymerase (Novagen) 
Buffer 1X NH4 buffer 
1X MangoTAQ reaction 
buffer 
1X KOD polymerase 
buffer 
MgCl2 1.5 mM - 2.5 mM 1.5 mM – 4.0 mM - 
MgSO4 - - 1.0 mM – 2.0 mM 
dNTPs 0.2 mM 0.2 mM 0.2 mM 
Primers 25.0 pM 25.0 pM 25.0 pM 
Polymerase 0.5 units 0.25 units 1.0 unit 
Total volume 25.0 μl 25.0 μl 25.0 μl 
 
The temperature cycling profile for products amplified using the BioTAQ (Bioline, UK)/PFU 
(Promega, WI, USA) polymerases comprised an initial denaturing step at 95 ˚C for three 
minutes for genomic- or cDNA, or five minutes for plasmid DNA; followed by 35 cycles of 
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denaturation at 94 ˚C for 30 seconds, annealing for 15 seconds (temperature set in accordance 
with primer pair used); and an extension step at 72 ˚C for which time was approximated using 
1 minute per 1.0 kb of DNA. The reaction was completed by a final extension step at 72 ˚C for 
five minutes. 
The temperature cycling profile for products amplified using the MangoTAQ (Bioline, UK) 
polymerases comprised an initial denaturing step at 95 ˚C for five minutes for plasmid DNA; 
followed by 35 cycles of denaturation at 95 ˚C for 15 seconds, annealing for 15 seconds 
(temperature set in accordance with primer pair used); and an extension step at 72 ˚C for 
which time was approximated using 1 minute per 1.0 kb of DNA. The reaction was completed 
by a final extension step at 72 ˚C for ten minutes. MangoTAQ was also the polymerase of 
choice for colony PCR screens (section 2.2.3.1). 
The temperature cycling profile for products amplified using the KOD polymerase 
(Novagen, Merck KGaA, Germany) comprised an initial denaturing step at 95 ˚C for three 
minutes for genomic- or cDNA, or five minutes for plasmid DNA; followed by 30-35 cycles of 
denaturation at 94 ˚C for 30 seconds, annealing for 30 seconds (temperature set in accordance 
with primer pair used); and an extension step at 75 ˚C for which time was approximated using 
20 seconds per 1.0 kb of DNA. The reaction was completed by a final extension step at 75 ˚C 
for 1 minute per 1.0 kb. 
Annealing temperature was calculated prior to optimisation of PCR conditions using 
the following formula: Tm = 4 (C + G) + 2 (A + T). Primers for PCR amplifications were all 
synthesised by Sigma-Aldrich, MO, USA. 
Sequences and annealing temperatures of primers used for DNA amplification procedures are 
summarised in subsequent cloning sections (2.2.3, 2.2.5.1, 2.2.5.3). 
The BioTAQ and MangoTAQ polymerase-based amplifications were used predominately for 
amplification of Y2H screen preys (Chapter 4) and identification of retinal isoforms of 
the identified preys (Chapter 5), whereas the KOD  polymerase-based amplification, utilising its 
proof-reading activity, was used in construction of baits and control constructs (Chapters 3 and 
5). 
 
2.2.2 AGAROSE GEL ELECTROPHORESIS 
DNA fragments were separated on agarose (Bioline, UK) gels (0.8 % - 2.0 %), buffered with 
1x TAE (Table 2-31) and supplemented with 0.01 μl/ml of ethidium bromide (Sigma-Aldrich, 
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MO, USA), or with 0.02 µl/ml of Gel Red (Biotium, CA, USA). BioRad (CA, USA) power packs and 
tanks were used.  
 
Table 2-31. TAE Buffer. 
TAE 
2.0 M TRIS-Acetate 
0.05 M EDTA 
 
Table 2-32. 1 % agarose gel. 
0.8 % - 2.0 % agarose gel 
2.4 g – 6.0 g of agarose 
0.01 μl/ml of ethidium bromide, or 
0.02 μl/ml of Gel Red 
300 ml 1X TAE 
 
 
Prior to electrophoresis the DNA samples were loaded using 1X bromophenol blue loading dye 
(Sigma-Aldrich, MO, USA); products of MangoTAQ PCR reactions, in which the coloured buffer 
was used, were loaded straight onto the gel without addition of bromophenol blue. Unless 
stated otherwise, Smart Ladder (Eurogentec, UK), Hyper Ladder I (Bioline, UK) and 1kb DNA 
Ladder (Promega, WI, USA) were used as markers to determine the size of the DNA fragments. 
This methods was utilised whilst performing cloning, screening and mRNA expression studies 
(Chapters 3, 4 and 5). 
 
2.2.3 BACTERIAL TRANSFORMATION 
Transformation of competent bacterial cells was used frequently throughout the project, 
specifically, for construction of Y2H vectors (Cahpters 3, 4 and 5). Firstly, whilst cloning 
(section 2.2.3) of the Y2H baits, and, subsequently, the preys into yeast as well as mammalian 
expression vectors.  
DH5α (Life Technologies, CA, USA) and XL1-Blue (Stratagene, CA, USA) strains of bacteria were 
used for cloning, unless stated otherwise. The cells were thawed on ice and aliquoted (50-
150 μl per transformation) into pre-chilled 1.5 ml tubes.  
If XL1-Blue cells were used, then β-mercaptoethanol was added to the tubes (1.7 μl 1.4 M per 
100 μl bacteria), and the mixtures were incubated on ice for ten minutes.  
Plasmid DNA (0.1-50.0 ng per transformation) was added to the competent bacteria, and 
gently mixed. The cells were incubated on ice for thirty minutes, heat-shocked (42 ˚C for 
45 seconds) and placed immediately back on ice for further 2 minutes.  
The bacteria were mixed with 100 µl SOC media (LifeTechnologies, CA, USA) and incubated 
with shaking (1 h, 37 ˚C, 225 rpm; Innova 4200 Incubator Shaker, New Brunswick Scientific, NJ, 
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USA). Cells were centrifuged at 10000 rpm for three minutes (Centrifuge 5417R, Eppendorf, 
Germany) and excess media was removed; the cells were re-suspended in 100-200 μl of media.  
The cells were spread onto LB agar plates supplemented with the relevant antibiotics (Table 
2-33); the plates were incubated at 37 ˚C for 12-24 hours. Single colonies were inoculated into 
1 ml LB-broth cultures with the relevant antibiotics (12-24 hours, 37 °C, 225 rpm; Innova 4200 
Incubator Shaker, New Brunswick Scientific, NJ, USA) for further analyses. 
 
Table 2-33. Luria-Bertani (LB) Media for bacterial culture. 
LB Agar Medium LB Liquid Medium 
4 g Tryptone 4 g Tryptone 
2 g Yeast extract 2 g Yeast extract 
3.2 g NaCl 4 g NaCl 
6 g Agar - 
400 ml dH2O 400 ml dH2O 
 
2.2.3.1 COLONY PCR 
Following a bacterial transformation, colonies can be screened for inserts prior to plasmid 
extraction. Each picked colony is first either: inoculated into liquid LB media, or: spotted on 
an LB agar plate (LB supplemented with relevant antibiotics), and then dipped in 
a corresponding well of a 96-well PCR plate, containing a vector- or insert-specific PCR mix. 
Inoculation into liquid media was used for lower throughput screening of up to fifty colonies; 
whereas spotting of colonies onto an agar plate, followed by subsequent inoculation of 
positive clones, was used for screening of fifty or more colonies. 
The colony PCRs were performed using the MangoTAQ DNA polymerase (Bioline, UK), as 
specified in section 2.2.1, using coloured buffer (Table 2-30). The temperature cycling profile 
was extended relative to a standard PCR: the initial denaturation step at 95 ˚C lasted ten 
minutes; followed by 30 cycles of denaturation at 95 ˚C for 1 minute, annealing for 1 minute 
(temperature set in accordance with primer pair used); and an extension step at 72 ˚C for 
which time was approximated using 1-2 minutes per 1.0 kb of DNA. The reaction was 
completed by a final extension step at 72 ˚C for ten minutes. 
 
2.2.4 DNA ISOLATION AND PURIFICATION 
DNA was extracted from microorganisms and purified at various stages throughout 
the project. Phenol/chloroform extraction and ethanol precipitation were carried out as 
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described in Sambrook et al. (2001) to isolate total DNA from a bacterial or a yeast cells 
(Chapters 3 and 4). The PureYield™ Plasmid Miniprep System (Promega, WI, USA) and the Easy 
Yeast Plasmid Isolation Kit (Clontech, CA, USA; section 2.1.6.1) were used, according to 
the respective manufacturer’s instructions, for isolation of sole plasmids from bacteria or 
yeasts, respectively (Chapters 3, 4 and 5). 
A number of purification kits, such as Wizard® SV Gel and the PCR Clean-up System (Promega, 
WI, USA) and QIAQuick Gel Extraction Kit (Qiagen, Netherlands) were used for purification of 
PCR products, and/or of DNA fragments excised from agarose gel, following electrophoresis 
(section 2.2.2). Such purified DNA fragments were then used for downstream procedures, such 
as cloning (e.g. a ligation reaction) (Chapters 3 and 5 and Appendices). 
Sequencing reaction products (section 2.2.7) were purified using either the MultiScreen HTS 
filter plates (Millipore, Merck KGaA, Germany) and the Sephadex® G-50 filtration gel (Sigma-
Aldrich, MO, USA), or the Montage Sequencing Reaction Clean-Up Kit (Millipore, Merck KGaA, 
Germany). In the first case the PCR products were transferred to the pre-washed Sephadex® G-
50 Plate and centrifuged at 910 x g for five minutes; the cleaned PCR product was pulled 
through the filtration gel and collected in a clean 96-well plate, leaving any impurities and 
sequencing primers within the gel. When using the Millipore method, 25 μl of Injection 
Solution (provided with kit) were added to each reaction before transferring the reactions to 
the Montage plate. The plate was then attached to a vacuum pump and the reaction mixture 
was aspirated through the base membrane leaving the sequencing products bound to the 
membrane. The membrane was washed twice with 25 μl Injection Solution; the sequencing 
reaction products were then re-suspended in 25 μl of Injection Solution by gentle shaking at 
1000 rpm for ten minutes (Stuart Mini orbital shaker SSM1, Bibby Scientific Limited, UK). 
 
2.2.5 CLONING 
Several cloning methods were used throughout the project, with different degrees of success, 
primarily due to challenges in sub-cloning TOPORS cDNA into a yeast vector. 
 
2.2.5.1 IN-FUSION CLONING 
In-Fusion Cloning (Clontech, CA, USA) was the primary method of choice for cloning TOPORS, 
and its fragments, as it would generate PCR amplicons capable of recombining with 
the Clontech (CA, USA) Y2H vectors, without the need for restriction digestion and ligation. 
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TOPORS deletion constructs were cloned using this method (Appendix 11.2). Prior to 
the cloning procedure the pGBKT7 vector (Clontech, CA, USA; Table 2-1) was digested with 
BamHI and EcoRI restriction enzymes (Promega, WI, USA) for 1 hour at 37 ˚C, using 1 unit (u) of 
nuclease per 1 µg of DNA. TOPORS and its fragments were amplified using primers 
(Table 2-34), which would generate amplicons, extended by tails, which would allow for 
recombination with the pGBKT7 plasmid. 
Table 2-34. Primer pairs used for PCR amplification of full-length, and shorter, TOPORS fragments for In-
fusion cloning. 
The primers were designed to incorporate restriction sites into the amplicon (indicated in italics within 
the primer sequences); the EcoRI site is included within all of the forward primers; the SalI site is found 
within the sequences of all of the reverse primers. F – forward primer, R – reverse primer. KOD 
polymerase was used for the amplification. 
Fragment 
name 
Amino 
acids 
Size 
(Bp) 
Primer name Sequence (5’  3’) 
Tm 
(˚C) 
Full-length 
TOPORS 
1-1045 3135 
TOP-in-fusion-1-
pGBKT7-F 
CATGGAGGCCGAATTCATGG
GGTCGCAGCCGCCGCTGGGG 
75 ˚C 
TOP-in-fusion-6-
pGBKT7-R 
GCAGGTCGACGGATCCTTAA
GACATATCACAGTCTCTACC 
N-term 
TOPORS 
1-380 1140 
TOP-in-fusion-1-
pGBKT7-F 
CATGGAGGCCGAATTCATGG
GGTCGCAGCCGCCGCTGGGG 
70 ˚C 
TOP-in-fusion-2-
pGBKT7-R 
GCAGGTCGACGGATCCTGAA
GGAGCAGGGCAATCATAATT 
Middle-
TOPORS 
373-
781 
1224 
TOP-in-fusion-3-
pGBKT7-F 
CATGGAGGCCGAATTCAATT
ATGATTGCCCTGCTCCTTCA 
70 ˚C 
TOP-in-fusion-5-
pGBKT7-R 
GCAGGTCGACGGATCCGTTA
GTACCCTCCAAATGCCGTGT 
C-term 
TOPORS 
705-
1045 
1020 
TOP-in-fusion-4-
pGBKT7-F 
CATGGAGGCCGAATTCACTTA
TTACAGTAGAAACAAGGAC 
70 ˚C 
TOP-in-fusion-6-
pGBKT7-R 
GCAGGTCGACGGATCCTTAA
GACATATCACAGTCTCTACC 
 
The amount of DNA to be used in the reaction was calculated, using the In-Fusion® Molar Ratio 
Calculator, available at the http://bioinfo.clontech.com/infusion/ webpage. 
The In-fusion reaction was set up in a total volume of 10 µl, containing 2 µl of the 5X In-fusion 
Reaction Buffer, 1 µl of the In-fusion enzyme, and the required amount of deionised water 
(Table 2-35). The reaction was incubated for 15 minutes, firstly, at 37 ˚C, and, subsequently, 
for 15 minutes at 50 ˚C to terminate the reaction. The reaction was cooled on ice and 40 µl of 
TE buffer (pH 8) were added. The reaction was either immediately used for transformation of 
competent Escherichia coli cells, or stored at -20 ˚C. 
The amplified DNA fragments and the vector have 15 bp-long regions of homology at 
the insertion site, which are recognised by the In-fusion enzyme. The enzyme removes one 
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strand at the homology region in both the PCR product and the linearised vector, forming 
single-stranded overhangs; it then ligates the two DNA molecules together (Figure 2-7). 
 
Table 2-35. In-fusion reaction components. 
Insert and vector recommended ratio is 2:1. The exact DNA weight required for this reaction is 
calculated based on the number of base pairs of both insert and vector, using the In-Fusion® Molar Ratio 
Calculator, available online: http://bioinfo.clontech.com/infusion/molarRatio.do 
Components Amount 
 [Calculated using the In-Fusion® Molar Ratio Calculator online] 
Linearised vector [Calculated using the In-Fusion® Molar Ratio Calculator online] 
5X In-fusion Reaction Buffer 2 µl 
In-fusion enzyme 1 µl 
dH2O Up to 10 µl 
Total volume 10 µl 
 
 
Figure 2-7. In-fusion cloning method.  
Figure from the In-Fusion® Advantage PCR Cloning Kit User Manual (Clontech, CA, USA). 
 
2.2.5.2 DIGESTION- AND LIGATION-BASED CLONING 
The ‘traditional’ cloning techniques were attempted when In-Fusion Cloning was not successful 
for full-length TOPORS cDNA. Initially, digestion of the amplicons prepared for In-Fusion 
cloning (Table 2-34) was performed. Primers, incorporating alternative restriction sites, were 
also designed (Table 2-36). 
This method was used in attempts to clone full-length TOPORS (Appendix 11.2). 
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Digestion by restriction endonucleases, vector dephosphorylation and ligation were 
subsequently performed. 
 
Table 2-36. Primer pair used for PCR amplification of full-length TOPORS for cloning, using restriction 
enzymes and ligase. 
The primers were designed to incorporate restriction sites into the amplicon (indicated in italics within 
the primer sequences); the NdeI site is included within the forward primer; the PstI site is found within 
the sequence of the reverse primer. F – forward primer, R – reverse primer. . KOD polymerase was used 
for the amplification. 
Fragment 
name 
Amino 
acids 
Bp 
Primer 
name 
Primer components Sequence (5’  3’) 
Tm 
(˚C) 
Full-length 
TOPORS 
1-1045 3135 
FL F 
‘GC F clamp’, NdeI seq., 
first 20 nt of TOPORS 
GCCGCATATGATGGGGT
CGCA CC CCG 
57 ˚C 
FL R 
‘GC R clamp’, PstI seq., 
last 20 nt of TOPORS 
(reverse complemented) 
GCGCCTGCAGTTAAGACA
TATCACAGTCTC 
 
2.2.5.2.1 RESTRICTION ENZYME DIGEST 
Restriction enzyme digests were performed on both plasmid DNA and the PCR products, using 
1 unit (u) of enzyme per 1 µg of DNA for 1 h at the optimal temperature for each specific 
enzyme, according to the manufacturer’s instructions. The reactions were set up in a total 
volume of 10 μl containing the DNA, restriction enzyme(s), 1X corresponding restriction 
buffer(s) and sterile deionised water (Table 2-37). Restriction enzymes and their corresponding 
buffers, manufactured by Promega (WI, USA), were used. The reaction products were purified 
prior to further treatment. 
 
Table 2-37. Components of restriction digest reaction. 
Components  
DNA 1 µg 
Restriction endonuclease(s) 1 u 
Restriction buffer 1X 
dH2O Up to 10 µl 
Volume 10 µl 
 
2.2.5.2.2 DEPHOSPHORYLATION OF VECTOR 5’ ENDS 
The digested plasmid molecules were dephosphorylated at their 5’ ends, using a calf intestinal 
alkaline phosphatase (CIAP; Promega, WI, USA) in order to prevent the plasmid ends from self-
ligating during the ligation reaction. The dephosphorylation was performed according to two 
different protocols. 
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The first dephosphorylation procedure was based on the Promega (WI, USA) protocol (Table 
2-38). Ten microlitres of CIAP 10 X reaction buffer were diluted at a 1:10 ratio in deionised 
water (dH2O) to yield CIAP 1 X reaction buffer. CIAP (1 u/µl) was diluted in the CIAP 1 X 
reaction buffer at a 1:50 ratio to yield 0.02 u/µl CIAP. 
According to the manufacturer 1 µg of 1 kb DNA is equal to 1.52 pmol of DNA, which is equal 
to 3.03 pmol of DNA ends. Ten picomoles of DNA ends were used per dephosphorylation 
reaction; the DNA was diluted up to 40 µl in Tris-HCl (pH 8). 
Five microlitres of CIAP 10 X reaction buffer and 5 µl of the 0.02 u/µl CIAP were subsequently 
added and the reaction was incubated at 37 ˚C for thirty minutes. Another 5 µl of the 0.02 u/µl 
CIAP were added to the reaction mixture and the incubation was repeated. 
An alternative simplified dephosphorylation method was used in parallel. Ten picomoles of 
DNA ends were incubated with 2 µl of CIAP 10 X reaction buffer and 1 µl of 1 u/µl CIAP in 
a total volume of 20 µl at 37 ˚C for 1 hour (Table 2-39). The reaction products were purified 
prior to further use. 
 
Table 2-38. Dephosphorylation reaction according to the Promega (WI, USA) protocol 
Components Volume 
10 pmol of DNA ends diluted up to 40 µl in Tris-HCl (p 40 µl 
CIAP 10 X reaction buffer 5 µl 
0.02 u/µl CIAP 5 µl (+5 µl) 
Total volume 50 μl (+5 µl) 
 
Table 2-39. Dephosphorylation reaction according to the simplified protocol 
Components Amount 
10 pmol of DNA ends 10 pmol of DNA ends 
CIAP 10 X reaction buffer 2 µl 
1 u/µl CIAP 1 µl 
dH2O Up to 20 μl 
Total volume 20 μl 
 
2.2.5.2.3 LIGATION 
The PCR fragments were cloned into dephosphorylated vectors, using T4 DNA Ligase 
(Promega, WI, USA) according to the manufacturer’s instructions. Reactions were prepared 
with vector:insert ratios of 1:1 to 1:3, and incubated at room temperature (RT) overnight, or at 
4 ˚C overnight. 
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2.2.5.3 GATEWAY CLONING 
The Gateway cloning technique (Life Technologies, CA, USA) was eventually utilised, when In-
Fusion and ‘traditional’ cloning attempts did not yield the expected results for TOPORS. 
Full-length TOPORS and its control protein interacting partner-encoding p53 as well as 
the novel interacting partners of TOPORS were cloned using the Gateway method (Appendices 
11.2, 11.5 and 11.8). ITM2B constructs, encoding the FBD, FDD and retinal dystrophy mutants, 
were kindly provided by Audo et al. (2013) in pBUD vectors and used for sub-cloning into yeast 
vectors. 
The method relies on the bacteriophage lambda (λ) site-specific recombination system, which 
in natural conditions facilitates the integration of the lambda virus into the Escherichia coli 
genome, and the switch between the lytic and lysogenic cycles.  
Site-specific attachment (att) sites are required for the recombination event; they serve as 
recognition sites for the recombination proteins. The att sites used in the Gateway system are 
denoted as attB on the E. coli chromosome and attP on the lambda chromosome (Figure 2-8). 
The crossing-over between two interacting DNA molecules occurs at the att sites, and it does 
not involve any loss or gain of nucleotides; i.e. the attB and attP sites are joined together to 
become a hybrid attL sequence. 
The lambda recombination adapted for the Gateway method is catalysed by a number of 
enzymes, which bring the att sites together, cleave them and covalently bind the DNA 
molecules.  
The actual crossing-over happens between 15-bp-long core DNA regions; however, a longer 
sequence is required for the recombination proteins to bind. In the endogenous lambda 
system the exact enzymes involved depend on whether the bacteriophage is undergoing 
the lytic or the lysogenic cycle.  
The lambda Integrase (Int) and the E. coli Integration Host Factor (IHF) proteins catalyse 
the recombination during the lysogenic cycle; this corresponds to the BP clonase enzyme mix 
in the Life Technologies Gateway system.  
During the lytic cycle, the recombination involves the above-mentioned lambda Int and 
E. coli IHF as well as a lambda Excisionase (Xis); in the Gateway system the equivalent proteins 
are known as the LR clonase enzyme mix. 
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PCRs were performed, using the KOD polymerase (section 2.2.1). Specific primers were 
designed encompassing the first 25 nucleotides near the 5’ end, and last 25 nucleotides near 
the 3’ end of the transcript for the forward and for the reverse primer, respectively; the attB1 
and attB2 sites were incorporated into the forward and reverse primers respectively, allowing 
them to be amplified in-frame either side of the intended DNA sequence (termed attb-[PCR]-
attb).  
The attB-PCR products were purified and recombined with the pDONR/Zeo vector (with 
corresponding attP1 and attP2 sequences). The resulting entry vector was then used as 
a shuttle vector for sub-cloning into various destination vectors. 
 
 
Figure 2-8. The Gateway BP and LR reactions. 
The Gateway system comprises two recombination events based on the lambda integration cycles. 
The BP reaction facilitates recombination between the attB substrate, i.e. the attB-PCR product, and 
the attP substrate, i.e. the donor vector (pDONR/Zeo; Table 2-2). These two att sites become joined 
together to form a hybrid attL site; hence, the key product obtained during the BP reaction is an entry 
clone containing the DNA sequence of interest, flanked by the attL sites. This entry clone is used as 
the attL substrate in the LR reaction, during which it is recombined with an attR substrate (destination 
vector; Table 2-2); the LR reaction results in a formation of the expression clone and the attB site. Figure 
from GibcoBRL Life Technologies Gateway cloning manual. 
 
The BP recombination involved combining the attB-PCR product (150 ng) with 150 ng of the 
pDONR vector, and TE buffer (pH 8.0) up to a final volume of 4 μl. The BP Clonase enzyme mix 
was thawed on ice for 2 minutes and vortexed briefly, before adding 2 μl to the reaction. The 
reaction mixtures were centrifuged briefly and incubated at 25˚ C for 1 hour. Proteinase K 
(1 μl) was added to terminate the reaction by incubating at 37˚C for ten minutes. 
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The entry clones were transformed into the DH5α competent E. coli bacterial strain and grown 
on selective media. Single colonies were picked and inoculated into overnight cultures of up to 
5 ml; the entry clone plasmids were isolated from the liquid cultures. 
Once verified by sequencing, the isolated entry clones were subject to the LR recombination 
with the relevant destination vectors. The reaction comprised the entry clone DNA (150 ng) 
and the destination vector (150 ng) in a total volume of 4 μl made up to with TE buffer 
(pH 8.0). The LR Clonase enzyme mix was thawed on ice for 2 minutes and vortexed briefly, 
before adding 2 μl to the reaction. The reaction mixtures were centrifuged briefly and 
incubated at 25˚ C for 1 hour. Proteinase K (1 μl) was added to terminate the reaction by 
incubating at 37˚ C for ten minutes. The new clones were confirmed by sequencing and 
digestion with restriction enzymes. This methods was used for successfully cloning TOPORS 
(Table 2-40), p53 (Table 2-41) for the control experiments, as well as the novel interacting 
partners of TOPORS (Tables 2-42, 2-43 and 2-44). 
Table 2-40. Primer pair used for PCR amplification of full-length TOPORS for cloning, using the Gateway 
system. 
The primers were designed to incorporate the attB1 and attB2 recombination sites into the amplicon 
(indicated in bold). F – forward primer, R – reverse primer.  
Fragment 
name 
Amino 
acids 
Length 
(Bp) 
Primer 
name 
Primer 
components 
Sequence (5’  3’) 
Tm 
(˚C) 
Full-
length 
TOPORS 
1-1045 3135 
Top-
attb-F 
attB1sequence, 
first 25 nt of 
TOPORS 
GGGGACAAGTTTGTA
CAAAAAAGCAGGCTT
CATGGGGTCGCAGCC
GCCGCTGGGGT 
60 ˚C 
Top-
attb-R 
attB2sequence, 
last 25 nt of 
TOPORS (reverse 
complemented) 
GGGGACCACTTTGTAC
AAGAAAGCTGGGTGT
TAAGACATATCACAGT
CTCTACCA 
Table 2-41. Primer pair used for PCR amplification of full-length p53 for cloning, using the Gateway 
system. 
The primers were designed to incorporate the attB1 and attB2 recombination sites into the amplicon 
(indicated in bold). F – forward primer, R – reverse primer.  
Fragment 
name 
Amino 
acids 
Length 
(Bp) 
Primer 
name 
Primer 
components 
Sequence (5’  3’) 
Tm 
(˚C) 
Tumour 
protein 
53 (p53) 
1-393 1182 
p53-
attb-F 
attB1 sequence, 
first 25 nt of p53 
GGGGACAAGTTTGTAC
AAAAAAGCAGGCTTCA
TGGAGGAGCCGCAGTC
AGATCCTA 
60 ˚C 
p53-
attb-R 
attB2 sequence, 
last 25 nt of p53 
(reverse 
complemented) 
GGGGACCACTTTGTAC
AAGAAAGCTGGGTGT
CAGTCTGAGTCAGGCC
CTTCTGTC 
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Table 2-42. Primer pair used for PCR amplification of ITM2B, its fragment, and disease-causing mutants 
for cloning, using the Gateway system. 
The primers were designed to incorporate the attB1 and attB2 recombination sites into the amplicon 
(indicated in bold). F – forward primer, R – reverse primer.  
Fragment 
name 
Amino 
acids 
Length 
(Bp) 
Primer 
name 
Primer 
components 
Sequence (5’  3’) 
Tm 
(˚C) 
Full-
length 
ITM2B 
1-266 801 
ITM2B-
attb-F 
attB1 sequence, 
first 25 nt of 
ITM2B 
GGGGACAAGTTTGTAC
AAAAAAGCAGGCTTCA
TGGTGAAGGTGACGTT
CAACTCCG 
60 ˚C 
ITM2B-
attb-R 
attB2 sequence, 
last 25 nt of 
ITM2B (reverse 
complemented) 
GGGGACCACTTTGTAC
AAGAAAGCTGGGTGT
CAAGAACAAATTAAAG
TTTCCACG 
ITM2B90 90-266 534 
ITM2B90-
attb-F 
attB1 sequence, 
first 25 nt of 
ITM2B 
GGGGACAAGTTTGTAC
AAAAAAGCAGGCTTC
GGAATAAAGTACATCA
AAGATGATG 
60 ˚C 
Reverse as for full-length ITM2B 
Full-
length 
ITM2B 
c.782A>C 
mutant 
(mu) 
1-266 801 
Froward as for full-length wild-type ITM2B 
60 ˚C 
ITM2B-
c.782A>C-
attb-R 
attB2 sequence, 
last 25 nt of 
ITM2B c.782A>C 
mu (reverse 
complemented) 
GGGGACCACTTTGTAC
AAGAAAGCTGGGTGT
CAAGAACAAATTAAAG
TTGCCACG 
Full-
length 
ITM2B 
c.799T>A 
mutant 
(mu) 
1-266 801 
Froward as for full-length wild-type ITM2B 
60 ˚C 
ITM2B-
c.799T>A-
attb-R 
attB2 sequence, 
last 25 nt of 
ITM2B c.799T>A 
mu (reverse 
complemented) 
GGGGACCACTTTGTAC
AAGAAAGCTGGGTGT
TAATTTTCCTCAATAAT
GTTTTTC 
Full-
length 
ITM2B 
c.795-
796ins 
TTTAATT
TGT 
mutant 
(mu) 
1-266 801 
Froward as for full-length wild-type ITM2B 
60 ˚C 
ITM2B-
c.795-
796ins 
TTTAATTT
GT-attb-R 
attB2 sequence, 
last 25 nt of 
ITM2B c.795-
796ins 
TTTAATTTGT mu 
(reverse 
complemented) 
GGGGACCACTTTGTAC
AAGAAAGCTGGGTGT
CAATAATGTTTTTCTTG
ACTGTTC 
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Table 2-43. Primer pair used for PCR amplification of full-length PTGDS for cloning, using the Gateway 
system. 
The primers were designed to incorporate the attB1 and attB2 recombination sites into the amplicon 
(indicated in bold). F – forward primer, R – reverse primer.  
Fragment 
name 
Amino 
acids 
Length 
(Bp) 
Primer 
name 
Primer 
components 
Sequence (5’  3’) 
Tm 
(˚C) 
Full-
length 
PTGDS 
1-190 573 
PTGDS
-attb-F 
attB1sequence, 
first 25 nt of 
PTGDS 
GGGGACAAGTTTGTACA
AAAAAGCAGGCTTCATGG
CTACTCATCACACACTGTG
GA 
60 ˚C 
PTGDS
-attb-R 
attB2sequence, 
last 25 nt of 
PTGDS (reverse 
complemented) 
GGGGACCACTTTGTACAA
GAAAGCTGGGTGCTATTG
TTCCGTCATGCACTTATCG 
 
Table 2-44. Primer pair used for PCR amplification of full-length PSMC1 for cloning, using the Gateway 
system. 
The primers were designed to incorporate the attB1 and attB2 recombination sites into the amplicon 
(indicated in bold). F – forward primer, R – reverse primer.  
Fragment 
name 
Amino 
acids 
Length 
(Bp) 
Primer 
name 
Primer 
components 
Sequence (5’  3’) 
Tm 
(˚C) 
Full-
length 
PSMC1 
1-440 1323 
PSMC1
-attb-F 
attB1sequence, 
first 25 nt of 
PSMC1 
GGGGACAAGTTTGTACA
AAAAAGCAGGCTTCATGG
GTCAAAGTCAGAGTGGTG
GTC 
60 ˚C 
PSMC1
-attb-R 
attB2sequence, 
last 25 nt of 
PSMC1 (reverse 
complemented) 
GGGGACCACTTTGTACAA
GAAAGCTGGGTGTTAGA
GATACAGCCCCTCAGGGG
TG 
 
2.2.6 SITE-DIRECTED MUTAGENESIS 
Site-directed mutagenesis (SDM) was carried out using the GeneArt® Site-Directed 
Mutagenesis System (Life Technologies, CA, USA; Figure 2-10) to ‘correct’ errors introduced 
(most likely) by the polymerase during PCR amplification of PSMC1 (Appendix 11.8.5). This 
SDM method comprises four major steps: 
 Mutation-specific primer design and synthesis; 
 Template plasmid methylation and PCR-based mutagenesis; 
 In vitro recombination reaction to enhance mutagenesis efficiency; 
 Transformation into One Shot® MAX Efficiency® DH5α™-T1R competent E. coli cells. 
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2.2.6.1 PRIMER DESIGN AND SYNTHESIS 
The forward and reverse primers were designed to begin and end with either a cytosine or 
a guanine nitrogen base and to be 32-35 nucleotides in length each with a 10-12 nucleotides 
long complementary overlapping region. The change to be introduced, i.e. the mutation site, 
was incorporated into each primer in the middle of its complementary overlap region. 
The primer oligo-nucleotides were synthesised by Sigma-Aldrich (MO, USA) and purified by 
desalting. An example of an SDM primer pair is shown in Figure 2-9. 
 
 
Figure 2-9. A fragment of a mutated sequence of pDONR-PSMC1 entry clone.  
SDM forward and reverse primer regions are highlighted within green and red arrow shapes, 
respectively. The mutagenesis site is highlighted within a blue box: a c.55G>A change is required. 
 
Table 2-45. Primer pair for GENEART SDM of pDONR-PSMC1 entry clone. 
Primer 
name 
Primer components Sequence (5’  3’) 
PSMC1 
SDM F 
Nucleotides 49 – 83 of PSMC1-
001 ENST00000261303 
cDNA 
GATGACAAGGACAAGAAAAAGAAATATGAACCTCC 
PSMC1 
SDM R 
Nucleotides 29 – 60 of PSMC1-
001 ENST00000261303 cDNA (reverse 
complemented) 
GTCCTTGTCATCCTTCTTGCCACCTCCAGGAC 
 
2.2.6.2 METHYLATION AND MUTAGENESIS 
Methylation of the plasmid template and the SDM both occur during one reaction (Table 2-46).  
All except for two components listed in the table are products of Life Technologies (CA, USA). 
The SDM primers were provided by Sigma-Aldrich (MO, USA) and the plasmid DNA is 
the substrate of the reaction, i.e. the template. PCR cycling conditions for the methylation and 
SDM reactions are summarised in Table 2.-47.  
  
Identification of Interacting Protein Partners of TOPORS in the Retina   ||   Barbara Czub 
PhD Thesis 2015   ||   Methods and Materials   - 128 - 
 
Table 2-46. Methylation and SDM reaction mixture. SAM = S-adenosine methionine. 
Components Volume Final concentration 
10X AccuPrime™ Reaction mix 5.0 μl 1X 
10X Enhancer 5.0 μl 1X 
SDM primer mix (10 µM each) X 0.3 µM each 
Plasmid DNA (40 ng/µl) X 40 ng in 50 µl 
DNA methylase (4 U/µl) 1.0 μl 4 U in 50 µl 
25X SAM 2.0 μl 1X 
AccuPrime™ Pfx (2.5 U/µl) 0.4 μl 1 U in 50 µl 
PCR H2O Up to 50 μl n/a 
Total volume 50.0 μl n/a 
 
Table 2-47. Methylation and SDM reaction cycling 
conditions. 
Temperature Duration Number 
of cycles 
37 ˚C 12-20 minutes 1 
94 ˚C 2 minutes 
94 ˚C 20 seconds 12-18 
57 ˚C 30 seconds 
68 ˚C 30 seconds/kb of 
plasmid 
68 ˚C five minutes 1 
4 ˚C Final hold 1 
 
The first 37 ˚C incubation allows for 
the methylation reaction to occur. 
The manufacturer recommends 
12 minutes incubation for 2.8 to 4.0 kb 
plasmids, and twenty minutes for 4.0 to 
14.0 kb plasmids. Furthermore, for optimal 
mutagenesis efficiency it is recommended 
to perform 12-15 reaction cycles for 2.8 to 
4.0 kb plasmids, and 18 cycles for 4.0 to 
14.0 kb plasmids. 
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The extension time in each cycle should be 30 seconds per 1 kb of plasmid DNA. Products (5 μl) 
of the mutagenesis PCR were evaluated on 0.8 % agarose gel. 
 
 
Figure 2-10. 
GENEART SDM 
workflow. 
The procedure 
relies on inherent 
DNA methylase 
properties, high 
fidelity Pfx DNA 
polymerase, 
recombination 
enzymes and 
MrcBC 
endonuclease.  
Figure from 
GENEART Site-
Directed 
Mutagenesis 
System User Guide 
(LifeTechnologies, 
CA, USA). 
 
 
2.2.6.3 RECOMBINATION REACTION 
Given that a clear band of the expected 
size was observed following 
the agarose gel electrophoresis, the in 
vitro recombination reaction (Table 
2-48) was set up in order to enhance 
the mutagenesis efficiency as well as to 
increase the colony yield following 
transformation of the competent cells.  
Table 2-48. In vitro recombination reaction. 
Components Volume Final 
concentration 
5X Reaction 
buffer 
4 μl 1X 
PCR H2O 10 μl n/a 
SDM PCR Sample 4 μl n/a 
10X Enzyme mix 2 μl 1X 
Total Volume 20 μl n/a 
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The reaction was incubated for ten minutes at room temperature, and subsequently stopped 
by adding 1 μl of 0.5 M EDTA. The reaction products were stored on ice until 
transformation. All reagents used for the reaction and its termination are from Life 
Technologies (CA, USA). 
 
2.2.6.4 TRANSFORMATION OF ONE SHOT® MAX EFFICIENCY® DH5Α™-T1R CELLS 
The cells were thawed on ice for approximately 5-7 minutes; one 50-μl vial was used per 
transformation. Two microliters of the in vitro recombination reaction were transferred into 
the vial with cells and mixed by tapping. The vials were covered completely with ice and 
incubated for 12 minutes. The cells were heat-shocked at 42 ˚C for 30 seconds and placed 
immediately back in ice (covered completely) for further 2 minutes. The bacteria were mixed 
with 250 µl of SOC media per vial and incubated with shaking (1 37 ˚C,225 rpm; Innova 4200 
Incubator Shaker, New Brunswick Scientific, NJ, USA). Dilutions of the cell suspensions were 
made (Table 2-49) using SOC media in a total volume of 100 µl. 
 
Table 2-49. Transformation reaction dilutions prior to plating. 
Plasmid Size Dilution 
3 kb 5 µl reaction + 95 µl SOC 
6 kb 10 µl reaction + 90 µl SOC 
9 kb 20 µl reaction + 80 µl SOC 
14 kb 50 µl reaction + 50 µl SOC 
 
The cells were spread, using plastic sterile spreaders, on LB agar plates supplemented with 
the relevant antibiotics; the plates were incubated at 37 ˚C for 16-20 hours. Single colonies 
were inoculated into 1 ml LB-broth cultures with the relevant antibiotics (16-20 hours, 37 °C, 
225 rpm; Innova 4200 Incubator Shaker, New Brunswick Scientific, NJ, USA) for further 
analyses. 
 
2.2.7 DNA SEQUENCING 
DNA sequencing was used regularly throughout the project in order to validate the outcomes 
of cloning (Chapters 3 and 5) and library characterisation and screening for the interacting 
partners of TOPORS (Chapters 3 and 5). The BigDyeTM Terminator v3.1 Cycle Sequencing Kit 
and the ABI PRISM® 3730 DNA Analyser (Applied Biosystems, Life Technologies, CA, USA) were 
used for DNA sequencing. The temperature cycling profile comprised an initial denaturing step 
at 94 ˚C for five minutes, followed by 25 cycles of denaturation at 96 ˚C for 10-15 seconds, 
Identification of Interacting Protein Partners of TOPORS in the Retina   ||   Barbara Czub 
PhD Thesis 2015   ||   Methods and Materials   - 131 - 
 
annealing at 50 ˚C for 5 seconds and an extension step at 60 ˚C for 4 minutes. The reaction was 
completed by a final hold step at 10 ˚C. The DNA (PCR product, 5-20 ng; plasmid, 100-150 ng) 
was sequenced using 1X BigDyeTM v3.1 Cycle ready mix (containing ddNTPs, dNTPs, Amplitaq® 
DNA polymerase, pyrophosphate and MgCl2), 1X BigDye
TM Sequencing Buffer, 1 μmol of primer 
and dH2O to a final volume of 20 μl. Sequencing electropherograms were analysed using the 
DNASTAR Software (DNASTAR Inc., WI, USA) and the ChromasTM program (Technylesium Pty 
Ltd., QLD, Australia). 
 
2.2.7.1 SEQUENCING PRIMERS 
Primers for sequencing of TOPORS cDNA and its control interacting partner p53 cDNA as well 
as its novel interacting partners identified via the Y2H screen are detailed in this section 
(Tables 2-50, 2-51, 2-52, 2-53, 2-54 and 2-55). 
 
Table 2-50. Vector-specific sequencing primers.  
Forward primers (denoted with an ‘F’ in the primer name, or not defined) were designed to bind to 
the sense vector strand. Reverse primers (always denoted with an ‘R’ in the primer name) were 
designed to bind to the anti-sense strand (hence their sequences are reverse-complemented relative to 
the template sense strand). Primer sequences are given in the 5’ to 3’ direction.  
Name Sequence (5’  3’) Vector 
Complementory base 
pairs on vector 
T7 TAATACGACTCACTATAGGG pGBKT7 (Clontech) 1213-1233 
M13F GTAAACGACGGCCAG 
pDONR/Zeo (Life 
Technologies) 
537-552 
M13R CAGGAAACAGCTATGAC 
pDONR/Zeo (Life 
Technologies) 
3027-3043 
pGBKT7 F TCATCGGAAGAGAGTAGT pGBKT7 (Clontech) 1155-1172 
pGBKT7 R1 TTTTCGTTTTAAAACCTAAGAGTC pGBKT7 (Clontech) 1487-1510 
pBD F GGAGACTGATATGCCTCTAACAT pBD8 1922-1944 
pBD R GAATTAGCTTGGCTGCAGTAAT pBD8 999-1020 
pAD_BRP 2F AAACCACTGTCACCTGGTTGG pAD8 1962-1982 
pAD_BRP R GTGCACGATGCACAGTTGAAGT pAD8 1043-1064 
 
  
                                                          
 
8 These vectors were a gift from Dr Ronald Roepman. They had been modified from original pBD-GAL4 Cam and 
pAD-GAL4-2.1 (Stratagene, CA, USA) vectors to contain the att sequences, i.e. to allow compatibility with Gateway 
cloning (LifeTechnologies, CA, USA; see section 2.2.5.3). 
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Table 2-51. Sequencing primers used for TOPORS.  
Forward primers (denoted with an ‘F’ in the primer name, or not defined) were designed to bind to 
the sense cDNA strand. Reverse primers (always denoted with an ‘R’ in the primer name) were designed 
to bind to the anti-sense strand (hence their sequences are reverse-complemented relative to 
the template sense strand). Primer sequences are given in the 5’ to 3’ direction.  
Primer Sequence  (5’  3’) Complementory base pairs on 
TOPORS cDNA 
F ATGGGGTCGCAGCCGCCGCTG 1-23 
S8 (R) CTCGGAGGATGCCGGCGCAG 179-198 
S1 GACAACTTTTCACCTAAAG 232-250 
S2 CGTACAACTCTGACAAGG 451-468 
S3 AACGTGAACTTACAGTTC 902-919 
S4 GGACCATCTTACTCAAGCTC 1264-1283 
S5 GTCATTGTGATTCTAGTAC 1643-1661 
S6 TCTCTAAGTAGTGAAAGC 1981-1997 
S7 TCTACCGGGACTGACCGG 2386-2403 
S9 CACCATGGAGATAATGCTTC 2786-2705 
S10 (R) GAGCTTGAGTAAGATGGTCC 1264-1283 
S11 (R) AGCAGGGCAATCATAATT 937-1134 
S12 (R) CATTTTCTCATAAGAACC 1513-1530 
S13 (R) ATGATTCTTCTGATCATG 1828-1845 
S14 (R) ATACTCCCATTTGTATCT 2095-2112 
S15 (R) CCGGTCAGTCCCGGTAGA 2386-2403 
R TTAAGACATATCACAGTC 3076-3138 
 
Table 2-52. Sequencing primers used for p53. 
Forward primers designed to bind to the sense p53 cDNA strand.  
Primer Sequence (5’ 3’) Complementory base pairs 
on p53 cDNA 
p53-S1 ATGGAGGAGCCGCAGTCA 1-18 
p53-S2 CATCTTCTGTCCCTTCCC 281-298 
p53-S3 CAGCATCTTATCCGAGTGGA 574-593 
p53-S4 GCACTAAGCGAGCACTGCC 908-926 
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Table 2-53. Sequencing primers for ITM2B.  
Forward primers (denoted with an ‘F’ in the primer name, or not defined) were designed to bind to 
the sense cDNA strand. Reverse primers (always denoted with an ‘R’ in the primer name) were designed 
to bind to the anti-sense strand (hence their sequences are reverse-complemented relative to 
the template sense strand). Primer sequences are given in the 5’ to 3’ direction. Primers with ‘PCR’ in 
the name were also optimised for cDNA amplification by PCR. ‘ITM2B90’ refers to cDNA, which encodes 
a peptide corresponding to ITM2B missing its first 90 amino acids, i.e. generating a non-membrane 
bound, soluble, form of ITM2B. 
 
Table 2-54. Sequencing primers for PTGDS.  
Forward primers (denoted with an ‘F’ in the primer name, or not defined) were designed to bind to 
the sense cDNA strand. Reverse primers (always denoted with an ‘R’ in the primer name) were designed 
to bind to the anti-sense strand (hence their sequences are reverse-complemented relative to 
the template sense strand). Primer sequences are given in the 5’ to 3’ direction. Primers with ‘PCR’ in 
the name were also optimised for cDNA amplification by PCR. 
Primer Sequence (5’ 3’) Complementory base pairs on 
PTGDS cDNA 
PTGDS-PCR-F ATGGCTACTCATCACACACTGTGGA 1-25 
PTGDS-PCR-R CTATTGTTCCGTCATGCACTTATCG 782-807 
PTGDS-S1-R TCTCACACTGGTTTTTCC 254-271 
PTGDS-S2 GGAAAAACCAGTGTGAGA 254-271 
 
Table 2-55. Sequencing primers for PSMC1. 
Primer Sequence (5’ 3’) Complementory base pairs on 
PSMC1 cDNA 
PSMC1-SF ATGGGTCAAAGTCAGAGT  1-18 
PSMC1-S1 GTGATAGGGGTGCTGATG 175-492 
PSMC1-S2-R CATCAGCACCCCTATCAC 175-492 
PSMC1-S3 TGGATGGATTTGATTCTA 947-964 
PSMC1-SR TTAGAGATACAGCCCCTC  1306-1323 
 
2.2.8 DNA PROCEDURES SUMMARY 
In summary, the DNA methods were used for cloning and validation of Y2H baits and preys 
(Chapters 3 and 5), for library construction and characterisation (Chapter 3), for identification 
of interacting partners of TOPORS (Chapter 4), and for identification of retinal isoforms of 
the novel interacting partners of TOPORS (Chapter 5).  
 
Primer Sequence (5’ 3’) Complementory base pairs 
on ITM2B cDNA 
 
ITM2B-PCR-F ATGGTGAAGGTGACGTTCAACTCCG 1-25  
ITM2B-PCR-R TCAAGAACAAATTAAAGTTTCCACG 776-801  
ITM2B-S1 ACATCAAAGATGATGTCA 278-295  
ITM2B-S2-R TCAATGCGATCAGTAATA 612-629  
ITM2B90-PCR-F GGAATAAAGTACATCAAAGATGATG 268-293  
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2.3 CELL CULTURE 
Three major classes of cells were used in order to fulfil the goals of this project. Initially 
the eukaryotic yeast Saccharomyces cerevisiae cells were essential for constructing the cDNA 
library and completing the Y2H PPI studies (section 2.1 and experimental Chapters 3, 4 and 5). 
For the purposes of cloning (section 2.2.3) and mutagenesis (section 2.2.6) several types of 
prokaryotic competent Escherichia coli cells were used. 
Finally, for experiments requiring the use of RNA and protein of human origin, adherent 
human cell lines were maintained in culture in order to fulfil the objectives of characterising 
the newly-identified PPIs (experimental Chapters 6 and 7). 
 
2.3.1 HUMAN CELL LINES MAINTENANCE 
Several different adherent cell lines were used throughout this project; a summary of their 
growing conditions is shown in Table 2-56. 
Table 2-56. Cell lines used for TOPORS characterisation and validation of interactions.  
FCS – foetal calf serum; P/S – penicillin/streptomycin antibiotic mixture. 
Name Details Media Supplements Source 
hTERT 
RPE1 
Human hTERT-
immortalised 
retinal pigment 
epithelial cell 
line 
DMEM/
F-12 
10 % FCS, 
1 % P/S 
Kindly provided by Dr Rosa M. Rios 
from the Andalusian Molecular 
Biology and Regenerative Medicine 
Centre (CABIMER; Seville, Spain)  
SK-N-SH Human 
neuroblastoma 
cell line 
DMEM/
F-12 
10 % FCS, 
1 % P/S 
Kindly provided by Prof Mike 
Cheetham from the UCL Institute of 
Ophthalmology (London, UK) 
HeLa Human 
adenocarcinom
a cell line 
DMEM 
(4.5g/L 
glucose) 
10 % FCS, 
1 % P/S 
Purchased from the American Type 
Culture Collection (ATCC; VA, USA) 
HEK293 Human 
embryonic 
kidney epithelial 
cell line 
DMEM 
(4.5g/L 
glucose) 
10 % FCS, 
1 % P/S 
Kindly provided by Prof David Hunt 
from the UCL Institute of 
Ophthalmology (London, UK) 
 
2.3.2 TRANSFECTION 
Prior to transfection adherent cells were grown to approximately 90 % of confluence at 37 °C 
with 5 % CO2 in a 24-well plate; the growth medium was removed and changed to serum-free 
media.  
Identification of Interacting Protein Partners of TOPORS in the Retina   ||   Barbara Czub 
PhD Thesis 2015   ||   Methods and Materials   - 135 - 
 
The prepared plasmid DNA was diluted in OptiMEM (Life Technologies, CA, USA) in a total 
volume of 50 µl per well. Simultaneously, Lipofectamine Reagent 2000 (Life Technologies, 
CA, USA) was diluted in OptiMEM (Life Technologies, CA, USA) in a total volume of 50 µl per 
well, and incubated at room temperature for five minutes.  
The two mixtures were combined and incubated at room temperature for twenty minutes.  
The total mixture was added directly into the wells (100 μl per well) containing 500 μl serum-
free media. The cells were incubated for four hours at 37 °C with 5 % CO2, and the media 
were changed to the standard growth media supplemented with 10 % FCS and 1 % P/S. 
The cells were incubated for 24 to 48 hours at 37 °C with 5 % CO2 prior to fixation. 
 
2.3.3 SERUM STARVATION STUDIES 
Human TERT RPE1 cells were cultured on sterile glass coverslips, in 24 well plates, until 
approximately 50 % confluent (growing in islands). Medium supplemented with 10 % FCS was 
then replaced with medium containing only 0.25 % FCS, and incubated for 48 hours at 37 °C. 
The cells were subsequently washed with PBS, and fixed for analysis by immunofluorescence 
(IF; section 2.6).   
 
2.3.4 CELL PROCEDURES SUMMARY 
In summary, the mammalian cell cultures were used for isolation of RNA to clone full-length 
fragments of the novel interacting partners of TOPORS (Appendix 11.8), for extraction of 
proteins for validation of expression and PPIs by Western blotting and coIP, respectively 
(Chapter 6) as well as for delineating the sub-cellular localisation of TOPORS and its novel 
interacting partners (Chapter 7). 
 
2.4 RNA TECHNIQUES 
Following the identification of novel protein interacting partners of TOPORS (experimental 
Chapter 4), the next objective was to amplify full-length cDNA corresponding to each 
interacting partner of interest pulled out from the Y2H PPI screen. 
For this purpose, RNA was extracted from the human telomerase reverse transcriptase-
immortalised retinal pigment epithelial-1 (hTERT-RPE1/hRPE1; ATCC® CRL-4000™) cell line in 
order to preserve the precious human RNA, purchased from Clontech (CA, USA) for library 
generation.  
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The extracted RPE1 RNA was subsequently used for cDNA synthesis, and then for amplification 
of the preys of interest (Appendix 11.8). 
The complementary DNA was also synthesised from the human retinal RNA purchased from 
Clontech (CA, USA) (originally for library generation) in order to identify potential protein-
coding isoforms of the newly-identified protein interacting partners of TOPORS (Chapter 5).  
Prior to RNA extraction, the required adherent mammalian cell line was grown in culture until 
it reached confluence. 
 
2.4.1 RNA EXTRACTION 
Pure Link RNA Mini Kit (LifeTechnologies, CA, USA) was used for RNA isolation from the hRPE1 
cell line. Five million cells were used per one procedure of RNA extraction. The manufacturer’s 
protocol was followed, except for minor changes. 
The growth medium was removed from cells, and the cells were washed once with PBS. Six 
hundred microlitres of the Lysis Buffer (provided with the kit), supplemented with 1 % 
β mercaptoethanol, were added onto the cell monolayer, and the mixture was incubated for 
seven minutes at room temperature. The cells were subsequently transferred into a 1.5 ml 
tube, and homogenised by passing fifteen times through an 18-gauge needle attached to 
a syringe.   
One volume of 70 % ethanol was added per one volume of cell homogenate. The homogenate 
suspension was mixed by vortexing, loaded into the Spin Cartridge with a Collection Tube 
(provided with the kit; 700 µl of sample per tube), and vortexed at top speed for five minutes. 
Wash Buffer I (350 µl per tube) was added to each Spin Cartridge with the bound RNA, and 
the tubes were centrifuged at top speed for five minutes; the flow-through was discarded, and 
the Spin Cartridge was transferred into a new Collection Tube.  
The RQ1 DNAse (Promega, WI, USA; 70 µl per tube) mixture (Table 2-57) was added directly 
onto the Spin Cartridge membrane, and the tubes were incubated at 37 ˚C for twenty minutes. 
The samples were then washed with Wash Buffer I (350 µl per tube); the tubes were 
centrifuged at top speed for one minute and the flow-through was discarded.  
Alternatively, the RQ1 DNAse treatment could have been omitted; a wash with 700 µl per 
sample of Wash Buffer I could have been performed instead prior to the next step. Five 
hundred microlitres of Wash Buffer II (provided with the kit), supplemented with ethanol 
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according to instructions, were added per sample, and the tubes were centrifuged at top 
speed for one minute; this washing step with Wash Buffer II was performed twice.  
The tubes were subsequently centrifuged at top speed for one minute to dry the membrane 
(with the bound DNA) of the Spin Cartridge; the Collection Tube was discarded and the Spin 
Cartridges were inserted into Recovery Tubes (provided with the kit).  
RNAse-Free Water (provided with the kit) was used for elution of the extracted RNA; 30 µl 
were added per sample, and incubated on the membrane for one minute at room 
temperature. The tubes were then centrifuged at top speed for one minute. 
 
Table 2-57. RQ1 DNAse (Promega, WI, USA) mix. 
Component Volume 
1 u/µl RQ1 DNAse (Promega, WI, USA) 3 µl 
RQ1 DNAse Buffer 7 µl 
RNAse-free dH2O 60 µl 
Total volume 70 µl 
 
2.4.1.1 RNA YIELD EVALUATION 
Firstly, the Nanodrop spectrophotometer was used to evaluate the yield of the extracted RNA 
as well as its purity from protein and organic solvents by measuring absorbance at 260 nm 
wave length. Subsequently, the RNA sample was analysed by gel electrophoresis. 
Prior to the electrophoresis procedure the electrophoresis tank and equipment for agarose gel 
preparation were sterilised to remove RNAses by soaking them in either 0.4 M NaOH or RNAse 
Away Reagent (Life Technologies, CA, USA) and thoroughly rinsed with dH2O. The gel tray, 
comb and rubbers were additionally wiped with RNAseZap™ (Sigma-Aldrich, MO, USA) prior to 
making the agarose gel. 
Fresh 1X TAE buffer was prepared using diethylpyrocarbonate (DEPC)-treated water, and it 
was used for making the 1.2 % agarose gel with ethidium bromide as well as for buffering 
the electrophoresis reaction; sterile bottles were used. 
The RNA sample (400 ng) to be tested was mixed with 1 µl of RNAse-free loading dye and with 
RNAse-free water up to 10 µl. The mixture was incubated at 65 ˚C for five minutes and then it 
was placed on ice for two minutes. After the two incubation steps, the RNA was subject to 
electrophoresis at 80 V for approximately one hour. The gel was subsequently visualised and 
photographed, using a UV Illuminator. If ribosomal RNA bands, corresponding to 28 S, 18 S and 
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5.0-5.8 S rRNA molecules, were observed, the extracted RNA sample was considered pure and 
fit for further experiments. If a smear was observed on the agarose gel rather than distinct 
bands, the RNA was considered degraded and was discarded. The extracted RNA was stored at 
-80 ˚C. 
 
2.4.1.2 DNAse TREATMENT FOLLOWING RNA EXTRACTION 
If no DNAse treatment was included during the RNA extraction procedure, the RQ1 DNAse 
(Promega, WI, USA) was used to treat the extracted RNA samples for removal of any residual 
DNA. One unit of RQ1 DNAse was used per 1 µg of treated RNA; the reaction components are 
summarised in Table 2-58. 
 
Table 2-58. DNAse treatment reaction components’ list. 
Component Amount 
RNA 1-8 µl 
RQ1 DNAse 10X Reaction Buffer 1 µl 
RQ1 DNAse 1 u/1 µg of RNA 
Nuclease-free water Up to 10 µl total volume 
 
2.4.2 cDNA SYNTHESIS 
Complementary DNA was synthesised, using the QuantiTect Reverse Transcription Kit (Qiagen, 
Netherlands), which involved two major stages: 
 Genomic DNA elimination reaction; 
 Reverse-transcription reaction. 
The manufacturer’s instructions were followed with several exceptions. 
 
2.4.2.1 GENOMIC DNA ELIMINATION 
The template RNA was thawed on ice, and approximately 1 µg was used for cDNA synthesis. 
The kit components, i.e. gDNA Wipeout Buffer, Quantiscript Reverse Transcriptase, 
Quantiscript RT Buffer, RT Primer Mix and RNAse-free water, were thawed at room 
temperature. The genomic DNA elimination reaction was prepared on ice (Table 2-59). 
The reaction was incubated at 42 ˚C for eight minutes, and then immediately cooled on ice. 
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Table 2-59. Genomic DNA elimination reaction components. 
Table modified from the QuantiTect Reverse Transcription Handbook 03/2009 (Qiagen, Netherlands). 
Components Volume Final concentration 
7X gDNA Wipeout Buffer 2 µl 1X 
Template RNA Up to 1 µg n/a 
RNAse-free dH2O Up to 14 µl n/a 
Total Volume 14 μl n/a 
 
2.4.2.2 REVERSE-TRANSCRIPTION 
The reverse-transcription reaction was prepared on ice (Table 2-60); total reaction from Table 
2-59 was added to the reverse-transcription master mix. The total reaction mixture was 
incubated for thirty minutes at 42 ˚C, and inactivated for three minutes at 95 ˚C. The reaction 
products were diluted in 20 µl RNAse-free dH2O and stored at -20 ˚C prior to further use. 
 
Table 2-60. Reverse-transcription mix. 
Table modified from the QuantiTect Reverse Transcription Handbook 03/2009 (Qiagen, Netherlands). 
Components Volume Final 
concentration 
Quantiscript Reverse Transcriptase with RNAse inhibitor 1 µl n/a 
5X Quantiscript RT Buffer with Mg2+ and dNTPs 4 µl 1X 
RT Primer Mix 1 µl n/a 
Total Volume 6 μl n/a 
 
2.4.2.2.1 cDNA QUALITY CONTROL 
Control PCR amplifications were performed on the newly synthesised cDNA in order to 
evaluate its quality. The optimised protocols and reaction components, including the GoTaq 
Mix (Promega, WI, USA; includes the Taq polymerase, dNTPs, MgCl2 and reaction buffer) as 
well as primers, were kindly provided by Dr Giovanna Alfano. 
The quality of the synthesised cDNA was evaluated by amplifying a housekeeping gene, HPRT1 
(NM_000194); expected amplicon: 150 bp. The control PCR for this gene had been optimised 
using GoTaq Mix (Promega, WI, USA) by Dr Alfano. The reaction components for this 
amplification are summarised in Table 2-61, and the PCR cycling conditions are given in Table 
2-62. The obtained PCR products (10 µl) were subject to agarose (1.5 %) gel electrophoresis for 
thirty minutes at 150 V. 
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Table 2-61. HPRT1 amplification reaction mix. 
Components Volume 
GoTaq Mix 12.5 µl 
HPRT1 forward primer 1.0 µl 
HPRT1 reverse primer 1.0 µl 
cDNA 1.0 µl 
dH2O 9.5 µl 
Total volume 25.0 µl 
 
Table 2-62. HPRT1 amplification PCR cycling conditions. 
Temperature Duration Number of cycles 
95 ˚C 10 minutes 1 
95 ˚C 30 seconds 33 
60 ˚C 30 seconds 
72 ˚C 45 seconds 
72 ˚C 10 minutes 1 
4 ˚C Final hold 1 
 
The cDNA was also tested for presence of larger genes, such as the homeobox gene VAX2 
(NM_012476); expected amplicon: 952 bp. The control PCR for this gene had been optimised 
using GoTaq Mix (Promega, WI, USA) by Dr Giovanna Alfano.   
The reaction components for this amplification are summarised in Table 2-63, and the PCR 
cycling conditions are given in Table 2-64. The obtained PCR products (10 µl) were subject to 
agarose (1.5 %) gel electrophoresis for thirty minutes at 150 V. The synthesised cDNA was 
stored at -20 ˚C. 
 
Table 2-63. VAX2 amplification reaction mix. 
Components Volume 
GoTaq Mix 12.5 µl 
VAX2 forward primer #2 1.0 µl 
VAX2 reverse primer #1 1.0 µl 
cDNA 1.0 µl 
dH2O 9.5 µl 
Total volume 25.0 µl 
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Table 2-64. VAX2 amplification PCR cycling conditions. 
Temperature Duration Number of cycles 
95 ˚C 10 minutes 1 
95 ˚C 30 seconds 40 
55 ˚C 30 seconds 
72 ˚C 1 minute 
72 ˚C 10 minutes 1 
4 ˚C Final hold 1 
 
2.4.3 PRIMERS FOR AMPLIFICATION OF TRANSCRIPTS OF INTEREST 
The hTERT-RPE1 cDNA was used for amplification of novel interacting partners of TOPORS 
using flanking PCR primers described in section 2.2.7.1 (these same primers were also used for 
sequencing). Primers details for ITM2B, PTGDS and PSMC1 amplification are given in Tables 2-
53, 2-54 and 2-55, respectively. The PCR products amplified from the cDNA using these primers 
were subsequently used as templates for Gateway cloning using the attb primers (section 
2.2.5.3: Table 2-42, Table 2-43 and Table 2-44). 
 
2.4.4 PRIMERS FOR AMPLIFICATION OF ALTERNATIVE TRANSCRIPTS 
Complementary DNA synthesised from human retinal RNA (Clontech, CA, USA) was used for 
determination of retinal expression of previously reported protein-coding isoforms of ITM2B, 
PTGDS and PSMC1. 
The following tables and corresponding figures provide an overview of primer binding regions 
corresponding to specific protein-coding isoforms. The tables also contain primer sequences, 
the expected amplicon length as well as the PCR names corresponding to specific results in 
Chapter 5.  
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Table 2-65. ITM2B primer details for isoform amplification to determine retinal expression.  
Primer names correspond to names in Figure 2-11, and the primer sequences are given in 
the neighbouring column. Fragments of isoforms expected to be amplified by the designed primers are 
included; the sizes of fragments, amplified from the expected isoforms are given in brackets. The last 
column contains a reference to the corresponding PCR result image. 
Primer 
name 
Primer Sequence Expected isoform fragments (size) 
PCR 
name 
Ex1F CTGGGAGGCTGCGAGATCCC 
Isoform 001 (918 bp) ITM2B-1 
Ex6R CTGGCTTCACGTTTCTGAATAC 
Ex1Fb ATGGTGAAGGTGACGTTCAACT 
Isoforms 001 (737 bp) & 003 (419 
bp) 
ITM2B-2 
Ex6R CTGGCTTCACGTTTCTGAATAC 
Ex1F CTGGGAGGCTGCGAGATCCC 
Isoform 001 (530 bp) ITM2B-3 
Ex3R CTTCAATTGTCTGGTAGAGAGCAGC 
Ex2F GACTAGCATTTATGCTTGCAGG 
Isoform 001 (445 bp) & 003 (127 bp) ITM2B-4 
Ex5R CGATCAGTAATAACCATGTGCTC 
Ex3F CAGATGACGTGTACTACTGTGGAAT 
Isoform 001 (490 bp) ITM2B-5 
Ex6R CTGGCTTCACGTTTCTGAATAC 
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Table 2-66. PTGDS primer details for isoform amplification to determine retinal expression.  
Primer names correspond to names in Figure 2-12, and the primer sequences are given in 
the neighbouring column. Fragments of isoforms expected to be amplified by the designed primers are 
included; the sizes of fragments, amplified from the expected isoforms are given in brackets. The last 
column contains a reference to the corresponding PCR result image (Figure 5-4). 
Primer 
name 
Primer Sequence Expected isoform fragments (size) 
PCR 
name 
Ex1F CTGCAGGAGAATGGCTACTCATC 
Isoforms 201 (845 bp) & 001 (743 
bp) 
PTGDS-1 
Ex7R GACTTGCTTCCGGAGTTTATTG 
Ex1F CTGCAGGAGAATGGCTACTCATC 
Isoform 003, 004, 201 (443 bp) PTGDS-2 
Ex3RII CTCCCACCCCATGGATCTCC 
Ex1F CTGCAGGAGAATGGCTACTCATC 
Isoform 004 (560 bp) PTGDS-3 
Ex3Rb GGCTCCAGAGAGGATCCAACC 
Ex2F GTTGTCCATGTGCAAGTCTGTGG 
Isoforms 201 (462 bp), 001 (391 bp) 
& 005 (360 bp) 
PTGDS-4 
Ex5R GGCAGGAAGACAATGGTATCCTCTG 
Ex2Fb GGAGACCGGAGGAGTAGACG 
Isoform 005 (624 bp) PTGDS-5 
Ex7Rb GAGCAGAGACATCCAGAGCG 
Ex3F CCAGTGTGAGACCCGAACC 
Isoforms 201 (418 bp) 001 (316 bp) 
005 (313 bp) 
PTGDS-6 
Ex6R CTATTGTTCCGTCATGCACTTAT 
Ex3Fb CACTTGCCGGGACGACTC 
Isoforms 201 & 003 (213 bp) PTGDS-7 
Ex5Rb TCTCCTTTAACTCAGCCCTG 
Ex4F GCAGCACCTACTCCGTGTCAG 
Isoforms 201 (399 bp) & 001 (396 
bp) 
PTGDS-8 
Ex7R GACTTGCTTCCGGAGTTTATTG 
Ex5F CCATTGTCTTCCTGCCCC 
Isoforms 201, 001 (207 bp) & 008 
(363bp) 
PTGDS-9 
Ex7R GACTTGCTTCCGGAGTTTATTG 
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Table 2-67. PSMC1 primer details for isoform amplification to determine retinal expression.  
Primer names correspond to names in Figure 2-13, and the primer sequences are given in 
the neighbouring column. Fragments of isoforms expected to be amplified by the designed primers are 
included; the sizes of fragments, amplified from the expected isoforms are given in brackets. The last 
column contains a reference to the corresponding PCR result image. 
Primer 
name 
Primer Sequence 
Expected isoform 
fragments (size) 
PCR name 
Ex1F GCTCAAGTGGCCAAGGCAAG Isoform  001 
(1495 bp), 002 
(1237 bp) 
PSMC1-1 
Ex11R GGCACTTACACATCGTACTCC 
Ex1F GCTCAAGTGGCCAAGGCAAG Isoform 001 (476 bp), 
002 (379 bp) & 004 
(67 bp) 
PSMC1-2 
Ex5R GAGCAGGACCGAGCAGCCA 
Ex2F CAGAGTGGTGGTCATGGTCC 
Isoform 001 (520 bp), 
002 (423 bp) 
PSMC1-3 
Ex6R TTTCTACCTTCATCACTGTGACC 
Ex3F GGGACCAGATGCTGCCAGC 
Isoforms 001 (569 
bp) 
PSMC1-4 
Ex7R CTGTGCCAGGTGGACCATAGAGAA 
Ex5F GATGTCAGTAGGAACCTTGG 
Isoforms 001 & 002 
(714 bp) 
PSMC1-5 
Ex9R GGTCTGATAAGTGCTGGAT 
Ex8F GAACTTATTCAGAAGTACCTAGGTG 
Isoforms 001 & 002 
(715 bp) 
PSMC1-6 
Ex11R GGCACTTACACATCGTACTCC 
 
2.4.5 RNA PROCEDURES SUMMARY 
In summary, the RNA procedures were used, firstly, for amplification of cDNA corresponding to 
the novel protein interacting partners of TOPORS (Appendix 11.8), and subsequently for 
identification of their isoforms in the human retina (Chapter 5). 
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2.5 PROTEIN TECHNIQUES 
Proteins evaluated throughout the project were extracted from mammalian as well as 
Saccharomyces cerevisiae yeast cells (section 2.1.7: details on preparation of protein samples 
from yeast cells. Analysis of mammalian protein lysates was described in Chapter 6. 
 
2.5.1 PREPARATION OF PROTEIN SAMPLES 
Following the validation of PPIs in yeast, protein expression and PPI studies were performed 
using mammalian cell lines. The purpose of these experiments was to demonstrate that 
the human proteins, shown to interact when exogenously expressed in yeast, are also 
expressed and associate with each other in native conditions, i.e. human cells. The robust HeLa 
cell line, originating from a cervix adenocarcinoma, was used for these studies. 
Total mammalian cell protein extracts were prepared using a Tx100-based buffer with 
an added mixture of protease and phosphatase inhibitors (Table 2-68); when available 
the ProteaseArrestTM (G Biosciences, MO, USA) reagent was used as an alternative to the 
individual protease inhibitors. 
The cell culture dish with cells was placed on ice and the cells were washed with ice-cold PBS. 
The PBS was removed and the cells were then lysed, using 1 ml of the lysis buffer (Table 2-68) 
per 100-mm dish.  
Cells were subsequently scraped off with a pre-cooled plastic cell scraper, and the resulting 
suspension was transferred into a pre-cooled micro-centrifuge tube. The suspension was 
incubated in the lysis buffer at 4°C for thirty minutes with gentle agitation. The suspension was 
then centrifuged at 4°C for ten minutes at the maximum speed.  
The supernatant was divided into aliquots on ice, and stored at -80 °C. The pellet was 
discarded. Five microliters of each extract were kept for concentration determination, using 
the Novagen® BCA Assay (Merck Group, Darmstadt, Germany). 
  
2.5.2 SDS-POLYACRYLAMIDE GEL ELECTROPHORESIS 
Proteins were separated using sodium dodecyl sulphate polyacrylamide gel electrophoresis 
(SDS-PAGE) with a discontinuous, 1X TRIS/glycine/SDS buffered system.  For this purpose 
10x Tris/Glycine/SDS #161-0772 (BioRad, CA, USA) was purchased and diluted with dH2O. For 
the purposes of this study, 7.5 % or 12 % gels were routinely used. 
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Table 2-68. Lysis buffer for protein extraction from human cell lines. 
Buffer basis 
150 mM NaCl 
1 % Triton X-100 
50 mM Tris 
Protease inhibitors 
10 µg/ml Aprotinin 
10 µg/ml Leupeptin hemisulphate 
10 µg/ml Pepstatin A 
50 µg/ml Benzamidine hydrochloride 
1 mM PMSF 
Phosphatase inhibitors 
50 mM NaF 
3 mM Na4P2O7 
1 mM Na3VO4 
Solvent Sterile dH2O 
 
The resolving gel mixture was prepared in a fume cupboard with: 7.25 ml sterile, deionised 
water (dH2O) and 3.75 ml acrylamide for 7.5 % gels; or 6 ml sterile dH2O and 5 ml acrylamide 
for 12 % gels; followed by 3.75 ml TRIS (pH 8.8), 150 μl SDS, 100 μl 10 % (w/v) APS and 25 μl 
TEMED (Sigma-Aldrich, MO, USA) in that order and mixed thoroughly. The stacking gel 
comprised: 3 ml sterile water, 0.625 ml acrylamide, 1.25 ml TRIS (pH 6.8), 50 μl SDS, 30 μl 10 % 
(w/v) APS and 10 μl TEMED (Sigma-Aldrich, MO, USA) (Table 2-19). Protein samples were 
denatured at 95 ˚C for ten minutes prior to loading. Gels were subject to electrophoresis until 
suitable separation of the marker had been achieved, typically at 100 V, 3 A, 30 W for one 
hour. Precision Plus Protein Standards (BioRad, CA, USA) was used as a marker for protein 
band size estimation. 
Table 2-69. SDS-PAGE gel composition. 
 Resolving gel: 7.5 % Resolving gel: 12 % Stacking gel 
dH20 7.25 ml 5.00 ml 3.00 ml 
30% acrylamide 3.75 ml 6.00 ml 625 μl 
1.5M Tris, pH 8.8 3.75 ml 3.75 ml - 
0.5 M Tris, pH 6.8 - - 1.25 ml 
10% (w/v) SDS 150 μl 150 μl 50 μl 
10% (w/v) APS 100 μl 100 μl 30 μl 
TEMED 25 μl 25 μl 10 μl 
 
2.5.3 WESTERN BLOTTING 
Proteins were transferred onto 
a nitrocellulose membrane using a semi-dry 
transfer system; the transfer buffer was 
prepared using 20 % methanol in the SDS-
 Table 2-70. Transfer buffer. 
 Volume 
10x Tris/Glycine/SDS 100 ml 
Methanol 200 ml 
dH2O 700 ml 
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PAGE running buffer (Table 2-70). 
Transfer was carried out at 25 V, 3 A and 30 W for between thirty minutes and an hour 
depending on the size of protein of interest.  
The membrane was then blocked 
overnight at 4 °C with agitation 
(60 rpm; Stuart Mini orbital shaker 
SSM1, Bibby Scientific Limited, UK), 
using 5 % milk (The Co-op, UK) in 
TBS–0.1 % (v/v) Tween-20 (Sigma-
Aldrich, MO, USA) (Table 2-71).  
 Table 2-71. Western blotting (WB) blocking buffer. 
 Volume 
10x Tris-buffered saline (TBS) 10 ml 
Tween20 0.1 ml 
Dried non-fat milk 5 g 
dH2O 89.9 ml 
 
Membranes were incubated with the primary antibody at room temperature for two to four 
hours with agitation (60 rpm; Stuart Mini orbital shaker SSM1, Bibby Scientific Limited, UK); 
the antibody was diluted according to the manufacturer’s instructions in blocking solution.  
Membranes were washed in TBS-0.1 % Tween-20 (TBS-T; 
four times for ten minutes each time), and were then 
incubated for 45 minutes with the HRP (horse-radish 
peroxidase) conjugated secondary antibody (diluted 1/5000 
in TBS-0.1 % Tween-20) at room temperature (Table 2-72). 
Table 2-72. TBS-T solution. 
 Volume 
10x TBS 100 ml 
Tween20 1.00 ml 
dH2O 899 ml 
 
Membranes were washed in TBS-0.1 % Tween-20 (five times for five minutes each time), and 
then in TBS only (twice for five minutes each time) prior to visualisation using the ECL 
development reagent (Amersham Bioscience, GE Healthcare, UK), according to the 
manufacturer’s instructions.  
Exposure time varied according to the strength of the signal; Super RX X-ray film (FujiFilm 
Europe GmBH, Germany) was used for imaging, using SRX-101A X-ray developer (Konica 
Minolta Medical Imaging U.S.A., Inc). 
 
2.5.4 CO-IMMUNO-PRECIPITATION 
Recombinant Protein G Agarose beads (Life Technologies, CA, USA) were washed with TBS, and 
100 μl were added to a sample, containing the cellular lysate pre-incubated with the mouse 
monoclonal anti-TOPORS antibody (Abnova) for one hour at 4 ˚C; this was then incubated for 
30’ at 4 ˚C. The tube was centrifuged at 13000 rpm for ten minutes (Centrifuge 5417R, 
Eppendorf, Germany) and the supernatant was removed, and the beads were washed three 
times with 1 % Triton-X100 in phosphate-buffered saline (PBS). 
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Laemmli Sample buffer was added to the sample, and heated to 70 ˚C for ten minutes. 
The supernatant was then loaded on to SDS-PAGE gels for analysis.  
 
2.5.5 PROTEIN METHODS SUMMARY 
In summary, the protein methods, described in this section, were implemented in 
the experimental Chapter 6. 
 
2.6 IMMUNOCYTOCHEMISTRY 
Following the validation of PPIs between TOPORS and its novel interacting partners, identified 
using the Y2H system and confirmed by co-immuno-precipitation from human cell lines, 
the sub-cellular localisation of the novel proteins needed to be evaluated (Chapter 7). 
Immunofluorescent (IF) staining studies of TOPORS, its identified interacting partners, and 
marker proteins were performed using human cell lines (section 2.3.1). 
 
2.6.1 METHODS OF FIXATION: ADHERENT CELLS 
Cells were cultured in 24-well plates on 12 mm sterilised cover slips until they reached 50-60 % 
confluence, unless stated otherwise. Prior to fixation the cells were washed with PBS, and fixed 
using paraformaldehyde (PFA)/Triton X-100 (Tx100) or methanol. 
 
2.6.1.1 PFA/Tx100 FIXATION 
In order to preserve cellular morphology, the PFA/Tx100 method was used, as PFA acts by 
forming cross-links between proteins, thus maintaining the structure.  
The cells were fixed for twenty minutes in 4 % PFA in 1x PBS at room temperature (500 µl per 
well). They were subsequently incubated in the permeabilisation solution (4 % Tx100 and 0.3 % 
BSA in 1x PBS) for five minutes at room temperature (300 µl per well).  
The cells were washed twice in immunocytochemistry 
(ICC) blocking buffer (0.5 % bovine serum albumin 
(BSA) & 20 mM glycine in 1x PBS; Table 2-73), followed 
by incubation in the blocking buffer for fifteen minutes. 
 Table 2-73. ICC blocking buffer. 
 Volume 
0.58 % BSA 1.16 g 
33.3 mM glycine 0.5 g 
1x PBS 200 ml 
 
The fixed cells were either immediately immuno-stained, or stored at 4 ˚C in an evaporation-
proof container. 
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2.6.1.2 METHANOL FIXATION 
Methanol fixation was used for preserving cytoskeletal proteins, rather than maintaining 
the overall morphology of the cells.  
Ice-cold methanol (-20 ˚C) was added to each well (500 µl per well), and the 24-well plate was 
incubated at -20 ˚C for five minutes. The methanol was removed and the cells were washed 
with 1x PBS twice, and rehydrated with 1x PBS for five minutes at room temperature.  
The fixed cells were then incubated in the blocking buffer (0.5 % BSA & 20 mM glycine in 
1x PBS) for fifteen minutes prior to immuno-staining or storage at 4 ˚C. 
 
2.6.2 IMMUNOFLUORESCENT STAINING OF CELLS 
The primary antibodies (1 ˚ Ab) were diluted according to the manufacturer’s instructions in 
blocking buffer (0.5 % BSA & 20 mM glycine in 1x PBS). Cover slips with the fixed cells were 
incubated with 1 ˚ Ab at room temperature for one hour; the cover slips were then washed 
three times for ten minutes in blocking buffer with gentle agitation.  
The corresponding fluorescent secondary antibodies (2 ˚ Ab; diluted 1:300 in blocking solution 
unless stated otherwise) were added, and the cells were incubated for 45 minutes at room 
temperature protected from exposure to light; the cover-slips were subsequently washed 
three times for ten minutes in blocking buffer. 
A nuclear stain (Hoechst or DAPI) was added onto the coverslips and the cells were incubated 
for ten minutes at room temperature protected from exposure to light; the cover-slips were 
subsequently washed twice for ten minutes in 01 % Tween20 in 1x PBS, and once for ten 
minutes in 1x PBS.  
The cells were then briefly stored in 1x PBS before mounting onto slides using ProLong Gold 
Antifade Mounting Medium (Life Technologies, CA, USA), or DAKO Fluorescence Mounting 
Medium (Agilent Technologies, CA, USA). 
 
2.6.3 IMMUNOCYTOCHEMISTRY SUMMARY 
In summary, methods, described in this section, were implemented in the experimental 
Chapter 7, in order to determine the sub-cellular (co)localisation of TOPORS and its novel 
interacting partners identified via the Y2H screen. 
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2.7 IMMUNOHISTOCHEMISTRY 
The ultimate aim of this project was to determine why mutations in TOPORS, which is 
ubiquitously expressed, are known to cause disease only in the retina. Consequently, once it 
was confirmed that TOPORS and its novel interacting partners, associate and co-localise in 
cultured human cells, an attempt was made to investigate the localisation of these proteins in 
the retina, i.e. the only tissue known to be affected by TOPORS mutations (experimental 
Chapter 8). 
Immunofluorescent staining studies were performed on mouse (Mus musculus) and macaque 
(Macaca fascicularis) retinal cryo-sections. Mouse eyes (strain C 57 Black 6 (C57Bl6) were 
kindly provided by Nozie (Dominic) Aghaizu (from a two-week-old mouse), Ewa Kubała (from 
mice aged 7-9 weeks) and Dr Kate Powell (from 6.5-month-old mouse). Primate (young adult 
macaque) retinal sections were kindly provided by Professor Glen Jeffery. 
 
2.7.1 MOUSE EYE TREATMENT FOLLOWING ENUCLEATING 
For each animal the left eye was intended for future extraction (of either protein or RNA), and, 
therefore, was frozen down on dry ice in a 2 ml tube immediately after being enucleated, 
whereas the right eye was intended for cryo-sectioning, i.e. it was washed in and immersed in 
ice-cold 1x PBS in a 15 ml tube (kept on ice) prior to paraformaldehyde (PFA) fixation.  
The eyes were stored in ice cold 1x PBS prior to fixation for ten to thirty minutes, depending on 
the number of animals and transfer time from the animal house to the laboratory. 
Additionally, a fragment of tail was taken from each animal and placed in a 1.5 ml tube, kept 
on ice, for genotyping, or sequencing, if required. 
The 2 ml tubes with eyes frozen for RNA or protein extraction and the 1.5 ml tubes with tail 
fragments were stored at -80 ˚C. 
 
2.7.2 FIXATION AND CRYO-SECTIONING 
This procedure was performed in a fume extraction cupboard. The ice-cold 1x PBS was 
removed from the 15 ml tubes, and 5 ml of 4 % PFA in 1x PBS were added per tube. The eyes 
were fixed for 24 hours at 4 ˚C with gentle shaking. 
The following day the 4 % PFA solution was discarded, and the eyes were subject to sucrose 
gradient using freshly prepared 20 % sucrose in 1x PBS (8 ml per tube) for 4-8 hours at 
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4 ˚C with gentle shaking. This solution was then discarded and followed by incubation 
overnight at 4 ˚C with gentle shaking in freshly prepared 30 % sucrose in 1x PBS (8 ml per 
tube). 
The following day the 30 % sucrose solution was discarded. Freshly prepared 30 % sucrose in 
1x PBS solution was mixed at 1:1 ratio with the Optimal Cutting Temperature (OCT) medium 
(VWR International, PA, USA). Each eye was then incubated in this mixture for two hours at 
room temperature. The eyes were subsequently positioned in embedding molds, filled with 
OCT, and frozen immediately on dry ice. The fixed, embedded eyes were permanently stored -
80 ˚C. 
Prior to cryo-sectioning, an embedded eye was transferred to -20 ˚C for an overnight 
incubation. The eyes were sectioned using a Leica CM1850 cryostat (Leica Biosystems, 
Germany) at a thickness of 10 µm, and collected on positively-charged Superfrost slides (VWR 
International, PA, USA). The slides were stored at -80 ˚C. 
 
2.7.3 IMMUNOFLUORESCENT STAINING OF TISSUE CRYO-SECTIONS 
Prior to immuno-staining, sections were thawed out and allow to dry in a fume extraction 
cupboard; they were subsequently washed with 1x PBS without shaking three times for ten 
minutes each time to remove excess OCT. Next, the sections were blocked for one hour at 
room temperature. 
Depending on the origin of the secondary antibody (2 ˚ Ab) to be used two different 
immunohistochemistry (IHC) blocking buffers (Table 2-74) were used: either 6 % bovine serum 
albumin (BSA), 5 % normal goat serum (NGS) & 0.3 % Tween20 in 1x PBS (blocking buffer A); 
or 5 % normal donkey serum (NDS) & 0.3 % TritonX-100 (Tx100) in 1x PBS (blocking buffer B). 
 
Table 2-74. IHC blocking buffers. 
Table A. NGS-based IHC blocking buffer. 
 Amount 
6 % BSA 0.6 g 
5 % NGS 500 µl 
0.3 % Tween20 30 µl 
1x PBS 9.47 ml 
 
Table B. NDS-based IHC blocking buffer. 
 Amount 
5 % NDS 500 µl 
0.3 % Tween20 30 µl 
1x PBS 9.47 ml 
 
 
After incubation in the blocking buffer, primary antibodies (1 ˚ Abs) were diluted in 
the blocking buffer according to manufacturers’ instructions, the sections were encircled with 
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a hydrophobic pen (Dako Pen, Agilent Technologies, CA, USA), and the relevant 1 ˚ Ab dilutions 
were applied within the circled areas. The sections were incubated with the 1 ˚ Ab in 
a humidified chamber overnight at 4 ˚C, followed by one-hour incubation at room 
temperature. 
The slides were then washed three times for ten minutes each with gentle shaking at room 
temperature. If blocking buffer A was used, the washes were performed with 0.1 % Tween20 
in 1x PBS, whereas if blocking buffer B was used, the washes were performed with 0.3 % Tx100 
in 1x PBS. 
The fluorescent 2 ˚ Abs were diluted in the relevant blocking buffers according to 
manufacturers’ instructions, and the sections were incubated with the 2 ˚ Abs in a dark 
humidified chamber for 45 minutes at room temperature.  
If the sections were being stained with peanut agglutinin (PNA) to mark the cone 
photoreceptors, this dye was applied at the same time as the 2 ˚ Abs. These steps, and those 
following, were all performed in an environment protected from light. 
The slides were then washed twice for ten minutes each time, with gentle agitation at room 
temperature, protected from light. As previously, if blocking buffer A was used, the washes 
were performed with 0.1 % Tween20 in 1x PBS; if blocking buffer B was used, the washes were 
performed with 0.3 % Tx100 in 1x PBS. 
Next the slides were washed once for ten minutes in 1x PBS, gently shaking at room 
temperature, protected from light. Following this, the tissue sections were subject to nuclear 
staining using 4’, 6-Diamidino-2-phenylindole dihydrochloride (DAPI; Sigma-Aldrich, MO, USA), 
diluted 1/10000 in 1x PBS, for ten minutes at room temperature. 
Finally the slides were washed three times for ten minutes each time in 1x PBS with; 
the washes were performed with gentle shaking at room temperature. 
The slides were then dried, and coverslips were mounted above the stained tissue sections 
using DAKO Fluorescence Mounting Medium (Agilent Technologies, CA, USA), and sealed with 
nail polish. 
 
2.7.4 ANTIGEN RETRIEVAL 
Sometimes the staining method, described in section 2.7.3, would yield no signal, suggesting 
that antigen epitopes were not available to the corresponding antibody. In order to expose 
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the antigens, the citrate-buffered Antigen Unmasking Solution (pH 6.0; Vector Laboratories, 
CA, USA) was used. After the first three 1x PBS washes (section 2.4.1.2), the slides were 
submerged in 1x Antigen Unmasking Solution (diluted in 1x PBS) in a 200 ml glass container 
with a lid. The container was then placed in a microwave oven (Model AM925EFP, Morphy 
Richards, UK) and boiled: at 80 % power (P80) for three minutes, at 50 % power (P50) for five 
minutes and at 10 % power (P10) for ten minutes. After the boiling steps the glass container 
was allowed to cool down for fifteen minutes at room temperature. The sections were then 
washed once for thirty minutes in 1x PBS at room temperature, following which they were 
blocked for one hour at room temperature, and the staining procedure was followed as 
described in section 2.7.3. 
 
2.7.5 IMMUNOHISTOCHEMISTRY SUMMARY 
In summary, the immunohistochemistry methods were implemented in the experimental 
Chapter 8. This allowed for defining the (co)localisation of TOPORS and its novel interacting 
partners in the retina, i.e. the tissue affected by retinitis pigmentosa. 
 
2.8 SUMMARY OF ANTIBODIES 
The antibodies were used for determining protein expression and interaction (Chapter 5) as 
well as localisation in cells (Chapter 7) and tissues (Chaper 8). All primary antibodies were 
purchased from commercial providers (Table 2-75). The Clontech antibody against GAL4 DNA-
BD (630403) was validated by the manufacturer by SDS-PAGE and Wetern blotting.  
 
Table 2-75. Primary Antibodies. 
Cat. No. Manufacturer Raised in Raised against 
630403 Clontech Mouse Yeast GAL4 DNA-BD 
H00010210-M01 Abnova Mouse Human TOPORS 
sc-292009 Santa Cruz Biotechnology Rabbit Human TOPORS 
AP13163b Abgent Rabbit Human ITM2B C-term 
HPA029292 Sigma-Aldrich Rabbit Human ITM2B 
sc-30067 Santa Cruz Biotechnology Rabbit Human PTGDS 
HPA000872 Sigma- Aldrich Rabbit Human PSMC1 
sc-27794 Santa Cruz Biotechnology Goat Human Centrin-2 
sc-50164 Santa Cruz Biotechnology Goat Human PCM1 
ab2642 Abcam Goat Human PLK4 
sc-803 Santa Cruz Biotechnology Rabbit 6His Probe 
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The Abnova anti-TOPORS antibody (H00010210), used in this project, was previously validated 
by Chakarova et al. (2007; 2011), who showed the antibody detects no TOPORS signal 
following knock-down by siRNA. TOPORS was shown to localise, in hTERT-RPE1, MDCK, ARPE19 
and IMCD3 cell lines, to centrosomes and basal bodies as well as the mid-body (Flemming 
body; in addition to the previously demonstrated nuclear localisation). In the retina of mouse, 
pig and human TOPORS was detected at the basal body of primary cilium and the nuclei of 
retinal ganglion cells. On immunoblots the antibody detected a band migrating at 150 kDa 
following separation of human lymphobastoid lysates (Figure 1-13). The antibody was also 
used by Yang el al. (2010) for Western blotting. 
The SCB anti-TOPORS antibody (sc-292009) was validated by the manufacturer by Western 
blotting on nuclear extracts from HeLa, Jurkat, K-562, HEL92.1.7 and IMR-32 cells as well as 
a whole cell lysate from NTERA-2 cl. D1 cells. The antibody detected a band migrating half-way 
between the 110 kDa and 222 kDa markers in all of the tested samples. 
The Abgent anti-ITM2B C-term antibody (AP13163b) was validated by the manufacturer. 
Western blot analysis of mouse cerebellum and lung tissue lysates detected bands migrating 
half-way between 36 kDa and 55 kDa markers. In the lung lysate an extremely faint additional 
band was also observed half-way between the 55 kDa and 72 kDa markers. 
The Sigma-Aldrich anti-ITM2B antibody (HPA029292) was used for protein characterisation for 
the Human Protein Atlas, demonstrating granular, perinuclear staining in human U-251MG cell 
line. Western blot analysis showed two bands migrating between the 36 kDa and 55 kDa 
markers (lysate from HEK293T cells over-expressing ITM2B). The antibody was also used by 
Audo et al. (2013) who demonstrated reactivity in the ganglion cell layer of mouse retina (in 
addition to less strong signal in inner nuclear layers). Cytoplasmic localisation was shown by 
immunocytochemistry. Baron et al. (2014) showed granular cytoplasmic staining and immuno-
reactive bands at 47 kDa and 50 kDa. 
The SCB anti-PTGDS antibody (sc-00067) validation by the manufacturer demonstrated 
cytoplasmic staining in HeLa cells and a cryo-section of normal mouse intestine. Chatterjee et 
al. (2012) demonstrated, using the antibody of interest, that PTGDS is expressed in mast cells 
lining the mesenteric lymphatic vessels, whereas Lim et al. (2015) used it for 
immunhistochemical studies of female reproductive tract. 
The Sigma-Aldrich anti-PSMC1 antibody (HPA000872) was used for protein characterisation for 
the Human Protein Atlas, demonstrating localisation in the nucleus (excluding the nucleoli) and 
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the cytoplasm in U-2 OS, U-251MG and A-431 cell lines. Western blotting on protein extracts 
from RT4, U-251MG and A-431 cells as well as liver and tonsil showed a band migrating about 
a quarter of the way from the 49 kDa marker to the 85 kDa marker (however the band was 
much fainter in the latter two lysate samples); an additional band was detected in the A-431 
lysate at 85 kDa.  
The SCB anti-Centrin2 antibody (sc-27794) was used by Cunningham et al. (2014) who 
demonstrated that just over a third of Centrin-2 signal in HeLa cells is centrosomal. Centrin-2 
knock-down by siRNA additionally validated antibody specificity. 
The SCB and-PCM1 antibody (sc-50164) was validated by the manufacturer demonstrating by 
Western blotting a 228 kDa band in lysates from U-562 and Ramos cells. 
The Abcam anti-PLK4 antibody (ab2642) was validated by the manufacturer who showed 
a band migrating at 110 kDa (lysate from normal human colon), which was also showed by 
Syed et al. (2006). Martindill et al. (2007) demonstrated localisation at nucleoli in Rcho-1 cells 
at the G2/M transition phase. On the other hand, Rosario et al. (2014) demonstrating, using 
this same antibody, localisation of PLK4 to tips of protrusions in motile and spreading mouse 
embryonic fibroblasts; whereas in spreading HeLa cells the protein was observed at cell 
boundaries/periphery. 
The SCB anti-six histidines (6 His) tag antibody (sc-803) was validated by the manufacturer by 
Western blot. It was also used by Vulsteke et al. (2004), providing additional evidence for its 
specificity to this probe. 
A summary of previously reported localisations of each protein, detected by the above-
mentioned antibodies (other than against the six histidine tag), is given in Table 2-76). 
Secondary antibodies used for immunofluorescence (IF) and Western blotting (WB) studies are 
summarised in Table 2-77. The antibodies were employed in Section 3.2, Appendix 11.4 as well 
as Chapters 6, 7 and 8. 
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Table 2-76. Reported immunocytochemical localisation of investigated proteins and markers. 
Protein 
localisation 
Sub-cellular Tissue 
TOPORS 
(topo-isomerase I-
binding, serine- 
and arginine-rich, 
E3 ubiquitin and 
SUMO1 ligase; 
Q9NS56) 
Nucleus (excluding nucleoli; including PML 
bodies and nuclear speckles) (Haluska et al., 
1999; Rasheed et al., 2002). Centrioles and 
centrosome; ciliary basal body; γ tubulin 
complex; mid-body; spindle pole (Chakarova et 
al., 2011). Ubiquitin ligase complex (Rajendra et 
al., 2004; Capelson e Corces, 2005; Guan et al., 
2008); SUMO1 ligase complex (Boutell, Orr e 
Everett, 2003; Weger, Hammer e Heilbronn, 
2005; Pungaliya et al., 2007). Cell 
boundaries/periphery (in mouse) (Braun et al., 
2012). Nuclear lamina (in fruit fly) (Capelson e 
Corces, 2005; Matsui et al., 2011). 
Basal body of 
photoreceptor 
connecting cilium; 
nuclei of retinal 
ganglion cells 
(Chakarova et al., 
2011). 
ITM2B  
(integral 
membrane 
protein 2B; 
Q9Y287) 
Intracellular membranes; cell membrane (Choi 
et al., 2001; Martin et al., 2008; Fluhrer et al., 
2012). Golgi/TGN membranes; intracellular and 
secretory vesicles  (Choi et al., 2004). 
Mitochondrial membrane (Fleischer, Ayllon e 
Rebollo, 2002). Neuronal processes (Akiyama et 
al., 2004). Pre-synaptic terminals (Saul et al., 
2013). Synaptic membranes (Matsuda, Tamayev 
e D'adamio, 2011; Tamayev et al., 2011). Peri-
nuclear (Berglund et al., 2008). Extracellular 
space/secreted9 (Martin et al., 2008; Tsachaki 
et al., 2011). 
Retinal ganglion cell 
layer (GCL); retinal 
inner nuclear layer 
(Audo et al., 2013). 
Blood vessels of 
nervous system; 
pancreas and 
myocardium 
(pathological ABri 
deposits) (Ghiso et al., 
2001; Holton et al., 
2001). 
 
                                                          
 
9 The protein is cleaved at three sites by three proteases resulting in some of its fragments remaining 
membrane-bound, and others being targeted for secretion (and putatively other cellular locations). 
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Protein 
localisation 
Sub-cellular Tissue 
PTGDS 
(lipocalin-type, 
glutathione-
independent, 
prostaglandin D2 
synthase; 
P41222) 
Peri-nuclear localisation (Berglund et al., 
2008). Cytoplasm; peri-nuclear cytoplasmic 
granules (Beuckmann et al., 2000). 
Endoplasmic reticulum and nuclear 
envelope (Urade et al., 1989). Golgi 
apparatus (Grabenhorst e Conradt, 1999). 
Ganglion cell membrane (ganglioside-
associated) (Mohri et al., 2006).  
Extracellular space/secreted: Cerebrospinal 
fluid (Harrington et al., 1993; Hoffmann et 
al., 1993; Tumani et al., 1998; Sampaio et 
al., 2009). Sub-retinal fluids (in detached 
retinae) (Jaggi et al., 2008). Amniotic fluid 
(Melegos, Yu e Diamandis, 1996; Shiki et 
al., 2004). Serum (Dorta-Contreras et al., 
1998; Cheung et al., 2013). Urine 
(pathological) (Hoffmann, Nimtz e Conradt, 
1997; Nagata et al., 2009; Tin et al., 2013). 
Retina (chick) (Yamakawa 
e Ogino, 1986). Retinal 
pigment epithelium (chick 
and rat)  (Beuckmann et 
al., 1996; Shiroma et al., 
1996). Interphotoreceptor 
space; photoreceptor cells 
(rat)  (Beuckmann et al., 
1996). Cerebral cortex 
(Mohri et al., 2006). 
Leptomeninges; choroid 
plexus (Beuckmann et al., 
2000). Testis (Ujihara et 
al., 1988; Fouchécourt, 
Dacheux e Dacheux, 1999; 
Wu et al., 2012; Shyu et 
al., 2013; Sreenivasulu et 
al., 2013). Spleen (Urade, 
Fujimoto, Ujihara, et al., 
1987).  
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Protein 
localisation 
Sub-cellular Tissue 
SMC1 
(26 S protease 
regulatory 
subunit 4; 
P62191) 
Cytoplasm; nucleus (N-myristoylation-dependent (Kimura, 
Kato e Hirano, 2012)), but not nucleolus; cell junctions 
(Berglund et al., 2008). Proteasome (ATPase hexa-ring of 
the regulatory subunit) (Müller et al., 2006; Bedford et al., 
2008; Kim e Demartino, 2011; Lee et al., 2011). Endoplasmic 
reticulum (ER)-associated degradation (ERAD) (Lipson et al., 
2008). Membrane/acrosome10 (Yi et al., 2009). Plant 
nucleosome assembly complex (Lee et al., 2011; Lee, K. H. et 
al., 2012). 
n/a 
Centrin-2 
(P41208) 
Centriole and centrosome cytoplasm; xeroderma 
pigmentosum group C complex (Araki et al., 2001). Centriole 
(Salisbury et al., 2002). Centrosome (Martinez-Sanz et al., 
2006; Cunningham et al., 2014).   Ciliary basal body 
(UniProtKB). 
n/a 
PCM1 
(peri-centriolar 
material 1; 
A2RUU9) 
Peri-centriolar (Kubo et al., 1999). Centrosome; nuclear 
membrane; cytoplasm (Berglund et al., 2008). 
n/a 
PLK4 
(polo-like kinase 4; 
O00444) 
Centrosome; nucleus; vesicles (Berglund et al., 2008). 
Centriole (Habedanck et al., 2005; Kuriyama, 2009). 
Deuterosome (Klos Dehring et al., 2013; Zhao et al., 2013). 
Acentriolar spindle poles and membrane (Coelho et al., 2013). 
Nucleoli (Martindill et al., 2007). 
n/a 
 
                                                          
 
10
 The acrosome is cap-like structure over the anterior half of the sperm's head. As the sperm 
approaches the zona pellucida of the egg, which is necessary for initiating the acrosome reaction, the 
membrane surrounding the acrosome fuses with the plasma membrane of the oocyte, exposing the 
contents of the acrosome. 
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Table 2-77. Secondary Antibodies.  
Key: Fitc, fluorescein; Cy3, Cyanine 3; A488, Alexa Fluor 488; A594, Alexa Fluor 594; HRP, horse-radish 
peroxidase; IF, immunofluorescence; WB, Western blotting. Specificity was verified during each 
individual experiment by control staining of fixed cells or tissue sections, which were not pre-stained 
with any primary antibody. 
Cat. No. Manufacturer Raised in Raised against Tagged with Application 
715-095-151 
Jackson Immuno 
Research 
Laboratories, Inc. 
(PA, USA) 
Donkey Mouse Fitc IF 
711-095-152 Donkey Rabbit Fitc IF 
705-095-147 Donkey Goat Fitc IF 
715-165-150 Donkey Mouse Cy3 IF 
711-165-152 Donkey Rabbit Cy3 IF 
705-165-003 Donkey Goat Cy3 IF 
A11001 
Life Technologies 
(CA, USA) 
Goat Mouse A488 IF 
A11008 Goat Rabbit A488 IF 
A11005 Goat Mouse A594 IF 
A11034 Goat Rabbit A594 IF 
A11055 Donkey Goat A488 IF 
A11058 Donkey Goat A594 IF 
115-035-003 Jackson Immuno 
Research 
Laboratories, Inc. 
(PA, USA) 
Goat Mouse HRP WB 
111-035-003 Goat Rabbit HRP WB 
305-035-003 Donkey Goat HRP WB 
 
2.9 MICROSCOPIC IMAGING 
Immunofluorescent samples were imaged using either fluorescent or confocal microscopy 
(experimental Chapters 7 and 8). Fluorescent microscopy imaging was performed using Zeiss 
Axiovert S100 inverted microscope (Carl Zeiss AG, Germany) and the corresponding software. 
All data were collected sequentially, using the same microscope settings. The resulting images 
were processed, using Adobe Photoshop CS4 (Adobe Systems, CA, USA). Confocal microscopy 
imaging was performed using the Zeiss laser scanning microscope (LSM) 700 and the LSM 
Software (Carl Zeiss AG, Germany). All data were collected sequentially, using the same 
microscope settings. The resulting images were processed, using ZEN 2012 (blue edition; Carl 
Zeiss AG, Germany). The microscopic imaging techniques were implemented in experimental 
Chapters 7 and 8. 
2.10 SUMMARY 
Chapter 2 provided details of all methods used in the project with references to specific 
experimental chapters given in individual methods sections. The subsequent Chapters 3-8 
include empirical data generated throughout the time course of the project. Chapters 9, 10 
and 11 comprise the final Discussion, Bibliography and the Appendix, respectively. 
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3 CONSTRUCTION OF RETINAL LIBRARIES AND TOPORS BAITS 
The primary aim of the project was to identify novel interacting protein partners of TOPORS 
from the human retina. TOPORS is ubiquitously expressed, yet its mutations are only known to 
cause disease in the retina. Hence it was hypothesised that TOPORS must have a retina-specific 
interacting partner, or it must participate in a retina-specific metabolic and/or signalling 
pathway, the impairment of which results in retinal degeneration.  
In the retina TOPORS protein was shown to localise to the basal body of the rod photoreceptor 
connecting cilium (Chakarova et al., 2011). The rod cells serve as photon receptors in dim light, 
in addition to mediating peripheral vision; along with cones they comprise the first order 
neurons involved in the transduction of visual signals (retina structure diagram: Figure 1-2). 
The signals then need to be conducted via the bipolar and the ganglion cells to the brain for 
processing, which, in addition to changes in membrane potentials, will also involve synaptic 
transmitter release and binding. This process will involve tightly controlled PPIs, demonstrating 
their importance of inter-cellular protein-protein interactions (PPIs) in signal transduction. For 
instance, following the release of glutamate by photoreceptor synapses, its binding to 
receptors on the post-synaptic bipolar cells is in itself an example of a PPI11 essential to retinal 
physiology. 
PPIs are equally important for intracellular signalling and metabolism, for which 
the photoreceptor cells provide perfect evidence. The cells comprise inner and outer segments 
(Figure 1-3), which results in the need for protein trafficking between these two 
compartments. TOPORS itself was shown to reside at the bottle-neck of this transport pathway 
at the base of the connecting cilium. Hence, it has been believed that TOPORS mutations lead 
to RP by impairing the entry and/or exit of proteins from the cilium. Furthermore, since 
TOPORS is known to possess E3 ubiquitin and SUMO1 ligase activities, this is very definite 
evidence for its central role in mediating protein interactions, and being directly involved in 
regulating the destiny of proteins modified by either ubiquitin or SUMO1. 
Identification of protein(s) from the retina, which interact with TOPORS, may help elucidate 
the part TOPORS plays in retinal homeostasis, and thus the putative disease mechanism. This 
understanding may then have wider implications for developing future therapies for retinal 
degeneration triggered by TOPORS mutations. 
                                                          
 
11
 In this example, it needs to be assumed that ‘amino acid’ and ‘protein’ are synonymous. 
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In proteomics, identification of protein interactions is usually performed using one of two very 
distinct methods: either a mass spectrometry-based analysis of protein complexes, or a screen 
of a cDNA library to detect direct binary interactions (reviewed in: Brückner et al., 2009). 
Performing yeast two-hybrid (Y2H) screens against human retina cDNA libraries, using TOPORS 
bait constructs, was the method selected for this project.  
The yeast two-hybrid (Y2H) method for detecting protein-protein interactions was pioneered 
by Fields and Song (1989), who demonstrated the advantageous properties of GAL4, a protein, 
which, in its endogenous environments, acts as a transcriptional activator of galactose 
utilisation genes in the yeast Saccharomyces cerevisiae (section 2.1 in Methods and Materials). 
 
3.1 HUMAN RETINAL cDNA LIBRARY CONSTRUCTION AND 
CHARACTERISATION 
Two human retinal cDNA libraries were constructed in the Y187 Saccharomyces cerevisiae 
yeast strain of mating type alpha (Matα), using the ‘Make Your Own “Mate & Plate” Library 
System’ (Clontech, CA, USA) , which utilises the SMARTTM technology (Zhu et al., 2001). 
The cDNA library was generated from commercially available total human retina RNA 
(Clontech, CA, USA) according to the manufacturer’s instructions. 
 
3.1.1 cDNA SYNTHESIS 
First strand cDNA was generated using the SMART technology. The cDNA was amplified by 
long distance PCR (LD PCR), and purified using CHROMA SPIN TE-400 columns (select for DNA 
molecules larger than 0.2 kb). Prior to the purification process products of the LD PCR were 
subject to agarose gel (1.2 %) electrophoresis. Inserts larger than 0.2 kb were expected, which 
was indicated by the smear observed on the agarose gel after the electrophoresis (Figure 3-1). 
 
Figure 3-1. SMART cDNA synthesis results. 
1.2 % agarose gel with ethidium bromide. 
Lane 1: marker: Hyper Ladder I. Lanes 2-3: 
oligo-dT-primed cDNA samples. Lanes 4-5: 
random-primed cDNA samples. Lane 6: 
Negative control for oligo-dT-primed PCR. 
Lane 7: Negative control for random-primed 
PCR. Expected sizes irrespective of primers: 
0.2-6.0 kb. 
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3.1.2 YEAST TRANSFORMATION WITH cDNA FRAGMENTS 
Two to five micrograms of cDNA were required for library transformation. Two cDNA libraries 
were constructed as described in section 2.1.8. The amount of cDNA used for construction of 
each one of the libraries was approximately 5 µg after the CHROMA-spin purification process: 
– Oligo-dT-primed  4.6 µg 
– Oligo-dT-primed  2.7 µg & random-primed  2.8 µg (~1:1) 
Purified double-stranded cDNA and linearised pGADT7-Rec vector were transformed into 
the Y187 yeast strain using the library-scale transformation procedure (section 2.1.3.2.2); 
the cultures were spread on approximately one hundred agar media plates (150 mm) per 
library. The cDNA amplicons were incorporated into the pGADT7-Rec plasmid in vivo using 
the endogenous homologous recombination machinery of the yeast. The cells were 
then harvested, and stored at -80 ˚C as 1 ml (short-term) and 50 ml (long-term) aliquots 
(summarised in Figure 3-2). 
Transformation efficiency and 
number of independent clones were 
calculated according to Equation 2.3 
and Equation 2.4, respectively. 
A library should only be harvested, if 
the number of independent clones is 
above 1.0 x 106. The obtained 
numbers of independent clones in 
both libraries are equal to or just 
above this threshold. The titre and 
cell density were calculated using 
Equation 2.5 and Equation 2.6, 
respectively; the obtained numbers 
represent the number of colonies and 
cells, respectively, per 1 ml of library 
(Table 3-1). 
 
Figure 3-2. Human retinal cDNA library construction in 
the Y187 yeast strain.  
Figure from Make Your Own “Mate & Plate™” Library 
System User Manual (PT4085-1; Clontech, CA, USA). 
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Table 3-1. Retinal cDNA library quantitative results. 
 
Oligo-dT library Oligo-dT + random library 
Transformation efficiency 
1.8 X 105 cfu/µg 
(of transformed DNA) 
1.3 X 105 cfu/µg 
(of transformed DNA) 
No. of Independent clones 1.9 X 106 1.0 X 106 
Titre (6.6 X 106 cfu/ml) (6.1 X 106 cfu/ml) 
Cell density 43.8 X 107 cells/ml 41.5 X 107 cells/ml 
 
3.1.3 RETINAL cDNA LIBRARY CHARACTERISATION AND VALIDATION 
Single colonies were picked from the cDNA library transformation plates and re-patched on 
fresh media. During the initial evaluation of the cDNA libraries 42 plasmids were isolated from 
each one of the two libraries, using the Easy Yeast Plasmid Isolation Kit (Clontech, CA, USA; 
section 2.1.6.1 in Methods and Materials). These plasmids were then subject to PCR, resulting 
in generation of 23 amplicons (~55 %) from the oligo-dT-primed (O-dT) library and 
35 amplicons (~83 %) from the random-&-oligo-dT-primed (R&O-dT) library (Figure 3-3). On 
average the insert size in O-dT library was 315 base pairs (bp), whereas in the R&O-dT library it 
was 444 bp. The isolated plasmids were subsequently sequenced, and the results submitted to 
genome browsers, such as BLAT (UCSC) and BLAST (NCBI); search results with the highest 
percentage identity were always selected for further analysis. 
Outcomes varied slightly depending on the database used, and are summarised in Table 3-2 
for the O-dT clones and in Table 3-3 for the R&O-dT clones. 
Among the 23 O-dT clones 14 showed no matches in either of the databases. One had no 
matches in the UCSC database, but it aligned with a human transcript in the NCBI database 
(highlighted in blue in Table 3-2). The remaining sequences all aligned with various fragments 
of the human genome, however, according to the UCSC browser, only three of them were 
exonic protein-coding sequences (two highlighted in magenta in Table 3-3); only one of the 
three transcripts (green) was in frame with the GAL4 AD sequence. 
Among the 35 R&O-dT clones seven showed no matches in the UCSC database; three of these 
seven sequences aligned with human DNA according to the NCBI database (highlighted in blue 
in Table 3-3). The remaining sequences aligned with fragments of the human genome, 
however, according to the UCSC browser, only three of them were protein-coding transcripts 
Identification of Interacting Protein Partners of TOPORS in the Retina   ||   Barbara Czub 
PhD Thesis 2015   ||   Construction of Retinal Libraries and TOPORS Baits    - 167 - 
 
(two are highlighted in magenta in Table 3-3); only one of these three transcripts (green) was 
in frame with the GAL4 AD sequence. 
 
 
Figure 3-3. Selection of the human retinal cDNA library amplicons. 
(A) Lanes 1 and 19: marker: Hyper Ladder I. Lanes 2-9: samples 1-8 isolated from the oligo-dT-primed 
cDNA library clones. Lanes 10-16: samples 1-7 isolated from the oligo-dT-&-random-primed cDNA library 
clones. Lane 17: positive control: empty pGADT7-Rec vector. Lane 18: negative control. (B) Lanes 1 and 
16: marker: Hyper Ladder I. Lanes 2-7: samples 9-14 isolated from the oligo-dT-primed cDNA library 
clones. Lanes 8-13: samples 8-13 isolated from the oligo-dT-&-random-primed cDNA library clones. 
Lane 14: positive control: empty pGADT7-Rec vector. Lane 15: negative control. 
 
Furthermore, the PCR and sequencing results collectively showed that the O-dT library 
contained a high proportion of sequences, which had no matches in either of the human 
genome databases, only 14/23 clones (61 %) were identifiable. The remaining nine aligned 
with protein-coding genes, but, except for three, which aligned with untranslated region (UTR) 
and/or intronic regions. 
Sequencing of the R&O-dT library fragments showed that only four of the 35 clones (11 %) had 
no matches in either database. The remaining proportion of the tested sequences revealed 
fragments of protein-coding genes; however, they also comprised mostly UTR and intronic 
regions. 
This preliminary evaluation of both libraries showed that clones of the R&O-dT library appear 
more likely to contain inserts. Based on this outcome, the R&O-dT library was subsequently 
characterised in more depth. In order to increase the throughput and lower the cost of library 
testing, the Yeast ‘Smash & Grab DNA’ method (section 2.1.6.2 in Methods and MAterials), 
based on a protocol optimised by Rose et al. (1990), was used to extract total DNA from 
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the yeast clones. Vector-specific primers were then used to amplify inserts from the library 
plasmids, and the resulting PCR products were purified and sequenced. The UCSC genome 
browser was used to identify the cDNA fragments. 
 
Table 3-2. Oligo-dT-primed library (O-dT) fragments. 
Key to colour coding: blue, fragments aligning with annotated transcripts in the NCBI database, but not 
in the UCSC database; magenta, protein-coding fragments not in frame with GAL4 AD; green, protein-
coding fragments in frame with GAL4 AD. In addition to inserts included in the table, 14 other clones 
were sequenced and showed no matches in either database. 
BLAT (UCSC) BLAST (NCBI) 
No matches 
Homo sapiens mRNA; cDNA DKFZp779E152 (from clone 
DKFZp779E152) 
Chr. 15: Homo sapiens ribosomal protein, large, P1 
(RPLP1), transcript variant 1, mRNA. 
Homo sapiens ribosomal protein, large, P1, mRNA 
(cDNA clone IMAGE:3864103) 
Chr. 9: 3’ UTR of Homo sapiens endoglin (ENG), 
transcript variant 3, mRNA. 
Homo sapiens endoglin (ENG), transcript variant 1, 
mRNA 
Chr. 15: Homo sapiens ribosomal protein, large, P1 
(RPLP1), transcript variant 1, mRNA. 
Homo sapiens ribosomal protein, large, P1, mRNA 
(cDNA clone IMAGE:3864103) 
Homo sapiens ribosomal protein S2 (RPS2), mRNA. 
Homo sapiens mRNA similar to collagen, type XVII, alpha 
1 (cDNA clone IMAGE:5431129) 
Chr. 3: Intronic region of Homo sapiens PEST 
proteolytic signal containing nuclear protein (PCNP), 
mRNA. 
Homo sapiens ribosomal protein S18 pseudogene 5 
(RPS18P5) on chromosome 3 
Chr. 12: Intronic region of Homo sapiens TAO kinase 3 
(TAOK3), mRNA. 
PREDICTED: Homo sapiens ribosomal protein S2 (RPS2), 
transcript variant X1, mRNA 
Chr. 1: Intronic region of Homo sapiens HFM1, ATP-
dependent DNA helicase homolog (S. cerevisiae) 
(HFM1), mRNA. 
Chain 5, Structure Of The H. Sapiens 60s rRNA 
Chr. 12: Intronic region of Homo sapiens chromobox 
homolog 5 (CBX5), transcript variant 3, mRNA. 
Homo sapiens SH2B adaptor protein 3 (SH2B3), 
RefSeqGene on chromosome 12 
 
Table 3-3. Random-&-oligo-dT-primed library (R&O-dT) fragments. 
Key to colour coding: blue, fragments aligning with annotated transcripts in the NCBI database, but not 
in the UCSC database; magenta, protein-coding fragments not in frame with GAL4 AD; green, protein-
coding fragments in frame with GAL4 AD. In addition to inserts included in the table, four other clones 
were sequenced and showed no matches in either database. 
BLAT (UCSC) BLAST (NCBI) 
No matches 
Homo sapiens mRNA; cDNA DKFZp686C06106 (from 
clone DKFZp686C06106) 
Chr. 4: Intronic region of Homo sapiens UDP-N-acetyl-
alpha-D-galactosamine:polypeptide N-
acetylgalactosaminyltransferase-like 6 (GALNTL6), 
mRNA. 
Homo sapiens FOSMID clone ABC8-40969800B21 from 
chromosome unknown, complete sequence 
Chr. M: Homo sapiens mRNA expressed only in 
placental villi, clone SMAP47, encoding mitochondrial 
rRNA. 
Homo sapiens haplogroup U4a3 mitochondrion, 
complete genome 
Homo sapiens RNA, tRNaseZL-interacting RNA B1. 
Homo sapiens RNA, 45S pre-ribosomal 5 (RNA45S5), 
ribosomal RNA 
Chr. 11: 5’UTR Homo sapiens MT-RNR2-like 8 
(MTRNR2L8), mRNA. 
Homo sapiens mRNA; cDNA DKFZp686B0995 (from 
clone DKFZp686B0995) 
Chr. 5: Intronic region of Homo sapiens SH3 and PX 
domains 2B (SH3PXD2B), mRNA. 
Homo sapiens SH3 and PX domains 2B (SH3PXD2B), 
RefSeqGene on chromosome 5 
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BLAT (UCSC) BLAST (NCBI) 
Chr. 10: Intronic region of Homo sapiens La 
ribonucleoprotein domain family, member 4B 
(LARP4B), mRNA. 
Human DNA sequence from clone RP11-363N22 on 
chromosome 10, complete sequence 
Chr. 16: Intronic region of Homo sapiens LUC7-like (S. 
cerevisiae) (LUC7L), transcript variant 1, mRNA. 
Homo sapiens interleukin 9 receptor (IL9Rps) 
pseudogene, complete sequence 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
Homo sapiens RNA, 45S pre-ribosomal 5 (RNA45S5), 
ribosomal RNA 
No matches 
Human DNA sequence from clone RP11-142J11 on 
chromosome 6, complete sequence 
Chr. 11: Intronic region of Homo sapiens zinc finger and 
BTB domain containing 16 (ZBTB16), transcript variant 
1, mRNA. 
Homo sapiens zinc finger and BTB domain containing 16 
(ZBTB16), RefSeqGene on chromosome 11 
 
Homo sapiens cDNA FLJ38039 fis, clone 
CTONG2013934. mRNA AK095358 
 
PREDICTED: Homo sapiens WD repeat and FYVE domain 
containing 2 (WDFY2), transcript variant X1, mRNA 
Chr. 1: Homo sapiens TSNAX-DISC1 read-through 
(TSNAX-DISC1), transcript variant 1, non-coding RNA. 
Homo sapiens disrupted in schizophrenia 1 (DISC1), 
RefSeqGene on chromosome 1 
Chr. 10: Intronic region of Homo sapiens inositol 
polyphosphate-5-phosphatase, 40kDa (INPP5A), 
mRNA. 
Human DNA sequence from clone RP11-500B2 on 
chromosome 10, complete sequence 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
Chain 5, Structure Of The H. Sapiens 60s rRNA 
Chr. 2: 3’ UTR of Homo sapiens endothelial PAS domain 
protein 1 (EPAS1), mRNA. 
Homo sapiens endothelial PAS domain protein 1 
(EPAS1), RefSeqGene on chromosome 2 
Chr. 11: Intronic region of Homo sapiens pleckstrin 
homology domain containing, family A member 7 
(PLEKHA7), mRNA. 
Homo sapiens FOSMID clone ABC9-43939000O16 from 
chromosome 11, complete sequence 
Chr. 3: Intronic region of Homo sapiens microtubule-
associated protein 4 (MAP4), transcript variant 4, 
mRNA. 
Homo sapiens chromosome 3 clone RP11-1029M24, 
complete sequence 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
Homo sapiens RNA, 45S pre-ribosomal 5 (RNA45S5), 
ribosomal RNA 
Homo sapiens RNA, tRNaseZL-interacting RNA B1. 
Homo sapiens mRNA; cDNA DKFZp686C06106 (from 
clone DKFZp686C06106) 
Homo sapiens RNA, tRNaseZL-interacting 
Homo sapiens isolate CEss737 18S ribosomal RNA gene, 
partial sequence 
Homo sapiens RNA, tRNaseZL-interacting RNA B1. 
Homo sapiens RNA, 45S pre-ribosomal 5 (RNA45S5), 
ribosomal RNA 
 
Chr. 2: Homo sapiens chromosome 2 open reading 
frame 71 (C2orf71), mRNA. 
Homo sapiens chromosome 2 open reading frame 71 
(C2orf71), mRNA 
No matches 
Homo sapiens mRNA; cDNA DKFZp779E152 (from clone 
DKFZp779E152) 
Chr. 8: Unannotated region 
Homo sapiens chromosome 8, clone RP3-388N13, 
complete sequence 
Chr. 11: Homo sapiens transgelin (TAGLN), transcript 
variant 2, mRNA. 
Homo sapiens transgelin (TAGLN), transcript variant 1, 
mRNA 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
Homo sapiens RNA, 45S pre-ribosomal 5 (RNA45S5), 
ribosomal RNA 
Chr. 1: Intronic region of Homo sapiens HFM1, ATP-
dependent DNA helicase homolog (S. cerevisiae) 
(HFM1), mRNA. 
Homo sapiens RNA, 45S pre-ribosomal 5 (RNA45S5), 
ribosomal RNA 
Chr. 12: Intronic region of Homo sapiens chromobox 
homolog 5 (CBX5), transcript variant 3, mRNA. 
Homo sapiens 12 BAC RP11-968A15 
 
Chr. 1: Unannotated region 
Human DNA sequence from clone CH507-528H12 on 
chromosome 21, complete sequence 
3’UTR of Homo sapiens kelch-like family member 21 
(KLHL21), mRNA. 
Homo sapiens kelch-like 21 (Drosophila), mRNA (cDNA 
clone IMAGE:6577755) 
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Plasmids were isolated from over six hundred clones (Appendix 11.1), leading to identification 
of several genes associated with retinal function and homeostasis (Table 3-4). The retina 
specificity of the R&O-dT human cDNA library was further validated by identification of 
the rhodopsin-encoding gene, RHO (MIM#180380; RefSeq: NM_000539; UniProt: P08100). 
Collectively, the results from Tables 3-3 and 3-5 show that 117 of the library inserts, found 
among the total 668 clones (i.e. 17.5 %), aligned with known protein-coding sequences. Retinal 
association could be found for eleven of these protein-coding inserts (Table 3-4); this is 
equivalent to 1.6 % (11/668) of total library inserts, and approximately 9.4 % (11/117) of all 
identified protein-coding sequences. Three (0.4 %) retinal sequences, which did not align with 
protein-coding exons, were also identified. Complementary DNA (cDNA) sequences of human 
mRNA molecules, described in published literature, made up 2.5 % (17 of 668) of the total 
library fragments, similarly to the expressed sequence tags (ESTs), which comprise 2.4 % (16 of 
668) of the fragments. Unannotated chromosomal regions aligned with 41 of the 668 library 
clones (6.1 %). Intronic regions and 3’ UTRs comprise 152 (22.8 %) and 67 (10.0 %) of the cDNA 
library fragments, respectively. Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA, was found in 16.8 % of clones (112 of 668). Nine inserts 
contained mitochondrial mRNA, encoding ribosomal RNA (rRNA), which, according to the UCSC 
search results, is expressed only in placental villi. Twenty nine sequences (4.3 %; other than 
LOC100507412 or the mitochondrial rRNA) aligned with annotated sequences, which did not 
code for proteins.  Ninety five searches (14.2 %) generated no matches at all (Table 3-5 and 
Appendix 11.1). 
Despite a high proportion of non-protein-coding inserts, the constructed human retina cDNA 
library was used for subsequent Y2H screens due to its content of retinal transcripts. Even 
though a human brain cDNA library was available for contingencies, it was crucial that retina-
specific proteins are expressed for the purpose of testing the main hypothesis (section 1.10). 
It was essential to analyse the content of the constructed retinal library thoroughly enough to 
allow for an objective subsequent interpretation of Y2H PPI screen results. 
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Table 3-4. Genes from the R&O-dT human cDNA library associated with the retina. 
Information regarding retinal relevance of the identified genes was obtained from the UCSC and/or 
UniProt databases, unless a reference is included. Protein-coding sequences are highlighted in green. 
Clone 
no
12. 
BLAT (UCSC) highest 
score result 
RefSeq & 
UniProt ID
s 
Relevance to retina 
71 
Chr. 1: Intronic region of 
Homo sapiens phosducin 
(PDC), transcript variant 
1, mRNA. 
NM_002597, 
P20941 
Potential regulation of visual phototransduction, or 
photoreceptor metabolism; forms a complex with beta and 
gamma subunits of transducin. Preferentially expressed in 
retina. 
 
83 
 
 
101 
 
 
107 
 
Chr. 9: Homo sapiens 
prostaglandin D2 
synthase 21kDa (brain) 
(PTGDS), mRNA. 
NM_000954, 
P41222 
Catalyses the conversion of PGH2 to PGD2; binds small non-
substrate lipophilic molecules, including retinal and retinoic 
acid; potential secretory retinoid and thyroid hormone 
transporter; possibly involved in development and 
maintenance of the blood-brain, blood-retina, blood-
aqueous humour and blood-testis barrier; potentially 
important for maturation and maintenance of the CNS. 
Preferentially expressed in brain. 
144 
Chr. 10: Intronic region of 
Homo sapiens retinal G 
protein coupled receptor 
(RGR), transcript variant 
1, mRNA. 
NM_002921, 
P47804 
Receptor for all-trans- and 11-cis-retinal. Binds 
preferentially to the former and may catalyse the 
isomerization of the chromophore by a retinochrome-like 
mechanism. 
182 
Chr. 18: Last exon and 
3’UTR of Homo sapiens 
transthyretin (TTR), 
mRNA. 
NM_000371, 
P02766 
Thyroid hormone-binding protein. Interacts with RBP4. 
About 40% of plasma transthyretin circulates in a tight 
protein-protein complex with the plasma retinol-binding 
protein (RBP). 
199 
Chr. 11: Bicistronic gene 
(two non-overlapping 
reading frames): Homo 
sapiens C1q and tumour 
necrosis factor related 
protein 5 (C1QTNF5), 
transcript variant 1, 
mRNA &  Homo sapiens 
membrane frizzled-
related protein (MFRP), 
mRNA. 
NM_015645; 
Q9BXJ0, 
Q9BY79 
 
C1QTNF5 – associated with autosomal dominant late-onset 
retinal degeneration. 
MFRP – associated with: Nanophthalmos 2: Rare autosomal 
recessive disorder of eye development; Microphthalmia, 
isolated, 5: A disorder characterized by posterior 
microphthalmia, retinitis pigmentosa, foveoschisis and optic 
disc drusen. 
 
223 
Chr. 19: Last exon and 
3’UTR of Homo sapiens 
retinol dehydrogenase 8 
(all-trans) (RDH8), mRNA. 
NM_015725, 
Q9NYR8 
A visual cycle enzyme located in the photoreceptor OS (aka 
photoreceptor retinol dehydrogenase): reduces all-trans-
retinal to all-trans-retinol (requires NADPH) - a rate-limiting 
step in the rhodopsin regeneration pathway 
                                                          
 
12
 A full list of identified library clones is included in Appendix 11.6. 
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Clone 
no
12. 
BLAT (UCSC) highest 
score result 
RefSeq & 
UniProt ID
s 
Relevance to retina 
264 
Chr. 1: 3' UTR of Homo 
sapiens opticin (OPTC), 
mRNA. 
 NM_014359.
3, Q9UBM4 
Opticin is present in significant quantities in the vitreous of 
the eye and also localizes to the cornea, iris, ciliary body, 
optic nerve, choroid, retina, and foetal liver. The opticin 
gene is mapped to a region of chromosome 1 that is 
associated with the inherited eye diseases age-related 
macular degeneration (AMD) and posterior column ataxia 
with retinosa pigmentosa (AXPC1). 
269 
Chr. 12: Homo sapiens 
premelanosome protein 
(PMEL), transcript variant 
1, mRNA. 
NM_0012000
54, P40967 
Photobleaching of RPE melanosomes makes RPE more 
sensitive to light-induced cytotoxicity; possibly, aged 
melanosomes increase RPE cell photic stress, contributing to 
impaired tissue function and to degeneration of the 
adjacent retina (Zareba et al., 2007) 
331 
 
 
342 
Chr. 3: Homo sapiens 
rhodopsin (RHO), mRNA. 
NM_000539, 
P08100 
Rod photoreceptor-specific protein rhodopsin. 
403 
Chr. 2: Homo sapiens S-
antigen; retina and pineal 
gland (arrestin) (SAG), 
mRNA. 
NM_000541, 
P10523 
One of major proteins of rod photoreceptor OS, which binds 
to photoactivated-phosphorylated rhodopsin; associated 
with night blindness and RP. 
515 
Chr. 11: Homo sapiens 
bestrophin 1 (BEST1), 
transcript variant 1, 
mRNA. 
NM_004183, 
O76090 
Predominantly expressed in the basolateral membrane of 
RPE; associated with retinal dystrophies 
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Table 3-5. Summary of composition of the R&O-dT library. 
Library feature 
Number in 
library 
Total library 
fragments 
evaluated 
% 
Known protein-coding sequences 117 668 17.5% 
Retinal protein-coding sequences 11 668 1.6% 
Retinal protein-non-coding sequences 3 668 0.4% 
Published cDNA sequences 17 668 2.5% 
Expressed sequence tags (ESTs) 16 668 2.4% 
Unannotated chromosomal regions 41 668 6.1% 
Intronic regions of genes 152 668 22.8% 
3’ untranslated regions (UTRs) of genes 67 668 10.0% 
Non-protein-coding annotated 
sequences13 
29 668 4.3% 
Homo sapiens uncharacterized 
LOC100507412 (LOC100507412), non-
coding RNA 
112 668 16.8% 
Chr. M: Homo sapiens mRNA expressed 
only in placental villi, clone SMAP47, 
encoding mitochondrial rRNA. 
9 668 1.3% 
No matches in UCSC database 95 668 14.2% 
 
  
                                                          
 
13
 Other than ‘Homo sapiens uncharacterized LOC100507412 (LOC100507412), non-coding RNA’ and 
‘Chr. M: Homo sapiens mRNA expressed only in placental villi, clone SMAP47, encoding mitochondrial 
rRNA.’ 
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3.2 BAIT CONSTRUCTION AND CHARACTERISATION 
Full-length TOPORS cDNA, cloned in frame downstream of the cDNA encoding the GAL4 BD, 
was used as bait in the Y2H screen. The bait was subsequently split into three fragments to 
generate TOPORS deletion constructs (Figure 3-5) for use in subsequent characterisation of 
interactions. TOPORS protein structure and function were reviewed in depth in section 1.6. 
The rationale for generating the constructs, highlighted in the figure, was to help determine, 
once TOPORS’ interacting partners would be known, which of the domains of TOPORS may be 
involved in mediating these novel PPIs, and thus to help explain their nature. 
The N-term TOPORS construct (red in Figure 3-5) comprises a PEST domain, the RING finger 
motif and a ciliary-targeting sequence (CTS), conserved among primate TOPORS orthologues. 
Hence, using this construct for PPI characterisation would help in establishing whether 
TOPORS acts as ubiquitin E3 ligase in a specific interaction. 
The mid-TOPORS construct (blue in Figure 3-5) includes two PEST regions, a CTS widely 
conserved among metazoan orthologues of human TOPORS, a nuclear localisation signal (NLS) 
and the SR/RS dipeptide-rich region. The construct also covers the locations of mutations, two 
of uncertain origin and effect (identified within an adRP panel with no proband family data), 
and one causing a pericentral retinal dystrophy in a Norwegian family (and also found in 
a patient from the adRP panel). The SR/RS domain would be the key component of this 
construct as it would help determine whether a potential prey may, in concert with TOPORS, 
be involved in genome stabilisation, or transcription. This fragment is also associated with 
mediating the SUMO1 E3 ligase activity of TOPORS, and also comprises a SUMO1 acceptor site 
(TOPORS itself is subject to SUMOylation). 
The C-term TOPORS construct (green in Figure 3-5) covers the mutational hotspot region of 
TOPORS as well as a small proportion of the SR/RS dipeptide region, the Lys/His domain and 
two PEST domains. The hotspot where adRP mutations occur is the strategic component of 
this construct. If a retina-specific protein would be among preys, identified by the Y2H screen, 
and it would then interact strongly with the C-term TOPORS construct, it could help elucidate 
the deleterious effects of TOPORS mutations on the retina.  
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3.2.1 GENERATION OF FULL-LENGTH TOPORS BAIT AND DELETION 
CONSTRUCTS 
Several attempts were made to sub-clone the full-length TOPORS gene into the pGBKT7 
(Clontech, CA, USA) Y2H vector, as summarised in the Appendix 11.2. Traditional restriction 
enzyme digestion and ligation (methods section 2.2.3) initially appeared successful; however, 
sequencing showed that the use of EcoRI and SalI restriction enzyme pair resulted in cleavage 
of TOPORS (Figure 11-10 in Appendix 11.2), despite prior bioinformatics-based verification that 
no restriction sites specific for these enzymes existed within the TOPORS sequence (DNASTAR 
SeqBuilder, Lasergene 8; Table 11-2 in Appendix 11.2). The insert was amplified using the In-
fusion primers that incorporated these restrictions sites (Table 2-34 in Material and Methods). 
Another attempt was made with similar primers with the NdeI and PstI restriction sites (Table 
2-36 in Material and Methods) and ligation (Figure 11-3 in Appendix 11.2) were successful; 
however, attempts to transform bacteria with the ligation reactions, resulted in identification 
of empty vectors only (108 clones screened by colony PCR). Yeast transformation was 
performed as an alternative method, which appeared to yield one positive clone (Figure 11-17 
in Appendix 11.2). However after the corresponding plasmid was isolated and used for 
transformation of bacteria, it did not appear to contain an insert (Figure 11-18 in Appendix 
11.2). The In-fusion method (Clontech, CA, USA; methods section 2.2.5.1) did not yield any 
positive results for full-length TOPORS. However, all three TOPORS deletion constructs were 
designed and sub-cloned in frame with the GAL4 BD using the In-fusion method  (Appendix 
11.2.1). 
The full-length TOPORS cDNA was eventually successfully sub-cloned into the pBD Y2H vector 
(Table 2-2 in Methods and Materials) using the Gateway system (Life Technologies, CA, USA; 
methods section 2.2.5.3) (Appendix 11.2.4).  
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3.2.2 CHARACTERISATION OF TOPORS BAIT AND DELETION 
CONSTRUCTS IN YEASTS 
Prior to library screening it was important to ascertain that TOPORS and its fragments are 
expressed in the yeast cells without affecting their physiology too adversely, and that they do 
not bind to the activation domain of GAL4. 
 
3.2.2.1 TRANSFORMATION OF Y2H GOLD STRAIN WITH THE BAIT AND DELETION 
CONSTRUCTS 
The following plasmids, generated as summarised in sections3.2.1 and 0, were transformed 
into the Y2H Gold yeast cells: 
 pBD-TOPORS; 
 pGBKT7-N-term; 
 pGBKT7-mid-TOPORS; 
 pGBKT7-C-term. 
The identity of the yeast clones was confirmed by plasmid isolation, followed by insert 
amplification by PCR and sequencing using vector-specific primers (Table 2-50 in Methods and 
Materials). As the plasmids were previously fully sequenced, the purpose for sequencing 
the generated PCR products after yeast transformation was to confirm the identity of 
the inserts. The obtained results are summarised in Appendix 11.3. 
 
3.2.2.2 DETERMINATION OF BAIT EXPRESSION 
Evaluation of the expression of the TOPORS proteins in the Y2H Gold strain was initially 
attempted by Western blotting. In preparation for the protein extraction process, 
the transformed yeast cells were cultured in selective, nutrient-limited media until the optimal 
OD600 was reached (methods section 2.1.7). The proteins were extracted from the yeast cells 
using the Urea/SDS method; they were then separated by SDS-PAGE and transferred onto 
a nitrocellulose membrane by Western blotting (section 2.5.3 in Methods and Materials). 
Detection of the hybrid GAL4 BD-bait proteins was performed using two different antibodies; 
a GAL4 BD monoclonal antibody (mAb; Clontech, CA, USA), purified from a murine hybridoma 
culture, which binds specifically to the binding domain (amino acids 1-147) of the GAL4 
protein, or a TOPORS monoclonal antibody, raised in mouse, which binds to amino acids 98-
205 of TOPORS protein. Positive detection of the GAL4 BD (without a bait protein fused to it) 
would have served as a positive control of protein expression from the yeast bait constructs. 
A horseradish peroxidise (HRP) anti-mouse antibody was used as the secondary antibody 
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(Table 2-75 in Methods and Materials). Three attempts were made at evaluating TOPORS 
protein expression, using this procedure; however, they were not successful (Appendix 11.4). 
As the expression of TOPORS could not be demonstrated by an immunochemical method; it 
was, therefore, shown indirectly by recreating the interaction between TOPORS and p53. 
These two proteins were first shown to interact in a Y2H assay (Zhou, Wen e Ao, 1999), and 
the interaction has since then been repeated by other research groups using alternative 
methods (Rajendra et al., 2004; Lin et al., 2005; Weger, Hammer e Heilbronn, 2005). Hence, 
a Y2H assay was performed to check for interaction between TOPORS and p53, in order to 
confirm TOPORS protein expression in yeast. Prior to the assay the cDNA encoding p53 had 
been cloned into a suitable Y2H vector in frame with GAL4 AD (Appendix 11.5). 
 
3.2.2.2.1 CONTROL INTERACTION: TOPORS X P53 
A control interaction with a previously reported interacting partner tumour protein 53 (p53) 
(Zhou, Wen e Ao, 1999) was performed to determine TOPORS protein expression in the host 
yeast system. Prior to the expression assay (control interaction), the relevant cultures were 
prepared: cultures carrying the pAD-p53 (control prey plasmid) were mated with cultures 
carrying plasmids encoding full-length TOPORS and the deletion constructs, fused with GAL4 
DNA-BD. The mated cultures were incubated with shaking (~20 h, 30 ˚C, 200 rpm; Innova 4200 
Incubator Shaker, New Brunswick Scientific, NJ, USA) prior to spreading on selective agar 
plates, as shown in figures 3-5, 3-6, 3-7 and 3-8, along with a key in Table 3-7. 
 SD/-W (lacks tryptophan) – selects for bait; 
 SD/-L (lacks leucine) – selects for prey; 
 DDO (lacks both: tryptophan and leucine) – selects for diploids; 
 DDO/X/A (lacks tryptophan and leucine, but is supplemented with X-α-galactose and 
aureobasidin A) – selects for diploids in which the PPI of interest occurred. 
SD/-W and SD/-L selected for bait and prey plasmids, respectively. Diploid cells were selected 
for on the double dropout (DDO) media, lacking both amino acids, therefore, the yeast needs 
both bait and prey plasmids in order to thrive on it. DDO media additionally supplemented 
with X-α-Gal (extra carbon source) and AbA (antifungal agent) selected for diploid cells 
(DDO/X/A media), in which protein interactions occurred; presence of the latter two 
ingredients in the media provides a readout, if reporter gene expression is triggered by 
interaction between the bait and prey. AbA is toxic to the yeast cells, they are not able to grow 
unless they express the resistance gene, Aur-C; the expression can only be triggered by 
Identification of Interacting Protein Partners of TOPORS in the Retina   ||   Barbara Czub 
PhD Thesis 2015   ||   Construction of Retinal Libraries and TOPORS Baits    - 178 - 
 
an interaction between the bait and the prey proteins, here: TOPORS (or its fragment) and 
p53. Consequently, any growth on DDO/X/A plates provides evidence for TOPORS-
p53 interaction. If the observed colonies are blue, this further demonstrates that expression of 
the other reporter gene, Mel1, was also activated. Hence, the Mel1 phenotype of colonies 
growing on the DDO/X/A plates can be indicative of the strength of the TOPORS-p53 
interaction; i.e. growth of white colonies indicates that Aur-C has been expressed, but perhaps 
the interaction was either not strong enough, or did not last long enough to additionally 
trigger the expression of Mel1, which would be demonstrated by blue growth. 
Overall, this control experiment has provided evidence for an interaction between TOPORS 
and p53 within the yeast two-hybrid (Y2H) system, supporting the previously published result 
(Zhou, Wen e Ao, 1999). More importantly, the demonstrated interaction verified 
the expression of TOPORS within the yeast host cell environment. 
 
3.2.2.3 AUTO-ACTIVATION AND TOXICITY EVALUATION OF BAIT CONSTRUCTS 
Prior to the auto-activation and toxicity experiments the GAL 4 BD vectors, all four TOPORS 
bait constructs and BD-only (empty pGBKT7 vector) were transformed into the Y2H Gold yeast 
strain; the yeast cells were transformed with the following plasmids (100 ng of DNA were used 
per transformation): 
 pBD-TOPORS; 
 pGBKT7-N-term; 
 pGBKT7-mid-TOPORS; 
 pGBKT7-C-term; 
 pGBKT7 (see Table 2-32). 
Following the transformation, each of the transformed yeast cultures were diluted 1:10 and 
1:100, and 100 µl of each of the following diluted cell suspensions were spread on 
the following agar media: 
 SD/-W (=SDO; lacks tryptophan); 
 SD/-W/+X-α-Gal (=SDO/X; lacks tryptophan, but is supplemented with X-α-
galactose);SD/-W/+ X-α-Gal/+AbA (=SDO/X/A; lacks tryptophan, but is supplemented 
with X-α-galactose and aureobasidin A). 
Table 3-6.  Control TOPORS (Y2H Gold) x p53 (Y187) interaction: mating outline. 
Host strain (vector-bait) 
X 
Host strain (vector-prey) 
Y2H Gold (pBD-TOPORS) 
Y187 (pAD-p53) 
Y2H Gold (pGBKT7-N-TOPORS) 
Y2H Gold (pGBKT7-mid-TOPORS) 
Y2H Gold (pGBKT7-C-TOPORS) 
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A. SD/-W medium, selecting for colonies 
expressing bait plasmids. 
 
B. SD/-L medium, selecting for colonies expressing 
prey plasmids. 
 
C. DDO medium, selecting for colonies expressing 
both: bait and prey plasmids. 
 
D. DDO/X/A medium, selecting for colonies 
expressing both: bait and prey plasmids, and PPIs, 
as indicated by the reporter gene expression: Mel1 
(blue growth) and Aur1-C (growth on media 
supplemented with AbA lethal to yeasts, which do 
not express the Aur1-C resistance gene). 
Key for labels in figures A-D: FL, Y2H Gold strain 
transformed with pBD-TOPORS (full-length); N, 
Y2H Gold strain transformed with pGBKT7-N 
(amino-terminal TOPORS fragment); M, Y2H 
Gold strain transformed with pGBKT7-M (mid-
TOPORS fragment); C, Y2H Gold transformed 
with pGBKT7-C (carboxy-terminal TOPORS 
fragment); p53, Y187 strain transformed with 
pAD-p53; FL, N, M, C and p53: patches of 
haploid transformed yeasts. C x p53, Y2H Gold 
[pGBKT7-C] x Y187 [pAD-p53] mating; M x p53, 
Y2H Gold [pGBKT7-M] x Y187 [pAD-p53] mating; 
N x p53, Y2H Gold [pGBKT7-N] x Y187 [pAD-p53] 
mating; FL x p53, Y2H Gold [pBD-TOPORS] x 
Y187 [pAD-p53] mating; pataches of the mated 
cultures all correspond to diploid yeasts, 
expressing both: a bait plasmid and a prey 
plasmid. 
 
E. Negative control experiment demonstrating that p53 
does not interact with GAL4 BD. Interaction positive 
(p53 x T Ag) and negative (Lamin C and T Ag) controls 
are shown. See labels for figure parts A-D for details of 
selection media (‘M.’). 
Figure 3-4. Demonstration of a PPI between TOPORS and p53. 
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3.2.2.3.1 AUTO-ACTIVATION TESTING 
Growth of white colonies was expected on the SDO as well as the SDO/X plates; in the latter 
case pale blue colonies could also be observed, as expression of the X-α-Gal reporter might not 
be stringent enough. No growth was expected on the SDO/X/A plates due to the toxic AbA. 
Diploid cultures expressing GAL 4 BD-p53 and GAL 4 AD-T Ag hybrid proteins, which have been 
shown to interact, were additionally spread on DDO/X/A plates as a positive control. 
The experiment was performed in triplicate. 
Representative results from one of the three experiments are summarised in Figure 3-6. As 
demonstrated by growth on SDO/X media, the pGBKT7-N-TOPORS appears to activate 
the Mel1 reporter to some extent (this was observed in two out of the three experiments); 
however, not as strongly as the positive control (interaction between p53 and SV40 large 
T antigen). This was deemed acceptable as per Clontech’s instructions, stating that the Mel1 
reporter may be ‘leaky’. The remaining constructs displayed growth without any hints of blue, 
providing evidence for there being no auto-activation. No growth, other than for the positive 
control, was observed on the SDO/X/A, validating the stringency of the AbA-based reporter 
gene. 
 
3.2.2.3.2 EFFECT OF TOPORS EXPRESSION ON HOST YEAST CELLS 
In order to determine how the expression of the bait constructs affected the host yeast cells, 
each bait construct and corresponding empty vector was transformed into the Y2H Gold strain, 
and incubated on SD/-W media to compare growth. If TOPORS and/or its fragments negatively 
affect the yeast cell, or are toxic, it is expected that the colonies containing these bait vectors 
will be significantly smaller than colonies carrying the empty vector encoding only the GAL4 
DNA-BD. 
A wide range of colony sizes (0.1 mm to 1.5 mm) was observed within as well as between all 
plates (Figure 3-7 - Figure 3-10). In general, colonies transformed with the TOPORS constructs 
appeared smaller, but more numerous. 
This suggests that expression of TOPORS protein is exerting a negative effect on the host cells. 
However, they are still able to grow and mate (as was demonstrated in section 3.2.2.2.1). 
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Figure 3-6. Bait auto-activation testing.  
Key: –ve ctrl = pGBKT7 only; N = pGBKT7-N-term; M = pGBKT7-mid-TOPORS; C = pGBKT7-C-term; FL =  
pBD-TOPORS; +ve ctrl = pGBKT7-p53 x pGADT7-T Ag  reporter activation positive control. Culture 
dilutions are indicated on the left-hand side. SD/-W medium selects for colonies expressing GAL4 BD-
bait proteins; SDO/X medium selects for colonies expressing GAL4 BD-bait proteins, which activate 
the Mel1 reporter gene (blue growth phenotype); SDO/X/A medium selects for colonies expressing 
GAL4 BD-bait proteins, which activate the Mel1 and Aur1-C reporter genes (blue growth phenotype and 
growth on media with Aba  lethal to yeasts that do not express Aur1-C respectively). 
 
Table 3-7. Results expected from the bait auto-activation testing. 
Media 
type 
SD/-W SDO/X SDO/X/A 
Media 
selectivity 
Colonies harbouring bait 
plasmids 
Colonies harbouring bait 
plasmids and activating 
the Mel1 reporter gene 
for utilisation of X-α-
galactose (resulting in 
blue metabolite being 
excreted by the yeasts) 
Colonies harbouring bait 
plasmids and activating 
the Mel1 reporter gene 
for utilisation of X-α-
galactose (resulting in 
blue metabolite being 
excreted by the yeasts) 
as well as the Aur1-C 
reporter gene enabling 
yeasts to break down 
the toxic AbA in 
the media 
Expected 
yeast 
growth 
phenotype 
White growth of samples 
and controls 
White, or pale blue, 
growth of samples; blue 
growth of controls 
No growth of samples; 
blue growth of controls 
 
Identification of Interacting Protein Partners of TOPORS in the Retina   ||   Barbara Czub 
PhD Thesis 2015   ||   Construction of Retinal Libraries and TOPORS Baits    - 183 - 
 
pGBKT7 pGBKT7-N-term 
 
Figure 3-7. Comparison of colony sizes transformed with pGBKT7 vs. pGBKT7-N-term. 
SD/-W media selects for colonies expressing GAL4 BD-bait proteins. Culture was diluted 10
-2
 prior to 
spreading on agar media. 
 
pGBKT7 pGBKT7-mid-TOPORS 
 
Figure 3-8. Comparison of colony sizes transformed with pGBKT7 vs. pGBKT7-mid-TOPORS.  
SD/-W media selects for colonies expressing GAL4 BD-bait proteins. Culture was diluted 10
-2
 prior to 
spreading on agar media. 
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pGBKT7 pGBKT7-C-term 
 
Figure 3-9. Comparison of colony sizes transformed with pGBKT7 vs. pGBKT7-C-term. 
SD/-W media selects for colonies expressing GAL4 BD-bait proteins. Culture was diluted 10
-2
 prior to 
spreading on agar media. 
 
pGBKT7 pBD-TOPORS 
 
Figure 3-10 Comparison of colony sizes transformed with pGBKT7 vs. pBD-TOPORS. 
SD/-W media selects for colonies expressing GAL4 BD-bait proteins. Culture was diluted 10
-2
 prior to 
spreading on agar media. 
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3.3 DISCUSSION 
This chapter described the construction and validation of the human retina cDNA libraries as 
well as the Y2H bait vectors, intended for library screening and subsequent PPI 
characterisation.  
The random- and oligo-dT-primed (R&O-dT) library was constructed in GAL4 activation domain 
(AD) vectors, and it was thoroughly characterised to determine the content of retina-specific 
fragments, and hence its suitability for the Y2H screen for retina-expressed interacting 
partners of TOPORS. The protein-coding retina-specific fragments comprised 1.6 % of total 
library inserts (n = 668; Table 3-1), which appears to be a high proportion (discussed in section 
3.3.1). 
The full-length TOPORS cDNA as well as its three fragments (shown in Figure 3-5) were sub-
cloned into GAL4 DNA-binding domain (BD). It was indirectly shown by repeating a known PPI 
that TOPORS protein is expressed within the yeast host cells (section 3.2.2.2). It was 
additionally demonstrated that TOPORS expression affects the host cells’ physiology 
negatively; however the cells were able to thrive (section 3.2.2.3.2). TOPORS or its fragments 
did not cause auto-activation of the Y2H reporter genes with the exception of the N-term 
TOPORS; this fragment activated the ‘leaky’ MEL1 reporter gene (but not the more stringent 
Aur1-C reporter gene, which was utilised in all screens and direct interaction testing). 
 
3.3.1 CONSTRUCTION AND VALIDATION OF CDNA LIBRARIES 
Two types of DNA libraries are commonly recognised: genomic libraries and cDNA libraries. By 
principle the genomic libraries comprise fragments of the whole genome of an organism, 
including coding as well as non-coding regions. On the other hand, cDNA libraries typically 
reflect the transcriptome of a single-celled organism, the transcriptome of a cell type, a tissue 
type, or of a multi-cellular organism. The library, generated using the Make Your Own “Mate & 
Plate™” Library System (Clontech, CA, USA), although referred to as a cDNA library by 
the manufacturer, actually also possesses features of genomic libraries. 
Total human retina RNA (Clontech, CA, USA) was used for construction of the cDNA library 
used for the screen, which was a starting point for this project. Hence, the cDNA, reverse-
transcribed from the RNA, and used for the library construction, was complimentary not only 
to messenger RNA (mRNA), but also to other RNA species, including transfer RNA (tRNA) and 
ribosomal RNA (rRNA). Non-spliced pre-mRNA as well as RNA species in the process of 
undergoing splicing will also have been included and reverse transcribed, thereby leading to 
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the inclusion of introns (non-protein-coding DNA). Overall, the rRNA would have comprised 
the most abundant RNA species within the starting material. 
Two cDNA libraries were constructed according to the manufacturer’s instructions using two 
types of primers: oligo-dT (O-dT) only and random (R) and O-dT (R&O-dT). The initial PCR 
results demonstrated that the R&O-dT library comprised more plasmids with protein-coding 
cDNA inserts than the O-dT library, i.e. 35/42 (83 %), and 23/45 (51 %), respectively. On 
average, the insert size was larger in the R&O-dT library (444 bp) than in the O-dT library 
(315 bp).  
It must be noted that the library insert sizes within the approximate range of 300 bp to 450 bp 
were smaller than expected. An analysis of the human genome organisation demonstrates that 
the length of an average human transcript or cDNA is 2822.4 bp. The exon sizes range from 
77 bp to 850 bp, where the average exon size is 288 bp; whereas the number of exons per 
gene ranges from one to 363 with the average exon number being 9.8 (Strachan e Read, 2010). 
This indicates that even within the O-dT&R-primed library the average insert size is over six 
times smaller (2822.4 bp/444 bp) than the average human cDNA clone.  
Such a discrepancy between the expected and observed insert sizes poses severe limitations to 
the usefulness of the library as a tool for identification of interacting protein partners of 
TOPORS. The existence of short library inserts indicates that only full-length transcripts of up 
to 500 bp will be expressed by the yeast (in addition to longer, but truncated, transcripts).  
Expression of non-full-length protein may lead to protein mis-folding and hence increase 
the chances of false-positive interactions being observed. On the other hand, whilst 
constructing a cDNA library, it is generally rare that many (if any) full-length cDNA clones will 
be generated. This is due to the fact that the use of an oligo-dT primer will often result in 
a higher proportion of cDNA clones representing the 3’ end transcript regions; whereas the 5’ 
end regions will be underrepresented. The use of a random primer aims to alleviate this issue 
to result in a more uniform representation of cDNA fragments, but, since it binds randomly, it 
will rarely result in a generation of a full-length cDNA molecule (Dale e Schantz, 2007).  
Still, it would be expected that the library inserts ought to be at least half-length of the average 
human transcript, given the library construction conditions as well as the positive cDNA 
synthesis results (Figure 3-1). Because it was demonstrated that fragments of up to 6000 bp 
were generated by the reverse transcription of human retinal RNA, and the library inserts are 
significantly smaller (444 bp), this indicates either that the CHROMA SPIN TE-400 purification 
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was not performed correctly (perhaps the columns were not properly equilibrated prior to 
use), resulting in excessive loss of the larger cDNA molecules, or that smaller cDNA fragments 
were preferentially incorporated into the library vectors by the homologous recombination 
performed by endogenous yeast enzymes. 
Figure 3-1 shows the range of cDNA molecules, generated by LD-PCR, prior to the CHROMA 
SPIN TE-400 procedure; perhaps an electrophoresis of the purified cDNA molecules should 
have been performed after the CHROMA SPIN TE-400 treatment and prior to homologous 
recombination in yeast in order to ensure that no errors occurred during the CHROMA SPIN 
TE-400 purification. Since that was not done, it is not possible to state, what issue potentially 
prevented the incorporation of the large inserts into the library vectors. These aspects were 
not addressed by the Make Your Own “Mate & Plate™” Library System User 
Manual Troubleshooting Guide (Clontech), however, it was previously shown that increasing 
the length of the homology region between the vector and insert sequences increases the 
homologous recombination efficiency (Oldenburg et al., 1997). It could be speculated that 
recombination of the larger inserts was less efficient as they potentially required larger regions 
of homology (relative to their overall size) to recombine with the vectors. In conclusion, 
the presence of small library fragments will decrease the chances of identifying putative 
interacting proteins, as fewer full-length proteins will be expressed within the library. 
Further evaluation of the R&O-dT library revealed that the protein-coding library fragments 
constituted about a fifth of all the total evaluated library fragments (n = 668; Table 3-1 and 
Appendix 11.1). This was reflected in the relatively high number of prey-sequences pulled out 
from the Y2H screens, which included fragments of, or comprised exclusively, non-protein 
coding genomic sequences. 
In order to enrich the protein-coding sequences in future cDNA-library construction projects, 
the RNA, used as starting material for cDNA synthesis, should be pre-filtered using oligo-dT 
beads prior to reverse transcription, to remove non-coding and immature RNA species. This 
would lead to generation of a greater number of protein-coding library fragments using not 
only the oligo-dT, but also the random primer, by limiting, if not completely eliminating,  
the extent of non-coding RNA inclusion. 
Furthermore, elimination of the highly abundant, non-coding sequences would increase 
the probability that rare inserts would also be isolated via Y2H screens, as they would be 
enriched in relation to other library clones. Even though no cDNA library can ever be 
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guaranteed to represent all of the transcriptome of interest, if the rarer transcripts did not 
have to ‘compete’ with the more numerous ones for reverse transcription, and later, insertion 
into the library vectors, it would result in the library being more representative of the tissue in 
question. 
Despite a lack of these potential beneficial changes, the number of independent clones in each 
one of the two libraries was a million, or higher, satisfying the quality criteria established by 
the manufacturer. 
Conversely, such a pre-filtering procedure would limit a transparent evaluation of the starting 
material. Nine inserts among the evaluated library clones contained mitochondrial mRNA, 
encoding ribosomal RNA (rRNA), which, according to the UCSC search results, is expressed only 
in placental villi. Such a result could indicate a previously unreported expression, or 
a contamination of the human retinal RNA with material from other tissues, which would 
otherwise be overlooked. 
Another aspect to consider, whilst evaluating cDNA library quality, is whether the inserted 
fragments were in frame with the GAL4 AD and other upstream vector sequences. Due to 
the nature of primers used for the library fragments’ amplification, the inserts would definitely 
recombine with the vector DNA in the correct orientation. However, there is just a 33 % 
chance that the library fragment would be inserted in frame. This feature had not been 
evaluated whilst characterising the library prior to screening; hence, it was essential to verify 
the reading frame of all the fragments of interest isolated from the Y2H PPI screen. ITM2B, 
PTGDS and PSMC1, the novel identified interacting partners of TOPORS, were found to be in 
frame with the library vector sequence; had they not been inserted in frame, they would have 
been required to be re-cloned for subsequent experiments, to verify findings. 
The library content of the retina-specific transcripts also appears insubstantial considering 
the total count of evaluated library clones (11/668 = 1.6 %; Table 3-1). However, it looks more 
specific, when it is considered as a proportion of all protein-coding sequences from the library 
(11/117 = 9.4 %). Still, it cannot be determined for certain how representative a sample of 668 
clones is of the library, if the total number of independent clones was determined as over 
a million, i.e. four orders of magnitude higher. However, this provided a somewhat 
representative overview of its composition. 
According to studies by Schulz et al. (2004) the retina-specific genes (including the RPE genes) 
should comprise approximately 0.33 % of total human retina transcriptome (43/13037 genes). 
Identification of Interacting Protein Partners of TOPORS in the Retina   ||   Barbara Czub 
PhD Thesis 2015   ||   Construction of Retinal Libraries and TOPORS Baits    - 189 - 
 
On the other hand, Strunnikova et al. (2010) analysed the human RPE transcriptome (exclusive 
of the neural retina), and found 154 ‘RPE signature genes’, which  would comprise 0.62 % - 
0.77 % of the total protein-coding human genome (20000 – 25000 genes) (Consortium, 2004). 
These results suggest that the proportion of the retina-specific protein-coding transcripts 
contained within the library, constructed for the purposes of this project, is actually rather 
high: 1.6 % of the evaluated library inserts, or 9.4 % (11/117) of the protein-coding library 
inserts. This outcome could reflect the fact that the library is not normalised, as according to 
the transcriptome studies the proportion of retinal genes should be lower. 
As a final point it is important to re-emphasise that the overall quality of the library was 
mediocre due to high content of very short (444 bp average) cDNA fragments as well as 
a majority of the inserts being non-coding (protein-coding cDNAs comprised only 17.5 % of 
library inserts). Whilst preparing a cDNA library in the future, it would be recommended to 
augment the protein-coding content of the starting material. Enriching for mRNA molecules 
using an oligo dT-based probe would generate a suitably purified template for cDNA synthesis, 
which would then be incorporated into appropriate vectors by homologous recombination 
inside the yeast cells. Still, following the manufacturer’s instructions, the resulting libraries 
with its features, described in section 3.1, and discussed here, was used for the Y2H screens 
and identification of novel interacting protein partners of TOPORS. 
 
3.3.2 BAIT CONSTRUCTION AND VALIDATION OF EXPRESSION 
Full-length TOPORS cDNA was cloned into a Y2H vector, and the subsequent goal was to 
validate the expression of this exogenous human TOPORS protein within the yeast system. It 
was initially attempted to verify the expression of TOPORS by Western blotting; however, this 
method did not yield positive results either due to inefficient protein extraction and/or a lack 
of abundance of the protein expression. It was concluded that the protein extraction was 
inefficient during the preliminary attempts (rather than that TOPORS was not expressed) since 
the GAL4 DNA-BD, serving as a control for protein expression, could not be detected either. 
Following manufacturer’s instructions, expression of GAL4 DNA-BD by itself without the bait 
protein fused to it, was to be used as control. An antibody raised against GAL4 DNA-BD 
(Clontech) was to be used for detection of both: the sole control GAL4 DNA-BD as well as 
the GAL4 DNA-BD-TOPORS fusion protein. Neither protein could be detected using this 
antibody; TOPORS could not be detected using the antibody raised against its amino-terminal 
epitope (Abnova) either. On the contrary, the Western blot showed a smear in all cases 
(Appendix 11.4), indicating either impure extracts and/or protein degradation. 
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Hence, to circumvent this issue, the subsequent aim was to repeat a previously reported 
protein interaction, involving murine TOPORS and p53 (Zhou, Wen e Ao, 1999), and, thus, 
indirectly confirming that TOPORS protein (bait) is indeed expressed in yeast. Fragments of 
TOPORS (Figure 3-5) were also tested for interaction with p53. Results of this experiment 
provided strong evidence for association between human TOPORS (including its fragments) 
and p53, thus validating bait expression. 
 
3.3.3 CONCLUSIONS 
The human retina cDNA libraries and the Y2H bait plasmids have been constructed and 
characterised, as described and discussed in this chapter. The quality of the library was 
mediocre due to high content of very short (444 bp average) cDNA fragments as well as 
a majority of the inserts being non-coding (protein-coding cDNAs comprised only 17.5 % of 
library inserts). The bait constructs were of fine quality, and the bait proteins did not activate 
stringent PPI reporter genes; however, they did have a slight negative impact on the yeasts’ 
growth. 
These procedures were essential pre-requisites for the cDNA library screening for interacting 
partners of TOPORS, which was the primary aim of this work. It was hypothesised that TOPORS 
must have a retina-specific interacting partner, which leads to a retina-restricted phenotype 
associated with TOPORS mutations. 
 The findings of the Y2H cDNA library screening for TOPORS’ retinal putative interacting 
partners are reported in Chapter 4. The interactors identified via the Y2H screen are 
subsequently verified and characterised as described in Chapters 5-8. The results are discussed 
in Chapter 9. 
  
Identification of Interacting Protein Partners of TOPORS in the Retina   ||   Barbara Czub 
PhD Thesis 2015   ||   Library Screening and Identification of Positive Interactions    - 191 - 
 
4 LIBRARY SCREENING AND IDENTIFICATION OF POSITIVE 
INTERACTIONS 
Chapter 3 provided a description of human retinal cDNA library construction and 
characterisation as well as it summarised the procedures involved in cloning and characterising 
of TOPORS bait constructs.  
Two libraries were constructed; one using only the oligo-dT primer, and one using two primers: 
the oligo-dT and random. The latter library was characterised in greater depth since 
preliminary analysis revealed that this library harboured a higher proportion of clones with 
inserts, and, when present, the inserts were on average 130 bp longer than in the oligo-dT 
only-primer library. Despite a thorough characterisation of only one library, both libraries were 
screened for protein interacting partners of TOPORS. 
The construction of the human retinal cDNA library and TOPORS bait plasmids were critical 
requirements for fulfilling the major goal of this project, i.e. identifying protein interacting 
partners of TOPORS using the Y2H screening method (section 2.1). As was already 
emphasised, identification of proteins, which associate with TOPORS, could help explain 
the aetiology of retinitis pigmentosa, caused by mutations in the TOPORS gene. Due to 
the ubiquitous expression of TOPORS along with TOPORS mutations being linked only to retinal 
disease, it was hypothesised that a protein, produced only in the retina, must be the critical 
interactor of TOPORS. The current chapter describes the outcomes of the Y2H screening 
procedures aiming to detect protein-protein interactions (PPIs) between TOPORS and a retinal 
protein. 
The workflow of the Y2H methods (Figure 4-1) includes the already described cDNA library 
(Section 3.1) and bait (Section 3.2) construction and characterisation (experimental Chapter 3; 
Methods and Materials section 2.1), which form the basis for identification of interactions that 
TOPORS is involved in (Chapter 4). 
Prior to performing the Y2H screens against the retina cDNA libraries, the bait was constructed 
by sub-cloning the TOPORS gene into a Y2H vector in frame with the GAL4 binding domain (BD) 
(‘Cloning’ in Figure 4-1; Methods and Materials section 2.2.5). The resulting construct was then 
used for the transformation of the Y2H Gold yeast strain of mating type a (Mata); the cDNA 
library constructs, i.e. preys, had been transformed into the Y187 strain of mating type alpha 
(Matα) in frame with the GAL4 activation domain (AD) (‘Yeast transformation’ in Figure 4-1; 
Methods and Materials section 2.1.3).   
Identification of Interacting Protein Partners of TOPORS in the Retina   ||   Barbara Czub 
PhD Thesis 2015   ||   Library Screening and Identification of Positive Interactions    - 192 - 
 
 
 
Figure 4-1. Overview of the Y2H library screen workflow. 
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Both of the transformed strains were subsequently cultured and mated in liquid media (‘Yeast 
mating’ in Figure 4-1; Methods and Materials section 2.1.5). The resulting mated cultures were 
then spread on agar media, selective for bait and prey plasmids as well as for PPIs based on 
two reporter genes; blue yeast colonies were expected to grow on agar supplemented with 
AbA and X-alpha-gal (‘Selection for interactions’ in Figure 4-1).  
Blue colonies were patched on higher stringency media, selective for PPIs based on four 
reporter genes; in addition to breaking down AbA and using X-alpha-gal as carbon source, 
the yeasts were required to produce histidine and adenine, which were lacking from the 
selective growth media (‘Higher stringency selection for interactions’ in Figure 4-1; Methods 
and Materials section 2.1.1).  
DNA was extracted from yeast patches (‘DNA extraction’ in Figure 4-1; Methods and Materials 
section 2.1.6), which activated all four reporter genes, and  primers, specific to the prey-
vector, were used to amplify the cDNA library inserts encoding the potential interacting 
proteins (‘PCR to amplify prey & gel electrophoresis’ in Figure 4-1; Methods and Materials 
sections 2.2.1 and 2.2.2).  
The resulting PCR products were purified and sequenced; the UCSC BLAT search engine was 
used to identify the inserts (NCBI BLAST was used for verification of some of the obtained 
results; ‘Sequencing & BLA(S)T search’ in Figure 4-1). The figure also indicates ‘in vitro studies’ 
as part of the workflow; the aim of these studies was to verify the identified interactions, using 
independent methods, other than the Y2H system (Methods and Materials sections 2.5, 2.6 
and 2.7), the outcomes of which were described in Chapters 6 - 8. 
 
4.1 YEAST MATING CONTROL EXPERIMENTS 
The Matchmaker™ Gold Yeast Two-Hybrid System User Manual (Clontech, CA, USA) provides 
instruction for performing two mating controls alongside the library screen(s). For the positive 
control the Y2H Gold strain, transformed with the pGBKT7-53 plasmid (carrying the p53 gene 
cDNA), was mated with the Y187 strain, and transformed with the pGADT7-T plasmid, 
encoding the T Ag. In the negative control experiment the pGADT7-Lam-transformed Y187 
strain was used instead (Table 2-16 in Methods and Materials). 
As full-length TOPORS was cloned using a different vector system (Gateway system; Table 2-
33), into pBD rather than pGBKT7 (In-Fusion system; Table 2-32), an additional control was 
performed to validate the compatibility of the two Y2H vector systems, using p53 in the pBD 
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Gateway vector and pGADT7-T In-Fusion vector. The p53 gene had previously been cloned 
into the pDONR vector (Appendix 11.5). The resulting pDONR-p53 entry vector was 
subsequently used in a Gateway LR recombination with the pBD vector. Resulting constructs 
were propagated in bacterial cells, and sequenced using p53-specific primers (Table 2-52 in 
Methods and Materials). The obtained sequences confirmed the successful cloning of p53 
into the pBD plasmid. 
The control Y2H constructs were transformed into yeast strains of opposite mating types, and 
the haploid yeast cells were mated as illustrated in Table 4-1. The resulting diploid yeast cells 
were spread on specific nutrient-limited, selective media (expected results in Table 4-2). All 
mating experiments were performed in triplicate. 
 
Table 4-1. Control mating to check for Y2H system performance. 
 Y187 [pGADT7-T] colony 
Y2H Gold [pGBKT7-p53] colony Positive control mating (1) 
Y2H Gold [pBD-p53] colony Positive control mating (2) 
Y2H Gold [pGBKT7-Lam] colony Negative control mating (1) 
Y2H Gold [pBD-pLC] colony Negative control mating (2) 
 
Table 4-2. Expected control Y2H PPI results. 
Expected growth 
On selective media 
Positive control mating Negative control 
mating 
SD/-W (bail selection) White colonies White colonies 
SD/-L (prey selection) White colonies White colonies 
DDO (diploid selection) White colonies White colonies 
DDO/X/A (PPI selection in diploid yeasts) Blue colonies No colonies 
 
The colonies resulting from both the positive and the negative control mating were all 
expected to be white, when grown on the SD/-L, the SD/-W, or the DDO media (section 2.1.5 in 
Methods and Materials), which was observed (data not shown). 
Growth on the DDO/X/A positive control agar plates was, as expected; round, blue colonies 
were observed, without any satellite colonies (Figure 4-2). These results demonstrated that 
a positive interaction had occurred between the p53 tumour suppressor protein and the large 
T antigen of the SV40 virus, leading to activation of transcription of the reporter genes, i.e. 
Mel1 and Aur-C.   
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A.  B.  
Figure 4-2. Y2H control p53 x SV40 T Ag PPI: a comparison of p53 constructs (pBD-p53 vs. pGBKT7-53).  
A, Y2H Gold [pBD-p53] x Y187 [pGADT7-T] diploid colonies. B, Y2H Gold [pGBKT7-53] x Y187 [pGADT7-T] 
diploid colonies. Dilutions of 10
-2
 of both cultures were spread on DDO/X/A (selects for colonies, within 
which a p53-T Ag interaction occurred). 
 
4.2 IDENTIFICATION OF POSITIVE INTERACTIONS BY Y2H SCREENS 
Two Y2H screens were performed using the pBD-TOPORS bait construct: one against 
the random-&-oligo-dT-primed (R&O-dT) library, and the other against the oligo-dT-primed (O-
dT) library (despite the latter one not having been as thoroughly characterised).  
The Y2H screens were subject to a two-tier selection process. Initially, for each Y2H screen, the 
mated culture was spread over 66 yeast media plates (selecting for activation of PPI reporter 
genes Mel1 and Aur-C). Between zero and three colonies grew on most plates; more colonies 
per plate were seldom observed (e.g. plates in Figure 4-3 and Figure 4-4). Over 107 clones from 
each of the two human retinal cDNA libraries were screened (Table 4-3). After the first 
selection 24 and 48 colonies resulted from the screen against O-dT and R&O-dT library, 
respectively. Following this, each observed colony was picked and patched on higher 
stringency media, aiming to activate reporter genes His3 and Ade2 in addition to Mel1 and 
Aur-C. Selection with additional two reporter genes led to a successful isolation of 21 and 32 
positive clones, respectively. 
The findings of the two screens were combined, and DNA was extracted from all 53 yeast 
patches. Library inserts were amplified by colony PCR using vector-specific primers, 
and amplicons larger than 300 bp were subsequently purified and sequenced. Figure 4-5 
exemplifies the extent of prey insert sizes; amplicons from lanes 2-6 were ≥600 bp in size, 
therefore they were extracted from the gel and sequenced. The 300 bp large amplicon from 
lane 7 was not considered in further analysis, as it was large enough to encompass mainly 
the insert-flanking regions of the library vector (equating to an empty vector). 
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Following the PCR-based insert analysis, 19 clones with large enough (≥300 bp) inserts were 
isolated from the O-dT library screen, and all 32 from the R&O-dT library. Among these, 12 and 
32, respectively, were found to align with genes; these alignments included 6 and 28 protein-
coding regions, respectively, as determined using the BLAT (UCSC) search (Table 4-4). 
Sequences aligning to intergenic, intronic or UTR were eliminated from further investigation. 
 
 
A  B  
Figure 4-3. A, Example of single plate from Y2H O-dT library screen.  
Initial selection: PPI reporter genes, Mel1 and Aur-C. Blue colouration suggests interaction of bait with 
unknown prey. B, All clones, isolated from the initial O-dT selection stage, were patched on to higher 
stringency media; reporter genes: Mel1, Aur-C, His3 and Ade2. Three of the 24 blue colonies, did not re-
grow. 
 
 
 
  
A  B  
Figure 4-4. A, Example of single plate from Y2H R&O-dT library screen. 
Initial selection: PPI reporter genes, Mel1 and Aur-C. Blue colouration suggests interaction of bait with 
unknown prey. B, All clones, isolated from the initial R&O-dT selection stage, were patched on to higher 
stringency media; reporter genes: Mel1, Aur-C, His3 and Ade2. Eleven of the 36 blue colonies patched 
on the plate presented in figure B, did not re-grow. 
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The clones, which aligned with exonic, protein-coding, gene fragments, were subsequently 
categorised, using the Swiss-Prot (UniProtKB) annotations, and RefSeq (NCBI) annotations. All 
clones were also checked against RetNet, a Retinal Information Network. 
Retina-associated proteins were categorised together based on their high expression in this 
tissue, and/or a specific (patho)physiological role (Table 4-6). The cytoskeletal and trafficking 
proteins were evaluated due to potential involvement in ciliary transport, which is vital to the 
health of photoreceptor cells, and as several proteins involved in this function have already 
been implicated in retinal degeneration. The category of protein turnover and modification 
was crucial due to the function of TOPORS as ubiquitin E3 ligase. 
Mitochondrial proteins were 
given attention due to high 
energy requirement of 
photoreceptors.  
Nuclear proteins were included 
based on known functions of 
TOPORS inside cell nucleus 
(Table 4-6 and Appendix 11.6). 
Table 4-3. Quantitative results of Y2H screens. 
 
Screen of O-dT 
library 
Screen of R&O-
dT library 
Number of 
clones  screened 
3.29 x 107 1.63 x 107 
AUR1-C+ve & 
MEL1+ve 
24 (six shown in 
Figure 4-3: A) 
48 (five shown in 
Figure 4-3: B) 
AUR1-C+ve, 
MEL1+ve, 
HIS3+ve & 
ADE2+ve 
21 (all shown in 
Figure 4-4: A) 
32 (25 shown in 
Figure 4-4: B) 
 
 
 
Figure 4-5. PCR amplification of prey inserts, 
pulled out from the R&O-dT cDNA Y2H library 
screen (Mango Taq polymerase).  
Lane 1: Hyper Ladder I marker. Lanes 2-7:  
Inserts amplified from prey colony patches. Lane 
8: Hyper Ladder I marker. Two microliters of 
the PCR product were loaded per well.  Bands 
≥300 bp large were purified form the gel and 
sequenced; size in base pairs (bp) is indicated on 
either side of the figure.  One percent agarose 
gel with ethidium bromide. 
 
Table 4-4. Quantitative results from prey selection process. 
 
Screen of O-dT library 
Screen of R&O-dT 
library 
Clones  obtained from Y2H screen 21 32 
Clones with inserts of ≥300 bp in size 19 32 
Clones with cistronic inserts 12 32 
Clones with exonic inserts 6 28 
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Table 4-5. Retina-associated Y2H preys. Functional data from UniProtKB and RefSeq (NCBI).  
Expression data from UniProtKB, or databases redirected to from protein-specific Swiss-Prot annotation 
page. 
Y2H 
clone 
Gene 
from 
BLAT 
search 
RefSeq Gene 
Summary 
Protein 
name (ID) 
Swiss-Prot 
Protein 
Function 
Summary 
Protein 
Expre-
ssion 
Other  
notes 
R&O-
dT 27 
ITM2B 
(aka 
BRI; 
abri; 
ABRI; 
BRI2; 
E25B;  
E3-16; 
imBRI2; 
BRICD2
B) 
Amyloid precursor 
proteins are 
processed by beta-
secretase and 
gamma-secretase to 
produce beta-
amyloid peptides 
which form the 
characteristic 
plaques of Alzheimer 
disease. This gene 
encodes a 
transmembrane 
protein which is 
processed at the C-
terminus by furin or 
furin-like proteases 
to produce a small 
secreted peptide 
which inhibits the 
deposition of beta-
amyloid. Mutations 
which result in 
extension of the C-
terminal end of the 
encoded protein, 
thereby increasing 
the size of the 
secreted peptide, are 
associated with two 
neurodegenerative 
diseases, familial 
British dementia and 
familial Danish 
dementia. 
Integral 
mem-
brane 
protein 
2B 
(Q9Y287) 
Plays a 
regulatory 
role in the 
processing of 
the beta-
amyloid A4 
precursor 
protein (APP) 
and acts as 
an inhibitor 
of the beta-
amyloid 
peptide 
aggrega-tion 
and fibrils 
deposition. 
Plays a role 
in the 
induction of 
neurite 
outgrowth. 
Functions as 
a protease 
inhibitor by 
blocking 
access of 
secretases to 
APP cleavage 
sites. 
Ubiqui-
tous; High 
in Brain 
Recently, 
ITM2B 
has also 
been 
associate
d with 
a domi-
nantly 
inherited 
retinal 
dystro-
phy 
(Audo et 
al., 
2013). 
R&O-
dT 29 
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Y2H 
clone 
Gene 
from 
BLAT 
search 
RefSeq Gene Summary 
Protein 
name (ID) 
Swiss-
Prot 
Protein 
Function 
Summary 
Protein 
Expre-
ssion 
Other  
notes 
R&O-
dT 28 
PDC 
(aka 
PHD; 
MEKA; 
PhLP; 
PhLOP) 
This gene encodes a 
phosphoprotein, which 
is located in the outer 
and inner segments of 
the rod cells in the 
retina. This protein may 
participate in the 
regulation of visual 
phototransduction or in 
the integration of 
photoreceptor 
metabolism. It 
modulates the 
phototransduction 
cascade by interacting 
with the beta and 
gamma subunits of the 
retinal G-protein 
transducin. This gene is 
a potential candidate 
gene for retinitis 
pigmentosa and Usher 
syndrome type II. 
Alternatively spliced 
transcript variants 
encoding different 
isoforms have been 
identified. 
Phos-ducin 
(P20941) 
May 
participat
e in the 
regulation 
of visual 
phototran
sduction 
or in the 
integratio
n of 
photorec
eptor 
metabolis
m. 
Inhibits 
the 
transcripti
onal 
activation 
activity of 
the cone-
rod 
homeobo
x CRX. 
Ubiqui-
tous; 
High in 
Retina 
Only of 
very small 
fragment 
of 
the library 
insert 
could be 
seq-
uenced 
(~60 bp). 
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Table 4-6. A summary of genes encoding potential interacting partners of TOPORS, as identified by prey 
sequencing.  
BLAT search (UCSC Genome Browser) was used to identify the sequenced preys, which were categorised 
according to reviewed Swiss-Prot (Protein Knowledgebase: UniProtKB) and RefSeq (NCBI database) 
annotations (included in the Appendix). 
Retina-
Associated 
Cytoskeleton & 
Trafficking 
Protein 
Turnover & 
Modification 
Mitochondrial Nuclear Others 
ITM2B, PDC, 
PTGDS  
TPT1, DYNC1LI2, 
DPYSL3 
UBA52, UBB, 
UBC, RPL10, 
PSMC1, CTSD, 
PPP1R16A, 
CSNK1D, 
MGEA5, NMT1 
NDUFB10, 
NDUFS2, PRDX5 
ZNF7, AES, 
SCAF4, PIAS1 
ENO3, RPS7, 
SLC22A6, 
LMAN1, RPL31, 
SOD1 
Table 4-5 Appendix 11.6 
  
The retina-associated clones were prioritised for further studies, which led to a more in depth 
analysis of alignments of PDC and PTGDS clones14 with their annotated sequences (UCSC 
Genome Browser was used). 
PDC, an attractive candidate due to its involvement in phototransduction responses, was 
disregarded, as only approximately 60 bp of the library clone (1.5 kb in size at PCR level) could 
be sequenced. The remainder of the sequence appeared as a noisy electropherogram (data 
not shown), a problem not resolved by repeated PCR amplification of the isolated library clone. 
PTGDS, encoding a brain prostaglandin D2 synthase, highly expressed in the retina, and 
previously suggested to play a role in retinal homeostasis (Yamakawa e Ogino, 1986; 
Beuckmann et al., 1996; Shiroma et al., 1996), was also evaluated. The interaction with this 
clone was picked up in three (out of a final 34) cases. Alignment analysis of the three clones 
suggested that they had probably originated from three copies of the same cDNA insert during 
the R&O-dT library construction (Figure 4-6 A-C). It should also be noted that all three clones 
cover virtually the entire protein-coding region of the PTGDS gene, isoform 001 (Ensembl 
database). This increases the chances of correct protein folding, and hence that probability 
that the observed interaction is genuine. It was also demonstrated that the PTGDS fragment 
was inserted in frame in all three clones: Figure 4-7 shows the reference sequence that 
the reading frames were checked against. The results for one of the three clones are 
summarised in Figure 4-8; the same result was observed in all three cases. 
                                                          
 
14
 ITM2B was originally placed in the ‘Protein Turnover & Modification’ category, as its association with 
retinal disease emerged only recently (Audo et al., 2013). 
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The sequence alignment and reading-frame verification procedure, outline in the PTGDS 
example, was applied to all of the candidate genes, which were listed in Table 4-6, and led to 
selection of additional two candidate interacting partners for Y2H PPI experiments. 
A soluble fragment of integral membrane protein 2B (ITM2B), previously linked to 
neurodegenerative disorders, was selected primarily due to its high expression in CNS, and 
the familial nature of diseases, in which it is involved (Vidal et al., 1999; Vidal et al., 2000). It 
had firstly been categorised with proteins involved in protein modification and degradation 
due to its role in APP processing (Matsuda et al., 2008). The association of ITM2B with isolated 
inherited retinal disease is a much more recent finding (Audo et al., 2013), which caused its 
reclassification as a retina-associated gene. 
The interaction with ITM2B was found in two (Figure 4-9) of the 34 clones selected through 
the Y2H screen. The gene fragment in both clones aligns with exons 3-6 of the ITM2B, isoform 
001 (Ensembl database), which approximately corresponds to the C-terminal fragment of 
the peptide. This fragment is typically cleaved during ITM2B processing; a membrane-bound, 
full-length ITM2B protein should not have been able to interact with TOPORS in 
a transcription-based Y2H assay, which was used here. The reading frame of both clones was 
correct; the result for one of the clones is shown in Figure 4-10. 
In addition to the two preys, associated with the retina, PSMC1 (Table 4-6) was also selected 
for evaluation. The PSMC1 protein is a regulatory ATPase subunit of the proteasome, essential 
for its correct function across eukaryotic kingdoms (Köhler et al., 2001; Bedford et al., 2008; 
Lee et al., 2011); it presumably acts downstream of TOPORS in the ubiquitin-proteasome 
system (UPS), and it may be directly involved in mediating retinal protein turn-over. 
Interestingly, the Arabidopsis orthologue of PSMC1, RPT2A/RPT2B, plays a role in mediating 
light-induced stress in plant cells (Lee, K. H. et al., 2012). It would be exciting to see whether 
PSMC1 might accordingly have photoreceptor-specific functions also in the animal kingdom. 
The amino-terminal half of PSMC1 (PSMC1-001; Ensembl database) was pulled out from 
the Y2H PPI screen with TOPORS used as bait (Figure 4-11). The gene appeared to be inserted 
in frame with GAL4 AD (Figure 4-12). 
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Figure 4-7. Multiple cloning site (MCS) of the pGADT7-Rec Vector, in which the human retinal cDNA 
library was constructed.  
The sequence used for reading frame verification of the inserts is highlighted in red. From the pGADT7-
Rec Vector Information brochure (Clontech, CA, USA).  
 
 
Figure 4-8. One of PTGDS library clones: sequence snapshot.  
The fragment highlighted in red corresponds to the vector reference sequence (Figure 4-7). The ATG 
start codon of PTGDS is highlighted in purple. The gene was inserted in frame with GAL4 AD sequence: 
42 nucleotides are included between the vector’s reference sequence and the gene’s start codon. 
Identical result was observed for all three clones. 
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A 
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Figure 4-9. ITM2B alignments. Snapshot of results obtained from BLAT (UCSC) genome search.  
A, clone R&O-dT 27; B, clone R&O-dT 29.  
 
Figure 4-10. One of ITM2B library clones: sequence 
snapshot.  
The fragment highlighted in red corresponds to 
the vector reference sequence (Figure 4-7). 
The CCT codon of ITM2B, which corresponds to 
Proline 133 of the ITM2B peptide, and forms 
the beginning of the ITM2B clone isolated here, is 
highlighted in purple.  
The gene was inserted in frame with GAL4 AD sequence: six nucleotides are included between 
the vector’s reference sequence and the gene’s CCT codon. Identical result was observed for both 
clones. 
 
Figure 4-11. PSMC1 clone R&O-dT 2.2 alignment.  
Snapshot of results obtained from BLAT (UCSC) genome search.  
 
Figure 4-12. PSMC1 library clone: sequence snapshot.  
The fragment highlighted in red corresponds to the vector reference sequence (Figure 4-7). The start 
codon of PSMC1, is highlighted in purple. The gene was inserted in frame with GAL4 AD sequence: 48 
nucleotides are included between the vector’s reference sequence and the gene’s start codon.  
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4.3 DISCUSSION 
The goal of the Y2H screening for protein interacting partners of TOPORS was to identify 
a protein expressed only in the retina, or fulfilling a role specific to this tissue. TOPORS is 
ubiquitously expressed, yet its mutations have only been associated with retinal disease 
phenotypes. Hence, it was hypothesised that TOPORS must have a retina-specific interacting 
partner essential for retinal homeostasis. 
No such protein, which would have an obvious strong association with either structure or 
function of the retina, was identified.  
However, three of the putative interacting partners of TOPORS, identified via the Y2H screen, 
were promising candidates, as they were previously shown to be associated with either 
the retina or, more widely, the central nervous system. These proteins, selected for further 
protein-protein interaction (PPI) validation studies, were ubiquitously expressed and 
comprised: 
 Integral membrane protein 2B (ITM2B); 
 Lipocalin-type, glutathione-independent prostaglandin D2 synthase (PTGDS); 
 26 S Protease regulatory subunit 4 ATPase (PSMC1). 
ITM2B was an attractive candidate due to its historic involvement in familial dementia (Vidal et 
al., 1999; Vidal et al., 2000) and, more recently, a retinal dystrophy (Audo et al., 2013). PTGDS, 
a multifunctional protein important for proper function of multiple bodily systems, was 
selected due to its high expression and activity in the central nervous system, and specifically, 
the retina as well as a potential role in maintenance of the blood-retina barrier (Beuckmann et 
al., 1996; Shiroma et al., 1996; Gerashchenko et al., 1998; Irikura et al., 2007). PSMC1 was 
selected for further evaluation due to its key role in the proteasomal system and 
neurodegeneration (Bedford et al., 2008; Bedford et al., 2009; Gómez-Garre et al., 2012; 
Rezvani et al., 2012). Consequently, in view of the well-established function of TOPORS as 
an E3 ubiquitin protein ligase, PSMC1 was an obvious candidate to investigate, despite its 
ubiquitous expression. 
The next section discusses the process of the Y2H screening for interacting partners. 
The selected candidate interacting partners are evaluated in sections 4.3.2 – 4.3.4. 
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4.3.1 Y2H SCREENS AND PREY IDENTIFICATION 
Following library validation and confirmation of bait expression, Y2H screens were performed 
in order to identify proteins, which interact with TOPORS. Two screens were performed; one of 
a library constructed using only the O-dT primer, and one using the R&O-dT library, 
constructed using the o-dT and the additional R primer. Both screens utilised the Mel1 and 
Aur-C reporter genes. Putative positive interacting partners isolated through this first round of 
screening were subsequently validated on higher stringency media, which in addition to 
the first two reporters, also required expression of two nutritional reporter genes, Ade2 and 
His3.  
The O-dT and R&O-dT screens yielded a high number of candidate interacting partners, 21 and 
32, respectively. However, subsequent analysis showed that only six of the 21 O-dT clones 
carried protein-coding gene fragments; on the other hand most (28/32) of clones pulled out 
from the R&O-dT library were protein coding (Table 4-3). This result provides additional 
indirect evidence for superiority of the R&O-dT library over the O-dT library, as analysed 
earlier. Genes from the positive clones were prioritised for subsequent validation based on 
information collated from genomic and protein databases. Such a strategy was necessary, as in 
view of the great number of candidate interactions, a thorough literature review for each one 
could not be performed. Three genes were selected for further interaction validation 
experiments based on the described criteria (section 4.2): ITM2B, PTGDS and PSMC1. The full-
length transcript of each gene (isoform corresponding to the one identified in the Y2H screen, 
and verified in the retinal isoform experiment: section 5.1) was cloned into the relevant Y2H 
vector for control experiments in yeast. Additionally, known ITM2B mutants as well as a gene 
fragment encoding a soluble ITM2B peptide fragment were also tested. It was, firstly, 
demonstrated that the PPI-indicative phenotypes, observed in yeast, were not due to 
interaction with the GAL4 BD (section 4.1). Subsequently, each prey was tested again for direct 
interaction with TOPORS (section 4.2) to ensure that the resulting full-length peptide was still 
able to associate with the bait. The preys, identified from the screen, corresponded to 
fragments of genes only, and consequently the expressed peptides were not representative of 
full-length proteins. This could have led to incorrect folding, and hence the apparent 
interaction could have been artificial. The use of full-length proteins increases the likelihood 
that the encoded proteins will be folded correctly, even when fused to the GAL4 AD; therefore, 
this experiment provided a valuable validation of the results, observed in the Y2H screens. 
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4.3.2 INTEGRAL MEMBRANE PROTEIN 2B 
Itm2B was first described in mouse by Pittois et al. (1998) who established its ubiquitous 
expression at mRNA level. This was supported by findings of Pickford et al. (2003), who 
demonstrated Itm2b mRNA expression in liver, heart, lung, kidney, and brain of mice with 
higher levels observed some brain regions, such as Purkinje cells in the cerebellum. At protein 
level Itm2B was elevated in the cerebellum, midbrain and olfactory bulb, and outside the brain 
in the lung, heart, kidney, liver, and skeletal muscle. Hippocampal expression was also 
documented (Meyer, 2014). In human tissues ITM2B mRNA was expressed ubiquitously, and at 
highest levels in kidney, brain, pancreas and placenta. ITM2B protein was detected in 
the cytoplasm of hippocampal neurons, and cerebellar Purkinje cells (Akiyama et al., 2004). 
 
4.3.2.1 ITM2B IN CONTEXT OF DEMENTIA AND NEURODEGENERATION 
In 1999, Vidal et al. demonstrated that a point mutation (c.799T>A) in ITM2B causes 
autosomal dominant Familial British Dementia (adFBD). Further symptoms included an overall 
cognitive impairment, spasticity, and cerebellar ataxia. Pathologically, the disease was 
characterised by cerebral amyloid angiopathy, non-neuritic and perivascular plaques, 
neurofibrillary tangles, and hippocampal neurofibrillar degeneration. 
The identified mutation occurs in the stop codon of ITM2B, resulting in an extension at the C-
terminus of the ITM2B protein (p.*267Argext*11). In physiological conditions the protein is 
constitutively cleaved near the C-terminus by furin, or a related protease (Kim et al., 1999), 
generating a 23-amino acid long peptide. In the FBD mutant, the generated C-terminus 
peptide, named ABri, is 34-residues long, and forms a component of amyloid complexes 
(unrelated to Aβ (Ghiso et al., 2000)). Kim et al. also demonstrated that the furin cleavage of 
the British (FBD) mutant is up-regulated, comparing to wild-type ITM2B. ABri formed both 
fibrillar (amyloid), and non-fibrillar (pre-amyloid) lesions in parenchyma and blood vessels of 
the nervous system; only the amyloid deposits triggered microglial and astrocytic response 
(Holton et al., 2001), and were associated with elevated levels of the complement cascade 
proteins (Rostagno et al., 2007). 
Shortly after identification of the British (FBD) mutant, a novel ITM2B mutation was identified 
in a Danish family, causing autosomal dominant Familial Danish Dementia (adFDD). Besides 
the memory loss, the patients additionally suffered from cataracts, deafness, and ataxia. 
Similarly to FBD, pathological changes included cerebral amyloid angiopathy, hippocampal 
plaques, and neurofibrillary tangles. 
Identification of Interacting Protein Partners of TOPORS in the Retina   ||   Barbara Czub 
PhD Thesis 2015   ||   Library Screening and Identification of Positive Interactions    - 209 - 
 
The ITM2B protein product also resulted in an extended C-terminal amyloid-forming fragment, 
denoted ADan; however, this was due to a decamer duplication: c.786_795dupTTTAATTTGT 
(p.Ser266Pheext*12). Like in case of the FBD ITM2B, the furin cleavage of the Danish (FDD) 
mutant was also enhanced in comparison to wild-type (Kim et al., 2002). Interestingly, 
although ABri presence was both intra- and extra-cellular, ADan was found predominantly 
inside the cells (Kim et al., 2002). 
Furthermore, multiple sclerosis studies showed that decreased levels of wild-type furin-
generated ITM2B C-terminal peptide in cerebrospinal fluid, were associated with cognitive 
problems (Harris et al., 2010). The study also demonstrated that ITM2B expression is down-
regulated in the cerebellum of multiple sclerosis patients. The documented association of 
ITM2B with diseases of the CNS system suggests it may have a unique role in neurons and/or 
other cell types of the CNS, despite its ubiquitous expression. 
 
4.3.2.2 ITM2B IS ASSOCIATED WITH AUTOSOMAL DOMINANT RETINAL 
DYSTROPHY 
Audo et al. (2013) recently demonstrated that a novel point mutation in ITM2B causes 
an isolated, dominantly inherited retinal dystrophy, characterised by defects in the inner retina 
and the retinal ganglion cells. ITM2B mRNA was detected in both INL and GCL, consistently 
with the affected areas. Moreover, the group also demonstrated ITM2B and APP co-
localisation in the GCL of the retina. Table 4-7 summarises the ITM2B-associated phenotypes 
identified to date. 
Although the proband experienced night blindness, which could suggest the initial stages of 
RP, only a sibling of the proband also reported night vision problems. All of the affected family 
members, including the two with night blindness, consistently experienced photophobia and 
a progressive loss of central vision. Peripheral vision was unaffected in all patients, and visual 
acuity varied. Three of the affected members experienced colour vision disorders. 
Ophthalmoscopic examination revealed pale optic discs and some foveal changes, whereas 
fundus auto-fluorescence was consistently enhanced around the macula. Optical coherence 
tomography typically revealed hyper-reflectivity within the inner retina and foveal ONL.  
The disease onset among the affected members typically occurred between 25 and 40 years of 
age. Importantly, no systemic symptoms and no dementia were experienced by any of 
the affected members.  
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Table 4-7. Summary of mutations identified in ITM2B to date. 
DNA 
mutation 
Protein 
mutation 
Phenotype Reference 
c.799T>A 
p.*267Argext
*11 
adFBD: dementia/cognitive impairment, spasticity, 
cerebellar ataxia,  cerebral amyloid angiopathy, non-
neuritic and perivascular plaques, neurofibrillary 
tangles, hippocampal neurofibrillar degeneration 
(Vidal et 
al., 1999) 
c.786_795
dupTTTAA
TTTG 
p.Ser266Phe
ext*12 
adFDD: cataracts, deafness, ataxia, dementia, cerebral 
amyloid angiopathy, hippocampal plaques, 
neurofibrillary tangles 
(Vidal et 
al., 2000) 
c.782A>C p.Glu261Ala 
adRD: retinal dystrophy with inner retinal dysfunction 
and ganglion cell layer defects; photophobia; decreased 
vision 
(Audo et 
al., 2013) 
 
4.3.2.3 ITM2B HAS A ROLE IN CANCERS 
ITM2B is a potential tumour suppressor gene, as loss of heterozygosity (LOH) at its 
chromosomal location (13q14) is among the most frequent changes associated with sporadic 
prostate cancer (Latil et al., 2003). ITM2B and three other genes found at this location are 
differentially expressed in prostate cancers; however, the strongest association was found for 
ITM2B, making it the major candidate. Furthermore, ITM2B was deleted in an atypical cell 
lipoma (Creytens et al., 2014), and it was differentially expressed in lung adenocarcinoma 
metastatic cell lines (Yang et al., 2003). 
Additionally, ITM2B is among genes differentially expressed in Wilms tumour, a common 
children’s neoplasia, where its expression is regulated by all-trans retinoic acid (Zirn et al., 
2005). This suggests that ITM2B may be a component of the retinoic acid signalling pathway, in 
which prostaglandin D2 synthase (PTGDS), an interacting partner of TOPORS identified during 
this project, also participates. PTGDS directly interacts with RIG1 (retinoic acid-inducable 
gene 1), and the pair appears to work in concert to suppress testicular cancer development 
(Wu et al., 2012; Shyu et al., 2013). 
In a human bladder cancer model it was shown that ITM2B is involved in mediating cell 
survival responses. Their effects could be silenced by methylation or mutations. Substitution 
mutations within and a deletion of the apoptosis-associated BH3 domain of ITM2BS all resulted 
in loss of regulated cell death activity. Furthermore, hypermethylation of the CpG island within 
the ITM2B promoter was found in six out of twelve bladder cancer cell lines, resulting in a two-
fold decrease in ITM2B expression; the group also found that hypermethylation of the ITM2B 
promoter occurred in 40 % of tumour samples from transitional cell carcinomas of the bladder. 
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The involvement of ITM2B in cancer suggests that it may possibly be involved in regulation of 
the cell cycle. TOPORS is also differentially expressed in a range of tumours, as well as it is 
closely associated with the centrosome. It could be speculated that perhaps this organelle is 
the site of interaction between ITM2B and TOPORS, where they may act in concert to 
coordinate cell cycle activities.   
 
4.3.3 PROSTAGLANDIN D2 SYNTHASE 
Prostaglandin D2 synthase (PTGDS) is the main arachidonic acid metabolite (Figure 4-13) 
produced in neurons and glia of the central nervous system (García-Fernández et al., 1998; 
Payne et al., 2008).  
In mouse brain Ptgds was shown to induce morphological changes in glia, resembling reactive 
gliosis. Glial cell migration enhanced actin filament and focal adhesion formation and 
activation of AKT, RhoA and JNK signalling pathways. At the same time, Ptgds was shown to 
promote migration and accumulation of astrocytes, possibly via its PPI with myristoylated 
alanine-rich protein kinase C substrate (MARCKS), which promotes cell migration (Lee, S. et al., 
2012). 
 
4.3.3.1 GENETIC INTERACTIONS OF PTGDS 
Notably, an association between TOPORS and PTGDS might occur, in addition to the identified 
PPI, also at a genetic level. It was shown in a human cell line, derived from 
the medulloblastoma of cerebellum (TE671 cells), that Hes1 (dHairy homologue known to 
interact with dTopors) binds to the N-box region within the PTGDS promoter. The activity of 
the PTGDS promoter increases by 220 % - 300 % due to deletion of the N-box. In agreement, 
expression of Notch cellular domain leads to an increased Hes1 expression, but to a decreased 
PTGDS expression; whereas silencing of Hes1 results in elevated PTGDS levels. These results 
indicate that the Notch-Hes1 signalling pathway acts to repress PTGDS expression (Fujimori, 
Kadoyama e Urade, 2005). 
The deletion of another fragment of the PTGDS promoter, the AP-2 element, leads to 
a significant decrease in the promoter’s activity to 10 % of its normal level. 
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Figure 4-13. Prostaglandin D2 (PGD) synthase as a component of arachidonic acid metabolism.  
PGG2, prostaglandin G2; PGH2, prostaglandin H2; PGF2α, prostaglandin F2α; PGD2, prostaglandin D2; 
PGE2, prostaglandin E2; PGI2, prostaglandin I2; TXA2, thromboxane A2. Figure from Sorokin (2011). 
 
The AP-2 element, is bound by the activator protein 2 (AP-2), a mammalian transcription 
factor, induced by retinoic acid, and which is specifically regulated during development. It 
should also be mentioned that retinoic acid also induces RIG1 expression, whose protein 
product PTGDS interacts with (Wu et al., 2012). Moreover, an over-expressed protein kinase C 
(PKC), which phosphorylates PTGDS, has also been shown to phosphorylate Hes1. The Hes1 
phosphorylation prevents it from binding to the N-box within the PTGDS promoter region. 
Exogenous expression of PKC has also been associated with up-regulating PTGDS expression 
via AP-2 (Fujimori, Kadoyama e Urade, 2005). 
 
4.3.3.2 ROLE OF PTGDS IN THE RETINA 
Prostaglandin D2 synthase was first studied in the retina of a chick by Yamakawa & Ogino 
(1986), who suggested that the enzyme was not active in the neural retina, but it had a high 
activity in the RPE. The activity was greatly enhanced by glutathione; however, at a slower rate 
prostaglandin (PG) D2 was also synthesised from PG H2 in its absence. No PG E2 synthesis (also 
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from PG H2; Figure 4-13), evaluated as a control, was observed either in the presence or 
absence of glutathione. 
It should be noted that two types of prostaglandin D2 synthase can be distinguished. The one 
identified in the Y2H screen, as an interacting partner of TOPORS, was the lipocalin-type 
glutathione-independent neurone (UniProt: P41222), encoded by the PTGDS gene. 
The enzyme activity, originally detected in the chick retina (Yamakawa & Ogino, (1986) was 
probably generated due to collective action of PTGDS  as well as the hematopoietic 
glutathione-dependent prostaglandin D2 synthase (UniProt: O60760), encoded by the HPGDS 
gene (UniProt: O60760). 
A year later, Goh et al. (1987) reported their findings on synthesis and levels of PG D2, E2, and 
F2α in different regions of the rat ocular system. They dissected the rat eye (Figure 1-1. 
Structure of the Eye.) into the anterior and posterior segments along the ora serrata, and 
isolated the ‘uveal complex’, i. e. the cornea, iris and ciliary body (the lens was removed) from 
the anterior half of the eye. The posterior part of the eye was further sub-divided into, 
the ‘retinal complex’, referring to neural retina and the vitreous, and the ‘scleral complex’, 
comprising the RPE, choroid and sclera. Out of the studied PGs, PG D2 formation was 
the highest in all three complexes, which was in agreement with the highest activity of soluble 
brain-type glutathione-independent PG D synthase in all these compartments (the other two 
detected activities corresponded to membrane-bound glutathione-dependent PG E synthase 
and to soluble PG F synthase). In fact, the only PG synthase activity, detected in the ‘retinal 
complex’, was the PG D synthase activity (Figure 4-13). Shiroma et al. (1996) showed that 
the equivalent is true in cultured chick RPE cells, which produce a larger amount of PG D2, 
than they do of PG E2, or PG F2α. 
At the same time, a study by Beuckmann et al. (1996) revealed that the glutathione-
independent PG D synthase, generally referred to as the brain-type PG D synthase (PTGDS), is 
significantly more active in the rat RPE and in the inter-photoreceptor matrix (IPM), than in 
the brain.  
Specifically, the enzyme activity was increased six-fold in the RPE, and it was even higher in 
the IPM. Additionally, the group provided evidence for existence of at least two glycosylation 
sites within this protein, as Western blot experiments showed that bands of three different 
sizes were identified in different cellular fractions from the RPE. 
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Table 4-8. Prostaglandin D2 synthase types. 
Gene PTGDS HPGDS 
UniProt-
recommended name 
Prostaglandin-H2 D-isomerase 
Hematopoietic prostaglandin D 
synthase 
Defined as 
 Brain-type 
 Lipocalin-type 
 Glutathione-independent 
 Hematopoietic 
 Glutathione-requiring 
Enzyme activities 
 Conversion of PGH2 to 
PGD2 
 Conversion of PGH2 to 
PGD2 
 Glutathione S-transfer 
Enzyme cofactor [none known] 
Glutathione (required for PGH2 
to PGD2 conversion) 
Other activities 
 Smooth muscle contraction/relaxation 
 Potent inhibition of platelet aggregation 
 Variety of CNS functions 
 Transport of small 
hydrophobic molecules, 
e.g. steroids, bilinrubin, 
retinoids, and lipids.  
 Possible involvement in 
development and 
maintenance of 
the blood-brain, blood-
retina, blood-aqueous 
humour and blood-testis 
barrier. 
[none known] 
 
The membrane-bound RPE fraction gives rise to immuno-reactive bands of 20 kDa and 23 kDa. 
The cytosolic RPE faction also contained the 23 kDa fraction, in addition to a larger 26 kDa 
species. The latter was also detected in the IPM. The cytosolic fraction of the neural retina cells 
appeared to contain a glycosylated 25 kDa peptide.  
The most intense immuno-histochemical signal was detected in the RPE, and some was also 
observed in the outer and inner segments of photoreceptors. However, in situ hybridisation 
signal was limited to the RPE, suggesting that these cells are the site of PTGDS synthesis. 
The protein is subsequently released into the IPM, where it accumulates, and is then taken up 
by the photoreceptors. 
It was subsequently shown that in addition to PG D2 synthesis, PTGDS also has a role as 
a retinoid transporter. Specifically, the protein binds all-trans- or 9-cis retinoic acid as well as 
all-trans- or 13-cis retinal. However, PTGDS did not bind vitamin A (all-trans retinol). 
Furthermore, the binding pocket for these retinoid compounds was the same as for PG H2 
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(the substrate for PG D2 synthesis), which, however, bound to a different site within this 
pocket (Tanaka et al., 1997; Shimamoto et al., 2007). 
 
4.3.3.3 PTGDS MAY BE INVOLVED IN DEVELOPMENT 
PTGDS has been implicated in the development of male reproductive structures (Fouchécourt, 
Dacheux e Dacheux, 1999; Fouchécourt et al., 2002; Fouchécourt et al., 2003; Philibert et al., 
2013). Furthermore, PTGDS interacts with RIG1, which is highly expressed in testicular cells, 
and which can enhance the activity of PTGDS. In cancers, RIG1 can also suppress cell migration 
via the PGD2 signalling pathway (Wu et al., 2012), similarly to its family member H-rev107, 
which co-localised with PTGDS in testes (Shyu et al., 2013). Interestingly, in catfish PTGDS is 
regulated in developing testes and seminal vesicles by thyroid hormone (Sreenivasulu et al., 
2013), which is also known to regulate PTGDS expression during rat brain development 
(García-Fernández et al., 1998). PTGDS, in addition to its prostaglandin synthase activity, has 
a role as a carrier of thyroid hormones as well as other lipophilic molecules such as retinoids 
(Ruano et al., 2007). It might be via regulating the thyroid hormone availability that PTGDS 
affects testes development. PTGDS has been additionally implicated in hair loss and 
lengthening (Nieves e Garza, 2014). 
 
4.3.4 26 S PROTEASE REGULATORY SUBUNIT 4 
The PSMC1 gene encodes a major regulatory component (RegP) of the 26 S proteasome; 
the PSMC1 protein belongs to a family of six ATPases (Tanahashi et al., 1998). The 26 S 
protease comprises a core barrel-shaped catalytic particle (CP) and either one, or two, flanking 
regulatory particles (RegP), which lack protease activity, but confer substrate specificity and 
dependence on ATP (Section 1.7.1.1: The 26 S Protease). The RegP is known to comprise at 
least twenty protein subunits, constituting a base and a cap. The former includes of a ring of 
six ATPases, one of which is PSMC1 (Figure 4-14). 
Among members of the ATPase hexameric ring PSMC1 is the only one of the six PSMC1-6 
hexamer components, whose ATPase activity is essential for peptidase activity of the CP. It is 
also required for opening of the CP gates, possibly for mediating the movement of the α2-4 
extensions of CP (Voges, Zwickl e Baumeister, 1999; Lee et al., 2011). 
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Figure 4-14. PSMC1 forms a key component of the regulatory ATPase ring of the 26 S protease. 
The labelled ubiquitin moieties are not visible on this modified image. Figure modified from Sullivan et 
al. (2003). 
 
It should also be highlighted that, in addition to its role in the 26 S proteasome function, 
the hexameric ATPase ring has been shown to exist and function separately (Kodadek, 2010). 
The yeast homologues of the mammalian hexameric ring components, as well as of the non-
ATPase subunits PSMD1 and PSMD2, were shown to bind DNA. 
Specifically, they were associated with the nucleotide excision DNA repair proteins; 
consequently, it was proposed that perhaps the ATPase activity of the ring could be used to 
remove transcription factors and/or other proteins from chromatin. 
This hypothesis would be in agreement with the observation that the Arabidopsis orthologue 
of PSMC1 is required for nucleosome assembly in the plant cells (Lee et al., 2011). Additional 
evidence from several independent sources suggests that light-induced signalling, involving 
ubiquitin ligase activity, affects chromatin condensation and de-condensation processes 
(reviewed in: Fransz e De Jong, 2011). 
Moreover, other non-proteasomal activities of the plant homologues were indicated by 
phenotypes, resulting from its mutations. Lee et al. (2011; 2012) provided evidence for a role 
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for the plant PSMC1 homologue in regulating cell elongation, apical growth (short/tall stature 
and root length), size and appearance of organs (e.g. leaves), proportion of trichome branching 
as well as DNA endoreduplication, protection form oxidative stress and zinc deficiency.  
The analysis of plant mutants also showed that it is the amino terminal portion of PSMC1, 
which is responsible for its function, as deletion of its eight carboxy-terminal residues 
(including the ΨYX motif) does not impair the protein’s activity. At the same time, the thirteen 
amino-terminal residues were required for the correct functioning of PSMC1. However, 
mutation of a consensus N-myristoylation site, also located at the N-terminal, had no effects 
on function (Lee, K. H. et al., 2012). 
 
4.3.4.1 PSMC1 AND LIGHT-INDUCED STRESS OF PLANT CELLS 
Lee et al. (2012) demonstrated that 
an Arabidopsis homologue of PSMC1 15  is 
involved in the plant’s responses to light-
induced stress. Mutations in the N-terminal 
portion of the protein affected the seedling 
morphology of Arabidopsis in a light-
dependent manner (Figure 4-15). 
Specifically, when plants, expressing wild-
type and mutant PSMC1 homologue, were 
grown in continuous light (24 h light), 
the seedling was developing very readily in 
the WT, whereas the mutant displayed 
a delayed and abnormal growth phenotype.  
The difference was less pronounced in 
the long day mode (16 h light and 8 h dark) 
experiment.  
 
Figure 4-15. PSMC1 mutation effects on 
the morphology of Arabidopsis thaliana seedlings. 
Plants expressing either wild-type (WT) or mutant 
(MU) PSMC1 homologue, at different light exposure 
duration periods (indicated on the left hand side of 
the figure). Figure modified from Lee et al. (2012). 
                                                          
 
15
 PSMC1 orthologue is encoded in A. thaliana by the RPT2A and RPT2B paralogues, which are 
functionally redundant, but differentially expressed (hence their mutations present with different 
phenotypes); not to be confused with the RPT2 gene, which codes for a protein, known as root 
phototropism 2. 
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However, the mutant was still developing at a noticeably slower rate.On the other hand, no 
differences in growth rates of the wild-type and the mutant were detected in plants cultivated 
in the short day mode (8 h light, 16 h light). 
It could be speculated that in animal cells, subject to light-stress, such as the photoreceptors 
and other retinal neurons, PSMC1 could also play a protective role. Perhaps the mechanism, by 
which the plant PSMC1 homologue modulates responses to light-stress, is as obvious as 
degradation of proteins damaged by reactive-oxygen species, generated due to light exposure. 
Protein turnover is also likely to be a key pathway in the retina, especially in the photoreceptor 
cells, which are highly metabolically active. This presents a sound hypothesis for PSMC1 being 
a central player in the retinal cells. 
 
4.3.4.2 PSMC1 HAS BEEN IMPLICATED IN NEURODEGENERATION 
PSMC1 gene has been suggested to have a role in Parkinson’s disease (PD). Mouse models 
demonstrate that proteasomal dysfunction is sufficient to trigger neuro-degeneration, and 
Psmc1 is an essential component of this protease complex (Bedford et al., 2008). 
However, data from human subjects suggests that the association between PSMC1 and PD is 
probably less robust than what the mouse models suggest (Gómez-Garre et al., 2012). 
Evidence has been presented, which suggests that ubiquitinated proteins are typically found in 
neurodegeneration-associated neuronal inclusions, suggesting that proteasomal dysfunction 
may be involved in disease pathogenesis (Bedford et al., 2009; Watabe et al., 2014). 
 
4.3.4.3 PSMC1 HAS A ROLE IN CANCERS 
PSMC1 has been found among tumour-associated antigens in serum samples from patients 
with monoclonal gammopathy of undetermined significance (MGUS) (Blotta et al., 2009). 
Silencing of PSMC1 in androgen receptor-positive prostate cancers results in suppression of 
cancer growth, and it enhances the anti-proliferative function of anti-androgens (Dahlman et 
al., 2012). 
Studies on mouse embryonic fibroblast (MEF) cells demonstrate that heterozygous PSMC1 
knock-down (KD) results in an arrest of these cells at the G2/M cell cycle phase. This is 
independent evidence for a role of PSMC1 in regulation of cell growth (Rezvani et al., 2012). 
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4.3.5 CONCLUSIONS 
Chapter 4 described Y2H screening for protein interacting partners of TOPORS. Conversely to 
what was hypothesised, no retina-specific protein was identified. Nonetheless, three candidate 
interactors were selected for further validation (Chapter 5) and characterisation (Chapters 6, 7 
and 8) studies; namely, ITM2B, PTGDS and PSMC1. 
The association of both ITM2B and PSMC1 with the cell cycle was previously described 
(sections 4.3.2.3 and 4.3.4.3). Since TOPORS associates with the centrosome in dividing cells 
and ciliary basal body in ciliated cells, experiments aiming to characterise their interactions 
(if/when validated) would aim to establish whether the molecules co-localise with centriolar 
markers as well as with each other in a centriole-like pattern in human cell lines (Section 1.8. 
The Centrosome Cycle).  
No evidence for ciliary association of the PTGDS has been found. However, based on 
the previous findings that it is synthesised in the RPE, released, and then taken up by 
photoreceptors, it could be hypothesised that it could be transported via the connecting 
cilium. Hence, if/when the PPI between PTGDS and TOPORS is validated, sub-cellular co-
localisation studies to investigate whether PTGDS also associates with centrioles, and/or 
primary cilium, would be performed. 
Evaluation of the putative association of the novel candidate interactors of TOPORS with 
the centrioles, or specifically, ciliary basal body, was a priority. As the identified proteins are 
not retina-specific, the next objective would be to investigate whether they co-localise with 
TOPORS are the primary cilium, which is a key organelle to the photoreceptor homeostasis. 
Prior to testing the hypotheses delineated above, validation of interactions in yeast (Chapter 5) 
and mammalian cells (Chapter 6) needed to be performed. Chapter 5 also describes results of 
splice variants’ identification study, the purpose of which was to determine whether 
alternatively spliced isoforms of the candidate TOPORS’ interactors are expressed in the retina 
(in addition to the ones identified via the Y2H screen). 
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5 VERIFICATION OF EXPRESSION AND INTERACTIONS 
The two previous chapters described construction and characterisation of the Y2H cDNA 
library and bait constructs used for screening (Chapter 3) as well as the Y2H screen for protein 
interacting partners of TOPORS (Chapter 4). Findings from the latter led to selection of three 
candidate interactors for further studies in context of the retinal disease associated with 
TOPORS mutations. This was necessary due to the fact that no retina specific interacting 
partner of TOPORS was identified (in contrary to what was originally hypothesised).  
The primary criterion for selecting the candidate interactors for further validation was 
a demonstrated link with the retina. This was clear for two of the interacting proteins: ITM2B, 
associated with a familial retinal dystrophy, and PTGDS, a lipocalin-type transporter of 
retinoids (and other lipophilic compounds), putatively involved in maintenance of the blood-
retina barrier. The third candidate, PSMC1, did not have an evident retinal association; it was 
selected due to, firstly, its role in neurodegeneration, secondly, mediating responses to light-
induced stress in plants, and thirdly, because it is a vital component of the ubiquitin-
proteasome system, of which TOPORS is also a member. 
In an attempt to further prioritise one of these three candidates an RT-PCR-based screen for 
alternatively-spliced retinal protein-coding transcripts of the interactors was performed 
(section 2.4.4. Amplification of Alternative Prey Transcripts). Several protein-coding isoforms 
of each one of the candidate interacting partners have been documented in genomic 
databases (Ensembl, NCBI, UCSC); data available from the Ensembl database was used for 
designed the experiments described here. The objective of this experiment was to attempt to 
amplify the alternative isoforms (in addition to the ones identified via the Y2H PPI screen) from 
the human retinal RNA (section 5.1). Amplification of the isoforms pulled out form the Y2H PPI 
screen would have served as an additional validation of the Y2H results, as only fragments of 
the isoforms were isolated via the Y2H methods (Chapter 4).  This would also have provided 
valuable information for interpretation of results of immunofluorescence (IF) staining on 
retinal cryo-sections (Chapter 8). Time-allowing, these isoforms could additionally have been 
sub-cloned into Y2H and mammalian expression vectors for use in control PPI and localisation 
experiments. 
Validation of interactions between TOPORS and its novel protein partners using the Y2H 
method was the final one of the Y2H experiments of this project (section 5.2), prior to co-
immuno-precipitation (coIP) studies to validate the interactions in human cell lines (section 
2.5.4 in Methods and Materials and experimental Chapter 6). Besides the full-length TOPORS 
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construct, the Y2H PPIs were additionally performed with TOPORS deletion constructs (shown 
in red, blue and green in Figure 3-5 in Chapter 3). The deletion constructs of TOPORS were 
designed to correspond to TOPORS regions known to convey a specific function; e.g. E3 
ubiquitin ligase (red) vs. E3 SUMO1 ligase (blue), or the mutational hot-spot region (green). 
The purpose of these additional Y2H PPI experiments was to try to define the putative nature 
of the interactions between TOPORS and its newly-isolated partners. 
Section 5.1 of this chapter describes the identification of the alternative transcripts of 
the novel candidate interactors, whereas section 5.2 deals with the experiments performed in 
yeast to validate the interactions identified in the Y2H screen. 
 
5.1 SPLICE VARIANTS OF ITM2B, PTGDS AND PSMC1 EXPRESSED IN 
THE RETINA 
The purpose of this section was to determine the expression of protein-coding transcript 
variants of ITM2B, PTGDS and PSMC1 in human retina at mRNA level. Human retina RNA 
(Clontech, CA, USA) was used to prepare cDNA as described in section 2.4. Primers were 
designed to identify and differentiate the protein-coding transcripts for each of the genes of 
interest according to details of splice variants available on the Ensembl database16 (section 
2.4.4 in Methods and Materials). PCRs were performed on retinal cDNA, generated in three 
independent experiments. Each PCR was performed at least in triplicate and a representative 
image for each result is presented. 
 
5.1.1 ITM2B ISOFORM EXPRESSION STUDY 
Two protein-coding transcripts have been reported for ITM2B according to the Ensembl 
database (Appendix: Figure 11-29), whereas the UCSC database contains only the longer 
isoform (Appendix: Figure 11-30). The UCSC display additionally summarises the reported ESTs 
from human retina and the RPE, as well as potential retinal disease loci. The USCS database 
uses the Human Feb. 2009 (GRCh37/hg19) Assembly of the human genome, hence information 
                                                          
 
16
 Alternative protein-coding transcripts, described and evaluated in this section, were accessible on 
the Ensembl database till July 2014 inclusive, and have been updated since then. Snapshots of those 
past database records are included in Appendix 11.7. In context of the retinal isoform evaluation, 
the update affects only PTGDS, as its isoform 201 has been removed from database records. As findings 
presented in this section will demonstrate, the old PTGDS-201 was not detected in the retina, thus, its 
removal would not significantly influence the analysis. No other changes, relevant to this project, have 
been noted. 
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regarding the involvement of ITM2B in retinal degeneration (Audo et al., 2013); is not 
indicated. 
All PCRs resulted in amplification of the longer ITM2B-001 isoform. No ITM2B-003 PCR 
products were generated using any of the primer pairs, designed to detect it (Table 2-65 in 
Methods and Materials). This is a positive result in view of the fact that TOPORS interacted 
with ITM2B peptide fragments, encoded by exons 3-6, i. e. a region corresponding to isoform 
001 (Figure 5-1). 
 
 
Figure 5-1. ITM2B isoform 001.  
Transcript structure from the UCSC database is shown in the top panel. Protein structure is shown in 
the bottom panel. N, amino-terminus; CTS, ciliary targeting sequence; TM, transmembrane domain; 
BH3, Bcl 2 homology 3 domain; BRICHOS, BRICHOS domain; C, carboxy-terminus; asterisks indicate 
known ITM2B mutation sites: retinal mutation (c.782A>C; p.Glu261Ala), FDD mutation (c.795-
796insTTTAATTTGT; p.Ser266Phefs*11), FBD mutation (c.799T>A; p.Stop267Argfs*11). Protein 
fragments corresponding to specific exons are indicated using dashed lines, joining an exon in the top 
panel with a region of ITM2B in the lower panel; alternating exons are differentiated using black and 
blue paired lines. The horizontal purple bar at the bottom of the figure corresponds to the ITM2B 
fragment, which was pulled out from the Y2H screen twice as an interacting protein partner of TOPORS 
(Figure 4-9 in Chapter 4). The alternative protein coding ITM2B isoform 003 differs from isoform 001 in 
lacking exons 3 and 4. Figure not to scale. 
 
Images of the amplified fragments are presented in Figure 5-2; the amplified fragments are 
typed in bold script in Table 5-1. The identity of the amplified PCR fragments was confirmed by 
sequencing. Only one sequence per band was identified, and no unexpected sequences were 
detected. 
Importantly, the results demonstrated that ITM2B-001, a fragment of which interacted with 
TOPORS in the Y2H screen, is expressed in the human retina. 
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Figure 5-2. Results of ITM2B isoform expression study.  
Expected band sizes for relevant isoform(s) in each PCR are given in Table 5-1Table 2-65. Five microliters 
of PCR products were loaded for ITM2B-1, ITM2B-2, and ITM2B-3; two microliters were loaded for 
ITM2B-4 and ITM2B-5. Key: M (marker): 1 kb DNA Ladder (Promega, WI, USA); cDNA, complementary 
DNA; gDNA, genomic DNA control; -ve, negative control. ITM2B-[number] corresponds to the PCR name 
given in Table 5-1. Gels (1.8 %) were run at 120 V for 1h 20’. 
 
Table 5-1. ITM2B primer details for isoform amplification. 
Primers correspond to those given in Table 2-52. Isoforms expected to be amplified by the designated 
primer pairs are indicated; and expected amplicon sizes from the corresponding isoforms are given in 
brackets. Isoforms, whose expression was detected in this experiment are in bold. The first column 
contains a reference to the corresponding PCR result image Figure 5-2. 
PCR name Primer pair Expected isoform fragments (size) 
ITM2B-1 
Ex1F 
Isoform 001 (918 bp) 
Ex6R 
ITM2B-2 
Ex1Fb 
Isoforms 001 (737 bp) & 003 (419 bp) 
Ex6R 
ITM2B-3 
Ex1F 
Isoform 001 (530 bp) 
Ex3R 
ITM2B-4 
Ex2F 
Isoform 001 (445 bp) & 003 (127 bp) 
Ex5R 
ITM2B-5 
Ex3F 
Isoform 001 (490 bp) 
Ex6R 
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5.1.2 PTGDS ISOFORM EXPRESSION STUDY 
Six protein-coding transcripts have been reported for PTGDS according to the Ensembl 
database (Appendix: Figure 11-31), whereas the UCSC database contains only two variants 
(Appendix: Figure 11-32). Full-length isoform PTGDS-001 (Ensembl) was isolated as 
an interacting protein partner of TOPORS three times (Chapter 4). 
The PCR results have provided strong evidence for retinal expression of PTGDS isoforms 001 
(PCR PTGDS-1), 004 (PCR PTGDS-3) and 005 (PCR PTGDS-5). As demonstrated in Figure 5-3, 
the product of PTGDS-1 PCR migrated at approximately 750 bp, very close to the expected 
PTGDS-001 amplicon size of 743 bp. Additionally, the band in PTGDS-4 PCR migrated between 
the 250 bp and 500 bp markers, at approximately 400 bp; this result also points towards 
the presence of a PTGDS-001 (390 bp); however it may also represent a PTGDS-005 amplicon 
of 360 bp. In either case, evidence from PTGDS-5 PCR clearly demonstrates that PTGDS-005 is 
indeed expressed in the human retina. Primers used in the PTGDS-3 PCR also amplify a product 
from just one isoform, PTGDS-004; the observed band migrated above the 500 bp marker, and 
the expected band for this isoform was 560 bp, confirming that it was present. 
Based on results of PCRs PTGDS-2 and PTGDS-7, it can also be concluded that either isoform 
003, or 201, or both, are also expressed in human retina. The band observed in PTGDS-2 PCR 
migrated slightly below 500 bp; the expected product from this reaction should have been 
443 bp long, which could correspond to isoform PTGDS-003, PTGDS-004 (expression confirmed 
by PTGDS-3 PCR result), or PTGDS-201. However, it must be noted that isoform PTGDS-201 
was not amplified in PTGDS-1 PCR; therefore, the obtained product is more likely to represent 
either isoform-004 or 003. 
Products of PTGDS-6 PCR include two bands, both migrating between the 250 bp and 500 bp 
markers, estimated to be between 300 bp and 400 bp in size. The lower faint product could 
represent either isoform 001 (316 bp), or isoform 005 (313 bp); the expression of both of them 
is confirmed by products of PCRs PTGDS-1 and PTGDS-5, respectively. The larger strong band 
could represent isoform 006; the expression of this splice variant has been reported (Ensembl) 
to result in a processed transcript only; hence, it was not intended for this analysis, as it should 
not encode a protein potentially interacting with TOPORS. 
The amplicons, which resulted from PCRs: PTGDS-8 and PTGDS-9, could both demonstrate 
the expression of either isoform 001 or 201. In the PTGDS-8 PCR the observed band migrated 
below 500 bp, showing an estimated size of approximately 400 bp; this band can represent 
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both isoforms, whose expected products in these reaction would be 399 bp and 396 bp, 
respectively. In PTGDS-9 PCR, amplification of both isoforms should result in a product of 
207 bp; the amplified band migrated below the 250 bp marker, demonstrating the presence of 
either PTGDS-001, or PTGDS-201, or both. However, it should again be emphasised that no 
product, corresponding to isoform 201, was amplified in PTGDS-1 PCR, therefore the band is 
more likely to represent PTGDS-001. 
 
Figure 5-3. Results of PTGDS isoform expression study. 
Expected band sizes for relevant isoform(s) in each PCR are given in Table 5-2. Five microliters of PCR 
products were loaded for all PCRs. Key: M (marker): 1 kb DNA Ladder (Promega, WI, USA); cDNA: 
complementary DNA; gDNA: genomic DNA control; -ve: negative control. PTGDS-[number] corresponds 
to the PCR name given in Table 5-2. Gels (1.8 % – 2.0 %) were run at 120 V for 1h 20’. 
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Alternatively, this PCR could have also yielded a larger product (363 bp), which would provide 
evidence for expression of isoform 008; this was not observed. 
These results are also summarised in Table 5-2. The identity of the amplified PCR fragments 
was confirmed by sequencing. Only one sequence per band was identified, and no unexpected 
sequences were detected.  
The outcomes of this study suggest that, except for PTGDS-008 and PTGDS-201, all of 
the reported protein-coding PTGDS splice variants, appear to be expressed in the human 
retina. Of particular note, it was demonstrated that PTGDS-001, which interacted with TOPORS 
in the Y2H screen, is expressed in the human retina. 
 
Table 5-2. PTGDS primer details for isoform amplification. 
Primers sequences are given in Table 2-53. Isoforms expected to be amplified by the designated primer 
pairs are indicated; and expected amplicon sizes from the corresponding isoforms are given in brackets. 
Isoforms, whose expression was detected in this experiment, are in bold (or in bold italics, where 
a product is not exclusive to the highlighted isoform, but the expression was confirmed by one of 
the other PCRs). Isoforms, which were potentially detected in this experiment, but their identity was not 
fully confirmed, are typed in italics. The first column contains a reference to the corresponding PCR 
result image (Figure 5-3). 
PCR name Primer pair Expected isoform fragments (size) 
PTGDS-1 
Ex1F 
Isoforms 201 (845 bp) & 001 (743 bp) 
Ex7R 
PTGDS-2 
Ex1F 
Isoform 003, 004, 201 (443 bp) 
Ex3RII 
PTGDS-3 
Ex1F 
Isoform 004 (560 bp) 
Ex3Rb 
PTGDS-4 
Ex2F 
Isoforms 201 (462 bp), 001 (391 bp) & 005 (360 bp) 
Ex5R 
PTGDS-5 
Ex2Fb 
Isoform 005 (624 bp) 
Ex7Rb 
PTGDS-6 
Ex3F 
Isoforms 201 (418 bp) 001 (316 bp) 005 (313 bp) 
Ex6R 
PTGDS-7 
Ex3Fb 
Isoforms 201 & 003 (213 bp) 
Ex5Rb 
PTGDS-8 
Ex4F 
Isoforms 201 (399 bp) & 001 (396 bp) 
Ex7R 
PTGDS-9 
Ex5F 
Isoforms 201, 001 (207 bp) & 008 (363bp) 
Ex7R 
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5.1.3 PSMC1 ISOFORM EXPRESSION STUDY 
Three protein-coding transcripts have been reported for PSMC1 according to the Ensembl 
database (Appendix: Figure 11-33), whereas the UCSC database contains two of these splice 
variants (Appendix: Figure 11-34).  
All PCRs resulted in amplification of the longest PSMC1 isoform 001 (Figure 5-4). Results of 
PCRs PSMC1-5 and PSMC1-6 may also suggest the expression of isoform 002, as sizes of 
the PCR products would be the same for both: PSMC1-001 and PSMC1-002 isoforms; however, 
in view of the findings from the other PCRs, it is more likely that the observed amplicons would 
indicate the presence of isoform 001. No bands migrating at sizes indicative of isoform 002 
expression were detected in PCRs: PSMC1-1, PSMC1-2, or PSMC1-3. Furthermore, no amplicon 
corresponding to isoform-004 was observed in PCR PSMC1-2 (nonetheless, it could not be 
excluded that this was a false negative result due to the very small size of the expected 
amplicon). The amplified fragments are typed in bold script in Table 5-3. The identity of 
the amplified PCR fragments was confirmed by sequencing (only one sequence per band was 
identified).  
 
 
Figure 5-4. Results of PSMC1 isoform expression study. 
Five microliters of PCR products were loaded for all PCRs. Five microliters of PCR products were loaded 
for all PCRs. Expected band sizes for relevant isoform(s) in each PCR are given in Table 5-3. Key: M 
(marker): 1 kb DNA Ladder (Promega, WI, USA); cDNA, complementary DNA; gDNA, genomic DNA 
control; -ve, negative control. PSMC1-[number] corresponds to the PCR name given in Table 5-3. Gels 
(2 %) were run at 120 V for 1h 20’. 
 
Identification of Interacting Protein Partners of TOPORS in the Retina   ||   Barbara Czub 
PhD Thesis 2015   ||   Verification of Expression and Interactions    - 228 - 
 
This is a positive result in view of the fact that in the Y2H screen TOPORS interacted with 
a PSMC1 peptide fragment, encoded by exons 1-6, corresponding to PSMC1 isoform 001. 
Unexpectedly, faint PCR products were also observed in the gDNA lanes in Figure 5-4. These 
products were purified and sequenced in triplicate. The gDNA band from PSMC1-2 PCR 
consistently aligned with an intergenic region on chromosome 1, upstream of gene SAMD11 
(Appendix: Figure 11-35). The remaining bands appeared to have no matches in the UCSC 
database. 
 
 
Figure 5-5. PSMC1 isoform 001.  
Transcript structure from the UCSC database is shown in the top panel. Protein structure is shown in 
the bottom panel. N, amino-terminus; Ub, ubiquitin; Ac, acetyl group; C, carboxy-terminus. Starting 
from the N-terminus: the lipid tail structure indicates N-myristoylation at Gly 2, and the box filled with 
wavy lines represents a consensus sequence for this modification; the region emphasised with straight 
diagonal black lines represents an NADH-binding site; the blue box represents a PSMC1 fragment 
indispensable for plant development. asterisks indicate phosphorylation sites; two red boxes represent 
ciliary targeting sequences (CTSs); the grey boxes represent regions required for ATP binding and 
hydrolysis, respectively, whereas the orange box indicates an aromatic loop mediating the hydrolysis of 
ATP; green box represents the proteasomal anchoring region. Protein fragments corresponding to 
specific exons are indicated using dashed lines, joining an exon in the top panel with a region of PSMC1 
in the lower panel; alternating exons are differentiated using black and blue paired lines. The horizontal 
purple bar at the bottom of the figure corresponds to the PSMC1 fragment, which was pulled out from 
the Y2H screen as an interacting protein partner of TOPORS (Figure 4-11 in Chapter 4). The alternative 
protein coding PSMC1 isoform 002 differs from isoform 001 in lacking exon 3; whereas isoform 004 lacks 
exons 2, 3, 4, 9, 10 and 11, and fragments of exons 5 and 8, relative to isoform 001. Figure not to scale. 
 
Identification of Interacting Protein Partners of TOPORS in the Retina   ||   Barbara Czub 
PhD Thesis 2015   ||   Verification of Expression and Interactions    - 229 - 
 
Table 5-3. PSMC1 primer details for isoform amplification. 
Primer sequences are given in Table 2-54. Isoforms expected to be amplified by the designated primer 
pairs are indicated; and expected amplicon sizes from the corresponding isoforms are given in brackets. 
Isoforms, whose expression was detected in this experiment, are typed in bold (or in bold italics, where 
a product is not exclusive to the highlighted isoform, but the expression was confirmed by one of 
the other PCRs). Isoforms, which were potentially detected in this experiment, but their identity was not 
fully confirmed, are typed in italics. The first column contains a reference to the corresponding PCR 
result image (Figure 5-4). 
PCR name Primer name Expected isoform fragments (size) 
PSMC1-1 
Ex1F 
Isoform  001 (1495 bp), 002 (1389 bp) 
Ex11R 
PSMC1-2 
Ex1F 
Isoform 001 (476 bp), 002 (379 bp) & 004 (67 bp) 
Ex5R 
PSMC1-3 
Ex2F 
Isoform 001 (520 bp), 002 (423 bp) 
Ex6R 
PSMC1-4 
Ex3F 
Isoforms 001 (569 bp) 
Ex7R 
PSMC1-5 
Ex5F 
Isoforms 001 & 002 (714 bp) 
Ex9R 
PSMC1-6 
Ex8F 
Isoforms 001 & 002 (715 bp) 
Ex11R 
 
The current section 5.1 provided a summary of expression of alternatively spliced variants of 
novel putative interactors of TOPORS in the human retina. 
The next section 5.2 includes evidence of diesct PPIs between TOPORS and its full-length 
interactors in yeast.  
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5.2 Y2H PPI VALIDATION EXPERIMENTS 
With the exception of PTGDS, preys identified in the Y2H screen comprised only fragments of 
protein-coding sequences rather than full-length complete transcripts. Consequently, having 
confirmed their retinal expression (section 5.1), but prior to performing the control 
experiments in yeast (section 5.1), the relevant transcript variants had to be cloned into 
the Y2H vectors (Appendix 11.8). The following splice variants (based on the Ensemble 
database) were used for cloning: 
 ITM2B-001 (ENST00000378565); 
 PTGDS-001 (ENST00000371625); 
 PSMC1-001 (ENST00000261303). 
 
5.2.1 CONTROL INTERACTION TESTING WITH GAL4 DNA-BD 
The final interacting partners, sub-cloned into GAL4 AD vector, were tested for putative 
interactions with the GAL4 DNA-BD, to ensure the interactions observed with TOPORS were 
not false-positives. Each interacting partner was transformed into the relevant yeast strain and 
then mated with the GAL4 DNA-BD yeast culture. Serial dilutions of the mated cultures were 
prepared, and seeded on selective media. The test was performed in triplicate, and 
demonstrated that the preys do not interact with the DNA-BD of GAL4. Representative results 
from one of the experiment replicates are summarised in two tables (Table 5-7 and Table 5-6). 
Results of a control experiment, involving p53 (the overall control interacting partner), PSMC1 
and PTGDS, are shown in the figures in Table 5-5. Results of a test involving ITM2B and its 
variants are shown in Table 5-6; full-length ITM2B and its non-membrane-bound fragment 
were tested, in addition to ITM2B mutants, previously described in section 4.3.2 (Chapter 4). 
The mated cultures were serially diluted (100 – 10-5) before plating. The expected results are 
delineated in Table 5-4. 
Table 5-4. Expected control Y2H PPI results. 
Expected growth 
On selective media 
Positive control mating Negative control mating 
SD/-W (bait selection) White colonies White colonies 
SD/-L (prey selection) White colonies White colonies 
DDO (diploid selection) White colonies White colonies 
DDO/X/A (PPI selection in 
diploid yeasts) 
Blue colonies No colonies 
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Table 5-5. Control yeast mating to confirm putative interacting partners (preys) of TOPORS do not bind 
the GAL4 DNA-BD. Part I. 
A putative interaction between p53 and GAL4 DNA-BD is included in the assay as an additional control 
(TOPORS x p53 Y2H PPI was published previously). All of the putative interacting proteins, as well as p53, 
are expressed as fusion proteins with GAL AD (preys) just as the cDNA library clones were. GAL4 DNA-BD 
was used as bait in the putative PPI testing. +ve PPI control: SV40 T Ag x p53. –ve PPI control: SV40 T Ag 
x Lamin C. SD/-W media selected for BD constructs; SD/-L media selected for AD constructs; DDO media 
selected for both BD and AD constructs, i.e. controlled for mating efficiency; DDO/X/A media selected 
for PPIs, as indicated by Mel1 and Aur-C
 
reporters (blue colonies and growth on the anti-fungal AbA 
agent, respectively); QDO/X/A media selected for PPIs, as indicated by Mel1, Aur-C, His3 and Ade2 
reporters (blue colonies, growth on AbA, growth without histidine and growth without adenine, 
respectively). Key: ‘M.’ = selective medium; ‘sel.’ = ‘selects for’. 
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Table 5-6. Control yeast mating to confirm putative interacting partners (preys) of TOPORS do not bind 
the GAL4 DNA-BD. Part II. 
All of the putative interacting proteins are expressed as fusion proteins with GAL AD (preys) just as 
the cDNA library clones were. GAL4 DNA-BD was used as bait in the putative PPI testing. +ve PPI control: 
SV40 T Ag x p53. –ve PPI control: SV40 T Ag x Lamin C. SD/-W media selected for BD constructs; SD/-L 
media selected for AD constructs; DDO media selected for both BD and AD constructs, i.e. controlled for 
mating efficiency; DDO/X/A media selected for PPIs, as indicated by Mel1 and Aur-C
 
reporters (blue 
colonies and growth on the anti-fungal AbA agent, respectively); QDO/X/A media selected for PPIs, as 
indicated by Mel1, Aur-C, His3 and Ade2 reporters (blue colonies, growth on AbA, growth without 
histidine and growth without adenine, respectively). Key: ITM2B: wild-type ITM2B; ITM2B90: soluble 
wild-type ITM2B fragment; RetMu: ITM2B retinal dystrophy mutant; FBD: ITM2B British Dementia 
mutant; FDD: ITM2B Danish Dementia mutant; ‘M.’: selective medium; ‘sel.’: ‘selects for’. 
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5.2.2 DIRECT PROTEIN-PROTEIN INTERACTIONS (PPIs) IN YEAST 
The primary purpose of this experiment was to validate the PPIs, identified by the Y2H cDNA 
library screening, by re-testing the interaction directly in yeast, using the relevant full-length 
transcript.  
Considering the variable nature of TOPORS and its potential multiple roles, an attempt was 
also made to understand which of the domains of this protein could be responsible for 
mediating its interactions with PTGDS, PSMC1 and non-membrane bound fragments of ITM2B. 
TOPORS deletion constructs, highlighted in Figure 3-4, were designed, cloned in frame with 
the GAL4 BD, and directly tested, using the Y2H method, for interactions with the three 
partners identified in the cDNA library screen. ITM2B mutants were also tested for PPIs with 
full-length TOPORS as well as its fragments. 
This Y2H-based experiment directly tested the PPIs between full-length TOPORS (FL), and each 
one of its domain-isolating fragments (N, M and C) with each of the identified interaction 
partners, i.e. ITM2B, PSMC1 and PTGDS. The interaction between the SV40 large T Ag (fusion 
protein with GAL4 AD) and p53 (fusion protein with GAL4 DNA-BD) was used as a positive 
control (AD-T Ag x BD-p53); whereas Lamin C bound to the DNA-BD and the SV40 large T Ag 
fused with the AD (AD-T Ag x BD-Lamin C) served as the negative control. 
In order to determine, which domains are involved, each experiment was repeated six times. 
The following tables (Table 5-8 – Table 5-15) contain figures with the raw results from one (of 
the six) representative experiment performed to evaluate the PPIs, whereas Table 5-16  
summarises the findings from all six repeats. A result was considered positive overall, if blue 
growth, indicating a PPI, was observed in at least four out of six experiments at a given 
stringency level (two or four reporter genes). The raw results are tabulated in the Appendix 
section 11.9.  
The mated cultures were serially diluted (100 – 10-5) before plating. SD/-W media selected for 
BD constructs; SD/-L media selected for AD constructs; DDO media selected for both BD and 
AD constructs, i.e. controlled for mating efficiency; DDO/X/A media selected for PPIs, as 
indicated by Mel1 and Aur-C reporter activation (blue colonies and growth on the anti-fungal 
AbA agent, respectively); QDO/X/A media selected for PPIs, as indicated by Mel1, Aur-C, His3 
and Ade2 reporter activation (blue colonies, growth on AbA, growth without histidine and 
growth without adenine, respectively; Table 5-7). 
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Table 5-7. An overview of expected results in Y2H PPI testing.  
Key: ‘Med.’ = selective medium; ‘Sel.’ = ‘selects for’. 
 
Table 5-8. Control yeast mating to test direct TOPORS-p53 PPI (published interaction used as an overall 
positive control). 
Key: FL: full-length TOPORS; N: N-term TOPORS, M: mid-TOPORS; C: C-term TOPORS; Pr.: prey; T, 
SV40 T Ag. All baits are expressed as fusion proteins with GAL4 DNA-BD. All preys are expressed as 
fusion proteins with GAL4 AD. ‘+’: PPI control: SV40 T Ag x p53. ‘–‘: PPI control: SV40 T Ag x Lamin C.  
                       + -     + - 
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Table 5-9. Control yeast mating to test direct TOPORS-ITM2B PPI. 
Key: FL: full-length TOPORS; N: N-term TOPORS, M: mid-TOPORS; C: C-term TOPORS; Pr.: prey; T, 
SV40 T Ag. All baits are expressed as fusion proteins with GAL4 DNA-BD. All preys are expressed as 
fusion proteins with GAL4 AD. ‘+’: PPI control: SV40 T Ag x p53. ‘–‘: PPI control: SV40 T Ag x Lamin C.  
                       + -     + - 
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Table 5-10. Control yeast mating to test direct TOPORS-ITM2B90 PPI. 
Key: FL: full-length TOPORS; N: N-term TOPORS, M: mid-TOPORS; C: C-term TOPORS; Pr.: prey; T, 
SV40 T Ag. All baits are expressed as fusion proteins with GAL4 DNA-BD. All preys are expressed as 
fusion proteins with GAL4 AD. ‘+’: PPI control: SV40 T Ag x p53. ‘–‘: PPI control: SV40 T Ag x Lamin C.  
                       + -     + - 
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Table 5-11. Control yeast mating to test direct TOPORS-ITM2B-RetMu PPI. 
Key: FL: full-length TOPORS; N: N-term TOPORS, M: mid-TOPORS; C: C-term TOPORS; Pr.: prey; T, 
SV40 T Ag. All baits are expressed as fusion proteins with GAL4 DNA-BD. All preys are expressed as 
fusion proteins with GAL4 AD. ‘+’: PPI control: SV40 T Ag x p53. ‘–‘: PPI control: SV40 T Ag x Lamin C.  
                       + -     + - 
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Table 5-12. Control yeast mating to test direct TOPORS-ITM2B-FBD PPI. 
Key: FL: full-length TOPORS; N: N-term TOPORS, M: mid-TOPORS; C: C-term TOPORS; Pr.: prey; T, 
SV40 T Ag. All baits are expressed as fusion proteins with GAL4 DNA-BD. All preys are expressed as 
fusion proteins with GAL4 AD. ‘+’: PPI control: SV40 T Ag x p53. ‘–‘: PPI control: SV40 T Ag x Lamin C.  
                       + -     + - 
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Table 5-13. Control yeast mating to test direct TOPORS-ITM2B-FDD PPI. 
Key: FL: full-length TOPORS; N: N-term TOPORS, M: mid-TOPORS; C: C-term TOPORS; Pr.: prey; T, 
SV40 T Ag. All baits are expressed as fusion proteins with GAL4 DNA-BD. All preys are expressed as 
fusion proteins with GAL4 AD. ‘+’: PPI control: SV40 T Ag x p53. ‘–‘: PPI control: SV40 T Ag x Lamin C. 
                       + -     + - 
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Table 5-14. Control yeast mating to test direct TOPORS-PTGDS PPI. 
Key: FL: full-length TOPORS; N: N-term TOPORS, M: mid-TOPORS; C: C-term TOPORS; Pr.: prey; T, 
SV40 T Ag. All baits are expressed as fusion proteins with GAL4 DNA-BD. All preys are expressed as 
fusion proteins with GAL4 AD. ‘+’: PPI control: SV40 T Ag x p53. ‘–‘: PPI control: SV40 T Ag x Lamin C. 
                       + -     + - 
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Table 5-15. Control yeast mating to test direct TOPORS-PSMC1 PPI.  
Key: FL: full-length TOPORS; N: N-term TOPORS, M: mid-TOPORS; C: C-term TOPORS; Pr.: prey; T, 
SV40 T Ag. All baits are expressed as fusion proteins with GAL4 DNA-BD. All preys are expressed as 
fusion proteins with GAL4 AD. ‘+’: PPI control: SV40 T Ag x p53. ‘–‘: PPI control: SV40 T Ag x Lamin C. 
                       + -     + - 
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Table 5-16. PPIs summary. 
Key: FL TOPORS = full length TOPORS; N-term TOPORS = amino-terminal TOPORS fragment; Mid-
TOPORS = TOPORS middle fragment; C-term TOPORS = carboxy-terminal TOPORS fragment; p53 = 
tumour protein 53; ITM2B = integral membrane protein 2B; ITM2B90 = soluble fragment of ITM2B (aa90 
- aa266); ITM2B_RetMu = ITM2B retinal dystrophy mutant; ITM2B_FBD = ITM2B British dementia 
mutant; ITM2B_FDD = ITM2B Danish dementia mutant; PSMC1 = 26 protease regulatory subunit 4; 
PTGDS = prostaglandin D2 synthase; + = PPI; - = No PPI. 
BD constructs FL TOPORS N-term TOPORS Mid-TOPORS C-term TOPORS 
AD constructs DDO/X/A QDO/X/A DDO/X/A QDO/X/A DDO/X/A QDO/X/A DDO/X/A QDO/X/A 
p53 + - + + + + + + 
ITM2B + - + + - - + + 
ITM2B90 + - + + + - + + 
ITM2B_RetMu + + + + + - + + 
ITM2B_FBD + - + + + + + + 
ITM2B_FDD - - - - - - + - 
PTGDS + - + + + - + - 
PSMC1 + - + - + + + + 
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All tested proteins apart from the Danish dementia mutant interacted with full-length TOPORS 
on DDO/X/A media, but only the association with ITM2B retinal dystrophy mutant appeared 
strong enough to activate the additional two reporters, selected for on the (most stringent) 
QDO/X/A media. 
The amino-terminal fragment of TOPORS (N-term), comprising one PEST domain and the RING 
finger region required for E3 ubiquitin ligase activity and a ciliary-targeting sequence (CTS), 
appeared to strongly interact with all, apart from two tested peptides, at both levels of 
stringency. The ITM2B Danish dementia mutant displayed no association with this TOPORS 
fragment at all, whereas the interaction with PSMC1 was observed only on the lower 
stringency media (DDO/X/A). 
The mid-TOPORS fragment, consisting of two CTS regions, two PEST domains, RS/SR region, 
nuclear localisation signal (NLS), within which two mutations are known to occur, interacted at 
both stringency levels with p53, PSMC1 and with the ITM2B British dementia mutant. A PPI at 
the lower stringency level was additionally observed with PTGDS, and the other ITM2B 
constructs, excluding the British mutant. 
The carboxy-terminal (C-term) mutational hotspot region of TOPORS (Lys/His domain and two 
PEST domains) interacted at both stringency levels with all tested proteins apart from 
the ITM2B Danish mutant and PTGDS, in which cases the interaction occurred only in less 
stringent conditions. 
 
5.3 DISCUSSION 
The full-length transcripts of each gene isoform corresponding to the ones identified in 
the Y2H screen (Chapter 4), and verified in the retinal isoform experiment (section 5.1) were 
cloned into the relevant Y2H vector for control experiments in yeast (section 5.2). Additionally, 
known ITM2B mutants as well as a gene fragment encoding a soluble ITM2B peptide fragment 
were also tested. It was, firstly, demonstrated that the PPI-indicative phenotypes, observed in 
yeast, were not due to an interaction with the GAL4 BD (section 5.2.1). Subsequently, each 
prey was tested again for direct interaction with TOPORS to ensure that the resulting full-
length peptide was still able to associate with the bait. PPIs involving the identified proteins 
were also tested for interaction with TOPORS fragments (section 5.2.2).  
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5.3.1 ISOFORM EXPRESSION EXPERIMENTS 
Identification of alternatively spliced retinal variants was performed by amplification of 
protein-coding isoforms (as reported on the Ensembl database), form cDNA, which was 
synthesised from human retinal total RNA (Clontech, CA, USA). The product sheet specified 
that the RNA was pooled from normal retinae of 25 suddenly deceased individuals (male and 
female), aged 24-65; however, no information was given, which would specify whether ‘retina 
RNA’ referred to RNA originated from neural retina only, or from neural retina and the RPE. 
For the purposes of this project it was assumed that the RNA was representative of all retinal 
cell types including the RPE and glial cells.  
 
5.3.1.1 ITM2B ALTERNATIVE RETINAL ISOFORM INVESTIGATION 
The Ensembl genomic database reports that two protein-coding isoforms of ITM2B were 
previously identified in human. The experiments described in section 5.1 aimed to determine 
whether both of these isoforms, namely ITM2B-001 and ITM2B-003 were also expressed in 
the retina. Only the reported protein-coding isoforms were evaluated, however their 
expression was verified at the mRNA rather than protein level. 
In the Y2H screen for human protein interacting partners of TOPORS a peptide corresponding 
to exons 3-6 of transcript ITM2B-001 was identified (Figure 5-1). Among the two known 
protein-coding ITM2B transcripts, the identified protein fragment could have been encoded 
only by isoform 001, as isoform 003 comprises only exons 1, 2, 5 and 6 of the ITM2B gene. 
Indeed the isoform study on human retinal cDNA did not lead to identification of ITM2B 
isoform 003. This finding could lead to the assumption that only one protein-coding transcript 
variant of ITM2B is expressed in the human retina. Nonetheless, it should be emphasised that 
as yet unidentified protein-coding isoforms may additionally exist.  
For instance, cell work performed by Fleischer et al. (2002) suggests that another alternatively 
spliced protein-coding ITM2B variant might exist, which the researchers denoted ITM2B-short 
(ITM2BS). This variant corresponds to a peptide comprising residues 57 – 266 of ITM2B 
encoded by isoform 001 (Fleischer et al., 2002). The protein structure of isoform 001 shows 
that methionine 57 is embedded within the transmembrane (TM) domain of this protein 
(Figure 6-4).  
On the other hand, this TM domain is also a site of intramembrane proteolysis by SPPL2a/b 
(Martin et al., 2008); therefore, rather than resulting from alternative splicing, ITM2BS might 
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be a product of ITM2B isoform 001 protein expression, followed by SPPL2a/b-mediated 
cleavage. Although the order of ITM2B-001 proteolytic processing was previously shown to 
commence at the carboxy-terminus with furin, followed by approximately centrally-cleaving 
ADAM10, and lastly the intramembrane proteolysis by SPPL2a/b, it could be speculated that 
an alternative order of peptide cleavage might generate the ITM2BS peptide.  
Pro-apoptotic factors could trigger a signal for ITM2B processing leading to formation of 
ITM2BS, as the latter was shown to play a key part in apoptosis by inducing loss of 
the mitochondrial membrane potential (Fleischer, Ayllon e Rebollo, 2002).  Nonetheless, no 
transcript corresponding to ITM2B-short was found in the Ensembl database; hence, this 
protein variant was not tested for retinal expression. 
Overall, the study presented in section 5.1.1 demonstrated that the protein-coding ITM2B 
isoform 001 is expressed in human retina at mRNA level; whereas isoform 003 is not. This 
result supports the findings from the Y2H screen for interacting protein partners of TOPORS, 
where a peptide, corresponding to a fragment of isoform 001, was isolated twice as a TOPORS’ 
interactor. 
 
5.3.1.2 PTGDS ALTERNATIVE RETINAL ISOFORM INVESTIGATION 
The alternative PTGDS variants, amplified from human retinal cDNA included isoforms 001, 
004 and 005. However, it could not be ascertained, in which retinal cell type their expression 
occurred, as the cDNA used in the isoform study was generated from RNA obtained from 
suddenly deceased individuals. The manufacturer’s datasheet did not specify whether the RNA 
was extracted only from the neural retinae, therefore, it was assumed that all of the retinal cell 
types served as a source for the RNA extraction. 
This assumption was a necessity; however, it would have been interesting to determine PTGDS 
expression in different retinal cell types, as previous studies in chick and rat showed the mRNA 
is expressed specifically in the RPE, even though the protein was also observed in 
the photoreceptors cells (and the interphotoreceptor matrix) (Beuckmann et al., 1996; 
Shiroma et al., 1996). Nonetheless, those studies did not evaluate alternative PTGDS isoforms. 
Still, the isoform study showed that, in addition to PTGDS-001, pulled out as an interactor of 
TOPORS from the Y2H screen, the protein-coding isoforms 004 and 005 are also expressed in 
human retina at the mRNA level. If this mRNA is subsequently translated into protein (as would 
be expected), this could prove to be a challenge for performing reliable immunohistochemical 
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(IHC) experiments aiming to determine the localisation of PTGDS-001 protein in retinal cryo-
sections (Chapter 8). 
As was mentioned at the end of 
section 4.3.3.2, PTGDS-001 
contains overlapping binding 
pockets for prostaglandin 
(PG) H2 (a PG D2 precursor) 
and for lipophilic compounds, 
such as retinoids (for which 
the protein serves as 
a transporter). A representative 
crystal structure of PTGDS-001 
depicts a bucket-shaped 
protein (Figure 5-6). 
The antibody, which will have 
been used in subsequent 
immuno-based studies (Chapter 
6, 7 and 8) was raised against 
a peptide corresponding to full-
length PTGDS isoform 001.  
 
Figure 5-6. PTGDS-001 protein crystal structure.  
The canonical PTGDS variant (isoform 001) protein forms 
a bucket-like structure with internal docking sites for lipophilic 
compounds, such as retinoids, and prostaglandin H2, 
the precursor of prostaglandin D2.  Image from PhosphoSitePlus 
(Hornbeck et al., 2004). 
Figure 5-7 shows sequence alignments of PTGDS isoform 004 with the antigen sequence; and 
Figure 5-8 shows the alignment of isoform 005 with the antigen sequence. Isoform 004 aligns 
with approximately the amino-terminal half of isoform 001 (the antigen), whereas isoform 005 
corresponds to approximately two thirds of the 001 isoform at its carboxy-terminal end.  
No crystal structures have been published for the alternative isoforms 004 and 005. 
Additionally, it has not been demonstrated that they perform either one of the main known 
functions of PTGDS-001. Based on the substantial region of sequence dissimilarity between 
PTGDS variant 001 and either one of the alternative isoforms 004 or 005, it could be expected 
that their tertiary structures would differ. This in turn should suggest that the antibody against 
PTGDS-001, used in Chapters 6 - 8, would not detect the alternatively-spliced PTGDS variants. 
Nonetheless, this could not be categorically excluded. 
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Figure 5-7. PTGDS-004 alignment with the sequence of the immunogen, used to generate the antibody 
against PTGDS-001 (sc-30067, Santa Cruz Biotechnology). 
Alignment with approximately only with the N-terminal half of PTGDS isoform 004 is shown. 
The red highlighted conflicts represent dissimilarities between the sequence corresponding to 
the PTGDS immunogen, and the sequence of isoform 004. Alignments were generated using SeqMan 
(DNAStar Inc., WI, USA). 
 
 
Figure 5-8. PTGDS-005 alignment with the sequence of the immunogen, used to generate the antibody 
against PTGDS-001 (sc-30067, Santa Cruz Biotechnology). 
Alignment with approximately the C-terminal two-thirds of PTGDS isoform 005 is shown. 
The red highlighted conflicts represent dissimilarities between the sequence corresponding to 
the PTGDS immunogen, and the sequence of isoform 005. Alignments were generated using SeqMan 
(DNAStar Inc., WI, USA). 
 
5.3.1.3 PSMC1 ALTERNATIVE RETINAL ISOFORM INVESTIGATION 
The search for retinal protein-coding isoforms of PSMC1 confirmed that PSMC1-001 is indeed 
expressed in the retina. On the contrary the study excluded the expression of isoform 002 in 
retinal cell types and, originally, also the expression of isoform 004. However, judging in 
retrospect, verification of the existence of protein-coding isoform PSMC1-004 in the retina 
should probably be repeated. 
Due to the extremely small size of the expected amplicon (67 bp), it could have been possible 
that even if this DNA fragment was amplified from the human retinal cDNA, it might have been 
lost from the 2 % agarose gel during the electrophoresis. In order to definitely confirm that 
isoform 004 is not expressed in human retina, in future experiments, a higher percentage 
agarose gel (2.5 %) could be used for separation of the expected PCR product. This would 
extend the electrophoresis time, but it would also increase resolution, and would additionally 
lead to retaining very small DNA amplicons that would be lost from the 2 % gel during 
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electrophoresis. Alternatively, new primer pairs, specific to isoform 004, could be designed, 
which would lead to amplification of a larger fragment of this PSMC1 variant. Then, sufficient 
evidence would have been provided to state that isoform PSMC1-004 is not expressed in cells 
of the human retina. 
Overall, the PSMC1 isoform study confirmed that isoform 001 is expressed in the human 
retina; therefore, enhancing the significance of results of the Y2H screen, where only 
a fragment of PSMC1 isoform 001 was found to interact with TOPORS. 
Furthermore, exclusion of the expression of other known protein-coding variants of PSMC1 in 
the retina would allow for a more unambiguous interpretation of immunohistochemical 
protein localisation results in retinal cryo-sections. Still, it must not be overlooked that other as 
yet unidentified protein-coding variants of PSMC1 could exist in the retinal cell types. 
 
5.3.2 Y2H DIRECT PPI VALIDATION EXPERIMENTS 
As is shown in Figure 5-9, the N-term fragment 
of TOPORS (residues 1-380) comprises the first 
PEST domain of the protein, the RING domain, 
and a ciliary targeting sequence (CTS), conserved 
among primates. The fragment also includes 
serine 98, which is a target for phosphorylation. 
A phosphomimetic mutation of serine 98 to 
asparagine was shown to increase the ubiquitin 
E3 ligase activity of TOPORS, as well as enhanced 
its binding to UbcH5a, an E2 conjugating enzyme 
(Park et al., 2008).   
 
Figure 5-9. Amino-terminus (N) TOPORS bait 
(residues 1-380). 
The orange box indicates a PEST domain; 
maroon narrow oval at Ser 98 denotes a known 
phosphorylation site (P*); dark grey box 
indicates the RING domain (conveys E3 
ubiquitin ligase activity); red narrow box 
represents a ciliary targeting sequence (CTS). 
Figure not to scale. 
The region required for DNA binding by TOPORS is also found within this fragment (Chu et al., 
2001), and it includes two consensus SUMOylation sites (at which, however, SUMO1 
attachment has not been demonstrated for TOPORS, which appears to be a true result (Weger, 
Hammer e Engstler, 2003; Weger, Hammer e Heilbronn, 2005)). No known mutations for 
TOPORS-associated retinal dystrophies are found within this fragment. 
The mid-TOPORS fragment (Figure 5-10; residues 373-781) comprises two PEST domains, 
a ciliary targeting sequence (CTS) conserved among vertebrates, and the SR/RS dipeptide 
region, divided by the NLS and inclusive of the SUMO1 acceptor site at lysine 560 and 
a phosphate acceptor site at serine 718. It also includes motifs required for interaction with 
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SUMO1, as well as residues necessary for SUMOylation of TOPORS at lysine 560. The region 
required for association with the cytoplasmic domain of syndecan 1 (S1CD), as demonstrated 
on murine proteins, is also included within this fragment and comprises a consensus site for 
casein kinase 2 modification (Braun et al., 2012).  
 
Figure 5-10. Mid-TOPORS (M) bait (residues 373-781). 
Orange boxes indicate PEST domains; maroon narrow oval 
at Ser 718 denotes a known phosphorylation sites (P*); red 
narrow box represents a ciliary targeting sequence (CTS); 
dark cross-hatched box represents the arginine- and serine-
rich (SR/RS) domain; a SUMO1 acceptor site at Lys 560, with 
a covalently bound SUMO1 modification (perpendicular 
black box), is indicated within the first SR/RS domain; 
a nuclear localisation signal (NLS) is located approximately 
centrally within the SR/RS domains. The fragment is 
required for E3 SUMO1 ligase activity. Figure not to scale. 
Moreover, this fragment overlaps 
with the TOPORS fragment (residues 
456-882) pulled out in a screen for 
interacting partners of human 
topoisomerase 1 (hTop1) (Haluska et 
al., 1999). A residue mutated in 
adPRD (p.Q402P) (Schob et al., 2009; 
Selmer et al., 2010) is also located 
within this fragment of TOPORS, in 
addition to two other residues found 
mutated in panels of adRP patients. 
The mutations found in these two residues (p.S606R, N755S) have not however been 
sufficiently characterised to ascertain that they are of pathological significance, since no family 
members of the probands were examined, and it has not been  ascertained that  the probands 
do not harbour mutations in other putative RP genes (Schob et al., 2009; Sullivan et al., 2013). 
The C-term TOPORS fragment (Figure 5-11; 
residues 705-1045) includes some of the SR/RS 
dipeptides region, located downstream of 
the NLS, including serine 718, which is also found 
within the mid-TOPORS fragment. 
 Phosphorylation of serine 718 by Plk-1 was 
shown to increase the E3 ubiquitin ligase activity 
of TOPORS, resulting in degradation of p53.  
A similar effect on ubiquitin E3 ligase activity was 
observed in case of serine 98 phosphorylation 
(N-term TOPORS fragment). 
 
Figure 5-11. Carboxy-terminus (N) TOPORS bait 
(residues 705-1045). 
The cross-hatched box represents a fragment 
of the arginine- and serine-rich (SR/RS) domain 
with the maroon narrow oval Ser 718 denoting 
a known phosphorylation site (P*);  the pink 
asterisk represents the mutational hot spot 
region of TOPORS; the blue oval indicates 
the location of a lysine- and histidine-rich 
motif; the orange boxes indicate PEST 
domains. Figure not to scale. 
However, unlike serine 98 phosphorylation, which had no effect on SUMO1 E3 ligase activity of 
TOPORS (Park et al., 2008), phosphorylation of serine 718 decreased it (Yang et al., 2009). This 
C-term fragment also includes the Lys/His motif, associated with speckled nuclear localisation 
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of TOPORS, and overlaps with the region required for minimal interaction of TOPORS with 
UBC9 and Rep proteins of AAV2 (residues 871-917). Two C-terminal PEST domains are also 
found within this fragment. The C-terminal region of TOPORS, required for interaction with 
SUMO1 overlaps with the two PEST domains as well as the Lys/His motif. This C-terminal 
fragment additionally harbours a mutational hotspot, associated with retinitis pigmentosa 
(RP). 
 
5.3.2.1 ITM2B INTERACTIONS 
The interaction between ITM2B and TOPORS fragments was tested using constructs, encoding 
full-length and a soluble portion of ITM2B. Additionally, known disease-causing mutants were 
included in the analysis. As was summarised in Table 5-16, a PPI was observed between full-
length ITM2B and full-length TOPORS as well as its N- and C-term fragments, but not with mid-
TOPORS. Furthermore the interactions between full-length ITM2B and the N- and C-term 
fragments were stronger than with full-length TOPORS, as shown by activation of four reporter 
genes, as opposed to two.  
Before potential reasons for these findings are discussed, it should also be noted that in 
endogenous conditions ITM2B forms homodimers via a cystine, formed from residue 89 of 
each monomer; furthermore, the protein is heavily proteolytically processed (described in 
section 6.2; briefly depicted in Figure 5-12).  
Firstly, ITM2B is cleaved by furin at the C-terminus to generate a mature protein and the CCTP 
fragment (peptide 7). Subsequent processing by ADAM10 results in shedding of the ITM2B 
ectodomain (peptide 6). The N-terminal membrane-bound fragment (NTF; peptide 3), which 
remains, is then cleaved within the membrane domain by SPPL2a/b, yielding a C-terminal 
secreted domain (SCD; peptide 5) and an intracellular domain (ICD; peptide 4). The GAL4 AD, 
to which the expressed ITM2B would be fused, is located at the N-terminus of ITM2B. 
Assuming that proteolytic cleavage of ITM2B in yeast resembles the mammalian processing 
pathway (if ITM2B becomes cleaved at all), it should be expected that the observed PPI 
phenotypes would be due to an interaction between TOPORS (and its fragments) and 
the intracellular domain (ICD; peptide 4) of ITM2B (the intra-cellular fragment remaining after 
the proteolytic action of SPPL2a/b; Figure 5-12).  
This is a necessary assumption as only a non-membrane bound peptide should have been able 
to reach the nucleus and activate the expression of interaction reporter genes in GAL4-based 
Y2H system. The ICD contains (peptide 4) one CTS and a cysteine residue, which was previously 
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shown not to be involved in disulphide bond formation; hence, it should probably be assumed 
that the expressed GAL4 AD-ICD hybrid, which interacted with TOPORS, was a monomer, 
unless it formed a homodimer with involvement of non-covalent bonds. 
 
Figure 5-12. ITM2B protein structure and processing details.  
Numbers at the top of the figure represent amino aci residues. Protein domains in order from 
the amino-terminus (N) to the carboxy-terminus (C) include ciliary-targeting sequences (CTS; aa: 44-46, 
166-168 and 174-176), indicated by red boxes; a transmembrane (TM) domain (aa 52-75); a Bcl 2 
homology 3 (BH3) domain (aa 91-96); a BRICHOS domain (aa 137-231) with an N-glycosylation site at 
Asn 170, denoted by a diamond. ITM2B is subject to proteolytic cleavage by proteases: SPPL2a/b, 
ADAM10, and Furin (cleaves between aa 243 and 244, generating a 23-aa peptide). Asterisks indicate 
mutations identified in ITM2B to date: Retinal mutation (c.782A>C; p.Glu261Ala) in pink; FDD mutation 
(c.786_795dupTTTAATTTGT; p.Ser266Pheext*12) in orange, produces a frameshift generating an 11-
residue longer precursor peptide; FBD mutation (c.799T>A; p.*267Argext*11) in blue at stop codon 
causes a read-through of the 3’UTR and also adds 11 additional residues to precursor.  
Putative and reported ITM2B peptides are numbered 1-10 in the lower part of the figure. The order of 
action of the proteases, determined to date, starts with furin cleavage (yielding peptides 2 and 7), 
followed by ADAM10 (yielding peptides 3 and 6), and subsequently by SPPL2a/b (yielding peptides 4 and 
5). The remaining peptides are hypothetical, and, with the exception of peptide 8 (Fleischer et al., 2002), 
their existence has not been empirically demonstrated. Figure not to scale. 
 
It could be speculated that the strong interaction with N-term TOPORS occurred due to 
involvement of TOPORS in ICD ubiquitination. The strong interaction with C-term TOPORS 
could suggest that in the full-length protein the binding actually occurs within this C-terminal 
region, even if then the N-terminal region mediates ubiquitin attachment to the bound 
substrate. A region within the C-term TOPORS fragment was previously shown to be required 
for the SUMOylation activity of TOPORS, and it was also shown to bind proteins of 
the SUMOylation machinery, so, alternatively, it also could suggest that the ITM2B ICD is 
a target for SUMO1 modification. Although no known SUMO1 consensus site was found within 
its sequence, it cannot be excluded that this protein may harbour a yet unidentified SUMO1 
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site. For instance, TOPORS possess two of the previously-identified SUMO1 sites, but, 
empirically, SUMO1 binding to TOPORS was shown at different fragments of this protein; this 
supports the hypothesis that the opposite may be true for ITM2B. It should also be highlighted 
that a mutational RP hotspot is found within this region. If these mutants are expressed in 
patients, which was hypothesised not to happen (Chakarova et al., 2007), then premature 
truncation of the protein could prevent binding of the interacting partners of TOPORS, 
including the ITM2B fragment: ICD (peptide 4). 
A soluble ITM2B90 fragment (residues 90-266, BH3 domain onwards in Figure 5-12) was also 
tested with TOPORS (and its fragments) for an interaction in yeast. This was considered 
essential since a membrane-bound protein would not be able to trigger an interaction 
phenotype in a GAL4-based Y2H system due to being unable to enter the cell nucleus. Residues 
90-266 of the ITM2B peptide are inclusive of the ITM2B fragment, which was identified as 
an interacting partner of TOPORS in the Y2H screen (Figure 5-1). 
Depending on the extent of proteolytic processing, which occurs before translocation of 
the GAL4 AD-ITM2B90 fusion protein to the yeast cell nucleus, the fragment interacting with 
TOPORS could comprise either full-length of the artificial ITM2B90 protein, or the following 
peptides, as highlighted in Figure 5-12: peptide 8 (comprising: SCD, ectodomain and CTPP), 
peptide 10 (comprising: SCD and ectodomain) and/or peptide 5 (comprising: SCD only). If 
the processing of this artificial ITM2B90 protein resembles that of full-length ITM2B, then it 
should be assumed that it is probably not peptide 8, which interacts with TOPORS, as furin 
cleavage of the CTPP was shown to be required for maturation of ITM2B. Thus, it should 
almost certainly be either peptide 10, or peptide 5 (excluding the amino acids normally found 
upstream of residue 90).  
As in case of the ICD (peptide 4), the strongest interaction for this ITM2B90 species was 
detected with the N- and C-term TOPORS fragments (activation of four reporter genes). 
However, it also robustly associated with full-length and mid-TOPORS (activation of two 
reporter genes). Reasons for association with the N- and C-terminal fragments would be 
the same as those given for the ICD (peptide 4). On the other hand, the interaction with mid-
TOPORS would provide additional evidence that TOPORS participates in its SUMOylation 
(however, no SUMO1 consensus sites have been found within ITM2B90 sequence).  
It should also be noted that ITM2B90 contains two CTS motifs within the BRICHOS domain, 
which forms a major part of the protein’s ectodomain. A potential SUMO1 attachment could 
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be a signal for changing the localisation of the molecule, for example, for either transporting 
this ITM2B fragment to the centrioles, or away from them, depending on environmental 
stimuli. It is also unknown whether glycosylation of this ITM2B fragment at asparagine 170 in 
yeast resembles the modification, known to occur in mammalian cells, which would certainly 
affect the observed interactions. 
The extent of branching of the attached carbohydrate would also influence the size of 
the modified ITM2B fragment, and, consequently, its ability to enter the nucleus. Still, 
the interaction would have been demonstrated in yeast as well as in mammalian cell lines 
(experimental Chapter 6). This suggests that the PPI is either not affected by asparagine 170 
modification; or, if it is, then the yeast glycosylation pattern must have resembled that from 
mammalian cell lines. 
 
5.3.2.1.1 ITM2B MUTANTS 
Experiments with ITM2B mutants showed association between TOPORS (and all its fragments) 
and the retinal (RetMu) and British dementia (FBD) mutants, but not with the Danish dementia 
(FDD) mutant.  
The mechanism underlying this result could be similar to that identified in mouse brain, where 
it was shown that, whereas wild-type ITM2B was expressed as a full-length protein, the Danish 
mutant protein was only detected as small peptides (~4 kDa) (Gibson et al., 2005); 
the researchers concluded this was due to protein degradation by proteolytic processing. If 
similar processing occurs in yeast, and the FDD mutant protein becomes degraded by cellular 
proteases, no blue yeast growth phenotype indicative of an interaction should be observed in 
the Y2H PPI assay. With regard to the retinal and British dementia mutants, the fact that 
an interaction is observed suggests that the proteins are expressed, and processed. As all 
known ITM2B mutations occur near its C-terminus, after expression and processing, 
the fragment(s) ultimately left fused to GAL4 AD should be the same as in case of wild-type 
ITM2B, i.e. the ICD (peptide 4). Nevertheless, the obtained results are not fully supportive of 
such reasoning since, unlike the wild-type ITM2B, the retinal and British dementia mutants 
interacted (to a greater or lesser extent: Table 5-16) with the mid-TOPORS fragment. On 
the other hand, it cannot be excluded that the mutations could affect the expression and 
processing via as yet unknown mechanisms.  
Identification of Interacting Protein Partners of TOPORS in the Retina   ||   Barbara Czub 
PhD Thesis 2015   ||   Verification of Expression and Interactions    - 250 - 
 
5.3.2.2 PTGDS INTERACTIONS 
PTGDS interacted with full-length TOPORS and all its three fragments, as indicated by 
activation of two reporter genes; however, a strong interaction (demonstrated by activation of 
four reporter genes) was observed only with the N-term TOPORS fragment (Table 5-16). CoIP 
experiments showed positive results, confirming PTGDS and TOPORS interaction in 
mammalian cell lines. As was previously mentioned in the case of ITM2B, it is possible that 
TOPORS is also involved in ubiquitination of PTGDS. It should be noted that PTGDS contains 
a signal peptide at its N-terminus. If proteolytic cleavage of this peptide occurs before 
the GAL4 AD-PTGDS fusion protein is transported into the yeast nucleus, then only the signal 
peptide would be interacting with TOPORS and its fragments. It could be that the interaction 
with N-term TOPORS appears stronger due to enhanced requirement for degradation of this 
signal peptide, which has fulfilled its signalling function, and so was removed from the main 
portion of the protein.  
Alternatively, if un-cleaved PTGDS protein enters the nucleus, its interaction with TOPORS 
could suggest a role for PTGDS in modulating the DNA binding of TOPORS, and its regulation of 
RNA polymerase II-transcription, as PTGDS was previously shown to influence gene expression 
of apoptotic factors (Ragolia, Hall e Palaia, 2007). Studies in the COS-7 cell line on 
the association between mouse TOPORS and p53 revealed that the association between over-
expressed mouse TOPORS and p53 stabilises p53 and enhances its transcription factor 
activities on p21(Waf1), MDM2 and Bax promoters, of which Bax is a positive regulator of 
apoptosis. Overall, increased TOPORS levels triggered suppression of cell proliferation, cell 
cycle arrest and induction of apoptosis (Lin et al., 2005). Independent findings showed that 
TOPORS interacts with death effector domain of caspase 8 subunit a (DEDa). This results in 
displacement of p53 from TOPORS, which then becomes available to activate pro-apoptotic 
genes, including caspase 8 (Yao et al., 2007). 
 
5.3.2.3 PSMC1 INTERACTIONS 
PPIs between PSMC1 and TOPORS showed the strongest association with the mid-TOPORS and 
C-term fragments (activation of four reporter genes); however, interactions still occurred with 
the N-term fragment and full length TOPORS (activation of two reporter genes; Table 5-16). 
The more readily occurring interactions with regions of TOPORS, implicated in SUMOylation, 
could suggest that TOPORS acts as a SUMO1 E3 ligase for PSMC1. Such modification by SUMO1 
could modulate the activity of PSMC1 within, or independently from the proteasome, such as 
ATP binding and/or hydrolysis. For example, PSMC1 was shown to act as a key regulator of 
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sperm surface ATP levels, crucial for successful fertilisation (Yi et al., 2009). SUMOylation could 
also determine what other post-translational modifications the protein undergoes, e. g. it can 
serve as a signal for ubiquitin-dependent degradation of SUMO-modified protein (Miteva et 
al., 2010).  
 
5.3.3 CONCLUSIONS 
This chapter provided an overview of expression and interaction control experiments 
performed in order to validate the Y2H screening results. Firstly, it was demonstrated that full-
length protein-coding transcripts, corresponding to human retinal cDNA library clones, 
identified in the screen for interactors of TOPORS, are indeed expressed in the retina at mRNA 
level. 
For ITM2B and PSMC1 the isoforms, pulled out from the Y2H screen, were shown to be 
the only known protein-coding variants of these respective genes to be expressed in 
the retina. However, as was discussed, the existence of alternatively spliced variant 004 could 
not be authoritatively excluded for PSMC1. On the other hand, the study of protein-coding 
PTGDS variants indicated that, in addition to PSMC1-001, at least two other isoforms are 
expressed in cells of the human retina.  
The second section of this chapter described the results of PPI verification by direct interaction 
in yeast. The findings confirmed that TOPORS does indeed interact with full-length PTGDS-001, 
ITM2B-001 and PSMC1-001, to varying extents. Additionally, it was also demonstrated which 
domains of TOPORS protein, potentially associated with which functions, could be involved in 
mediating the observed interactions. 
On the whole, the results described in Chapter 5 demonstrated that exogenously expressed 
human TOPORS and its newly-identified human retinal protein partners interact directly in 
yeast; and their expression in human retina was confirmed at mRNA level. The observed 
outcomes provided a sound basis for further validation and characterisation experiments. 
Chapter 6 provides an overview the studies of protein expression of TOPORS, ITM2B, PTGDS 
and PSMC1 in human cell lines, demonstrated by Western blotting (section 2.5.3). The key 
sections of Chapter 6 also demonstrate that the novel interactors of TOPORS are found in 
protein complexes precipitated from cell lysates using an antibody against TOPORS (section 
2.5.4 Co-immuno-precipitation).  
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6 PROTEIN EXPRESSION AND INTERACTION ANALYSIS IN CELLS  
The experimental chapters so far described the construction and characterisation of 
the human retinal cDNA library in yeast (Chapter 3); two Y2H screening assays for novel 
protein interacting partners of TOPORS (Chapter 4); and verification experiments 
demonstrating retinal mRNA expression of protein-coding isoforms of the identified 
interactors, as well as direct Y2H PPI experiments confirming the newly-identified interactions 
in yeast (Chapter 5). 
The following objectives were to confirm that the novel PPIs also occur in mammalian cells 
between endogenous proteins. Prior to this the protein expression of the new interacting 
partners of TOPORS, namely ITM2B, PTGDS and PSMC1, had to be demonstrated. These 
experiments utilised sodium-dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE; 
section 2.5.2 in Methods and Materials) for protein separation, approximately, by size, and 
then protein transfer and Western blotting (WB; section 2.5.3 in Methods and Materials) for 
proteins of interest (detection using commercially available antibodies; section 2.8 in Methods 
and Materials). Evaluation of the PPIs was achieved by precipitating protein complexes using 
an antibody against TOPORS, separating the mixture by SDS-PAGE, and then Western blotting 
for one of the identified interacting partners (sections 2.5.2. – 2.5.4 in Methods and Materials). 
WB and coIP studies were performed using the HeLa cell line, which is the oldest and most 
frequently used human cell line. It was derived from the cervix tumour tissue in the early 
1950s, and has been dividing autonomously ever since (Rahbari et al., 2009). It should be 
emphasised that the purpose of this chapter was to demonstrate the interaction between 
TOPORS and its novel partners in a mammalian host. As no ideal retinal neuronal cell line 
exists, the HeLa cells were selected for the protein expression and interaction experiments.  
Due to the cancerous nature of HeLa cells, it may appear to be an inappropriate cell type for 
this project. Nonetheless, perhaps counter-intuitively, tumours share many metabolic features 
with the mammalian retina. Most importantly, as was reviewed by Ng et al. (2014), both: 
neoplastic and retinal tissues are very metablically active. In fact, they both rely not only on 
the mitochondrial oxidative phosphorylation for energy generation, but they also perform 
aerobic glycolysis. This process, also known as the Warburg effect, has been additionally 
documented in several types of white blood cells and in embryonic stem cells.  
The photoreceptors are the predominant retinal cell type involved in aerobic glycolysis. 
Interestingly, it was shown in pig, that as much 60 % of photoreceptor glucose metabolism is 
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performed via the glycolytic, rather than oxidative, pathway (Wang, Törnquist e Bill, 1997a; b). 
This is supported by prominent expression of lactate dehydrogenase (LDH) in the mammalian 
retina; this enzyme is typically up-regulated in neoplasms (Saavedra e Anderson, 1983). 
Another feature of energy metabolism shared by HeLa cells and the photoreceptors is 
the presence of active brain-type creatine kinase (CK-B). This enzyme catalyses the re-creation 
of ATP from phospho-creatine (PCr) at sites, where energy is required. In photoreceptors 
the process typically occurs at synaptic terminals where it is needed for glutamate release 
(Zhao et al., 1994; Linton et al., 2010). Furthermore, both: the HeLa cell line and retinal cells 
are enriched in glucose transporters GLUT1 and GLUT3, allowing this sugar to passively and 
continuously enter cells, where it is used for energy generation (Wong-Riley, 2010). 
Biosynthetic requirements are also a characteristic shared by both: cancers and the retina. 
The photoreceptor homeostasis involves daily outer segment phagocytosis by the retinal 
pigment epithelial (RPE) cells, resulting in a continuing necessity for synthesis of rhodopsin and 
other ciliary and outer segment-specific proteins. These biosynthetic demands for renewal of 
photoreceptor outer segments resemble the physiology of cancer cells, which also rely on 
constant protein synthesis for cell growth and migration. 
Hence, due to reasons outlined above, the use of HeLa cells for investigation of protein 
expression and verification of the novel PPIs was not considered disadvantageous.  
These experiments were necessary prior to performing subsequent studies aiming to better 
characterise the proteins’ relationships. Positive co-immuno-precipitation (coIP; section 2.5.4 
in Methods and Materials) results would have demonstrated that, in mammalian cells, TOPORS 
and its interacting partners are indeed found together in a protein complex within the same 
cellular compartment, thus strengthening the outcomes of the Y2H screens. The latter 
demonstrated the occurrence of binary interactions between two exogenously-expressed 
proteins; however, it provided no evidence that those two proteins could actually encounter 
each other in native conditions. Hence, the coIP experiments were fundamental for proceeding 
with further work, such as sub-cellular and tissue localisation studies. 
Section 6.1 provides an overview of TOPORS protein expression, and shows a verification of 
one of its previously published interactions, demonstrated by coIP. Sections 6.2 – 6.4 contain 
evaluations of expression of ITM2B, PTGDS and PSMC1, as well as coIP experiments 
demonstrating interactions between TOPORS and its new partners in native conditions. 
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6.1 TOPORS PROTEIN EXPRESSION ANALYSIS 
TOPORS monoclonal antibody (M α-TOPORS), raised in mouse against residues 98-205 of 
human, GST-tagged TOPORS (Table 2-752-75), was used for Western blot and co-immuno-
precipitation (coIP) studies, as well as in immunofluorescent studies (Chapters 7 and 8). 
Specifically, the immunogen for this antibody includes serine 98, the phosphorylation of which 
is associated with the ubiquitin ligase (but not SUMO1 ligase) activity of TOPORS (Park et al., 
2008); the RING finger domain (residues 103-141), also involved in ubiquitination; and a ciliary 
targeting sequence (CTS; residues 172-174; identification summarised in section 7.5). 
Furthermore, the epitope maps to a fragment shown to be required for DNA-binding (residues 
51-374) in a zinc-dependent manner (Chu et al., 2001). 
An alternative TOPORS polyclonal antibody (Rb α-TOPORS), raised in rabbit against amino acids 
251-377 of human TOPORS, was also evaluated. Just as in case of the mouse antibody, 
the immunogen of this rabbit antibody forms a part of the zinc-dependent DNA-binding 
TOPORS fragment. Otherwise, it is not aligned with any distinct functional domains, except for 
a putative SUMO1 modification site (residues 300-303), ΨKxE, where Ψ is a hydrophobic 
amino acid, and x can represent any amino acid. TOPORS protein structure and domains were 
already discussed in detail in the introduction in section 1.6; an overview is summarised and 
presented in Figure 6-3. 
 
6.1.1 TOPORS WESTERN BLOT EXPERIMENTS 
Western blot (WB) results (Figure 6-1) demonstrated the pattern of TOPORS bands, detected 
by both antibodies, is mostly the same; however, their intensity differs significantly. The three 
most distinct bands, detected using the mouse antibody, migrated at 150 kDa, approximately 
half way between the 100 kDa and 75 kDa markers, and just below the 50 kDa marker band, 
respectively. The Rb α-TOPORS antibody detected the top two of these bands, but the signal 
was considerably weaker. The strongest band observed with the Rb α-TOPORS antibody 
migrated at approximately 75 kDa. The signal for the corresponding Abnova band, using the M 
α-TOPORS antibody was considerably weaker. 
 
Identification of Interacting Protein Partners of TOPORS in the Retina   ||   Barbara Czub 
PhD Thesis 2015   ||   Protein Expression and Interaction Analysis in Cells    - 255 - 
 
 
Figure 6-1. Western blots against TOPORS. 
Input: total endogenous protein extract from non-synchronised 
HeLa cells. Exposure time: 1 minute. 
 
6.1.2 CONTROL COIP EXPERIMENT 
It was previously reported (Chakarova et al., 2011) that γ-tubulin was found in complexes 
immuno-precipitated with TOPORS. This interaction was used as a positive control in 
the subsequent coIP experiments. The observed results demonstrated a weak interaction 
(Figure 6-2), but they were reproduced consistently. All of the coIP assays, including 
the control interaction with γ-tubulin, were performed at least in triplicate, and representative 
images are presented. Reverse coIP experiments were attempted in triplicate for all 
interactions, but they did not yield positive results (data not shown). This may have occurred 
due to the interacting partners of TOPORS being potentially embedded within a protein 
complex, which would prevent antibodies from accessing them, and consequently from 
binding. If TOPORS was located on the outside of a complex of proteins, it could be accessed 
and bound by an antibody raised against it. 
 
 
Figure 6-2. Gamma tubulin is detected in complexes 
precipitated from HeLa cell extract with antibody against 
TOPORS, raised in mouse. 
Input: total cell extract; antibody-negative beads control is 
indicated by a minus (-), whereas complexes, precipitated 
with mouse anti-TOPORS antibody-conjugated beads, are 
indicated with a plus (+). A faint γ tubulin band in the positive 
coIP lane is indicated with an arrow. 
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 This was demonstrated by a Y2H involving murine TOPORS and S1CD, not human (Braun et al., 2012). 
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6.2 ITM2B PROTEIN EXPRESSION ANALYSIS 
Two antibodies against the ITM2B protein were used in this project, both raised in rabbit. 
An antibody against the carboxy-terminal region of ITM2B, specifically amino acids 218-247 of 
the human 266-residue long protein (Abgent # AP13163b: ITM2B C-term), was used in 
the initial stages of cell-based studies. A second antibody, used by Audo et al. (2013), was later 
included in additional analysis (Sigma-Aldrich # HPA029292: ITM2B); this antibody was raised 
against residues 78-224 of the human ITM2B peptide. ITM2B is synthesised as a full-length 
trans-membrane protein, which subsequently undergoes regulated proteolytic cleavage. 
Figure 6-4 delineates the various potential peptides resulting from ITM2B processing, and 
demonstrates that the Sigma-Aldrich antibody is likely to detect two further putative peptides, 
which would not be recognised by the C-term antibody, i.e. NFT (fragment 3) and SCD 
(fragment 5). 
 
6.2.1 ITM2B WESTERN BLOT EXPERIMENTS 
The Western blot analysis of non-synchronised HeLa cell extracts demonstrated ITM2B is 
expressed in mammalian cells (Figures 6-5 and 6-6, where the first figure represents 
endogenous proteins, whereas the latter represents protein extracts from cells transfected 
using N-terminally six-His-tagged ITM2B). 
Specifically, a band migrating at 37 kDa was detected 
by in all blots. A 50 kDa band was detected only by 
the α-ITM2B C-term antibody (Figures 6-5 and 6-6 A). 
A band, migrating just below the 75 kDa marker, was 
detected by the α-ITM2B C-term antibody in 
the endogenous extract (Figure 6-5), and also by 
the α-six-His antibody in the transfected cell extract 
(Figure 6-6 C). Additionally, some bands were 
observed between the 37 kDa and 50 kDa markers 
(Figures 6-6 A and 6-6 C), as well as between 
the 15 kDa and 20 kDa markers (Figure 6-5). 
The ITM2B C-term antibody detects several bands 
(Figure 6-4 and Figure 6-6: A), an observation 
consistent with the known existence of several ITM2B 
peptides due to proteolytic cleavage.  
 
Figure 6-4. Western blot against 
endogenous ITM2B C-term (Ab diluted 
1/250). 
Input: total protein extract from non-
synchronised HeLa cells. Exposure time: 
30 seconds. 
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Figure 6-5. ITM2B Protein Domain Structure. 
Amino acids (aa) residues are indicated above the figure. (a) Ciliary-targeting sequences (CTS; aa: 44-46, 
166-168 and 174-176) are indicated by red boxes. Transmembrane domain (TM: aa 52-75); Bcl 2 
homology 3 (BH3: aa 91-96) domain; BRICHOS domain (aa 137-231) N-glycosylation site at Asn 170, 
denoted by a diamond. ITM2B is subject to proteolytic cleavage by proteases: SPPL2a/b, ADAM10, and 
Furin (cleaves between aa 243 and 244, generating a 23-aa peptide). Asterisks indicate mutations 
identified in ITM2B to date: Retinal mutation (c.782A>C; p.Glu261Ala) in pink; FDD mutation 
(c.786_795dupTTTAATTTGT; p.Ser266Pheext*12) in orange, produces a frameshift generating an 11-
residue longer precursor peptide; FBD mutation (c.799T>A; p.*267Argext*11) in blue at stop codon 
causes a read-through of the 3’UTR and also adds 11 additional residues to precursor. (b) Peptide-
nomenclature: Furin-mediated cleavage results in the release of a 23 aa C-terminal pro-peptide (CTPP); 
a large part of the remaining ectodomain (BRICHOS domain) is shed extracellularly by ADAM10, leaving 
the membrane-bound N-terminal fragment (NTF). The NTF undergoes intramembrane proteolysis by 
SPPL2a or SPPL2b, generating the intracellular domain (ICD) and the secreted C-term domain (SCD). 
Regions (and hence peptides) potentially recognised by antibodies are indicated in blue (residues 78-
224) – Sigma-Aldrich; and green (residues 218-247) – Abgent. (c) Putative and reported peptides are 
numbered 1-10. The order of action of the proteases, determined to date, starts with furin cleavage 
(yielding peptides 2 and 7), followed by ADAM10 (yielding peptides 3 and 6), and subsequently by 
SPPL2a/b (yielding peptides 4 and 5). However, it cannot be excluded that in some circumstances 
the protein may undergo different, not yet known, combinations of proteolytic processing, which could 
generate additional peptide species (8-10) from the ITM2B full-length protein. For instance, 
the initiation methionine of ITM2BS corresponds to residue 57 of the full-length protein, i. e. following 
the known order of proteolysis, it could give rise to peptides 7 and 10, and subsequently to 5 and 6. 
Peptide 9 is not unlikely to exist either, as the pro-apoptotic activities have been observed only with 
ITM2BS, suggesting that it would be processed, or modified differently than full-length ITM2B, for which 
no apoptotic involvement has been shown. Furthermore, protein expression of isoform ITM2B-003 
would yield a peptide comprising only ICD (peptide 4) and CTPP (peptide 7), which would result in one 
more peptide variant (4 + 7); however, the presence of this isoform would not be detected with either 
of the two antibodies used. (d) Nine cysteine (C, Cys) residues found within the ITM2B peptide. Figure 
not to scale. 
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A B C 
 
Figure 6-6. Western blot against over-expressed ITM2B. 
Input: total protein extract from non-synchronised HeLa cells, transfected with six-His-tagged ITM2B. A, 
Detected using α-ITM2B C-term Ab, diluted 1/250 (Abgent); B, detected using α-ITM2B Ab, diluted 
1/250 (Sigma-Aldrich); C, detected using 6His-Ab, diluted 1/250. Exposure time: 3 minutes 30 seconds 
for all three blots. 
 
Additionally, many of the observed bands are larger than the predicted 29 kDa of the full size 
protein, which is consistent with the presence of N-acetyl glucosamine modification at 
asparagine 170 and predicted glycation and phosphorylation sites.  
It was previously reported that the full-length ITM2B protein forms homodimers (Tsachaki et 
al., 2010), therefore, it is also possible that the bands represent dimers (or fragments of 
the dimers), which perhaps had not been completely denatured prior to electrophoresis. 
The band, migrating between the 50 kDa and 75 kDa markers, could potentially correspond to 
ITM2B homodimers, similar to the 66 kDa band, observed by Tsachaki et al. 
The two bands, which were consistently detected by the ITM2B C-term antibody, migrate at 
50 kDa and 37 kDa, respectively. This is consistent with observations by Akiyama et al. (2004) 
who detected bands estimated to migrate at 35 kDa and just above 50 kDa. The observed 
~50 kDa bands could represent either a full-length ITM2B protein or ITM2B without the CTPP 
fragment, with all the potential post-translational modifications. Depending on the exact 
cleavage point of ADAM10, the 35/37 kDa fragment could represent either the ITM2B 
ectodomain, or the membrane-bound N-terminal fragment (NTF).  
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Two smaller bands, migrating between the 20 kDa and 15 kDa size markers (endogenous 
ITM2B: Figure 6-4), were also observed. They could either represent ITM2B degradation 
products, or, for instance, the ITM2B ectodomain without any modifications.  
The Sigma-Aldrich ITM2B antibody appears to detect predominantly what appear to be two 
bands around 37 kDa, with fainter bands also observed migrating at approximately 50- and 75 
kDa (Figure 6-6 B). These fragments could represent either the ITM2B ectodomain or the NTF 
domain, or these two fragments joint together. Alternatively, the largest band could even 
represent non-denaturised dimers of the full-length, or cleaved, ITM2B. These bands, resulting 
from over-expression of ITM2B, tagged with six-histidines (six-His) at the amino terminus, were 
also strong, when detected using an antibody against the six-histidine peptide (Figure 6-6 C). 
This finding would be in support of the 37 kDa band potentially representing the NTF fragment, 
as the six-His tag would be fused to it directly. The anti-six-His antibody also detected a band 
migrating between the 50 kDa and 75 kDa markers, which could represent a fragment of 
ITM2B homodimer, analogous to the 66 kDa band, observed by Tsachaki et al. (2010). A band 
of similar size was also detected by the anti-ITM2B C-term antibody (Figure 6-4) in 
the endogenous extract. 
 
6.2.2 ITM2B IS FOUND IN PROTEIN COMPLEXES WITH TOPORS 
CoIP experiments were conducted using mammalian cells to validate the ITM2B interaction 
identified in the Y2H studies, using HeLa cell extracts (Figure 6-7).  
 
 
Figure 6-7. ITM2B C-term (Abgent) is 
detected in complexes precipitated 
from HeLa cell extracts with antibody 
against TOPORS, raised in mouse. 
Input: total cell extract; antibody-
negative beads control is indicated by 
a minus (-), whereas complexes, 
precipitated with mouse anti-TOPORS 
antibody-conjugated beads, are 
indicated with a plus (+). Two bands 
are detected in the positive coIP lane. 
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Full-length ITM2B and/or ITM2B proteolytic processing products are found in protein 
complexes with TOPORS in endogenous extracts from mammalian cells. Western blotting for 
ITM2B on protein extracts precipitated with TOPORS yielded two bands, one migrating just 
around the 37 kDa marker band, and a larger one migrating approximately half way between 
the 37 kDa and 50 kDa markers. 
The remaining bands detected in the input with the antibody against ITM2B did not appear to 
co-precipitate with TOPORS (Figure 6-7). As already analysed above, the 37 kDa could 
represent the NTF and/or the ectodomain, jointly or separately, depending on post-
translational modifications. The larger band is probably more likely to represent these two 
domains together, or it may represent full length ITM2B with just a few of the potential post-
translational modifications. 
Other bands, which have been detected multiple times, but inconsistently, include two bands 
migrating between the 37 kDa and 50 kDa size markers (overexpressed ITM2B: Figure 6-6 A). 
This double band pattern was shown by Tsachaki et al. (2010) in their results figure , 
demonstrating ITM2B monomers, and both bands were detected here in protein complexes, 
precipitated with an antibody against TOPORS (Figure 6-7). 
They could potentially represent full-length ITM2B (or ITM2B without the CTPP fragment) 
modified by only some of the predicted post-translational modifications. This coIP result 
indicates that in mammalian cells ITM2B is found in endogenous protein complexes with 
TOPORS, and it serves as a validation of the direct PPI between these two proteins, 
demonstrated in the Y2H system. 
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6.3 PTGDS PROTEIN EXPRESSION ANALYSIS 
An antibody raised in rabbit against full-length human PTGDS (sc-30067, Santa Cruz 
Biotechnology, TX, USA) was used in all immuno-based experiments. 
PTGDS is a small, stable molecule, refolding correctly even after heat and/or protease 
treatment. It exists as a monomer, and assumes a β-barrel structure with two overlapping 
hydrophobic pockets: one for hydrophobic ligand binding and another for catalysis of PG D2 
synthesis (ÅKerströM, 2006). PTGDS is known to be glycosylated at three sites, a feature, 
which has probably greatly affected the range of its reported sizes. It is also known to be 
phosphorylated, and four potential sites have been predicted for this modification. No other 
post-translational modifications of this protein have been reported. A summary of PTGDS 
protein domains and modifications is given in Figure 6-8. 
 
6.3.1 PTGDS WESTERN BLOT EXPERIMENTS 
The Western blot analysis of non-synchronised HeLa cell extracts demonstrated PTGDS is 
expressed in mammalian cells (Figure 6-9). Two strong bands immuno-reactive for PTGDS are 
observed: one migrating just above and one just below the 50 kDa marker. The predicted 
calculated weight of PTGDS is 21 kDa; however, according to published reports, the protein 
electrophoretic size range spans from 19 kDa to 29 kDa.  
Nonetheless, it cannot be excluded that the observed antibody binding is non-specific. 
The manufacturer validated the antibody only for immunostaining of cultured cells and tissue 
sections (section 2.8 in Methods and Materials). In those experimental conditions PTGDS 
would have maintained its native bucket-shaped (or barrel-shaped) conformation, which is 
probably of key importance for specificity, as the antibody was raised against a full-length 
protein. As was mentioned in the introduction to section 1.3, PTGDS is a readily refolding 
protein, thus, since the antibody was raised against the full-length PTGDS peptide, it was 
probably in its native conformation.  
Proteins subject to the denaturing SDS-PAGE would undergo electrophoretic separation as 
unfolded peptides. This possible change in tertiary structure of PTGDS could have resulted in 
loss of specificity of the antibody, which was raised against a native bucket-shaped molecule.  
Alternatively (although unlikely), the denaturising conditions of SDS-PAGE might be insufficient 
to trigger (complete) PTGDS unfolding, as this protein is known for structural stability. If PTGDS 
is not fully denatured (unfolded), then it would be travelling through the porous gel as a more 
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bukly structure (rather than a linearised peptide). This would lead to its apparent 
electrophoretic size being significantly larger than expected, as the bulky shape would slow 
down the proteins passage through the porous acrylamide gel. 
 In rat retina the reported size range for PTGDS was 20 kDa – 26 kDa (Beuckmann et al., 1996). 
Some of the lower weight species could potentially be represented by the very faint bands 
observed between approximately 20 kDa and 37 kDa. Otherwise, they could represent one of 
the alternative isoforms (004 or 005), identified in the human retinal cDNA (section 5.1.2). 
 
 
Figure 6-8. PTGDS Protein Domain Structure. 
Amino acids (aa) residues are indicated above and below the figure. (a) Signal peptide (aa 1-22) is 
removed by proteolytic cleavage (indicated with an arrow); PTGDS is modified by glycosylation at three 
sites: Ser 29 is modified by O-linked glycosylation (denoted by a circle), whereas Asn 51 and Asn 78 are 
N-glycosylated (denoted by diamonds); catalytic activity of PTGDS is conferred by Cys 65 (denoted by 
a green oval), whereas Cys 89 and Cys 186 (denoted by red ovals) form a disulphide bridge. Ser106, 
phosphorylated by PKC, is denoted by an asterisk. (b) Apart from the signal peptide (aa 1-22), PTGDS 
structure is rich in β-pleated sheets. Exceptions include four α-helices (indicated by boxes filled with 
undulating lines: aa 36-39; aa 53-60; aa 139-142; aa 174-176) and a proline-including turn (indicated by 
a blue box: aa 110-113); ciliary-targeting sequences (CTS; aa: 30-32 and 69-71) are denoted by red 
boxes. Figure not to scale. 
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In case of the 19 kDa species, isolated from 
cerebrospinal fluid (CSF) (Harrington et al., 1993), 
PTGDS was probably missing its signal peptide (Figure 
6-8), resulting in a size below the expected 21 kDa. 
The largest PTGDS species that the group observed 
was migrating at 24 kDa, as demonstrated by two-
dimensional electrophoresis (2DE), and the protein pI 
ranged from 5.2 to 8.5. The researchers determined 
that the increase in size was due to N-linked 
modifications, involving sialic acid (also known as 
neuraminic acid). The larger (up to 29 kDa) PTGDS 
reactive bands have been reported several times 
independently (Hoffmann et al., 1993; Hoffmann et 
al., 1994; Yamashima et al., 1997; Ragolia et al., 
2003). 
 
Figure 6-9. Western blot against PTGDS 
(Ab diluted 1/500).  
Input: total endogenous protein extract 
from non-synchronised HeLa cells. 
Exposure time: 30 seconds. 
Hoffmann et al. (1993; 1994) detected bands ranging from 21 kDa to 29 kDa in samples of 
human CSF. They determined that the 21 kDa band represents unglycosylated PTGDS, a 24 kDa 
band is equivalent to a monoglycosylated species, whereas the highest band represented 
PTGDS, modified at two, or more, glycosylation sites. The authors referred to these N-
glycosylation sites as asparagine 29 and asparagine 56, as the existence of the cleavable signal 
peptide was not known at the time; these residues actually correspond to asparagine 51 and 
asparagine 78 of PTGDS, respectively (Figure 6-8).  
 
6.3.2 PTGDS IS FOUND IN PROTEIN COMPLEXES WITH TOPORS 
CoIP experiments using HeLa cell extracts confirmed that PTGDS is found in protein complexes 
with TOPORS in endogenous extracts from mammalian cells. 
It should also be emphasised that two bands (rather than one) were consistently observed on 
PTGDS Western blots, one migrating just above the 50 kDa marker, and one just below it. 
However, only the PTGDS band migrating just under the 50 kDa marker was found in 
complexes with TOPORS (Figure 6-10). The slightly smaller size could potentially reflect a lack 
of the signal peptide, or alternatively, a lack of a posttranslational modification(s), or both. This 
coIP result indicates that in mammalian cells PTGDS is found in endogenous protein complexes 
with TOPORS, and it serves as a validation of the direct PPI between these two proteins, 
demonstrated in the Y2H system. 
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Figure 6-10. PTGDS is detected in complexes precipitated from HeLa 
cell extract with antibody against TOPORS, raised in mouse. 
Input: total cell extract; antibody-negative beads control is indicated 
by a minus (-), whereas complexes, precipitated with mouse anti-
TOPORS antibody-conjugated beads, are indicated with a plus (+). 
The band detected in the positive coIP lane is migrating just below 
50 kDa. 
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6.4 PSMC1 PROTEIN EXPRESSION ANALYSIS 
An antibody against the carboxy-terminal residues 295-436 of human PSMC1 (Sigma-Aldrich 
# HPA000872) was used in all immuno-based experiments (Figure 6-11). It should be noted 
that the antibody recognises a region of PSMC1, located close to the sequence, required for 
anchoring PSMC1, together with other ATPases of the regulatory proteasomal hexameric ring, 
onto the core catalytic particle (Figure 6-11). This may pose difficulties in localisation studies, 
as in its native form, this region might be hidden inside the proteasome.  
 
 
Figure 6-11. PSMC1 Protein Domain Structure. 
Amino acids (aa) residues are indicated above and below the figure. Region recognised by the antibody 
(aa: 295-436), is indicated with a light green bar, shown between diagrams (a) and (b). (a) Post-
translational modifications of PSMC1. N-myristoylation at Gly 2 (modification indicated by a lipid 
notation); two phosphorylation sites, denoted by red asterisks, at Ser4 and Tyr 439; ubiquitination at 
Lys 237, which forms a glycyl lysine isopeptide bond with a C-terminal peptide of ubiquitin; N-
acetylation at Lys 258. Functionally indispensable O-linked glycosylation (represented by a floating 
lollipop) has also been reported for PSMC1; however, the site of modification has not yet been 
determined. (b) Functionally-significant sequence motifs. N-myristoylation consensus sequence: 
MGxxx(S/T) (aa: 1-6); NADH-binding motif: xGxGxxGx (aa: 7-14); Arabidopsis thaliana PSMC1 orthologue 
fragment of high functional significance for plant development (aa: 1-13) (Lee, K. H. et al., 2012); ciliary-
targeting motifs (CTS; aa: 52-54 and 238-242); ATP-binding loop: GxxxxGK(T/S) (aa: 226-233); axially-
positioned aromatic loop: (K/M)Y(V/L/I)G (aa: 258-261), coordinated with ATP hydrolysis region: hhhhDE 
(aa: 281-286; h, hydrophobic residue); proteasomal regulatory ATPase-anchoring sequence: hYx 
(aa: 438-440). Figure not to scale; compiled based on findings from human and mouse cell lines, and 
PSMC1 orthologues from S. cerevisiae and A. thaliana. 
 
On the other hand, the plant orthologue of PSMC1 was shown to exist and function 
independently in chromatin regulation (section 4.3.4); hence, its detection should not be 
entirely discounted. In fact, the presence of its NADH-binding activity may signify a role in 
regulation of gene expression in response to redox stress (Fjeld, Birdsong e Goodman, 2003). 
The acetyl at residue 258 may be a regulatory component, which competes with ubiquitin 
and/or ubiquitin-like proteins, for lysine 258 (Caron, Boyault e Khochbin, 2005), and hence 
defines the purpose of the modified PSMC1 peptide. This lysine acetylation could also directly 
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influence the activity of the aromatic loop, which follows directly afterwards, and whose 
function is directly associated with the ATP hydrolysis (site located twenty residues 
downstream). 
These variable activities would require PSMC1 to be differentially, post-translationally 
modified either to mark it for targeting to a specific cellular location, and/or to perform 
a specific function. For instance, a SUMOylation could determine whether PSMC1 should 
be acting as a component of the 26 S proteasome, or whether perhaps it should be mediating 
an independent process. 
 
6.4.1 PSMC1 WESTERN BLOT EXPERIMENTS 
The Western blot analysis of non-synchronised HeLa cell extracts demonstrated that PSMC1 is 
expressed in mammalian cells (Figure 6-13). 
The expected calculated weight of PSMC1 was 48.5 kDa. Western blot analysis demonstrated 
specifically that the band, immuno-reactive for PSMC1, migrated between the 50 kDa and 
75 kDa markers (Figure 6-13), approximately at 55 kDa - 60 kDa. This was observed 
consistently, and a band of similar size was also shown in studies by Zhang et al. (2003). 
 
6.4.2 PSMC1 IS FOUND IN PROTEIN COMPLEXES WITH TOPORS 
CoIP experiments revealed that PSMC1 is found in protein complexes with TOPORS in 
endogenous extracts from mammalian cells. 
The same-sized band, migrating approximately at 55 kDa - 60 kDa, was observed in both 
the total input lane, as well as in the lane loaded with protein extract precipitated with 
an antibody against TOPORS (Figure 6-13). This size shift could signify a covalent modification 
with a monomer or ubiquitin (8.5 kDa), perhaps the modification at lysine 237, which is 
immediately followed by a CTS. 
This coIP result indicates that in mammalian cells PSMC1 is found in endogenous protein 
complexes with TOPORS, and it serves as a validation of the direct PPI between these two 
proteins, demonstrated in the Y2H system. 
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Figure 6-12. Western blot against 
endogenous PSMC1 (Ab diluted 
1/250). 
Input: total protein extract from 
non-synchronised HeLa cells. 
Exposure time: 3 minutes. 
 
 
Figure 6-13. PSMC1 is detected in complexes precipitated from 
HeLa cell extract with antibody against TOPORS. 
Input: total cell extract 
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6.5 DISCUSSION 
The novel interacting partners of TOPORS, namely ITM2B, PTGDS and PSMC1, were shown to 
be expressed in the human cancerous HeLa cell line. This cell line might not at first appear to 
be the right choice for experiments conducted in context of this project due to its cancerous 
nature, as the retina comprises mostly non-dividing neuronal cells.  
Nonetheless, as was explained in the introductory section of Chapter 6, the purpose of 
the experiments described here was predominantly to demonstrate that PPIs between 
TOPORS and its novel interacting partners do indeed occur between endogenous proteins in its 
native conditions in mammalian cells.  
Secondly, analogies between cancer cells and the retina, especially the photoreceptor cells, 
were additionally highlighted in order to demonstrate that HeLa cells are not a bad model for 
these PPI studies. Importantly, both: cancer cells and photoreceptor cells have large energy 
requirements and high biosynthetic rates. Especially, the latter characteristic appears that 
HeLa cells are more suitable model cell line than for instance the hTERT-RPE1 cells, which in its 
native tissue perform predominantly phagocytosis and protein breakdown (rather than 
synthesis). The neuroblastoma SK-N-SH cell line would also have been adequate for 
the purposes of this study, or even better, as it is both: of neuronal origin and it is a cancerous 
cell line. Nonetheless, this cell line was not yet available in the mid-stages of the project when 
the WB and coIP experiments were being performed. 
 
6.5.1 ITM2B PROTEIN EXPRESSION 
Based on molecular mass calculations the predicted mass of the full-length ITM2B protein 
should be approximately 30 kDa; the predictions for the various peptide combinations, 
potentially recognised by the two ITM2B antibodies, are given in Table 6-1, based on published 
data on ITM2B structure and processing.  
It should also be noted that in addition to the N-glycosylation site, which appears to shift 
the electrophoretic mass of ITM2B by approximately 2 kDa, bioinformatics research predicted 
eight glycation (non-enzymatic sugar residue attachment) sites as well as eight 
phosphorylation sites within the ITM2B peptide sequence (Tsachaki et al., 2011). These 
additional post-translational modifications, if empirically confirmed, collectively could explain 
the significantly larger mass shift of approximately 15 kDa – 20 kDa observed for ITM2B (Figure 
6-5). 
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Table 6-1. Expected fragment sizes of ITM2B monomers detected by anti-ITM2B antibodies. 
Fragments are indicated by numbers and/or names, as shown in Figure 6-4. Length is given as number of 
amino acid (aa) residues, and it is predicted for fragments, arising due to ADAM10 processing, as 
the exact cleavage point is not known. The expected size (kDa) was calculated assuming the average 
weight of an amino acid residue as 110 Da. Antibodies expected to detect the specified fragments are 
denoted as α-ITM2B (Sigma-Aldrich) and α-ITM2B C-term (Abgent).  
Fragment 
Predicted 
Length (aa) 
Expected size 
(kDa) 
Ab expected to detect fragment(s) of 
interest 
Full length 
ITM2B/1 
266 29 α-ITM2B and α-ITM2B C-term 
ICD/4 60 7 Neither 
SCD/5 40 4 α-ITM2B 
NTF/3 100 11 α-ITM2B 
Ecto/6 143 16 α-ITM2B and α-ITM2B C-term 
NTF + Ecto/2 243 27 α-ITM2B and α-ITM2B C-term 
CTPP/7 23 3 Neither 
SCD+Ecto+CTPP/8 206 23 α-ITM2B and α-ITM2B C-term 
Ecto+CTPP/9 166 18 α-ITM2B and α-ITM2B C-term 
SCD+Ecto/10 183 20 α-ITM2B and α-ITM2B C-term 
iso-003/ 4+7 160 18 Neither 
 
It should also not be excluded that ITM2B (or one/several of its proteolytic cleavage products) 
is modified by a covalent attachment of ubiquitin, or a ubiquitin-like protein, which would 
result in an apparent size shift of approximately 8 kDa to 10 kDa per single attached molecule. 
Proteolytic processing of ITM2B begins in the cis- to median-Golgi apparatus, where 
the protease furin removes the carboxy-terminal peptide of ITM2B (CTPP), triggering its 
maturation, and subsequent transport in secretory vesicles towards the plasma membrane 
and endosomes (Choi et al., 2004; Matsuda et al., 2011). Furin cleavage occurs between 
residues 243 and 244 (Kim et al., 1999), and the resulting CTPP fragment has a predicted 
weight of only 3 kDa. The glycosylation at asparagine 170 is required for transport of ITM2B to 
the plasma membrane, and for maintaining the protein’s levels there, which suggests that 
ADAM10 does not cleave ITM2B until it reaches the cell membrane. It was demonstrated that 
cleavage of ephrin by ADAM10, a single-pass type I protein, occurs in trans (Janes et al., 2005); 
therefore, it could be speculated that also in case of ITM2B cleavage, ADAM10 may be located 
within the membrane of a neighbouring cell.  
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The precise cleavage site recognized by ADAM10, which in ITM2B mediates shedding of 
the BRICHOS-containing ectodomain, remains to be determined. In Figure 6-4 the ADAM10 
cleavage site is indicated with an arrow between the BH3 (residues 91-96) and BRICHOS 
(residues 137-231) domains; however, it may well be found between the TM (residues 52-74) 
and BH3 domains, or even within the BH3 domain itself. It was shown that residues 46-106 of 
ITM2B were sufficient for intra-membrane interaction with APP in cis (Fotinopoulou et al., 
2005), which could suggests that the cleavage should occur beyond amino acid 106; however, 
the authors did not test smaller constructs, therefore, it cannot be excluded that ADAM10 
cleavage site occurs nearer the TM domain.  
The membrane-bound N-terminal fragment (NTF), which remains after ADAM10 proteolysis, 
contains the TM domain, which has a high α-helical content and four conserved glycine 
residues. NTF is further split into the intracellular domain (ICD) and a soluble C-terminal 
domain (SCD), following intra-membrane proteolytic processing by SPPL2a/b. 
The transmembrane (TM) domain has a high α-helical content, which has an inhibitory effect 
on potential proteolysis. The four conserved glycine residues within the TM domain could 
potentially destabilize the α-helix, and, therefore, enhance proteolysis; however, only glycine 
60 affects the secondary structure of the TM domain, and, thus, its cleavage (Fluhrer et al., 
2012). Martin et al. (2008; 2009) also determined that ten residues of the ICD, adjacent to 
membrane, as well as 23 amino acids from the SCD, were additionally involved in mediating 
the SPPL2b cleavage, which was further enhanced by prior ectodomain shedding by ADAM10. 
The 37 kDa band, consistently observed in non-synchronised HeLa extracts, may represent 
the same peptide fragment, which was detected by Akiyama et al. (2004); the researchers 
generated three different antibodies against ITM2B for the purposes of their study, and all 
three of those detected a band, which migrated approximately at 35 kDa. Based on 
the observation by Tsachaki et al. (2011) that the N-glycosylation at asparagine 170 affects 
the electrophoretic mass of ITM2B by 2 kDa, the 35 kDa fragment observed by Akiyama et al. 
(2004) may represent a non-glycosylated version of the equivalent fragment, observed in this 
study, which could in this case be glycosylated. The Akiyama et al. (2004) publication also 
shows a WB band, which could represent the glycosylated form of the protein; however, in 
opposition of such analysis is the fact that the three antibodies, detecting the 35 kDa band, 
were raised against residues 7-21, 11-26 and 223-243, respectively. This would suggest that 
the observed 35 kDa should represent the NTF domain and the ectodomain joint together (i.e. 
ITM2B without the C-terminal CTPP peptide). This is not consistent with findings from this 
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project, or with outcomes of the Tsachaki et al. (2011) study. However, this could be explained 
by the possibility that ITM2B is subject to different patterns and/or extents of post-
translational modifications, depending on cell or tissue type, in which it is expressed. 
Akiyama et al. (2004) also observed bands migrating at or slightly above 50 kDa, as shown in 
Figure 6-5, or 6-6 A.  
Following ITM2B synthesis, the protein forms homo-dimers with the involvement of an inter-
molecular disulphide bridge between cysteine 89 of each monomer. The full-length ITM2B 
protein additionally comprises a further eight cysteine residues; the total odd number of these 
amino acids (shown in Figure 6-4 D) initially prompted the investigation into dimer formation 
(Tsachaki et al., 2010). The authors tested cysteine 38 despite its location in the cytoplasmic 
region of the protein, a reducing environment, which does not predispose towards disulphide 
bond formation; it was shown not to form an inter-molecular disulphide bond. Cysteine 
residues 54, 56 and 58 were disregarded due to their location within the TM domain, within 
a lipid bilayer, which does not favour disulphide bond formation either. Among the cysteines 
found in the oxidising extracellular environment, cysteine 246 and cysteine 265 form an intra-
molecular disulphide bridge once the CTPP is released; cysteine 164 and cysteine 223 of 
the BRICHOS domain also form an intra-molecular disulphide bond, allowing for formation of 
a functional BRICHOS loop. This only left cysteine 89 available for interaction; two cysteine 89 
residues were shown to form an inter-molecular disulphide linkage between two ITM2B 
monomers (Tsachaki et al., 2010). The researchers showed that the dimer molecules migrated 
at approximately 88 kDa, whereas they assigned the 44 kDa species to monomers. They also 
observed bands migrating at 22 kDa and 66 kDa, which could be fragments of the dimers 
and/or monomers. The dimers are additionally stabilized by non-covalent interactions 
(Tsachaki et al., 2010), and glycosylated at asparagine 170 within the BRICHOS domain 
(Tsachaki et al., 2011) prior to export from the endoplasmic reticulum (ER). As already 
mentioned, the 66 kDa band could correspond to the band observed in this study, migrating 
between the 50 kDa and 75 kDa markers (Figures 6-5 and 6-6 C). 
 
6.5.1.1 ITM2B AND TOPORS CO-IMMUNO-PRECIPITATE FROM CELL LYSATES 
Co-immuno-precipitation experiments on human cell lines showed that two large species of 
ITM2B were consistently found in protein complexes with TOPORS, at 37 kDa and ~42 kDa 
(Figure 6-7). The 37 kDa species could have represented post-translationally-modified NTF 
domain together with, or separately from, the ectodomain. On the other hand, the ~42 kDa 
species could represent both the NTF and ectodomain together, or be indicative of full length 
Identification of Interacting Protein Partners of TOPORS in the Retina   ||   Barbara Czub 
PhD Thesis 2015   ||   Protein Expression and Interaction Analysis in Cells    - 273 - 
 
ITM2B. Both, full-length ITM2B and the NTF, are inclusive of the ICD domain, which is 
hypothetically involved in interactions with TOPORS and its fragments in the Y2H direct PPI 
experiments.  
 
6.5.2 PTGDS PROTEIN EXPRESSION 
Hoffmann et al. (1993; 1994) analysed the nature of the N-linked carbohydrates, and saw no 
qualitative differences in the glycan composition at both sites. They determined that 10 % of 
modifications at both asparagine residues are either bi- or triantennary with lactosamine 
repeats; of these triantennary structures were twice as numerous at asparagine 51 as at 
asparagine 78. Ninety percent of all the N-linked carbohydrates are biantennary with different 
combinations of sialic acid modifications (which were more abundant at asparagine 51), which 
is in agreement with the findings of Harrington et al. (1993). Among them 20 % contain two N-
acetyl neuraminic acid residues, 40 % have one, and the remaining 40 % include no such 
component.  
Sialic acid was previously shown to affect the SDS-PAGE migration of human Chorionic 
Gonadotropin (hCG) (Gam e Latiff, 2005) as well as of esterase’s (Small e Hemingway, 2000); in 
the latter case, a removal of sialic acids caused the proteins to migrate more slowly.   
Overall, the modifications involved a substantial amount of fucosylation, which was 
peripherally located and more abundant at asparagine 78; this is in agreement with the finding 
by Jia et al. (2009) that asparagine 78 of PTGDS is a major fucosylation site. It was 
demonstrated on viral envelope proteins that a modification by fucose can increase 
the apparent protein size even by 10 kDa (Ng, Wood e Arlinghaus, 1982). The researches 
additionally noted that fucosylation is a sugar modification, which occurs in the final stages 
of glycoprotein maturation. This could indicate that perhaps the small PTGDS reactive bands 
(20 kDa – 37 kDa in Figure 6-9) represent PTGDS species, which were extracted before they 
could become mature, and therefore had no fucose modifications. 
N-acetyl glucosamine was most frequently identified as the bisecting component of 
the attached sugar, and it was also more abundant at asparagine 78. N-acetyl glucoseamine 
and galactose were typically found at terminals of the carbohydrate branches (Hoffmann et al., 
1994). Since 90 % of sugar modifications on PTGDS were shown to be biantennary, and N-
acetyl glucosamine, the sugar conveying this property was additionally found terminally, this 
suggests that the N-linked modifications can be rather bulky, and, thus, likely to decrease 
the speed of SDS-PAGE migration of PTGDS, thus increasing the protein’s apparent size. 
Identification of Interacting Protein Partners of TOPORS in the Retina   ||   Barbara Czub 
PhD Thesis 2015   ||   Protein Expression and Interaction Analysis in Cells    - 274 - 
 
In a high-throughput analysis of human urinary glycoproteins Halim et al. (2012) detected 
an N-linked glycosylation at asparagine 78 of PTGDS. They additionally determined that 100 % 
of glycan modifications at this site are of the dHexHex5HexNAc4 type, where ‘d’ stands for 
‘deoxy-’, Hex denotes a hexose, whereas HexNAc is an abbreviation for N-acetyl hexoseamine. 
It is noteworthy that fucose, which was shown to greatly delay the migration of viral envelope 
proteins (Ng, Wood e Arlinghaus, 1982), is an example of a deoxy-hexose sugar. This 
carbohydrate composition approximately corresponds to the exemplary modification, shown 
in Figure 6-10 A; the difference is that Halim et al. identified a deoxy-hexose in place of 
the sialic acid on the diagram. Again, if the carbohydrate is branched, as is depicted on 
the image, and therefore potentially bulky, this would negatively affect the SDS-PAGE 
migration. The HexNAc component in N-linked glycans of the urinary PTGDS typically contains 
glucosamine; the hexose could be, for example, a mannose, a fucose or a galactose. 
a) b) c) 
   
Example of an N-linked 
glycosylation 
 
Key: 
N, asparagine; X, any amino 
acid; S, serine; T, threonine. 
Example of an O-linked 
glycosylation (core 
carbohydrates) 
 
Key: 
S, serine; T, threonine. 
Key: 
Neu5Ac, neuraminic acid   
(sialic acid); Gal, galactose; 
Hex, hexose; Man, mannose; 
GlcNAc, acetyl glucosamine; 
HexNAc, acetyl hexosamine; 
GalNAc, acetyl 
galactoseamine  
Figure 6-14. Visual representation of putative carbohydrate modifications. 
Figure modified from Halim et al. (2013). 
 
Lack of identified sialic acid components within the asparagine 78 glycan, as shown by Halim et 
al., may suggest that this type of modification is specific to PTGDS found in urine samples, as 
Hoffmann et al. found sialic acid at asparagine 78 on PTGDS from CSF. This demonstrates that 
PTGDS is likely to be differentially modified, depending on which cell type it originates from. 
These differences, even if minor, could affect the migration of PTGDS on SDS-PAGE gels. 
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N-linked glycosylation at asparagine 51 was also detected by Chen et al. (2009) in a mass 
spectrometry analysis of glycoproteins from human liver tissue. On the other hand, Liu et 
al. (2005) determined that in human plasma asparagine 78 of PTGDS is modified by 
glycosylation. It was not investigated further, therefore, it not known whether the type of the 
attached glycan corresponds to the one from urine, or perhaps the one from CSF, or whether it 
is unique in composition. 
An additional N-glycosylation modification, containing sialic acid, was also detected at 
asparagine 87 (Rajagopal et al., 2011). However, this modification was identified on a PTGDS, 
originating from CSF of children patients with medulloblastoma, and has never been observed 
on PTGDS originating from healthy CSF; hence, it is not mapped in Figure 6-8. Nonetheless, this 
indicates that additional glycosylation sites could also be present on PTGDS proteins, 
expressed by the HeLa cell line, which is also cancerous nature, similarly to 
the medulloblastoma sample. 
In CSF samples from patients with neurological disorders, the PTGDS bands were migrating 
considerably more slowly between 34 kDa and 64 kDa (2DE) (Harrington et al., 2006). These 
PTGDS bands are closer in size to those observed using HeLa cell extract (Figure 6-9), which 
could again be due to the cancerous disease state of this cell line. The control group in 
the study by Harrington et al. (2006) appeared to contain much lighter PTGDS species in their 
CSF samples, 25 kDa on average (4.5 > pI > 8.0); however, in three controls (out of 21) 
the bands were observed between 28 kDa and 34 kDa, and had a narrower charge range: 5.8 > 
pI > 7.5. Still, these size are considerably smaller than the major bands, observed in Figure 6-9, 
which migrated around the 50 kDa maker. 
Perhaps this significantly increased apparent size of PTGDS in the disease samples was due to 
modification by ubiquitin (a ubiquitin monomer would increase the apparent mass by about 
8 kDa), or another covalently attached small protein, e. g. NEDD8 (Neural precursor cell 
Expressed Developmentally Down-regulated protein 8, a monomer of approximately 9 kDa). 
There is no consensus site for SUMOylation within the PTGDS peptide. It cannot be excluded 
that such a covalent modification by a ubiquitin, or a ubiquitin-like protein, could also have 
occurred in the HeLa protein extract, used in this project. 
Harrington et al. (2006) additionally performed a mass spectrometric analysis to identify 
potential molecules, affecting the size and charge variations of PTGDS, and identified two 
peptides. The first peptide comprised residues 23-38 of PTGDS; therefore, it could have arisen 
Identification of Interacting Protein Partners of TOPORS in the Retina   ||   Barbara Czub 
PhD Thesis 2015   ||   Protein Expression and Interaction Analysis in Cells    - 276 - 
 
due to the O-glycosylation of serine 29 (Figure 6-8). The second peptide (residues 169-185) is 
not known to be post-translationally modified; it was also detected by Hoffmann et al. (1994), 
but it was not glycosylated, and hence excluded from downstream analysis. This second 
peptide is located right upstream of cysteine 186, involved in disulphide bond formation, and 
includes an α-helix region; it could be speculated that another, as yet unknown, modification 
occurs at a residue within this region, whose attachment or removal would influence protein 
folding, and/or disulphide bond formation. This region includes a lysine, which could serve as 
an attachment site for e. g. ubiquitin.  
The O-glycosylation of serine 29 of PTGDS in human CSF was recently determined to be of 
the HexHexNAc type (Halim et al., 2013). It should be noted that this study determined just 
the core of this O-linked glycan, and numerous additional carbohydrates could subsequently 
be attached to it in physiological conditions (Roth, Yehezkel e Khalaila, 2012). Figure 6-14 B 
provides a visual representation of a core structure of an O-linked carbohydrate.  
Among additional modifications, PTGDS was shown to be phosphorylated by protein kinase C 
at serine 106 (Ragolia et al., 2003; Ragolia, Hall e Palaia, 2007). Its phosphorylation by casein 
kinase II was also demonstrated (Angenstein, Buchner e Staak, 1999). However, it is not 
expected that phosphorylation of PTGDS could affect the apparent size of PTGDS to the extent 
observed on SDS-PAGE. A summary of the reported post-translational modifications of PTGDS 
is given in Table 6-2. 
The Western blot experiments consistently resulted in bands significantly higher (~50 kDa) 
than the expected size (21 kDa - 29 kDa) of PTGDS, suggested by literature reports 
(representative result in Figure 6-9). This could have resulted from differential glycosylation, as 
observed in various disease states (Lescuyer et al., 2005; Harrington et al., 2006), which could 
also reflect the cancerous nature of the HeLa cell line, from which the protein complexes were 
extracted. Further support for differential glycosylation comes from Hoffmann et al. (1994) 
who emphasised that the N-glycosylation pattern of proteins expressed in the brain/CNS is 
different than of those in other body parts, and PTGDS found in CSF was modified by 
the ‘brain-type’ N-glycosylation. Hence, the glycosylation pattern of PTGDS in cell lines should 
be expected to differ from that in CSF. 
However, an apparent increase of over 20 kDa is probably too high to be justified by 
differential glycosylation on its own. It is plausible that this increase in size is caused by as yet 
unidentified covalently attached protein modification(s). 
Identification of Interacting Protein Partners of TOPORS in the Retina   ||   Barbara Czub 
PhD Thesis 2015   ||   Protein Expression and Interaction Analysis in Cells    - 277 - 
 
Table 6-2. Summary of reported post-translational modifications of PTGDS. 
Protein was obtained from a healthy source (tissue or body fluid) unless specifically stated otherwise. 
Position Modification PTGDS source  Potential size shift Reference(s) 
Asp 51 N-linked 
carbohydrate; mostly 
biantennary with sialic 
acid components 
Human CSF 
3 kDa - 4 kDa per 
modified residue 
(Harrington et 
al., 1993; 
Hoffmann et 
al., 1993; 
Hoffmann et 
al., 1994) 
Asp  78 
Asp  78 
dHexHex5HexNAc4 
No sialic acid. 
Human urine 
Predicted  
3 kDa - 4 kDa  
or larger
18
 
(Halim et al., 
2012)
19
 
Asp  51 N-linked carbohydrate Human liver 
Predicted  
3 kDa - 4 kDa  
or larger
18
 
(Chen et al., 
2009)
19
 
Asp  78 N-linked carbohydrate Human plasma 
Predicted  
3 kDa - 4 kDa  
or larger
18
 
(Liu et al., 
2005)
19
 
Asp  87 
N-linked 
carbohydrate; with 
sialic acid components 
Human children 
medulloblastoma CSF 
Unknown 
(Rajagopal et 
al., 2011) 
Unknown Unknown 
CSF of human adults 
with neurological 
disorders 
10 kDa – 40 kDa 
(Harrington et 
al., 2006) 
Ser 29 
O-linked carbohydrate 
modification with 
a HexHexNAc core 
Human CSF Unknown 
(Harrington et 
al., 2006; 
Halim et al., 
2013) 
Ser 106 
Phosphorylation by 
PKC 
Rat cultured vascular 
smooth muscle cells  
None or minor 
(Ragolia, Hall 
e Palaia, 
2007) 
Unknown 
Phosphorylation by 
CKII and PKC 
Rat hippocampal slices None or minor 
(Angenstein, 
Buchner e 
Staak, 1999) 
 
Ubiquitination and neddylation are two candidates with the first one supported by the role of 
TOPORS as an E3 Ubiquitin ligase. In the central nervous system, neddylation should not be 
excluded either, especially considering that roles of PTGDS in development have been 
frequently reported, and only a few substrates of NEDD8 modification have been identified to 
                                                          
 
18
 This would depend on fucose content – see main text. 
19
 Chen et al. did not detect a modification at asparagine 78 on PTGDS from human liver cells, whereas 
Liu at al. and Halim et al. did not detect a modification at asparagine 51 on PTGDS from human plasma 
and urine, respectively. 
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date (UniProtKB: Q15843). SUMOylation can probably be excluded as no consensus sites for 
this modification are found within the PTGDS sequence. 
 
6.5.2.1 PTGDS AND TOPORS CO-IMMUNO-PRECIPITATE FROM CELL LYSATES 
It should be highlighted that Western blot analysis of protein complexes from human cell lines 
consistently showed two bands immuno-reactive for PTGDS, one migrating just above, and one 
just below the 50 kDa marker (Figure 6-9), which could correspond to PTGDS with and without 
the signal peptide. The two bands could represent the two largest PTGDS isoforms: 001 
(peptide corresponding to this isoform was identified in the Y2H screen with TOPORS) as the 
lower band, and the larger band of the two observed, could represent PTGDS isoform 201, 
which codes for a peptide about twenty residues longer20. Only the smaller band was found in 
complexes immuno-precipitated with an antibody against TOPORS. This could suggest that 
TOPORS associates with PTGDS following its signal peptide cleavage. Alternatively, the size 
difference between the two PTGDS bands could also indicate a post-translational modification, 
such as a bulky fucose glycosylation (PTGDS glycosylation sites were shown in Figure 6-8).  
The protein, which interacted in the Y2H screen with TOPORS, was encoded by PTGDS isoform 
001. DNA sequence alignment (SeqMan, DNA Star) of the protein-coding isoforms of PTGDS 
demonstrates that the sc-30067 antibody immunogen aligns specifically with isoform 001 
(Appendix 11.10). It also showed partial alignment with isoforms 003, 004 and 005; however, it 
is difficult to predict whether the antibody, raised against full-length isoform 001, would bind 
to them. Unlike for PTGDS 001, no crystal structures of isoforms 003, 004 and 005 are known; 
it is not known whether they fold in similar manner as 001, as well as whether the properties 
of their outward-facing amino acids are similar to those in 001. It is not known whether 
peptides encoded by these additional isoforms also form the characteristic kink, so important 
in PTGDS 001 for formation of the bucket-shaped docking site for PG H2 and retinoids 
(summarised in section 4.3.3.2), and, presumably, also important in recognition by 
the antibody. 
According to the Ensembl records the biochemical properties of peptides encoded by 
the protein-coding PTGDS transcripts are rather diverse. The isoelectric point (pI) and charge of 
                                                          
 
20
 PTGDS isoform 201 was included in the PTGDS gene record, accessible on the Ensembl database until 
July 2014 inclusive, and has been removed since. Snapshots of those past database records are included 
in Appendix 11.7.  
Identification of Interacting Protein Partners of TOPORS in the Retina   ||   Barbara Czub 
PhD Thesis 2015   ||   Protein Expression and Interaction Analysis in Cells    - 279 - 
 
PTGDS 001 are 7.69 and 2.5, respectively. Similar properties are recorded for PTGDS 003 with 
a pI of 7.89 and a charge of 3.0. On the other hand, isoform 004 has a similar pI of 9.77; 
however, its charge is much higher, i.e. 7.0. Moreover, these numbers are even higher for 
PTGDS 005 (pI: 10.36; charge: 12.5). On the contrary, isoform 008 (which, however, shows 
almost no sequence alignment with the antibody immunogen, as shown in Appendix 11.10) 
has a pI as low as 5.69, and carries a slightly negative charge of -0.5. The great diversity of 
these biochemical properties prompts a speculation that the antibody is probably specific for 
detection of PTGDS 001 (at least for immuno-staining of tissue sections and cultured cells, as it 
is not certain that it would detect a denatured protein on a WB membrane). It could also 
potentially detect isoform 003, however, the sequence dissimilarities between the C-terminal 
half of this isoform and the immunogen provide evidence against this. 
 
6.5.3 PSMC1 PROTEIN EXPRESSION 
The polyclonal antibody against PSMC1 consistently detected only one band, without 
background, migrating approximately 5 kDa - 10 kDa above its predicted size. The protein is 
known to form a glycyl lysine isopeptide link with ubiquitin. A single molecule of the latter 
could increase the apparent PSMC1 by 8.5 kDa. Alternatively, such an increase in size could 
indicate a covalent attachment of another ubiquitin-like protein, for instance SUMO1, as was 
suggested in Chapter 5. Other known modifications of PSMC1 include lipidation by N-linked 
myristoyl on glycine 2, two phosphorylation modifications at serine 4 and 439 and acetylation 
at lysine 258. It is not expected that these modifications, if present, would have a pronounced 
effect on the apparent electrophoretic size of PSMC1. This protein is also modified by an O-
linked carbohydrate; however, the attachment site for this modification has not been 
identified yet. Depending on the extent of carbohydrate branching, a glycolysation could have 
an effect on the apparent protein size. 
 
6.5.3.1 PSMC1 AND TOPORS CO-IMMUNO-PRECIPITATE FROM CELL LYSATES 
The hypothesis that PSMC1 is probably SUMOylated by TOPORS, as it was shown to interact 
most strongly with TOPORS regions, associated with SUMOylation activity, could explain 
the results of Western blot and coIP experiments on protein extracts from human cell lysates, 
which consistently showed one band immuno-reactive for PSMC1 (Figure 6-13), migrating 
approximately 10 kDa above its calculated/predicted size. This observation could be indicative 
of modification by mono-ubiquitin, or another ubiquitin-like molecule, such as SUMO1, as 
suggested in yeast by the strong direct PPI with mid-TOPORS and C-term TOPORS fragments.  
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6.5.4 CONCLUSIONS 
The findings described in Chapter 6 demonstrated that TOPORS, ITM2B, PTGDS and PSMC1 are 
endogenously expressed in human cells, specifically the HeLa cell line. Furthermore, it was 
shown that these novel interacting partners of TOPORS, identified via the Y2H screen, are 
found in protein complexes immuno-precipitated from cell lysates using the mouse 
monoclonal antibody against human TOPORS protein (Abnova; Table 2-75 in Methods and 
Materials).  
The evidence for interactions in stronger for ITM2B and PSMC1 than for PTGDS in view of 
the uncertainty regarding the specificity of the anti-PTGDS antibody (SCB; Table 2-75) for 
the denatured protein, which would be expected on a Western blot. In the future alternative 
antibodies against PTGDS should be tested for WB and coIP experiments. Using exogenously 
expressed tagged proteins could also help identify the reason for the observed size.  
Results of coIP experiments with TOPORS and PSMC1 appear to be the most reliable in view of 
the unquestionable antibody specificity (Sigma-Aldrich;  Table 2-75), generating a clean band, 
within up to 10 kDa of the expected size, and with no background, even when blotted for on 
total cell lysate.  
The interpretation of the coIP results between TOPORS and ITM2B is more ambiguous due to 
the widespread proteolytic cleavage of the protein. The experiments demonstrated that two 
bands, corresponding to two of the ITM2B bands observed on the WB for total cell lysates, 
were also observed within the protein complexes precipitated using the TOPORS antibody 
raised in mouse. The Abgent ITM2B C-term antibody (Table 2-75) was used to blot for ITM2B, 
which could be pulling out putative peptides 6, 8, or 9, or perhaps even a full-length protein. 
Studies on tagged constructs of individual ITM2B fragments would help explain the observed 
findings and verify the ITM2B peptide identity of the observed bands. 
Overall, the results, depicted in Chapter 6, demonstrated that TOPORS and its novel Y2H 
interacting protein partners: ITM2B (or its fragments) and PSMC1 do interact in human cells as 
endogenously expressed proteins. The evidence also suggest that an interaction between 
TOPORS and PTGDS probably occurs as well; however, this requires further verifications, as 
was specified above. 
The subsequent Chapter 7 contains a collection of cellular localisation studies on TOPORS and 
its interactors from the Y2H system: ITM2B, PTGDS and PSMC1. The goal of Chapter 7 was to 
identify the cellular compartments and/or organelles that the Y2H-identified interactors 
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localise to in human cells. The focus of the sub-cellular localisation work was on 
the centrosome both: in dividing and ciliated cells. This non-membranous organelle was 
prioritised due to TOPORS’ association with it throughout the cell cycle in cultured cells and, at 
the ciliary basal body in photoreceptor cells (section 1.5).  
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7 CELLULAR LOCALISATION STUDIES 
The previous experimental Chapters 3, 4 and 5 described construction of the human retinal 
cDNA library, the Y2H screen for interacting protein partners of TOPORS, and validation 
experiments demonstrating the relevant direct interactions in yeast, as well as confirming 
the retinal mRNA expression of full-length clones of the Y2H interactors of TOPORS, 
respectively. This work lead to identification of ITM2B, PTGDS and PSMC1 as new protein 
partners of TOPORS, as demonstrated by the Y2H assay. 
The purpose of Chapter 6 was to determine the endogenous expression of the novel 
interactors in human cells and to demonstrate their interaction with TOPORS in these cells. 
This was successfully completed for PSMC1 and ITM2B. The outcomes of WB and coIP studies 
with PTGDS were also positive, however, future experiments should aim to validate the results, 
as antibody specificity for denatured PTGDS could not be ascertained. 
The current chapter aimed to evaluate the sub-cellular localisation of the three newly-
identified proteins. Specifically, in view of TOPORS’ association with the centrosome and 
the ciliary basal body (section 1.5), the primary objective of the localisation studies was to 
show whether the novel interacting partners co-localise with TOPORS at these centriole-based 
organelles. 
As was described in section 1.8, in dividing cells the centrosome forms the microtubule-
organising centre (MTOC). It closely associated with the nucleus as well as with the Golgi 
apparatus. In the former case it is a key component of the mitotic spindle during nuclear 
division. During interphase, the microtubules organised by the centrosome serve to preserve 
the ordered structure of the Golgi apparatus (it becomes dissociated into irregular membrane-
enclosed compartments during mitosis and cytokinesis). The microtubules also aid in vesicular 
trafficking, important here in context of primary cilia formation and function. The centrosome 
is also closely associated with the 26 S proteasome (section 1.7.1.1), at least in ciliated cells 
(Gerdes et al., 2007; Liu et al., 2014). 
Hence, the goal of this chapter was to determine whether ITM2B, PTGDS and PSMC1 co-
localise with TOPORS at the MTOC, either in dividing, or in ciliated cells. 
For the purposes of experiments described in this chapter cells were maintained either as 
mitotic culture, or they were stimulated to exit the cell cycle and become ciliated. The dividing 
cells were grown either as a non-synchronised culture, approximately 60 % confluent. In order 
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to produce primary cilia, a culture of dividing cells was subject to serum starvation (0.25 % FCS) 
for 48 hours. 
Several cell lines were used for the optimisation experiments, namely HEK293, hTERT-RPE1 
and SK-N-SH cells (Table 2-56 in Methods and Materials).  
Prior to immunofluorescent (IF) labelling of TOPORS and its interacting partners the cells were 
fixed to preserve the proteins of interest. 
Preservation of proteins within cells (as well as tissues) is most frequently performed using 
a solution of 4 % paraformaldehyde (PFA) in PBS, followed by permeabilisation with 
a detergent, such as Tx100, which removes lipids from membranes.  PFA forms methylene (-
CH2-) cross-links between proteins, thus it is usually the fixative of choice for preserving 
cellular structures. 
However, the cross-linking may prevent access to some antigens; therefore, an alternative 
fixation method, using ice-cold methanol, was also tested during optimisation procedures. 
Methanol competes with water for protein hydrogen bonds, and dehydration subsequently 
triggers protein precipitation on cellular structures. Consequently, cellular localisation of an 
antigen is less well preserved than in PFA fixation; changes in protein conformation may also 
affect binding of antibodies to their targets. However, this fixation method could be suitable 
for detecting cell surface proteins (such as ITM2B) as well as antigens associated with 
the cytoskeleton, such as actin and tubulin filaments.  
Ultimately, the co-localisation studies with TOPORS were performed in the hTERT-RPE1 cells 
due to their documented readiness to develop primary cilia (Pitaval et al., 2010; Spalluto, 
Wilson e Hearn, 2013). The 4 % PFA fixation, followed by permeabilisation with 0.3 % Triton X-
100, was chosen as the fixation method for the co-localisation studies. Firstly, it is more likely 
to preserve the proteins’ locations at their native sub-cellular structures; secondly, as is shown 
in the subsequent sections, no major differences were demonstrated in localisation of 
the tested proteins in the hTERT-RPE1 cells, irrespective of fixation method. 
 
7.1 CELLULAR LOCALISATION OF TOPORS 
The TOPORS monoclonal antibody (M01, clone 5G11; Abnova, Taiwan; M α-TOPORS; section 
2.8 in Methods and Materials), raised in mouse was used for immunofluorescence 
experiments. The antibody was used in previously published studies (Chakarova et al., 2011), 
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where the centriolar localisation of TOPORS was demonstrated in addition to the previously 
known nuclear localisation. 
TOPORS signal was observed throughout the cytoplasm and in the nucleus in 4 % PFA-fixed 
hTERT-RPE1 and SK-N-SH cells, permeabilised with 0.3 % Tx100. It is noteworthy that in 
the hTERT-RPE1 cells, the cytoplasmic staining was almost filamentous, to some extent actin-
like (Figure 7-1), which may indicate that a close association exists between TOPORS and 
the actin cytoskeleton. No distinct staining was observed along the edges of the hTERT-RPE1 
cells, unlike what was demonstrated for the mouse Topors protein (Braun et al., 2012); and 
TOPORS displayed its characteristic punctate pattern of localisation in the nucleus, which is in 
agreement with its previously demonstrated localisation at the PML bodies (Rasheed et al., 
2002). 
 
 
Figure 7-1. Cytoplasmic TOPORS signal appears partly filamentous and partly granular in both retinal 
epithelial and neuroblastoma cell types. 
Dispersed TOPORS signal, partly filamentous-like, is observed in the cytoplasm of the hTERT-RPE1 (RPE1) 
cells; speckled nuclear localisation is observed simultaneously in addition to sporadic granular signal, 
which could be indicative of centrioles. The nuclear TOPORS staining in the SK-N-SH cells appears more 
uniform; the net-like appearance of the cytoplasmic staining, apparent in the magnified image, could be 
indicative of the endoplasmic reticulum; one cell also appears to be strongly stained on the edges, which 
could represent an association with the cell membrane as was previously shown in mice (Braun et al., 
2012).  TOPORS signal (Ab diluted 1/100) observed in non-synchronised dividing cells, grown in compete 
media, fixed with 4 % PFA and permeabilised with 0.3 % Tx100. Scale bar: 20 µm. Fluorescent 
microscope images. 
 
In the SK-N-SH cells the staining looked less filamentous inside the cells; however, in some cells 
it was more apparent along their edges. The signal, throughout the cell, appeared more as 
discreet small points joint by thin threads; this net-like appearance strongly resembled 
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endoplamic reticulum (ER) staining. The nuclear speckled localisation was not observed in 
these cells. 
Immunofluorescence (IF) staining of ice cold methanol-fixed cells demonstrated nuclear signal 
in HEK293 cells, mostly cytoplasmic expression in SK-N-SH cells, and both nuclear and 
cytoplasmic staining in hTERT-RPE1 (RPE-1) cells (Figure 7-2). Hence, for the latter two cell 
types, the staining pattern looked very similar here to that in PFA/TritoxX100-fixed cells. 
The only exception was the appearance of peri-nuclear centriole-like signal in the SK-N-SH 
cells. 
The localisation differences were probably affected by the specific nature of the studied cells 
and possibly stages of the cell cycle, at which the observed cells were fixed.  
HEK293 is an embryonic cell line; hence, it would be constantly dividing until it reaches a signal 
to specialise, resulting in TOPORS signal being observed mostly in the nucleus. Nonetheless, in 
the HEK293 cells the nuclear TOPORS signal appeared more diffuse, or less PML-like. 
The cytoplasmic staining appeared scarce probably due to two major reasons. As was 
mentioned above, the methanol-fixation method causes soluble proteins to precipitate onto 
sub-cellular structures. Since the HEK293 cells are dividing rapidly, their organelle contents 
would be minimal, and the nucleus would be taking up most of the intracellular space. These 
two aspects may help explain why the cytoplasmic TOPORS staining appeared most intense 
around the nuclei. Nonetheless, the protein was additionally observed at protrusions, which 
neighbouring cells extended to each other. 
TOPORS signal at cell extensions and at cell edges was also seen in the methanol-fixed hTERT-
RPE1 cells, in addition to diffuse cytoplasmic staining, which, however, appeared more 
punctate throughout the cytoplasm than in the PFA-fixed cells. This could possibly reflect 
the precipitation of TOPORS protein onto cytoskeletal structures, or membranes of the ER. 
The nuclear staining in this cell type appeared speckled as was expected.  
In ice-cold methanol-fixed samples of SK-N-SH cells some TOPORS signal was observed in cell 
nuclei; however, it was most intense in the cytoplasm. Distinct peri-nuclear puncta were visible 
in several cells; these could perhaps represent centrioles. 
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Figure 7-2. TOPORS signal in both retinal epithelial and neuroblastoma cell types appears mostly 
cytoplasmic: partly filamentous and partly granular; whereas the localisation is mostly nuclear in 
embryonic cells. 
HEK293 cells display mostly nuclear and peri-nuclear staining as opposed to the hTERT-RPE1 (RPE1) cells, 
in which it is cytoplasmic. Strong diffuse cytoplasmic staining is also observed in the SK-N-SH cells, in 
addition to sporadic dot-like staining, which could correspond to centrioles. TOPORS signal (Abnova Ab 
diluted 1/100) observed in non-synchronised dividing cells, grown in compete media, fixed with ice-cold 
methanol. Scale bar: 20 µm. Fluorescent microscope images.  
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7.2 CELLULAR LOCALISATION OF ITM2B 
Previous studies in PFA/Tx100-fixed HEK293 cells demonstrated that over-expressed ITM2B 
localised at the Golgi body together with the SPPL2b protease, which cleaves it at 
the transmembrane domain (Martin et al., 2008). 
Another study showed the protein was found at the ER and plasma membrane (Matsuda et al., 
2011). Fluhrer et al. (2012) and Audo et al. (2013) also independently observed ITM2B at 
the cell membrane as well as inside the cytoplasm in HEK293 and HeLa cells as well as COS-7 
cells, respectively. The overall diffuse cytoplasmic staining, documented by Fluhrer et al. also 
included a peri-nuclear signal of higher intensity.  
In mouse T cell line TS1αβ, fixed with PFA/Tx100, a shorter ITM2B isoform was observed co-
localising with mitochondrial markers (Fleischer, Ayllon e Rebollo, 2002).  
Secretion of ITM2B peptides has also been demonstrated (Kim et al., 1999), in addition to 
localisation in neuronal processes (Akiyama et al., 2004), pre-synaptic terminals (Saul et al., 
2013) and synaptic membranes (Matsuda, Tamayev e D'adamio, 2011; Tamayev et al., 2011). 
Two antibodies against ITM2B were used throughout the project. An antibody against 
the carboxy-terminal region of ITM2B (Abgent # AP13163b: ITM2B C-term) was used 
throughout the cell-based studies. A second additional antibody, used by Audo et al. (2013), 
was used sporadically for additional analysis (Sigma-Aldrich # HPA029292: ITM2B).  
Nonetheless, the Abgent # AP13163b: ITM2B C-term antibody was used in most experiments 
due to its inability to bind the membrane-bound NTF fragment. Since in the Y2H assay TOPORS 
would have been able to interact only with soluble proteins, here the focus remained on non-
membrane-bound ITM2B fragments. 
In the hTERT-RPE1 cells the ITM2B C-term antibody generated a cytoplasmic diffuse signal with 
some punctate regions on higher intensity. This was observed irrespectively of which fixation 
method was used (top panels in Figures 7-3 and 7-4), and suggests that ITM2B is present 
within intracellular membranous organelles, such as the ER or Golgi, as well as vesicles. This 
would be in agreement with previously published findings on ITM2B sub-cellular localisation. 
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Table 7-1. Comparison of ITM2B antibodies. 
ITM2B Fragment Antibody which probably detects it 
Full-length ITM2B AP13163b (C-term) & HPA029292 
NTF + ECTODOMAIN AP13163b (C-term)  & HPA029292 
SCD + ECTODOMAIN AP13163b (C-term)  & HPA029292 
ECTODOMAIN AP13163b (C-term)  & HPA029292 
NTF HPA029292 
SCD HPA029292 
Key:
 
ITM2B protein diagram, highlighting known proteolytic cleavage points (top panel), and 
the resulting ITM2B peptide fragments (lower panel). The epitope against which the AP13163b 
antibody was raised is denoted by the green bar; the HPA029292 epitope is denoted by 
the blue bar. Diagram not to scale. 
 
On the other hand, the SK-N-SH cells did not display such a prominent cytoplasmic localisation. 
In fact the signal was mostly just peri-nuclear, either dotted, as would be expected for 
centrioles, or sac-like, which could have represented the Golgi apparatus (lower panels in 
Figures 7-3 and 7-4). It is not immediately obvious what could be the reasons for the observed 
dissimilarities. Perhaps they do not reflect differences in the actual localisation, but only 
appear to convey such a message due to their much smaller size, and putatively more compact 
morphology. 
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Figure 7-3. ITM2B C-term localises throughout the cytoplasm in retinal epithelial and neuroblastoma cell 
types. 
Dispersed granular cytoplasmic staining is observed in the hTERT-RPE1 (RPE1) and some is also visible in 
the SK-N-SH cells. Signal in the SK-N-SH cells appears more polarised and resembles the Golgi 
membranes. Centriole-like dotted regions of higher intensity are observed in the RPE1 cells (magnified 
in ‘zoom’). ITM2B C-term signal (Ab diluted 1/50) observed in non-synchronised dividing cells, grown in 
compete media, fixed with 4 % PFA and permeabilised with 0.3 % Tx100. Scale bar: 20 µm. Fluorescent 
microscope images. 
 
 
Figure 7-4. ITM2B C-term localises throughout the cytoplasm in retinal epithelial and neuroblastoma cell 
types; however, the signal appears more polarised in the latter. 
Dispersed granular cytoplasmic staining is observed in the hTERT-RPE1 (RPE1) cells. Signal in the SK-N-SH 
cells appears more polarised and strongly resembles the Golgi apparatus. Centriole-like dotted regions 
of higher intensity are observed in both cell lines (examples magnified in ‘zoom’). ITM2B C-term (Ab 
diluted 1/100) observed in non-synchronised dividing cells, grown in complete media, fixed with ice-cold 
methanol.  Scale bar: 20 µm. Fluorescent microscope images. 
 
Identification of Interacting Protein Partners of TOPORS in the Retina   ||   Barbara Czub 
PhD Thesis 2015   ||   Cellular Localisation Studies    - 290 - 
 
Alternatively, if the observed staining really does indicate the highest cellular concentration of 
ITM2B in the Golgi apparatus, this could reflect potential differential modifications (section 
6.2), and hence roles of ITM2B in neuronal versus other cell types. The very polarised 
localisation could reflect the direction of ITM2B transfer towards a potential synaptic terminal, 
a localisation demonstrated for this protein previously. 
IF staining of PFA-fixed hTERT-RPE1 cells, permeabilised with Tx100, showed that the Sigma-
Aldrich ITM2B antibody also detects punctate signal in the cells (Figure 7-5), distributed 
throughout the cytoplasm with some regions stained more intensely than others. As was 
shown in Figure 6-5, the Sigma-Aldrich ITM2B antibody can additionally detect the NTF and 
SCD fragments, which would not be stained for by the Abgent ITM2B C-term antibody, which 
could explain the more diversified staining pattern in Figure 7-5. Possibly, these are 
the fragment(s) that remain bound within membranes of transport vesicles, spreading towards 
more distant sub-cellular localisations. 
 
 
Figure 7-5. ITM2B localises throughout the cytoplasm in a granular pattern in retinal epithelial cells. 
Dispersed granular cytoplasmic staining is observed. Regions of higher intensity are apparent; some of 
them might be centrioles; other could represent small transport vesicles. ITM2B (Sigma-Aldrich; Ab 
diluted 1/200) observed in non-synchronised dividing hTERT-RPE1 (RPE1) cells, grown in compete 
media, fixed with 4 % PFA and permeabilised with 0.3 % Tx100. Scale bar: 20 µm. Fluorescent 
microscope images. 
 
In cellular co-localisation studies, endogenous ITM2B was observed together with endogenous 
TOPORS at infrequent punctate locations in hTERT-RPE1 cells (Figure 7-6), with an additional 
background diffuse cytoplasmic staining, as previously observed. This was demonstrated using 
the ITM2B C-term antibody (Abgent), and the TOPORS antibody, raised in mouse (Abnova). 
The punctate signal looks very much centriole-like. 
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Figure 7-6. ITM2B C-term and TOPORS co-localise in retinal epithelial cells in a centriole-like pattern. 
Punctate co-localisation of TOPORS and ITM2B C-term is observed at both puncta, presumed to be 
centrioles. Insets show a magnification of signals enclosed in the dashed squares. Backround staining is 
apparent for both proteins. Unsynchronised  dividing hTERT-RPE1 cells, cultured in complete media, 
fixed with 4 % PFA and permeabilised with 0.3 % Tx100.Scale bar: 10 µm. Fluorescent microscope 
images. 
 
Further imaging showed another distinct localisation: in some cells ITM2B was observed not 
just co-localising with TOPORS, but also found to form a cloud-like structure around 
the TOPORS signal (Figure 7-7), in addition to the cytoplasmic staining, surrounding 
the nucleus. It is known that centrosomes are often found in close proximity to the Golgi 
apparatus, as the microtubules play a key role in maintaining the stacked structure of this 
organelle, as well as they are involved in transport of vesicles between the individual Golgi 
compartments and other membranous organelles.  
 
Figure 7-7. ITM2B C-term co-localises with TOPORS and forms an additional cloud-like signal around 
the region of co-localisation. 
ITM2B C-term signal co-localises with as well as surrounds the TOPORS signal in hTERT-RPE1 cells. 
The observed TOPORS localisation is reminescent of centrioles. The strongest ITM2B C-term signal is co-
localising with TOPORS, but the proximal signal is also substantial. Given that TOPORS marks centrioles 
in this image, the ‘cloud’ of ITM2B signal could potentially represent the Golgi apparatus, which is 
closely associated with the MTOC in most cell types, and which relies on microtubules entirely for 
preserving its structure. ITM2B is synthesised as a membrane-bound glycoprotein, therefore, its 
presence in the Golgi complex should be expected. Insets show a magnification of signals enclosed in 
the dashed squares. Unsynchronised dividing hTERT-RPE1 cells, cultured in complete media, fixed with 
4 % PFA and permeabilised with 0.3 % Tx100. Scale bar: 10 µm. Fluorescent microscope images. 
  
Identification of Interacting Protein Partners of TOPORS in the Retina   ||   Barbara Czub 
PhD Thesis 2015   ||   Cellular Localisation Studies    - 292 - 
 
Furthermore, centrosomes are dynamic structures, constantly dividing throughout the cell 
cycle (section 1.8). This process requires that an active shuttle of relevant proteins towards 
and away from the MTOC must be maintained. Figure 7-7 seems to depict a situation in which 
ITM2B is being transported either towards or away from the centrosome. 
The co-localisation of ITM2B with TOPORS in distinct punctate locations was considered 
strongly reminiscent of centriolar staining. TOPORS itself has been shown to localise to the 
both centrioles of the centrosome in dividing cells, and at the base of the cilium (the basal 
body of ciliated cells) (Chakarova et al., 2011), hence centriolar markers were used to better 
define the observed localisation for ITM2B.  
Peri-centriolar material 1 (PCM1) protein, which is a component of centriolar satellites, i.e. 
electron dense granules scattered around centrosomes (Kubo et al., 1999), was observed co-
localising with ITM2B (Figure 7-8).  
 
 
Figure 7-8. ITM2B C-term co-localises with the peri-centriolar marker: PCM1. 
Both panels show ITM2B C-term co-localising with PCM1 at the centrosome and individual centrioles. 
Insets show a magnification of signals enclosed in the dashed squares; three dots are observed 
suggesting that the centrosome was dividing when the cell was fixed, and it was probably in its S phase. 
Unsynchronised dividing hTERT-RPE1 cells, cultured in complete media, fixed with 4 % PFA and 
permeabilised with 0.3 % Tx100. Scale bar: 10 µm. Fluorescent microscope images. 
 
At times, the co-localisation signal was observed in a 3-4 dotted cluster (insets in lower panel 
of the figure), but consistently showed localisation to both centrioles. Co-localisation was 
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additionally observed with a centriolar kinase, PLK4 (Habedanck et al., 2005), and centrin-2 
(Salisbury et al., 2002) (Figure 7-9 and Figure 7-10). 
Images presented in the lower panel in Figure 7-8 suggest that ITM2B is associated with 
the centrosome, during its duplication. Specifically, the three PCM1 dots depicted on 
the micrograph indicate that the cell is probably in its S phase at the time of imaging. ITM2B is 
co-localising with at least two of the three PCM1 dots. The number of stained puncta is more 
difficult to delineate in the upper panel; nonetheless, the ITM2B signal is certainly co-localising 
with the PCM1 signal at one of the dots. 
The co-staining with PLK4 generally resulted in the expected centriolar staining with some 
cytoplasmic background (Figure 7-9). However, there is also a signal, proximal, or overlapping, 
with the nuclear signal, which potentially suggests the presence of a deuterosome. 
  
 
Figure 7-9. ITM2B C-term co-localises with the centriolar and deuterosomal marker: PLK4. 
ITM2B C-term co-localised with PLK4. Insets show a magnification of signals enclosed in the dashed 
squares. Most of the signal appears to be centriolar; however, the magnified peri-nuclear structure 
could potentially be a deuterosome, with which PLK4 is known to associate. Unsynchronised dividing 
hTERT-RPE1 cells, cultured in complete media, fixed with 4 % PFA and permeabilised with 0.3 % Tx100. 
Scale bar: 10 µm. Fluorescent microscope images. 
 
It was recently shown that PLK4 is involved in centriole biogenesis in multi-ciliated cells (Zhao 
et al., 2013). It was previously shown that a substantial proportion of the RPE cells in 
rodent retinae can exist in a binucleated form, as a result of mitoses not followed by 
cytokineses (Stroeva e Panova, 1983; Al-Hussaini et al., 2008). It is not clear whether, or why, 
the RPE1 cells would go via the deuterosome pathway (rather than simply the centrosome 
cycle) to generate another set of centrioles for its putative second nucleus, but at this stage it 
cannot be excluded that this is indeed happening on the presented image. It could also be 
speculated that perhaps, when the cells reach a certain age, they will replace their old set of 
centrioles with new ones via the deuterosome pathway, however, this hypothesis also seems 
Identification of Interacting Protein Partners of TOPORS in the Retina   ||   Barbara Czub 
PhD Thesis 2015   ||   Cellular Localisation Studies    - 294 - 
 
unlikely. In order to clarify whether ITM2B does localise to deuterosomes, like Figure 7-9 might 
suggest, the staining could be performed on multi-ciliated cells, for instance, cells of 
the respiratory tract. 
Similarly to PCM1 the observed Centrin-2 staining presents as either a single dot, or as double 
dots (Figure 7-10). Here again, ITM2B appears to co-localise predominantly (if not only) with 
just one dot. Overall, there seems to be a larger amount of the Centrin-2 signal at the co-
localisation areas, suggesting that ITM2B localises only to a specific part of the centrosome. 
This was also evident when centrioles were stained with PCM1 (Figure 7-8), but not as much 
with PLK4 (Figure 7-9), which phosphorylates only specific components of the MTOC. 
 
 
Figure 7-10. ITM2B C-term co-localises with the centriolar marker: Centrin-2. 
ITM2B C-term co-localised with Centrin-2; both antibodies appear to stain two centrioles, suggesting 
that the cell was fixed at the G1 phase. Insets show a magnification of signals enclosed in the dashed 
squares. Unsynchronised dividing hTERT-RPE1 cells, cultured in complete media, fixed with 4 % PFA and 
permeabilised with 0.3 % Tx100. Scale bar: 10 µm. Fluorescent microscope images. 
 
To understand whether ITM2B, like TOPORS, also associated with the basal body at the base of 
the primary cilium, further localisation studies were conducted in ciliated cell cultures, using 
an antibody against α-tubulin as a marker for the cilium. The markers excluded γ tubulin in 
this analysis, as the available antibody against it, was raised in rabbit, just like the antibodies 
against interacting partners of TOPORS.  
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In ciliated cultures, ITM2B did not show localisation to the basal body (Figure 7-11). However, 
it co-localised with α-tubulin at locations other than at the base of primary cilium, at speckles 
resembling centrioles (indicated by arrows in the figure). These speckles could represent the 
centrosome/centrioles of un-ciliated cells.  
Since in Figures 7-8, 7-9 and 7-10 ITM2B was observed at multi-dotted structures, stained with 
centriolar markers, that fact that it is absent from the base of the cilium, suggests that it may 
have a role in centrosome duplication. In view of this hypothesis, once the cells are ciliated, 
then there is no need for ITM2B at the centrosome anymore. 
 
 
Figure 7-11. ITM2B C-term does not localise to the ciliary basal body.  
ITM2B C-term did not localise to the base of the primary cilium (shown here by α-tubulin staining); 
however, in non-ciliated cells, ITM2B C-term localised at α-tubulin-stained puncta, suggesting that it 
associates with the centrosome in dividing but not in quiescent cells. Inset shows magnification of 
the primary cilium. Serum-starved ciliated hTERT-RPE1 cells, cultured in media with low serum 
concentration, fixed with 4 % PFA and permeabilised with 0.3 % Tx100. Scale bar: 10 µm. Fluorescent 
microscope images. 
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7.3 CELLULAR LOCALISATION OF PTGDS 
As described in section 4.3.3.2, PTGDS was shown to be produced in retinal epithelial cells of 
rat and chick retinae. Specifically, PTGDS localised to distinct cytoplasmic structures within 
the RPE cells.  
Urade et al. (1987) also showed localisation of PTGDS at rough ER as well as the nuclear 
envelope of glial cells. Yamashima et al. (1997) detected PTGDS in the rough ER and peri-
nuclear region in human arachnoid and meningioma cells. In the arachnoid cells it was also 
detected in the Golgi body and secretary vesicles as well as in spherical cytoplasmic structures.  
Additionally, it was found in the microphages and perivascular microglial cells, localising to 
circular cytoplasmic structures. In 2012, Wu et al. demonstrated again that PTGDS showed a 
predominantly peri-nuclear localisation, with some diffuse staining throughout the cytoplasm 
of the NTERA-2 cl.D1 (NT2/D1) human testicular carcinoma cell line.  
However, PTGDS has mainly been recognised as a protein secreted into various bodily fluids, 
predominantly the CSF. 
The antibody raised in rabbit against full-length human PTGDS (sc-30067, Santa Cruz 
Biotechnology, TX, USA) was used in all immunofluorescence studies, as well as experiments 
on cellular protein extracts (section 2.8).  
PTGDS displayed some variation in the observed signal, depending on cell fixation method and 
cell line used. The signal appeared speckled and wide-spread throughout the cytoplasm in 
hTERT-RPE1 cells fixed with 4 % PFA, with some intense spots of signal visible (and more 
apparent) closer to the cell nucleus; whereas in the SK-N-SH cells, fixed with PFA, very little 
signal was observed, if any (Figure 7-12). This closely resembles the signals observed in 
the same cell lines for ITM2B following 4 % PFA fixation (Figure 7-3).  
In methanol-fixed hTERT-RPE1 cells the PTGDS signal in the cytoplasm appeared somehow less 
granular and more diffuse overall; however, the dot-like signal, which could putatively 
represent centrioles, appeared more distinct on this background (top panel in Figure 7-13). 
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Figure 7-12. PTGDS localises throughout the cytoplasm of retinal epithelial (hTERT-RPE1) cells in 
a granular pattern, but appears absent from the neuroblastoma (SK-N-SH) cells. 
PTGDS signal (Ab diluted 1/250) observed in unsynchronised dividing hTERT-RPE1 (RPE1) and SK-N-SH 
cells, cultured in complete media, fixed with 4 % PFA and permeabilised with 0.3 % Tx100. Scale bar: 
20 µm. Fluorescent microscope images. 
 
 
Figure 7-13. PTGDS localises throughout the cytoplasm of retinal epithelial (hTERT-RPE1) 
and neuroblastoma (SK-N-SH) cells, including more intensely-stained centriole-like puncta. 
PTGDS (Ab diluted 1/50) observed in unsynchronised dividing hTERT-RPE1 (RPE1) and SK-N-SH cells, 
cultured in complete media, fixed with ice-cold methanol. Scale bar: 20 µm. Fluorescent microscope 
images. 
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In methanol-fixed SK-N-SH cells a strong signal was observed in small points located proximally 
to the nuclei, and additionally a cloud of a more diffuse, wide-spread signal was observed 
throughout the cells with a slightly more distinct peri-nuclear staining. In some cells PTGDS 
actually appears to form a ring encircling the nucleus (lower panel in Figure 7-13). 
Observations from both cell types are consistent with previously published findings regarding 
sub-cellular localisation of PTGDS, summarised in the beginning of the current section. 
In addition to the peri-nuclear and background cytoplasmic staining, punctate co-localisation 
with TOPORS was observed in hTERT-RPE1 cells in a pattern, which could be centriolar (Figure 
7-14 and Figure 7-15).  
 
 
Figure 7-14. PTGDS co-localises with TOPORS in retinal epithelial cells in a centriole-like pattern. 
PTGDS co-localised with TOPORS, additionally strong cytoplasmic staining was also observed for both 
proteins. Insets show a magnification of signals enclosed in the dashed squares. Unsynchronised dividing 
hTERT-RPE1 cells, cultured in complete media, fixed with 4 % PFA and permeabilised with 0.3 % Tx100. 
Scale bar: 10 µm. Fluorescent microscope images. 
 
 
Figure 7-15. PTGDS co-localises with TOPORS in retinal epithelial cells in a centriole-like pattern. 
PTGDS co-localised with TOPORS at distinct cytoplasmic puncta. Insets show a magnification of signals 
enclosed in the dashed squares. Unsynchronised dividing hTERT-RPE1 cells, cultured in complete media, 
fixed with 4 % PFA and permeabilised with 0.3 % Tx100. Scale bar: 10 µm. Fluorescent microscope 
images. 
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The two images demonstrate two distinct localisation patterns that were observed in cells 
from the same culture, which were stained with PTGDS. In Figure 7-14 the signal is peri-nuclear 
and diffuse throughout the cytoplasm (but becoming more widely scattered further away from 
the nucleus); in addition there are two puncta of higher intensity signal, reminiscent of 
centrioles, and co-localising with TOPOPRS (which is also showing some nuclear staining).  
On the contrary, the sole signal detected using both antibodies (against PTGDS and TOPORS) in 
Figure 7-15 appeared to like strikingly like centrioles.  
Similarly to ITM2B, further localisation studies using centriolar markers confirmed that PTGDS 
localised to the centrioles, as demonstrated by co-staining with PCM1 (Figure 7-16), PLK4 
(Figure 7-17) and centrin-2 (Figure 7-18).  
PTGDS and PCM1 co-localised precisely in a centriolar pattern (Figure 7-16); however, PCM1 
also stained a peri-nuclear location, from which PTGDS was mostly absent (except for 
extremely faint speckles at four points). The opposite would be expected, as PTGDS was 
previously shown (in earlier figures and in referenced studies) to localise around the nucleus. 
Presumably, PTGDS is targeted to different peri-nuclear domains than PCM1, or at different 
points in the cell cycle. 
Co-localisation between PTGDS and PLK4 was very precise and the two signals overlapped 
almost entirely (Figure 7-17). Overall, the PTGDS signal appeared to cover a slightly larger 
surface area, but it is not possible to ascertain at this stage whether it was due to a higher 
concentration of PTGDS (than PLK4) at the centrioles, or whether perhaps this observation was 
fluorophore-dependent.  
On the contrary, Centrin-2 (Figure 7-18) certainly stained other MTOC components in addition 
to those, which were also stained by PTGDS. Where a single centriole is visible, the overlap 
with PTGDS signal is very precise. However, at the structure, which appears to comprise three 
or more dots (inset in Figure 7-18), PTGDS co-localises only with two of the brighter dots. This 
structure probably represents a centrosome in the process of becoming duplicated, and 
perhaps PTGDS is localising to either only the mother centrioles, or the daughter centrioles, of 
the two resulting centrosomes, or perhaps to mother and daughter centriole of the ‘old’ 
centrosome. Nonetheless, it is certainly not co-localising with this structure fully. The three-to-
four dotter Centrin-2 staining pattern suggests that the cells was probably in transition from 
the S phase to the G2 phase at the time of fixation. 
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Unlike ITM2B, PTGDS was observed at the base of the cilium, as shown by co-staining with α-
tubulin (Figure 7-19). In fact, further analysis showed that in some cells PTGDS signal was 
observed even along the axoneme of the cilium itself (Figure 7-20). 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
 
Figure 7-16. PTGDS co-localises with the peri-centriolar marker: PCM1. 
PTGDS co-localised with PCM1 in a centriole-like pattern. Both proteins additionally localised proximally 
to the nucleus, but the PCM1 staining was much more intense. Insets show a magnification of signals 
enclosed in the dashed squares. Unsynchronised dividing hTERT-RPE1 cells, cultured in complete media, 
fixed with 4 % PFA and permeabilised with 0.3 % Tx100. Scale bar: 10 µm. Fluorescent microscope 
images. 
 
 
Figure 7-17. PTGDS co-localises with the centriolar and deuterosomal marker: PLK4. 
PTGDS co-localised with PLK4, as well as appeared to localise around it (the PTGDS signal covers a larger 
surface area in comparison to PLK4). Insets show a magnification of signals enclosed in the dashed 
squares. Unsynchronised dividing hTERT-RPE1 cells, cultured in complete media, fixed with 4 % PFA and 
permeabilised with 0.3 % Tx100. Scale bar: 10 µm. Fluorescent microscope images. 
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Figure 7-18. PTGDS co-localises with the centriolar marker: Centrin-2. 
PTGDS co-localised with Centrin-2. Insets show a magnification of signals enclosed in the dashed 
squares, in which three distinct dots can be discriminated. Unsynchronised dividing hTERT-RPE1 cells, 
cultured in complete media, fixed with 4 % PFA and permeabilised with 0.3 % Tx100. Scale bar: 10 µm. 
Fluorescent microscope images. 
 
The same images provide evidence for punctate localisation with α-tubulin away from primary 
cilia (inset in Figure 7-19), which was also observed for ITM2B.  
PTGDS is a highly glycosylated protein, which would support its previously demonstrated 
localisation within intracellular membranous organelles, which mediate glycosylation, i.e. 
the endoplasmic reticulum and Golgi apparatus. It was also shown to localise to secretory 
vesicles and ganglion cell membranes. No PTGDS localisation at the primary cilium was 
previously shown. Nonetheless, it was demonstrated that prostaglandin (PG) E2, a product of 
PG E2 synthase, rather than PG D2 synthase (PTGDS), has important role in ciliary function in 
development (Jin et al., 2014; Jin, Liu e Zhong, 2015). This information, coupled to the known 
high PTGDS expression in the rodent RPE layer, suggests that the observed localisation of 
PTGDS along the cilium can be true. 
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Figure 7-19. PTGDS localises to both centrioles of the ciliary basal body. 
PTGDS localised to both centrioles at the base of the primary cilium (marked with α-tubulin). 
Additionally PTGDS co-localised with α-tubulin at dotted points other than the base of the cilium. Insets 
show a magnification of signals enclosed in the dashed squares. More wide-spread peri-nuclear PTGDS 
staining was also observed. Serum-starved ciliated hTERT-RPE1 cells, cultured in media with low serum 
concentration, fixed with 4 % PFA and permeabilised with 0.3 % Tx100. Scale bar: 10 µm. Fluorescent 
microscope images. 
 
 
Figure 7-20. PTGDS localises to the ciliary basal body and along the ciliary axoneme. 
PTGDS localised to the base and along the length of primary cilium (marked with α-tubulin); Insets show 
a magnification of signals enclosed in the dashed squares. In addition peri-nuclear PTGDS signal was 
detected. Serum-starved ciliated hTERT-RPE1 cells, cultured in media with low serum concentration, 
fixed with 4 % PFA and permeabilised with 0.3 % Tx100. Scale bar: 10 µm. Fluorescent microscope 
images. 
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7.4 CELLULAR LOCALISATION OF PSMC1 
Evidence from the Human Protein Atlas (Berglund et al., 2008) demonstrated in three different 
cell lines (U-2 OS, A-431, and U-251 MG) that PSMC1 localises to the nucleus and throughout 
the cytoplasm; in all the cell lines the nuclear localisation excludes the nucleoli, which was 
additionally supported by findings by de Mateo et al. (2011). 
An antibody against a carboxy-terminal fragment of human PSMC1 (Sigma-Aldrich # 
HPA000872), as denoted in Figure 6-11, was used in all immuno-based experiments.  
The antibody signal was observed in hTERT-RPE1 cells and SK-N-SH cells, fixed with PFA and 
permeabilised with Tx100 (top panel in Figure 7-21, and Figure 7-22, respectively), as well as 
hTERT-RPE1 cells fixed with ice-cold methanol (lower panel in Figure 7-21), but it was not 
detected in methanol-fixed SK-N-SH cells (data not shown). 
Figure 7-21 (top panel) shows that in hTERT-RPE1 cells PSMC1 localises throughout 
the cytoplasm and to the nuclei; however, as in case of the immuno-staining images, recorded 
in the Human Protein Atlas, the nuclear localisation appears to be exclusive of the nucleoli.  
In the ice-cold methanol-fixed hTERT-RPE1 cells the staining was most intense in distinct areas, 
located adjacently to the nucleus, or inside it, accompanied by peri-nuclear cytoplasmic 
background staining (Figure 7-22). 
 
Figure 7-21. PSMC1 localises throughout the cytoplasm of retinal epithelial (hTERT-RPE1) 
and neuroblastoma (SK-N-SH) cells with a distinct region of higher intensity in the latter. 
PSMC1 signal (Ab diluted 1/250) observed in unsynchronised dividing hTERT-RPE1 (RPE1) and SK-N-SH 
cells, cultured in complete media, fixed with 4 % PFA and permeabilised with 0.3 % Tx100. Scale bar: 
20 µm. Fluorescent microscope images. 
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In fact, the PSMC1 localisation observed in hTERT-RPE1 cells, fixed with methanol, strongly 
resembled the PSMC1 signal, detected in SK-N-SH cells, fixed with PFA (lower panel in Figure 
7-21). Perhaps the intensely stained regions, observed in these experiments, represent 
aggregates of the 26 S proteasome, which are recruited to the nucleus in times of stress. It is 
also possible that they may be artefacts. 
 
 
Figure 7-22. PSMC1 localises throughout the cytoplasm of retinal epithelial (hTERT-RPE1) cells 
with distinct regions of higher intensity. 
PSMC1 (Ab diluted 1/100) observed in unsynchronised dividing hTERT-RPE1 (RPE1) and SK-N-SH cells, 
cultured in complete media, fixed with ice-cold methanol. Scale bar: 20 µm. Fluorescent microscope 
images. 
 
Apart from the already demonstrated wide-spread cytoplasmic and nuclear distribution 
demonstrated in PFA-fixed hTERT-RPE1 cells, punctate signal was also observed, as distinct 
dots, located proximally to the cell nucleus, in a pattern similar to that of centrioles (Figure 
7-23). Subsequent experiments showed that PSMC1 sporadically co-localised with TOPORS 
(Figure 7-24). 
Furthermore, PSMC1 co-localised with centriolar marker PCM1 (Figure 7-25), but not at all 
times (Figure 7-26). Co-localisation with PLK4 was also observed; however, PSMC1 signal was 
co-localising with only one of the two centrioles marked by PLK4 (Figure 7-27). PSMC1 and 
Cenrin-2 co-staining also showed sporadic co-localisation (Figure 7-28). 
Additionally, as was also observed for ITM2B and PTGDS on some of the presented 
micrographs, the PSMC1 signal was sometimes widespread throughout the cell, and other 
times it appeared extremely specific (compare Figures 7-26 and 7-27). 
The outcomes of PSMC1 co-staining with the centriolar markers (PCM1, PLK4, and Centrin-2) 
were not consistent, even within the same experiment. Co-localisation was always observed in 
a subset of cells, but never all of the cells, suggesting an association with the cell cycle as 
unsynchronised cell cultures were used for all localisation experiments.  
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Figure 7-23. PSMC1 localises throughout the cytoplasm in a dotted pattern, some of which is 
reminiscent of centrioles (arrows).  
PSMC1 localised throughout the cell, and sometimes more distinct punctate peri-nuclear signal (arrows) 
was also observed. Unsynchronised dividing hTERT-RPE1 cells, cultured in complete media, fixed with 
4 % PFA and permeabilised with 0.3 % Tx100. Scale bar: 10 µm. Fluorescent microscope images. 
 
 
Figure 7-24. PSMC1 co-localises with TOPORS in a centriole-like pattern. 
PSMC1 localised throughout the cell; the signal included more distinct points, co-localising with TOPORS 
staining (arrows). Unsynchronised dividing hTERT-RPE1, cultured in complete media, fixed with 4 % PFA 
and permeabilised with 0.3 % Tx100.  Scale bar: 10 µm. Fluorescent microscope images. 
 
 
Figure 7-25. In the selected cells PSMC1 co-localises with the peri-centriolar marker: PCM1. 
PSMC1 co-localised with PCM1 at structures resembling centrioles, but it did not co-localise with 
a slightly more diffuse spot of PCM1 signal (which could represent a centriole, which is out of focus). 
Insets show a magnification of signals enclosed in the dashed squares. Unsynchronised dividing hTERT-
RPE1 cells, cultured in complete media, fixed with 4 % PFA and permeabilised with 0.3 % Tx100. Scale 
bar: 10 µm. Fluorescent microscope images. 
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Figure 7-26. In the selected cells PSMC1 does not co-localise with the peri-centriolar marker: PCM1. 
PSMC1 did not consistently co-localise with PCM1 (arrows); nonetheless, co-localisation with both 
centrioles one cell in this figure is also apparent. Unsynchronised dividing hTERT-RPE1 cells, cultured in 
complete media, fixed with 4 % PFA and permeabilised with 0.3 % Tx100.  Scale bar: 25 µm. Fluorescent 
microscope images. 
 
 
Figure 7-27. PSMC1 co-localises with the centriolar and deuterosomal marker: PLK4. 
PSMC1 co-localised with PLK4 at one of the two centrioles marked with PLK4. The PSMC1 also appears 
to co-localise with to linker molecules holding the two centrioles together. Insets show a magnification 
of signals enclosed in the dashed squares. Unsynchronised dividing hTERT-RPE1 cells, cultured in 
complete media, fixed with 4 % PFA and permeabilised with 0.3 % Tx100. Scale bar: 10 µm. Fluorescent 
microscope images. 
 
Figure 7-28. In selected cells PSMC1 co-localises with the centriolar marker: Centrin-2. 
PSMC1 localised peri-nuclearly, sporadically co-localising with Centrin-2; the PSMC1 overalpped with as 
well as surrounded the Cenrin-2 signal. Insets show a magnification of signals enclosed in the dashed 
squares. Unsynchronised dividing hTERT-RPE1 cells, cultured in complete media, fixed with 4 % PFA and 
permeabilised with 0.3 % Tx100. Scale bar: 10 µm. Fluorescent microscope images. 
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It is interesting to note that in cells where PSMC1 does localise at the centrioles, there appears 
to be a stronger signal from one centriole, over the other, suggesting preference for either the 
mother or daughter centriole, and also suggestive of a cell cycle function.  A role for PSMC1 in 
the cell cycle has been demonstrated in mouse embryonic fibroblasts (Rezvani et al., 2012).  
Furthermore, regulated proteolysis is essential for cell cycle progression, and proteasomal 
degradation of cyclins, their associated kinases and other accessory proteins has been 
demonstrated, which would fit with the known role of PSMC1 (reviewed in: Vermeulen, Van 
Bockstaele e Berneman, 2003). 
Similarly, the staining pattern with α-tubulin did not provide evidence that PSMC1 localises to 
primary cilium (Figure 7-29); but, like ITM2B, and to some degree PTGDS, it co-localised with α-
tubulin at distinct, solitary points proximal to the cell nucleus (inset in Figure 7-29). 
 
 
Figure 7-29. PSMC1 does not localise to the ciliary basal body. 
PSMC1 did not co-localise with the primary cilium (marked with α-tubulin, inset); however, it co-
localised with α-tubulin in a punctate, centriole-like pattern, in cells in which no primary cilium was 
observed, suggesting that it associates with the MTOC at some points in the life cycle of dividing cells 
but not in quiescent cells. Serum-starved ciliated hTERT-RPE1 cells, cultured in media with low serum 
concentration, fixed with 4 % PFA and permeabilised with 0.3 % Tx100.  Scale bar: 10 µm. Fluorescent 
microscope images. 
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7.5 IDENTIFICATION OF CILIARY TARGETING SEQUENCES 
Based on cellular localisation experiments, all three interacting partners of TOPORS, ITM2B, 
PTGDS and PSMC1, appear to co-localise with TOPORS, at or around the centrioles and/or 
centrosome. This is a novel observation for each of the three interacting partners, neither of 
which have been implicated as ciliary, or cilia-related proteins, prior to this work.  
Given the unexpected localisation results, an attempt was made to identify potential ciliary 
targeting sequences (CTS) (Mazelova et al., 2009; Hsiao, Tuz e Ferland, 2012) within these 
proteins. These motifs were already referred to in Chapter 6, and were mapped onto Figures 
6-3, 6-5, 6-8 and 6-11. This section describes why they were searched for, and how they were 
identified. 
Firstly, the amino acid conservation of was determined for each interacting partner, using 
the PRALINE multiple sequence alignment tool (The Centre for Integrative Bioinformatics VU 
(IBIVU), University of Amsterdam, Netherlands). Once the alignment files had been generated, 
the results were saved as .pdf files, and the sequence was annotated manually, as well as 
employing the ‘find’ function to identify potential CTS sites. Several different CTS have been 
identified; these include VxPx, RVxP, KVHPSST, AxEGG and Ax(S/A)xQ, amongst others (Hsiao, 
Tuz e Ferland, 2012), all of which were searched for. 
Based on the bioinformatics analysis human TOPORS contains two VxP sequences. The first 
CTS is located shortly after the RING finger (Table 7-2), and according to PRALINE is conserved 
among apes and monkeys. The second CTS, located between the second and third PEST 
domains, and show an even greater conservation; in addition to primates, it has been found in 
other vertebrates, such as mouse, the African clawed frog and zebrafish. 
Interestingly, three CTS sites were identified in ITM2B, the first before the transmembrane 
domain, and the latter two closer to the C-terminal end of the protein (shown in Figure 6-5), 
and showing complete conservation in the species tested (Figures 11-52 and 11-53 in Appendix 
11.10). 
Two sites were identified in PTGDS, at amino acids 30-32 and 69-71, both of which were 
conserved in higher mammals, the second of the two, also in dog and frog. PSMC1 showed one 
VxP CTS site in the N-terminus (amino acids 52-54), the second being the Ax(S/A)xQ site found 
approximately mid-protein at amino acids 238-242. 
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The CTS VxP is considered a generic sequence, and was the main CTS identified for TOPORS 
and the three interacting partners, with the exception of PSMC1 which additionally contained 
an Ax(S/A)xQ, usually associated with G-protein coupled receptors (Hsiao, Tuz e Ferland, 
2012). 
Given time this work could be developed further by using SDM to mutagenize each of these 
putative CTS sites in turn, to better understand the role (if only) they play in determining 
the localisation of each of the said proteins.  
 
Table 7-2. CTS domains identified in TOPORS and its interacting partners. 
PROTEIN 
AMINO ACID NUMBER 
(according to human sequence) 
AMINO ACID SEQ 
TOPORS 
172-174 VTP 
484-486 VKP 
ITM2B 
44-46 VVP 
166-168 VIP 
174-176 VMP 
PTGDS 
30-32 VQP 
69-71 VAP 
PSMC1 
52-54 VTP 
238-242 AVANQ 
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7.6 DISCUSSION 
The findings described in this chapter demonstrated that, although not throughout the cell 
cycle, the novel interactors of TOPORS do indeed localise to the centrioles. The localisation of 
TOPORS at these strategic organelles was previously demonstrated by Chakarova et al. (2011), 
who showed that this protein associated with centrosomes in both dividing and ciliated cells. 
The centrosome was the organelle of interest as the study additionally demonstrated that in 
retinal sections TOPORS localises to the basal body of rod photoreceptor connecting cilium. It 
was hypothesised that the localisation of TOPORS at the photoreceptors’ literal bottle-neck 
was the reason why its mutations resulted in retinitis pigmentosa. Hence, it was interesting to 
evaluate whether the interacting partners of TOPORS also localised to the centrosome, or 
specifically, the ciliary basal body.  
Cellular co-staining studies with TOPORS were indicative of localisation of the interacting 
proteins to the centrosome, which was confirmed by co-staining for each interacting protein 
and centriolar markers.  As was described in section 1.8, the centrosome comprises two 
centrioles and forms the microtubule organising centre (MTOC) of the cell. Furthermore, in 
cells, which have exited the cell cycle, it serves as the basal body of the primary cilium (section 
1.9).  
 
7.6.1 EVALUATION OF LOCALISATION 
Table 7-3 provides a summary of the co-localisation experiments, which show that, in this 
study, in hTERT-RPE1 cell line only PTGDS was observed at the primary cilium. ITM2B and 
PSMC1 did indeed localise to centrioles in dividing cells; however, they were both absent from 
the ciliary basal body in cells at the G0 cell cycle phase. 
ITM2B showed co-localisation with TOPORS at the centrosome (Figure 7-6 and 7-7), localising 
to both centrioles, as confirmed by co-localisation studies with centriolar markers PCM1, PLK4 
and Centrin-2 (Figures 7-8, 7-9, and 7-10). It appeared that ITM2B remains associated with 
both centrioles throughout the cell cycle: ITM2B co-localised with PCM1 and PLK4 in a 3-
dotted pattern (Figure 7-8 and Figure 7-9), respectively, which could indicate that it localises to 
centrioles in S-phase cells (or perhaps G2-phase) cells, given that PCM1 and PLK4 staining 
could be interpreted similarly to centrin-2 staining.  
The signal depicted in Figure 7-9 also shows co-localisation at two dots spread apart on two 
sides of a nucleus, possibly indicating centrosome separation at the G2/M transition. 
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Table 7-3. Summary of localisation study with centriolar markers. 
The cell cycle stages are just hypothetical, they were determined solely based on the appearance of 
the centriolar staining as indicated by markers. 
 ITM2B (C-term) PTGDS PSMC1 
TOPORS 
Co-localised in 
a centriole-like pattern. 
In some cells ITM2B 
displayed additional 
‘cloud’-like signal around 
the co-localisation area. 
Co-localised in 
a centriole-like pattern in 
addition to diffuse 
cytoplasmic signal 
observed for both 
proteins. 
In some cells 
the cytoplasmic PTGDS 
signal appeared very 
granular, whereas in 
others it was almost 
unnoticeable. 
Co-localised in 
a centriole-like (G1 
phase) pattern in some 
cells in addition to diffuse 
cytoplasmic signal 
observed for both 
proteins (much more 
extensive for PSMC1). 
 
PCM1 
Co-localised in cells fixed 
at S phase. 
Co-localised in 
a centriole-like pattern. 
Did not co-localise 
proximally to the nucleus. 
Co-localised in 
a centriole-like pattern in 
some cells, but did not 
co-localise at all in 
others. 
PLK4 
Co-localised in 
a centriole-like pattern. 
Co-localisation at a larger 
deutrosome-like 
structure was also 
observed. 
Co-localised in 
a centriole-like pattern. 
Additionally, both 
proteins were observed in 
the cytoplasm where 
some of their signals co-
localised. 
PSMC1 co-localised with 
one of the two PLK4-
stained centrioles 
(S phase). 
Centrin-2 
Co-localised in cells fixed 
at G1 phase. 
Co-localised in cells fixed 
at G1 and S phases. 
Co-localised in cells fixed 
at G1 phase. The PSMC1 
signal overlapped with 
and surrounded 
the PCM1 signal (but it 
was continuous rather 
cloud-like as in case of 
ITM2B). 
α-tubulin 
Co-localised in a dot-like 
pattern reminiscent of 
centrioles.  
Did not co-localise at 
the ciliary basal body. 
Co-localised in a dot-like 
pattern reminiscent of 
centrioles at G1 and S 
phases.  
Co-localised at both 
centrioles of the ciliary 
basal body and along 
the axoneme. 
Co-localised in a dot-like 
pattern reminiscent of 
centrioles.  
Did not co-localise at 
the ciliary basal body. 
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The fact that nuclear staining of the cell, within which the two dots are observed resembles 
the appearance of chromatin undergoing condensation, supports this hypothesis. 
Co-staining with centrin-2, whose localisation at the centrioles/centrosome can be used to 
determine cell cycle stages, shows a two-dotted pattern (Figure 7-10), suggesting cells were at 
G1 stage at fixation. No ITM2B signal was observed at the basal body of primary cilia in cells 
displaying this characteristic (Figure 7-11), which suggests that this protein does not associate 
with the centrosome in cells, which have exited the cell cycle, and are quiescent at the G0 
phase. 
PTGDS, like ITM2B, was found localising to the centrioles with TOPORS and the other centriolar 
markers. PTGDS displayed a 3-4 dotted co-localisation pattern with PCM1 (Figure 7-16); 
whereas the PLK4 signal appeared mostly as single dots in the same non-synchronised cell 
batch, putatively indicating the G2/M transition of the cell cycle (Figure 7-17).  
PTGDS co-staining with Centrin-2 showed a speckled 3-4 dotted signal, suggesting that the co-
localisation occurred either at the S- or in the beginning of G2-phase. However, unlike ITM2B, 
PTGDS was found to localise to the basal body of ciliated hTERT-RPE1 cells, and it was also 
observed along the length of the ciliary axoneme (Figure 7-19 and Figure 7-20), demonstrating 
that it remains localised to the centrosome in quiescent cells, also implying it might remain 
associated with the centrosome/centrioles throughout the cell cycle.  
Interestingly, lack of PTGDS staining in SK-N-SH cells was shown in Figure 7-12. This result 
could support the previously published findings, stating that, in the retina, PTGDS is not 
synthesised in the neuronal photoreceptor cells (Beuckmann et al., 1996). The study showed 
that the protein is synthesised in the retinal pigmented epithelial (RPE) cells, secreted into 
the interphotoreceptor space, and then taken up by the photoreceptor cells. It could be 
speculated that perhaps the retina is not the only tissue in the CNS, where PTGDS produced by 
an epithelial cell type (or another cell type) is at some point taken up by a neuronal cell type.  
For example, it was previously reported that PTGDS production by oligodendrocytes protected 
neighbouring neurons from death by apoptosis (Taniike et al., 2002). Other studies also 
demonstrated that PTGDS in neurons has an anti-apoptotic activity (Fujimori, Fukuhara, et al., 
2012; Fukuhara et al., 2012). High levels of PTGDS were also recorded in detached human 
retinae (Jaggi et al., 2008), which could be explained by the protective anti-apoptotic function 
of this protein. Nonetheless, the above speculation must remain purely hypothetical since 
PTGDS signal was recorded in cells fixed with ice-cold methanol (Figure 7-13). 
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In contrast to the other two interacting partners, co-localisation of PSMC1 with TOPORS, as 
well as with centriolar markers, was only observed sporadically, which suggested that its 
localisation to the centrioles and/or centrosome could be cell cycle phase-dependent. Where 
a pair of dots was observed, shown by co-staining with PLK4 to be centrioles (Figure 7-27), 
PSMC1 was observed localising to just one of them, suggesting a preference for either 
the mother, or the daughter centriole. PSMC1 signal was not detected at the basal body of 
the primary cilium. Nonetheless, efficient and highly-regulated proteasomal degradation is 
essential for correct progression of the cell cycle, therefore, the observed co-localisation of 
PSMC1 with centriolar markers is most likely true. 
There is evidence to suggest that centrosomes may act as peri-nuclear scaffold structures, 
onto which proteasomes are docked (Wigley et al., 1999). Furthermore, it was also 
demonstrated that proteasomes associated with centrosomes are involved in homeostasis of 
centrosomal proteins (Didier et al., 2008).  
This function could be especially relevant to protein hubs at centrosomes and basal bodies, 
where proteins are unloaded from and prepared for transport by components of 
the intraflagellar transport (IFT) system. The exact conditions, determining when the two 
cellular structures associate, probably depend on cell cycle stage as well as cellular 
stresses/responses to environmental stimuli, which could help explain the inconsistent 
localisation of PSMC1 to the centrioles.  
The implication of PSMC1 in cell cycle defects was previously demonstrated (Rezvani et al., 
2003; Rezvani et al., 2012); therefore, despite the observed inconsistencies PSMC1 is expected 
to play an important role in cell cycle regulation.  
Remarkably, as was summarised in Table 7-2, all three proteins: ITM2B, PTGDS and PSMC1, as 
well as TOPORS, possess ciliary-targeting sequences (CTSs) of the same type (VxPx) as those 
found in rhodopsin, or polycystin-2, both of which are involved in debilitating ciliopathies. 
Hence, even though the functionality of these CTS motifs was not demonstrated in this sub-
cellular localisation study, it cannot be excluded that they would localise to the primary cilium 
in different circumstances. For instance, if the experiment was repeated in another cell type, 
or if the localisation was evaluated within a tissue section harbouring ciliated cells, then 
perhaps a ciliary signal would have been observed. Specific signalling events, possibly from 
neighbouring cells of a different type, might be necessary in order to trigger a translocation of 
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a certain protein at the ciliary base. Clearly, a CTS motif is not the only determinant of 
a protein’s localisation to the primary cilium. 
For PTGDS it was previously demonstrated that serum-starvation resulted in an enhanced 
production of this protein (Fujimori, Aritake e Urade, 2008). In order to simulate the hTERT-
RPE1 cells to grow primary cilia, they were firstly subject to serum starvation. On this basis, it 
could be speculated that the increased synthesis of PTGDS, hypothetically triggered by serum-
starvation, was required in order for a subset of the protein to localise to the cilium. 
If this could be confirmed as the necessary environmental stimulus for PTGDS, it could be 
speculated that alternative environmental stimuli exist for ITM2B and/or PSMC1, which could 
trigger ciliary localisation of these proteins. 
Overall, centrioles comprise the main building blocks of the MTOC in mammalian cells. During 
the interphase cells depend on the centrosomes for maintaining the cellular cytoskeleton as 
well as the correct positioning of organelles. For instance, when cells are undergoing mitosis 
and cytokinesis, the stacks of the Golgi apparatus dissociate from each other and diffuse freely 
throughout the cytosol, as they do not have the cytoskeletal support of microtubules anymore 
since the centrosomes are participating in the mitotic spindle formation. 
Consequently, if a protein, such as TOPORS, which is associated with the centrosome 
throughout the cell cycle, becomes mutated, this could affect the overall cell physiology, 
irrespectively of whether the cell is dividing or ciliated. TOPORS, specifically, is believed to be 
of key importance to the MTOC due to its enzymatic activities. The protein possesses dual E3 
ubiquitin and SUMO1 ligase activities, both of which are crucial to regulation of proteasomal 
degradation, which in turn is key to cell cycle progression in dividing cells and to signalling 
functions in ciliated cells. 
Among the three evaluated interactors PTGDS was the only protein, for which both: 
the centriolar and ciliary localisations were demonstrated. Roles of prostaglandins (PGs) in 
signalling, including signalling via the primary cilium, were previously reported (Fujimori, 
Kadoyama e Urade, 2005; Fujimori, Maruyama, et al., 2012; Lee, S. et al., 2012; Jin et al., 2014; 
Jin, Liu e Zhong, 2015). Hence, it is not unreasonable for a PG synthase, such PTGDS, to be 
present at the primary cilium. Nonetheless, the function that it has there does not necessarily 
need to involve PTGDS synthesis. PTGDS might be involved in signalling cascades conveyed 
through the cilium through its role as a transporter of lipophilic compounds, here specifically 
retinoids (section 4.3.3.2). 
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7.6.2 CONCLUSIONS 
The data presented in the current Chapter 7 demonstrated that ITM2B, PTGDS and PSMC1 all 
co-localised with TOPORS as well as centriolar markers (PCM1, PLK4 and Centrin-2) in 
the human retinal pigmented epithelial cell line: hTERT-RPE1. Furthermore, a bioinformatics 
analysis revealed that all three interactors as well as TOPORS possess ciliary targeting 
sequences (CTS) within their peptide chains. These CTF motifs were of the same type as those 
found in rhodopsin or polycystin-2, in which they were demonstrated to be functional. 
Nonetheless, PTGDS was the only one of the three interactors, which was observed at 
the primary cilium of the hTERT-RPE1 cells. This suggests that, in addition to the CTS motifs, 
other factors must also be involved in targeting of the identified proteins to primary cilia (if 
the CTS regions are indeed functional). 
Still, the localisation of all three proteins to centrioles in dividing cells was evident. These 
results supported the findings from the Y2H assays as well as coIP studies (even though 
the later resulted in a less strong evidence of interaction between TOPORS and PTGDS), as 
they demonstrated that these proteins localise to the same sub-cellular compartments as 
TOPORS in human cells. Since the proteins are able to encounter each other in the native 
intracellular environment, this strengthens the importance of the protein interaction findings. 
In view of the above as well as due to the previously reported ubiquitous expression of 
TOPORS, it could be hypothesised that, in the retina, TOPORS associates with its novel 
interactors not at the ciliary basal bodies of rod photoreceptor cells (or, perhaps for PTGDS, 
not only there). As the expression of TOPORS’ interactors also appears ubiquitous, perhaps 
the association between them (or one of them) and TOPORS actually occurs in the RPE layer, 
actively phagocytising the photoreceptor outer segments, which undergo a continual renewal 
process.  
The outcomes of immuno-fluorescent (IF) staining experiments on retinal cryo-sections 
(Chapter 8), should provide evidence to either support or disregard this hypothesis. A co-
staining for each interacting pair will have been performed to determine whether TOPORS and 
its interactors are found within a reachable proximity to each other within the retinal tissue. 
The results of these immunohistochemical (IHC) IF studies should aid in interpretation of 
the other empirical findings described throughout this thesis. 
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8 RETINAL TISSUE LOCALISATION STUDIES 
The results described in the experimental chapters so far described the construction of 
the human retinal cDNA library in yeast, the identity of which was validated by isolating clones 
of rhodopsin (rho) (Chapter 3). Subsequently, a Y2H screen for human retinal protein 
interacting partners of TOPORS was performed using the newly constructed retinal cDNA 
library. The screen led to identification and selection of three novel candidates for validation 
and characterisation of interactions, namely ITM2B, PTGDS and PSMC1 (Chapter 4). 
The Y2H results were subsequently re-demonstrated by direct interaction in yeast, using full 
length clones as well as relevant deletion constructs. These experiments confirmed that 
interactions between these human exogenous proteins do indeed occur in yeast. Moreover, it 
was shown that ITM2B interacts most strongly with the N-terminal and C-terminal fragments 
of TOPORS, conveying the E3 ubiquitin ligase activity and comprising the mutational hotspot, 
respectively. PTGDS interacted most strongly with the N-terminal TOPORS fragment, whereas 
PSMC1 associated most readily with mid-TOPORS fragment (associated with E3 SUMO1 ligase 
activity) and the C-terminal fragment. An additional study aimed at identifying alternatively 
spliced retinal variants of the novel Y2H interactors of TOPORS was also performed and 
showed that at mRNA level one protein-coding isoform is expressed in the retina of both 
ITM2B and PSMC1 (corresponding to the isoforms pulled out from the Y2H screen); however, 
a total of three protein-coding PTGDS isoforms (including the one pulled out from the Y2H 
screen) were shown to be expressed in the human retina at mRNA level (Chapter 5). 
Co-immuno-precipitation studies (Chapter 6) provided sound evidence that ITM2B and PSMC1 
are both found in HeLa endogenous protein complexes with TOPORS. On the other hand, 
the band observed for PTGDS (for total cell lysates as well as complexes immuno-precipitated 
with an antibody detecting TOPORS) was consistently migrating about 20 kDa higher than 
expected, suggesting that, although it did appear in the coIP complex with TOPORS, 
the interaction with this protein requires further verification. 
Findings from cellular localisation studies showed that in the hTERT-RPE1 cells TOPORS co-
localised with its three novel interacting partners from the Y2H screen in a punctate pattern 
resembling centrioles. Further co-immuno-staining of centriolar markers and the TOPORS’ 
interactors did indeed demonstrate that all three: ITM2B, PTGDS and PSMC1 localise to 
the centrioles, although in variable patterns, which could be cell-cycle dependent.  
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PTGDS was the only protein, which was observed at the ciliary basal body in ciliated non-
dividing cells. In non-ciliated cells within the same population ITM2B and PSMC1 also co-
localised with α tubulin (which was used as the ciliary marker in ciliated cells) in a dotted 
pattern reminiscent of MTOCs. The results in the previous chapter demonstrated that, in 
dividing cells, TOPORS and its interacting protein partners localise to the same non-membrane-
bound organelles, specifically the centrioles, therefore supporting the outcomes of the coIP 
studies. 
The purpose of the current chapter is to evaluate the localisation of the novel interacting 
partners of TOPORS in retinal tissue cryo-sections. Although co-IPs and immuno-localisation in 
cells can provide some degree of confirmation towards the interaction in question, to begin to 
understand the biological significance and relevance of the identified interacting proteins, it is 
important to determine how and where they localise in the tissue of interest. In this case the 
tissue affected by mutations in the gene of interest, TOPORS, is the retina. Murine and primate 
retinae were used for co-localisation studies. 
The first objective was to perform an optimisation of the immuno-histochemical staining and 
the preparatory procedures. This was achieved by repeating the immuno-staining experiment, 
which previously demonstrated retinal localization of TOPORS at the connecting cilium 
(Chakarova et al., 2011), using the same antibody (Abnova #H00010210-M01). Additionally, 
a co-staining was performed with PNA (marker for cone photoreceptors). A signal, strongly 
resembling the previously demonstrated retinal localisation of TOPORS at the connecting 
cilium (CC) of the photoreceptor layer, was observed in mouse sections (Figure 8-1). This 
experiment was used as an overall positive control for subsequent tissue staining studies. 
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Figure 8-1. TOPORS and PNA staining: C57 Black 6 mouse retina section (2 weeks old at time of tissue 
collection). 
TOPORS signal is observed at the CC, whereas peanut agglutinin (PNA) is a cone marker. OS, rod 
photoreceptor outer segment; CC, rod photoreceptor connecting cilium; IS, rod photoreceptor inner 
segment; ONL, outer nuclear layer. Scale bar: 25 µm. Nuclei stained using DAPI. Confocal microscope 
images. Secondary antibody control images were collected using the same settings and generated no 
signals in the red and green channels. 
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8.1 RETINAL LOCALISATION OF ITM2B 
Previously, the localisation of ITM2B in the retina was detected in the inner retinal layers, with 
highest intensity in the ganglion cell layer (Audo et al., 2013). In this study, immuno-
fluorescence staining experiments were performed using the ITM2B C-term antibody (Abgent 
# AP13163b). In young mice (2 weeks), the strongest ITM2B signal was observed in 
the photoreceptor cell layer, in what looks to be the inner segment (IS): however, some signal 
was also detected in the outer plexiform layer (OPL), inner plexiform layer (IPL), and the 
ganglion cell layer (GCL) (Figure 8-2). Heat-induced epitope retrieval (HIER) treatment of adult 
(6.5 months) mouse sections resulted in a higher intensity ITM2B C-term signal also in the GCL 
(Figure 8-3), as was previously reported.  
It must be emphasised that Audo et al. (2013) used the Sigma-Aldrich # HPA029292 antibody. 
As was indicated in Table 7-1 (Chapter 7), in addition to full-length ITM2B presumably detected 
by both antibodies, the Sigma-Aldrich # HPA029292 antibody is expected to detect ITM2B 
fragments that the Abgent # AP13163b antibody is not able to bind to; specifically, 
the membrane-bound ITM2B N-terminal fragment (NTF) and the ITM2B secreted C-term 
domain (SCD). It cannot be excluded that the differences in the observed localisation patterns 
result from the possibility that ITM2B NTF is highly abundant within cellular membranes of 
the ganglion cell layer due to the ITM2B being more readily processed in these neuronal cells 
(relative to other cell types). Hence, a stronger signal was detected there with the Sigma-
Aldrich # HPA029292 antibody in comparison to other retinal layers.  
On the contrary, the similar-looking signal presented in this chapter, in the image of the HIER-
treated section (Figure 8-3), would be representative of ITM2B protein prior to ADAM10 
cleavage, i.e. inclusive of the BRICHOS domain since the Abgent # AP13163b antibody would 
not bind to ITM2B NTF (Table 7-1).  
Co-staining with TOPORS (Figure 8-4) allowed further dissection of the ITM2B signal observed 
in Figures 8-2 and 8-3 at the photoreceptor cell layer. In Figure 8-4 the most distinct signal 
appeared to be located in the inner segments, with some overlap with TOPORS signal at the 
connecting cilium as indicated by the yellow signal (lower panel). A weaker overlap of the 
TOPORS-ITM2B signals was also observed in the ganglion cell layer and both plexiform layers. 
ITM2B localisation was also tested in primate retinal sections (Figure 8-5). The signals co-
localised at regions appearing to correspond to rod photoreceptor outer segments, as 
indicated by the yellow staining. The ITM2B reactivity is particularly distinct at a region, which 
Identification of Interacting Protein Partners of TOPORS in the Retina   ||   Barbara Czub 
PhD Thesis 2015   ||   Retinal Tissue Localisation Studies    - 320 - 
 
could represent either rod inner segments, or cone outer segments, confirming observations in 
the mouse retinae (Figures 8-2 and 8-3), and it also seems to be present in the RPE (Figure 8-5, 
lower panel). Intense ITM2B staining is additionally observed in a few cells in the ganglion cell 
layer; weak TOPORS signal is observed at the same location. Overall, ITM2B immuno-staining 
of primate retinal sections demonstrated strong immuno-reactivity in the inner and outer 
segments of photoreceptor cells as well as the ganglion cell layer. 
Overall, in retinal sections obtained from mice, which were two weeks old at time of tissue 
collection, the most intense ITM2B signal was observed in what appear to be the rod inner 
segments and/or cone outer segments as well as the plexiform layers (Figures 8-2 A and 8-3). 
In summary, ITM2B co-localised with TOPORS in the photoreceptor cells as well as the retinal 
ganglion cells in both: murine and macaque retinae. These findings are discussed at the end of 
the current experimental chapter (section 8.4.1). 
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Figure 8-2. ITM2B and PNA (marking cone photoreceptors) staining: C57 Black 6 mouse retina section (2 
weeks old at time of tissue collection).  
ITM2B and PNA signals overlap partly at the level of the cone cells. Weaker ITM2B signal is additionally 
observed at both plexiform layers and the GCL. PR, photoreceptor outer and inner segments; ONL, outer 
nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer; GCL, 
ganglion cell layer. Scale bar: 40 µm. Nuclei stained using DAPI. Confocal microscope images. Secondary 
antibody control images were collected using the same settings and generated no signals in the red and 
green channels. 
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Figure 8-3. ITM2B staining: C57 Black 6 mouse retina section (6.5 weeks old at time of tissue collection) 
subject to heat-induced epitope retrieval (HIER).  
ITM2B immuno-staining is observed throughout the retina; the signal is more distinct in the PR layer, the 
GCL and the regions of OPL and IPL immediately adjacent to the INL (peri-nuclear staining within the 
latter is also apparent). The ITM2B immuno-reactive signal at the GCL is magnified in the lower panel. 
PR, photoreceptor outer and inner segments; ONL, outer nuclear layer; OPL, outer plexiform layer; INL, 
inner nuclear layer; IPL, inner plexiform layer; GCL, ganglion cell layer. Scale bars: 40 µm. Nuclei stained 
using DAPI. Confocal microscope images. Secondary antibody control images were collected using the 
same settings and generated no signals in the red and green channels. 
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Figure 8-4. TOPORS and ITM2B staining: C57 Black 6 mouse retina sections (2 weeks old at time of tissue 
collection). 
Upper panel: ITM2B and TOPORS signal do not overlap; assuming that TOPORS immuno-staining is 
specific to the connecting cilium, ITM2B signal is limited to PR inner segments. Lower panel: As in the 
upper panel, ITM2B signal appears the strongest in the presumed inner segments; however, in this 
section there is an overlap with TOPORS signal at a region with could represent the connecting cilia 
and/or the outer segments. Diffuse weak signal, generated by both antibodies is observed in both 
plexiform layers and the GCL. PR, photoreceptor outer and inner segments; ONL, outer nuclear layer; 
OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer; GCL, ganglion cell layer. 
Scale bars: 38 µm. Nuclei stained using DAPI. Confocal microscope images. Secondary antibody  control 
images were collected using the same settings and generated no signals in the red and green channels. 
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Figure 8-5. ITM2B & TOPORS co-staining in primate (Macaca fascicularis) retina section – kindly provided 
by Prof. Glen Jeffery (section details: #2, 992G, young, 6 & 7, 10 µm, peripheral retina). 
ITM2B and TOPORS co-localise in the OS and the GCL; TOPORS signal is weaker in the latter, thus the co-
localisation is not immediately apparent. OS, rod photoreceptor outer segment; IS, rod photoreceptor 
inner segment; ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner 
plexiform layer; GCL, ganglion cell layer. Scale bar: 30 µm. Nuclei stained using DAPI. Upper and lower 
panels show magnified regions of co-localisation. Confocal microscope images. Secondary antibody 
control images were collected using the same settings and generated no signals in the red channel, but 
a faint signal was observed in the region of photoreceptor outer segments. 
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8.2 RETINAL LOCALISATION OF PTGDS 
Previous studies in chick and rat retinae demonstrated that PTGDS was produced in the RPE, 
released into the inter-photoreceptor matrix, and taken up by the photoreceptor cells 
(Yamakawa e Ogino, 1986; Goh et al., 1987; Beuckmann et al., 1996; Shiroma et al., 1996). 
Here, immunofluorescent staining of the mouse and macaque retinae, using the already 
described PTGDS antibody, revealed PTGDS immuno-reactivity throughout the retinal layers, 
but excluding the outer and inner nuclear layers (ONL and INL) (Figures 8-6, 8-7, 8-8 and 8-9).  
No co-localisation with PNA was observed (Figure 8-6), whereas co-staining with TOPORS 
(Figure 8-7) showed some overlap of the two signals at the regions of the inner segment and 
connecting cilium (indicated by the yellow staining). Further analysis showed consistent signal 
for PTGDS through the inner segment, co-localising with TOPORS at the region of 
the connecting cilium (Figure 8-8).  
This immuno-staining additionally confirmed the integrity of the outer retina, and revealed 
faint PTGDS signal from the outer segment. This outer segment signal could have been due to 
the auto-fluorescence based on the nature of the outer segment themselves; however, there 
was also some PTGDS signal noted along the axoneme in ciliated hTERT-RPE1 cells (Figure 7-
20). Since photoreceptor outer segments (together with the connecting cilia) form highly 
specialised primary cilia, it is reasonable to assume that the weaker signal seen in the outer 
segments is true. PTGDS signal was also observed at the plexiform layers, as in earlier figures.  
Staining of the primate retinal section revealed PTGDS signal throughout the entire retina (but 
excluding the inner and outer nuclear layers), with immuno-reactivity observed at the RPE, 
photoreceptor cells, both plexiform layers and the ganglion cell layer (Figure 8-9). PTGDS and 
TOPORS signals were co-localising at the photoreceptor outer segments. Some TOPORS signal, 
which overlapped with PTGDS signal, was also observed in the plexiform layers and 
the ganglion cell layer, but it was much less abundant than the PTGDS reactivity.   
In summary, PTGDS signal was consistently observed in the plexiform layers, the ganglion cell 
layer and the inner segment, connecting cilium region and outer segment of photoreceptors in 
both: mouse and primate retinae. Furthermore, in the inner segment/connecting cilium region 
in mouse the PTGDS and TOPORS signals overlap. Additionally, signal in the adult mouse retina 
appears much stronger than in sections from the young mouse or the primate. These findings 
are discussed at the end of the current experimental chapter (section 8.4.2). 
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Figure 8-6. PTGDS and PNA staining: C57 Black 6 mouse retina section (2 weeks old at time of tissue 
collection). 
Strongest PTGDS signal is observed in both the plexiform layers, and at the GCL. PTGDS immuno-
reactivity at the PR layer is weaker. PR, photoreceptor outer and inner segments; ONL, outer nuclear 
layer; OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer; GCL, ganglion cell 
layer. Scale bar: 30 µm. Nuclei stained using DAPI. Confocal microscope images. Secondary antibody  
control images were collected using the same settings and generated no signals in the red and green 
channels. 
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Figure 8-7. TOPORS and PTGDS staining: C57 Black 6 mouse retina sections (2 weeks old at time of tissue 
collection). 
Some overlap of PTGDS and TOPORS signal is observed at the PR layer, possibly at the interface between 
the inner segments and connecting cilia (both: upper and lower panels). Strong yellow co-localisation 
signal was also detected in the region most likely to be the choroid (upper panel). TOPORS and PTGDS 
also co-localised at the GCL; strong PTGDS reactivity was also observed throughout both plexiform 
layers (lower panel). Ch., choroid; RPE, retinal pigment epithelium; PR, photoreceptor outer and inner 
segments; ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner 
plexiform layer; GCL, ganglion cell layer. Scale bars: 38 µm. Nuclei stained using DAPI. Confocal 
microscope images.. Secondary antibody control images were collected using the same settings and 
generated no signals in the red and green channels. 
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Figure 8-8. PTGDS and TOPORS staining in C57 Black 6 mouse retina sections (6.5 months old at time of 
tissue collection). 
Strong PTGDS signal observed throughout the retinal layers (apparently more intense that in young 
mouse retina: Figures 8-6 and 8-7), co-localising with TOPORS at the IS and/or the connecting cilia 
(magnified in the lower panel). RPE, retinal pigmented epithelium; OS, rod photoreceptor outer 
segment; IS, rod photoreceptor inner segment; ONL, outer nuclear layer; OPL, outer plexiform layer; INL, 
inner nuclear layer; IPL, inner plexiform layer; GCL, ganglion cell layer. Top panel scale bar: 30 µm. 
Bottom panel scale bars: 8 µm. Nuclei stained using DAPI. Confocal microscope images. Secondary 
antibody  control images were collected using the same settings and generated no signals in the red 
channel; some faint signal was observed in the green channel (shown in the lower panel: -ve ctrl, 
negative control). 
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Figure 8-9. PTGDS & TOPORS staining in primate (Macaca fascicularis) retina sections (slide details: #2, 
992G, young, 6 & 7, 10 µm, periphery – kindly provided by Prof. Glen Jeffery). 
Signals co-localise at OS (both: upper and lower panels) as well as GCL, where TOPORS reactivity was 
weaker (lower panel). The PTGDS staining was additionally visible at plexiform layers, and it was 
especially distinct at the IPL. RPE, retinal pigment epithelium; OS, rod photoreceptor outer segment; IS, 
rod photoreceptor inner segment; ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner 
nuclear layer; IPL, inner plexiform layer; GCL, ganglion cell layer. Scale bar: 30 µm. Nuclei stained using 
DAPI. Confocal microscope images. Secondary antibody control images were collected using the same 
settings and generated no signals in the red channel, but a faint signal was observed in the region of 
photoreceptor outer segments. 
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8.3 RETINAL LOCALISATION OF PSMC1 
Interestingly, no PSMC1 staining was observed in retinal sections of young (2 weeks old) mice 
(data not shown). This may be due to inadequate tissue fixation and putative lack of 
compatibility with the antibody; however, it could also reflect a genuine absence of the PSMC1 
protein from the young mouse retina. Attempts to optimise the antibody conditions (i.e. by 
antigen retrieval, data not shown) did not alleviate this issue. 
Staining using the adult mouse retina did however show a signal: the signal observed in 
the adult appears to be very specifically localised at the interface between the photoreceptor 
outer segment and the RPE layer (Figure 8-10). This was considered a very promising 
observation since PSMC1 acts as a regulatory subunit of the proteasome. Moreover, 
the PSMC1 is involved in the ER-phagosome pathway, in which the ER fuses with the cell 
membrane to aid in forming nascent phagosomes. This function is conserved in PSMC1 
orthologues of yeasts, plants, rodents and humans (UniProtKD). 
Thus, its localisation to the tips of the outer segment and/or the apical RPE1 surface could 
indicate that it is actively involved in recycling of the tips of the outer segments. 
The PSMC1 immuno-reactivity at the RPE-OS interface was also observed, when the retinal 
sections were subject to heat-induced epitope retrieval (HIER). However, this treatment 
additionally resulted in PSMC1 signal being detected in the photoreceptor inner segments 
(Figure 8-11). Immuno-staining of a primate retinal section (not subject to HIER treatments) 
was attempted, but it did not yield positive results (data not shown). 
Overall, findings described in this section indicate that PSMC1 is possibly down-regulated in 
young retinae, as PSMC1 immuno-reactivity was not detected in retinal cryo-sections obtained 
from the two-week-old mouse (data not shown). Alternatively, this could have been a false 
negative result, obtained, for instance, due to the antigen being inaccessible to the antibody. 
The latter could also explain a lack of reactivity with the primate retinal section (data not 
shown). 
In adult mouse retinal sections strong PSMC1 signal was observed at the RPE-OS interface. 
Additional PSMC1 immuno-staining was detected in the inner segments of photoreceptors, 
following a heat treatment of the cryo-sections, aiming to retrieve the antigens. These findings 
are discussed at the end of the current experimental chapter (section 8.4.3). 
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Figure 8-10. PSMC1 and TOPORS co-staining: C57 Black 6 mouse retina sections (6.5 months old at time 
of tissue collection). 
Upper panel: PSMC1 signal was observed at the interface between rod OS and the RPE; whereas 
TOPORS signal was observed throughout the inner and outer segments (IS and OS) and it was most 
intense at their interface where the connecting cilia (CC) reside; additional TOPORS signal was seen in 
the retinal ganglion cell layer (GCL). Scale bar: 30 µm. Lower panel: PSMC1 signal was observed at 
the interface between rod OS and the RPE; localisation was determined using the DIC image. Scale bar: 
10 µm. RPE, retinal pigment epithelium; OS, rod photoreceptor outer segment; IS, rod photoreceptor 
inner segment; ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner 
plexiform layer; GCL, ganglion cell layer. Nuclei stained using DAPI. Confocal microscope images. 
Secondary antibody control images were collected using the same settings and generated no signals in 
the red and green channels. 
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Figure 8-11. PSMC1 and TOPORS co-staining: C57 Black 6 mouse retina section (6.5 months old at time 
of tissue collection) subject to heat-induced epitope retrieval (HIER). 
Some PSMC1 immuno-reactivity is apparent at the interface between the OS and the RPE, as was 
observed in sections not treated to retrieve antigens (Figure 8-10). However, following antigen retrieval, 
strong PSMC1 signal was observed in the IS. RPE, retinal pigment epithelium; OS, rod photoreceptor 
outer segment; IS, rod photoreceptor inner segment; ONL, outer nuclear layer; OPL, outer plexiform 
layer; INL, inner nuclear layer. Secondary antibody control images were collected using the same 
settings and generated no signals in the red and green channels. 
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8.4 DISCUSSION 
The current chapter described data suggesting that, in mammalian retinae, ITM2B, PTGDS and 
PSMC1 could all interact with TOPORS at the basal body of the photoreceptor connecting 
cilium, based on the observed localisation patterns (Figures 8-4, 8-7, 8-8 and 8-11).  
Furthermore, immuno-reactivity of in the primate retinal sections demonstrated strong 
TOPORS signal in the photoreceptor outer segments, which overlapped with ITM2B as well as 
PTGDS signals (Figures 8-5 and 8-9, respectively). 
ITM2B immuno-reactivity was additionally observed at the ganglion cell layer (Figures 8-2, 8-3, 
8-4 and 8-5), where the signal overlapped with TOPORS staining (Figures 8-4 and 8-5: TOPORS 
signal weaker in comparison to ITM2B signal). PTGDS immuno-staining also showed reactivity 
in the plexiform layers and the ganglion cell layer, where co-localisation was seen with 
the weaker TOPORS signal (Figures 8-7, 8-8 and 8-9). 
PSMC1 signal was observed at the interface of distal regions of photoreceptor outer segments 
and the RPE (Figure 8-10), as well as in photoreceptor inner segments (Figure 8-11), but 
the latter was observed only following antigen retrieval by heat treatment. Attempts to 
elucidate the PSMC1 immuno-staining pattern in young mice (2 weeks of age), or in primate 
retinae, were unsuccessful (data not shown). 
A summary of the observed localisation patterns is included in Table 8-1, whereas the putative 
functions and significance of TOPORS interactors at the observed retinal layers are discussed 
individually in the following sections. 
The phenotype associated with TOPORS mutations in human appears to affect predominantly 
the retina, and, at later stages, also the choroid (Chakarova et al., 2007; Chakarova et al., 
2011). This phenotype have been puzzling as, in the retina, TOPORS was shown to localise to 
the basal body of the connecting cilium in rod photoreceptor cells (Chakarova et al., 2011).  
Given the fact that dysfunctions in components of the intraflagellar transport (IFT) system 
previously showed to affect cilia function overall, leading to syndromic ciliopathies, rather than 
being limited to photoreceptors (reviewed in: Sung e Chuang, 2010), it should be concluded 
that TOPORS is not involved in transport of cargo through the cilium, or rather from the cilium 
to the cytoplasm. The association of TOPORS with the dynein–dynactin complex proteins, 
demonstrated by Chakarova et al. (2011), could have, consequently, represented 
the involvement of TOPORS in transport of cargoes from the cytoplasm towards the base of 
the cilium. 
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Table 8-1. Summary of interactors’ localisation in retinal tissues.  
Key: PR, photoreceptor; PNA, peanut agglutinin; RPE, retinal pigment epithelium; OS, rod photoreceptor 
outer segment; CC, connecting cilium; IS, rod photoreceptor inner segment; ONL, outer nuclear layer; 
OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer; GCL, ganglion cell layer; 
HIER, heat-induced epitope retrieval. 
 
ITM2B PTGDS PSMC1 
Mouse 
sections – 
2 weeks 
old 
Localised at the PR cell layer, where 
partial signal overlap was observed 
with PNA (cone marker) (Figure 8-2) 
and TOPORS at the distal/outer part 
of PR layer, indicating it could be 
the CC and/or OS (Figure 8-4, lower 
panel). Localised at the plexiform 
layers (both OPL and IPL) and the GCL 
(Figure 8-2), where the signal 
appeared granular and partial signal 
overlap was observed with TOPORS 
(Figure 8-4, lower panel). In one 
section ITM2B and TOPORS signals 
were observed adjacent to each 
other, but not co-localising (Figure 8-
4, upper panel). 
Localised at both plexiform layers (where 
some higher intensity granular signals 
were observed overlaying the overall 
diffuse signal: Figure 8-7), the GCL and 
the PR cell layer (Figure 8-6, lower panel), 
as well as the RPE layer (Figure 8-7). 
At the PR layer PTGDS did not co-localise 
with PNA (cone marker; Figure 8-6); 
however, it did co-localise with TOPORS 
at the distal/outer part of PR layer, 
indicating it could be the CC and/or OS 
(Figure 8-7). 
Co-localisation of PTGDS and TOPORS 
signals was also observed within cells of 
the choroid (Figure 8-7; upper panel). 
No PSMC1 signal was 
observed at all (data 
not shown). 
Mouse 
sections – 
6.5 
months 
old 
In sections subject to HIER, ITM2B 
immuno-staining was observed 
throughout the retina, where the 
signal was most distinct within the PR 
layer, the GCL and the regions of OPL 
and IPL immediately adjacent to the 
INL (Figure 8-3).   
Localised at the plexiform layers (both 
OPL and IPL), the GCL and at the PR cell 
layer (Figure 8-8). At the PR layer PTGDS 
co-localised with TOPORS in a pattern 
strongly indicative of the CC (Figure 8-8; 
lower panel). 
Localised at the RPE-
OS interface only 
(Figures 8-10). 
In sections subject to 
HIER, PSMC1 immuno-
staining was observed 
in IS as well as 
the RPE-OS interface; 
here, an overlap with 
TOPORS signal was 
seen at the apical IS 
regions (Figure 8-11). 
Macaque 
sections – 
young 
adult 
Co-localised with TOPORS at PR cell 
layer, resembling the OS, the RPE, 
and the GCL (peri-nuclear signals). 
Additionally localised at plexiform 
layers (both OPL and IPL), where 
the signal appeared granular; higher 
intensity signals were also observed 
at the interface between OPL and INL 
(Figure 8-5). 
Localised at both plexiform layers 
(stronger signal at IPL), the GCL and at 
the PR cell layer, as well as the RPE layer 
(Figure 8-9); signal intensity was 
the greatest in the OS and in the IPL. 
TOPORS was observed in the PR OS layer 
and, to a lesser extent, in the plexiform 
layers and the GCL. PTGDS and TOPORS 
co-localised at the OS layer (both strong 
signals), as well as the GCL (strong PTGDS 
signal and weak TOPORS signal). 
No PSMC1 signal was 
observed at all (data 
not shown). 
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This would be supported by the proteins’ Gene Ontology (GO) Biological Processes and 
Functions, which include: 
- Retrograde transport from endosome to Golgi apparatus (p150glued, Dynactin subunit 
1: Q14203); 
- Organelle organisation (p50-dynamitin; dynactin subunit 2: Q13561); 
- Vesicle transport along microtubules (cytoplasmic dynein 1 intermediate chain 1: 
O14576); 
- Microtubule-based movement (cytoplasmic dynein 1 intermediate chain 2: Q13409). 
Whereas in most cells, which possess primary cilia, a certain extent of redundancy probably 
exists regarding protein transport towards the cilium, in photoreceptors an impairment of one 
of the transport systems could be expected to lead to degeneration due to the unusual (for 
terminally differentiated cells) requirement of these cells for constant biosynthesis and 
delivery of rhodopsin to their outer segments. In fact, Kong et al. (2013) previously showed in 
mice that a knock-down of dynein light intermediate chain (DLIC, DYNC1LI), a component of 
the dynein multimer, leads to photoreceptor dysfunction; however, it is not lethal despite 
ubiquitous expression and function. Specifically, the findings showed that the knock-down 
resulted in impaired photoreceptor ciliogenesis, as well as an impaired transport of outer 
segment proteins from the Golgi apparatus to the basal body of the cilium. 
Furthermore, the mouse model showed that deficiency of the dynein light intermediate chain 
resulted in defective trafficking of Rab11 vesicles to the base of the cilium in photoreceptor 
cells (Kong et al., 2013). The photoreceptor outer segments have a great biosynthestic 
requirement not only for proteins (mostly rhodopsin), but also for lipids. Mayhew and Astle 
(1997) showed in rat that in order to maintain the photoreceptor outer segment renewal, 
77 cm2 of disc membrane must be synthesised per day per rat retina (cited in: Sung e Chuang, 
2010) containing 3 x 107 photoreceptors. Malfunctioning vesicular trafficking to the base of 
the connecting cilium, which TOPORS appears to be involved in, would negatively affect 
the renewal of the disc membranes in photoreceptors outer segments. 
The associated GO terms (UniProtKB), specifically melanosome transport, also suggest a key 
role for the dynein–dynactin complex along with the associated TOPORS protein in the retinal 
pigmented epithelial (RPE) layer due to the involvement of p150glued and p50-dynamitin in 
the above-mentioned process. A dysfunction of the melanosome transport in the RPE would 
make this cell layer more prone to light-induced stress, and consequently deterioration of RPE 
function and, eventually, retinal degeneration. This process could to some extent occur 
Identification of Interacting Protein Partners of TOPORS in the Retina   ||   Barbara Czub 
PhD Thesis 2015   ||   Retinal Tissue Localisation Studies    - 336 - 
 
naturally in aging RPE cells, contributing to symptoms of age-related macular degeneration 
(AMD). The age component would explain why TOPORS mutations do not always manifest in 
early age, especially that protein quality control processes decline with age (Balch et al., 2008; 
Rezvani et al., 2012).  
On the other hand, impaired melanosome transport, could help explain the perivascular retinal 
dystrophy, observed in children affected by TOPORS mutations. With age this phenotype 
disappeared (but the retina also degenerated further), suggesting that possibly 
the melanosomes were being subject to autophagy within the RPE cells. Once, this removal 
system became over-loaded, the RPE cells would begin to die, but they melanin pigment would 
be visible. Nonetheless, it would be more difficult to explain why this type of dystrophy should 
display only a peri-vascular pattern. This concept will be evaluated further in section 8.4.3 of 
this discussion in context of the PSMC1 protein being involved in the ER-phagosome pathway 
(function conserved in eukaryotes: UniProtKD) as well as in responses to light-induced stress, 
demonstrated in plant cells (Lee, K. H. et al., 2012). 
Finally, given the nature and purpose of photoreceptor cells, it cannot be excluded that 
the localisation of TOPORS’ interactors within the photoreceptor cells, is at least partly 
dependent on light exposure. The light-dependent translocation of transducin, arrestin and 
recoverin have been established and characterised (Calvert et al., 2006). The light-driven 
protein translocation process also seems to happen exclusively in photoreceptor cells; notably, 
it is conserved in the Drosophila rhabdomeres, which are actin-based microvilli (Sung e 
Chuang, 2010), rather than microtubule-based cilia, as is the case in vertebrate 
photoreceptors, suggesting convergent evolution, and thus an important function.  
TOPORS was also previously observed to be differentially localised within photoreceptor cells, 
depending on whether the retina had been exposed to light or not. Specifically, in light-
adapted mice TOPORS was always observed at the connecting cilium of photoreceptor cells, 
whereas its localisation was widespread in the retinae of dark-adapted mice, and, notably, it 
excluded the connecting cilium (Dr Amna Z. Shah: personal communication). It could be 
speculated that the novel interactors of TOPORS may display analogous light-dependent 
localisation patterns. 
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8.4.1 EVALUATION OF ITM2B LOCALISATION 
In all three types of sections tested: the young two-week-old mouse, the adult mouse and 
the young adult macaque similar ITM2B reactivity pattern was observed. Specifically, ITM2B 
and TOPORS co-localised in the apical area of photoreceptor inner segments, or the connecting 
cilia, in mice, and in the outer segments in primate, as well as fragments of the plexiform 
layers and the ganglion cell layer. No distinct age-related staining pattern was observed, 
however, HIER treatment significantly enhances ITM2B reactivity in the adult mouse. The focus 
of this discussion is on the photoreceptor localisation due to the hypothetical key role of 
TOPORS at the connecting cilium. 
Firstly, it appears that the localisation of ITM2B at the apical inner segment region, possibly 
the ciliary basal body, is not in agreement with findings from the cellular localisation studies 
(Chapter 7). In the hTERT-RPE1 cells it was shown that ITM2B was associated with centrioles in 
dividing cells (Figures 7-6, 7-7, 7-8, 7-9 and 7-10); however, it did not localise to the base of 
primary cilium in quiescent ciliated cells (Figure 7-11). Nonetheless, it cannot be excluded that 
the result from the cell culture studies as well as the finding from the tissue immuno-staining 
are both true. For example, it was previously shown by Chuang and Sung (1998) that targeting 
of rhodopsin to the primary cilia is less efficient in ciliated epithelial cells, in comparison to 
photoreceptors. Furthermore, the apical localisation of ITM2B in photoreceptors may depend 
of a post-translational modification, which perhaps does not occur in the hTERT-RPE1 cells.  
For instance, Li et al. (2012) showed in worm that targeting of sensory receptors to primary 
cilia depends on SUMOylation of Arl-13 (homologue of Arl13b). TOPORS did not interact with 
Arl13b in the Y2H screen (which could also be a false negative results, as these can never be 
excluded); however, it might be involved in SUMOylation of another small GTPase, involved in 
vesicular trafficking to primary cilia, or specifically the photoreceptor connecting cilia, which in 
turn could affect the ciliary targeting of other proteins, such as ITM2B. It could be speculated 
that the pathways of protein interactions and or modifications, necessary for ITM2B targeting 
to cilia, occur only in neuronal cell types, hence, no localisation to base of the cilium was 
observed in Figure 7-11. 
Furthermore, it was shown that the phosphorylation status of small GTPases involved in ciliary 
targeting could influence their affinity for ciliary-targeted cargoes; e.g. Rab8-GDP binds ciliary-
targeting sequences (CTS) of other proteins more readily than Rab8-GTP does (Hsiao, Tuz e 
Ferland, 2012). ITM2B possesses a total of three conserved CTS motifs of the same type as 
Identification of Interacting Protein Partners of TOPORS in the Retina   ||   Barbara Czub 
PhD Thesis 2015   ||   Retinal Tissue Localisation Studies    - 338 - 
 
the one found in rhodopsin, i.e. ‘VxPx’ (Figures 8-12 and 8-13). The precise location of these 
motifs within the ITM2B protein structure was shown in Figure 6-5 (Chapter 6). 
 
Figure 8-12. ITM2B CTS#1: AA44 – AA46. Species and CTS are boxed inside purple rectangles.  
Key: Hum, human; Xentrop, western clawed frog (Xenopus tropicalis); Musmus, mouse (Mus musculus); 
Pantrog, common chimpanzee (Pan troglodytes); Macmul, rhesus macaque (Macaca mulatta);  Bostau, 
cattle (Bos taurus); Canfam, family Canidae (includes dogs and wolves); Scrofo, wild boar (Sus scrofa); 
Danrer, zebrafish (Danio rerio); Galgal, chicken (Gallus gallus); Dromel, fruit-fly (Drosophila 
melanogaster). Note: p.Val44del is reported on Ensembl (in frame); source: NHLBI Exome Sequencing 
Project (ESP). PRALINE alignment – a modified snapshot (Simossis, Kleinjung e Heringa, 2003). 
 
 
Figure 8-13. ITM2B CTS#2 and #3. Species and CTS are boxed inside purple rectangles.  
Key: Hum, human; Xentrop, western clawed frog (Xenopus tropicalis); Musmus, mouse (Mus musculus); 
Pantrog, common chimpanzee (Pan troglodytes); Macmul, rhesus macaque (Macaca mulatta);  Bostau, 
cattle (Bos taurus); Canfam, family Canidae (includes dogs and wolves); Scrofo, wild boar (Sus scrofa); 
Danrer, zebrafish (Danio rerio); Galgal, chicken (Gallus gallus); Dromel, fruit-fly (Drosophila 
melanogaster). Note: p. Ile167Thr and p.Val174Ile are reported on Ensembl; source: dbSNP (NCBI). [AA 
numbers refer to human protein sequence on Ensembl]. he missense change resulting in Ile instead Thr 
in CTS#1 would probably not affect the ciliary targeting, whereas the change to CTS#2 may well cause 
disruption as Val is a conserved part of the consensus sequence.  PRALINE alignment – a modified 
snapshot (Simossis, Kleinjung e Heringa, 2003). 
 
Secondly, it is important to emphasise that lack of peri-nuclear ITM2B immuno-reactive 
staining in rod photoreceptors is not conflicting with the perinuclear staining evident in 
the second and third order neurons of the inner retinal layer and the ganglion cell layer 
(Figures 8-2, 8-3, 8-4 and 8-5). Being a membrane-bound protein, ITM2B is synthesised on 
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the ER membranes and processes in the Golgi apparatus. In canonical nerve cells these 
membranous organelles are found within the cell body proximally to the nucleus, which is also 
observed in dividing cells. Photoreceptors are highly specialised neurons, modified in such 
a way that, except for the nucleus, which resides in the cell body like in typical neurons, 
the majority of its organelles are located within the inner segments. Hence, the observed 
retinal localisations actually provide indirect evidence that ITM2B is very likely associated with 
membranes of the ER and the Golgi body.  
It should also be noted that in some of the photographed mouse sections, the ITM2B immuno-
staining appears restricted to the inner segment and is only proximal to, but not overlapping 
with, the TOPORS signal marking the connecting cilium (Figure 8-4, upper panel). On the other 
hand, TOPORS-ITM2B co-staining of other sections from the same animal demonstrated 
an undisputable co-localisation (Figure 8-5, lower panel). As both of the presented sections 
originated from the same young mouse, it cannot be speculated that this apparent 
inconsistency of signals is due to putative light-induced translocation, which would have been 
an attractive hypothesis. However, it could be speculated that a differential expression 
gradient of ITM2B occurs across the retina, resulting in one localisation pattern nearer 
the central retina, and changing towards the periphery. Such a spatial expression patterning 
was previously shown in mouse cones for genes encoding the M and S opsins (Applebury et al., 
2000), therefore, it should not be excluded that similar differential patterning occurs also in 
case of other genes and in other retinal cell types.   
Additionally, the ITM2B signal within the plexiform layers appeared granular both in murine 
and primate retinae (Figures 8-2, 8-3 and 8-5), and appeared especially distinct in the primate 
(Figure 8-5). This granular staining pattern could be indicative of the association of ITM2B with 
intracellular vesicles, as was previously demonstrated in neuronal cell cultures (Choi et al., 
2004). Nonetheless, according to these previously published findings, only the smallest 
carboxy-terminal, CTPP (Figure 6-5, Chapter 6) fragment of ITM2B is transported within 
the vesicles along the neuronal axons. Only a few amino acids from this CTPP are included 
within the epitope, which was used to raise the Abgent # AP13163b: ITM2B C-term antibody, 
therefore, it is unlikely that the signal observed in the retinal sections corresponds to this 
fragment on its own. Nonetheless, impairment of vesicular trafficking has been shown to be 
a significant contributor to retinal degenerations (Sung e Chuang, 2010; Wright et al., 2010).  
As was already specified, photoreceptor cells are modified neurons, and possess some unique 
features, such as the outer segment acting as a highly specialised primary cilium. This 
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exceptional organelle is the site of onset of photoreception, i .e. when photons of light hit 
the opsin molecules within the outer segments, this triggers a cascade of reactions, which 
result in visual perception upon reaching the brain. Remarkably, photoreceptors lack 
dendrites, which serve as signal receivers in the canonical neuronal types. Choi et al. (2004) 
showed that in neuronal cell culture, ITM2B stimulates neurite outgrowth. It would be 
interesting to investigate whether it could similarly stimulate primary cilia growth. If 
the answer was positive, this would allow speculating that the role of ITM2B in photoreceptor 
cells is to stimulate the growth of the outer segment, which is a specialised primary cilium, and 
is functionally analogous to dendrites in context of neurons. The outer segments undergo 
constant renewal necessary due to the light-induced oxidative stress, which they encounter, 
and stimuli, which trigger this constant outer segment production must persist for correct 
photoreceptor functioning. 
If the above hypothesis was true, then the role of TOPORS in the described process would be 
purely regulatory. It would be expected to degrade ITM2B and/or its fragment(s), when 
the latter is no longer needed, or when less of it is needed. Such a role would be supported by 
the Y2H study results, which showed that ITM2B interacted most strongly with the N-term 
TOPORS fragment, conveying its E3 ubiquitin ligase activity, as well as with the C-term 
TOPORS, within which the mutational hotspot is located (Chapter 5, Table 5-16).   
 
8.4.2 EVALUATION OF PTGDS LOCALISATION 
It was initially surprising to observe PTGDS reactivity in the inner retinal layers (Figures 8-6, 8-
7, 8-8 and 8-9) since in a rat retina the immuno-staining for this enzyme generated signal 
mostly in the RPE and, to a lesser extent, in the photoreceptor outer segments, but not in 
other regions of this tissue (Beuckmann et al., 1996). Nonetheless, in an earlier study, Goh et 
al. (1987) demonstrated PTGDS (‘prostaglandin D synthetase of the brain type’ as opposed to 
the ‘GSH-dependent enzyme’) activity was present at high levels throughout the rat eye, 
including its anterior regions and the vitreous humour in addition to the retina and other 
posterior fractions. Thus it cannot be excluded that this enzyme is present within the inner 
retinal layers, even if only due to its presence in the vitreous humour, within which 
the neurons would be immersed. Perhaps lack of reactivity in the tissues tested by Beuckmann 
et al. (1996) could have resulted from a preceding tissue treatment potentially preventing 
antigen accessibility. 
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Furthermore, as was shown in Chapter 5, at least three alternatively spliced variants of PTGDS 
are expressed at mRNA level in the human retina (Table 5-2 in section 5-1) (tissue source 
included both the RPE and the neural retina). It cannot be excluded that the antibody used by 
Beuckmann et al. (1996) could have been specific only to isoform PTGDS-001; whereas 
the antibody used in this project, which was raised against full-length human PTGDS-001 (sc-
30067, Santa Cruz Biotechnology) could perhaps also detect isoforms PTGDS-004 and PTGDS-
005, which share a partial sequence overlap with PTGDS-001 (Figures 5-7 and 5-8 in Chapter 
5). The specificity of the sc-30067 antibody requires further validation also due to 
the unexpectedly large bands observed by Western blotting (Figures 6-9 and 6-10 in Chapter 
6). 
Nonetheless, in this study, in which the antibody raised against full-length human isoform 
PTGDS-001 (sc-30067) was used, PTGDS immuno-reactivity was observed in all retinal layers 
except for the outer nuclear layer (Figures 8-6, 8-7, 8-8 and 8-9) of mouse and primate retinae. 
The signal was strong in both plexiform layers, and weaker in the inner nuclear layer; however, 
the latter probably reflects the fact this region is dominated by neuronal nuclei, which leaves 
little space for cytoplasmic components, thus generating weaker reactivity (Figures 8-7, 8-8 
and 8-9). In mice the signal was also strong in photoreceptor inner segments (Figures 8-6, 8-7 
and 8-8), at the apical end of which the signal co-localised with TOPORS signal (Figures 8-7 and 
8-8).  
In the adult (6.5 months old) mouse the PTGDS signal was also observed in the outer segments 
of photoreceptors, but it appeared weaker there. In the primate section (Figure 8-9) PTGDS 
localised in the plexiform layers and the inner nuclear layer, as already stated, as well as in 
the inner and outer segments of photoreceptor cells. Notably, TOPORS was also observed 
localising in the outer segments (most strongly on its edges) as well as at the apical end of 
the inner segments, assumed to be the connecting cilia. The interesting localisation of TOPORS 
on the edges of outer segments is also visible in Figure 8-5; the potential significance of this 
immuno-reactivity pattern will be discussed in Chapter 9. It is worth noting that the ATP-
binding cassette transporter (ABCR), involved in the recycling of retinal (section 1.2.4), localises 
to rim regions of disc membranes, where is translocates all-trans retinal from disc lumen to 
cytosol. It would be interesting to investigate whether PTGDS (known to bind all-trans retinal) 
(section 4.3.3.2) or TOPORS may participate in this process. 
It was shown that cyclic nucleotide-gated (CNG) ion channels from rod photoreceptors can be 
inhibited by 9-cis and 11-cis retinal. This was prevented by the cellular retinoid binding 
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protein II (CRBP II) (He et al., 2006).  Although PTGDS is not known to bind either the 9-cis or 
the 11-cis retinal, it could be speculated that the retinoids, which it was shown to transport, 
specifically, all-trans- or 9-cis-retinoic acid as well as all-trans- or 13-cis-retinal (Tanaka et al., 
1997), could have a similar putative inhibitory effect on the ion channels, and PTGDS could 
serve as their scavenger. It could be speculated further that this protein may have a similar 
role also in other retinal neurons.   
PTGDS has two ciliary-targeting sequences (CTS) of the same type as those found in rhodopsin, 
i.e. ‘VxPx.’ The first one is conserved in humans, mice and macaques, and, intriguingly, it is 
missing in the chimpanzee PTGDS protein along with a longer preceding peptide fragment 
(Figure 8-14). The second CTS motif appears to be more widely conserved, specifically, in 
human, cattle, mouse, macaque, dog and chimpanzee. The presence of these motifs supports 
the observed localisation of PTGDS at the apical region of inner segments, where it co-localised 
with TOPORS in mouse, as well as in the outer segments, where it co-localised with TOPORS in 
the primate. 
Furthermore, the observed localisation is additionally supported by the findings from cell 
culture studies (Chapter 7), where PTGDS was seen localising at the basal body and along 
the primary cilium (Figure 7-20), or at the tip of this organelle (Figure 7-19). It would be 
interesting to determine whether it is present there as a soluble protein or whether it is 
perhaps anchored to the ciliary membrane via one of its oligosaccharide modifications (PTGDS 
is highly glycosylated: Figure 6-8). Live cell imaging experiment would be a useful tool for 
clarifying this.  
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Figure 8-14. PTGDS CTS#1. Species and CTS are boxed inside purple rectangles.  
Note: p.Gln31Leu is reported on Ensembl; source: dbSNP (NCBI). Key: Hum, human; Xentrop, western 
clawed frog (Xenopus tropicalis); Musmus, mouse (Mus musculus); Pantrog, common chimpanzee (Pan 
troglodytes); Macmul, rhesus macaque (Macaca mulatta);  Bostau, cattle (Bos taurus); Canfam, family 
Canidae (includes dogs and wolves); Scrofo, wild boar (Sus scrofa); Danrer, zebrafish (Danio rerio); 
Galgal, chicken (Gallus gallus); Dromel, fruit-fly (Drosophila melanogaster). PRALINE alignment – 
a modified snapshot (Simossis, Kleinjung e Heringa, 2003). 
 
Figure 8-15. PTGDS CTS#2. Species and CTS are boxed inside purple rectangles. 
Note: p.Val69Met is reported on Ensembl; source: Somatic mutations found in human cancers from the 
COSMIC project (release 67). Key: Hum, human; Xentrop, western clawed frog (Xenopus tropicalis); 
Musmus, mouse (Mus musculus); Pantrog, common chimpanzee (Pan troglodytes); Macmul, rhesus 
macaque (Macaca mulatta);  Bostau, cattle (Bos taurus); Canfam, family Canidae (includes dogs and 
wolves); Scrofo, wild boar (Sus scrofa); Danrer, zebrafish (Danio rerio); Galgal, chicken (Gallus gallus); 
Dromel, fruit-fly (Drosophila melanogaster). PRALINE alignment – a modified snapshot (Simossis, 
Kleinjung e Heringa, 2003). 
 
Involvement of PTGDS in the regulation of sleep was also demonstrated (Urade e Hayaishi, 
1999). This finding suggests that PTGDS plays a role in light- and dark-adaptation responses 
and the circadian regulation in general, which could affect the function of the retina 
specifically, and an organism overall. This functional association of PTGDS could help explain 
its observed localisation in retinal tissues. For instance, at the outer-most RPE layer PTGDS 
could be associated with regulation of timing of photoreceptor outer segment phagocytosis by 
the RPE cells. On the other hand, in the inner retina it could be linked to the intrinsically 
photosensitive retinal ganglion cells (ipRGCs), which, among other functions, entrain central 
circadian clocks and modulate the sleep-wake processes (Lucas, 2013). Some co-localisation 
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with TOPORS was also noted within the layer of retinal ganglion cells; however, TOPORS’ signal 
was never as strong as the signal of PTGDS (Figures 8-7, 8-8 and 8-9). 
 
8.4.3 EVALUATION OF PSMC1 LOCALISATION 
PSMC1 immuno-reactivity was observed at the site of RPE phagocytosis (Figures 8-10 and 8-11) 
as well as in the photoreceptor inner segments (Figure 8-11); the later signal was detectable 
only following HIER treatment. 
It was previously shown that protein folding is an error-prone process (Guo et al., 2014). It was 
also shown that photoreceptor cells have extremely high biosynthetic requirements, similar to 
tumour cells (Ng et al., 2014). Consequently, errors in protein quality control systems, 
mediated by chaperonins and heat-shock proteins, or in protein degradation systems, such as 
the ubiquitin-proteasome system or autophagy, would probably lead to cell stress due to 
aberrant protein folding and/or degradation. TOPORS and PSMC1 are both associated with 
protein degradation. 
At molecular level neurodegeneration is often characterised by neuronal inclusions of protein 
aggregates, e.g. the neuronal intranuclear inclusion disease (NIID) (Lieberman et al., 1998). It 
should be highlighted that, whereas in dividing cells nuclear protein aggregates can often be 
cleared out by autophagy, when the nuclear envelope dissociates during cell division, 
terminally differentiated neurons can only rely on the intranuclear ubiquitin-proteasome 
system since their nuclear membrane never dissociates.  
The primary cilium was previously shown to be structured as a ‘privileged membrane domain,’ 
protected from the surrounding cytosolic contents by the transition zone, forming a ciliary 
diffusion barrier, or the ciliary necklace (Chih et al., 2012). This barrier comprises nuclear pore-
like structures within the ciliary necklace restricting access to the intraciliary compartment 
(Kee e Verhey, 2013; Nozawa, Lin e Chuang, 2013). Consequently, it is possible that 
the intraciliary space may be subject to similar stresses due to protein misfolding and 
aggregation as the intranuclear space. This would be an important point to consider in context 
of the photoreceptor outer segments, i.e. highly specialised primary cilia.  
Even though the outer segments are regularly turned over by RPE phagocytosis at their distal 
ends, the outer segments’ regions proximal to the connecting cilium must rely on another 
protein degradation pathway, if one is required. Photoreceptor cells are constantly exposed to 
light-induced stress, which would result in generation of reactive oxygen species, which in turn 
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would be damaging to both proteins as well as lipids. The RPE phagocytosis serves as the major 
mechanism of outer segment renewal, thus protecting this highly specialised cilium from 
prolonged effects of exposure to oxidative damage. However, it cannot be excluded that 
the ubiquitin-proteasome system is also required to tackle potential protein damage near 
the base of the outer segment. If this latter mechanism is impaired, this may lead to intraciliary 
stress due to protein misfolding, analogous to that observed in neuronal nuclei. This 
hypothetical scenario would justify the co-localisation of TOPORS and PSMC1 at the interface 
between the inner and outer segments (Figure 8-11).  
It would be interesting to determine whether mice heterozygous for TOPORS have protein 
aggregate-containing inclusions in their nuclei and/or proximally to the connecting cilia, 
perhaps within the outer segments as this TOPORS localisation was observed in primate 
retinae (Figures 8-5 and 8-9). No PSMC1 signal was detected in the primate tissue (data not 
shown); however, similarly, no PSMC1 signal was observed in young mice (2 weeks old), 
whereas inner segment-specific PSMC1 reactivity in adult mice (6.5 months old) was revealed 
only after HIER treatment. No HIER, or another antigen retrieval method, was attempted on 
the primate retinal sections, or the young mouse sections, which could help explain the lack of 
apparent signal. Still, it cannot be excluded that PSMC1 expression increases with age to 
compensate for the age-related deterioration of protein quality control processes (Balch et al., 
2008). 
Still, it would be expected that PSMC1 is targeted to the primary cilia, specifically the rod 
photoreceptor outer segments, also in the primate retina. Bioinformatics analysis revealed 
that this conserved eukaryotic protein possesses two ciliary-targeting sequences (CTS) of 
different types (reviewed in: Hsiao, Tuz e Ferland, 2012), both of which are conserved in 
human, primates, rodents and other vertebrates (Figures 8-16 and 8-17). The first CTS of 
PSMC1 is of the same type as the one found in the carboxy-terminal regions of rhodopsin, i.e. 
‘VxPx’ (Figure 8-16), whereas the second CTS of PSMC1 is typical for G protein-coupled 
receptors, such as: Sstr3, Htr6 and Mchr1, and fits the consensus of: ‘Ax(S/A)xQ’ (Figure 8-17).  
The existence of two different CTS motifs within the PSMC1 sequence suggests that different 
molecular mechanisms are probably involved in their recognition and implementation of 
the ciliary targeting. Their recognition could depend on the intracellular environment of 
a specific cell type, an environmental stimulus, or perhaps an energy status of the cell. For 
instance, the ciliary targeting of the NPHP3 protein is modulated by its GTP-GDP status, as well 
as myristoylation. The latter is a post-translational lipid modification, which is also found in 
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PSMC1. Palmitoylation is another form of lipid modification, and it is found in rhodopsin. 
Myristoylation and palmitoylation both serve as membrane attachment points, and were 
shown to be required for ciliary targeting of some proteins, such as NPHP3 (but not rhodopsin 
(Chuang e Sung, 1998) (reviewed in: Hsiao, Tuz e Ferland, 2012). 
 
 
Figure 8-16. PSMC1 CTS#1. 
Species and CTS are boxed inside purple rectangles. Key: Hum, human; Xentrop, western clawed frog 
(Xenopus tropicalis); Musmus, mouse (Mus musculus); Pantrog, common chimpanzee (Pan troglodytes); 
Macmul, rhesus macaque (Macaca mulatta);  Bostau, cattle (Bos taurus); Canfam, family Canidae 
(includes dogs and wolves); Scrofo, wild boar (Sus scrofa); Danrer, zebrafish (Danio rerio); Galgal, 
chicken (Gallus gallus); Dromel, fruit-fly (Drosophila melanogaster). PRALINE alignment – a modified 
snapshot (Simossis, Kleinjung e Heringa, 2003). 
 
 
Figure 8-17. PSMC1 CTS#2. 
Species and CTS are boxed inside purple rectangles. Key: Hum, human; Xentrop, western clawed frog 
(Xenopus tropicalis); Musmus, mouse (Mus musculus); Pantrog, common chimpanzee (Pan troglodytes); 
Macmul, rhesus macaque (Macaca mulatta);  Bostau, cattle (Bos taurus); Canfam, family Canidae 
(includes dogs and wolves); Scrofo, wild boar (Sus scrofa); Danrer, zebrafish (Danio rerio); Galgal, 
chicken (Gallus gallus); Dromel, fruit-fly (Drosophila melanogaster). PRALINE alignment – a modified 
snapshot (Simossis, Kleinjung e Heringa, 2003). 
 
The PSMC1 localisation at the outer segment-RPE boundary (Figures 8-10 and 8-11) is 
consistent with the conserved role of this protein in the ER-phagosome pathway, which is 
likely to contribute to the overall phagocytic activity of the RPE cell layer. In vertebrates RPE 
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phagocytosis of rod outer segments was shown to peak two hours after the onset of dawn (La 
Vail, 1976: referred to by Sung and Chuang, 2010). As was review by Wong-Riley (2010), 
the RPE microvilli interdigitate with photoreceptor outer segments, and they also release ATP 
into the sub-retinal space. This ATP could be involved in circadian regulation of outer retina’s 
function. PSMC1 binds as well as hydrolyses ATP (Rezvani et al., 2012), and given its 
consistently observed localisation at the strategic position, it could be hypothesised that this 
ATPase may be involved in circadian regulation. This in turn could affect the rhythmicity of 
phagocytosis by the RPE. If TOPORS acted upstream, e.g. by SUMOylating PSMC1, mutations in 
the former could lead to impairment in PSMC1-conveyed functions at the boundary regions 
between the RPE and the outer segments. 
It should also be emphasised that a plant orthologue of PSMC1 is involved in mediating 
responses to light-induced stress (Lee, K. H. et al., 2012). Perhaps the observed high immuno-
reactivity at the site of RPE phagocytosis reflects an analogous function in the mouse, 
assuming that distal regions of outer segments would be expected to have undergone 
substantial light-induced stress, and perhaps even damage, by the time they become 
phagocytised.  
PSMC1 is also involved in regulation of ubiquitin-protein ligase activity in mitotic cell cycle 
(UniProtKD). It could be speculated that it may also modulate the activity of other ubiquitin 
ligases involved in mitophagy. Apart from their role in ATP generation, mitochondria also serve 
as buffering spaces for calcium cations as well as intracellular transducers of apoptotic signals 
(Schapira, 2010). Molnar et al. (2012) previously showed that in saturating light conditions, 
the level of intracellular calcium cations in rods decreases, which in turn is toxic to these cells.  
It cannot be excluded that PSMC1 could play a role in these processes, as its strong reactivity 
was observed in inner segments of photoreceptors (Figure 8-11), which is rich in mitochondria 
as well as other ‘house-keeping’ organelles. It was previously shown to regulate ubiquitin 
ligases in cell division (UniProtKD), so there is a possibility that it could regulate these enzymes 
also in other intracellular pathways, especially in terminally differentiated cells such as rods. 
Finally, PSMC1 is conserved among eukaryotes, and in plants it was shown to mediate 
responses to cellular stress triggered by light. Photoreceptors cells could also rely on PSMC1 on 
mediation of these responses, and it could possibly be via the intercellular calcium levels’ 
regulation.  
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More recently, it was shown in cell culture that PSMC1 binds not only ATP, but also NADH 
(Tsvetkov et al., 2014). This characteristic provides further evidence that PSMC1 could be 
associated with mitochondrial structure and function, where it could be mediating light-
induced redox stress responses. Moreover, NADH was shown to stabilise 26 S proteasomes in 
the absence of ATP; this effect was abolished by increasing calcium levels, which, however, did 
not affect 26 S proteasomes stabilised by ATP rather than NADH. Further cellular studies 
showed that mitochondrial inhibition lead to increase in the intracellular NADH/NAD+ ratios 
and in higher levels of the proteasome complex. Importantly, not only a decrease, but also 
an increase in calcium levels could also result in cytotoxicity (Kolb et al., 1995). 
Moreover, removal of the NADH-binding site from the PSMC1 sequence rendered the host 
cells less viable during mitochondrial inhibition. It is noteworthy that the central nervous 
system, which includes the retina, was previously shown to exhibit lower ATP levels and higher 
NADH/NAD+ ratios in comparison to other tissues (Veech et al., 1979: referred to in Tsvetkov 
et al., 2014). Perhaps mutations in TOPORS, an interactor of PSMC1, could lead to an impaired 
cross-talk between the mitochondria and the ubiquitin-proteasome system (of which they 
both form a part), which would lead to cell death, as the mitochondria act intracellularly as  
apoptotic signal transducers.  
This would not necessarily need to involve the E3 ubiquitin ligase activity of TOPORS. For 
instance, the Parkin-mediated mitophagy is independent of its E3 ubiquitin ligase activity (Um 
et al., 2010). In the Y2H screen PSMC1 interacted most strongly with the mid-TOPORS 
fragment, linked to the protein’s E3 SUMO1 ligase activity, as well as with the C-term TOPORS 
fragment, which includes the mutational hotspot region of TOPORS (Chapter 5, Table 5-16). 
Thus, it could be speculated that SUMOylation of PSMC1 is involved in this process (if TOPORS 
acts upstream of PSMC1). Or hypothetically, perhaps PSMC1 might modulate the E3 SUMO1 
ligase activity of TOPORS, perhaps via binding its C-term mutational hot-spot region, if TOPORS 
acts downstream of PSMC1. 
Calcium levels could affect photoreceptor physiology also via a different pathway. 
The maintenance of the ‘dark current’ consumes the highest level of energy out of all 
physiological processes performed by photoreceptor cells (Okawa et al., 2008), and calcium 
cations contribute to approximately 15 % of this ‘dark current’ (Kolb et al., 1995). Thus, 
disruption of calcium levels could lead to defective phototransduction, which eventually could 
result in processes leading to apoptosis. 
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Overall, findings presented in this thesis, together with previously published data, indicate that 
PSMC1 can serve important roles both in the rod inner segments (including their apical 
regions, where is associates with TOPORS: Figure 8-11), as well as phagocytic region at 
the interface between the outer segments and the RPE (Figures 8-10 and 8-11). 
 
8.4.4 CONCLUSIONS 
The data presented in this chapter demonstrated that the novel Y2H interactors of TOPORS are 
detected in mammalian retinae using commercially available antibodies. Furthermore, co-
localisation of TOPORS’ and the interactors’ immuno-reactivity was observed at the apical 
regions of photoreceptor inner segments, suggesting that they may interact at the basal 
bodies of connecting cilia. Some co-localisation of detected signals was also observed in 
the inner retinal layers.  
The results from this chapter are crucial for either supporting or rejecting the validity of results 
obtained in the earlier experimental chapters in context of the retinal environment. 
The demonstration that TOPORS can co-localise with all: ITM2B, PTGDS and PSMC1 at 
the ciliary area in the photoreceptors cells of mammalian retinae supports findings from 
Chapters 4, 5 and 6, showing PPIs and retinal expression, as well as co-localisation in cultured 
cell lines. 
It was hypothesised prior to onset of this project that TOPORS mutations lead to 
photoreceptor degeneration, specifically due to its localisation at the basal body of 
the connecting cilia of these highly specialised, and equally vulnerable cells. The evidence of 
co-localisation at this bottle-neck region with the interacting partners of TOPORS may aid in 
understanding the origin of the observed retina-specific phenotype despite the genes’ 
ubiquitous expression.  
The findings obtained throughout the project and presented in the experimental Chapters 3-8 
will be collectively summarised and discussed in Chapter 9 in order to try to elucidate 
the nature of the TOPORS-linked autosomal dominant retinitis pigmentosa (adRP) phenotype 
(RP31). 
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9 DISCUSSION 
It was very intriguing that despite the ubiquitous expression of TOPORS and 
the multifunctional character of the encoded protein, the mutations in this gene are known to 
cause disease only in the retina (Chakarova et al., 2007). 
A putative explanation for these observations could be that TOPORS has a novel, unique role in 
the retina in one of its homeostatic pathways, or that it has a retina-specific interacting protein 
partner. In either case the starting point to either accepting or rejecting this hypothesis, was to 
perform a screen to identify proteins from the retina that associate with TOPORS. 
Initially human retinal cDNA libraries were constructed in a Saccharomyces cerevisiae yeast 
strain Y187 (Clontech, CA, USA) suitable for yeast two-hybrid (Y2H) screening (Chapter 3). Two 
libraries were generated: one using an oligo-dT primer (O-dT) only, and one using a random 
primer and an oligo-dT primer (R&O-dT). A preliminary library characterization revealed that 
that the R&O-dT library appeared to contain more protein-coding sequences and more longer 
inserts than the O-dT library. Thus the library constructed using both primers was then 
characterized in greater depth in order to validate its retinal status.  
Bait plasmids for Y2H screens were constructed in parallel, and they were tested for auto-
activation of Y2H PPI reporter genes, for the effects they have on the host cells (potential 
toxicity), as well as for bait protein expression (Chapter 3). The final experiment proved to be 
the most challenging and eventually TOPORS bait expression needed to be confirmed 
indirectly by re-creating a previously published Y2H PPI between TOPORS and p53. Attempts to 
determine protein expression by Western blotting (WB) were not successful (Appendix 11.4). 
The smudges on images from the WB experiments (Figures 11-25, 11-26 and 11-27) suggest 
that the procedures were unsuccessful due to inefficient protein extraction from the yeast 
cells, or possibly protein degradation due to the lengthy extraction process (section 2.1.7 in 
Methods and Materials). On the contrary, the method of protein extraction from mammalian 
cells (section 2.5.1 in Methods and Materials) can be performed much faster, making it easier 
to prevent protein degradation, and subsequently allowing for successful SDS-PAGE and WB 
procedures (Chapter 6). 
Y2H screens were performed once the retinal library and baits were generated and 
characterised. Both libraries were used: one Y2H screen for interacting partners of TOPORS 
was performed per library (Chapter 4). Due to time constrains the O-dT library had been less 
thoroughly characterised than the R&O-dT library; the latter had been prioritised due to 
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an overall higher content of longer inserts, which corresponded to protein-coding gene 
regions. This had been determined based on an initial evaluation of a small number of 
samples. Since these few randomly selected samples might not have been representative of all 
of the library clones, both libraries were screened for interactors of TOPORS. 
The Y2H screens resulted in identification of ITM2B and PTGDS proteins among clones of 
the R&O-dT library, whereas PSMC1 was an interactor pulled out from the O-dT library. 
The retinal cDNA was subsequently screened for alternatively spliced variants of the identified 
candidate interactors (Chapter 5). The full-length clones of candidates pulled out from 
the screen were also generated and re-tested in yeast to confirm that the observed 
interactions could be reproduced, and that they had not been false positive results, which 
could have occurred, for instance, due to direct activation of Y2H PPI reporter genes (Chapter 
5). The interactions were subsequently verified in mammalian cell cultures (Chapter 6), and 
their cellular (Chapter 7) and retinal (Chapter 8) localisations were demonstrated. 
The next sections summarise and briefly discuss the findings obtained for each individual 
TOPORS’ interactor (sections 9.1 – 9.3). The subsequent two sections, respectively, outline 
potential future work (section 9.4), which could be performed as a continuation of this PhD 
project, as well as provide an overview of alternative research methods (section 9.5), which 
could have been used instead of the approaches applied in this PhD project.  
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9.1 ITM2B COULD HAVE MULTIPLE ROLES IN THE RETINA 
ITM2B is ubiquitously expressed, and at least two protein-coding isoforms of this gene exist in 
human. However, just one of them was shown to be expressed at mRNA level in human 
retinae (section 5.1.1); this was the same isoform as the one pulled out from the Y2H screen 
and evaluated in this project. 
Mutations in ITM2B were first identified in patients with familial, Alzheimer-like forms of 
dementia, and more recently in a family with a dominant retinal dystrophy. This latter disease 
association made ITM2B the most attractive gene to follow up in the context of this project. 
However, except for the proband and their sibling, who presented with night-blindness, 
the overall symptoms experienced by the affected family members were indicative of 
a dystrophy involving the cone photoreceptor pathway. Importantly, as in the case of TOPORS, 
the observed phenotype was restricted to the retina with no dementia and no systemic 
symptoms. However, if future functional studies confirm that it is indeed the cone signalling 
pathway, which is predominantly affected by the retinal ITM2B mutation, then the nature of 
its association with TOPORS, whose mutations appear to initially affect rod cells, will be harder 
to explain in context of retinal physiology (unless the association occur in the ganglion cell 
layer). 
Once the PPIs between full-length TOPORS and ITM2B were demonstrated in yeast, 
experiments were performed, which aimed to delineate the domains of TOPORS, which 
mediate its interactions with the newly-identified protein partners. A result was considered 
positive overall, if blue growth, indicating a PPI, was observed in at least four out of six 
experiments at a given stringency level (i.e. activation of two reporter genes: D+; and 
activation of four reporter genes: Q+). Table 9-1 includes a summary of the obtained results for 
full-length ITM2B (which would be expected to be membrane-bound, and thus not able to 
enter the nucleus until after proteolytic cleavage: Figure 6-5). However, the ITM2B protein 
is heavily proteolytically-processed by at least three different proteases, resulting in a diverse 
range of peptides (Figure 6-5). Due to the nature of the protein, it is expected that the PPIs 
observed for the full-length ITM2B construct, probably reflect a PPI involving only the amino-
terminal cytoplasmic fragment of ITM2B (denoted ICD in Figure 6-5 b). The table also 
summarises the PPI with a construct called ITM2B90, which lacks the first ninety residues of 
ITM2B, including the trans-membrane (TM) domain; therefore, ITM2B90 is expected to 
be soluble.  
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Table 9-1. TOPORS and ITM2B interactions in yeast. 
Key: D+ = growth on DDO/X/A (a lower stringency medium, indicating a PPI based on activation of two 
reporter genes); D- = no growth on DDO/X/A, i.e. no PPI; Q+ = growth on QDO/X/A (a higher stringency 
medium, indicating a PPI based on activation of four reporter genes); Q- = no growth on QDO/X/A, i.e. 
no PPI. TM, trans-membrane; BH3, Bcl 2 homology 3; PEST, Proline, Glutamate, Serine, and Threonine-
rich region; CTS, ciliary-targeting sequence; SR/RS, arginine and serine-rich region; SUMO1, Small 
ubiquitin-related modifier 1; NLS, nuclear localisation signal; Lys/His, lysine- and histidine-rich region. 
Refer to Chapter 6 for detailed figures demonstrating the position of motifs within TOPORS and ITM2B 
proteins.  
 
Preys Baits: Full-length TOPORS and its fragments 
Construct 
Full-length 
ITM2B 
ITM2B90 
Full-length 
TOPORS 
N-term 
TOPORS 
Mid-
TOPORS 
C-term 
TOPORS 
Motifs 
Full-length: 
CTS # 1, 2 and 
3; TM 
domain; BH3 
domain; 
BRICHOS 
domain; N-
glycosylation 
site; C-term 
mutational 
hot spot 
(Figure 6-5). 
BH3 
domain; 
CTS # 2 and 
3; BRICHOS 
domain; N-
glycosylatio
n site; C-
term 
mutational 
hot spot 
Full-length 
(Figure 6-2, 
or subse-
quent 
columns). 
PEST 
domain # 1; 
phospho-
serine 98; 
RING finger 
domain; 
CTS # 1 
(Figure 5-9). 
PEST 
domains # 2 
and 3; 
CTS # 2; 
SR/RS-
rich domain 
# 1 and # 2; 
SUMO1 
acceptor 
site; NLS; 
phospho-
serine 718; 
(Figure 5-
10). 
SR/RS-
rich domain 
# 2; 
phospho -
serine 718; 
mutational 
hot spot; 
Lys/His 
motif; PEST 
domains # 4 
and 5 
(Figure 5-
11). 
PPI 
summary 
Full-length 
ITM2B 
n/a D+ Q- D+ Q+ D- Q- D+ Q+ 
PPI 
summary 
n/a ITM2B90 D+ Q- D+ Q+ D+ Q- D+ Q+ 
 
Findings presented in Table 9-1 show that irrespective of the ITM2B fragment tested, 
the strongest association was observed with the N-term TOPORS and with the C-term TOPORS, 
containing the RING domain and the mutational hot-spot region, respectively. The RING 
domain is known to convey the E3 ubiquitin ligase activity of TOPORS, which suggests that 
TOPORS could be marking ITM2B for degradation. The C-term TOPORS fragment, so frequently 
mutated in RP31, could be acting as an accessory binding region for ubiquitination substrates. 
This part of TOPORS has also been linked to SUMOylation activities; however, to a lesser 
extent than the mid-TOPORS fragment (Figure 6-1). Still, it could be speculated that TOPORS is 
involved specifically in degradation of SUMOylated ITM2B, as it was previously demonstrated 
that the latter modification is often a pre-requisite for ubiquitination, marking the protein for 
degradation (Perry, Tainer e Boddy, 2008; Denuc e Marfany, 2010; Miteva et al., 2010). 
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Due to the proteolytic processing of ITM2B, and the uncertainty regarding ITM2B folding in 
the yeast cells, especially whilst being bound to the GAL4 AD, makes it difficult to predict 
whether the observed PPIs represent physiological associations. It is possible that TOPORS is 
simply involved in degradation of the ‘random’ ITM2B fragments as they do not represent 
the native protein. Furthermore, ITM2B is glycosylated at the centre of its BRICHOS domain. It 
cannot be ensured that this glycosylation occurs in yeast, and if it does not, how this would 
affect the proteolytic processing and/or PPIs. 
The co-immuno-precipitation experiments on mammalian cell extracts tested interactions 
between endogenous proteins (Chapter 6), which were thought to be full-length (with 
the exception of the smaller ITM2B band, identified in a protein complex with TOPORS: Figure 
6-7). Protein localisations in cultured cells as well as in retinal tissue sections were 
subsequently evaluated (Chapters 7 and 8) (Table 9-2). It was established in hTERT-RPE1 cells 
that endogenous ITM2B localises to centrioles in dividing cells, but not in ciliated cells, in which 
it was absent from the ciliary basal body. This finding was not entirely consistent with results 
of retinal localisation studies.  
ITM2B was observed in the inner segments of rod photoreceptors (Figure 8-2). Furthermore, 
the signal overlapped with PNA staining (yellow in merged image), thus suggesting that ITM2B 
could also be expressed in cones. ITM2B signal was also evident in the ganglion cell layer, 
the outer plexiform layer, and at the interface between the inner plexiform and the inner 
nuclear layers. 
Co-localisation of ITM2B and TOPORS signals at a photoreceptor cell region, which appeared to 
correspond to the connecting cilia and/or the outer segments was also demonstrated (Figure 
8-4). Some signal within the distal area of inner segments cannot be excluded either. 
The diffuse localisation of both proteins at the plexiform layers and the ganglion cell layer 
suggests that these may also comprise putative sites of interaction. 
This apparent co-localisation at the connecting cilium, as well as in the outer segments of 
primate photoreceptors (Figure 8-5), indicates that in neuronal cell types ITM2B can be 
targeted to primary cilia, even if this does not apparently occur in epithelial cell types (Figure 
7-11). Thus, the observed discrepancy could be cell-type dependent. The aim of future cell 
work could be to compare ITM2B targeting in cell lines originating from different tissues. 
The ciliary targeting of ITM2B in photoreceptors could be related to its role as a protease 
inhibitor. Specifically, ITM2B was previously shown to inhibit proteolysis of the amyloid 
precursor protein (APP) by blocking access of secretases to its cleavage sites (Fotinopoulou et 
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al., 2005; Matsuda et al., 2005); furthermore, it was also shown that the carboxy-terminal 
ITM2B fragment (CCTP in Figure 6-5 b), which becomes elongated from 23 to 34 amino acids 
due to the British and Danish familial dementia mutations, in its native form is responsible for 
preventing deposition and aggregation of amyloid-beta (Aβ) (Kim et al., 2008). 
 
Table 9-2. ITM2B localisation summary. 
Key: PCM1, peri-centriolar material 1; PLK4, polo-like kinase 4; PR, photoreceptor; PNA, peanut 
agglutinin; CC, connecting cilium; OS, outer segment; RPE, retinal pigmented epithelium; GCL, ganglion 
cell layer; INL, inner nuclear layer; IPL, inner plexiform layer; OPL, outer plexiform layer; IS, inner 
segment; OS, outer segment. 
Sub-cellular localisation in hTERT-RPE1 
cells 
Localisation within retinal tissue cryo-sections 
Dividing 
cells 
Co-localised with TOPORS in 
a centriole-like pattern. In 
some cells ITM2B displayed 
additional ‘cloud’-like signal 
around the co-localisation 
area. 
 Co-localised with 
PCM1 during 
interphase. 
 Co-localised with 
PLK4 in a centriole-
like pattern, and also 
at a larger aggregate, 
possibly representing 
a deutrosome. 
 Co-localised with 
Centrin-2 during 
interphase. 
Mouse – 
2 weeks 
old 
Localised at the PR IS/OSl layer, where partial 
signal overlap was observed with: 
 PNA (cone marker) (Figure 8-2); 
 TOPORS at the distal/outer part of PR 
layer, indicating it could be the CC 
and/or OS (Figure 8-4, lower panel). 
Localised at the plexiform layers (both OPL and 
IPL) and the GCL (Figure 8-2), where partial 
signal overlap was observed with TOPORS 
(Figure 8-4, lower panel). 
Mouse – 
6.5 
months 
old 
In sections subject to HIER, ITM2B immuno-
staining was observed throughout the retina, 
where the signal was most distinct within the 
PR layer, the GCL and the regions of OPL and 
IPL immediately adjacent to the INL (Figure 8-
3).   
Ciliated 
cells 
 Co-localised with 
α tubulin (used as 
a ciliary marker) in a 
dot-like pattern 
reminiscent of 
centrioles, but did 
not co-localise at the 
ciliary basal body. 
Macaque  
Co-localised with TOPORS at: 
 PR OS; 
 RPE (weaker TOPORS signal); 
 GCL (peri-nuclear signals; weaker 
TOPORS signal). 
Additionally localised at plexiform layers (both 
OPL and IPL) with higher intensity signals 
observed at the interface between INL and OPL 
(Figure 8-5). 
 
 
It was previously demonstrated by Hoh Kam, Lenassi and Jeffery (2010) that Aβ deposition 
occurs in aging retinae of mice as well as humans. Based on these published data, it could be 
speculated that perhaps ITM2B (or its fragment) is targeted to the outer segments in order to 
modulate APP processing at their surface, and or to act as a scavenger of Aβ. Therefore, an 
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impairment of ITM2B targeting to photoreceptor outer segments, either due to mutation in 
TOPORS or ITM2B itself, could lead to pre-mature cell degeneration due to an excess of Aβ 
accumulation of the surface of the outer segments. 
Moreover, if, after binding Aβ, the secondary role of ITM2B (or its fragment) would be to re-
enter the cells to help target it for proteasomal degradation, then TOPORS mutations would 
affect this process. It is less obvious that this would be of significance in mice, in which TOPORS 
localisation appeared to be restricted to the connecting cilia (Chapter 8); however, in primate 
retinae TOPORS immuno-reactivity was observed throughout the outer segments (and was 
most intense at their edges) (Figures 8-5 and 8-9). Thus, it is probable that TOPORS may have 
a role in degradation of Aβ via the ubiquitin-proteasome system, mediated by ITM2B (or its 
fragment). However, it would seem more likely that the ITM2B CCTP-bound Aβ would be 
cleared out by the RPE phagocytosis. Weak TOPORS immuno-reactivity was sometimes seen in 
the RPE retinal layer (Figures 8-5, 8-7 and 8-9), thus it cannot be excluded that this protein may 
also be important for RPE phagocytosis. This would be supported by its endogenous expression 
in hTERT-RPE1 cultured cells (Chapter 7) as well as its ubiquitous and multifunctional nature. 
The finding by Audo et al. (2013) that retinal ITM2B reactivity appears limited to the ganglion 
cell layer, rather than being detected in most retinal regions (Figures 8-2, 8-3, 8-4 and 8-5), 
probably reflects differences in specificity of the used antibodies. The antibody used by Audo 
et al. (2013) would detect membrane-bound ITM2B fragments, which perhaps were more 
easily accessible to the antibody in the ganglion cell layer. Therefore, the signal appeared 
stronger there, making to harder to detect weaker ITM2B immuno-reactivity in other retinal 
layers. Moreover, the differences in the obtained immuno-staining results could also reflect 
difference in the treatment of tissue prior to immuno-staining. For instance, the localisation of 
PSMC1 in the inner photoreceptor segment was revealed only after HIER treatment; whereas 
staining of untreated tissues showed PSMC1 immuno-reactivity only at the region of RPE 
phagocytosis (Figures 8-10 and 8-11).  
It should also be noted that unlike the previously identified ITM2B mutants, implicated in 
dementia, the retinal mutation probably does not lead to amyloid formation. Unlike 
the dementia mutations, which lead to formation of extended C-terminal peptides, which tend 
to aggregate, the retinal mutation results in an amino acid substitution (p.Glu261Ala). 
Glutamic acid is known to have phosphomimetic properties, resembling those of a phospho-
serine, or a phospho-threonine. Consequently, this residue is likely to be important for 
maintaining ITM2B protein activity, which would be abolished by mutating it to alanine; in fact, 
Identification of Interacting Protein Partners of TOPORS in the Retina   ||   Barbara Czub 
PhD Thesis 2015   ||   Discussion    - 357 - 
 
in experiments aiming to determine the significance of phosphorylation of serine or threonine 
residues, they are frequently mutated to alanine to generate phospho-deficient mutants.  
If the mutation does not affect cleavage, it might influence intra-molecular bond formation. 
Cysteines 246 and 265 (Figure 6-4) form a disulphide bridge within the ITM2B C-terminal 
peptide (CTPP), once it is released by furin cleavage (Tsachaki et al., 2010). Perhaps, the retinal 
mutation may prevent formation of this bond due to incorrect peptide folding; however, 
the hydrophobic side chain of alanine is small (as opposed to a charged side chain found in 
glutamate). In fact, it was demonstrated that an aspartate residue within a furin precursor 
peptide forms an active site, which is essential for auto-proteolytic activation of furin at its 
consensus cleavage site (Leduc et al., 1992). Perhaps substrates for furin processing, such 
as ITM2B, also comprise glutamate active sites, required to trigger proteolysis by this enzyme 
at the consensus cleavage site.  
If the above hypothesis is true, this would indicate that the retinal dystrophy mutant (ITM2B 
RetMu) is never processed at its C-terminus, which prevents the formation of mature ITM2B. 
Only mature protein should be able to leave the Golgi body, where proteolytic processing was 
shown to occur (Choi et al., 2004). If ITM2B never matures, but the protein is expressed, then 
it would probably accumulate in the Golgi complex, stressing this organelle, and thus 
preventing correct and efficient processing of other proteins. By extrapolation, it could for 
instance be hypothesised that retinal ITM2B mutations impair the processing and/or transport 
of photoreceptor opsins, which could eventually lead to apoptosis and retinal degeneration. 
In context of the interaction with TOPORS, if it is indeed the N-terminal fragment of ITM2B 
and/or the intracellular domain (NTF and ICD, respectively, in Figure 6-4), which are/is involved 
in the PPI with TOPORS, it could be speculated that the nature of this interaction is analogous 
to that between murine Topors and the cytoplasmic domain of syndecan 1 (Braun et al., 2012). 
Specifically, ITM2B may serve as a membrane receptor, and TOPORS binding may be involved 
in signal transduction, possibly serving to maintain the differentiated state of 
the photoreceptor cells. Disruption of such signalling might trigger the photoreceptor cells to 
attempt to re-enter the cell cycle, eventually resulting in apoptosis, as growth and division 
would not be supported within cellular environment of the retina. This would be supported by 
the observed localisation of TOPORS on the edges of OS (Figure 8-5 and 8-9). 
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Alternatively, the association between ITM2B and TOPORS may be related to regulating 
the energy metabolism of retinal cells. A short mouse Itm2B splice variant (Itm2BS)
21, for which 
as yet no orthologue has been confirmed in human, is able to induce apoptosis. The long 
transcript (Itm2B aka Itm2BL) appears to have no such function (Fleischer et al., 2002). This 
mouse Itm2BS protein contains a Bcl 2 homology 3 (BH3) domain, found in members of Bcl-2 
protein family, e. g. in Bax, whose transcription is activated by p53 due to TOPORS over-
expression (Lin et al., 2005). Itm2BS interacts with anti-apoptotic protein Bcl-2, but not with 
the pro-apoptotic BH3-containing protein Bad.  
The BH3 domain includes key leucine and aspartic acid residues; an identical sequence is not 
conserved in human ITM2B, which contains isoleucine (Ile91) rather than leucine, found at 
the corresponding position in mice. Leucine and isoleucine are isomers, which differ in 
the attachment position of a methyl group on a side chain; this appears to be a minor 
modification, however, the associated conformational and spatial change may as well prevent 
a BH3 domain-associated apoptotic function. 
Despite this, Lee et al. (2007) reported that ITM2BS and ITM2BL alternatively spliced variants 
are both expressed in human urothelial and bladder cancer cells at the protein level. They also 
demonstrated that exogenous expression of ITM2BS triggers apoptosis (based on pro-
caspase 3 processing and DNA fragmentation), whereas exogenously expressed ITM2BL caused 
no such effects. This supports the results obtained with the mouse orthologues (Fleischer et 
al., 2002), and also provides evidence that the isoleucine in the human sequence is sufficient 
for reconstituting a functional BH3 domain. 
Fleischer et al. (2002) showed that localisation of Itm2BS to mitochondria was associated with 
the loss of mitochondrial membrane potential, and accompanied by a release of cytochrome C 
to the cytoplasm, which triggered apoptosis, even when cells were stimulated by IL-2, acting as 
a growth factor.  
Photoreceptors are metabolically highly active cells, therefore, any problems with the energy-
generating mitochondria may manifest as degeneration. RP disease pathways all converge on 
apoptosis irrespective of the causative mutation(s). It cannot be excluded that ITM2BS also 
                                                          
 
21
 This mouse Itm2B transcript is found only in the UCSC Genome Browser Assembly: Dec 2011 
(GRCm38/mm10) and corresponds to mRNA AB030204, covering mouse exons 2-6. It is not homologous 
to the short protein-coding splice variant of human ITM2B (ITM2B-003 ENST00000378549) recoded in 
the Ensembl Genome Browser, which covers human exons 1-2 and 5-6. 
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exists in photoreceptor cells, where it associates with mitochondria, and possibly mediates 
the final apoptotic cell death.  
TOPORS could then be involved in mitophagy, i.e. autophagy of damaged mitochondria, 
similarly to the E3 ubiquitin ligase, Parkin (encoded by PARK2), associated with familial 
Parkinson’s disease (Deas, Wood e Plun-Favreau, 2011). Furthermore, Parkin activity is 
modulated by phosphorylation; this modification was also shown to regulate the E3 ubiquitin 
and SUMO1 ligase activities of TOPORS (Park et al., 2008; Yang et al., 2009). This hypothesis is 
supported by the preliminary Y2H findings from this project, where several proteins with key 
mitochondrial functions were also identified as putative interacting partners of TOPORS (Table 
11-7 in Appendix 11-6).  
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9.2 PTGDS COULD BE REQUIRED FOR INTRA-RETINAL SIGNALLING 
PTGDS is ubiquitously expressed, however, it has been commonly named the ‘brain-type’ 
prostaglandin D2 synthase to differentiate it from the glutathione-dependent prostaglandin D2 
synthase (Table 4-8), which was initially purified from rat spleen (referred to in: Goh et al., 
1987). No direct PTGDS involvement in retinal diseases has ever been shown; but the protein 
plays a role in maintenance of the blood-retina barrier, as well as it acts as a transporter of 
retinoid compounds. It also mediates the sleep-wake cycle processes, which would be 
expected to affect retinal homeostasis. 
Once the PPIs between full-length TOPORS and PTGDS were demonstrated in yeast, 
experiments were performed, which aimed to delineate the domains of TOPORS, which 
mediate its interactions with this newly-identified protein partner. A result was considered 
positive overall, if blue growth, indicating a PPI, was observed in at least four out of six 
experiments at a given stringency level (i.e. activation of two reporter genes: D+; and 
activation of four reporter genes: Q+). 
In the Y2H direct PPI experiments (Table 9-3) PTGDS interacted most strongly with the N-term 
TOPORS fragment, which comprises the RING domain, and therefore, conveys the ubiquitin E3 
ligase activity of this enzyme (Table 5-16). Nonetheless, it should be noted that full-length 
PTGDS-001 construct was used for this experiment, which would result in synthesis of full-
length PTGDS protein, which would include the amino-terminal signal peptide. Since 
the GAL4 AD, expressed as a hybrid protein with PTGDS, was fused to its amino-terminal, it 
cannot be excluded that the observed strong interaction involved the amino-terminal signal 
peptide of PTGDS rather than the whole protein. Since TOPORS is a component of 
the ubiquitin-proteasome system, it is very possible that it could be involved in degrading 
signal peptides, which have fulfilled their roles. Future experiments should aim to repeat this 
interaction, using a PTGDS construct, which would lack the signal peptide. Nonetheless, 
the TOPORS-PTGDS co-localisation signals observed in the hTERT-RPE1 cells, as well as 
the murine and primate retinal sections, indicate that an association with full-length PTGDS 
probably also occurs in mammalian systems.  
Cellular localisation studies (Chapter 7 and Table 9-4) showed that endogenous PTGDS 
localised along the axoneme as well as at the base of primary cilia in cultured hTERT-RPE1 
cells. Furthermore, at the basal body it co-localised with TOPORS, whereas the findings did not 
provide evidence for co-localisation in other cellular compartments, which, however, should 
not be excluded. If PTGDS is taken up by the photoreceptors near the site of its origin, the RPE 
Identification of Interacting Protein Partners of TOPORS in the Retina   ||   Barbara Czub 
PhD Thesis 2015   ||   Discussion    - 361 - 
 
cell layer, then it would be taken up by the outer segments, which are modified primary cilia. 
However, this would suggest that PTGDS moved through the cilia in a retrograde direction, 
whereas the observation of the PTGDS along the axoneme in the cultured RPE1 cells, suggests 
that it was transported into the cilium in the anterograde direction. Still, it could also be 
possible that PTGDS was released by a population of the hTERT-RPE1 cells (the cells were not 
synchronised) into the media, and was subsequently taken up by another population of cells, 
following binding to receptors on the primary cilia. In order to better define these 
observations, it would be necessary to determine whether PTGDS interacts with molecules of 
the anterograde or retrograde IFT proteins.  
 
Table 9-3. TOPORS and PTGDS interactions in yeast. 
Key: D+ = growth on DDO/X/A (a lower stringency medium, indicating a PPI based on activation of two 
reporter genes); D- = no growth on DDO/X/A, i.e. no PPI; Q+ = growth on QDO/X/A (a higher stringency 
medium, indicating a PPI based on activation of four reporter genes); Q- = no growth on QDO/X/A, i.e. 
no PPI. TM, trans-membrane; BH3, Bcl 2 homology 3; PEST, Proline, Glutamate, Serine, and Threonine-
rich region; CTS, ciliary-targeting sequence; SR/RS, arginine and serine-rich region; SUMO1, Small 
ubiquitin-related modifier 1; NLS, nuclear localisation signal; Lys/His, lysine- and histidine-rich region. 
Refer to Chapter 6 for detailed figures demonstrating the position of motifs within TOPORS and PTGDS 
proteins.  
 
Prey Baits: Full-length TOPORS and its fragments 
Construct PTGDS 
Full-length 
TOPORS 
N-term 
TOPORS 
Mid-TOPORS 
C-term 
TOPORS 
Motifs 
Full-length: N-term signal 
peptide; O-linked 
glycosylation site; N-linked 
glycosylation sites # 1 and 2; 
CTS # 1 and 2; catalytic 
active site at cysteine 65; 
cysteines 89 and 186, 
forming an intramolecular 
disulphide bridge; phospho-
serine 106; four α helix 
regions and a proline-
containing turn motif 
(Figure 6-8). 
Full-length 
(Figure 6-2, 
or 
the subse-
quent 
columns). 
PEST 
domain # 1; 
phospho-
serine 98; 
RING finger  
domain; 
CTS # 1 
(Figure 5-9). 
PEST 
domains # 2 
and 3; 
CTS # 2; 
SR/RS-
rich domain 
# 1 and # 2; 
SUMO1 
acceptor 
site; NLS; 
phospho-
serine 718; 
(Figure 5-
10). 
SR/RS-
rich domain 
# 2; 
phospho -
serine 718; 
mutational 
hot spot; 
Lys/His 
motif; PEST 
domains # 4 
and 5 
(Figure 5-
11). 
PPI summary D+ Q- D+ Q+ D+ Q- D+ Q- 
 
PTGDS localisation at the RPE and the photoreceptor inner and outer segment layers is in 
agreement with the previous findings from immuno-staining studies (Beuckmann et al., 1996). 
Prominent PTGDS presence in the inner retinal layers, ranging from the ganglion cell layer to 
the outer plexiform layer (Figures 8-6, 8-7, 8-8 and 8-9), is in agreement with data, obtained by 
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measuring the enzyme activity of ‘brain-type’ prostaglandin D2 synthase in the eye, in which it 
was wide-spread and high (Goh et al., 1987). Furthermore, the immuno-staining pattern 
(Figures 8-6, 8-7, 8-8 and 8-9), which was not observed before, could suggest that the antibody 
(sc-30067) might also bind to PTGDS isoforms other that PTGDS-001. It was shown (Chapter 5) 
that at least two more protein-coding PTGDS isoforms are expressed in human retina at 
the mRNA level, therefore, cross-reactivity cannot be excluded. 
It could be worth investigating where RIG1/RARRES3 (retinoid-inducible gene 1/retinoic acid 
receptor responder protein 3; UniProt # Q9UL19) localises in hTERT-RPE1 and neuronal cell 
lines and in the retina; it may be possible that this receptor is enriched on the ciliary (outer 
segment) membrane. Wu et al. (2012) showed that PTGDS and RIG1 interacted in a Y2H 
screen. If PTGDS is important for transport of retinoid compounds in the retina, it would be 
expected that PTGDS would deliver the retinoids to specific receptors. In rat PTGDS was shown 
to be produced in the RPE, from where it was released into the inter-photoreceptor matrix, 
and then taken up by the photoreceptors (Beuckmann et al., 1996). RIG1 is a single pass 
membrane receptor protein, which belongs to a family of H-rev107 proteins, which has five 
members in humans, including lecithin retinol acyltransferase (LRAT).  
Proteins of the H-rev107 family have been shown to be actively involved in cell differentiation 
processes and suppression of cell migration and invasion (in malignant cells). This function of 
H-rev107 family proteins, to which RIG1 and LRAT both belong, would be important in highly 
specialised terminally differentiated cells such as photoreceptors in order to prevent them 
from re-entering the cell cycle.  
Furthermore, the suppression of cell migration and invasion is very relevant in context of 
the highly energetically- and biosynthetically-demanding and constantly turning over 
photoreceptor outer segments. These highly modified primary cilia are structures undergoing 
continuous growth and phagocytosis by the RPE cells. It is probable that RIG1 and/or LRAT 
might act to prevent the outer segments from invading the space of neighbouring outer 
segments.  
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Table 9-4. PTGDS localisation summary. 
Key: PCM1, peri-centriolar material 1; PLK4, polo-like kinase 4; PR, photoreceptor; PNA, peanut 
agglutinin; CC, connecting cilium; OS, outer segment; RPE, retinal pigmented epithelium; GCL, ganglion 
cell layer; INL, inner nuclear layer; IPL, inner plexiform layer; OPL, outer plexiform layer; IS, inner 
segment; OS, outer segment. 
Sub-cellular localisation in hTERT-RPE1 cells Localisation within retinal tissue cryo-sections 
Dividin
g cells 
Co-localised with TOPORS in 
a centriole-like pattern in addition to 
diffuse cytoplasmic signal observed 
for both proteins (sometimes having 
a granular appearance in case of 
PTGDS).  
 Co-localised with PCM1 
during interphase, but 
distally from the cell 
nucleus. 
 Co-localised with PLK4 in a 
centriole-like pattern. 
Additionally, both proteins 
localised in the cytoplasm 
where some of their signals 
overlapped. 
 Co-localised with Centrin-2 
during interphase. 
Mouse – 2 
weeks old 
Localised at the plexiform layers (both 
OPL and IPL), the GCL and at the PR 
IS/OS layer (Figure 8-6, lower panel), 
as well as the RPE layer (Figure 8-7). 
At the PR IS/OS layer PTGDS: 
 Did not co-localise with PNA 
(cone marker; Figure 8-6); 
 Co-localised with TOPORS at 
the distal/outer part of PR 
IS/OS layer, indicating it could 
be the CC and/or OS 
(Figure 8-7). 
Co-localisation of PTGDS and TOPORS 
signals was also observed within cells 
of the choroid (Figure 8-7; upper 
panel). 
Mouse – 6.5 
months old 
Localised at the plexiform layers (both 
OPL and IPL), the GCL and at the PR 
IS/OS layer (Figure 8-8). At the PR 
IS/OS layer PTGDS co-localised with 
TOPORS in a pattern strongly 
indicative of the CC (Figure 8-8; lower 
panel). 
Ciliate
d cells 
 Co-localised with α tubulin 
(used as a ciliary marker) in 
a dot-like pattern 
reminiscent of centrioles, 
and co-localised at both 
centrioles of the ciliary basal 
body as well as along 
the primary cilium. 
Macaque  
Localised at the plexiform layers (both 
OPL and IPL), the GCL and at the PR 
IS/OS layer, as well as the RPE layer 
(Figure 8-9); signal intensity was 
the highest at the RPE-OS interface 
and in the IPL. 
TOPORS was observed in the PR OS 
layer and, to a lesser extent, in 
the plexiform layers and the GCL. 
PTGDS and TOPORS co-localised at: 
 OS layer (both strong signals); 
 GCL (strong PTGDS signal and 
weak TOPORS signal). 
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Proteins from this family also display a phospholipase A1/A2 activity, i. e. they are able to 
hydrolyse acyl bonds of membrane phospholipids, such as phosphatidylcholine (PC/lecithin), or 
phosphatidylethanolamine (PE/cephalin). It is noteworthy that RIG1 is indeed involved in 
hydrolysis of PC and PE, and LRAT uses PC as a donor of acyl group for esterification of retinol 
in the processes of replenishing 11-cis retinal during the visual cycle (section 1.2.4). It cannot 
be excluded that PTGDS is also involved in this retinoid metabolism even though it has not 
been shown to bind 11-cis retinal. Since TOPORS immuno-reactivity was also observed in 
primate outer segments, especially on the cell edges (Figures 8-5 and 8-9), it could 
be speculated that this dual E3 ubiquitin and SUMO1 ligase can be also involved in retinoid 
metabolism, even if only by regulating the amounts and/or quality of retinoid transporters 
and/or isomerases. 
On the other hand, assuming that PTGDS, released from the RPE, enters the photoreceptor 
outer segments and is then transported via the cilium in the retrograde direction, it would 
potentially interact with TOPORS prior to being transported to its subsequent destination. 
Possibly a specific ubiquitin modification by TOPORS (other than with ubiquitin-48- and -63-
linked chains, which would target for degradation by the proteasome and lysosome, 
respectively) (reviewed in: Komander e Rape, 2012), would direct PTGDS to its intended 
destination, where it could play an as yet unidentified role. 
As was already described in section 4.3.3.2, PTGDS was shown to have a high affinity for 
binding all-trans-retinoic acid and 9-cis retinoic acid as well as all-trans retinal and 13-cis 
retinal, but not vitamin A (all-trans retinol) (Tanaka et al., 1997). The authors additionally 
highlighted that nuclear receptors for retinoids also bind 9-cis retinoid acid and all-trans 
retinoic acid, resulting in transcription of retinoid-responsive genes. 
Overall, two types of retinoid transporters can be differentiated: extracellular, such as plasma 
retinol-binding protein (RBP), and intracellular, e. g. cellular RBP, or cellular retinoic acid 
binding protein (CRABP). PTGDS has been detected in various body fluids, in and outside of 
the CNS, as well as inside the cells. Consequently, it could be involved in retinoid transport 
both: intra- and extracellularly. It could be speculated that PTGDS may work as a messenger 
molecule between the RPE cells and the photoreceptors. Perhaps it is released from the RPE 
cells, with a retinoic acid bound within its pocked, and it is subsequently taken up by 
the photoreceptors, putatively following recognition by RIG1. Subsequently, it could travel 
towards the nucleus where it may transfer the retinoic acid compound to a specific nuclear 
retinoid receptor (or to another transporter, which would in turn dock it onto a nuclear 
Identification of Interacting Protein Partners of TOPORS in the Retina   ||   Barbara Czub 
PhD Thesis 2015   ||   Discussion    - 365 - 
 
receptor); depending on the conformation of the retinoic acid (all-trans or 9-cis), a message to 
transcribe, or suppress, specific genes could be conveyed.  
PTGDS was previously shown to possess both: pro- as well as anti-apoptotic activities 
depending on the environment (Ragolia et al., 2001; Ragolia et al., 2003; Fujimori, Fukuhara, et 
al., 2012; Fukuhara et al., 2012; Maesaka et al., 2013). It could be speculated that PTGDS 
affects expression of genes involved in regulation of cell survival and apoptosis. Regulation of 
PTGDS levels by ubiquitination by TOPORS could act upstream to indirectly regulate this 
putative pathway. Since, photoreceptor degenerations are known to converge on a common 
apoptotic pathway (Wright et al., 2010), this option forms a reasonable possibility. 
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9.3 PSMC1 COULD HAVE PROTECTIVE FUNCTIONS IN THE RETINA 
PSMC1 is a ubiquitously expressed essential component of the 26 S protease. PSMC1 appears 
to have no direct link to the retina, according to literature published to date; however, it is 
often purposefully knocked down in a conditional manner to generate neurodegeneration 
mouse models (Bedford et al., 2008; Gómez-Garre et al., 2012; Paine et al., 2013). Hence it 
could also be involved in retinal neurodegeneration. 
Remarkably, a PSMC1 orthologue was shown to mediate responses to light-induced stress in 
plants. It would be interesting to investigate whether PSMC1 is perhaps of similar functional 
importance in tissues, such as the retina, which are exposed to light stress in the animal 
kingdom. The structure of PSMC1 and its orthologues is conserved among plant, animal and 
fungi kingdoms, which presents a sound basis for consequent conservation of its function. 
Indeed, its role in proteasomal degradation in these three kingdoms has been documented 
(Hartmann-Petersen, Tanaka e Hendil, 2001; Takeuchi e Tamura, 2004; Park et al., 2009; Bar-
Nun e Glickman, 2012; Lee, K. H. et al., 2012), and is supportive of its interaction with TOPORS, 
which is also involved in protein homeostasis via its E3 ubiquitin ligase activity.   
Once the PPIs between full-length TOPORS and PSMC1 were demonstrated in yeast, 
experiments were performed to delineate the domains of TOPORS, which mediate its 
interactions with this newly-identified protein partner. A result was considered positive 
overall, if blue growth, indicating a PPI, was observed in at least four out of six experiments at 
a given stringency level (i.e. activation of two reporter genes: D+; and activation of four 
reporter genes: Q+).  
Findings presented in Table 9-5 show that PSMC1 interacted most strongly with the mid-
TOPORS and the C-term TOPORS fragments. Both of these fragments are involved in 
SUMOylation activities; in addition the mutational hotspot of TOPORS is located within the C-
term TOPORS fragment (Figure 6-1). These results suggest that TOPORS may be important for 
SUMOylation of PSMC1. This could hypothetically regulate the proteasomal function. At least 
one SUMO-interacting motif (SIM: ΨKxE, where Ψ is a hydrophobic amino acid, K is lysine, x is 
any amino acid, and E is glutamate) is found within human PSMC1 sequence at residues 
63LKLE66 (where L is leucine). It is possible that fragment 174MKVE177 (where M is 
methionine, and V is valine) could act as another SIM, however, methionine is only weakly 
hydrophobic, making this region less likely to be involved in SUMO binding. PSMC1 
SUMOylation has never been demonstrated empirically; however, based on the bioinformatics 
data, future work should aim to investigate this possibility. 
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Table 9-5. TOPORS and PSMC1 interactions in yeast. 
Key: D+ = growth on DDO/X/A (a lower stringency medium, indicating a PPI based on activation of two 
reporter genes); D- = no growth on DDO/X/A, i.e. no PPI; Q+ = growth on QDO/X/A (a higher stringency 
medium, indicating a PPI based on activation of four reporter genes); Q- = no growth on QDO/X/A, i.e. 
no PPI. TM, trans-membrane; BH3, Bcl 2 homology 3; PEST, Proline, Glutamate, Serine, and Threonine-
rich region; CTS, ciliary-targeting sequence; SR/RS, arginine and serine-rich region; SUMO1, Small 
ubiquitin-related modifier 1; NLS, nuclear localisation signal; Lys/His, lysine- and histidine-rich region. 
Refer to Chapter 6 for detailed figures demonstrating the position of motifs within TOPORS and PSMC1 
proteins.  
 
Prey Baits: Full-length TOPORS and its fragments 
Construct PSMC1 
Full-length 
TOPORS 
N-term 
TOPORS 
Mid-
TOPORS 
C-term 
TOPORS 
Motifs 
Full-length: N-myristoylation 
site and consensus motif; 
NADH-binding site; CTS # 1 and 
2; ATP-binding loop; ATP-
hydrolysis site and aromatic 
loop; proteasomal ATPase-
anchoring region;  phospho-
serine 4; phospho-tyrosine 439; 
ubiquitin acceptor site; N-
acetylation site; O-linked 
glycosylation site(Figure 6-11). 
Full-length 
(Figure 6-2, 
or 
the subse-
quent 
columns). 
PEST 
domain # 1; 
phospho-
serine 98; 
RING finger
 domain; 
CTS # 1 
(Figure 5-
9). 
PEST 
domains # 
2 and 3; 
CTS # 2; 
SR/RS-
rich domain 
# 1 and # 2; 
SUMO1 
acceptor 
site; NLS; 
phospho-
serine 718; 
(Figure 5-
10). 
SR/RS-
rich domain 
# 2; 
phospho -
serine 718; 
mutational 
hot spot; 
Lys/His 
motif; PEST 
domains 
# 4 and 5 
(Figure 5-
11). 
PPI summary D+ Q- D+ Q- D+ Q+ D+ Q+ 
 
Similarly to the mitochondrial hypothesis, mentioned in case of ITM2BS, robust protein 
turnover mechanisms are also critical to correct functioning of highly active cellular systems, 
such as the retina. In specialised cell types with such high metabolic rates proteins need to 
keep undergoing constant quality control, which would involve protein degradation pathways.  
PSMC1 orthologues, studied thoroughly in plant systems, were additionally shown to perform 
functions, such as regulation of cell growth, histone dynamics and nucleosome assembly 
(Sonoda et al., 2009; Lee et al., 2011; Lee, K. H. et al., 2012).  
Work in plants also showed that a PSMC1 homologue is involved in regulation of the cell cycle, 
specifically DNA replication and regulation of the G2/M checkpoint, which is in agreement with 
its involvement in nucleosome and histone regulation; the mutation phenotype is associated 
with an abnormal polyploidy, and leading to an enlarged leaf phenotype due to increased cell 
size. RNAi-mediated knock-down of PSMC1 in mammalian cells could be used to investigate, 
whether similar effects are observed in mammalian systems. In fact, the involvement of 
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PSMC1 in cell cycle defects was documented in mammals (Rezvani et al., 2003; Rezvani et al., 
2012), which is in agreement with localisation of PSMC1 to centrosomes in human cell lines; 
this was, however, observed inconsistently (Chapter 7 and Table 9-7). 
 
Table 9-6. PSMC1 localisation summary. 
Key: PCM1, peri-centriolar material 1; PLK4, polo-like kinase 4; OS, photoreceptor outer segment; RPE, 
retinal pigmented epithelium. 
Sub-cellular localisation in hTERT-RPE1 cells 
Localisation within retinal tissue 
cryo-sections 
Dividing 
cells 
Co-localised with TOPORS in a centriole-like pattern in 
some cells at interphase; diffuse cytoplasmic signal was 
also observed for both proteins (PSMC1 signal appeared 
stronger). 
 Co-localised with PCM1 during interphase in 
some cells, but no co-localisation at all was 
observed in others. 
 Co-localised with PLK4 at interphase in 
a centriole-like pattern; however, where two 
PLK4-stained dots were stained, PSMC1 always 
co-localised with only one of them. 
 Co-localised with Centrin-2 during interphase, 
as well as surrounded it (the surrounding signal 
was uniformly continuous with the area of 
signals’ co-localisation; not cloud-like, or 
granular).  
Mouse – 
2 weeks 
old 
No PSMC1 signal was 
observed at all (data 
not shown). 
Mouse – 
6.5 
months 
old 
Localised at the RPE-
OS interface only in 
sections not treated 
to retrieve antigen 
(Figure 8-10). 
In sections subject to 
HIER, PSMC1 
immuno-staining 
was observed in IS as 
well as the RPE-OS 
interface (Figure 8-
11). 
Ciliated 
cells 
Co-localised with α tubulin (used as a ciliary marker) in a 
dot-like pattern reminiscent of centrioles, but was not 
observed at the ciliary basal body.  
Macaque  
No PSMC1 signal was 
observed at all (data 
not shown). 
 
It could be speculated that in photoreceptors, or in neurons, in general, which are non-
dividing, differentiated cells, PSMC1 is additionally required for mediating signalling pathways, 
which prevent cellular growth. SUMOylation by TOPORS could modulate such a function, and 
its impairment might result in cells attempting to re-enter the cell cycle and start growing and 
dividing again. Within the retina this would eventually trigger apoptotic pathways, leading to 
photoreceptor cell death. 
The PSMC1 protein contains a consensus N-myristoylation sequence (residues 1-6), conserved 
in humans, Saccharomyces cerevisiae (yeast), Drosophila melanogaster (fruit-fly), and in 
Arabidopsis thaliana (mouse-ear cress); this modification was demonstrated in yeast and 
plants (Kimura, Kato e Hirano, 2012; Lee, K. H. et al., 2012). It is noteworthy that in the initial 
Y2H screen TOPORS interacted with glycylpeptide N-tetradecanoyltransferase 1 (NMT1; Table 
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11-6 in Appendix 11-6), which catalyses the myristoylation of certain cellular and viral proteins 
(UniProt: P30419). This putative interaction was never confirmed, but it could be speculated 
that TOPORS acts upstream of NMT1 to stimulate, or prevent, PSMC1 myristoylation. 
N-myristoylation of PSMC1 is required for localisation of the proteasomal complex to 
the nucleus, potentially by anchoring it within the nuclear envelope. Mutations of glycine 2, 
otherwise modified by the myristoyl attachment, trigger re-location of the proteasome from 
the nucleus to the cytoplasm (Kimura, Kato e Hirano, 2012). However, modification of this 
glycine does not appear to affect protein function, as even transgenes lacking this residue, 
were able to rescue the developmental phenotype and proteasomal stress, induced by 
silencing of the PSMC1 orthologue in plants (Lee et al., 2011). Conversely, a transgene lacking 
the N-terminal thirteen residues was not able to rescue the developmental phenotype, and 
plants still displayed abnormal leaf morphology, delayed root growth, and an excess of 
trichome branching (Lee, K. H. et al., 2012). 
Importantly, the myristoylation modification may be important for docking PSMC1 onto 
cellular vesicles targeted for the primary cilium and/or photoreceptor outer segments. It may 
also allow for ‘hitch-hiking’ of other 26 S protease components to the OS. There the proteins 
could work in concert with TOPORS to tackle protein degradation requirements near 
the basolateral outer segment membrane. 
  
Identification of Interacting Protein Partners of TOPORS in the Retina   ||   Barbara Czub 
PhD Thesis 2015   ||   Discussion    - 370 - 
 
9.4 FUTURE PERSPECTIVES 
Three interacting partners of TOPORS were identified using a Y2H-based screen of human 
retinal cDNA library. The interactions were validated and evaluated in mammalian cells and 
tissues in addition to further experiments in yeast. Two of these interacting proteins have 
documented functions in the retina: ITM2B has been implicated in autosomal dominant retinal 
dystrophy; whereas PTGDS was suggested to play a role in maintaining the blood-retina barrier 
as well as in transport of retinoid compounds. The third interacting partner of TOPORS, 
PSMC1, was selected for evaluation since, like TOPORS, it participates in protein turnover by 
the ubiquitin-proteasome system, in which it plays a key regulatory function; it had a strong 
association with neurodegeneration in mammals, and was shown to play crucial roles in 
responses to light-induced stress in plants. 
Neither one of these three proteins displays a specific retina expression pattern. On 
the contrary, just like TOPORS, all three are ubiquitous.  
Based on findings from direct interactions in yeast, involving TOPORS fragments, it can be 
speculated that the interactions between TOPORS and ITM2B, as well as between TOPORS and 
PTGDS, would likely involve ubiquitination of these interacting partners by TOPORS. 
An alternative scenario, in which TOPORS participated in a putative ITM2B signalling pathway, 
could also occur. The strongest associations between TOPORS and PSMC1, involved fragments 
required for the SUMO1 E3 ligase activity of TOPORS, thus it was speculated that TOPORS 
SUMOylated PSMC1. Future experiments, aiming to verify these findings could include 
ubiquitination and SUMOylation assays in mammalian cell lines. A basal level of modification 
of the proteins of interest by ubiquitin and/or SUMO1 would first be determined. In 
subsequent experiments TOPORS would be over-expressed and/or silenced, and effects of this 
manipulation on levels on ubiquitination and/or SUMOylation would be determined by 
Western blotting. 
Further work, planned to explain the observed results, involves Western blotting and coIP of 
proteins from cellular lysates, extracted from specific cellular fractions. Additionally, treatment 
of these protein extracts with enzymes, which would remove the putative glycosylation (and 
other) modifications, would also help clarify the observations from current Western blot and 
co-IP experiments. This could be especially helpful in understanding the processing of ITM2B 
and PTGDS, which are subject to proteolytic cleavage and heavy post-translational 
modification. Additionally, these post-translational features may be related to the presence of 
the proteins of interest in specific cellular compartments. For instance, it would be interesting 
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to determine whether glycosylation is at all important for ciliary targeting of these proteins in 
a similar manner to lipidation (reviewed in: Hsiao, Tuz e Ferland, 2012). The glycosylation site 
of ITM2B is located very closely to two of its ciliary-targeting sequences (CTS) on the BRICHOS 
domain (Figure 6-5). Two of the three confirmed carbohydrate modifications of PTGDS are also 
found proximally to the protein’s CTS motifs (Figure 6-8). The site of PSMC1 glycosylation has 
not been established yet; however, its myristoylation modification (Figure 6-11) could play 
a role in ciliary targeting, as is known to happen for NPHP3. 
It is noteworthy that in the initial Y2H screen TOPORS interacted with bifunctional protein 
NCOAT (MGEA5; Table 10-6 in Appendix 10-6), which catalyses the cleavage of N-acetyl 
glucosamine, but not N-acetyl galactosamine, from glycopeptides; it was also shown to possess 
hyaluronidase and acetylase activities (UniProt: O60502). However, the putative interaction 
between TOPORS and this enzyme was never confirmed. If MGEA5 became validated as a true 
interacting partner of TOPORS, it would be interesting to investigate whether perhaps it works 
in concert with TOPORS to modulate the glycosylation modifications of ITM2B, PTGDS and 
PSMC1. It could also be required for the acetyl modification of PSMC1 (Figure 6-11). 
Furthermore, TOPORS and its three interacting partners were observed to co-localise at 
the centrosomes in the human RPE1 cell line. This indicates a potential involvement of these 
proteins in the cell cycle and/or centrosome replication cycle. Nonetheless, only PTGDS was 
observed along the axoneme and at the basal bodies of primary cilia as well as co-localising 
with TOPORS at the connecting cilium in retinal sections, suggesting that this one interacting 
partner may have a more specific role in quiescent differentiated cells, whereas ITM2B and 
PSMC1 are perhaps more important for centrosomal homeostasis of dividing cells.  
Still, in mouse retinal sections, some co-localisation was observed between TOPORS and 
ITM2B in the region of connecting cilia. Nonetheless, this observation requires a further, more 
thorough investigation. This could be achieved by silencing and/or over-expressing TOPORS to 
evaluate how the localisation of its interacting partners is affected (if at all) in mammalian cell 
culture systems. Additionally, future cell work with the three interacting partners of TOPORS 
should incorporate cell cycle arrest experiments to delineate the relevant cell cycle stages 
more precisely. RNA interference (RNAi)-mediated knock-down of each interacting protein 
could be used to observe the effects on the cell cycle of losing that particular interacting 
partner. For example, the pattern of co-staining with centriolar markers (Table 7-3 or Tables 9-
2, 9-4 and 9-6) indicated that the association of the TOPORS’ interactors with centrioles 
occurred at very precise cell cycle stages, and sometimes with a preference for only one of 
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the two centrioles of a centrosome (Figures 7-27 and 7-28). Yet, this was concluded solely on 
the observations of fluorescent micrographs, depicting non-synchronised cell cultures. 
If cells were synchronised by serum starvation (which blocks them at G0, which triggers cilia 
growth), and then simultaneously released from the starvation, this would help to more 
precisely distinguish the cell cycle stage(s), at which co-localisation with centrioles occurs. Cell 
cycle arrest at specific phases, using chemical compounds would ensure an even greater 
accuracy; however, this method may be more detrimental to the overall physiology of the cell 
cycle-arrested cell.  
Furthermore, studies in cells cultured at different confluence levels could also help 
characterise the cellular localisations observed for all three interacting proteins. For instance, 
in ciliated cells cultured to a high confluence levels TOPORS localises to the basal bodies of 
primary cilia. However, in dividing cells, which have not experienced contact-induced 
inhibition, TOPORS is observed throughout the cytoplasm, where it is associated with the actin 
cytoskeleton (Dr Amna Z. Shah: personal communication). This observation may reflect 
the sub-cellular localisation of TOPORS in a differentiated and growing tissue, respectively. It is 
possible that the interactors of TOPORS would display analogous changes in apparent cellular 
localisations depending on cell culture confluence level, or on the tissue type that they are 
expressed in.  
Site-directed mutagenesis (SDM) of the ciliary-targeting sequences (CTS) within TOPORS, as 
well as those identified in ITM2B, PTGDS and PSMC1, could also be performed in order to 
determine whether these bioinformatics-predicted sequences do indeed affect the localisation 
of the proteins of interest to the primary cilia. Additionally, the fate of ITM2B, PTGDS and 
PSMC1 could be studied in a TOPORS knock-down mouse model, which should provide 
additional explanations regarding the nature of associations between TOPORS and these 
interacting partners.  
Defining the basal protein levels of TOPORS and its interacting partners in different cellular 
compartments, preferably by extracting proteins from cellular fraction of synchronised cells at 
specific cell cycle stages, would also help delineate their potential roles, and, thus, the nature 
of the observed interactions. This would be especially relevant to PTGDS and ITM2B, as they 
are both expected to carry different post-translational modifications, depending on whether 
they are still undergoing processing in intracellular compartments, or whether they are 
excreted, or bound to plasma membrane, respectively. With regard to ITM2B, represented by 
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several peptides on Western blotted membranes (Figures 6-4, 6-6 and 6-7), this would 
additionally serve to verify the published data about where and when the protein undergoes 
specific proteolytic processing steps. In order to obtain more definite results the protein 
extracts should additionally be treated with de-glycosylation enzymes prior to SDS-PAGE.  
To test the hypothetical effects of the ITM2B retinal mutant, an experiment could be 
performed, which would involve silencing of endogenous ITM2B in cell lines, followed by over-
expression of wild-type ITM2B (as control) and the retinal mutant ITM2B, tagged at the C-
terminus. Western blots could then be performed, using an antibody against the tag. 
The tagged CCTP fragment should be detected in cells, expressing the wild-type protein; 
however, no corresponding band should be observed for the retinal mutant, if the retinal 
ITM2B mutation does indeed impair proteolytic cleavage by furin.  
Further work, to better understand the nature of the interaction between TOPORS, ITM2B and 
PSMC1 could focus on mitochondrial homeostasis. Mitochondrial localisation of 
a shorter ITM2B isoform was associated with loss of membrane potential of this organelle and 
apoptosis, which could suggest converging functions of ITM2B and TOPORS at this organelle 
(Fleischer, Ayllon e Rebollo, 2002; Fleischer et al., 2002; Fleischer e Rebollo, 2004). In mouse 
models of neurodegeneration PSMC1 has also been implicated in mitochondrial protein quality 
control and homeostasis, providing further support for focusing on this organelle in context of 
the retina (Paine et al., 2013). Additionally, mitochondrial DNA damage might occur due to 
light-induced oxidative stress. If PSMC1 was found to mediate responses to these stresses, this 
would provide evidence of a functional correlation with the plant orthologue of PSMC1. 
This section provided an overview of experiments, which could be performed as a continuation 
of this PhD project. The next section offers a different outlook at the initial question of 
the project; i.e. why mutations in ubiquitously expressed genes, here TOPORS, result in retina-
restricted disease.  
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9.5 ALTERNATIVE APPROACHES 
Mutations, which were originally identified in TOPORS in German and French Canadian families 
presenting with autosomal dominant retinitis pigmentosa (adRP), concentrate closer to the C-
terminal region of the TOPORS protein: after the RS/SR domain, but before the Lys/His 
domain. They lead to a shift of the protein reading frame, resulting in early termination 
codons. Thus they are believed to cause the production of truncated TOPORS proteins, which 
become immediately degraded, or perhaps the transcripts are subject to nonsense-mediated 
decay. Hence, haploinsufficiency was the proposed as the disease mechanism for these 
mutants.  
More recently, a Scandinavian study identified a missense mutation in TOPORS, located within 
the second PEST domain in close proximity to the second CTS region. The mutation, also 
inherited in a dominant manner, causes a single amino acid change, and the resulting disease, 
a pericentral retinal dystrophy, is less severe than adRP.  
The specific pericentral retinal degeneration may reflect a putative differential expression of 
TOPORS across the retina. Perhaps the rod photoreceptors located pericentrally naturally 
express a lower level of TOPORS, compared to those towards the periphery. This could explain 
why the periphery is not affected by the ‘mild’ p.Glu402Pro mutation, as sufficient wild-type 
protein is probably produced from the un-mutated gene copy. It is also possible that 
the mutant is still able to retain some functions of TOPORS, conveyed by residues located away 
from the mutation site.  
On the other hand, complete removal of a copy of TOPORS due to a potential truncating 
mutation, results in a more severe RP phenotype. 
In order to better understand the nature of the retinal phenotypes, associated with TOPORS 
mutations, several alternative approaches could have been undertaken. 
Firstly, bioinformatics methods could have been implemented to evaluate conservation of 
TOPORS between species. Creation of a phylogenetic tree for this gene would allow for 
determining how long ago it evolved and in what types of organisms it is present, and hence it 
would at least help  determine its putative importance, if not delineate its function. 
Identification of expression profiles of TOPORS in different tissues would also help characterise 
the gene; for instance, it would be interesting to determine whether it perhaps came into 
existence as a fusion between two genes (phylogeny study would aid in determining this), 
giving rise to a “Rosetta stone protein,” and what it could mean. Such an event could 
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be expected to have occurred, as very few proteins exist, which possess a dual E3 ubiquitin as 
well as SUMO1 ligase activity. In fact, TOPORS was the first protein known to perform both 
these enzymatic activities. Understanding the origin of this gene, and determining whether or 
not it came to exist as a fusion between two genes, could help recognize why it emerged and 
thus what its roles are.  
Bioinformatics could also be used as an alternative to the Y2H screen for trying to predict 
the protein-protein interactions (PPIs) in silico. Various algorithms could be utilised for 
determining the PPIs. For instance, compatibility of the tertiary structures of different proteins 
could be determined; the emphasis on tertiary structure is key, as proteins can sometime 
display homology of their three-dimensional structures, even if they lack homology at the level 
of the amino acid sequence (primary structure). Additionally, primary structure evaluation 
could be used for identifying “signature sequences” of the protein of interest, available in 
genomic databases, based on empirically verified data, which could then be linked to 
“signature sequences” of putative interactors. Alternatively, the focus could be on specific 
domains of the protein of interest, aiming to identify other domains (and thus indirectly 
proteins), which the domain of the protein of interest would interact with. 
Affinity chromatography-based approaches, coupled to mass spectrometry based peptide 
sequencing would aid in delineating whole putative protein networks rather than solely binary 
interactions.  It would be helpful to elucidate wider protein networks, which TOPORS forms 
a part of within the different cell types of the retina, not only neuronal, but also glial and 
epithelial. It would also help establish the basis of this interaction, e.g. to determine whether 
TOPORS participates in ubiquitination and/or SUMOylation of certain components of 
the network. 
Gene expression profiling would be a very informative alternative to PPI studies. Microarray 
experiments could be performed, for instance, to compare gene expression a wild-type animal 
and a mutant TOPORS animal model. Alternatively, gene expression in different regions of 
the retina, e.g. centre vs. periphery, or from different retinal cell types, could help explain 
the peri-central retinal dystrophy observed in the Scandinavian pedigree. Furthermore, 
a comparison of gene expression in light- and dark-adapted animals (both: wild-type and 
mutant) could perhaps explain the light-dependent translocation pattern of TOPORS within 
photoreceptor cells. 
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An animal model should also be studied at the protein level. Specifically, the histology of 
tissues, hypothetically affected by TOPORS mutations, should be compared between the wild-
type and mutant animals. Gene profiling in tissues affected at protein level could then also be 
performed. Moreover, electron microscopy imaging should be performed in the affected 
tissues in order to accurately examine and compare the structure of primary cilia between 
wild-type animals and mutants. It would also be important to conduct the described 
experiments at different developmental stages, focusing on the tissue of primary interest, 
here: the retina. 
At the cell culture level constructs of TOPORS, carrying mutations, identified in patients could 
be studied. Firstly, to re-confirm the truncating mutations of the RP31 phenotype, and 
secondly to characterize the Scandinavian TOPORS mutant, which is expected to be expressed. 
Alternatively, TOPORS plasmids could be constructed, in which the proteins’ functional 
domains would be individually removed. If they were then expressed in a cell line, stably 
transfected with a plasmid encoding the shRNA against TOPORS, aiming to knock-down 
the endogenous TOPORS, this could help determine the significance of individual TOPORS 
protein domains for cellular functions and survival. 
Finally, TOPORS regulatory DNA sequences could also be studied in different tissues, or cell 
types, to try to determine whether anything unique happens in the retina in terms of TOPORS 
expression due to a difference in its regulation at genetic level. Perhaps retina-specific DNA-
binding regulatory elements are involved. 
Many of the approaches described in this section could have been used instead of the Y2H as 
well as the following verification procedures. For instance, a thorough characterisation of 
the mouse model would probably comprise a whole separate project on its own. Similarly, 
the procedures and analysis involved in affinity chromatography- and mass spectrometry-
based peptide sequencing, which would include identification of proteins found in a complex 
with TOPORS as well as their modifications, would probably also require a substantial amount 
of time and resources. This would also to a large extent be true for micro-array based gene 
profiling studies. 
On the other hand, many of the bioinformatics methods could have been used as 
an alternative to the Y2H screening only, and the results of these in silico experiments could 
then have been verified empirically, using many of the same procedures involved in validation 
of Y2H screening results. An initial affinity chromatography- and mass spectrometry-based 
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identification of TOPORS’ interactors could also have been performed instead of the Y2H 
screen (yet, it would result in identification of constituents of whole protein complexes rather 
than binary interactions), which could have been followed by a characterisation in cell lines 
and tissue sections. 
Overall, a thorough characterisation of a gene, and its protein product(s), should probably 
include most, if not all, of the approaches referred to in this section. No one method can ever 
give a full picture of genes and/or proteins roles; therefore, diverse complementary methods 
should probably be used in order to answer such an ambiguous research question as: why 
mutations in a widely-expressed gene appear to result in tissue-restricted phenotypes. 
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9.6 CONCLUSIONS 
The primary aim of this PhD project was to determine why mutations in TOPORS, which is 
a ubiquitously expressed gene, cause a phenotype specific to the retina. It was hypothesised 
that TOPORS protein associates with a retina-specific protein at the basal body of the rod 
photoreceptor connecting cilium; when the interaction is impaired, this leads to photoreceptor 
degeneration and cell death. 
The results generated throughout this project contribute only a minute component to 
the overall knowledge of retinal functions, or a specific role of TOPORS in the retina. Thus, 
the answer to the initial research question remains largely elusive.  
The work led to identification of ITM2B, PTGDS and PSMC1 proteins as interacting partners of 
TOPORS using the Y2H screen. They were all shown to be expressed in the human retina at 
mRNA levels, were found together in protein complexes precipitated from human HeLa cells, 
and co-localised with TOPORS in human hTERT-RPE1 cell lines as well as mammalian retinal 
cryo-sections. Their precise functions in the retina require further elucidation; however, 
findings from this project have made it possible to develop several novel hypotheses, 
regarding the association between TOPORS and its interactors, and their significance in context 
of retinal homeostasis.  
ITM2B was shown to be involved in regulation of APP processing and Aβ levels in cell 
(Fotinopoulou et al., 2005; Matsuda et al., 2008); thus, it could by hypothesised that it has 
the same role in photoreceptors outer segments, which are affected by increasing Aβ 
deposition, correlated with aging (Hoh Kam, Lenassi e Jeffery, 2010). TOPORS mutations could 
affect the retrograde transport of ITM2B-containing vesicles from the Golgi membranes to 
the base of the connecting cilium, or their docking at the base of the cilium. This in turn could 
result in impaired trafficking of ITM2B to outer segments, and photoreceptor dysfunction due 
to the Aβ deposition. 
PTGDS could possibly be involved in recycling of retinoid compounds between the RPE cell 
layer and the photoreceptor outer segments lines (Tanaka et al., 1997; Shimamoto et al., 
2007), as well as it could be involved in inter-cellular signalling from the RPE cells to 
the photoreceptor cells. In the latter case it may need to interact with TOPORS at the basal 
body of primary cilium, whilst being transported from the RPE, via the outer segment to 
the inner segment of a photoreceptor cell. There, it might affect gene expression by, e.g. 
docking retinoic acid molecules on specific nuclear receptors. 
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PSMC1 is conserved across eukaryotes and has a documented protective role in plants 
subjected to light-induced stress (Lee, K. H. et al., 2012). Furthermore, the protein and its 
orthologues have been associated with ER-phagosomes (UniProtKD), which is supportive of 
the prominent presence of PSMC1 at the region of RPE phagocytosis in the retina. TOPORS is 
an E3 ubiquitin ligase, expressed in the RPE layer (although to a lesser extent than PSMC1); 
therefore, it could also possibly be involved in RPE phagocytosis. 
Hence, the obtained data allowed for speculating about putative roles of TOPORS’ interactors 
in the retina, and thus, indirectly, about hypothetical retina-specific roles of TOPORS. Yet, no 
definitive conclusions could be drawn as to why mutations in TOPORS, which is a ubiquitously 
expressed gene, cause a retina-restricted disease. Instead, the findings resulted in generation 
of new hypotheses summarised above. 
The data obtained throughout this project contributes to the general knowledge about 
the retina, even if it does not accurately determine the role of the ubiquitous gene TOPORS in 
causing a retina-restricted disease. An in-depth insight into the tissue of interest, here 
the retina, forms a pre-requisite for inventing treatments for tissue-specific diseases, such as 
retinitis pigmentosa. Consequently, the results presented in this thesis could indirectly aid in 
development of future therapies for retinal dystrophies by complementing our current 
understanding of the highly specialised and complex retinal tissue. 
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11 APPENDIX 
11.1 RETINAL cDNA LIBRARY CHARACTERISATION 
Table 11-1. Genes identified in the R&O-dT human cDNA library.  
Protein-coding sequences are highlighted in green. 
Clone # Gene symbol BLAT (UCSC) highest score result Sequencing file(s) 
A - No matches 
A09_AS9_2011-06-
16_1_23-34-22.ab1 
B - No matches 
B09_AS10_2011-06-
16_1_23-34-22.ab1 
C GALNTL6 
Chr. 4: Intronic region of Homo sapiens UDP-N-acetyl-
alpha-D-galactosamine:polypeptide N-
acetylgalactosaminyltransferase-like 6 (GALNTL6), mRNA. 
C09_AS11_2011-06-
16_1_23-34-22.ab1 
D - 
Chr. M: Homo sapiens mRNA expressed only in placental 
villi, clone SMAP47, encoding mitochondrial rRNA. 
D09_AS12_2011-06-
16_1_23-34-22.ab1 
E - Homo sapiens RNA, tRNaseZL-interacting RNA B1. 
E09_AS13_2011-06-
16_1_23-34-22.ab1 
F MTRNR2L8 
Chr. 11: 5’UTR Homo sapiens MT-RNR2-like 8 
(MTRNR2L8), mRNA. 
F09_AS14_2011-06-
16_1_23-34-22.ab1 
G SH3PXD2B 
Chr. 5: Intronic region of Homo sapiens SH3 and PX 
domains 2B (SH3PXD2B), mRNA. 
G09_AS15_2011-06-
16_1_23-34-22.ab1 
H LARP4B 
Chr. 10: Intronic region of Homo sapiens La 
ribonucleoprotein domain family, member 4B (LARP4B), 
mRNA. 
G02_AS7_2011-06-
29_1_19-23-56.ab1 
I LUC7L 
Chr. 16: Intronic region of Homo sapiens LUC7-like (S. 
cerevisiae) (LUC7L), transcript variant 1, mRNA. 
H02_AS8_2011-06-
29_1_19-23-56.ab1 
J - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
A04_AS9_2011-06-
29_1_19-23-56.ab1 
K - No matches 
B04_AS10_2011-06-
29_1_19-23-56.ab1 
L - No matches 
C04_AS11_2011-06-
29_1_19-23-56.ab1 
M ZBTB16 
Chr. 11: Intronic region of Homo sapiens zinc finger and 
BTB domain containing 16 (ZBTB16), transcript variant 1, 
mRNA. 
D04_AS12_2011-06-
29_1_19-23-56.ab1 
N - 
Homo sapiens cDNA FLJ38039 fis, clone CTONG2013934. 
mRNA AK095358 
 
A02_AS1_2011-10-
11_1_20-46-43.ab1 
O TSNAX-DISC1 
Chr. 1: Homo sapiens TSNAX-DISC1 read-through (TSNAX-
DISC1), transcript variant 1, non-coding RNA. 
B02_AS2_2011-10-
11_1_20-46-43.ab1 
P INPP5A 
Chr. 10: Intronic region of Homo sapiens inositol 
polyphosphate-5-phosphatase, 40kDa (INPP5A), mRNA. 
C02_AS3_2011-10-
11_1_20-46-43.ab1 
R - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
D02_AS4_2011-10-
11_1_20-46-43.ab1 
S EPAS1 
Chr. 2: 3’ UTR of Homo sapiens endothelial PAS domain 
protein 1 (EPAS1), mRNA. 
E02_AS5_2011-10-
11_1_20-46-43.ab1 
T PLEKHA7 
Chr. 11: Intronic region of Homo sapiens pleckstrin 
homology domain containing, family A member 7 
(PLEKHA7), mRNA. 
F02_AS6_2011-10-
11_1_20-46-43.ab1 
U MAP4 
Chr. 3: Intronic region of Homo sapiens microtubule-
associated protein 4 (MAP4), transcript variant 4, mRNA. 
G02_AS7_2011-10-
11_1_20-46-43.ab1 
V - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
A04_AS9_2011-10-
11_1_20-46-43.ab1 
W - Homo sapiens RNA, tRNaseZL-interacting RNA B1. 
B04_AS10_2011-10-
11_1_20-46-43.ab1 
X - Homo sapiens RNA, tRNaseZL-interacting 
C04_AS11_2011-10-
11_1_20-46-43.ab1 
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Clone # Gene symbol BLAT (UCSC) highest score result Sequencing file(s) 
Y - Homo sapiens RNA, tRNaseZL-interacting RNA B1. 
D04_AS12_2011-10-
11_1_20-46-43.ab1 
Z C2orf71 
Chr. 2: Homo sapiens chromosome 2 open reading frame 
71 (C2orf71), mRNA. 
E04_AS13_2011-10-
11_1_20-46-43.ab1 
AA - No matches 
F04_AS14_2011-10-
11_1_20-46-43.ab1 
AB - Chr. 8: Unannotated region 
G04_AS15_2011-10-
11_1_20-46-43.ab1 
AC TAGLN 
Chr. 11: Homo sapiens transgelin (TAGLN), transcript 
variant 2, mRNA. 
H04_AS16_2011-10-
11_1_20-46-43.ab1 
AD - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
A05_AS17_2011-11-
11_1_16-20-46.ab1 
AE HFM1 
Chr. 1: Intronic region of Homo sapiens HFM1, ATP-
dependent DNA helicase homolog (S. cerevisiae) (HFM1), 
mRNA. 
B05_AS18_2011-11-
11_1_16-20-46.ab1 
AF - No matches 
C05_AS19_2011-11-
11_1_16-20-46.ab1 
AG CBX5 
Chr. 12: Intronic region of Homo sapiens chromobox 
homolog 5 (CBX5), transcript variant 3, mRNA. 
D05_AS20_2011-11-
11_1_16-20-46.ab1 
AH - Chr. 1: Unannotated region 
E05_AS21_2011-11-
11_1_16-20-46.ab1 
AI KLHL21 
3’UTR of Homo sapiens kelch-like family member 21 
(KLHL21), mRNA. 
F05_AS22_2011-11-
11_1_16-20-46.ab1 
AJ - Na matches 
G05_AS23_2011-11-
11_1_16-20-46.ab1 
1 IGFBP7 
Chr. 4: Homo sapiens insulin-like growth factor binding 
protein 7 (IGFBP7), transcript variant 1, mRNA. 
A01_AS1_2011-11-
18_1_18-20-29.ab1 
2 SLC4A7 
Chr. 3: Intronic region of Homo sapiens solute carrier 
family 4, sodium bicarbonate cotransporter, member 7 
(SLC4A7), transcript variant 1, mRNA. 
A03_AS9_2011-11-
18_1_18-20-29.ab1 
3 - 
Chr. M: Homo sapiens mRNA expressed only in placental 
villi, clone SMAP47. 
B01_AS2_2011-11-
18_1_18-20-29.ab1 
4 TTR 
Chr. 18: 3’UTR of Homo sapiens transthyretin (TTR), 
mRNA. 
B03_AS10_2011-11-
18_1_18-20-29.ab1 
5 ROMO1 
Chr. 20: Homo sapiens reactive oxygen species 
modulator 1 (ROMO1), nuclear gene encoding 
mitochondrial protein, mRNA. 
C01_AS3_2011-11-
18_1_18-20-29.ab1 
6 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
C03_AS11_2011-11-
18_1_18-20-29.ab1 
7 GAPDH 
Retro-GAPDH. Retroposed gene: Homo sapiens 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), 
transcript variant 1, mRNA. 
D01_AS4_2011-11-
18_1_18-20-29.ab1 
8 - No matches 
D03_AS12_2011-11-
18_1_18-20-29.ab1 
9 TRAFD1 
Chr. 12: Intronic region of Homo sapiens TRAF-type zinc 
finger domain containing 1 (TRAFD1), transcript variant 2, 
mRNA. 
E01_AS5_2011-11-
18_1_18-20-29.ab1 
10 ARL8B 
Chr. 3: Intronic region of Homo sapiens ADP-ribosylation 
factor-like 8B (ARL8B), mRNA. 
F01_AS6_2011-11-
18_1_18-20-29.ab1 
11 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
G01_AS7_2011-11-
18_1_18-20-29.ab1 
12 ZNHIT1 
Chr. 7: 3’UTR of Homo sapiens zinc finger, HIT-type 
containing 1 (ZNHIT1), mRNA. 
H01_AS8_2011-11-
18_1_18-20-29.ab1 
13 SLC4A7 
Chr. 3: Intronic region of Homo sapiens solute carrier 
family 4, sodium bicarbonate cotransporter, member 7 
(SLC4A7), transcript variant 1, mRNA. 
A03_AS9_2011-11-
18_1_18-20-29.ab1 
14 TTR 
Chr. 18: 3’UTR of Homo sapiens transthyretin (TTR), 
mRNA. 
B03_AS10_2011-11-
18_1_18-20-29.ab1 
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15 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
C03_AS11_2011-11-
18_1_18-20-29.ab1 
16 - No matches 
D03_AS12_2011-11-
18_1_18-20-29.ab1 
17 SLC25A6 
Chr. X & Chr. Y: 3’UTR of Homo sapiens solute carrier 
family 25 (mitochondrial carrier; adenine nucleotide 
translocator), member 6 (SLC25A6), nuclear gene 
encoding mitochondrial protein, mRNA. 
E03_AS13_2011-11-
18_1_18-20-29.ab1 
18 TIAM2 
Chr. 6: 3’UTR of Homo sapiens T-cell lymphoma invasion 
and metastasis 2 (TIAM2), transcript variant 1, mRNA. 
F03_AS14_2011-11-
18_1_18-20-29.ab1 
19 ATG7 
Chr. 3: Homo sapiens autophagy related 7 (ATG7), 
transcript variant 1, mRNA. 
G03_AS15_2011-11-
18_1_18-20-29.ab1 
20 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
H03_AS16_2011-11-
18_1_18-20-29.ab1 
21 - No matches 
A01_BC1_2011-11-
30_1_16-20-47.ab1 
22 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
A03_BC9_2011-11-
30_1_16-20-47.ab1 
23 - No matches 
A05_BC17_2011-11-
30_1_16-20-47.ab1 
24 MIR143HG 
Chr. 5: Intronic region of Homo sapiens MIR143 host 
gene (non-protein coding) (MIR143HG), non-coding RNA. 
A07_BC25_2011-11-
30_1_16-20-47.ab1 
25 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
A09_BC33_2011-11-
30_1_16-20-47.ab1 
26 - No matches 
B01_BC2_2011-11-
30_1_16-20-47.ab1 
27 SEMA3F 
Chr. 3: 3’UTR of Homo sapiens sema domain, 
immunoglobulin domain (Ig), short basic domain, 
secreted, (semaphorin) 3F (SEMA3F), mRNA. 
B03_BC10_2011-11-
30_1_16-20-47.ab1 
28 - 
Homo sapiens similar to ubiquitin-associated protein 1 
(predicted), mRNA (cDNA clone IMAGE:6471394). 
B05_BC18_2011-11-
30_1_16-20-47.ab1 
29 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
B07_BC26_2011-11-
30_1_16-20-47.ab1 
30 - 
Chr. 10: mRNA AF205216: Homo sapiens clone KC9 Alu 
repeat sequence. 
B09_BC34_2011-11-
30_1_16-20-47.ab1 
31 COL4A3BP 
Chr. 5: Intronic region of Homo sapiens collagen, type IV, 
alpha 3 (Goodpasture antigen) binding protein 
(COL4A3BP), transcript variant 1, mRNA. 
C01_BC3_2011-11-
30_1_16-20-47.ab1 
32 SEMA3F 
Chr. 3: 3’UTR of Homo sapiens sema domain, 
immunoglobulin domain (Ig), short basic domain, 
secreted, (semaphorin) 3F (SEMA3F), mRNA. 
C03_BC11_2011-11-
30_1_16-20-47.ab1 
33 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
C05_BC19_2011-11-
30_1_16-20-47.ab1 
34 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
C07_BC27_2011-11-
30_1_16-20-47.ab1 
35 TTR 
Chr. 18: 3’UTR of Homo sapiens transthyretin (TTR), 
mRNA. 
D01_BC4_2011-11-
30_1_16-20-47.ab1 
36 UPF2 
Chr. 10: Intronic region of Homo sapiens UPF2 regulator 
of nonsense transcripts homolog (yeast) (UPF2), 
transcript variant 2, mRNA. 
D03_BC12_2011-11-
30_1_16-20-47.ab1 
37 EPHX2 
Chr. 8: 3’UTR of Homo sapiens epoxide hydrolase 2, 
cytoplasmic (EPHX2), transcript variant 1, mRNA. 
D05_BC20_2011-11-
30_1_16-20-47.ab1 
38 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
D07_BC28_2011-11-
30_1_16-20-47.ab1 
39 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
E01_BC5_2011-11-
30_1_16-20-47.ab1 
40 ZNF625 
Chr. 19: Intronic region of  Homo sapiens zinc finger 
protein 625 (ZNF625), transcript variant 2, non-coding 
RNA. 
E03_BC13_2011-11-
30_1_16-20-47.ab1 
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41 - Chr. 12: Unannotated region. 
E05_BC21_2011-11-
30_1_16-20-47.ab1 
42 - No matches 
E07_BC29_2011-11-
30_1_16-20-47.ab1 
43 SH3RF3 
Chr. 2: Intronic region of Homo sapiens SH3 domain 
containing ring finger 3 (SH3RF3), mRNA. 
F01_BC6_2011-11-
30_1_16-20-47.ab1 
44 UBR1 
Chr. 15: Intronic region of Homo sapiens ubiquitin 
protein ligase E3 component n-recognin 1 (UBR1), mRNA. 
F03_BC14_2011-11-
30_1_16-20-47.ab1 
45 - No matches 
F05_BC22_2011-11-
30_1_16-20-47.ab1 
46 - 
Homo sapiens mRNA, HERV-K LTR element, isolate:HKL-
FB8. 
F07_BC30_2011-11-
30_1_16-20-47.ab1 
47 - No matches 
G01_BC7_2011-11-
30_1_16-20-47.ab1 
48 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
G03_BC15_2011-11-
30_1_16-20-47.ab1 
49 FTH1 
Chr. 11: Homo sapiens ferritin, heavy polypeptide 1 
(FTH1), mRNA. 
G05_BC23_2011-11-
30_1_16-20-47.ab1 
50 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
G07_BC31_2011-11-
30_1_16-20-47.ab1 
51 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
H01_BC8_2011-11-
30_1_16-20-47.ab1 
52 - No matches 
H03_BC16_2011-11-
30_1_16-20-47.ab1 
53 - Homo sapiens RNA, tRNaseZL-interacting RNA B1. 
H05_BC24_2011-11-
30_1_16-20-47.ab1 
54 FTO 
Chr. 16: Intronic region of Homo sapiens fat mass and 
obesity associated (FTO), mRNA. 
H07_BC32_2011-11-
30_1_16-20-47.ab1 
55 KALRN 
Chr. 3: Intronic region of Homo sapiens kalirin, RhoGEF 
kinase (KALRN), transcript variant 1, mRNA. 
A02_BC1_2011-12-
02_1_20-02-54.ab1 
56 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
B02_BC2_2011-12-
02_1_20-02-54.ab1 
57 FTL 
Chr. 19: Homo sapiens ferritin, light polypeptide (FTL), 
mRNA. 
A01_BC1_2011-12-
05_1_17-10-32.ab1 
58 - No matches 
A03_BC9_2011-12-
05_1_17-10-32.ab1 
59 - No matches 
B01_BC2_2011-12-
05_1_17-10-32.ab1 
60 - No matches 
B03_BC10_2011-12-
05_1_17-10-32.ab1 
61 RAB2B 
Chr. 14: 3’UTR of Homo sapiens RAB2B, member RAS 
oncogene family (RAB2B), transcript variant 2, mRNA. 
C01_BC3_2011-12-
05_1_17-10-32.ab1 
62 ENO3 
Chr. 17: Homo sapiens enolase 3 (beta, muscle) (ENO3), 
transcript variant 2, mRNA. 
C03_BC11_2011-12-
05_1_17-10-32.ab1 
63 TPT1 
Chr. 13: Homo sapiens tumour protein, translationally-
controlled 1 (TPT1), mRNA. 
D01_BC4_2011-12-
05_1_17-10-32.ab1 
64 PTGDS 
Chr. 9: Homo sapiens prostaglandin D2 synthase 21kDa 
(brain) (PTGDS), mRNA. 
D03_BC12_2011-12-
05_1_17-10-32.ab1 
65 NLK 
Chr. 17: Intronic region of Homo sapiens nemo-like 
kinase (NLK), mRNA. 
E01_BC5_2011-12-
05_1_17-10-32.ab1 
66 TMEM57 
Chr. 1: Intronic regions of Homo sapiens transmembrane 
protein 57 (TMEM57), mRNA. 
F01_BC6_2011-12-
05_1_17-10-32.ab1 
67 RBM48 
Chr. 7: Last exon and 3’UTR of Homo sapiens RNA binding 
motif protein 48 (RBM48), mRNA. 
G01_BC7_2011-12-
05_1_17-10-32.ab1 
68 TAPBP 
Chr. 6: 3’UTR of Homo sapiens TAP binding protein 
(tapasin) (TAPBP), transcript variant 1, mRNA. 
H01_BC8_2011-12-
05_1_17-10-32.ab1 
69 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
A01_BC1_2011-12-
07_1_19-30-29.ab1 
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70 CTSD Chr. 11: Homo sapiens cathepsin D (CTSD), mRNA. 
A03_BC9_2011-12-
07_1_19-30-29.ab1 
71 PDC 
Chr. 1: Intronic region of Homo sapiens phosducin (PDC), 
transcript variant 1, mRNA & Homo sapiens microRNA 
548f-1 (MIR548F1), microRNA. 
A05_BC17_2011-12-
07_1_19-30-29.ab1 
72 CDH23 
Chr. 10: Intronic region of Homo sapiens cadherin-related 
23 (CDH23), transcript variant 5, mRNA. 
A07_BC25_2011-12-
07_1_19-30-29.ab1 
73 ABS 
Chr. 19: 3’UTR of Homo sapiens amino-terminal enhancer 
of split (AES), transcript variant 2, mRNA. 
B01_BC2_2011-12-
07_1_19-30-29.ab1 
74 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
B03_BC10_2011-12-
07_1_19-30-29.ab1 
75 ITM2B 
Chr. 13: Homo sapiens integral membrane protein 2B 
(ITM2B), mRNA. 
B05_BC18_2011-12-
07_1_19-30-29.ab1 
76 - 
Chr. 7: Homo sapiens uncharacterized LOC402483 
(FLJ45340), non-coding RNA. 
B07_BC26_2011-12-
07_1_19-30-29.ab1 
77 DYNC1LI2 
Chr. 16: 3’UTR of Homo sapiens dynein, cytoplasmic 1, 
light intermediate chain 2 (DYNC1LI2), mRNA. 
C01_BC3_2011-12-
07_1_19-30-29.ab1 
78 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
C03_BC11_2011-12-
07_1_19-30-29.ab1 
79 - 
mRNA AF205216: Homo sapiens clone KC9 Alu repeat 
sequence. 
C05_BC19_2011-12-
07_1_19-30-29.ab1 
80 - Chr. 7: Unannotated region 
C07_BC27_2011-12-
07_1_19-30-29.ab1 
81 TGFBR2 
Chr. 3: Intronic region of Homo sapiens transforming 
growth factor, beta receptor II (70/80kDa) (TGFBR2), 
transcript variant 2, mRNA. 
D01_BC4_2011-12-
07_1_19-30-29.ab1 
82 DPYSL3 
Chr. 5: Intronic region of Homo sapiens 
dihydropyrimidinase-like 3 (DPYSL3), transcript variant 1, 
mRNA. 
D03_BC12_2011-12-
07_1_19-30-29.ab1 
83 PTGDS 
Chr. 9: Homo sapiens prostaglandin D2 synthase 21kDa 
(brain) (PTGDS), mRNA. 
D05_BC20_2011-12-
07_1_19-30-29.ab1 
84 - Chr. 17: Unannotated region 
D07_BC28_2011-12-
07_1_19-30-29.ab1 
85 HECTD1 
Chr. 14: Intronic region of Homo sapiens HECT domain 
containing E3 ubiquitin protein ligase 1 (HECTD1), mRNA. 
E01_BC5_2011-12-
07_1_19-30-29.ab1 
86 SCAF4 
Chr. 21: Last exon and 3’UTR of Homo sapiens SR-related 
CTD-associated factor 4 (SCAF4), transcript variant 1, 
mRNA. 
E03_BC13_2011-12-
07_1_19-30-29.ab1 
87 MGEA5 
Chr. 10: 5’UTR, exon and intron of Homo sapiens 
meningioma expressed antigen 5 (hyaluronidase) 
(MGEA5), transcript variant 1, mRNA. 
E05_BC21_2011-12-
07_1_19-30-29.ab1 
88 SERPINB1 
Chr. 6: 3’UTR of Homo sapiens serpin peptidase inhibitor, 
clade B (ovalbumin), member 1 (SERPINB1), transcript 
variant 2, non-coding RNA. 
F01_BC6_2011-12-
07_1_19-30-29.ab1 
89 - No matches 
F03_BC14_2011-12-
07_1_19-30-29.ab1 
90 RPL31 
Chr. 2: Homo sapiens ribosomal protein L31 (RPL31), 
transcript variant 1, mRNA. 
F05_BC22_2011-12-
07_1_19-30-29.ab1 
91 MIR210HG 
Chr. 11: Homo sapiens MIR210 host gene (non-protein 
coding) (MIR210HG), non-coding RNA. 
G01_BC7_2011-12-
07_1_19-30-29.ab1 
92 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
G03_BC15_2011-12-
07_1_19-30-29.ab1 
93 RPL31 
Chr. 2: Homo sapiens ribosomal protein L31 (RPL31), 
transcript variant 1, mRNA. 
G05_BC23_2011-12-
07_1_19-30-29.ab1 
94 RPL31 
Chr. 2: Homo sapiens ribosomal protein L31 (RPL31), 
transcript variant 1, mRNA 
H01_BC8_2011-12-
07_1_19-30-29.ab1 
95 ITM2B 
Chr. 13: Homo sapiens integral membrane protein 2B 
(ITM2B), mRNA. 
H03_BC16_2011-12-
07_1_19-30-29.ab1 
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96 RPL31 
Chr. 2: Homo sapiens ribosomal protein L31 (RPL31), 
transcript variant 1, mRNA 
H05_BC24_2011-12-
07_1_19-30-29.ab1 
97 SAR1B 
Chr. 5: 3’UTR of Homo sapiens SAR1 homolog B (S. 
cerevisiae) (SAR1B), transcript variant 1, mRNA. 
A01_BC1_2011-12-
20_1_23-16-12.ab1 
98 PRDX5 
Chr. 11: Homo sapiens peroxiredoxin 5 (PRDX5), nuclear 
gene encoding mitochondrial protein, transcript variant 
1, mRNA. 
A03_BC9_2011-12-
20_1_23-16-12.ab1 
99 HFM1 
Chr. 1: Homo sapiens HFM1, ATP-dependent DNA 
helicase homolog (S. cerevisiae) (HFM1), mRNA. 
A05_BC17_2011-12-
20_1_23-16-12.ab1 
100 - No matches 
B01_BC2_2011-12-
20_1_23-16-12.ab1 
101 PTGDS 
Chr. 9: Homo sapiens prostaglandin D2 synthase 21kDa 
(brain) (PTGDS), mRNA. 
B03_BC10_2011-12-
20_1_23-16-12.ab1 
102 LMF1 
Chr. 16: Intronic region of Homo sapiens lipase 
maturation factor 1 (LMF1), transcript variant 3, non-
coding RNA. 
B05_BC18_2011-12-
20_1_23-16-12.ab1 
103 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
C01_BC3_2011-12-
20_1_23-16-12.ab1 
104 SCAF4 
Chr. 21: Last exon and 3’UTR of Homo sapiens SR-related 
CTD-associated factor 4 (SCAF4), transcript variant 1, 
mRNA. 
C03_BC11_2011-12-
20_1_23-16-12.ab1 
105 - No matches 
C05_BC19_2011-12-
20_1_23-16-12.ab1 
106 
ABCA11P, 
ZNF721 
Chr. 4: Intronic region of two genes: Homo sapiens ATP-
binding cassette, sub-family A (ABC1), member 11, 
pseudogene (ABCA11P), non-coding RNA & Homo 
sapiens zinc finger protein 721 (ZNF721), mRNA. 
D01_BC4_2011-12-
20_1_23-16-12.ab1 
107 PTGDS 
Chr. 9: Homo sapiens prostaglandin D2 synthase 21kDa 
(brain) (PTGDS), mRNA. 
D03_BC12_2011-12-
20_1_23-16-12.ab1 
108 SRPK2 
Chr. 7: Intronic region of Homo sapiens SRSF protein 
kinase 2 (SRPK2), transcript variant 2, mRNA. 
E01_BC5_2011-12-
20_1_23-16-12.ab1 
109 CLSTN2 
Chr. 3: Intronic region of Homo sapiens calsyntenin 2 
(CLSTN2), mRNA. 
E03_BC13_2011-12-
20_1_23-16-12.ab1 
110 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
F01_BC6_2011-12-
20_1_23-16-12.ab1 
111 RBM33 
Chr. 7: 3’UTR of Homo sapiens RNA binding motif protein 
33 (RBM33), mRNA. 
F03_BC14_2011-12-
20_1_23-16-12.ab1 
112 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
G01_BC7_2011-12-
20_1_23-16-12.ab1 
113 - 
Chr. 14: Sequences coding for parts of antibodies, mostly 
variable regions. 
G03_BC15_2011-12-
20_1_23-16-12.ab1 
114 SRPK2 
Chr. 7: Intronic region of Homo sapiens SRSF protein 
kinase 2 (SRPK2), transcript variant 2, mRNA. 
H01_BC8_2011-12-
20_1_23-16-12.ab1 
115 XRCC1 
Chr. 19: Homo sapiens X-ray repair complementing 
defective repair in Chinese hamster cells 1 (XRCC1), 
mRNA. 
H03_BC16_2011-12-
20_1_23-16-12.ab1 
116 HFM1 
Chr. 1: Intronic region of  Homo sapiens HFM1, ATP-
dependent DNA helicase homolog (S. cerevisiae) (HFM1), 
mRNA. 
A01_BC1_2012-01-
05_1_17-26-31.ab1 
117 - No matches 
A03_BC9_2012-01-
05_1_17-26-31.ab1 
118 LMF1 
Chr. 16: Intronic region of Homo sapiens lipase 
maturation factor 1 (LMF1), transcript variant 3, non-
coding RNA. 
B01_BC2_2012-01-
05_1_17-26-31.ab1 
119 - No matches 
B03_BC10_2012-01-
05_1_17-26-31.ab1 
120 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
C01_BC3_2012-01-
05_1_17-26-31.ab1 
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121 SLC26A5 
Chr. 7: Intronic region of Homo sapiens solute carrier 
family 26, member 5 (prestin) (SLC26A5), transcript 
variant b, mRNA. 
C03_BC11_2012-01-
05_1_17-26-31.ab1 
122 - No matches 
D01_BC4_2012-01-
05_1_17-26-31.ab1 
123 - No matches 
D03_BC12_2012-01-
05_1_17-26-31.ab1 
124 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
E01_BC5_2012-01-
05_1_17-26-31.ab1 
125 RPS15 
Retro-RPS15. Retroposed gene: Homo sapiens ribosomal 
protein S15 (RPS15), mRNA. 
F01_BC6_2012-01-
05_1_17-26-31.ab1 
126 - 
Chr. 17: Homo sapiens RNASEK-C17orf49 read-through 
(RNASEK-C17orf49), non-coding RNA. 
G01_BC7_2012-01-
05_1_17-26-31.ab1 
127 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
H01_BC8_2012-01-
05_1_17-26-31.ab1 
128 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
A02_BC1_2012-01-
06_1_19-25-37.ab1 
129 HFM1 
Chr. 1: Intronic region of Homo sapiens HFM1, ATP-
dependent DNA helicase homolog (S. cerevisiae) (HFM1), 
mRNA. 
A04_BC9_2012-01-
06_1_19-25-37.ab1 
130 CHCHD6 
Chr. 3: Homo sapiens coiled-coil-helix-coiled-coil-helix 
domain containing 6 (CHCHD6), mRNA. 
A06_BC17_2012-01-
06_1_19-25-37.ab1 
131 - Homo sapiens RNA, tRNaseZL-interacting RNA B1. 
B02_BC2_2012-01-
06_1_19-25-37.ab1 
132 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
B04_BC10_2012-01-
06_1_19-25-37.ab1 
133 SFRP2 
Chr. 4: 3’UTR of Homo sapiens secreted frizzled-related 
protein 2 (SFRP2), mRNA. 
B06_BC18_2012-01-
06_1_19-25-37.ab1 
134 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
C02_BC3_2012-01-
06_1_19-25-37.ab1 
135 EIF4H 
Chr. 7: Intronic region of Homo sapiens eukaryotic 
translation initiation factor 4H (EIF4H), transcript variant 
1, mRNA. 
C04_BC11_2012-01-
06_1_19-25-37.ab1 
136 GNA11 
Chr. 19: Homo sapiens mRNA; cDNA DKFZp434J194 (from 
clone DKFZp434J194) & Homo sapiens guanine 
nucleotide binding protein (G protein), alpha 11 (Gq 
class) (GNA11), mRNA. 
D02_BC4_2012-01-
06_1_19-25-37.ab1 
137 - 
Chr. 5: Intronic region of Homo sapiens NR2F1 antisense 
RNA 1 (NR2F1-AS1), non-coding RNA. 
D04_BC12_2012-01-
06_1_19-25-37.ab1 
138 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
E02_BC5_2012-01-
06_1_19-25-37.ab1 
139 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
E04_BC13_2012-01-
06_1_19-25-37.ab1 
140 RPS2 
Chr. 16: Homo sapiens ribosomal protein S2 (RPS2), 
mRNA. 
F02_BC6_2012-01-
06_1_19-25-37.ab1 
141 - 
Chr. 9: Sequence from an article: PubmedCentral and 
Elsevier (2006277966) 
F04_BC14_2012-01-
06_1_19-25-37.ab1 
142 - No matches 
G02_BC7_2012-01-
06_1_19-25-37.ab1 
143 NUMA1 
Chr. 11: 3’UTR of Homo sapiens nuclear mitotic 
apparatus protein 1 (NUMA1), mRNA. 
G04_BC15_2012-01-
06_1_19-25-37.ab1 
144 RGR 
Chr. 10: Intronic region of Homo sapiens retinal G protein 
coupled receptor (RGR), transcript variant 1, mRNA. 
H02_BC8_2012-01-
06_1_19-25-37.ab1 
145 PXN 
Chr. 12: 3’UTR of Homo sapiens paxillin (PXN), transcript 
variant 3, mRNA. 
H04_BC16_2012-01-
06_1_19-25-37.ab1 
146 - No matches 
A02_BC1_2012-01-
11_1_01-47-48.ab1 
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147 NFKBIA 
Chr. 14: Homo sapiens nuclear factor of kappa light 
polypeptide gene enhancer in B-cells inhibitor, alpha 
(NFKBIA), mRNA. 
A04_BC9_2012-01-
11_1_01-47-48.ab1 
148 - No matches 
A06_BC17_2012-01-
11_1_01-47-48.ab1 
149 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
A08_BC25_2012-01-
11_1_01-47-48.ab1 
150 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
A10_BC33_2012-01-
11_1_01-47-48.ab1 
151 - Chr. 7: Unannotated sequence 
A12_BC41_2012-01-
11_1_01-47-48.ab1 
152 ATP6V1E1 
Chr. 22: 3’UTR of Homo sapiens ATPase, H+ transporting, 
lysosomal 31kDa, V1 subunit E1 (ATP6V1E1), transcript 
variant 1, mRNA. 
B02_BC2_2012-01-
11_1_01-47-48.ab1 
153 
NDUFA13, 
YJEFN3 
Chr. 19: Intronic region of Homo sapiens NADH 
dehydrogenase (ubiquinone) 1 alpha subcomplex, 13 
(NDUFA13), nuclear gene encoding mitochondrial 
protein, mRNA & Homo sapiens YjeF N-terminal domain 
containing 3 (YJEFN3), transcript variant 2, mRNA. 
B04_BC10_2012-01-
11_1_01-47-48.ab1 
154 TOP1 
Chr. 20: Intronic region of Homo sapiens topoisomerase 
(DNA) I (TOP1), mRNA. 
B06_BC18_2012-01-
11_1_01-47-48.ab1 
155 - 
Chr. M: Intronic region of Homo sapiens piRNA piR-
34804, complete sequence & Homo sapiens potential 
LAG1 interactor mRNA, partial cds. 
B08_BC26_2012-01-
11_1_01-47-48.ab1 
156 TUBD1 
Chr. 17: Intronic region of Homo sapiens tubulin, delta 1 
(TUBD1), transcript variant 5, mRNA. 
B10_BC34_2012-01-
11_1_01-47-48.ab1 
157 - No matches 
B12_BC42_2012-01-
11_1_01-47-48.ab1 
158 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
C02_BC3_2012-01-
11_1_01-47-48.ab1 
159 - 
Chr. 1: mRNA S77581: HERVK10/HUMMTV reverse 
transcriptase homolog (clone RT211) 
C04_BC11_2012-01-
11_1_01-47-48.ab1 
160 PARVA 
Chr. 11: Intronic region of Homo sapiens parvin, alpha 
(PARVA), mRNA. 
C06_BC19_2012-01-
11_1_01-47-48.ab1 
161 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
C08_BC27_2012-01-
11_1_01-47-48.ab1 
162 - 
Chr. 17: Homo sapiens RNASEK-C17orf49 read-through 
(RNASEK-C17orf49), non-coding RNA. 
C10_BC35_2012-01-
11_1_01-47-48.ab1 
163 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
C12_BC43_2012-01-
11_1_01-47-48.ab1 
164 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
D02_BC4_2012-01-
11_1_01-47-48.ab1 
165 NESH 
Chr. 3: Intronic region of Homo sapiens ABI family, 
member 3 (NESH) binding protein (ABI3BP), mRNA. 
D04_BC12_2012-01-
11_1_01-47-48.ab1 
166 FTH1 
Chr. 11:  Homo sapiens ferritin, heavy polypeptide 1 
(FTH1), mRNA. 
D06_BC20_2012-01-
11_1_01-47-48.ab1 
167 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
D08_BC28_2012-01-
11_1_01-47-48.ab1 
168 - Chr. 12: Unannotated region. 
D10_BC36_2012-01-
11_1_01-47-48.ab1 
169 - No matches 
D12_BC44_2012-01-
11_1_01-47-48.ab1 
170 PPARA 
Chr. 22: Homo sapiens peroxisome proliferator-activated 
receptor alpha (PPARA), transcript variant 5, mRNA. 
E02_BC5_2012-01-
11_1_01-47-48.ab1 
171 RAB2B 
Chr. 14: 3’UTR of Homo sapiens RAB2B, member RAS 
oncogene family (RAB2B), transcript variant 1, mRNA. 
E04_BC13_2012-01-
11_1_01-47-48.ab1 
172 OPHN1 
Chr. X. Intronic region of Homo sapiens oligophrenin 1 
(OPHN1), mRNA. 
E06_BC21_2012-01-
11_1_01-47-48.ab1 
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173 - No match 
E08_BC29_2012-01-
11_1_01-47-48.ab1 
174 - 
Chr. 17: Homo sapiens RNASEK-C17orf49 read-through 
(RNASEK-C17orf49), non-coding RNA. 
E10_BC37_2012-01-
11_1_01-47-48.ab1 
175 CA10 
Chr. 17: Intronic region of Homo sapiens carbonic 
anhydrase X (CA10), transcript variant 1, mRNA. 
F02_BC6_2012-01-
11_1_01-47-48.ab1 
176 - No match 
F04_BC14_2012-01-
11_1_01-47-48.ab1 
177 SLC16A3 
Chr. 17: Homo sapiens solute carrier family 16 
(monocarboxylate transporter), member 3 (SLC16A3), 
transcript variant 2, mRNA. 
F06_BC22_2012-01-
11_1_01-47-48.ab1 
178 
RASSF4, 
C10orf10 
Chr. 10: Intronic region of Homo sapiens Ras association 
(RalGDS/AF-6) domain family member 4 (RASSF4), mRNA 
& 3’UTR of Homo sapiens chromosome 10 open reading 
frame 10 (C10orf10), mRNA. 
F08_BC30_2012-01-
11_1_01-47-48.ab1 
179 - 
Chr. 17: Homo sapiens RNASEK-C17orf49 read-through 
(RNASEK-C17orf49), non-coding RNA. 
F10_BC38_2012-01-
11_1_01-47-48.ab1 
180 TCF12 
Chr. 15: Intronic region of Homo sapiens transcription 
factor 12 (TCF12), transcript variant 2, mRNA. 
G02_BC7_2012-01-
11_1_01-47-48.ab1 
181 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
G04_BC15_2012-01-
11_1_01-47-48.ab1 
182 TTR Chr. 18: Homo sapiens transthyretin (TTR), mRNA. 
G06_BC23_2012-01-
11_1_01-47-48.ab1 
183 ANO6 
Chr. 12: Homo sapiens anoctamin 6 (ANO6), transcript 
variant 3, mRNA. 
G08_BC31_2012-01-
11_1_01-47-48.ab1 
184 - Chr. 10: Unannotated sequence. 
G10_BC39_2012-01-
11_1_01-47-48.ab1 
185 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
H02_BC8_2012-01-
11_1_01-47-48.ab1 
186 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
H04_BC16_2012-01-
11_1_01-47-48.ab1 
187 JUN Chr. 1: Homo sapiens jun proto-oncogene (JUN), mRNA. 
H06_BC24_2012-01-
11_1_01-47-48.ab1 
188 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
H08_BC32_2012-01-
11_1_01-47-48.ab1 
189 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
H10_BC40_2012-01-
11_1_01-47-48.ab1 
190 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
A03_BC7_2012-01-
25_1_01-24-53.ab1 
191 ZC3H7A 
Chr. 16: Homo sapiens zinc finger CCCH-type containing 
7A (ZC3H7A), mRNA. 
B03_BC8_2012-01-
25_1_01-24-53.ab1 
192 MMP15 
Chr. 16: 3’UTR of Homo sapiens matrix metallopeptidase 
15 (membrane-inserted) (MMP15), mRNA. 
C01_BC1_2012-01-
25_1_01-24-53.ab1 
193 PITPNC1 
Chr. 17: Intronic region of Homo sapiens 
phosphatidylinositol transfer protein, cytoplasmic 1 
(PITPNC1), transcript variant 2, mRNA. 
D01_BC2_2012-01-
25_1_01-24-53.ab1 
194 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
E01_BC3_2012-01-
25_1_01-24-53.ab1 
195 RPS11 
Chr. 19: Homo sapiens ribosomal protein S11 (RPS11), 
mRNA. 
F01_BC4_2012-01-
25_1_01-24-53.ab1 
196 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
G01_BC5_2012-01-
25_1_01-24-53.ab1 
197 GOT2 
Chr. 16: Intronic region of Homo sapiens glutamic-
oxaloacetic transaminase 2, mitochondrial (GOT2), 
nuclear gene encoding mitochondrial protein, mRNA. 
H01_BC6_2012-01-
25_1_01-24-53.ab1 
198 LMF1 
Chr. 16: Intronic region of Homo sapiens lipase 
maturation factor 1 (LMF1), transcript variant 3, non-
coding RNA. 
A01_BC1_2012-01-
26_1_24-37-39.ab1 
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199 FAM120A 
Chr. 9: Homo sapiens family with sequence similarity 
120A (FAM120A), mRNA. 
A03_BC9_2012-01-
26_1_24-37-39.ab1 
200 - No matches 
B01_BC2_2012-01-
26_1_24-37-39.ab1 
201 CKB 
Chr. 14: Homo sapiens creatine kinase, brain (CKB), 
mRNA. 
B03_BC10_2012-01-
26_1_24-37-39.ab1 
202 TAOK3 
Chr. 12: Intronic region of Homo sapiens TAO kinase 3 
(TAOK3), mRNA. 
C01_BC3_2012-01-
26_1_24-37-39.ab1 
203 TMEM117 
Chr. 12: Intronic region of Homo sapiens transmembrane 
protein 117 (TMEM117), mRNA. 
C03_BC11_2012-01-
26_1_24-37-39.ab1 
204 TAOK3 
Chr. 12: Intronic region of Homo sapiens TAO kinase 3 
(TAOK3), mRNA. 
D01_BC4_2012-01-
26_1_24-37-39.ab1 
205 - Chr. M: Alignment with several published sequences 
D03_BC12_2012-01-
26_1_24-37-39.ab1 
206 FAM120A 
Chr. 9:  Homo sapiens family with sequence similarity 
120A (FAM120A), mRNA. 
E01_BC5_2012-01-
26_1_24-37-39.ab1 
207 SAR1B 
Chr. 5: 3’UTR of Homo sapiens SAR1 homolog B (S. 
cerevisiae) (SAR1B), transcript variant 1, mRNA. 
F01_BC6_2012-01-
26_1_24-37-39.ab1 
208 - 
Chr. M: Homo sapiens mRNA expressed only in placental 
villi, clone SMAP47. 
G01_BC7_2012-01-
26_1_24-37-39.ab1 
209 - Chr. M: Alignment with several published sequences 
H01_BC8_2012-01-
26_1_24-37-39.ab1 
210 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
A01_1_2012-01-27_1_01-
08-38.ab1 
211 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
A03_9_2012-01-27_1_01-
08-38.ab1 
212 - Chr. M: Alignment with several published sequences 
B01_2_2012-01-27_1_01-
08-38.ab1 
213 HBA2 
Chr. 16: Homo sapiens haemoglobin, alpha 2 (HBA2), 
mRNA. 
B03_10_2012-01-
27_1_01-08-38.ab1 
214 - Homo sapiens RNA, tRNaseZL-interacting RNA B1. 
C01_3_2012-01-27_1_01-
08-38.ab1 
215 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
C03_11_2012-01-
27_1_01-08-38.ab1 
216 FTO 
Chr. 16: Intronic region of Homo sapiens fat mass and 
obesity associated (FTO), mRNA. 
D01_4_2012-01-27_1_01-
08-38.ab1 
217 - Homo sapiens RNA, tRNaseZL-interacting RNA B1. 
E01_5_2012-01-27_1_01-
08-38.ab1 
218 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
F01_6_2012-01-27_1_01-
08-38.ab1 
219 CCDC50 
Chr. 3: mRNA AK096400: Homo sapiens cDNA FLJ39081 
fis, clone NT2RP7018340 & mRNA HQ448050: Synthetic 
construct Homo sapiens clone IMAGE:100071429; 
CCSB012307_01 coiled-coil domain containing 50 
(CCDC50) gene, encodes complete protein. 
G01_7_2012-01-27_1_01-
08-38.ab1 
220 GSTM1 
Chr. 1: Homo sapiens glutathione S-transferase mu 1 
(GSTM1), transcript variant 1, mRNA 
H01_8_2012-01-27_1_01-
08-38.ab1 
221 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
A01_BC1_2012-02-
03_1_18-18-36.ab1 
222 MFRP 
Chr. 11: Homo sapiens membrane frizzled-related protein 
(MFRP), mRNA. 
A03_BC9_2012-02-
03_1_18-18-36.ab1 
223 RDH8 
Chr. 19: Homo sapiens retinol dehydrogenase 8 (all-trans) 
(RDH8), mRNA. 
A05_BC17_2012-02-
03_1_18-18-36.ab1 
224 GSTM1 
Chr. 1: Homo sapiens glutathione S-transferase mu 1 
(GSTM1), transcript variant 1, mRNA 
B01_BC2_2012-02-
03_1_18-18-36.ab1 
225 FAM81A 
Chr. 15: 3’UTR of  Homo sapiens family with sequence 
similarity 81, member A (FAM81A), mRNA. 
B03_BC10_2012-02-
03_1_18-18-36.ab1 
226 GBA 
Chr. 1: Homo sapiens glucosidase, beta, acid (GBA), 
transcript variant 1, mRNA. 
B05_BC18_2012-02-
03_1_18-18-36.ab1 
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227 VAC14 
Chr. 16: 3’UTR of Homo sapiens Vac14 homolog (S. 
cerevisiae) (VAC14), mRNA. 
C01_BC3_2012-02-
03_1_18-18-36.ab1 
228 COX7A1 
Chr. 19: Homo sapiens cytochrome c oxidase subunit VIIa 
polypeptide 1 (muscle) (COX7A1), nuclear gene encoding 
mitochondrial protein, mRNA. 
C03_BC11_2012-02-
03_1_18-18-36.ab1 
229 RPL19 
Chr. 5: Retro-RPL19. Retroposed gene: Homo sapiens 
ribosomal protein L19 (RPL19), mRNA. 
C05_BC19_2012-02-
03_1_18-18-36.ab1 
230 RPL7A 
Chr. 9: Homo sapiens ribosomal protein L7a (RPL7A), 
mRNA. 
D01_BC4_2012-02-
03_1_18-18-36.ab1 
231 CAP1 
Chr. 1: 3’UTR of Homo sapiens CAP, adenylate cyclase-
associated protein 1 (yeast) (CAP1), transcript variant 1, 
mRNA. 
D03_BC12_2012-02-
03_1_18-18-36.ab1 
232 GAB2 
Chr. 11: Intronic region of  Homo sapiens GRB2-
associated binding protein 2 (GAB2), transcript variant 1, 
mRNA. 
D05_BC20_2012-02-
03_1_18-18-36.ab1 
233 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
E01_BC5_2012-02-
03_1_18-18-36.ab1 
234 UBC Chr. 12: Homo sapiens ubiquitin C (UBC), mRNA. 
E03_BC13_2012-02-
03_1_18-18-36.ab1 
235 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
E05_BC21_2012-02-
03_1_18-18-36.ab1 
236 - No matches 
F01_BC6_2012-02-
03_1_18-18-36.ab1 
237 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
F03_BC14_2012-02-
03_1_18-18-36.ab1 
238 GPR124 
Chr. 8: 3’UTR of Homo sapiens G protein-coupled 
receptor 124 (GPR124), mRNA. 
F05_BC22_2012-02-
03_1_18-18-36.ab1 
239 TMTC1 
Chr. 12: Intronic region of Homo sapiens transmembrane 
and tetratricopeptide repeat containing 1 (TMTC1), 
transcript variant 1, mRNA. 
G01_BC7_2012-02-
03_1_18-18-36.ab1 
240 - 
Chr. M: Homo sapiens cDNA: FLJ22894 fis, clone 
KAT04907. 
G03_BC15_2012-02-
03_1_18-18-36.ab1 
241 MICAL3 
Chr. 22: Intronic region of Homo sapiens microtubule 
associated monooxygenase, calponin and LIM domain 
containing 3 (MICAL3), transcript variant 1, mRNA. 
H01_BC8_2012-02-
03_1_18-18-36.ab1 
242 NRL 
Chr. 14: 3’UTR of Homo sapiens neural retina leucine 
zipper (NRL), mRNA. 
H03_BC16_2012-02-
03_1_18-18-36.ab1 
243 LPHN1 
Chr. 19: Intronic region of Homo sapiens latrophilin 1 
(LPHN1), transcript variant 1, mRNA. 
A02_BC17_2012-02-
10_1_20-41-28.ab1 
244 EEF2 
Chr. 19: 3’UTR of Homo sapiens eukaryotic translation 
elongation factor 2 (EEF2), mRNA. 
A04_BC25_2012-02-
10_1_20-41-28.ab1 
245 - No matches 
A06_BC33_2012-02-
10_1_20-41-28.ab1 
246 MOB3B 
Chr. 9: Intronic region of  Homo sapiens MOB kinase 
activator 3B (MOB3B), mRNA. 
A08_BC41_2012-02-
10_1_20-41-28.ab1 
247 COA3 
Chr. 17:  Homo sapiens cytochrome c oxidase assembly 
factor 3 (COA3), mRNA. 
A09_BC1_2012-02-
10_1_18-25-29 
248 SAR1B 
Chr. 5: 3' UTR of Homo sapiens SAR1 homolog B (S. 
cerevisiae) (SAR1B), transcript variant 1, mRNA. 
A10_BC49_2012-02-
10_1_20-41-28 
249 DNAJC1 
Chr. 10: Intronic region of Homo sapiens DnaJ (Hsp40) 
homolog, subfamily C, member 1 (DNAJC1), mRNA. 
A11_BC9_2012-02-
10_1_18-25-29 
250 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
A12_BC57_2012-02-
10_1_20-41-28 
251 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
B02_BC18_2012-02-
10_1_20-41-28 
252 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
B04_BC26_2012-02-
10_1_20-41-28 
253 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
B06_BC34_2012-02-
10_1_20-41-28 
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254 STAB2 
Chr. 12: Intronic region of Homo sapiens stabilin 2 
(STAB2), mRNA. 
B08_BC42_2012-02-
10_1_20-41-28 
255 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
B09_BC2_2012-02-
10_1_18-25-29 
256 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
B10_BC50_2012-02-
10_1_20-41-28 
257 - No matches 
B11_BC10_2012-02-
10_1_18-25-29 
258 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
B12_BC58_2012-02-
10_1_20-41-28 
259 SPG7 
Chr. 16: 3' UTR of Homo sapiens spastic paraplegia 7 
(pure and complicated autosomal recessive) (SPG7), 
nuclear gene encoding mitochondrial protein, transcript 
variant 1, mRNA. 
C02_BC19_2012-02-
10_1_20-41-28 
260 - 
Chr. M: Homo sapiens mRNA expressed only in placental 
villi, clone SMAP47. 
C04_BC27_2012-02-
10_1_20-41-28 
261 - Chr. 11: Unannotated region. 
C06_BC35_2012-02-
10_1_20-41-28 
262 - 
Chr. M: Sequences from articles: PubMed Central and 
Elsevier 
C08_BC43_2012-02-
10_1_20-41-28 
263 - No matches 
C09_BC3_2012-02-
10_1_18-25-29 
264 OPTC Chr. 1: 3' UTR of Homo sapiens opticin (OPTC), mRNA. 
C10_BC51_2012-02-
10_1_20-41-28 
265 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
C11_BC11_2012-02-
10_1_18-25-29 
266 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
C12_BC59_2012-02-
10_1_20-41-28 
267 NUDC 
Chr. 1: Homo sapiens nuclear distribution C homolog (A. 
nidulans) (NUDC), mRNA. 
D02_BC20_2012-02-
10_1_20-41-28 
268 RSF1 
Chr. 11: Intronic region of Homo sapiens remodelling and 
spacing factor 1 (RSF1), mRNA. 
D04_BC28_2012-02-
10_1_20-41-28 
269 PMEL 
Chr. 12: Homo sapiens premelanosome protein (PMEL), 
transcript variant 1, mRNA. 
D06_BC36_2012-02-
10_1_20-41-28 
270 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
D08_BC44_2012-02-
10_1_20-41-28 
271 RAB7A 
Chr. 3: Intronic region of Homo sapiens RAB7A, member 
RAS oncogene family (RAB7A), mRNA. 
D09_BC4_2012-02-
10_1_18-25-29 
272 - Chr. 2: Unannotated region. 
D10_BC52_2012-02-
10_1_20-41-28 
273 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
D11_BC12_2012-02-
10_1_18-25-29 
274 - No matches 
D12_BC60_2012-02-
10_1_20-41-28 
275 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
E02_BC21_2012-02-
10_1_20-41-28 
276 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
E04_BC29_2012-02-
10_1_20-41-28 
277 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
E06_BC37_2012-02-
10_1_20-41-28 
278 - Chr. 15: Unannotated region. 
E08_BC45_2012-02-
10_1_20-41-28 
279 ILK 
Chr. 11: Homo sapiens integrin-linked kinase (ILK), 
transcript variant 2, mRNA. 
E09_BC5_2012-02-
10_1_18-25-29 
280 C1QB 
Chr. 1: Homo sapiens complement component 1, q 
subcomponent, B chain (C1QB), mRNA. 
E10_BC53_2012-02-
10_1_20-41-28 
281 - No matches 
E11_BC13_2012-02-
10_1_18-25-29 
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282 RBM39 
Chr. 20: Intronic region of Homo sapiens RNA binding 
motif protein 39 (RBM39), transcript variant 1, mRNA. 
F02_BC22_2012-02-
10_1_20-41-28 
283 ZCCHC11 
Chr. 1: Intronic region of  Homo sapiens zinc finger, CCHC 
domain containing 11 (ZCCHC11), transcript variant 1, 
mRNA. 
F04_BC30_2012-02-
10_1_20-41-28 
284 FTX 
Chr. X: Intronic region of Homo sapiens FTX transcript, 
XIST regulator (non-protein coding) (FTX), non-coding 
RNA. 
F06_BC38_2012-02-
10_1_20-41-28 
285 - No matches 
F08_BC46_2012-02-
10_1_20-41-28 
286 - No matches 
F09_BC6_2012-02-
10_1_18-25-29 
287 - 
Chr. M: Sequences from articles: PubMed Central and 
Elsevier 
F10_BC54_2012-02-
10_1_20-41-28 
288 GPI 
Chr. 19: Intronic region of Homo sapiens glucose-6-
phosphate isomerase (GPI), transcript variant 1, mRNA. 
F11_BC14_2012-02-
10_1_18-25-29 
289 BAP1 
Chr. 3: 3' UTR of Homo sapiens BRCA1 associated 
protein-1 (ubiquitin carboxy-terminal hydrolase) (BAP1), 
mRNA. 
G02_BC23_2012-02-
10_1_20-41-28 
290 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
G04_BC31_2012-02-
10_1_20-41-28 
291 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
G06_BC39_2012-02-
10_1_20-41-28 
292 ASB1 
Chr. 2: 3' UTR of Homo sapiens ankyrin repeat and SOCS 
box containing 1 (ASB1), mRNA. 
G08_BC47_2012-02-
10_1_20-41-28 
293 C10orf11 
Chr. 10: Intronic region of  Homo sapiens chromosome 
10 open reading frame 11 (C10orf11), mRNA. 
G09_BC7_2012-02-
10_1_18-25-29 
294 C1QB 
Chr. 1: Homo sapiens complement component 1, q 
subcomponent, B chain (C1QB), mRNA. 
G10_BC55_2012-02-
10_1_20-41-28 
295 - Chr. 9: Unannotated region. 
G11_BC15_2012-02-
10_1_18-25-29 
296 GCC2 
Chr. 2: Intronic region of Homo sapiens GRIP and coiled-
coil domain containing 2 (GCC2), transcript variant 2, 
non-coding RNA. 
H02_BC24_2012-02-
10_1_20-41-28 
297 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
H04_BC32_2012-02-
10_1_20-41-28 
298 RNASE1 
Chr. 14: Intronic region of Homo sapiens ribonuclease, 
RNAse A family, 1 (pancreatic) (RNASE1), transcript 
variant 3, mRNA. 
H06_BC40_2012-02-
10_1_20-41-28 
299 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
H08_BC48_2012-02-
10_1_20-41-28 
300 - No matches 
H09_BC8_2012-02-
10_1_18-25-29 
301 LRP2 
Chr. 2: 3' UTR of Homo sapiens low density lipoprotein 
receptor-related protein 2 (LRP2), mRNA. 
H10_BC56_2012-02-
10_1_20-41-28 
302 MYL6 
Chr. 12:  Homo sapiens myosin, light chain 6, alkali, 
smooth muscle and non-muscle (MYL6), transcript 
variant 2, mRNA. 
H11_BC16_2012-02-
10_1_18-25-29 
303 - Chr. 19: Unannotated sequence 
A01_BC1_2012-02-
17_1_21-47-04.ab1 
304 - 
Chr. 14: Intronic region of Homo sapiens cDNA FLJ36573 
fis, clone TRACH2012370. 
A02_BC49_2012-02-
17_1_23-44-30.ab1 
305 - 
Chr. M: Homo sapiens mRNA expressed only in placental 
villi, clone SMAP47. 
A03_BC9_2012-02-
17_1_21-47-04.ab1 
306 - Chr. 21: Unannotated sequence 
A04_BC57_2012-02-
17_1_23-44-30.ab1 
307 SLC6A13 
Chr. 12: 3’ UTR of Homo sapiens solute carrier family 6 
(neurotransmitter transporter, GABA), member 13 
(SLC6A13), transcript variant 1, mRNA. 
A05_BC17_2012-02-
17_1_21-47-04.ab1 
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308 - Chr. 12: Unannotated sequence 
A06_BC65_2012-02-
17_1_23-44-30.ab1 
309 ZCCHC11 
Chr. 1: Intronic region of Homo sapiens zinc finger, CCHC 
domain containing 11 (ZCCHC11), transcript variant 1, 
mRNA. 
A07_BC25_2012-02-
17_1_21-47-04.ab1 
310 CCP110 
Chr. 16: 3’ UTR of Homo sapiens centriolar coiled coil 
protein 110kDa (CCP110), transcript variant 1, mRNA. 
A08_BC73_2012-02-
17_1_23-44-30.ab1 
311 COX4I1 
Chr. 16: Homo sapiens cytochrome c oxidase subunit IV 
isoform 1 (COX4I1), nuclear gene encoding mitochondrial 
protein, mRNA. 
A09_BC33_2012-02-
17_1_21-47-04.ab1 
312 MFSD11 
Chr. 17: Intronic region of Homo sapiens major facilitator 
superfamily domain containing 11 (MFSD11), transcript 
variant 3, mRNA. 
A10_BC81_2012-02-
17_1_23-44-30.ab1 
313 PDC 
Chr. 1: Homo sapiens phosducin (PDC), transcript variant 
2, mRNA. 
A11_BC41_2012-02-
17_1_21-47-04.ab1 
314 - Chr. 16: Unannotated sequence 
B01_BC2_2012-02-
17_1_21-47-04.ab1 
315 ANKRD30BL 
Chr. 2: Intronic region of Homo sapiens ankyrin repeat 
domain 30B-like (ANKRD30BL), transcript variant 2, non-
coding RNA. 
B02_BC50_2012-02-
17_1_23-44-30.ab1 
316 NOTCH2 
Chr. 1: Intronic region of Homo sapiens notch 2 
(NOTCH2), transcript variant 1, mRNA. 
B03_BC10_2012-02-
17_1_21-47-04.ab1 
317 - No matches 
B04_BC58_2012-02-
17_1_23-44-30.ab1 
318 - No matches 
B05_BC18_2012-02-
17_1_21-47-04.ab1 
319 ATP1B1 
Chr. 1: Intronic region of Homo sapiens ATPase, Na+/K+ 
transporting, beta 1 polypeptide (ATP1B1), mRNA. 
B06_BC66_2012-02-
17_1_23-44-30.ab1 
320 ENO3 
Chr. 17: Homo sapiens enolase 3 (beta, muscle) (ENO3), 
transcript variant 2, mRNA. 
B07_BC26_2012-02-
17_1_21-47-04.ab1 
321 - Chr. 2: Unannotated sequence 
B08_BC74_2012-02-
17_1_23-44-30.ab1 
322 SPSWAP 
Chr. 12: Intronic region of Homo sapiens splicing factor, 
suppressor of white-apricot homolog (Drosophila) 
(SFSWAP), transcript variant 1, mRNA. 
B09_BC34_2012-02-
17_1_21-47-04.ab1 
323 - No matches 
B10_BC82_2012-02-
17_1_23-44-30.ab1 
324 PDC 
Chr. 1: Homo sapiens phosducin (PDC), transcript variant 
2, mRNA. 
B11_BC42_2012-02-
17_1_21-47-04.ab1 
325 CBLB 
Chr. 3: Intronic region of Homo sapiens Cbl proto-
oncogene, E3 ubiquitin protein ligase B (CBLB), mRNA. 
C01_BC3_2012-02-
17_1_21-47-04.ab1 
326 MEF2D 
Chr. 1: 3’ UTR of Homo sapiens myocyte enhancer factor 
2D (MEF2D), transcript variant 2, mRNA. 
C02_BC51_2012-02-
17_1_23-44-30.ab1 
327 DAPK1 
Chr. 9: Intronic region of Homo sapiens death-associated 
protein kinase 1 (DAPK1), mRNA. 
C03_BC11_2012-02-
17_1_21-47-04.ab1 
328 GSN 
Chr. 9: Intronic region of Homo sapiens gelsolin (GSN), 
transcript variant 2, mRNA. 
C04_BC59_2012-02-
17_1_23-44-30.ab1 
329 - Chr. 5: Unannotated sequence 
C05_BC19_2012-02-
17_1_21-47-04.ab1 
330 - Chr. 18: Unannotated sequence 
C06_BC67_2012-02-
17_1_23-44-30.ab1 
331 RHO Chr. 3: Homo sapiens rhodopsin (RHO), mRNA. 
C07_BC27_2012-02-
17_1_21-47-04.ab1 
332 - Chr. 3: Unannotated sequence 
C08_BC75_2012-02-
17_1_23-44-30.ab1 
333 RBM5 
Chr. 3: Intronic region of Homo sapiens RNA binding 
motif protein 5 (RBM5), transcript variant 1, mRNA. 
C09_BC35_2012-02-
17_1_21-47-04.ab1 
334 PDC 
Chr. 1: Homo sapiens phosducin (PDC), transcript variant 
2, mRNA. 
C11_BC43_2012-02-
17_1_21-47-04.ab1 
Identification of Interacting Protein Partners of TOPORS in the Retina   ||   Barbara Czub 
PhD Thesis 2015   ||   Appendix    - 417 - 
 
Clone # Gene symbol BLAT (UCSC) highest score result Sequencing file(s) 
335 PLD3 
Chr. 19: 3’ UTR of Homo sapiens phospholipase D family, 
member 3 (PLD3), transcript variant 1, mRNA. 
D01_BC4_2012-02-
17_1_21-47-04.ab1 
336 FAM222B 
Chr. 17: Homo sapiens family with sequence similarity 
222, member B (FAM222B), transcript variant 1, mRNA. 
D02_BC52_2012-02-
17_1_23-44-30.ab1 
337 ZSCAN32 
Chr. 16: Intronic region of Homo sapiens zinc finger and 
SCAN domain containing 32 (ZSCAN32), mRNA. 
D03_BC12_2012-02-
17_1_21-47-04.ab1 
338 CBLB 
Chr. 3: Intronic region of Homo sapiens Cbl proto-
oncogene, E3 ubiquitin protein ligase B (CBLB), mRNA. 
D04_BC60_2012-02-
17_1_23-44-30.ab1 
339 - Chr. 21: Unannotated sequence 
D05_BC20_2012-02-
17_1_21-47-04.ab1 
340 TXNL4A 
Chr. 18: Intronic region of Homo sapiens thioredoxin-like 
4A (TXNL4A), mRNA. 
D06_BC68_2012-02-
17_1_23-44-30.ab1 
341 - mRNA DL491865 
D07_BC28_2012-02-
17_1_21-47-04.ab1 
342 RHO Chr. 3: Homo sapiens rhodopsin (RHO), mRNA. 
D08_BC76_2012-02-
17_1_23-44-30.ab1 
343 - No matches 
D09_BC36_2012-02-
17_1_21-47-04.ab1 
344 PDC 
Chr. 1: Homo sapiens phosducin (PDC), transcript variant 
2, mRNA. 
D11_BC44_2012-02-
17_1_21-47-04.ab1 
345 - 
mRNA L09269: Human dinucleotide repeat 
polymorphism at the D11S982E locus mRNA. 
E01_BC5_2012-02-
17_1_21-47-04.ab1 
346 - No matches 
E02_BC53_2012-02-
17_1_23-44-30.ab1 
347 - Chr. 9: Unannotated sequence 
E03_BC13_2012-02-
17_1_21-47-04.ab1 
348 - No matches 
E04_BC61_2012-02-
17_1_23-44-30.ab1 
349 EPN2 
Chr. 17: Intronic region of Homo sapiens epsin 2 (EPN2), 
transcript variant 1, mRNA. 
E05_BC21_2012-02-
17_1_21-47-04.ab1 
350 NOTCH2NL 
Chr. 1: Intronic region of Homo sapiens notch 2 N-
terminal like (NOTCH2NL), mRNA. 
E06_BC69_2012-02-
17_1_23-44-30.ab1 
351 DUOX1 
Chr. 15: Intronic region of Homo sapiens dual oxidase 1 
(DUOX1), transcript variant 1, mRNA. 
E07_BC29_2012-02-
17_1_21-47-04.ab1 
352 SUCLG2 
Chr. 3: Intronic region of Homo sapiens succinate-CoA 
ligase, GDP-forming, beta subunit (SUCLG2), nuclear gene 
encoding mitochondrial protein, transcript variant 1, 
mRNA. 
E08_BC77_2012-02-
17_1_23-44-30.ab1 
353 - Chr. 16: Unannotated sequence 
E09_BC37_2012-02-
17_1_21-47-04.ab1 
354 PDC 
Chr. 1: Homo sapiens phosducin (PDC), transcript variant 
2, mRNA. 
E11_BC45_2012-02-
17_1_21-47-04.ab1 
355 CLASP2 
Chr. 3: Homo sapiens cytoplasmic linker associated 
protein 2 (CLASP2), transcript variant 1, mRNA. 
F01_BC6_2012-02-
17_1_21-47-04.ab1 
356 - No matches 
F02_BC54_2012-02-
17_1_23-44-30.ab1 
357 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
F03_BC14_2012-02-
17_1_21-47-04.ab1 
358 EHBP1 
Chr. 2: Intronic region of Homo sapiens EH domain 
binding protein 1 (EHBP1), transcript variant 3, mRNA. 
F04_BC62_2012-02-
17_1_23-44-30.ab1 
359 TRIOBP 
Chr. 22: Intronic region of Homo sapiens TRIO and F-actin 
binding protein (TRIOBP), transcript variant 6, mRNA. 
F05_BC22_2012-02-
17_1_21-47-04.ab1 
360 NOTCH2NL 
Chr. 1: Intronic region of Homo sapiens notch 2 N-
terminal like (NOTCH2NL), mRNA. 
F06_BC70_2012-02-
17_1_23-44-30.ab1 
361 - No matches 
F07_BC30_2012-02-
17_1_21-47-04.ab1 
362 RPL13A 
Chr. 19: 3’ UTR of Homo sapiens ribosomal protein L13a 
(RPL13A), transcript variant 1, mRNA. 
F08_BC78_2012-02-
17_1_23-44-30.ab1 
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363 NOTCH2 
Chr. 1: Intronic region of Homo sapiens notch 2 
(NOTCH2), transcript variant 1, mRNA. 
F09_BC38_2012-02-
17_1_21-47-04.ab1 
364 PDC 
Chr. 1: Homo sapiens phosducin (PDC), transcript variant 
2, mRNA. 
F11_BC46_2012-02-
17_1_21-47-04.ab1 
365 - Chr. 19: Unannotated sequence 
G01_BC7_2012-02-
17_1_21-47-04.ab1 
366 CHTOP 
Chr. 1: 3’ UTR of Homo sapiens chromatin target of 
PRMT1 (CHTOP), transcript variant 1, mRNA. 
G02_BC55_2012-02-
17_1_23-44-30.ab1 
367 - Chr. 16: Unannotated sequence 
G03_BC15_2012-02-
17_1_21-47-04.ab1 
368 - Chr. 16: Unannotated sequence 
G04_BC63_2012-02-
17_1_23-44-30.ab1 
369 PTPRG 
Chr. 3: Intronic region of Homo sapiens protein tyrosine 
phosphatase, receptor type, G (PTPRG), mRNA. 
G05_BC23_2012-02-
17_1_21-47-04.ab1 
370 NOTCH2 
Chr. 1: Intronic region of Homo sapiens notch 2 
(NOTCH2), transcript variant 1, mRNA. 
G06_BC71_2012-02-
17_1_23-44-30.ab1 
371 - Chr. Y: Unannotated sequence 
G07_BC31_2012-02-
17_1_21-47-04.ab1 
372 NOTCH2 
Chr. 1: Intronic region of Homo sapiens notch 2 
(NOTCH2), transcript variant 1, mRNA. 
G08_BC79_2012-02-
17_1_23-44-30.ab1 
373 - No matches 
G09_BC39_2012-02-
17_1_21-47-04.ab1 
374 PDC 
Chr. 1: Homo sapiens phosducin (PDC), transcript variant 
2, mRNA. 
G11_BC47_2012-02-
17_1_21-47-04.ab1 
375 - Chr. X: Unannotated sequence 
H01_BC8_2012-02-
17_1_21-47-04.ab1 
376 - Chr. M: Unannotated sequence 
H02_BC56_2012-02-
17_1_23-44-30.ab1 
377 ATRX 
Chr. X: Intronic region of Homo sapiens alpha 
thalassemia/mental retardation syndrome X-linked 
(ATRX), transcript variant 1, mRNA. 
H03_BC16_2012-02-
17_1_21-47-04.ab1 
378 - Chr. 21: Unannotated sequence 
H04_BC64_2012-02-
17_1_23-44-30.ab1 
379 TXNL4A 
Chr. 18: Intronic region of Homo sapiens thioredoxin-like 
4A (TXNL4A), mRNA. 
H05_BC24_2012-02-
17_1_21-47-04.ab1 
380 SLC6A9 
Chr. 1: 3’ UTR of Homo sapiens solute carrier family 6 
(neurotransmitter transporter, glycine), member 9 
(SLC6A9), transcript variant 2, mRNA. 
H06_BC72_2012-02-
17_1_23-44-30.ab1 
381 - Chr. 19: Unannotated sequence 
H07_BC32_2012-02-
17_1_21-47-04.ab1 
382 - No matches 
H08_BC80_2012-02-
17_1_23-44-30.ab1 
383 - No matches 
H09_BC40_2012-02-
17_1_21-47-04.ab1 
384 - No matches 
H11_BC48_2012-02-
17_1_21-47-04.ab1 
385 - 
Chr. M: Sequences from articles: PubMed Central and 
Elsevier 
A01_1_2012-03-01_1_23-
37-43 
386 - No matches 
A03_17_2012-03-
01_1_23-37-43 
387 TBC1D23 
Chr. 3: Intronic region of  Homo sapiens TBC1 domain 
family, member 23 (TBC1D23), transcript variant 1, 
mRNA. 
A05_33_2012-03-
01_1_23-37-43 
388 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
A07_49_2012-03-
01_1_23-37-43 
389 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
A09_65_2012-03-
01_1_23-37-43 
390 - Chr. 5: Unannotated sequence. 
A11_81_2012-03-
01_1_23-37-43 
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391 - 
Chr. M: Sequences from articles: PubMed Central and 
Elsevier 
B01_2_2012-03-01_1_23-
37-43 
392 UBAP1L 
Chr. 15: Intronic region of Homo sapiens ubiquitin 
associated protein 1-like (UBAP1L), mRNA. 
B03_18_2012-03-
01_1_23-37-43 
393 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
B05_34_2012-03-
01_1_23-37-43 
394 - No matches 
B07_50_2012-03-
01_1_23-37-43 
395 - Chr. 3: Unannotated region. 
B09_66_2012-03-
01_1_23-37-43 
396 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
B11_82_2012-03-
01_1_23-37-43 
397 - No matches 
C01_3_2012-03-01_1_23-
37-43 
398 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
C03_19_2012-03-
01_1_23-37-43 
399 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
C05_35_2012-03-
01_1_23-37-43 
400 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
C07_51_2012-03-
01_1_23-37-43 
401 - No matches 
C09_67_2012-03-
01_1_23-37-43 
402 MOB3B 
Chr. 9: Intronic region of Homo sapiens MOB kinase 
activator 3B (MOB3B), mRNA. 
C11_83_2012-03-
01_1_23-37-43 
403 SAG 
Chr. 2: Homo sapiens S-antigen; retina and pineal gland 
(arrestin) (SAG), mRNA. 
D01_4_2012-03-01_1_23-
37-43 
404 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
D03_20_2012-03-
01_1_23-37-43 
405 HFM1 
Chr. 1: Intronic region of Homo sapiens HFM1, ATP-
dependent DNA helicase homolog (S. cerevisiae) (HFM1), 
mRNA. 
D05_36_2012-03-
01_1_23-37-43 
406 - Chr. 2: Unannotated region. 
D07_52_2012-03-
01_1_23-37-43 
407 - No matches 
D09_68_2012-03-
01_1_23-37-43 
408 - No matches 
D11_84_2012-03-
01_1_23-37-43 
409 - Chr. 19: Alignments with several ZNF proteins 
E01_5_2012-03-01_1_23-
37-43 
410 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
E03_21_2012-03-
01_1_23-37-43 
411 MPV17L 
Chr. 16: Intronic region of Homo sapiens MPV17 
mitochondrial membrane protein-like (MPV17L), nuclear 
gene encoding mitochondrial protein, transcript variant 
1, mRNA. 
E05_37_2012-03-
01_1_23-37-43 
412 - Chr. 9: Unannotated region. 
E07_53_2012-03-
01_1_23-37-43 
413 - Chr. 2: Unannotated region. 
E09_69_2012-03-
01_1_23-37-43 
414 CLU 
Chr. 8: Homo sapiens clusterin (CLU), transcript variant 4, 
non-coding RNA. 
E11_85_2012-03-
01_1_23-37-43 
415 PEA15 
Chr. 1: 3' UTR of Homo sapiens phosphoprotein enriched 
in astrocytes 15 (PEA15), mRNA. 
F01_6_2012-03-01_1_23-
37-43 
416 MECOM 
Chr. 3: Intronic region of Homo sapiens MDS1 and EVI1 
complex locus (MECOM), transcript variant 4, mRNA. 
F03_22_2012-03-
01_1_23-37-43 
417 CPE 
Chr. 4: Intronic region of Homo sapiens carboxypeptidase 
E (CPE), mRNA. 
F05_38_2012-03-
01_1_23-37-43 
418 - 
Chr. M: Homo sapiens mRNA expressed only in placental 
villi, clone SMAP47. 
F07_54_2012-03-
01_1_23-37-43 
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419 ABR 
Chr. 17: Intronic region of Homo sapiens active BCR-
related (ABR), transcript variant 2, mRNA. 
F09_70_2012-03-
01_1_23-37-43 
420 KIAA2022 
Chr. X: Intronic region of Homo sapiens KIAA2022 
(KIAA2022), mRNA. 
F11_86_2012-03-
01_1_23-37-43 
421 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
G01_7_2012-03-01_1_23-
37-43 
422 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
G03_23_2012-03-
01_1_23-37-43 
423 DCAF11 
Chr. 14: 3' UTR of Homo sapiens DDB1 and CUL4 
associated factor 11 (DCAF11), transcript variant 3, 
mRNA. 
G05_39_2012-03-
01_1_23-37-43 
424 RPS27A 
Chr. 2: Homo sapiens ribosomal protein S27a (RPS27A), 
transcript variant 2, mRNA. 
G07_55_2012-03-
01_1_23-37-43 
425 RPS6KA5 
Chr. 14: Intronic region of Homo sapiens ribosomal 
protein S6 kinase, 90kDa, polypeptide 5 (RPS6KA5), 
transcript variant 1, mRNA. 
G09_71_2012-03-
01_1_23-37-43 
426 KIAA2022 
Chr. X: Intronic region of Homo sapiens KIAA2022 
(KIAA2022), mRNA. 
G11_87_2012-03-
01_1_23-37-43 
427 - No matches 
H01_8_2012-03-01_1_23-
37-43 
428 ANKRD34A 
Chr. 1:  Homo sapiens ankyrin repeat domain 34A 
(ANKRD34A), mRNA. 
H03_24_2012-03-
01_1_23-37-43 
429 - 
Chr. M: Homo sapiens piRNA piR-34804, complete 
sequence. 
H05_40_2012-03-
01_1_23-37-43 
430 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
H07_56_2012-03-
01_1_23-37-43 
431 KIF13A 
Chr. 6: Intronic region of Homo sapiens kinesin family 
member 13A (KIF13A), transcript variant 4, mRNA. 
H09_72_2012-03-
01_1_23-37-43 
432 CTNNA2 
Chr. 2: Intronic region of Homo sapiens catenin 
(cadherin-associated protein), alpha 2 (CTNNA2), 
transcript variant 1, mRNA. 
H11_88_2012-03-
01_1_23-37-43 
433 - No matches 
A02_9_2012-03-02_1_24-
33-05 
434 ST6GALNAC3 
Chr. 1: Intronic region of  Homo sapiens ST6 (alpha-N-
acetyl-neuraminyl-2,3-beta-galactosyl-1, 3)-N-
acetylgalactosaminide alpha-2,6-sialyltransferase 3 
(ST6GALNAC3), transcript variant 1, mRNA. 
A04_25_2012-03-
02_1_24-33-05 
435 CPE 
Chr. 4: Intronic region of Homo sapiens carboxypeptidase 
E (CPE), mRNA. 
A06_41_2012-03-
02_1_24-33-05 
436 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
A08_57_2012-03-
02_1_24-33-05 
437 HSPE1 
Chr. 2: Homo sapiens heat shock 10kDa protein 1 
(chaperonin 10) (HSPE1), nuclear gene encoding 
mitochondrial protein, mRNA. 
A10_73_2012-03-
02_1_24-33-05 
438 GLYR1 
Chr. 16: 3' UTR of Homo sapiens glyoxylate reductase 1 
homolog (Arabidopsis) (GLYR1), mRNA. 
A12_89_2012-03-
02_1_24-33-05 
439 STARD13 
Chr. 13: Intronic region of Homo sapiens StAR-related 
lipid transfer (START) domain containing 13 (STARD13), 
transcript variant 4, mRNA. 
B02_10_2012-03-
02_1_24-33-05 
440 ANK2 
Chr. 4: Intronic region of Homo sapiens ankyrin 2, 
neuronal (ANK2), transcript variant 3, mRNA. 
B04_26_2012-03-
02_1_24-33-05 
441 RPL13A 
Chr. 19: Intronic region of Homo sapiens ribosomal 
protein L13a (RPL13A), transcript variant 1, mRNA. 
B06_42_2012-03-
02_1_24-33-05 
442 - No matches 
B08_58_2012-03-
02_1_24-33-05 
443 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
B10_74_2012-03-
02_1_24-33-05 
444 MINOS1-NBL1 
Chr. 1: 3' UTR of Homo sapiens MINOS1-NBL1 read-
through (MINOS1-NBL1), transcript variant 1, mRNA. 
B12_90_2012-03-
02_1_24-33-05 
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445 RCSD1 
Chr. 1: 3' UTR of Homo sapiens RCSD domain containing 
1 (RCSD1), mRNA. 
C02_11_2012-03-
02_1_24-33-05 
446 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
C04_27_2012-03-
02_1_24-33-05 
447 MYL6 
Chr. 12: Homo sapiens myosin, light chain 6, alkali, 
smooth muscle and non-muscle (MYL6), transcript 
variant 1, mRNA. 
C06_43_2012-03-
02_1_24-33-05 
448 LIN54 
Chr. 4: Intronic region of Homo sapiens lin-54 homolog 
(C. elegans) (LIN54), transcript variant 1, mRNA. 
C08_59_2012-03-
02_1_24-33-05 
449 ARID2 
Chr. 12: Intronic region of  Homo sapiens AT rich 
interactive domain 2 (ARID, RFX-like) (ARID2), mRNA. 
C10_75_2012-03-
02_1_24-33-05 
450 SMARCC1 
Chr. 3: Intronic region of Homo sapiens SWI/SNF related, 
matrix associated, actin dependent regulator of 
chromatin, subfamily c, member 1 (SMARCC1), mRNA. 
C12_91_2012-03-
02_1_24-33-05 
451 - 
mRNA S77581: HERVK10/HUMMTV reverse transcriptase 
homolog 
D02_12_2012-03-
02_1_24-33-05 
452 RAB1A 
Chr. 2: Intronic region of Homo sapiens RAB1A, member 
RAS oncogene family (RAB1A), transcript variant 2, 
mRNA. 
D04_28_2012-03-
02_1_24-33-05 
453 VPS28 
Chr. 8: Homo sapiens vacuolar protein sorting 28 
homolog (S. cerevisiae) (VPS28), transcript variant 1, 
mRNA. 
D06_44_2012-03-
02_1_24-33-05 
454 WDR33 
Chr. 2: Intronic region of Homo sapiens WD repeat 
domain 33 (WDR33), transcript variant 1, mRNA. 
D08_60_2012-03-
02_1_24-33-05 
455 COX6C 
Chr. 8: Homo sapiens cytochrome c oxidase subunit VIc 
(COX6C), nuclear gene encoding mitochondrial protein, 
mRNA. 
D10_76_2012-03-
02_1_24-33-05 
456 CST3 Chr. 20: Homo sapiens cystatin C (CST3), mRNA. 
D12_92_2012-03-
02_1_24-33-05 
457 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
E02_13_2012-03-
02_1_24-33-05 
458 FMOD 
Chr. 1: 3' UTR of Homo sapiens fibromodulin (FMOD), 
mRNA. 
E04_29_2012-03-
02_1_24-33-05 
459 - Chr. 6: Unannotated region. 
E06_45_2012-03-
02_1_24-33-05 
460 WDR33 
Chr. 2: Intronic region of Homo sapiens WD repeat 
domain 33 (WDR33), transcript variant 1, mRNA. 
E08_61_2012-03-
02_1_24-33-05 
461 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
E10_77_2012-03-
02_1_24-33-05 
462 MAP1B 
Chr. 5: Homo sapiens microtubule-associated protein 1B 
(MAP1B), mRNA. 
E12_93_2012-03-
02_1_24-33-05 
463 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
F02_14_2012-03-
02_1_24-33-05 
464 - No matches 
F04_30_2012-03-
02_1_24-33-05 
465 - Chr. 2: Unannotated region. 
F06_46_2012-03-
02_1_24-33-05 
466 POLR2G 
Chr. 11: Intronic region of Homo sapiens polymerase 
(RNA) II (DNA directed) polypeptide G (POLR2G), mRNA. 
F08_62_2012-03-
02_1_24-33-05 
467 - Chr. 6: Unannotated region. 
F10_78_2012-03-
02_1_24-33-05 
468 - 
Chr. M Sequences from articles: PubmedCentral and 
Elsevier 
F12_94_2012-03-
02_1_24-33-05 
469 NFAT5 
Chr. 16: Intronic region of Homo sapiens nuclear factor of 
activated T-cells 5, tonicity-responsive (NFAT5), transcript 
variant 1, mRNA. 
G02_15_2012-03-
02_1_24-33-05 
470 - 
Chr. M: Homo sapiens piRNA piR-34804, complete 
sequence. 
G04_31_2012-03-
02_1_24-33-05 
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471 RAB28 
Chr. 4: Intronic region of Homo sapiens RAB28, member 
RAS oncogene family (RAB28), transcript variant 2, 
mRNA. 
G06_47_2012-03-
02_1_24-33-05 
472 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
G08_63_2012-03-
02_1_24-33-05 
473 FTH1 
Chr. 11: Homo sapiens ferritin, heavy polypeptide 1 
(FTH1), mRNA. 
G10_79_2012-03-
02_1_24-33-05 
474 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
H02_16_2012-03-
02_1_24-33-05 
475 - Sequences from Articles: PubmedCentral and Elsevier 
H04_32_2012-03-
02_1_24-33-05 
476 EI24 
Chr. 11: 3' UTR of Homo sapiens etoposide induced 2.4 
(EI24), transcript variant 1, mRNA. 
H06_48_2012-03-
02_1_24-33-05 
477 - 
mRNA U61101: Human NTera2D1 cell line mRNA 
containing L1 retroposon, clone R5. 
H08_64_2012-03-
02_1_24-33-05 
478 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
H10_80_2012-03-
02_1_24-33-05 
479 - No matches 
A01_1_2012-03-02_1_01-
29-04 
480 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
A03_9_2012-03-02_1_01-
29-04 
481 - No matches 
A05_17_2012-03-
02_1_01-29-04 
482 - No matches 
A07_25_2012-03-
02_1_01-29-04 
483 - Chr. 22: Unannotated region. 
A09_33_2012-03-
02_1_01-29-04 
484 - 
Chr. M Sequences from articles: PubmedCentral and 
Elsevier 
A11_41_2012-03-
02_1_01-29-04 
485 - No matches 
B01_2_2012-03-02_1_01-
29-04 
486 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
B03_10_2012-03-
02_1_01-29-04 
487 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
B05_18_2012-03-
02_1_01-29-04 
488 NTN1 Chr. 17: 3' UTR of Homo sapiens netrin 1 (NTN1), mRNA. 
B07_26_2012-03-
02_1_01-29-04 
489 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
B09_34_2012-03-
02_1_01-29-04 
490 - No matches 
B11_42_2012-03-
02_1_01-29-04 
491 FOXJ2 
Chr. 12: Intronic region of Homo sapiens forkhead box J2 
(FOXJ2), mRNA. 
C01_3_2012-03-02_1_01-
29-04 
492 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
C03_11_2012-03-
02_1_01-29-04 
493 - No matches 
C05_19_2012-03-
02_1_01-29-04 
494 HFM1 
Chr. 1: Intronic region of Homo sapiens HFM1, ATP-
dependent DNA helicase homolog (S. cerevisiae) (HFM1), 
mRNA. 
C07_27_2012-03-
02_1_01-29-04 
495 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
C09_35_2012-03-
02_1_01-29-04 
496 OSBPL9 
Chr. 1: Intronic region of Homo sapiens oxysterol binding 
protein-like 9 (OSBPL9), transcript variant 5, mRNA. 
C11_43_2012-03-
02_1_01-29-04 
497 - Chr. 11: EST N85959 and EST DB454841 
D01_4_2012-03-02_1_01-
29-04 
498 MMP2 
Chr. 16: Homo sapiens matrix metallopeptidase 2 
(gelatinase A, 72kDa gelatinase, 72kDa type IV 
collagenase) (MMP2), transcript variant 1, mRNA. 
D03_12_2012-03-
02_1_01-29-04 
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499 - 
mRNA S77581: HERVK10/HUMMTV reverse transcriptase 
homolog (clone RT211) [human, multiple sclerosis, brain 
plaques, mRNA Partial, 90 nt]. 
D05_20_2012-03-
02_1_01-29-04 
500 RFNG 
Chr. 17: 3' UTR of Homo sapiens RFNG O-fucosylpeptide 
3-beta-N-acetylglucosaminyltransferase (RFNG), mRNA. 
D07_28_2012-03-
02_1_01-29-04 
501 - 
mRNA S77581: HERVK10/HUMMTV reverse transcriptase 
homolog (clone RT211) [human, multiple sclerosis, brain 
plaques, mRNA Partial, 90 nt]. 
D09_36_2012-03-
02_1_01-29-04 
502 - No matches 
D11_44_2012-03-
02_1_01-29-04 
503 TAOK3 
Chr. 12: Intronic region of Homo sapiens TAO kinase 3 
(TAOK3), mRNA. 
E01_5_2012-03-02_1_01-
29-04 
504 - No matches 
E03_13_2012-03-
02_1_01-29-04 
505 ABI3BP 
Chr. 3: Intronic region of Homo sapiens ABI family, 
member 3 (NESH) binding protein (ABI3BP), mRNA. 
E05_21_2012-03-
02_1_01-29-04 
506 CEP68 
Chr. 2: Intronic region of Homo sapiens centrosomal 
protein 68kDa (CEP68), mRNA. 
E07_29_2012-03-
02_1_01-29-04 
507 - 
Chr. M: Homo sapiens mRNA expressed only in placental 
villi, clone SMAP47. 
E09_37_2012-03-
02_1_01-29-04 
508 TMTC1 
Chr. 12: Intronic region of Homo sapiens transmembrane 
and tetratricopeptide repeat containing 1 (TMTC1), 
transcript variant 1, mRNA. 
E11_45_2012-03-
02_1_01-29-04 
509 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
F01_6_2012-03-02_1_01-
29-04 
510 CUL1 
Chr. 7: Intronic region of Homo sapiens cullin 1 (CUL1), 
mRNA. 
F03_14_2012-03-
02_1_01-29-04 
511 - No matches 
F05_22_2012-03-
02_1_01-29-04 
512 CST3 Chr. 20: Homo sapiens cystatin C (CST3), mRNA. 
F07_30_2012-03-
02_1_01-29-04 
513 - 
Chr. M: Homo sapiens mRNA expressed only in placental 
villi, clone SMAP47. 
F09_38_2012-03-
02_1_01-29-04 
514 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
F11_46_2012-03-
02_1_01-29-04 
515 BEST1 
Chr.11: Homo sapiens bestrophin 1 (BEST1), transcript 
variant 2, mRNA. 
G01_7_2012-03-02_1_01-
29-04 
516 CUL1 
Chr. 7: Intronic region of omo sapiens cullin 1 (CUL1), 
mRNA. 
G03_15_2012-03-
02_1_01-29-04 
517 ABI3BP 
Chr. 3: Intronic region of Homo sapiens ABI family, 
member 3 (NESH) binding protein (ABI3BP), mRNA. 
G05_23_2012-03-
02_1_01-29-04 
518 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
G07_31_2012-03-
02_1_01-29-04 
519 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
G09_39_2012-03-
02_1_01-29-04 
520 - No matches 
G11_47_2012-03-
02_1_01-29-04 
521 COMMD2 
Chr. 3: Homo sapiens COMM domain containing 2 
(COMMD2), mRNA. 
H01_8_2012-03-02_1_01-
29-04 
522 CUL1 
Chr. 7: Intronic region of omo sapiens cullin 1 (CUL1), 
mRNA. 
H03_16_2012-03-
02_1_01-29-04 
523 ABI3BP 
Chr. 3: Intronic region of Homo sapiens ABI family, 
member 3 (NESH) binding protein (ABI3BP), mRNA. 
H05_24_2012-03-
02_1_01-29-04 
524 TNIK 
Chr. 3: Intronic region of Homo sapiens TRAF2 and NCK 
interacting kinase (TNIK), transcript variant 5, mRNA. 
H07_32_2012-03-
02_1_01-29-04 
525 PTPRM 
Chr. 18: Intronic region of Homo sapiens protein tyrosine 
phosphatase, receptor type, M (PTPRM), transcript 
variant 2, mRNA. 
H09_40_2012-03-
02_1_01-29-04 
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526 - No matches 
H11_48_2012-03-
02_1_01-29-04 
527 TNPO1 
Chr. 5: Intronic region of Homo sapiens transportin 1 
(TNPO1), transcript variant 1, mRNA. 
A02_49_2012-03-
02_1_03-26-30 
528 PPM1G 
Chr. 2: 3' UTR of Homo sapiens protein phosphatase, 
Mg2+/Mn2+ dependent, 1G (PPM1G), mRNA. 
A04_57_2012-03-
02_1_03-26-30 
529 - 
Chr. M: Homo sapiens piRNA piR-34804, complete 
sequence. 
B02_50_2012-03-
02_1_03-26-30 
530 - No matches 
B04_58_2012-03-
02_1_03-26-30 
531 CKB 
Chr. 14: 3' UTR of Homo sapiens creatine kinase, brain 
(CKB), mRNA. 
C02_51_2012-03-
02_1_03-26-30 
532 MRPS11 
Chr. 15: Homo sapiens mitochondrial ribosomal protein 
S11 (MRPS11), nuclear gene encoding mitochondrial 
protein, transcript variant 2, mRNA. 
C04_59_2012-03-
02_1_03-26-30 
533 RPL7A 
Chr. (: Homo sapiens ribosomal protein L7a (RPL7A), 
mRNA. 
D02_52_2012-03-
02_1_03-26-30 
534 - No matches 
D04_60_2012-03-
02_1_03-26-30 
535 - Chr. 2: Unannotated region. 
E02_53_2012-03-
02_1_03-26-30 
536 - 
Chr. M: Homo sapiens mRNA expressed only in placental 
villi, clone SMAP47. 
E04_61_2012-03-
02_1_03-26-30 
537 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
F02_54_2012-03-
02_1_03-26-30 
538 - No matches 
F04_62_2012-03-
02_1_03-26-30 
539 - No matches 
G02_55_2012-03-
02_1_03-26-30 
540 WDR33 
Chr. 2: 3' UTR of Homo sapiens WD repeat domain 33 
(WDR33), transcript variant 1, mRNA. 
H02_56_2012-03-
02_1_03-26-30 
541 GIT1 
Chr. 17: 3' UTR of Homo sapiens G protein-coupled 
receptor kinase interacting ArfGAP 1 (GIT1), transcript 
variant 1, mRNA. 
A02_BC1_2012-03-
07_1_18-53-57.ab1 
542 - Chr. 16: Unannotated sequence 
A04_BC9_2012-03-
07_1_18-53-57.ab1 
543 GUSBP11 
Chr. 22: Intronic region of Homo sapiens glucuronidase, 
beta pseudogene 11 (GUSBP11), non-coding RNA. 
A06_BC17_2012-03-
07_1_18-53-57.ab1 
544 CAPNS1 
Chr. 19: 3' UTR of Homo sapiens calpain, small subunit 1 
(CAPNS1), transcript variant 1, mRNA. 
B02_BC2_2012-03-
07_1_18-53-57.ab1 
545 - No matches 
B04_BC10_2012-03-
07_1_18-53-57.ab1 
546 - No matches 
B06_BC18_2012-03-
07_1_18-53-57.ab1 
547 - No matches 
C02_BC3_2012-03-
07_1_18-53-57.ab1 
548 ASTN2 
Chr. 9: Intronic region of Homo sapiens astrotactin 2 
(ASTN2), transcript variant 1, mRNA. 
C04_BC11_2012-03-
07_1_18-53-57.ab1 
549 GLC1N 
Chr. 15: Intronic region of Homo sapiens KCC, mRNA; and 
Homo sapiens GLC1N, mRNA. 
C06_BC19_2012-03-
07_1_18-53-57.ab1 
550 PPP1R16A 
Chr. 8: Homo sapiens protein phosphatase 1, regulatory 
subunit 16A (PPP1R16A), mRNA. 
D02_BC4_2012-03-
07_1_18-53-57.ab1 
551 - Human foetal eye ESTs BM676228 and BM715662 
D04_BC12_2012-03-
07_1_18-53-57.ab1 
552 NDUFS2 
Chr. 1: Homo sapiens NADH dehydrogenase (ubiquinone) 
Fe-S protein 2, 49kDa (NADH-coenzyme Q reductase) 
(NDUFS2), nuclear gene encoding mitochondrial protein, 
transcript variant 1, mRNA. 
E02_BC5_2012-03-
07_1_18-53-57.ab1 
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553 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
E04_BC13_2012-03-
07_1_18-53-57.ab1 
554 - Human foetal eye ESTs BM676228 and BM715662 
F02_BC6_2012-03-
07_1_18-53-57.ab1 
555 - No matches 
F04_BC14_2012-03-
07_1_18-53-57.ab1 
556 KCC, GLC1N 
Chr. 15: Intronic region of Homo sapiens KCC, mRNA; and 
Homo sapiens GLC1N, mRNA. 
G02_BC7_2012-03-
07_1_18-53-57.ab1 
557 CSNK1D 
Chr. 17: Homo sapiens casein kinase 1, delta (CSNK1D), 
transcript variant 2, mRNA. 
G04_BC15_2012-03-
07_1_18-53-57.ab1 
558 PLEKHA7 
Chr. 11: Intronic region of Homo sapiens pleckstrin 
homology domain containing, family A member 7 
(PLEKHA7), mRNA. 
H02_BC8_2012-03-
07_1_18-53-57.ab1 
559 - No matches 
H04_BC16_2012-03-
07_1_18-53-57.ab1 
560 CAPNS1 
Chr. 19: 3' UTR of Homo sapiens calpain, small subunit 1 
(CAPNS1), transcript variant 2, mRNA. 
A02_BC1_2012-04-
13_1_17-15-21 
561 - Human brain EST HY324267 
A04_BC9_2012-04-
13_1_17-15-21 
562 PDDC1 
Chr. 11: 3' UTR of Homo sapiens Parkinson disease 7 
domain containing 1 (PDDC1), mRNA. 
A06_BC17_2012-04-
13_1_17-15-21 
563 CCDC174 
Chr. 3: 3' UTR of Homo sapiens coiled-coil domain 
containing 174 (CCDC174), mRNA. 
A08_BC25_2012-04-
13_1_17-15-21 
564 - No matches 
A10_BC33_2012-04-
13_1_17-15-21 
565 NDUFS2 
Chr. 1: Homo sapiens NADH dehydrogenase (ubiquinone) 
Fe-S protein 2, 49kDa (NADH-coenzyme Q reductase) 
(NDUFS2), nuclear gene encoding mitochondrial protein, 
transcript variant 1, mRNA. 
B02_BC2_2012-04-
13_1_17-15-21 
566 - Human brain EST HY324267 
B04_BC10_2012-04-
13_1_17-15-21 
567 - 
Brain hippocampus mRNA BC045622: Homo sapiens 
uncharacterized serine/threonine-protein kinase SgK494, 
mRNA (cDNA clone MGC:39533 IMAGE:5259536), 
complete cds. 
B06_BC18_2012-04-
13_1_17-15-21 
568 UBA52 
Chr. 19: Homo sapiens ubiquitin A-52 residue ribosomal 
protein fusion product 1 (UBA52), transcript variant 1, 
mRNA. 
B08_BC26_2012-04-
13_1_17-15-21 
569 - Human brain EST HY324267 
C02_BC3_2012-04-
13_1_17-15-21 
570 - Human brain EST HY324267 
C04_BC11_2012-04-
13_1_17-15-21 
571 DOCK5 
Chr. 8: Intronic region of Homo sapiens dedicator of 
cytokinesis 5 (DOCK5), mRNA. 
C06_BC19_2012-04-
13_1_17-15-21 
572 PIAS1 
Chr. 15: Homo sapiens protein inhibitor of activated 
STAT, 1 (PIAS1), mRNA. 
C08_BC27_2012-04-
13_1_17-15-21 
573 TBC1D2B 
Chr. 15: 3' UTR of Homo sapiens TBC1 domain family, 
member 2B (TBC1D2B), transcript variant 1, mRNA. 
D02_BC4_2012-04-
13_1_17-15-21 
574 - No matches 
D04_BC12_2012-04-
13_1_17-15-21 
575 SLC22A6 
Chr. 11: Homo sapiens solute carrier family 22 (organic 
anion transporter), member 6 (SLC22A6), transcript 
variant 1, mRNA. 
D06_BC20_2012-04-
13_1_17-15-21 
576 NMT1 
Chr. 17: Homo sapiens N-myristoyltransferase 1 (NMT1), 
mRNA. 
D08_BC28_2012-04-
13_1_17-15-21 
577 PLEKHA7 
Chr. 11: Intronic region of Homo sapiens pleckstrin 
homology domain containing, family A member 7 
(PLEKHA7), mRNA. 
E02_BC5_2012-04-
13_1_17-15-21 
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578 CSNK1D 
Chr. 17: Homo sapiens casein kinase 1, delta (CSNK1D), 
transcript variant 2, mRNA. 
E04_BC13_2012-04-
13_1_17-15-21 
579 UBC 
Chr. 12: Homo sapiens mRNA for ubiquitin C variant 
protein. 
E06_BC21_2012-04-
13_1_17-15-21 
580 PLEKHA7 
Chr. 11: Intronic region of Homo sapiens pleckstrin 
homology domain containing, family A member 7 
(PLEKHA7), mRNA. 
E08_BC29_2012-04-
13_1_17-15-21 
581 RPS27A 
Chr. 2: Homo sapiens ribosomal protein S27a (RPS27A), 
transcript variant 2, mRNA. 
F02_BC6_2012-04-
13_1_17-15-21 
582 GUSBP11 
Chr. 22: Homo sapiens glucuronidase, beta pseudogene 
11 (GUSBP11), non-coding RNA. 
F04_BC14_2012-04-
13_1_17-15-21 
583 - 
Brain hippocampus mRNA BC045622: Homo sapiens 
uncharacterized serine/threonine-protein kinase SgK494, 
mRNA (cDNA clone MGC:39533 IMAGE:5259536), 
complete cds. 
F06_BC22_2012-04-
13_1_17-15-21 
584 LMAN1 
Chr. 18: Homo sapiens lectin, mannose-binding, 1 
(LMAN1), mRNA. 
F08_BC30_2012-04-
13_1_17-15-21 
585 UBA52 
Chr. 19: Homo sapiens ubiquitin A-52 residue ribosomal 
protein fusion product 1 (UBA52), transcript variant 1, 
mRNA. 
G02_BC7_2012-04-
13_1_17-15-21 
586 - Human brain EST HY324267 
G04_BC15_2012-04-
13_1_17-15-21 
587 NDUFB10 
Chr. 16: Homo sapiens NADH dehydrogenase 
(ubiquinone) 1 beta subcomplex, 10, 22kDa (NDUFB10), 
nuclear gene encoding mitochondrial protein, mRNA. 
G06_BC23_2012-04-
13_1_17-15-21 
588 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
G08_BC31_2012-04-
13_1_17-15-21 
589 ASTN2 
Chr. 9: Intronic region of Homo sapiens astrotactin 2 
(ASTN2), transcript variant 1, mRNA. 
H02_BC8_2012-04-
13_1_17-15-21 
590 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
H04_BC16_2012-04-
13_1_17-15-21 
591 - 
Homo sapiens uncharacterized LOC100507412 
(LOC100507412), non-coding RNA. 
H06_BC24_2012-04-
13_1_17-15-21 
592 PSMC1 
Chr. 14: Homo sapiens proteasome (prosome, 
macropain) 26 S subunit, ATPase, 1 (PSMC1), mRNA. 
H08_BC32_2012-04-
13_1_17-15-21 
593 - No matches 
A02_BC1_2012-04-
19_1_17-22-10 
594 PLEKHA7 
Chr. 11: Intronic region of Homo sapiens pleckstrin 
homology domain containing, family A member 7 
(PLEKHA7), mRNA. 
A04_BC9_2012-04-
19_1_17-22-10 
595 CSNK1D 
Chr. 17: Homo sapiens casein kinase 1, delta (CSNK1D), 
transcript variant 2, mRNA. 
A06_BC17_2012-04-
19_1_17-22-10 
596 CAPNS1 
Chr. 19: 3' UTR of Homo sapiens calpain, small subunit 1 
(CAPNS1), transcript variant 1, mRNA. 
A08_BC25_2012-04-
19_1_17-22-10 
597 - Human brain EST HY324267 
A10_BC33_2012-04-
19_1_17-22-10 
598 GIT1 
Chr. 17: 3' UTR of Homo sapiens G protein-coupled 
receptor kinase interacting ArfGAP 1 (GIT1), transcript 
variant 1, mRNA. 
B02_BC2_2012-04-
19_1_17-22-10 
599 RPS27A 
Chr. 2: Homo sapiens ribosomal protein S27a (RPS27A), 
transcript variant 2, mRNA. 
B04_BC10_2012-04-
19_1_17-22-10 
600 - No matches 
B06_BC18_2012-04-
19_1_17-22-10 
601 NDUFS2 
Chr. 1: Homo sapiens NADH dehydrogenase (ubiquinone) 
Fe-S protein 2, 49kDa (NADH-coenzyme Q reductase) 
(NDUFS2), nuclear gene encoding mitochondrial protein, 
transcript variant 2, mRNA. 
B08_BC26_2012-04-
19_1_17-22-10 
602 - Human brain EST HY324267 
B10_BC34_2012-04-
19_1_17-22-10 
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603 CAPNS1 
Chr. 19: 3' UTR of Homo sapiens calpain, small subunit 1 
(CAPNS1), transcript variant 2, mRNA. 
C02_BC3_2012-04-
19_1_17-22-10 
604 UBA52 
Chr. 19: Homo sapiens ubiquitin A-52 residue ribosomal 
protein fusion product 1 (UBA52), transcript variant 1, 
mRNA. 
C04_BC11_2012-04-
19_1_17-22-10 
605 GUSBP11 
Chr. 22: Intronic region of Homo sapiens glucuronidase, 
beta pseudogene 11 (GUSBP11), non-coding RNA. 
C06_BC19_2012-04-
19_1_17-22-10 
606 - Human brain EST HY324267 
C08_BC27_2012-04-
19_1_17-22-10 
607 - No matches 
C10_BC35_2012-04-
19_1_17-22-10 
608 - No matches 
D02_BC4_2012-04-
19_1_17-22-10 
609 RPL10 
Chr. X: Homo sapiens ribosomal protein L10 (RPL10), 
transcript variant 1, mRNA. 
D04_BC12_2012-04-
19_1_17-22-10 
610 CSNK1D 
Chr. 17: Homo sapiens casein kinase 1, delta (CSNK1D), 
transcript variant 2, mRNA. 
D06_BC20_2012-04-
19_1_17-22-10 
611 - No matches 
D08_BC28_2012-04-
19_1_17-22-10 
612 - No matches 
D10_BC36_2012-04-
19_1_17-22-10 
613 PPP1R16A 
Chr. 8: Homo sapiens protein phosphatase 1, regulatory 
subunit 16A (PPP1R16A), mRNA. 
E02_BC5_2012-04-
19_1_17-22-10 
614 - Human brain EST HY324267 
E04_BC13_2012-04-
19_1_17-22-10 
615 - 
Chr. M: Homo sapiens piRNA piR-34804, complete 
sequence. 
E06_BC21_2012-04-
19_1_17-22-10 
616 - No matches 
E08_BC29_2012-04-
19_1_17-22-10 
617 - No matches 
E10_BC37_2012-04-
19_1_17-22-10 
618 NDUFS2 
Chr. 1: Homo sapiens NADH dehydrogenase (ubiquinone) 
Fe-S protein 2, 49kDa (NADH-coenzyme Q reductase) 
(NDUFS2), nuclear gene encoding mitochondrial protein, 
transcript variant 2, mRNA. 
F02_BC6_2012-04-
19_1_17-22-10 
619 - Human brain EST HY324267 
F04_BC14_2012-04-
19_1_17-22-10 
620 TBC1D2B 
Chr. 15: 3' UTR of  Homo sapiens TBC1 domain family, 
member 2B (TBC1D2B), transcript variant 1, mRNA. 
F06_BC22_2012-04-
19_1_17-22-10 
621 RPS27A 
Chr. 2: Homo sapiens ribosomal protein S27a (RPS27A), 
transcript variant 2, mRNA. 
F08_BC30_2012-04-
19_1_17-22-10 
622 - No matches 
F10_BC38_2012-04-
19_1_17-22-10 
623 - Human brain EST HY324267 
G02_BC7_2012-04-
19_1_17-22-10 
624 - No matches 
G04_BC15_2012-04-
19_1_17-22-10 
625 - Human brain EST HY324267 
G06_BC23_2012-04-
19_1_17-22-10 
626 UBA52 
Chr. 19: Homo sapiens ubiquitin A-52 residue ribosomal 
protein fusion product 1 (UBA52), transcript variant 1, 
mRNA. 
G08_BC31_2012-04-
19_1_17-22-10 
627 - No matches 
G10_BC39_2012-04-
19_1_17-22-10 
628 TBC1D2B 
Chr. 15: 3' UTR of Homo sapiens TBC1 domain family, 
member 2B (TBC1D2B), transcript variant 1, mRNA. 
H02_BC8_2012-04-
19_1_17-22-10 
629 - No matches 
H04_BC16_2012-04-
19_1_17-22-10 
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630 - Human brain EST HY324267 
H06_BC24_2012-04-
19_1_17-22-10 
631 - 
mRNA L09269: Human dinucleotide repeat 
polymorphism at the D11S982E locus mRNA. 
H08_BC32_2012-04-
19_1_17-22-10 
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11.2 SUMMARY OF INITIAL ATTEMPTS TO CLONE TOPORS 
The initial objective was to clone full-length TOPORS and its shorter fragments, using the In-
fusion method marketed by Clontech (CA, USA), which was therefore most suitable for the 
MatchmakerTM Gold Yeast Two-Hybrid (Y2H) System (Clontech, CA, USA) used throughout this 
project. This cloning procedure worked efficiently only for the shorter fragments (TOPORS 
deletion constructs), whereas other methods, such as ‘traditional’ cloning and the Gateway 
system (Life Technologies, CA, USA), had to be employed for the purpose of cloning the full-
length gene. 
 
11.2.1 IN-FUSION CLONING 
TOPORS and its fragments were amplified from a cDNA clone, using the In-fusion primers, 
which have 15 nt homology to pGBKT7 (Table 2-34). A range of primer annealing temperatures 
was used in order to optimise the reaction, i.e. 75 ˚C – 85 ˚C for the full-length gene, and 
65 ˚C – 75 ˚C for the three shorter fragments (Figure 3-4). Amplifications of all fragments were 
successful. Full-length TOPORS amplification products are shown in Figure 11-1, whereas 
Figure 11-2, Figure 11-3 and Figure 11-4 illustrate the results of amplification of DNA 
fragments, encoding the short ‘baits’, i.e. the N-terminus TOPORS (N), the middle TOPORS (M) 
and the C-terminus TOPORS (C), respectively. Amplification of full-length TOPORS was 
successful only once, and was not possible to repeat. 
The PCR amplicons were purified and then used for the In-Fusion reaction, the aim of which 
was to clone the full-length TOPORS gene, as well as its three fragments (highlighted in Figure 
3-4) into the Clontech pGBKT7 vector, in-frame with the GAL4 DNA BD. DH5α Escherichia coli 
cells (Life Technologies, CA, USA) were transformed with the In-fusion reaction products, 
the aim of which was to clone the full-length TOPORS gene, as well as its three fragments. 
The bacterial transformations resulted in growth of 2 to 33 colonies per plate (data not 
shown). In addition, there were approximately thirty colonies growing on each of 
the transformed positive control plates, and no growth was observed on the negative control 
plates (data not shown; please refer to sections IX and X of the In-Fusion® Advantage PCR 
Cloning Kit User Manual, Clontech, CA, USA). 
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Figure 11-1. PCR amplification of full-length 
TOPORS, using KOD polymerase. 
Lane 1: Smart Ladder marker. Lanes 2-4: PCR 
products achieved at the different primer annealing 
temperatures (75 ˚C, 80 ˚C and 85 ˚C, respectively). 
15 µl of the PCR product were loaded per well. 
The expected band size was approximately 3.1 kb. 
One per cent agarose gel with ethidium bromide. 
 
Figure 11-2. PCR amplification of the N-terminal 
TOPORS fragment, using KOD polymerase. 
Lane 1: Smart Ladder marker. Lanes 2-4:PCR 
products achieved at the different primer 
annealing temperatures (65 ˚C, 70 ˚C and 75 ˚C, 
respectively). 15 µl of the PCR product were 
loaded per well. The expected band size was 
approximately 1.1 kb. One per cent agarose gel 
with ethidium bromide. 
 
 
Figure 11-3. PCR amplification of the Mid-
TOPORS fragment, using KOD polymerase. 
Lane 1: Smart Ladder marker. Lanes 2-4: PCR 
products achieved at the different primer 
annealing temperatures (65 ˚C, 70 ˚C and 75 ˚C, 
respectively). 15 µl of the PCR product were 
loaded per well. The expected band size was 
approximately 1.2 kb. One per cent agarose gel 
with ethidium bromide. 
 
Figure 11-4. PCR amplification of the C-terminal 
TOPORS fragment, using KOD polymerase. 
Lane 1: Smart Ladder marker. Lanes 2-4: PCR 
products achieved at the different primer annealing 
temperatures (65 ˚C, 70 ˚C and 75 ˚C, respectively). 
15 µl of the PCR product were loaded per well. 
The expected band size was approximately 1.0 kb. 
One per cent agarose gel with ethidium bromide. 
According to the manual the presence of a low number of colonies on both control plates 
indicates that either too much of the In-fusion reaction products were used per 
transformation, or the quality of the DNA was poor; there should have been several hundred 
of colonies observed on the positive control plate, and a few colonies were to be expected on 
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the negative control plate. Despite the fact that the observed results for the control 
transformations did not correlate with the expected results for the control transformation, 
the transformation of the In-fusion reaction products was successful for the three TOPORS 
fragments. The results were verified by sequencing. 
Eight experiments were performed in an attempt to clone the full-length TOPORS gene, using 
the In-fusion method, all unsuccessful. Hence, the next attempts to clone TOPORS, focused on 
more traditional methods, i.e. the use of restriction enzymes (Promega, WI, USA) and T4 DNA 
ligase (Promega, WI, USA). 
 
11.2.2 ECORI & SALI RESTRICTION DIGEST AND LIGATION 
Cloning TOPORS using the In-fusion method was not successful; however, the amplicons, 
generated for the purpose of In-fusion cloning (Figure 11-1), contained specific restriction 
sites, which were utilised in the subsequent cloning experiments. Details of the primers 
containing the relevant restriction sequences are summarised in Table 2-34. 
The sequence of the TOP-in-fusion-1-pGBKT7-F primer contains an EcoRI restriction site, 
whereas the TOP-in-fusion-6-pGBKT7-R primer comprises the SalI restriction site; hence, both 
restriction sites become incorporated into the resulting PCR amplicon. Both of these sites are 
also found on the pGBKT7 vector, as the primers for the In-fusion reaction are based on 
homology to the target vector, and allow the insert to be cloned in-frame. 
In order to prevent digestion of TOPORS itself, restriction sites found within the pGBKT7 
plasmid sequence were consecutively checked for their presence within the gene, using 
the SeqBuilder software (DNASTAR Lasergene 8). Restriction sites found within the plasmid, 
but not within the gene are listed in Table 11-2. 
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Table 11-2. Restriction enzymes which have been shown not to cut TOPORS (DNASTAR SeqBuilder, 
Lasergene 8). 
The reference TOPORS sequence submitted to the software analysis was obtained from the Ensembl 
database. 
Restriction enzyme Restriction site sequence Conditions (Promega, WI, 
USA) 
NdeI CA’TATG Buffer D; 37 ˚C 
SfiI GGCCNNNN’NGGCC Buffer B; 50 ˚C 
EcoRI G’AATTC Buffer H; 37 ˚C 
SmaI CCC’GGG Buffer J; 25 ˚C 
XmaI GCC’GGG Buffer B; 37 ˚C 
SalI G’TCGAC Buffer D; 37 ˚C 
PstI CTGCA’G Buffer H; 37 ˚C 
 
The full-length TOPORS PCR product (Figure 11-1) and the pGBKT7 vector were both digested 
with the EcoRI and SalI restriction enzymes (Promega, WI, USA). The digestion was performed 
sequentially in order to avoid the potential ‘star activity’ caused by certain reaction buffers. It 
was confirmed by agarose gel electrophoresis that the digestion reaction worked successfully 
(Figure 11-5 and Figure 11-6); the DNA bands representing the linearised molecules were 
expected to appear larger than the band corresponding to the circular plasmid, which can 
super-coil, and, thus, travel through the agarose gel faster. 
The digestion reaction products were purified, and the inserts and vectors were ligated 
together at a 3:1 insert: vector ratio, using the T4 DNA ligase (Promega, WI, USA). In order to 
confirm that the ligation reaction had worked, PCR was performed, using a vector-specific 
primer, such as T7 (Table 2-50), and a TOPORS-specific primer, such as S8 (Table 2-51) to 
amplify across the 5’ ligation site as shown in Figure 11-7. 
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Figure 11-5. Gel electrophoresis of undigested and 
digested pGBKT7 vectors. 
Lane 1: Hyper Ladder I; Lane 2: undigested vector; 
Lane 3: SalI-digested vector. 1 µl of the respective 
digestion products was loaded into each well. 
 
 
Figure 11-6. Gel electrophoresis of undigested and 
digested pGBKT7 vector. 
Lane 1: Hyper Ladder I; Lane 2: undigested vector; 
Lane 3: EcoRI-digested vector. 1 µl of 
the respective digestion products was loaded into 
each well. 
 
 
 
Figure 11-7. Schematic representation of the region of the vector-
insert construct, which would be amplified using the T7 and S8 
primers. 
 
Results of one of two separate ligation reactions verified in this way are shown in Figure 11-8. 
Although this confirms the ligation reaction has worked, the sensitive nature of PCR means 
that a single molecule can be amplified exponentially, therefore results have to be interpreted 
carefully. 
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Figure 11-8. PCR amplification using the ligation 
reaction as template (vector and insert digestion 
with EcoRI and SalI), using vector-specific primer 
T7 (Table 2-50), and TOPORS-specific primer S8 
(Table 2-51). 
Lane 1: Smart Ladder marker. Lane 2: PCR product 
amplified from N-term TOPORS fragment (positive 
control). Lane 3: PCR product amplified from 
the ligation reaction products. 5 µl of the PCR 
product were loaded per well. 
 
 
The ligation reaction product was used to transform DH5α E. coli cells (Life Technologies, CA, 
USA). In order to optimise the transformation procedure different amounts of the ligation 
reaction product were used; i.e. 10 ng, 20 ng and 50 ng. Half of the plates were incubated at 
37 ˚C overnight, and the other half were incubated at 30 ˚C for approximately 48 hours; 
the purpose of the extended incubation time at the lower temperature was to enhance 
the growth of colonies, expressing TOPORS, in case they were growing slower than those, 
which did not express the insert. Abundant growth was observed on all transformation plates 
(hundreds of colonies). A total of 60 colonies were screened by colony PCR, using either 
the pair of T7 and S8 primers, or the S9 and R primers (for primer sequences please refer to 
Table 2-50 and Table 2-51), amplifying across the 5’ and adjacent to the 3’ ligation sites, 
respectively. 
Primers T7 and S8 serve to amplify a fragment of the pGBKT7 vector, which commences with 
the T7 Promoter, and includes the first 198 nucleotides of the inserted DNA fragment. This 
part of the insert is located near the 5’ end of the gene, which corresponds to the amino 
terminus of the protein; hence, the pGBKT7 vector, carrying an insert, which encodes 
a confirmed N-terminus TOPORS fragment, was used as a control in the PCR screening 
procedure.  
Primers S9 and R serve to amplify a DNA fragment, consisting of the last 354 nucleotides of 
the TOPORS gene. This part of the gene sequence is located near its 3’ end, which corresponds 
to the carboxyl terminus of the protein; hence, the pGBKT7 vector, carrying an insert, which 
encodes a confirmed C-terminus TOPORS fragment, was used as a control in this PCR screening 
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procedure. Several colonies tested positive; results from one of the experiments are shown in 
Figure 11-9.  
Glycerol stocks were made of each of the selected clones, and their plasmids were isolated and 
sequenced. The result of the sequencing reaction was unexpected. As shown in Figure 11-10, 
some of the vectors contained inserted fragments, which comprised two 
approximately 20 nucleotides long sequences, identical to the sequences found at 
the beginning and at the end of full-length TOPORS; however, the majority of the gene 
sequence from in between these two very short sequences was missing. This result suggests 
that the restriction enzymes had probably cut TOPORS at unspecific sequences, which were 
perhaps similar to their canonical restriction sites.  
 
 
Figure 11-9. Colony PCR screening of DH5α bacterial cells transformed with the ligation reaction 
(following vector and insert digestion with EcoRI and SalI). 
TOPORS sequencing primers S9 and R (Table 2-51). Lane 1: Smart Ladder marker. Lane 2: PCR product 
amplified from C-term TOPORS fragment (positive control). Lanes 3-15: PCR products (1.5 µl in each) 
amplified from bacterial clones from the transformation. Key: example: #2-10 ng-37 ˚C  clone #2 from 
DH5α bacterial transformation. 
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Figure 11-10. Result obtained from sequencing of plasmids, isolated from colonies, which appeared to 
contain the TOPORS insert, based on the colony PCR results (Figure 11-9). 
The first 6-nucleotides long sequence represents the EcoRI restriction site (highlighted in green). 
The section, between the first two green bars, corresponds to a 23-nucleotides long fragment, identical 
to the sequence found at the beginning of the full-length TOPORS; whereas the section, between 
the second and third green bar, corresponds to 21-nucleotides long fragment, identical to the sequence 
found at the end of the full-length TOPORS; the sequence shown between bars three and four is 
unknown, whereas the last six nucleotides correspond to the SalI restriction site (highlighted in orange). 
 
The sequencing results (Figure 11-10) were not consistent with the ligation reaction (Figure 
11-8) and colony PCR (Figure 11-9) results; therefore, another experiment was performed in 
order to verify whether the pGBKT7 DNA fragments may have been amplified in these 
screening experiments (Figure 11-11). For all of the tested samples it was expected that no 
amplicons would be generated. 
The S8 primer (Table 2-51) used in the first primer pair (T7 & S8) is a TOPORS gene-specific 
primer, therefore it was not expected that this primer would anneal to and lead to 
amplification of a fragment of the pGBKT7 vector. Although the sizes of the obtained products 
were not identical with the size of the positive control fragment, the PCR amplicon of pGBKT7-
N-TOPORS plasmid, a part of the vector was still amplified.  
The S9 and R primers (Table 2-51) used as the second primer pair, are also TOPORS-specific 
primers, thus no amplification of any fragment of the pGBKT7 plasmid was expected. 
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The obtained products were of the exact same size as the positive control fragment, the PCR 
amplicon of pGBKT7-C-TOPORS plasmid. 
This experiment demonstrated that the S8, S9 and R primers anneal to and amplify fragments 
of the pGBKT7 vector DNA (Figure 11-11), despite being designed specifically for the TOPORS 
sequence. Hence, these primers cannot be used in screening experiments for TOPORS, when 
using this particular vector.  
 
Figure 11-11. Control experiment to clarify 
the inconsistency of results (obtained 
amplicon sizes) between the ligation reaction 
PCR (Figure 11-8) and the colony PCR (Figure 
11-9). 
Lane 1: Hyper Ladder I marker. Lane 2: PCR 
product amplified from an N-term TOPORS 
fragment; a positive control for products 
amplified using the vector-specific primer T7 
(Table 2-50) and the TOPORS-specific primer 
S8 (Table 2-51). Lanes 3-4: PCR products 
amplified from the empty vector using the T7 
and S8 primers. Lane 5: PCR product 
amplified from a C-term TOPORS fragment; 
a positive control for products amplified 
using the TOPORS-specific primers S9 and R 
(Table 2-51). Lanes 6-7: PCR products 
amplified from the empty vector using the S9 
and R primers. 5 µl of the PCR product were 
loaded per well. 
11.2.3 NDEI & PSTI RESTRICTION DIGEST AND LIGATION 
It was deduced from the sequencing results shown in Figure 11-10 that despite inactivation of 
the EcoRI and SalI enzymes TOPORS had probably been digested by the EcoRI and/or SalI 
enzymes at sites similar to the actual respective recognition sites. As a consequence a different 
set of restriction endonucleases was chosen from Table 11-2 for further cloning experiments. 
The NdeI and PstI restriction enzymes were selected from Table 11-2, as an alternative to 
the previously used EcoRI and SalI. New primers for TOPORS amplification were designed, 
which would include these two alternative restriction sites and maintained the correct reading 
frame (FL F and FL R; Table 2-36).  
The annealing temperatures for the FL F and the FL R primers were calculated, yielding 70.5 ˚C 
and 50.1 ˚C, respectively. In order to optimise the PCR conditions the primers were tested for 
TOPORS amplification at three different annealing temperatures within the range of 50.0-
70.0 ˚C; a pCATCH-TOPORS (22.5 ng/µl) vector (containing a full-length verified TOPORS 
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sequence), and a full-length TOPORS PCR product from a previous amplification were used as 
templates. The KOD polymerase was used; conditions were kept, as previously described 
(section 2.2.1 and Table 2-30). 
Amplification from the pCATCH-TOPORS at an annealing temperature of 57 ˚C resulted in 
the best outcome (Figure 11-12). 
 
Figure 11-12. PCR amplification of TOPORS using the FL F and FL R primers (Table 2-36). 
Lane 1: Hyper Ladder I marker. Lane 2: pCATCH-TOPORS as template; 57 ˚C. Lane 3: PCR product; 57 ˚C. 
Lane 4: pCATCH-TOPORS; 62 ˚C. Lane 5: PCR product; 62 ˚C. Lane 6: pCATCH-TOPORS; 67 ˚C. Lane 7: PCR 
product; 67 ˚C. 1.5 µl of products were loaded into each well. The expected band size was approximately 
3.1 kb. 
 
The reaction was successfully repeated (Figure 11-13) and a substantial amount of TOPORS 
was amplified, which could be used for subsequent sub-cloning. In order to confirm that 
the obtained PCR product was indeed TOPORS, the beginning and the end of the gene were 
sequenced using primers FL F and FL R. The results were verified by sequencing. 
Identification of Interacting Protein Partners of TOPORS in the Retina   ||   Barbara Czub 
PhD Thesis 2015   ||   Appendix    - 439 - 
 
 
Figure 11-13. PCR amplification of TOPORS using the FL F and FL R primers. 
Lane 1: Marker: Hyper Ladder I. Lane 2: Negative control; Lanes 3-8: PCR products of TOPORS 
amplification from pCATCH-TOPORS (57 ˚C). 1 µl of each product was loaded per well. Expected band 
size: ~3.1 kb. 
 
PCR amplification of TOPORS with the FL F and FL R primers resulted in generation of DNA 
fragments with restriction enzyme sites at both ends of the DNA molecule. The sequence of 
the FL F primer encodes the NdeI restriction site, whereas the FL R primer comprises the PstI 
restriction site. Both of these sites are also found in the pGBKT7 MCS, and both restriction 
enzymes have previously been shown, using a bioinformatics analysis, not to cut TOPORS 
(Table 11-2). 
The full-length TOPORS amplicon and the pGBKT7 vector were both digested with the NdeI and 
PstI restriction enzymes (Promega, WI, USA). The digestion was performed sequentially in 
order to avoid the potential ‘star activity’ caused by certain reaction buffers. It was confirmed 
after every digestion reaction that it had worked by visualising the digested and undigested 
vectors on an agarose gel following electrophoresis (Figure 11-14); the DNA bands 
representing the linearised molecules were expected to appear larger than the band 
corresponding to the circular plasmid, which can super-coil, and, thus, travel through the 
agarose gel faster. 
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Figure 11-14. Gel electrophoresis of digested and undigested pGBKT7 vector. 
Lane 1: Hyper Ladder I; Lane2: NdeI-digested vector; Lane 3: PstI-digested vector; Lane 4: undigested 
vector. 1 µl of the respective digestion products was loaded into each well. The digested reaction 
products were purified, and the inserts and vectors were ligated together at a 3:1 insert: vector ratio, 
using the T4 DNA ligase (Promega, WI, USA). In order to confirm that the ligation reaction had worked, 
a fragment of the purified product was amplified by PCR, using a vector-specific primer, such as 
the pGBKT7 R1 primer (Table 2-50) and a TOPORS-specific primer, such as S9 (Table 2-51), amplifying 
across the 3’ ligation site (Figure 11-15). Fragments of the expected size (0.7 kb) were amplified (Figure 
11-16). 
 
 
Figure 11-15. Schematic representation of 
the region of the vector-insert construct, which 
would be amplified using the S9 and pGBKT7 R1 
primers. 
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Figure 11-16. PCR amplification using the ligation reaction as template, (vector and insert digestion with 
EcoRI and SalI as well as NdeI and PstI). 
Lane 1: Hyper Ladder I marker. Lane 2: negative control, i.e. dH2O was used instead of DNA. Lane 3: PCR 
product amplified from a C-term TOPORS fragment (positive control). Lane 4-5: PCR products amplified 
from the ligation reaction products following digestion with EcoRI and SalI. Lanes 6-7: PCR products 
amplified from the ligation reaction products following digestion with NdeI and PstI. 5 µl of the PCR 
product were loaded per well. 
 
The ligation reaction was used for transformation of the competent DH5α E. coli cells (Life 
Technologies, CA, USA), the super-competent XL-1 Blue E. coli cells (Stratagene, CA, USA) and 
the Y2H Gold yeast cells (Clontech, CA, USA). All types of cells were transformed, or, where 
appropriate, made competent, according to the respective manufacturer’s instructions.  
Initially, DH5α cells were used for all transformations; however, as was shown by scarce 
growth of cells transformed with plasmids, carrying short TOPORS fragments, these DNA 
molecules appeared to have a toxic effect on their host bacterial cells, as indicated by low 
number of colonies growing after the transformations. The DH5α cells did not appear to take 
up the pGBKT7-TOPORS plasmid; therefore, the super-competent XL-1 Blue cells (less sensitive 
to potential toxic effects of plasmids, which they take up) were used subsequently. The use of 
super-competent bacterial cells did not lead to better outcomes either. Since the pGKBT7-
TOPORS construct appeared to exert significantly toxic effects on both of the previously used 
bacterial cell types, transformation of competent yeast cells with the ligation reaction directly 
was considered as an alternative viable option. 
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Ten nanograms of DNA were used per each transformation of the DH5α cells (Life 
Technologies, CA, USA), and all plates were incubated overnight at 37 ˚C; abundant growth 
(hundreds of colonies) was observed. One hundred and eight colonies were screened by 
colony PCR, using TOPORS-specific primers. All results were negative (data not shown).  
The XL-1 Blue cells (Stratagene, CA, USA) were transformed with several different amounts of 
DNA in order to determine what amount was optimal (based on the manufacturer’s 
information the cells can be transformed with any amount of DNA within the range of 0.1-
50.0 ng). All plates were incubated overnight at 37 ˚C; abundant growth was observed. One 
hundred and eighty eight clones were screened by colony PCR. Half of the colonies was 
screened using a vector-specific primer, such as the pGBKT7 R1 (Table 2-50), and a TOPORS-
specific primer, such as S9 (Table 2-51). The other half was screened using two vector specific 
primers, i.e. the pGBKT7 F and the pGBKT7 R1 primers (Table 2-50). All results were negative 
(data not shown).  
The transformation of the yeast cells (Clontech, CA, USA) was performed using 100 ng of DNA, 
and plates were incubated at 30 ˚C until colonies appeared, i.e. for approximately 72 hours. 
Nine clones were screened by yeast colony PCR, using the pGBKT7 R1 primer (Table 2-50), and 
the S9 primer (Table 2-51); one colony tested positive (Figure 11-17). 
The positive clone was purified and sequenced. The results were negative, no primers 
appeared to have annealed (data not shown). The plasmids were isolated from the colony-
PCR-positive clone, and another attempt was made to sequence this time the isolated DNA; 
the result was negative again (data not shown). 
The isolated DNA was then amplified by PCR in order to verify that the vector with the insert 
had indeed been isolated; the same primers were used as for the yeast colony PCR, which 
resulted in the original positive band as seen in Figure 11-17. The PCR results indicated that 
the pGBKT7-TOPORS plasmid was present (Figure 11-18).  
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Figure 11-17. Yeast colony PCR screening for TOPORS (the ligation reaction products were used for 
a pilot transformation of the yeast, following unsuccessful attempts to transform bacteria). 
Lane 1: Hyper Ladder I marker. Lane 2: negative control, i.e. dH2O was used instead of DNA. Lanes 3-11: 
PCR products amplified from the selected yeast colonies. 5 µl were loaded per well.  The expected 
fragment size was 657 bp (indicated by white arrow). Key: not cleaned: the PCR product was used 
directly in the ligation reaction without prior treatment; Wizard-cleaned: the PCR product was purified 
using the Wizard® SV Gel and PCR Clean-Up System (Promega, WI, USA); ethanol-precipitated: the PCR 
product was precipitated using ethanol to concentrate it prior to ligation. 
 
The presumed pGBKT7-TOPORS plasmid was then used for transformation of the XL-1 Blue 
supercompetent cells (Stratagene, CA, USA). Thirty two colonies were picked and screened by 
yeast colony PCR, using the pGBKT7 F and the pGBKT7 R1 primers (Table 2-50). The obtained 
bands’ sizes indicated that, although the vector was present, it contained no insert (Figure 
11-19). The conclusion was that the original yeast clone must have taken up several plasmids 
(it was shown by Gietz and Schiestl (1991) competent yeast cells are able to take up more than 
one DNA vector during a transformation reaction), some without the insert, and the one with 
the insert was consequently lost over generations. 
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Figure 11-18. PCR amplification of plasmids isolated from the yeast colony PCR positive clone (see Figure 
11-17). 
Lane 1: Marker: Hyper Ladder I. Lanes 2-4: PCR products amplified from three different samples of 
the isolated plasmids. Lane 5: Positive control: PCR product amplified from a pGBKT7-C-TOPORS 
plasmid. 5 µl were loaded per well. Expected fragment size: ~0.7 kb. Key: Wizard-cleaned: the PCR 
product was purified using the Wizard® SV Gel and PCR Clean-Up System (Promega, WI, USA). 
 
 
Figure 11-19. Colony PCR screening for TOPORS in the plasmids isolated from bacteria, previously 
transformed with plasmid isolated from positive yeast clone (see Figure 11-17). 
Lane 1 and 10: Hyper Ladder I marker. Lanes 2-9: PCR products amplified from the screened bacterial 
colonies. 10 µl were loaded per well. The expected fragment size was over 3 kb. Wizard-cleaned: 
the PCR product was purified using the Wizard® SV Gel and PCR Clean-Up System (Promega, WI, USA). 
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11.2.4 GATEWAY CLONING 
Attempts to clone TOPORS using traditional methods or the In-fusion system 
(Clontech, CA, USA) failed. A Gateway system developed by Life Technologies (CA, USA) was 
used as an alternative; the technique is based on the endogenous recombination system used 
by bacteriophage λ in order to incorporate itself into the E. coli genome (described in 
section 2.2.5.3). 
Primers for TOPORS amplification for Gateway cloning were designed to incorporate the attB1 
and attB2 sites (section 2.2.5.3; Table 2-40). The pCATCH-TOPORS construct (containing 
previously cloned full-length TOPORS cDNA sequence) was used as template for the PCR 
amplification by KOD polymerase (section 2.2.1; Table 2-30), and the optimum annealing 
temperature for this primer pair was determined to be 60 ˚C. The gene was successfully 
amplified (Figure 11-20), using KOD polymerase, yielding a band of the expected size of 3.1 kb. 
 
Figure 11-20. Full-length TOPORS PCR product amplified 
using Gateway-specific primers. 
Lane 1: Smart Ladder marker was used. Lane 2: PCR 
products of the expected fragments size at approximately 
3.2 kb. 
The amplified PCR product was cloned 
into the pDONR/Zeo vector (Table 2-33) 
during the Gateway BP reaction 
(section 2.2.5.3). The resulting entry 
vectors were then transformed into 
DH5α bacterial cells, spread on 
selective media, and incubated 
overnight at 37 ˚C. 
The nature of the pDONR/Zeo vectors is 
that they do not allow growth of their 
host cell unless an insert has become 
incorporated during the BP reaction, 
replacing the lethal ccdB gene; 
i.e. all colonies that have grown following the transformation should contain only 
the recombinant entry vectors.The entry vectors (pDONR-TOPORS) were then purified and 
used in the Gateway LR reaction with the pBD destination vector (Table 2-33). The reaction 
products were used for transformation of bacteria (DH5α), which were subsequently grown on 
selective media. The plasmids were isolated from the clones, and sequenced using TOPORS-
specific primers (Table 2-51). The sequencing reactions were not efficient (22 primers were 
needed to cover the ~3.1 kb of full-length TOPORS), most likely due to its GC-rich and 
3000 
             
bp      
   
Identification of Interacting Protein Partners of TOPORS in the Retina   ||   Barbara Czub 
PhD Thesis 2015   ||   Appendix    - 446 - 
 
somewhat repetitive sequence; however, the obtained sequence was correct: TOPORS was 
sub-cloned successfully into the pBD destination vector (Figure 11-21). 
 
 
Figure 11-21. Complete full-length TOPORS sequence cloned into the pBD vector. 
 
11.3 Y2H GOLD YEAST TRANSFORMATION RESULTS 
The obtained TOPORS 
constructs (full length and 
fragments) were then used 
for transformation of yeast 
cells prior to the Y2H screens. 
Each transformation was 
verified by plasmid isolation 
from the resulting colonies, 
PCR amplification (Figure 
11-22, Figure 11-23, Figure 
11-24), and sequencing. 
 
Figure 11-22. PCR amplification product of TOPORS from pBD-
TOPORS vectors isolated from yeast (clones A-D). 
Lane 1: Hyper Ladder I was used as the band size marker. Lanes 2-5: 
PCR products from the four different plasmid preparations, 
amplified using vector-specific primers (Table 2-50; 5 µl per well). 
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Figure 11-23. PCR amplification product of N-term and C-term TOPORS fragments from the pGBKT7-
TOPORS vectors isolated from yeast. 
Hyper Ladder I was used as the band size marker. Samples from six N-term and six C-term clones were 
prepared, and the plasmid preparations were amplified using vector-specific primers. 10 µl of each PCR 
product were loaded per well. 
 
 
Figure 11-24. PCR amplification products of the short TOPORS fragments cloned into pGBKT7 constructs 
isolated from yeast. 
Lanes 1 and 10: Hyper Ladder I was used as the band size marker. Samples from two N-term, two C-term 
and two mid-TOPORS clones were prepared, and the plasmid preparations were amplified using vector-
specific primers. 10 µl of each PCR product were loaded per well. 
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11.4 SUMMARY OF INITIAL ATTEMPTS TO CONFIRM BAIT AND 
DELETION CONSTRUCT PROTEIN EXPRESSION IN TRANSFORMED 
YEAST CELLS 
Several attempts were made to detect protein expression by Western blotting, however 
the results were not successful (Figure 11-25-Figure 11-27). The denatured protein extracts, 
obtained from yeast cells transformed with pBD-TOPORS were subject to SDS-PAGE on a 7.5 % 
gel; whereas protein extracts, isolated from yeast cells transformed with pBD-wt and pGBKT7 
(for both plasmids’ details please refer to Table 2-33 and Table 2-32, respectively) underwent 
electrophoresis on a 12.0 % gel. Protein extracts obtained from untransformed yeast cells 
were used as negative control in all experiments. Semi-dry transfer from the acrylamide gels 
onto a nitrocellulose membrane was subsequently performed; membranes on which GAL4 BD-
TOPORS hybrid proteins were expected to have bound were incubated with antibodies against 
GAL4 BD (Figure 11-25) as well as against TOPORS (Figure 11-26). The membrane with proteins 
transferred from the 12 % gel, where only GAL4 BD peptide was expected, was incubated only 
with the anti GAL4 BD antibody (Figure 11-27). Protein sizes are not indicated due to the fact 
that marker was not visible on the membrane. When membranes, on which the proteins were 
blotted are aligned next to each other, the proteins visualised on the blots shown in Figure 
11-25 and Figure 11-26 appear to have travelled a similar, short distance down the gel; on 
the contrary the proteins shown in Figure 11-27 appear to have travelled at least three times 
as far down the gel, indicating that they are indeed significantly smaller. These results would 
appear promising despite lack of the size marker, if the same blotting pattern was not 
observed in the negative control well. It is possible that the antibodies did not bind selectively 
enough; however, problems were being experienced whilst setting up the electrophoresis 
tanks, and some protein samples spilt over into the neighbouring wells. Nonetheless, such 
error would only explain the patterns observed in Figure 11-25and Figure 11-26. In Figure 
11-27 an empty well was left between wells, into which the sample and the control were 
loaded. 
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Figure 11-25. Anti GAL4 BD Ab. 
7.5 % gel. Western blot results. M 
= marker, Precision Plus Protein 
Standards, Dual Color (Bio-]Rad); 
T/A = Full-length TOPORS 
protein, clone T/A, conjugated 
with GAL4 BD (~131 kDa); T/B = 
Full-length TOPORS protein, 
clone T/B, conjugated with GAL4 
BD (~131 kDa); 
-ve = negative control, 
untransformed Y2H Gold yeast 
cells. Protein sizes are not 
indicated as marker faded away 
from the membrane. 
 
Figure 11-26. Anti TOPORS Ab. 
7.5 % gel. Western blot results. 
M = marker, Precision Plus 
Protein Standards, Dual Color 
(BioRad); T/A = Full-length 
TOPORS protein, clone T/A, 
conjugated with GAL4 BD (~131 
kDa); T/B = Full-length TOPORS 
protein, clone T/B, conjugated 
with GAL4 BD (~131 kDa); 
-ve = negative control, 
untransformed Y2H Gold yeast 
cells. Protein sizes are not 
indicated as marker faded away 
from the membrane. 
 
Figure 11-27. Anti GAL4 BD Ab. 
12.0 % gel. Western blot results. 
M = marker, Precision Plus 
Protein Standards, Dual Color 
(BioRad); GAL4 BD = GAL4 BD on 
its own (~16 kDa); -ve = negative 
control, untransformed Y2H 
Gold yeast cells. Protein sizes 
are not indicated as marker 
faded away from 
the membrane. 
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11.5 p53 CLONING USING GATEWAY SYSTEM 
Primers for p53 amplification for Gateway cloning had been designed to incorporate the attB1 
and attB2 sites essential for this cloning method (Table 2-41).  
The pGBKT7-53 vector (Clontech, CA, 
USA, provided as a separate positive 
control for this system) was used as 
template for the PCR amplification. 
The optimum annealing temperature 
for this primer pair was determined 
to be 60 ˚C (section 2.2.1 and Table 
2-30). The gene was successfully 
amplified (Figure 11-28). 
The amplified PCR product was 
cloned into the pDONR/Zeo vector 
(for details see Table 2-33) using 
the Gateway BP reaction 
(section 2.2.5.3). 
 
Figure 11-28. Full-length p53 PCR product amplified using 
Gateway-specific primers. 
Lane 1: Smart Ladder marker. Lane 2: PCR product of 
the expected fragment size, at approximately 1.2 kb. 
The reaction was transformed into DH5α cells, spread on selective media, and incubated 
overnight at 37 ˚C. Single colonies were picked and inoculated into liquid culture. 
The entry vectors were subsequently isolated from the bacteria, confirmed via sequencing and 
used in the Gateway LR reaction with destination vectors (Table 2-33). The p53 gene was 
cloned into a pAD vector for indirect TOPORS expression experiments (section 3.2.2.2), and it 
was simultaneously cloned into a pBD vector for experiments demonstrating the compatibility 
of In-Fusion and Gateway Y2H vectors (section 4.1). 
The reaction products were again used to transform bacteria, which were subsequently grown 
on selective media. After the incubation plasmids were isolated from the cells, and sequenced 
using p53-specific primers (Table 2-52). The obtained sequences were correct: p53 was cloned 
successfully into the pAD and pBD vectors. The cloning outcomes were confirmed by 
sequencing. 
 
1200 
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11.6 CANDIDATE INTERACTING PARTNERS OF TOPORS 
A total of 34 potential candidates were identified as interacting partners of TOPORS in the two 
Y2H library screens (Table 11-3 and Table 11-4). A summary of their key characteristics is 
provided in the subsequent tables. 
 
Table 11-3. Identities of prey clones from the O-dT library screen, as identified by BLAT (UCSC) genome 
search. 
Key: #, number of O-dT Y2H screen clone; D., date sequenced; F., file identifier. 
# D. F. Top BLAT (UCSC) search result 
2
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0
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.0
3.
0
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C
 
1
 
Chr. 17. 3' UTR of gene GIT1 (99.9 % identity; Homo sapiens G protein-coupled receptor kinase 
interacting ArfGAP 1 (GIT1), transcript variant 1) 
3
 
B
C
 
2
 
Chr. 19. 3' UTR of gene CAPNS1 (99.9 % identity; Homo sapiens calpain, small subunit 1 
(CAPNS1), transcript variant 2) and numerous ESTs 
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.
0
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Chr. 19. 3' UTR of gene CAPNS1 (99.2 % identity; Homo sapiens calpain, small subunit 1 
(CAPNS1), transcript variant 2) and numerous ESTs 
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0
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4
 
Chr. 8. PPP1R16A (100% identity; Homo sapiens protein phosphatase 1, regulatory subunit 16A) 
and numerous ESTs 
6
 
B
C
 
5
 
Chr. 1. NDUFS2 (99.8% identity; Homo sapiens NADH dehydrogenase (ubiquinone) Fe-S protein 
2, 49kDa (NADH-coenzyme Q reductase) (NDUFS2), nuclear gene encoding mitochondrial 
protein, transcript variant 1) 
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Chr. 1. NDUFS2 (99.8% identity; Homo sapiens NADH dehydrogenase (ubiquinone) Fe-S protein 
2, 49kDa (NADH-coenzyme Q reductase) (NDUFS2), nuclear gene encoding mitochondrial 
protein, transcript variant 1 and numerous ESTs 
8
 
B
C
 
3
 
Chr. 19. Some ESTs, including from eye and retina: BM676228 
9
 
B
C
 
4
 
Chr. 15. 3' UTR of gene TBC1D2B (98 % identity; Homo sapiens TBC1 domain family, member 2B 
(TBC1D2B), transcript variant 2) and numerous ESTs 
1
0
 
2
0
1
2
.
0
3
.0
7 
B
C
 
9
 
Chr. 16. Two pseudogenes and about 20 ESTs 
1
0
 
2
0
1
2
.0
4.
1
6 
B
C
 
5
 
Chr. 11. intronic region of gene PLEKHA7 (100 % identity; Homo sapiens pleckstrin homology 
domain containing, family A member 7 (PLEKHA7)) and some ESTs 
1
1
 
B
C
 
6
 
Chr. 16. Two pseudogenes and about 20 ESTs 
1
2
 
B
C
 
7
 
Chr. 19. UBA52 (99.7% identity; Homo sapiens ubiquitin A-52 residue ribosomal protein fusion 
product 1 (UBA52), transcript variant 2) and numerous ESTs 
1
4
 
B
C
 
8
 
Chr. X. RPL10 (99.0 % identity; Homo sapiens ribosomal protein L10 (RPL10), transcript variant 
1, CYTOPLASMIC)  
1
5
 
B
C
 
9
 
Chr. 19. Some ESTs, including from eye and retina: BM715662 
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# D. F. Top BLAT (UCSC) search result 
1
6
 
B
C
 
1
0
 Chr. 19. Some ESTs, including from eye and retina: BM676228 
1
7
 
B
C
 
1
1
 Homo sapiens uncharacterized LOC100507412 (LOC100507412), non-coding RNA 
1
8
 
B
C
 
1
2
 seq. Not readable 
1
9
 
B
C
 
1
3
 
Chr. 17. CSNK1D (99.8% identity; Homo sapiens casein kinase 1, delta (CSNK1D), transcript 
variant 2) and numerous ESTs 
2
2
 
B
C
 
1
4
 
Chr. 22. intronic region of gene GUSBP11 (100 % identity; Homo sapiens glucuronidase, beta 
pseudogene 11 (GUSBP11), non-coding RNA) and some ESTs 
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Table 11-4. Identities of prey clones from the R&O-dT library screen, as identified by BLAT (UCSC) 
genome search. 
Key: #, number of R&O-dT Y2H screen clone; D., date sequenced; F., file identifier. 
# D. F.  Top BLAT (UCSC) search result 
2
 
2
0
1
1
.1
1
.3
0
 
B
C
3
5
 
 Chr. 8. ZNF7 (zinc finger protein 7) and numerous ESTs 
4
 
B
C
3
7
 
 Chr. 17. UBB (99.5 % identity; ubiquitin B precursor) and numerous ESTs 
7
 
2
0
1
1
.1
2
.0
5
 
B
C
1
1
 
 Chr. 17. ENO3 (99.8 % identity; enolase) and numerous ESTs 
8
 
B
C
1
2
 
 Chr. 13. TPT1 (99.7 % identity; tumour protein, translationally controlled 1) 
1
0
 
2
0
1
1
.1
2
.0
6
 
B
C
2
 
 
Chr. 19. AES (100 % identity; amino-terminal enhancer of split isoform b) and numerous 
ESTs 
1
1
 
B
C
3
 
 
Chr. 16. DYNC1LI2 (99.6 % identity; dynein, cytoplasmic, light intermediate) and numerous 
ESTs 
1
5
 
B
C
6
 
 
Chr. 6. 5' UTR of gene SERPINB1 (100 % identity; serine (or cysteine) proteinase inhibitor, 
clade) and numerous ESTs 
1
7
 
B
C
8
 
 Chr. 2. RPL31 (100 % identity; ribosomal protein L31 isoform 3) and numerous ESTs 
1
8
 
B
C
9
 
 Chr. 11. CTSD (99.7 % identity; cathepsin D preproprotein) and numerous ESTs 
2
3
 
B
C
1
2
 
 Chr. 5. DPYSL3 (97.1 % identity; dihydropyrimidinase-like 3)  and numerous ESTs 
2
4
 
B
C
1
3
 
 
Chr. 21. SCAF4 (99.9 % identity; splicing factor, arginine/serine-rich 15 isoform; Homo 
sapiens SR-related CTD-associated factor 4 (SCAF4), transcript variant 3, mRNA) and 
numerous ESTs 
2
7
 
B
C
1
6
 
 Chr. 13. ITM2B (99.9 % identity; integral membrane protein 2B) and numerous ESTs 
2
8
 
B
C
1
7
 
 Chr. 1. PDC (98.0 % identity; phosducin isoform a) and numerous ESTs.  
2
9
 
B
C
1
8
 
 Chr. 13. ITM2B (99.9 % identity; integral membrane protein 2B) and numerous ESTs 
3
1
 
B
C
2
0
 
 Chr. 9. PTGDS (99.7 % identity; prostaglandin D2 synthase, brain) and numerous ESTs 
3
2
 
B
C
2
1
 
 
Chr. 10. MGEA5 (99.9 % identity; meningioma expressed antigen 5 (hyaluronidase) and 
numerous ESTs 
3
6
 
2
0
1
1
.1
2
.2
1
 
B
C
1
 
 Chr. 5. 3' UTR of gene SAR1B (99.9 % identity)   and some ESTs including brain and foetal 
4
4
 
B
C
9
 
 Chr. 11. PRDX5 (100 % identity; peroxiredoxin 5 isoform a precursor)   and numerous ESTs 
4
5
 
B
C
1
0
 
 Chr. 9. PTGDS (99.7 % identity; prostaglandin D2 synthase, brain)   and numerous ESTs 
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# D. F.  Top BLAT (UCSC) search result 
4
6
 
B
C
1
1
 
 Chr.21. SOD1 (99.4% identity; superoxide dismutase 1, soluble)   and numerous ESTs 
4
7
 
B
C
1
2
 
 Chr. 9. PTGDS (99.7 % identity; prostaglandin D2 synthase, brain)   and numerous ESTs 
2
.3
 
B
C
 
1
7
 Chr. 11. 3' UTR of gene PDDC1 (89.8 % identity; Homo sapiens Parkinson disease 7 domain 
containing 1 (PDDC1)) and numerous ESTs 
2
.5
 
B
C
 
1
8
 Chr. 2. RPS7 (100 % identity; Homo sapiens ribosomal protein S7 (RPS7); CYTOPLASMIC)   
and numerous ESTs 
2
.6
 
B
C
 
1
9
 Chr. 8. intronic region of gene DOCK5 (100 % identity; Homo sapiens dedicator of 
cytokinesis 5 (DOCK5)) and some ESTs 
2
.7
 
B
C
 
2
0
 Chr. 2. SLC22A6 (99.8 % identity; Homo sapiens solute carrier family 22 (organic anion 
transporter), member 6 (SLC22A6), transcript variant 1)   and numerous ESTs 
2
.8
 
B
C
 
2
1
 Chr. 2. UBC (99.8 % identity; Homo sapiens ubiquitin C (UBC))   and numerous ESTs 
2
.1
0
 
B
C
 
2
3
 
Chr. 16. NDUFB10 (99.6 % identity; Homo sapiens NADH dehydrogenase (ubiquinone) 1 
beta subcomplex, 10, 22kDa (NDUFB10), nuclear gene encoding mitochondrial protein)   
and numerous ESTs 
2
.1
3
 
B
C
 
2
6
 Chr. 15. UBA52 (99.7 % identity; Homo sapiens ubiquitin A-52 residue ribosomal protein 
fusion product 1 (UBA52), transcript variant 2)   and numerous ESTs 
2
.1
4
 
B
C
 
2
7
 Chr. 15. PIAS1 (100 % identity; Homo sapiens protein inhibitor of activated STAT, 1 (PIAS1))   
and numerous ESTs 
2
.1
5
 
B
C
 
2
8
 Chr. 17. NMT1 (100 % identity; Homo sapiens N-myristoyltransferase 1 (NMT1))   and 
numerous ESTs 
2
.1
8
 
B
C
 
3
0
 Chr. 18. LMAN1 (99.7 % identity; Homo sapiens lectin, mannose-binding, 1 (LMAN1))   and 
numerous ESTs 
2
.2
0
 
B
C
 
3
2
 Chr. 14. PSMC1 (99.5 % identity; Homo sapiens proteasome (prosome, macropain) 26 S 
subunit, ATPase, 1 (PSMC1))   and numerous ESTs 
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Table 11-5. Y2H preys associated with cytoskeleton and trafficking. Functional data from UniProtKB and 
RefSeq (NCBI). 
Expression data from UniProtKB, or databases redirected to from protein-specific Swiss-Prot annotation 
page. 
Clone 
Gene from 
BLAT 
search 
RefSeq Gene 
Summary 
Protein name 
Swiss-Prot 
Protein Function Summary 
Protein 
Expression 
R&O-
dT 8 
TPT1 (aka 
HRF; p02; 
p23; TCTP) 
- 
Translationally-
controlled tumour 
protein 
Involved in calcium binding and 
microtubule stabilization. 
Ubiquitous 
R&O-
dT 11 
DYNC1LI2 
(aka LIC2; 
DNCLI2) 
Cytoplasmic 
dynein is 
a microtubule-
associated 
motor protein 
(Hughes et al., 
1995 [PubMed 
7738094]). See 
DYNC1H1 
(MIM 600112) 
for general 
information 
about dyneins. 
Cytoplasmic dynein 1 
light intermediate 
chain 2 
Acts as one of several non-
catalytic accessory components 
of the cytoplasmic dynein 1 
complex that are thought to be 
involved in linking dynein to 
cargos and to adapter proteins 
that regulate dynein function. 
Cytoplasmic dynein 1 acts as 
a motor for the intracellular 
retrograde motility of vesicles 
and organelles along 
microtubules. May play a role in 
binding dynein to membranous 
organelles or chromosomes. 
Ubiquitous 
R&O-
dT 23 
DPYSL3 
(aka DRP3; 
ULIP; 
CRMP4; 
DRP-3; 
LCRMP; 
CRMP-4; 
ULIP-1) 
- 
Dihydropyrimidinase-
related protein 3 
Necessary for signalling by class 
3 semaphorins and subsequent 
remodelling of the 
cytoskeleton. Plays a role in 
axon guidance, neuronal 
growth cone collapse and cell 
migration. 
Mainly 
expressed 
in heart and 
skeletal 
muscle. 
Also 
strongly 
expressed 
in CNS. 
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Table 11-6. Y2H preys associated with protein turnover and modification. 
Functional data from UniProtKB and RefSeq (NCBI). Expression data from UniProtKB, or databases 
redirected to from protein-specific Swiss-Prot annotation page. 
Clone 
 
Protein 
name 
Gene from 
BLAT 
search 
RefSeq Gene Summary 
Swiss-Prot 
Protein Function Summary 
Protein 
Expression 
R&O-dT 
2.13 
 
O-dT 12 
 
Ubiquitin-
60S 
ribosomal 
protein 
L40 
 
UBA52 
(aka L40; 
CEP52; 
RPL40; 
HUBCEP52) 
Ubiquitin is a highly 
conserved nuclear and 
cytoplasmic protein 
that has a major role in 
targeting cellular 
proteins for 
degradation by the 26 S 
proteasome. It is also 
involved in 
the maintenance of 
chromatin structure, 
the regulation of gene 
expression, and the 
stress response. 
Ubiquitin is synthesized 
as a precursor protein 
consisting of either 
poly-ubiquitin chains or 
a single ubiquitin 
moiety fused to an 
unrelated protein. This 
gene encodes a fusion 
protein consisting of 
ubiquitin at the N 
terminus and ribosomal 
protein L40 at the C 
terminus, a C-terminal 
extension protein 
(CEP). Multiple 
processed pseudogenes 
derived from this gene 
are present in 
the genome. 
Ubiquitin: exists either covalently attached to 
another protein, or free (unanchored). When 
covalently bound, it is conjugated to target 
proteins via an isopeptide bond either as 
a monomer (mono-ubiquitin), a polymer 
linked via different Lys residues of the 
ubiquitin (poly-ubiquitin chains) or a linear 
polymer linked via the initiator Met of the 
ubiquitin (linear poly-ubiquitin chains). Poly-
ubiquitin chains, when attached to a target 
protein, have different functions depending 
on the Lys residue of the ubiquitin that is 
linked: Lys-6-linked may be involved in DNA 
repair; Lys-11-linked is involved in ERAD 
(endoplasmic reticulum-associated 
degradation) and in cell-cycle regulation; Lys-
29-linked is involved in lysosomal 
degradation; Lys-33-linked is involved in 
kinase modification; Lys-48-linked is involved 
in protein degradation via the proteasome; 
Lys-63-linked is involved in endocytosis, DNA-
damage responses as well as in signalling 
processes leading to activation of 
the transcription factor NF-kappa-B. Linear 
polymer chains formed via attachment by the 
initiator Met lead to cell signalling. Ubiquitin 
is usually conjugated to Lys residues of target 
proteins, however, in rare cases, conjugation 
to Cys or Ser residues has been observed. 
When poly-ubiquitin is free (unanchored-poly-
ubiquitin), it also has distinct roles, such as in 
activation of protein kinases, and in signalling. 
Ubiquitous 
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Clone 
 
Protein 
name 
Gene 
from 
BLAT 
search 
RefSeq Gene Summary 
Swiss-Prot 
Protein 
Function 
Summary 
Protein 
Expression 
R&O-dT 4 
 
Poly-
ubiquitin-B 
UBB 
This gene encodes ubiquitin, one of the most conserved 
proteins known. Ubiquitin has a major role in targeting 
cellular proteins for degradation by the 26 S proteasome. 
It is also involved in the maintenance of chromatin 
structure, the regulation of gene expression, and the stress 
response. Ubiquitin is synthesized as a precursor protein 
consisting of either poly-ubiquitin chains or a single 
ubiquitin moiety fused to an unrelated protein. This gene 
consists of three direct repeats of the ubiquitin coding 
sequence with no spacer sequence. Consequently, the 
protein is expressed as a poly-ubiquitin precursor with a 
final amino acid after the last repeat. An aberrant form of 
this protein has been detected in patients with Alzheimer's 
disease and Down syndrome. Pseudogenes of this gene 
are located on chromosomes 1, 2, 13, and 17. Alternative 
splicing results in multiple transcript variants. 
As above Ubiquitous 
R&O-dT 
2.8 
 
Poly-
ubiquitin-C 
 
UBC (aka 
HMG20) 
This gene represents a ubiquitin gene, ubiquitin C. The 
encoded protein is a poly-ubiquitin precursor. Conjugation 
of ubiquitin monomers or polymers can lead to various 
effects within a cell, depending on the residues to which 
ubiquitin is conjugated. Ubiquitination has been 
associated with protein degradation, DNA repair, cell cycle 
regulation, kinase modification, endocytosis, and 
regulation of other cell signalling pathways. 
As above Ubiquitous 
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Clone 
 
Protein 
name 
Gene from 
BLAT 
search 
RefSeq Gene Summary 
Swiss-Prot 
Protein Function 
Summary 
Protein 
Expression 
O-dT 14 
 
60S 
ribosomal 
protein L10 
RPL10 
(aka QM; 
L10; NOV; 
AUTSX5; 
DXS648; 
DXS648E) 
Ribosomes, the organelles that catalyse protein 
synthesis, consist of a small 40S subunit and a large 
60S subunit. Together these subunits are composed of 
four RNA species and approximately 80 structurally 
distinct proteins. This gene encodes a ribosomal 
protein that is a component of the 60S subunit. The 
protein belongs to the L10E family of ribosomal 
proteins. It is located in the cytoplasm. In vitro studies 
have shown that the chicken protein can bind to c-Jun 
and can repress c-Jun-mediated transcriptional 
activation, but these activities have not been 
demonstrated in vivo. This gene was initially identified 
as a candidate for a Wilms tumour suppressor gene, 
but later studies determined that this gene is not 
involved in the suppression of Wilms tumour. This 
gene has been referred to as 'laminin receptor 
homolog' because a chimeric transcript consisting of 
sequence from this gene and sequence from the 
laminin receptor gene was isolated; however, it is not 
believed that this gene encodes a laminin receptor. 
Alternative splicing results in multiple transcript 
variants. This gene also uses multiple polyA signals, 
with the 3'-most polyA signal overlapping the 
deoxyribonuclease I-like 1 gene on the opposite 
strand. This gene is co-transcribed with the small 
nucleolar RNA gene U70, which is located in its fifth 
intron. As is typical for genes encoding ribosomal 
proteins, there are multiple processed pseudogenes 
of this gene dispersed through the genome. 
Component of the 
large ribosomal 
subunit. Mature 
ribosomes consist 
of a small (40S) 
and a large (60S) 
subunit. The 40S 
subunit contains 
about 33 different 
proteins and 1 
molecule of RNA 
(18S). The 60S 
subunit contains 
about 49 different 
proteins and 3 
molecules of RNA 
(28S, 5.8S and 5S). 
Ubiquitous 
R&O-dT 18 
 
Cathepsin 
D 
CTSD (aka 
CPSD; 
CLN10; 
HEL-S-
130P) 
This gene encodes a lysosomal aspartyl protease 
composed of a dimer of disulphide-linked heavy 
and light chains, both produced from a single 
protein precursor. This proteinase, which is a 
member of the peptidase C1 family, has a 
specificity similar to but narrower than that of 
pepsin A. Transcription of this gene is initiated 
from several sites, including one which is a start 
site for an oestrogen-regulated transcript. 
Mutations in this gene are involved in the 
pathogenesis of several diseases, including breast 
cancer and possibly Alzheimer disease. 
Acid protease 
active in 
intracellular 
protein 
breakdown. 
Involved in the 
pathogenesis of 
several diseases 
such as breast 
cancer and 
possibly Alzheimer 
disease. 
Ubiquitous 
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Clone 
 
Protein 
name 
Gene 
from 
BLAT 
search 
RefSeq Gene Summary 
Swiss-Prot 
Protein 
Function 
Summary 
Protein 
Expression 
R&O-dT 
2.2 
 
26 S 
protease 
regulatory 
subunit 4 
PSMC1 
(aka S4; 
p56; 
P26 S4) 
The 26 S proteasome is a multicatalytic proteinase 
complex with a highly ordered structure composed of 2 
complexes, a 20S core and a 19S regulator. The 20S core 
is composed of 4 rings of 28 non-identical subunits; 2 
rings are composed of 7 alpha subunits and 2 rings are 
composed of 7 beta subunits. The 19S regulator is 
composed of a base, which contains 6 ATPase subunits 
and 2 non-ATPase subunits, and a lid, which contains up 
to 10 non-ATPase subunits. Proteasomes are distributed 
throughout eukaryotic cells at a high concentration and 
cleave peptides in an ATP/ubiquitin-dependent process 
in a non-lysosomal pathway. An essential function of a 
modified proteasome, the immuno-proteasome, is the 
processing of class I MHC peptides. This gene encodes 
one of the ATPase subunits, a member of the triple-A 
family of ATPases which have a chaperone-like activity. 
This subunit and a 20S core alpha subunit interact 
specifically with the hepatitis B virus X protein, a protein 
critical to viral replication. This subunit also interacts 
with the adenovirus E1A protein and this interaction 
alters the activity of the proteasome. Finally, this subunit 
interacts with ataxin-7, suggesting a role for the 
proteasome in the development of spinocerebellar 
ataxia type 7, a progressive neurodegenerative disorder. 
The 26 S 
protease is 
involved in the 
ATP-
dependent 
degradation of 
ubiquitinated 
proteins. The 
regulatory (or 
ATPase) 
complex 
confers ATP 
dependency 
and substrate 
specificity to 
the 26 S 
complex. 
Ubiquitous 
O-dT 5 
 
Protein 
phospha-
tase 1 
regulatory 
subunit 
16A 
PPP1R16A 
(aka 
MYPT3) 
- 
Inhibits 
protein 
phosphatase 1 
activity toward 
phosphorylase, 
myosin light 
chain and 
myosin 
substrates. 
Ubiquitous 
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Clone 
 
Protein 
name 
Gene 
from 
BLAT 
search 
RefSeq Gene Summary 
Swiss-Prot 
Protein 
Function 
Summary 
Protein 
Expression 
O-dT 19 
 
Casein 
kinase I 
isoform 
delta 
CSNK1D 
(aka ASPS; 
HCKID; 
FASPS2; 
CKIdelta) 
This gene is a 
member of the 
casein kinase I (CKI) 
gene family whose 
members have 
been implicated in 
the control of 
cytoplasmic and 
nuclear processes, 
including DNA 
replication and 
repair. The encoded 
protein may also be 
involved in the 
regulation of 
apoptosis, circadian 
rhythm, 
microtubule 
dynamics, 
chromosome 
segregation, and 
p53-mediated 
effects on growth. 
The encoded 
protein is highly 
similar to the 
mouse and rat CK1 
delta homologs. 
Three transcript 
variants encoding 
different isoforms 
have been found 
for this gene. 
Essential serine/threonine-protein kinase that 
regulates diverse cellular growth and survival 
processes including Wnt signalling, DNA repair and 
circadian rhythms. It can phosphorylate a large 
number of proteins. Casein kinases are 
operationally defined by their preferential 
utilization of acidic proteins such as caseins as 
substrates. Phosphorylates connexin-43/GJA1, 
MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, 
EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, 
DNMT1, PKD2, YAP1, PER1 and PER2. Central 
component of the circadian clock. In balance with 
PP1, determines the circadian period length 
through the regulation of the speed and rhythmicity 
of PER1 and PER2 phosphorylation. Controls PER1 
and PER2 nuclear transport and degradation. YAP1 
phosphorylation promotes its SCF(beta-TRCP) E3 
ubiquitin ligase-mediated ubiquitination and 
subsequent degradation. DNMT1 phosphorylation 
reduces its DNA-binding activity. Phosphorylation of 
ESR1 and AIB1/NCOA3 stimulates their activity and 
co-activation. Phosphorylation of DVL2 and DVL3 
regulates WNT3A signalling pathway that controls 
neurite outgrowth. EIF6 phosphorylation promotes 
its nuclear export. Triggers down-regulation of 
dopamine receptors in the forebrain. Activates DCK 
in vitro by phosphorylation. TOP2A phosphorylation 
favours DNA cleavable complex formation. May 
regulate the formation of the mitotic spindle 
apparatus in extravillous trophoblast. Modulates 
connexin-43/GJA1 gap junction assembly by 
phosphorylation. Probably involved in lymphocyte 
physiology. Regulates fast synaptic transmission 
mediated by glutamate. 
Ubiquitous 
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Clone 
 
Protein 
name 
Gene 
from 
BLAT 
search 
RefSeq Gene Summary 
Swiss-Prot 
Protein Function Summary 
Protein 
Expression 
R&O-dT 32 
 
Bifunctional 
protein 
NCOAT 
MGEA5 
(aka OGA; 
MEA5; 
NCOAT) 
The dynamic modification of 
cytoplasmic and nuclear 
proteins by O-linked N-acetyl 
glucosamine (O-GlcNAc) 
addition and removal on serine 
and threonine residues is 
catalysed by OGT (MIM 
300255), which adds O-GlcNAc, 
and MGEA5, a glycosidase that 
removes O-GlcNAc 
modifications. 
Cleaves GlcNAc but not GalNAc from 
glycopeptides. Can use p-
nitrophenyl-beta-GlcNAc as 
substrate but not p-nitrophenyl-
beta-GalNAc or p-nitrophenyl-alpha-
GlcNAc. Possesses hyaluronidase 
activity. Acetylates 'Lys-8' of histone 
H4 and 'Lys-14' of histone H3. 
Ubiquitous; 
Abundant 
in brain, 
placenta 
and 
pancreas 
R&O-dT 
2.15 
 
Glycyl-
peptide N-
tetra-
decanoyl-
transfe-
rase 1 
NMT1 
(aka: 
NMT) 
Myristate, a rare 14-carbon 
saturated fatty acid, is co-
translationally attached by an 
amide linkage to the N-terminal 
glycine residue of cellular and 
viral proteins with diverse 
functions. N-
myristoyltransferase (NMT; EC 
2.3.1.97) catalyses the transfer 
of myristate from CoA to 
proteins. N-myristoylation 
appears to be irreversible and is 
required for full expression of 
the biologic activities of several 
N-myristoylated proteins, 
including the alpha subunit of 
the signal-transducing guanine 
nucleotide-binding protein (G 
protein) GO (GNAO1; MIM 
139311). 
Adds a myristoyl group to the N-
terminal glycine residue of certain 
cellular and viral proteins. 
Ubiquitous 
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Table 11-7. Y2H preys associated with mitochondrial function. 
Functional data from UniProtKB and RefSeq (NCBI). Expression data from UniProtKB, or databases 
redirected to from protein-specific Swiss-Prot annotation page. 
Clone 
Gene 
from 
BLAT 
search 
RefSeq Gene Summary Protein name 
Swiss-Prot 
Protein Function Summary 
Protein 
Expression 
R&O-
dT 
2.1 
NDUFB10 
(aka 
PDSW) 
- 
NADH 
dehydrogenase 
[ubiquinone] 1 
beta subcomplex 
subunit 10 
Accessory subunit of 
the mitochondrial 
membrane respiratory 
chain NADH 
dehydrogenase (Complex 
I), that is believed not to be 
involved in catalysis. 
Complex I functions in 
the transfer of electrons 
from NADH to 
the respiratory chain. 
The immediate electron 
acceptor for the enzyme is 
believed to be ubiquinone. 
Ubiquitous 
O-dT 
6 
NDUFS2 
(aka CI-
49) 
The protein encoded by this 
gene is a core subunit of the 
mitochondrial membrane 
respiratory chain NADH 
dehydrogenase (complex I). 
Mammalian mitochondrial 
complex I is composed of at 
least 43 different subunits, 
7 of which are encoded by 
the mitochondrial genome, 
and the rest are the 
products of nuclear genes. 
The iron-sulphur protein 
fraction of complex I is 
made up of 7 subunits, 
including this gene product. 
Complex I catalyses the 
NADH oxidation with 
concomitant ubiquinone 
reduction and proton 
ejection out of the 
mitochondria. Mutations in 
this gene are associated 
with mitochondrial complex 
I deficiency for this gene. 
NADH 
dehydrogenase 
[ubiquinone] 
iron-sulphur 
protein 2, 
mitochondrial 
Core subunit of 
the mitochondrial 
membrane respiratory 
chain NADH 
dehydrogenase (Complex I) 
that is believed to belong 
to the minimal assembly 
required for catalysis. 
Complex I functions in 
the transfer of electrons 
from NADH to the 
respiratory chain. 
The immediate electron 
acceptor for the enzyme is 
believed to be ubiquinone. 
Ubiquitous 
O-dT 
7 
 
  
Identification of Interacting Protein Partners of TOPORS in the Retina   ||   Barbara Czub 
PhD Thesis 2015   ||   Appendix    - 463 - 
 
Clone 
Gene from 
BLAT 
search 
RefSeq Gene Summary 
Protein 
name 
Swiss-Prot 
Protein Function 
Summary 
Protein 
Expression 
R&O-
dT 44 
PRDX5 (aka 
PLP; ACR1; 
B166; 
PRXV; 
PMP20; 
PRDX6; prx-
V; SBBI10; 
AOEB166; 
HEL-S-55) 
This gene encodes a member of the 
peroxiredoxin family of antioxidant 
enzymes, which reduce hydrogen 
peroxide and alkyl hydroperoxides. 
The encoded protein may play an 
antioxidant protective role in different 
tissues under normal conditions and 
during inflammatory processes. This 
protein interacts with peroxisome 
receptor 1. The crystal structure of this 
protein in its reduced form has been 
resolved to 1.5 angstrom resolution. This 
gene uses alternate in-frame translation 
initiation sites to generate mitochondrial 
or peroxisomal/cytoplasmic forms. Three 
transcript variants encoding distinct 
isoforms have been identified for this 
gene. 
Peroxi-
redoxin-5, 
mito-
chondrial 
Reduces 
hydrogen 
peroxide and 
alkyl hydro-
peroxides with 
reducing equi-
valents provided 
through the thio-
redoxin system. 
Involved in intra-
cellular redox 
signalling. 
Ubiquitous 
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Table 11-8. Y2H preys associated with cell nucleus. 
Functional data from UniProtKB and RefSeq (NCBI). Expression data from UniProtKB, or databases 
redirected to from protein-specific Swiss-Prot annotation page. 
Clone 
Gene 
from 
BLAT 
search 
RefSeq Gene Summary Protein name 
Swiss-Prot 
Protein Function Summary 
Protein 
Expression 
R&O-
dT 2 
ZNF7  
(aka 
KOX4; 
zf30; 
HF.16) 
- 
Zinc finger 
protein 7 
May be involved in 
transcriptional regulation. 
Ubiquitous 
R&O-
dT 10 
AES 
(aka 
GRG; 
ESP1; 
GRG5; 
TLE5; 
AES-1; 
AES-2) 
The protein encoded by this 
gene is similar in sequence 
to the amino terminus of 
Drosophila enhancer of split 
Groucho, a protein involved 
in neurogenesis during 
embryonic development. 
The encoded protein, which 
belongs to the groucho/TLE 
family of proteins, can 
function as a homo-
oligomer or as a hetero-
ologimer with other family 
members to dominantly 
repress the expression of 
other family member genes. 
Three transcript variants 
encoding different isoforms 
have been found for this 
gene.  
Amino-terminal 
enhancer of 
split 
Acts as dominant repressor 
towards other family members. 
Inhibits NF-kappa-B-regulated 
gene expression. May be 
required for the initiation and 
maintenance of 
thedifferentiated state. 
Ubiquitous 
R&O-
dT 24 
SCAF4 
(aka 
SRA4; 
SFRS15) 
This gene likely encodes 
a member of the 
arginine/serine-rich splicing 
factor family. A similar 
protein in Rat appears to 
bind the large subunit of 
RNA polymerase II and 
provide a link between 
transcription and pre-mRNA 
splicing. Alternatively 
spliced transcript variants 
have been described.  
Splicing factor, 
arginine/serine-
rich 15 
May act to physically and 
functionally link transcription 
and pre-mRNA processing. 
Ubiquitous 
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Clone 
Gene 
from 
BLAT 
search 
RefSeq Gene Summary 
Protein 
name 
Swiss-Prot 
Protein Function Summary 
Protein 
Expression 
R&O-
dT 
2.14 
PIAS1 
(aka 
GBP; 
ZMIZ3; 
DDXBP1; 
GU/RH-
II) 
This gene encodes a member of 
the mammalian PIAS [protein 
inhibitor of activated STAT-1 
(signal transducer and activator 
of transcription-1)] family. This 
member contains a putative zinc-
binding motif and a highly acidic 
region. It inhibits STAT1-
mediated gene activation and 
the DNA binding activity, binds 
to Gu protein/RNA helicase 
II/DEAD box polypeptide 21, and 
interacts with androgen receptor 
(AR). It functions in testis as 
a nuclear receptor 
transcriptional co-regulator and 
may have a role in AR initiation 
and maintenance of 
spermatogenesis. 
E3 
SUMO-
protein 
ligase 
PIAS1 
Functions as an E3-type small 
ubiquitin-like modifier (SUMO) 
ligase, stabilizing the interaction 
between UBE2I and the substrate, 
and as a SUMO-tethering factor. 
Plays a crucial role as 
a transcriptional co-regulation in 
various cellular pathways, 
including the STAT pathway, 
the p53 pathway and the steroid 
hormone signalling pathway. In 
vitro, binds A/T-rich DNA. The 
effects of this transcriptional co-
regulation, transactivation or 
silencing, may vary depending 
upon the biological context. 
Together with PRMT1, may 
repress STAT1 transcriptional 
activity, in the late phase of 
interferon gamma (IFN-gamma) 
signalling. SUMOylates PML 
(at'Lys-65' and 'Lys-160') and 
PML-RAR and promotes their 
ubiquitin-mediated degradation. 
PIAS1-mediated SUMOylation of 
PML promotes its interaction with 
CSNK2A1/CK2 which in turn 
promotes PML phosphorylation 
and degradation. 
Ubiquitous 
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Table 11-9. Y2H preys – not categorised. 
Functional data from UniProtKB and RefSeq (NCBI). Expression data from UniProtKB, or databases 
redirected to from protein-specific Swiss-Prot annotation page. 
Clone 
Gene 
from 
BLAT 
search 
RefSeq Gene Summary 
Protein 
name 
Swiss-Prot 
Protein Function Summary 
Protein 
Expression 
R&O-
dT 7 
ENO3 
This gene encodes one of 
the three enolase isoenzymes 
found in vertebrates. Enolase is 
a dimeric enzyme that converts 
2-phosphoglycerate to 
phosphoenolpyruvate as part of 
the glycolytic pathway. This 
isozyme is found in skeletal 
muscle where it is involved in 
muscle development and 
regeneration. Alternative 
splicing results in multiple 
transcript variants. 
Beta-
enolase 
Appears to have a function in 
striated muscle development and 
regeneration. 
Ubiquitous; 
Abundant 
in Muscle 
R&O-
dT 
2.5 
RPS7 
(aka 
S7; 
DBA8) 
Ribosomes, the organelles that 
catalyse protein synthesis, 
consist of a small 40S subunit 
and a large 60S subunit. 
Together these subunits are 
composed of 4 RNA species and 
approximately 80 structurally 
distinct proteins. This gene 
encodes a ribosomal protein 
that is a component of the 40S 
subunit. The protein belongs to 
the S7E family of ribosomal 
proteins. It is located in 
the cytoplasm. As is typical for 
genes encoding ribosomal 
proteins, there are multiple 
processed pseudogenes of this 
gene dispersed through 
the genome. 
40S 
ribosomal 
protein 
S7 
Required for rRNA maturation. 
Brain, 
heart, 
kidney, 
liver, testis, 
spleen, 
lung 
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Clone 
Gene 
from 
BLAT 
search 
RefSeq Gene 
Summary 
Protein 
name 
Swiss-Prot 
Protein Function Summary 
Protein 
Expression 
R&O-
dT 
2.7 
SLC22A6 
The protein 
encoded by this 
gene is involved 
in the sodium-
dependent 
transport and 
excretion of 
organic anions, 
some of which 
are potentially 
toxic. The 
encoded protein 
is an integral 
membrane 
protein and may 
be localized to 
the basolateral 
membrane. Four 
transcript 
variants 
encoding four 
different 
isoforms have 
been found for 
this gene.  
Solute 
carrier 
family 22 
member 6 
Involved in the renal elimination of 
endogenous and exogenous organic anions. 
Functions as organic anion exchanger when 
the uptake of one molecule of organic anion is 
coupled with an efflux of one molecule of 
endogenous dicarboxylic acid (glutarate, 
ketoglutarate, etc). Mediates the sodium-
independent uptake of 2,3-dimercapto-1-
propanesulfonic acid (DMPS). Mediates 
the sodium-independent uptake of p-
aminohippurate (PAH), ochratoxin (OTA), 
acyclovir (ACV), 3'-azido-3-'deoxythymidine 
(AZT), cimetidine (CMD), 2,4-dichloro-
phenoxyacetate (2,4-D), hippurate (HA), 
indoleacetate (IA), indoxyl sulphate (IS) and 3-
carboxy-4-methyl-5-propyl-2-furanpropionate 
(CMPF), cidofovir, adefovir, 9-(2-
phosphonylmethoxyethyl) guanine (PMEG), 9-
(2-phosphonylmethoxyethyl) diaminopurine 
(PMEDAP) and edaravone sulphate. PAH 
uptake is inhibited by p-
chloromercuribenzenesulphonate (PCMBS), 
diethyl pyrocarbonate (DEPC), sulindac, 
diclofenac, carprofen, glutarate and okadaic 
acid. PAH uptake is inhibited by 
benzothiazolylcysteine (BTC), S-
chlorotrifluoroethylcysteine (CTFC), cysteine 
S-conjugates S-dichlorovinylcysteine (DCVC), 
furosemide, steviol, phorbol 12-myristate 13-
acetate (PMA), calcium ionophore A23187, 
benzylpenicillin, furosemide, indomethacin, 
bumetamide, losartan, probenecid, phenol 
red, urate, and alpha-ketoglutarate. 
CNS, kidney, 
skeletal 
muscle, eye 
(incl. retina), 
adipose 
tissue, 
blood, male 
and female 
reproductive 
structures 
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Clone 
Gene 
from 
BLAT 
search 
RefSeq Gene Summary 
Protein 
name 
Swiss-Prot 
Protein Function 
Summary 
Protein 
Expression 
R&O-
dT 
2.18 
LMAN1 
(aka 
MR60; 
gp58; 
F5F8D; 
FMFD1; 
MCFD1; 
ERGIC53; 
ERGIC-
53) 
The protein encoded by this gene is 
a type I integral membrane protein 
localized in the intermediate region 
between the endoplasmic reticulum and 
the Golgi, presumably recycling between 
the two compartments. The protein is 
a mannose-specific lectin and is a 
member of a novel family of plant lectin 
homologs in the secretory pathway of 
animal cells. Mutations in the gene are 
associated with a coagulation defect. 
Using positional cloning, the gene was 
identified as the disease gene leading to 
combined factor V-factor VIII deficiency, 
a rare, autosomal recessive disorder in 
which both coagulation factors V and VIII 
are diminished. 
Protein 
ERGIC-53 
Mannose-specific 
lectin. May recognize 
sugar residues of 
glycoproteins, 
glycolipids, or 
glycosylphosphatidyl 
inositol anchors and 
may be involved in 
the sorting or 
recycling of proteins, 
lipids, or both. 
The LMAN1-MCFD2 
complex forms 
a specific cargo 
receptor for the ER-
to-Golgi transport of 
selected proteins. 
Ubiquitous 
R&O-
dT 17 
RPL31 
Ribosomes, the organelles that catalyse 
protein synthesis, consist of a small 40S 
subunit and a large 60S subunit. 
Together these subunits are composed of 
4 RNA species and approximately 80 
structurally distinct proteins. This gene 
encodes a ribosomal protein that is 
a component of the 60S subunit. 
The protein belongs to the L31E family of 
ribosomal proteins. It is located in 
the cytoplasm. Higher levels of 
expression of this gene in familial 
adenomatous polyps compared to 
matched normal tissues have been 
observed. As is typical for genes 
encoding ribosomal proteins, there are 
multiple processed pseudogenes of this 
gene dispersed through the genome. 
Alternatively spliced transcript variants 
encoding distinct isoforms have been 
found for this gene. 
60S 
ribosomal 
protein 
L31 
- Ubiquitous 
 
  
Identification of Interacting Protein Partners of TOPORS in the Retina   ||   Barbara Czub 
PhD Thesis 2015   ||   Appendix    - 469 - 
 
Clone 
Gene 
from 
BLAT 
search 
RefSeq Gene Summary 
Protein 
name 
Swiss-Prot 
Protein Function 
Summary 
Protein 
Expression 
R&O-
dT 46 
SOD1 
(aka 
ALS; 
SOD; 
ALS1; 
IPOA; 
hSod1; 
HEL-S-
44) 
The protein encoded by this gene binds 
copper and zinc ions and is one of two 
isozymes responsible for destroying free 
superoxide radicals in the body. 
The encoded isozyme is a soluble 
cytoplasmic protein, acting as a 
homodimer to convert naturally-
occurring but harmful superoxide 
radicals to molecular oxygen and 
hydrogen peroxide. The other isozyme is 
a mitochondrial protein. Mutations in 
this gene have been implicated as causes 
of familial amyotrophic lateral sclerosis. 
Rare transcript variants have been 
reported for this gene. 
Superoxide 
dismutase 
[Cu-Zn] 
Destroys radicals 
which are normally 
produced within the 
cells and which are 
toxic to biological 
systems. 
Ubiquitous 
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11.7 DETERMINATION OF RETINAL EXPRESSION 
An overview of isoforms of ITM2B, PTGDS and PSMC1 in the Ensemble and UCSC data bases is 
summarised in the subsequent figures (Figure 11-29 - Figure 11-34). A sequencing result of 
a PCR product of genomic origin, which emerged during the PSMC1 expression analysis, is also 
included (Figure 11-35). 
 
 
Figure 11-29. Snapshot of ITM2B transcript details and the resulting splice variants from the Ensembl 
database. 
 
Figure 11-30. Snapshot of ITM2B transcript details from the EyeBrowse Gateway, powered by the UCSC 
database. 
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Figure 11-31. Snapshot of PTGDS transcript details and the resulting splice variants from the Ensembl 
database. 
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Figure 11-32. Snapshot of PTGDS transcript details from the EyeBrowse Gateway, powered by the UCSC 
database. The image was trimmed: not all of the RPE ESTs are displayed. 
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Figure 11-33. Snapshot of PSMC1 transcript details and the resulting splice variants from the Ensembl 
database. 
 
Identification of Interacting Protein Partners of TOPORS in the Retina   ||   Barbara Czub 
PhD Thesis 2015   ||   Appendix    - 474 - 
 
 
Figure 11-34. Snapshot of PSMC1 transcript details from the EyeBrowse Gateway, powered by the UCSC 
database. 
 
 
Figure 11-35. Genomic alignments of PCR products amplified from gDNA, using PSMC1 exon-specific 
primers. 
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11.8 CLONING OF ITM2B, PTGDS AND PSMC1 
ITM2B is a membrane-bound protein; therefore, it is highly unlikely that the full-length protein 
would interact with TOPORS in the transcription-based Y2H system. In fact, the ITM2B 
fragments inserted into the library vectors, both comprise exons 3-6 of ITM2B isoform 001 
(Figure 4-9), which roughly correspond to the ectodomain of ITM2B, shedded during its 
processing. Therefore, the direct PPI was tested not only using full-length ITM2B (residues 1-
266), but also using its non-membrane-associated ectodomain (residues 90-266), encoded by 
ITM2B-001 whose retinal expression was confirmed. Additionally, neurodegeneration-
associated ITM2B mutants were also cloned into the GAL4 AD vector to further characterise 
the TOPORS-ITM2B interactions. Full-length PTGDS isoform 001 and PSMC1 isoform 001, which 
appeared to correspond to cDNA library clones identified in the Y2H screen against TOPORS, 
and whose retinal expression was confirmed, were used in the other two interactions. For 
cloning purposes, total RNA was extracted from hTERT-RPE1 cells, and reverse-transcribed for 
cDNA synthesis, which was in turn used for amplification of the prey genes for subsequent 
experiments. The amplified PSMC1, PTGDS and ITM2B transcripts were sub-cloned in frame 
with GAL4 AD using the Gateway system (LifeTechnologies, CA, USA, section 2.2.5.3). 
 
11.8.1 RNA EXTRACTION AND CHARACTERISATION 
The RNA was extracted from hTERT-RPE1 cell line, as described in section 2.4.1. Three 
variations of the extraction method were tested in order to evaluate, which protocol is optimal 
for removal of any potentially contaminating DNA. On the one hand, the RNA extraction was 
performed without any DNAse treatment during the procedure; after extraction a half of 
the resulting RNA sample was treated with DNAse (Sample A), and the other half was left 
untreated (Sample B). On the other hand, the RNA extraction method incorporated the DNAse 
on-column treatment during the extraction procedure (Sample C). The determined RNA yields 
and purity ratios for each sample are summarised in Table 11-10. 
 
Table 11-10. Yields and purity ratios of the extracted RNA samples. 
Ratio results written in green are representative of clean RNA samples (typically ≥2.00). Ratios written in 
red are much lower than expected in a clean sample, and here indicate the presence of organic 
compound impurities, absorbing at the 230 nm wavelength. 
Sample [RNA] (ng/µl) 260/280 260/230 
A 180 1.66 0.85 
B 751 2.11 1.82 
C 397 1.80 1.27 
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All three samples were 
subsequently evaluated by gel 
electrophoresis. It was expected 
that three bands corresponding 
to the ribosomal RNA molecules, 
i.e. 28 S, 18 S and 5 S/5.8 S, 
which collectively make up 
approximately 80 % of total RNA 
of a cell, would be observed. 
A DNA Hyper Ladder I was loaded 
as reference. 
 
Figure 11-36. Extracted RNA samples A-C. 
1.2 % gel, run at 80 V for 1 h. Marker: HL I (Hyper Ladder I - DNA 
size marker). 
 
 
11.8.2 COMPLEMENTARY DNA GENERATION AND 
CHARACTERISATION 
The cDNA was synthesised 
as described in section 2.4.2. 
The results of a subsequent 
control experiment, aiming 
to confirm the content of 
house-keeping genes 
(HPRT), as well as genes 
closer in size to the Y2H 
interacting partners of 
TOPORS, are summarised in 
Figure 11-37. 
 
 
Figure 11-37. HPRT and VAX2 amplicons, generated to test the quality 
of the newly synthesised cDNA. 
Marker: HL I (Hyper Ladder I). 1.5 % agarose gel, run at: 150 V for 
thirty minutes. 
11.8.3 AMPLIFICATION OF ITM2B AND ITS FRAGMENTS 
Primers (ITM2B-PCR-F and -R in Table 2-53) were designed for amplification of the longest 
protein coding transcript of the ITM2B (transcript: ITM2B-001 ENSG00000136156) from human 
cDNA (Clontech, CA, USA). The resulting PCR product (Figure 11-38) was used as template for 
PCR using the Gateway BP reaction-specific primers with the attb tails (ITM2B-attb-F and -R in 
Table 2-53). The soluble fragment of ITM2B (referred to as ITM2B90) was amplified using 
the same forward primers as the full-length transcript; details of the reverse primers for 
amplification from cDNA as well as for Gateway cloning are given in section 2.2.5.3 (Methods 
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and Materials). All amplicons were sequenced (data not shown) to confirm their identity prior 
to Gateway cloning. 
ITM2B mutant constructs, encoding the FBD, FDD and retinal dystrophy mutants, were kindly 
provided by Audo et al. (2013) in pBUD vectors. These constructs were used as templates for 
amplification by KOD polymerase (Novagen, Merck KGaA, Germany) for sub-cloning into 
tagged Gateway vectors. The constructs were verified by sequencing (Figure 11-42, Figure 
11-43, Figure 11-44) prior to downstream experiments. 
 
 
Figure 11-38. ITM2B amplicon from RPE1 cDNA. 
Expected size: 801 bp. Marker: HL I (Hyper 
Ladder I). 
 
 
Figure 11-39. attb-ITM2B-attb amplicons. 
Expected size: 861 bp. Marker: HL I (Hyper Ladder I). 
PCR optimisation run at three annealing 
temperatures for the primer pair: 56 °C, 60 °C, and 
64 °C. 
 
 
Figure 11-40. Putative attb-ITM2B90-attb amplicons. 
Expected size: 594 bp. Marker: HL I (Hyper Ladder I). PCR optimisation run at three different annealing 
temperatures for the primer pair, at 48 °C, 52 °C and 56 °C. PCR template used is denoted by ‘c’ (RPE1 
cDNA), or ‘p’ (PCR amplicon from Figure 11-38).  
 
Identification of Interacting Protein Partners of TOPORS in the Retina   ||   Barbara Czub 
PhD Thesis 2015   ||   Appendix    - 478 - 
 
 
Figure 11-41. Mutant ITM2B Gateway amplicons. 
Marker: SL (Smart Ladder). PCR optimisation run at three different annealing temperatures for each 
primer pair, at 60 °C, 64 °C and 68 °C. PCR template used is denoted by ‘c’ (RPE1 cDNA), or ‘p’ (PCR 
amplicon from Figure 11-38).  Ctrl: PCR positive control (did not work). ‘R’ denotes ITM2B retinal 
dystrophy mutant construct; ‘B’, ITM2B British Dementia mutant construct; and ‘D’, ITM2B Danish 
Dementia mutant construct. Expected band sizes: Retinal dystrophy mutant with attb tails 861 bp; 
British Dementia mutant with attb tails 894 bp; Danish Dementia mutant with attb tails 894 bp.  
 
 
Figure 11-42. Confirmed sequence of the attb-ITM2B_RetMu-attb amplicon (ITM2B retinal dystrophy 
mutant). 
Itm2b-001(1>801): wild-type ITM2B reference sequence. Itm2b-001_C-D template-c.782A-C(1>801): 
retinal dystrophy mutant ITM2B sequence. Mutation indicated by arrow. 
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Figure 11-43. Confirmed sequence of the attb-ITM2B_FBD-attb amplicon (ITM2B Familial British 
Dementia mutant). 
Itm2b-001(1>801): wild-type ITM2B reference sequence. Itm2b-001_G-H template-c.799T-A(1>834): 
British Dementia mutant ITM2B sequence. Mutation indicated by arrow. 
 
 
 
Figure 11-44. Confirmed sequence of the attb-ITM2B_FDD_Mu-attb amplicon (ITM2B Familial Danish 
Dementia mutant). 
Itm2b-001(1>801): wild-type ITM2B reference sequence. Itm2b-001_E-F template-c.795-796(1>834): 
Danish Dementia mutant ITM2B sequence. The decamer sequence highlighted in black is duplicated in 
the Danish mutant. The duplicated region is indicated by the brackets. 
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11.8.4 PTGDS AMPLIFICATION 
Primers (Table 2-54) were designed for amplification of the second longest protein coding 
transcript of the PTGDS (transcript: PTGDS-001 ENSG00000107317). The resulting amplicon 
(Figure 11-45) was then used as template for nested PCR using the Gateway BP reaction-
specific primers with attb tails (Table 2-54). The full-length PTGDS transcript was amplified as 
shown in Figure 11-46. All amplicons were sequenced (data not shown) prior to Gateway 
cloning to confirm their identity and ensure sequence integrity. 
 
 
Figure 11-45. PTGDS amplicons from RPE1 cDNA. 
Expected size: 573 bp. Marker: HL I (Hyper 
Ladder I). PCR optimisation run at two annealing 
temperatures for the primer pair, at 60 °C and 
64 °C. 
 
Figure 11-46. attb-PTGDS-attb amplicons. 
Expected size: 633 bp. Marker: HL I (Hyper 
Ladder I). PCR optimisation run at three annealing 
temperatures for the primer pair, at 56 °C, 60 °C 
and 64 °C. 
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11.8.5 PSMC1 AMPLIFICATION 
The longest protein coding transcript of the PSMC1 (transcript: PSMC1-001 ENST00000261303) 
was kindly provided in a pBluescript (pBS) vector by T. Jake Liang, MD, and Zhensheng Zhang 
from the Intramural Research Program (IRP) of the National Institutes of Health (NIH). The pBS-
PSMC1 construct was used as template for PCR with the Gateway BP reaction-specific primers 
with attb tails (Table 2-55). All amplicons were sequenced (data not shown) prior to Gateway 
cloning to confirm their identity. 
Gel electrophoresis revealed several amplicons, two bands additional to and above the desired 
band (Figure 11-47), therefore the amplicon of the expected size was excised from the gel, 
purified and sequenced (Figure 11-48).  
A missense mutation was identified, which 
was also confirmed in the original pBS-
PSMC1 construct. However, the purified 
mutant amplicon was still used for 
the Gateway cloning, and the mutation 
corrected, after the BP recombination step, 
in the resulting pDONR constructs, using 
site-directed mutagenesis (Figure 11-49). 
The corrected pDONR_PSMC1 construct was 
subsequently used for Gateway LR 
recombination. The cloning outcomes were 
verified by sequencing. 
 
Figure 11-47. attb-PSMC1-attb amplicons. 
Expected size: 1383 bp. HL I: Hyper Ladder I. 56: PCR 
denaturation step at 56 °C. 60: PCR denaturation 
step at 60 °C. 64: PCR denaturation step at 64 °C. 
 
 
Figure 11-48. Missense mutation (c.55A>G  p.Lys19Glu) was identified in the PSMC1 amplicon of the 
expected size, as well as the construct. 
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Figure 11-49. pDONR_PSMC1 amplicon (linear 
vector). 
Expected size: 3168 bp (1785 bp vector + 1383 bp 
insert). Marker: HL I (Hyper Ladder I). SDM: site-
directed mutagenesis PCR product (full-length 
construct amplified with mutation-correcting 
constructs). 
 
 
11.9 FULL-LENGTH TOPORS AND DOMAIN FRAGMENTS (N, M AND C) 
INTERACTIONS IN YEAST – RAW RESULTS 
Six experiments were performed to delineate the domains of TOPORS, which mediate its 
interactions with the newly-identified protein partners. A result was considered positive 
overall, if blue growth, indicating a PPI, was observed in at least four out of six experiments at 
a given stringency level.  
 
Table 11-11. TOPORS x p53 interactions.  
Key: D+ = growth on DDO/X/A; D- = no growth on DDO/X/A; Q+ = growth on QDO/X/A; Q- = no growth 
on QDO/X/A.  
# Experiment date Results of tested interactions +ve  -ve 
  3 pBD-
TOPORS  
4 pGBKT7-N 5 pGBKT7-
M 
6 pGBKT7-
C 
1 pBD-
p53 
7 pBD-
Lam 
  C      pAD_p53 A pGADT7-
T 
A pGADT7-
T 
1 28-Oct-13  D+ Q-  D+ Q-  D+ Q+  D+ Q+  D+ Q+  n/a 
2 06-Nov-13  D+ Q-  D+ Q-  D+ Q+  D+ Q+  D+ Q+  n/a 
3 12-Nov-13  D+ Q+  D+ Q+  D+ Q-  D+ Q+  D+ Q+  n/a 
4 23-Jan-14  D- Q-  D+ Q+  D+ Q+  D+ Q+  D+ Q+  D- Q- 
5 08-Apr-14  D+ Q+  D+ Q+  D+ Q+  D- Q+  D+ Q+  D- Q- 
6 23-Apr-14  D+ Q+  D+ Q+  D+ Q-  D+ Q-  D+ Q+  D- Q- 
 Overall Result  D+ Q-  D+ Q+  D+ Q+  D+ Q+  D+ Q+  D- Q- 
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Table 11-12. TOPORS x ITM2B interactions.  
Key: D+ = growth on DDO/X/A; D- = no growth on DDO/X/A; Q+ = growth on QDO/X/A; Q- = no growth 
on QDO/X/A.  
# Experiment date Results of tested interactions +ve  -ve 
  3 pBD-
TOPORS  
4 pGBKT7-N 5 pGBKT7-
M 
6 pGBKT7-
C 
1 pBD-p53 7 pBD-
Lam 
  C      pAD_ITM2B  pGADT7-
T 
 pGADT7-
T 
1 28-Oct-13  D- Q-  D+ Q+  D- Q-  D+ Q+  D+ Q+  n/a 
2 06-Nov-13  D- Q-  D+ Q+  D- Q-  D+ Q+  D+ Q+  n/a 
3 12-Nov-13  D+ Q+  D+ Q+  D+ Q-  D+ Q+  D+ Q+  n/a 
4 23-Jan-14  D+ Q+  D+ Q+  D- Q-  D- Q+  D+ Q+  D- Q- 
5 08-Apr-14  D+ Q+  D- Q-  D+ Q+  D+ Q+  D+ Q+  D- Q- 
6 23-Apr-14  D+ Q-  D+ Q+  D+ Q-  D+ Q-  D+ Q+  D- Q- 
 Overall Result  D+ Q-  D+ Q+  D- Q-  D+ Q+  D+ Q+  D- Q- 
 
Table 11-13. TOPORS x ITM2B90 interactions. 
Key: D+ = growth on DDO/X/A; D- = no growth on DDO/X/A; Q+ = growth on QDO/X/A; Q- = no growth 
on QDO/X/A.  
# Experiment date Results of tested interactions +ve  -ve 
  3 pBD-
TOPORS  
4 pGBKT7-N 5 pGBKT7-
M 
6 pGBKT7-
C 
1 pBD-
p53 
7 pBD-
Lam 
  EpAD_ITM2B90 A pGADT7-
T 
A pGADT7-
T 
1 28-Oct-13  D+ Q-  D+ Q+  D- Q-  D+ Q+  D+ Q+  n/a 
2 06-Nov-13  D+ Q-  D+ Q+  D- Q-  D+ Q+  D+ Q+  n/a 
3 12-Nov-13  D+ Q+  D+ Q+  D+ Q+  D+ Q-  D+ Q+  n/a 
4 23-Jan-14  D+ Q+  D+ Q+  D+ Q+  D+ Q+  D+ Q+  D- Q- 
5 08-Apr-14  D+ Q+  D- Q-  D+ Q+  D+ Q+  D+ Q+  D- Q- 
6 23-Apr-14  D+ Q-  D+ Q+  D+ Q-  D+ Q-  D+ Q+  D- Q- 
 Overall result  D+ Q-  D+ Q+  D+ Q-  D+ Q+  D+ Q+  D- Q- 
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Table 11-14. TOPORS x ITM2B_Ret interactions. 
Key: D+ = growth on DDO/X/A; D- = no growth on DDO/X/A; Q+ = growth on QDO/X/A; Q- = no growth 
on QDO/X/A.  
# Experiment date Results of tested interactions +ve  -ve 
  3 pBD-
TOPORS 
4 pGBKT7-N 5 pGBKT7-
M 
6 pGBKT7-
C 
1 pBD-
p53 
7 pBD-
Lam 
  pAD_ITM2B_Ret A pGADT7-
T 
A pGADT7-
T 
1 28-Oct-13  n/a  n/a  n/a  n/a  n/a  n/a 
2 06-Nov-13  n/a  n/a  n/a  n/a  n/a  n/a 
3 12-Nov-13  n/a  n/a  n/a  n/a  n/a  n/a 
4 23-Jan-14  D+ Q+  D+ Q+  D+ Q-  D+ Q+  D+ Q+  D- Q- 
5 08-Apr-14  D+ Q+  D+ Q+  D- Q+  D- Q+  D+ Q+  D- Q- 
6 23-Apr-14  D+ Q-  D+ Q+  D+ Q-  D+ Q-  D+ Q+  D- Q- 
 Overall result  D+ Q+  D+ Q+  D+ Q-  D+ Q+  D+ Q+  D- Q- 
 
Table 11-15. TOPORS x ITM2B_FBDinteractions. 
Key: D+ = growth on DDO/X/A; D- = no growth on DDO/X/A; Q+ = growth on QDO/X/A; Q- = no growth 
on QDO/X/A.  
# Experiment date Results of tested interactions +ve  -ve 
  3 pBD-
TOPORS 
4 pGBKT7-N 5 pGBKT7-
M 
6 pGBKT7-
C 
1 pBD-
p53 
7 pBD-
Lam 
  IpAD_ITM2B_ABri A pGADT7-
T 
A pGADT7-
T 
1 28-Oct-13  n/a  n/a  n/a  n/a  n/a  n/a 
2 06-Nov-13  n/a  n/a  n/a  n/a  n/a  n/a 
3 12-Nov-13  n/a  n/a  n/a  n/a  n/a  n/a 
4 23-Jan-14  D+ Q+  D+ Q+  D+ Q+  D+ Q+  D+ Q+  D- Q- 
5 08-Apr-14  D+ Q-  D+ Q+  D+ Q+  D- Q-  D+ Q+  D- Q- 
6 23-Apr-14  D+ Q-  D+ Q+  D+ Q-  D+ Q-  D+ Q+  D- Q- 
 Overall result  D+ Q-  D+ Q+  D+ Q+  D+ Q+  D+ Q+  D- Q- 
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Table 11-16. TOPORS x ITM2B_FDD interactions. 
Key: D+ = growth on DDO/X/A; D- = no growth on DDO/X/A; Q+ = growth on QDO/X/A; Q- = no growth 
on QDO/X/A.  
# Experiment date Results of tested interactions +ve  -ve 
  3 pBD-
TOPORS 
4 pGBKT7-N 5 pGBKT7-
M 
6 pGBKT7-
C 
1 pBD-
p53 
7 pBD-
Lam 
  JpAD_ITM2B_FDD A pGADT7-
T 
A pGADT7-
T 
1 28-Oct-13  n/a  n/a  n/a  n/a  n/a  n/a 
2 06-Nov-13  n/a  n/a  n/a  n/a  n/a  n/a 
3 12-Nov-13  n/a  n/a  n/a  n/a  n/a  n/a 
4 23-Jan-14  D- Q-  D- Q-  D- Q-  D- Q-  D+ Q+  D- Q- 
5 08-Apr-14  D- Q-  D- Q-  D- Q-  D+ Q-  D+ Q+  D- Q- 
6 23-Apr-14  D+ Q-  D+ Q+  D+ Q-  D+ Q-  D+ Q+  D- Q- 
 Overall result  D- Q-  D- Q-  D- Q-  D+ Q-  D+ Q+  D- Q- 
 
Table 11-17. TOPORS x PTGDS interactions. 
Key: D+ = growth on DDO/X/A; D- = no growth on DDO/X/A; Q+ = growth on QDO/X/A; Q- = no growth 
on QDO/X/A.  
# Experiment date Results of tested interactions +ve  -ve 
  3 pBD-
TOPORS 
4 pGBKT7-N 5 pGBKT7-
M 
6 pGBKT7-
C 
1 pBD-
p53 
7 pBD-
Lam 
  pAD_PTGDS A pGADT7-
T 
A pGADT7-
T 
1 28-Oct-13  D- Q-  D+ Q+  D+ Q+  D+ Q+  D+ Q+  n/a 
2 06-Nov-13  D+ Q-  D+ Q+  D+ Q+  D+ Q+  D+ Q+  n/a 
3 12-Nov-13  D+ Q+  D+ Q-  D+ Q+  D+ Q-  D+ Q+  n/a 
4 23-Jan-14  D+ Q-  D+ Q+  D+ Q-  D+ Q-  D+ Q+  D- Q- 
5 08-Apr-14  D+ Q-  D+ Q+  D+ Q-  D+ Q+  D+ Q+  D- Q- 
6 23-Apr-14  D+ Q+  D+ Q+  D- Q-  D+ Q-  D+ Q+  D- Q- 
 Overall result  D+ Q-  D+ Q+  D+ Q-  D+ Q-  D+ Q+  D- Q- 
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Table 11-18. TOPORS x PSMC1 interactions. 
Key: D+ = growth on DDO/X/A; D- = no growth on DDO/X/A; Q+ = growth on QDO/X/A; Q- = no growth 
on QDO/X/A.  
# Experiment date Results of tested interactions +ve  -ve 
  3 pBD-
TOPORS 
4 pGBKT7-N 5 pGBKT7-
M 
6 pGBKT7-
C 
1 pBD-
p53 
7 pBD-
Lam 
  GpAD_PSMC1 A pGADT7-
T 
A pGADT7-
T 
1 28-Oct-13  D+ Q-  D+ Q-  D+ Q+  D+ Q+  D+ Q+  n/a 
2 06-Nov-13  D+ Q-  D+ Q-  D+ Q+  D+ Q+  D+ Q+  n/a 
3 12-Nov-13  D+ Q+  D+ Q-  D+ Q+  D+ Q+  D+ Q+  n/a 
4 23-Jan-14  D+ Q+  D- Q-  D- Q+  D- Q+  D+ Q+  D- Q- 
5 08-Apr-14  D- Q-  D+ Q-  D+ Q-  D- Q-  D+ Q+  D- Q- 
6 23-Apr-14  D+ Q-  D+ Q+  D+ Q-  D+ Q-  D+ Q+  D- Q- 
 Overall result  D+ Q-  D+ Q-  D+ Q+  D+ Q+  D+ Q+  D- Q- 
 
11.10 ALIGNMENT OF PROTEIN-CODING PTGDS ISOFORMS 
The sequence of the immunogen, used to generate the antibody against PTGDS (sc-30067, 
Santa Cruz Biotechnology), corresponds to the PTGDS isoform 001 (Figure 11-50). Alignments 
with isoforms PTGDS-004 and PTGDS-005, found to be expressed in human retina, were given 
in section 5.3.1.2 of Chapter 5. Alignments with isoform PTGDS-001, pulled out from the Y2H 
screen, and found to be expressed in the retina, as well as aligmnets with isoforms PTGDS-003 
and PTGDS-008, found to not be expressed in human retina, are shown below. 
 
 
Figure 11-50. The sequence of the immunogen, used to generate the antibody against PTGDS (sc-30067, 
Santa Cruz Biotechnology), corresponds to the PTGDS isoform 001. 
The highlighted conflict corresponds to a silent change in a codon for threonine. 
 
  
Identification of Interacting Protein Partners of TOPORS in the Retina   ||   Barbara Czub 
PhD Thesis 2015   ||   Appendix    - 487 - 
 
 
Figure 11-51. The sequence of the immunogen, used to generate the antibody against PTGDS (sc-30067, 
Santa Cruz Biotechnology), aligns approximately with the N-terminal half of PTGDS isoform 003. 
The red highlighted conflicts represent dissimilarities between the sequence corresponding to 
the PTGDS immunogen, and the the sequence of isoform 003. 
 
 
Figure 11-52. The sequence of the immunogen, used to generate the antibody against PTGDS (sc-30067, 
Santa Cruz Biotechnology), shows virtually no alignment with PTGDS isoform 008. 
The red highlighted conflicts represent dissimilarities between the sequence corresponding to 
the PTGDS immunogen, and the the sequence of isoform 008. 
 
11.11 POSTERS PRESENTED AT SCIENCE CONFERENCES 
Abstracts and size-reduced copies of the four posters, listed on page 4 (Publications), are 
presented on the following pages. 
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Title: Identification of Interacting Protein Partners of TOPORS in the Retina 
Authors: Barbara Czub1, Amna Shah1, Giovanna Alfano1, Lourdes Valdes Sanchez2, Christina 
Chakarova1 and Shomi S. Bhattacharya1, 2  
1Institute of Ophthalmology, UCL, London EC1V 9EL, UK 
2 Department of Cell Therapy and Regenerative Medicine, Andalusian Molecular Biology and 
Regenerative Medicine Centre (CABIMER), Avda. Americo Vespucio, Seville 41092, Spain 
 
Purpose: Retinitis pigmentosa (RP) is a clinically and genetically heterogeneous disease 
characterised by loss of rod photoreceptors. Historically genes linked to RP were associated 
with rod-specific functions. Recently a novel class of ubiquitously expressed causative genes 
emerged including splicing factor genes and TOPORS. To date studies show TOPORS is 
expressed in all tested human tissues including retina and localises to several compartments of 
the cell. However, mutations in TOPORS only cause RP (no systemic symptoms); this may be 
due to retina-specific protein interactions, which are perturbed as a result of mutations. This 
work aims to understand why mutations in this ubiquitously expressed gene cause a retina-
only disease by identifying interacting partners of TOPORS from human retina. 
Methods: Human retinal cDNA library was constructed from total retinal cDNA directly in Y187 
S.cerevisiae yeast strain by homologous recombination in-frame with GAL4 AD. Retina-
specificity was validated by sequencing. Bait plasmids (full-length TOPORS and deletion 
constructs) were cloned in-frame with GAL4 BD. The library was screened for protein 
interacting partners of TOPORS using MatchmakerTM Gold Yeast Two-Hybrid (Y2H) System. 
Results: Library validation identified several retina-specific genes including RHO (NM_000539). 
Over 107 cDNA clones were subsequently screened, leading to isolation of 53 potential 
interactions. The identified peptides were prioritised for further evaluation and re-tested in 
yeast leading to identification of three candidates: A brain prostaglandinD2 synthase (PTGDS; 
NM_000954) highly expressed in the retina, previously suggested to play a role in retinal 
homeostasis; regulatory subunit 4 of the 26 S protease (PSMC1; NM_002802) conferring 
substrate specificity to the proteasome complex during degradation of ubiquitinated proteins; 
and a soluble fragment of integral membrane protein 2B (ITM2B; NM_0219999) previously 
linked to neurodegenerative disorders. 
Conclusions: The Y2H screen identified potential interacting partners of TOPORS and, following 
validation experiments, three distinct proteins were selected for further studies. Defining their 
roles will help elucidate the functions of TOPORS as well as better understand 
the photoreceptor cell biology. The outcomes could help explain how mutations in TOPORS 
result only in RP despite its ubiquitous expression and multifunctional character. 
  
Identification of Interacting Protein Partners of TOPORS in the Retina   ||   Barbara Czub 
PhD Thesis 2015   ||   Appendix    - 489 - 
 
 
Identification of Interacting Protein Partners of TOPORS in the Retina   ||   Barbara Czub 
PhD Thesis 2015   ||   Appendix    - 490 - 
 
Title: Characterisation of associations between TOPORS and selected interacting protein 
partners  
Authors: Barbara Czub1, Amna Shah1, Giovanna Alfano1, Lourdes Valdes Sanchez2, Berta De La 
Cerda Haynes2, Christina Chakarova1 and Shomi S. Bhattacharya1, 2  
1Institute of Ophthalmology, UCL, London EC1V 9EL, UK 
2 Department of Cell Therapy and Regenerative Medicine, Andalusian Molecular Biology and 
Regenerative Medicine Centre (CABIMER), Avda. Americo Vespucio, Seville 41092, Spain 
 
Purpose: A novel class of genes implicated in Retinitis Pigmentosa (RP) has recently emerged 
including splicing factor genes and TOPORS. To date studies show mutations in TOPORS only 
cause RP despite ubiquitous expression; this may be due to retina-specific protein interactions, 
which are perturbed as a result of mutations. We previously identified several protein 
interacting partners of TOPORS, one of which has also recently been shown to be implicated in 
autosomal dominant inherited retinal dystrophy. This work aims to elucidate which protein 
domains of TOPORS mediate these interactions. 
Methods: TOPORS deletion constructs (Figure 1) were cloned in-frame with GAL4 BD. Genes of 
interest were amplified from human retinal cDNA (from human retina total RNA, Clontech) and 
cloned in-frame with GAL4 AD. Direct interactions between each identified interacting partner 
and individual fragments of TOPORS, corresponding to each of the deletion constructs, were 
tested in yeast.  
Results: TOPORS interacting partners identified by yeast two-hybrid screen include:  
prostaglandinD2 synthase highly expressed in the retina (PTGDS); regulatory subunit 4 of 
the 26 S protease (PSMC1); soluble fragment of integral membrane protein2B (ITM2B) 
originally linked to neurodegenerative disorders and recently associated with inherited retinal 
dystrophy. Co-immunoprecipitation experiments for each interactant validated association 
with full-length TOPORS. Preliminary experiments in yeast with short TOPORS fragments were 
performed with p53, a known interactant of TOPORS, which showed strongest interaction with 
the TOPORS middle fragment, as opposed to either the N- or C-terminus fragments. The 
domains involved may reflect the role(s) of the interacting proteins.  
Conclusions: The Y2H study helped identify domains of TOPORS, which may be involved in 
mediating interactions between TOPORS and the identified interacting partners. Results 
contribute towards understanding the relationship between the interactants and TOPORS in 
the retina. Characterising these interactions in more detail will help elucidate their putative 
function(s) in the retina. The outcomes could help explain how mutations in TOPORS result 
only in RP despite its ubiquitous expression and multifunctional character. 
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Title: ITM2B, implicated in familial dementias and retinal dystrophy, associates with ciliary-
centrosomal protein, TOPORS 
Authors: Barbara Czub1, Amna Shah1, Przemysław Kruczek1, Giovanna Alfano1, Christina 
Chakarova1 and Shomi S. Bhattacharya1  
1Institute of Ophthalmology, UCL, London EC1V 9EL, UK 
 
Purpose: TOPORS (MIM 609507) is a ubiquitously expressed gene implicated in autosomal 
dominant retinitis pigmentosa (RP [MIM 268000]); mutations are known to cause only RP with 
no systemic symptoms. We performed yeast two-hybrid (Y2H) screens of human retinal cDNA 
libraries to identify proteins interacting with TOPORS, which could explain the restricted 
phenotype. This led to the isolation of a soluble fragment of integral membrane protein 2B 
(ITM2B [MIM 603904]), mutations in which are associated with inherited forms of dementia 
and, most recently, a dominant form of retinal dystrophy. 
Methods: MatchmakerTM Gold Y2H System (Clontech) was used for library screening and 
testing direct protein-protein interactions (PPIs). Results were validated in HeLa and hTERT-
RPE1 (RPE1) cell extracts by co-immunoprecipitation. Immunofluorescence methods were 
used for co-localisation studies in RPE1 cells and mouse retina cryo-sections. ProteoExtract® 
Subcellular Proteome Extraction Kit (Merck) was used to prepare cellular fractions (HeLa). 
Results: The TOPORS-ITM2B PPI, identified by screening, was selected for further study due to 
the role of ITM2B in retinopathy. It was detected in complexes with TOPORS precipitated from 
HeLa and RPE1 extracts, and both proteins co-localised at the centrosome in RPE1 cells. In 
mouse retina sections the strongest ITM2B signal was observed in rod photoreceptor inner 
segment, with a weaker signal in the ganglion cell layer. Direct PPI experiments in yeast with 
artificial TOPORS fragments (corresponding to different protein domains) implied that its 
mutation hotspot region may be required for association with ITM2B. Interaction with 
the TOPORS’ RING finger region was also consistently observed, suggesting ITM2B could be 
modified by ubiquitination. Preliminary Western blot results suggest differential expression of 
proteolytically cleaved ITM2B peptides in cellular fractions. 
Conclusions: ITM2B is a novel interacting partner of TOPORS; defining the cellular processes in 
which they both associate could explain their roles and the phenotypes resulting from their 
mutations. Furthermore, evaluation of their relationship could lead to a better understanding 
of neurodegeneration mechanisms overall. Subsequent work will aim to delineate the roles of 
the various ITM2B peptides, generated by physiological proteolytic cleavage of the membrane-
bound precursor protein, which could clarify the centrosomal co-localisation with TOPORS. 
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Title: Prostaglandin-D2 synthase localises to centrioles and primary cilium, and interacts with 
TOPORS, implicated in retinal ciliopathy 
Authors: Barbara Czub1, Amna Shah1, Przemysław Kruczek1, Giovanna Alfano1, Christina 
Chakarova1 and Shomi S. Bhattacharya1  
1Institute of Ophthalmology, UCL, London EC1V 9EL, UK 
 
Objective: Prostaglandin-D2 synthase (PTGDS; MIM#176803) is a novel protein-partner of 
TOPORS (TOPORS; MIM#609507), a ubiquitously expressed nuclear and ciliary protein, 
implicated in retinitis pigmentosa. This study investigated the localisation of PTGDS and its 
potential mechanism-of-association with TOPORS. 
Methods: Yeast two-hybrid screens, using TOPORS as bait, were performed against human 
retinal cDNA libraries. Validation and interaction-characterisation were performed in yeast, 
and by co-immunoprecipitation (co-IP) from HeLa cell extracts. Co-localisation studies were 
performed in hTERT-RPE1 cell line, and in murine retina cryo-sections. PTGDS expression was 
validated by RT-PCR. 
Results: Co-IP demonstrated PTGDS was found in endogenous protein complexes with 
TOPORS, whereas in yeast PTGDS interacted most strongly with TOPORS’ residues 1-380, 
comprising the RING-domain conferring its E3-ubiquitin-ligase activity. PTGDS co-localised with 
TOPORS, and centriolar markers in dividing cells, and was observed at basal body and 
along ciliary axoneme in ciliated cells. In mouse retina PTGDS was observed in several cell 
layers, partly overlapping with TOPORS in the photoreceptor layer. In human retina, RT-PCR 
studies demonstrated expression of several PTGDS isoforms.  
Conclusions: PTGDS, a novel component of the primary cilium, could be involved in centriolar-
ciliary homeostasis. This putative role of prostaglandin synthases, is additionally supported by 
independent findings on the role of prostaglandin-E2 in ciliogenesis. Results suggest TOPORS 
could regulate PTGDS levels at the cilium by marking it for degradation by the ubiquitin-
proteasome system, providing a basis for understanding the retinal ciliopathy associated with 
TOPORS mutations.  
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